cell_line_id,drug_id,response
SKM-1,9825149,0.9402099583911157
A4/Fukuda,44137675,1.307300702935143
SNU-308,11404337,1.2327957985917497
SET-2,3081361,2.3239444576412995
HARA [Human squamous cell lung carcinoma],9907093,5.03391680027973
GOS-3,9911463,4.370946765627494
BT 248,24779724,5.957496049021181
CA46,216468,1.7849524837603168
Hs 683,10427712,4.853333023483971
ESS-1,selumetinib-MK-2206 (8-1 mol-mol),3.588494409489328
TE 617.T,168312962,2.958125582565616
H-STS,navitoclax-pluripotin (1-1 mol-mol),-0.8846642449593193
NU-DHL-1,3136844,3.805099216127406
BT 330,6918638,2.094290704712354
BT 330,439501,-3.680620250809701
CML-T1,119607,4.0157878157192375
BT 328,5329102,2.931007183375298
AU565,5494449,3.8187307918252262
PaTu 8988s,16219061,4.781688826460346
SNU-1272,1750826,-1.393591916045707
HCC2218,BRD-A02303741-navitoclax (2-1 mol-mol),3.8967353048757394
HEC-151,15953870,3.67347109220223
BT 248,24889392,1.8419989874192408
YH-13,17755052,1.8478012162745872
LCLC-103H,5329102,3.4078908422932623
BT 504,3101542,4.410397106007866
RERF-LC-Ad2,16659841,4.34581560235471
EJM,10296883,2.9448984253361057
LoVo,selumetinib-GDC-0941 (4-1 mol-mol),0.7605582392782264
KYSE-70,135398516,2.3739819683449697
CA46,44491742,3.801952242992866
SNU-1214,5282054,3.5501375835129756
YH-13,285033,-0.9199224136230332
SNU-308,4259181,0.5010319397561465
RERF-LC-A1,6610355,4.628296118847641
CML-T1,56963564,-0.6939066710243597
AN3-CA,56649450,1.7999761644788916
PE/CA-PJ49,10113978,4.077453278392179
CA46,9549297,1.0960598621603344
AN3-CA,4521392,6.410981335600101
KMS-20,5335621,4.346191921531872
Raji,73707438,3.789338953981761
YH-13,24856436,1.6547595238479382
LNCaP clone FGC,4705,3.099970805518314
AN3-CA,6450551,0.9036335088039008
HCC2218,16065773,1.4581065516563485
SNU-1272,445643,4.475083566650203
KYSE-410,409805,4.5262440773568
BT 504,selumetinib-UNC0638 (4-1 mol-mol),3.744065757918503
ML-1 [Human thyroid carcinoma],6505803,-0.5261965004955029
BT 330,6918328,1.744082398516909
SET-2,navitoclax-pluripotin (1-1 mol-mol),-1.6885811961175636
NCI-H1395,5281672,6.220750867773061
ML-1 [Human thyroid carcinoma],10385095,1.881738472046862
IST-Mes1,135440466,1.140650487435685
Raji,60700,-1.0505645112477118
IST-Mes1,16736978,2.528104664048346
PaTu 8988s,11175137,3.15610689750579
OAW28,2858523,3.071437644261336
Hs 683,52912189,4.080493710637406
ESS-1,387447,-5.037795986549112
KMBC-2,selumetinib-MK-2206 (8-1 mol-mol),1.3312821672012836
NCI-H2172,9911463,3.8994270098936745
SEM,54143018,-0.980630372208269
KP-4,12001922,1.8310999373499832
PaTu 8988s,11964036,1.6421369085466544
HARA [Human squamous cell lung carcinoma],446155,2.5576922800664006
IST-Mes1,16720766,0.7299606902549882
OAW28,selumetinib-vorinostat (8-1 mol-mol),2.294734084050853
KMRC-2,46907787,4.616997253710001
BT 330,vorinostat-navitoclax (4-1 mol-mol),1.1563637796794242
BFTC-909,123631,2.8792987518934403
CML-T1,24951314,-0.110872768404616
AU565,25154868,3.4836730381065424
KMS-27,doxorubicin-navitoclax (2-1 mol-mol),-3.301354518616035
NCI-H1395,5282054,4.370285426965396
HuT 78,vorinostat-navitoclax (4-1 mol-mol),0.0137878809652615
KP-4,6450551,1.734325636888487
SW1990,25161177,4.580361629509595
MM1.S,24753719,4.473744821146246
PE/CA-PJ34 (clone C12),2746,3.651379195242312
Ku812,1242560,2.376914084475441
NCI-H1395,5278396,4.323134607051869
HSC-4,9935249,3.700870290975298
NCI-N87,176870,1.1060804163410003
SK-N-AS,4705,3.5227875242438103
SKM-1,23635314,-2.3855466073838913
Kasumi-2,6450551,0.5816635943537883
Ku812,2841722,3.36819681330492
SEM,44620216,4.3298868043431975
ESS-1,241158,3.69128431914065
BT 330,2949965,2.2304640179968827
Aska-SS,19582717,3.474703226130623
OE21,doxorubicin-navitoclax (2-1 mol-mol),-0.7978006740829118
SEM,54596558,4.142091338652408
IST-Mes1,3503,2.9550990055374413
LoVo,89928392,0.5944678691764933
NCI-H1395,9803433,5.44811246769085
SKM-1,159324,-1.3530804275700197
Ku812,4788,3.899894541585596
MM1.S,9908783,5.963347561700224
KYSE-70,2749,2.2442090130660577
HuT 78,10385095,0.3743213193570641
TE-15,262093,3.281434334474844
OE21,9825149,2.195531408914893
RERF-LC-Ad2,piperlongumine-MST-312 (1-1 mol-mol),2.0244589143138763
OAW28,135411,2.218427323792269
TE-15,15953870,1.748445900477018
NCI-N87,46199207,2.9512504868324565
KP-4,tretinoin-carboplatin (2-1 mol-mol),4.750587250577382
H-STS,148124,4.085792664518574
ML-1 [Human thyroid carcinoma],46199207,3.5690585114534024
HMCB,JQ-1-vorinostat (2-1 mol-mol),1.2235343393627285
SET-2,4477,0.5083274914311526
WM983B,46215462,1.6111393376429497
HARA [Human squamous cell lung carcinoma],675434,4.319126364052166
KMS-27,selumetinib-GDC-0941 (4-1 mol-mol),-1.985163652094814
D283 Med,53495165,-4.057226120074279
EJM,erlotinib-PLX-4032 (2-1 mol-mol),3.5502108693148973
BT 139,12003241,-0.7824976089919207
CML-T1,135440466,1.4712310181015782
A4/Fukuda,2708,3.0461577581065007
LNCaP clone FGC,208908,1.9496007840678085
SNU-308,984333,1.720970386122563
RPMI-7951,426756,3.7939477986224786
OAW42,44491742,3.912370337658794
SW1990,53495165,-0.9290580990156484
TE 617.T,44607530,-0.1464450418354875
EJM,12001922,1.7275636633087754
PaTu 8988s,45279963,3.4965151761067985
KYSE-410,11497983,3.552400835840505
SNU-308,24772860,-1.8975415647068492
SW1990,11497983,4.192407052388532
OAW28,23582824,0.6142488529896691
Kasumi-2,2871966,-1.247169917955711
SK-MEL-1,16038120,1.941639255788896
BT 328,5470400,1.931366636892646
A4/Fukuda,11626560,-1.03034976821798
NCI-H2110,JQ-1-navitoclax (2-1 mol-mol),2.104417955521832
KYSE-70,637858,2.812350468450961
SNU-1272,6610216,4.610007140028073
A4/Fukuda,6914657,-5.308594861321554
BT 139,selumetinib-GDC-0941 (4-1 mol-mol),0.4945119496988254
TE 617.T,89183176,5.544457080682588
HuT 78,49766530,-1.6423396691241603
HuT 78,1566236,0.8672075486868017
SNU-1272,25195348,5.361331640653284
KMS-27,387447,-5.343247809144446
KMBC-2,241158,4.749872704815576
PE/CA-PJ49,16725315,3.2704146260359335
BT 320,64971,4.224921006781723
HSC-4,tanespimycin-gemcitabine (1-1 mol-mol),-4.488052486534361
LNCaP clone FGC,54678924,0.8118061161726199
BT 139,selumetinib-BRD-A02303741 (4-1 mol-mol),7.331254221783839
OAW28,navitoclax-pluripotin (1-1 mol-mol),-0.843922258994718
HCC2218,136227924,2.978872567688762
BFTC-909,82146,3.493415453952883
EJM,6505803,0.0546883993617254
SK-LMS-1,5113032,4.854711943911216
ESS-1,168312962,3.040527705732362
GOS-3,SNX-2112-bortezomib (250-1 mol-mol),-0.0982198118702868
Kasumi-2,46907787,-1.0712711351942366
NCI-H2081,409805,3.646579192169883
ESS-1,5311281,1.2479290608780562
PE/CA-PJ34 (clone C12),serdemetan-SCH-529074 (1-1 mol-mol),2.712414122638107
IST-Mes1,9911463,4.127098730346426
KMS-27,15983966,-4.691446519193063
PE/CA-PJ34 (clone C12),selumetinib-tretinoin (2-1 mol-mol),1.4850534564898672
SNU-8,46191454,1.2400504834841688
TE 617.T,50905018,4.442001170768214
Hs 683,navitoclax-birinapant (1-1 mol-mol),2.3623030418922566
LNCaP clone FGC,5470400,-1.212361408528563
SNU-1033,1750826,-3.4063740524017785
NU-DHL-1,24964624,0.3458888815745198
SNU-308,9911830,3.1003297251909845
RERF-LC-Ad2,4578,5.041786487447376
HSC-4,BRD-A02303741-navitoclax (2-1 mol-mol),3.4165254570204953
CML-T1,11404337,-1.4571467715346416
PaTu 8988s,3081361,-0.9003151729601504
Aska-SS,5460769,3.7674682150871552
HEC-151,7326481,2.637733193864536
SW1990,4096211,2.802021609981973
BT 330,11485656,2.0154555749445486
NCO2,3025986,-2.0734101496529815
EJM,54626689,4.594595753018125
BT 330,16659841,3.5039239914317255
NCO2,5311281,1.122869431667234
KMBC-2,46224516,3.7476992828736737
OAW28,2871966,-1.501513911524366
H-STS,3062316,1.2556156573704025
MM1.S,675434,3.752127211451784
PE/CA-PJ34 (clone C12),carboplatin-etoposide (40-17 mol-mol),3.8374450875844297
BT 139,5494449,2.762901803316331
KMBC-2,44607531,1.206215949573423
PaTu 8988s,24775005,3.785412045398248
Hs 683,10385095,1.154404132181591
BFTC-909,25262965,-1.7887871070762158
LNCaP clone FGC,49766530,1.5259250948267933
TE-15,11238147,1.9681475739859464
RERF-LC-Ad2,46398810,3.2113913243121757
Ku812,25183872,-1.9764593240115311
CML-T1,11167602,0.5863351465273275
SW1990,doxorubicin-navitoclax (2-1 mol-mol),-0.7027617594545444
HMCB,387447,-4.760692258076148
PE/CA-PJ34 (clone C12),25150857,2.980955844336646
D283 Med,JQ-1-vorinostat (2-1 mol-mol),0.6259651679916352
HuT 78,9826308,-1.5248554066187403
OAW28,navitoclax-piperlongumine (1-1 mol-mol),0.6841862022765504
SK-LMS-1,24753719,4.4754402870161485
TE-15,135440466,2.1391462006279216
GOS-3,136227924,2.1351760440562533
HEC-151,3465537,1.222208329394757
SK-MEL-1,44589607,3.053518412675279
NCI-H2081,selumetinib-MK-2206 (8-1 mol-mol),3.504748246371747
Hs 683,54613361,-1.1051240356391956
ML-1 [Human thyroid carcinoma],16219061,3.525142786131821
Ku812,54619238,3.9506340253533834
OAW42,441298,3.384860231550553
HCC2218,5738263,2.5233825878614193
KMBC-2,400769,-0.6422603462472702
D283 Med,44491742,3.738153910971064
RERF-LC-A1,4477,-0.4420916601265455
Ku812,73707440,4.534867519967767
RERF-LC-A1,11626560,2.2424599405609076
AN3-CA,6918837,-2.3890611994888293
OAW42,24856436,0.6195624958195651
OAW28,JQ-1-carboplatin (1-1 mol-mol),2.7763585253391625
SNU-308,11152667,0.4634525960285107
KMBC-2,16720766,1.1424969689441744
KMBC-2,122327,5.100342441776212
SNU-1033,6918638,0.9929294920003592
IST-Mes1,4477,0.8135431021107292
HuT 78,52912189,-0.7415735278682234
SEM,44607530,0.9041857053195362
HARA [Human squamous cell lung carcinoma],17755052,1.9898088824831797
RPMI-7951,60750,-3.7488570048538254
BFTC-909,2733526,3.41724914482818
RERF-LC-A1,16741245,1.6773420649420734
RERF-LC-A1,crizotinib-PLX-4032 (2-1 mol-mol),2.1725748432396816
MM1.S,tanespimycin-gemcitabine (1-1 mol-mol),-5.682330250440317
AU565,4259181,-0.781957409712965
SNU-8,docetaxel-tanespimycin (2-1 mol-mol),-4.581039340886612
CML-T1,11964036,0.6626338262041811
HuT 78,227681,1.5978856071996634
A4/Fukuda,12003241,-4.192136354440014
HSC-4,5470400,-1.775367561967962
Raji,135421197,1.3656726509446273
CML-T1,16720766,-1.7114419714530344
OE21,107985,-4.136076680497118
ML-1 [Human thyroid carcinoma],168312962,4.623396193395582
SKM-1,6438330,1.742877849242422
NCI-H1092,36462,1.746172568826328
TE 617.T,9840324,5.809707926516217
YH-13,5738263,3.9080181125060496
SK-LMS-1,11152667,1.335730322583835
D283 Med,5311,-0.2786348864571751
SNU-8,5329102,2.2855954751690692
NCI-N87,42642645,0.5523493290598761
SK-N-AS,1750826,-1.7798677806747554
AU565,46843906,2.01919943296107
BFTC-909,10074640,3.0053798884123837
Hs 683,241158,4.572594529470727
RPMI-7951,16725315,3.4897623746856308
HEC-151,51039095,3.2248906020910444
EJM,126941,1.4597619440351868
OAW42,JQ-1-navitoclax (2-1 mol-mol),2.2376010038870615
SNU-1214,54619238,4.665437411925521
HMCB,44620216,3.75907635673166
OAW28,72193861,2.7871547903709266
A4/Fukuda,53232,1.4709221708336295
SW1990,9866186,-0.356042877423586
YKG-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.005827491367844
SKM-1,387447,-5.418764341651642
CML-T1,23725625,2.2812581172519124
SNU-1272,11609586,3.189761140355052
AU565,46398810,1.9802808058059196
Hs 683,6918837,-3.551122123117506
JIMT-1,49850262,3.8130852207198314
SKM-1,3854666,-0.271294085602593
OE21,SNX-2112-bortezomib (250-1 mol-mol),-2.31253131529281
Aska-SS,10385095,1.4450418871576047
HCC2218,5351362,1.9073731200214807
BT 504,1242560,3.5601475900474124
CML-T1,16736978,1.2014198902848654
NCI-H1092,JQ-1-UNC0638 (2-1 mol-mol),3.1709081396689496
LCLC-103H,docetaxel-tanespimycin (2-1 mol-mol),-3.9002676474542537
NCI-H2110,44462760,4.189023964938422
WM983B,5280436,2.836316939935807
WM983B,9549297,3.964303436890225
SK-N-AS,11656518,2.3375831359332704
SET-2,9952709,2.441958952741518
A4/Fukuda,148124,-6.6912736941139865
NCI-N87,sirolimus-bortezomib (250-1 mol-mol),-1.2024587113239409
PE/CA-PJ49,10074640,3.2196511192392254
MM1.S,68056272,3.565537338229292
TE-15,16065773,3.2085213823347094
A4/Fukuda,9826308,-1.4955537783248567
A4/Fukuda,66577038,2.118562328013949
NCI-H1092,44237094,3.0131214117675835
LCLC-103H,16038120,1.6751985461646637
WM983B,568763,1.6629042583878648
NCI-H1395,JQ-1-MK-0752 (1-1 mol-mol),2.3863379692228976
SET-2,10385095,0.921007815514528
SNU-308,selumetinib-UNC0638 (4-1 mol-mol),3.862265734158656
BT 504,4788,5.87427610868987
SEM,46398810,0.2793522314631458
YKG-1,24901704,4.300110329432471
Hs 683,82146,4.206888158378674
KMS-27,15953870,3.4686718283353453
NCI-H2172,60700,2.910113972841169
OAW28,selumetinib-UNC0638 (4-1 mol-mol),3.3800048421879314
BT 328,7251185,2.5751215328420676
NCI-H2110,24785538,0.2009701166765833
LoVo,135421197,2.0078610802467307
Kasumi-2,60700,-3.733340750045026
TE-15,1242560,2.8326724591930517
Hep-G2,6505803,-2.5933743398692894
LNCaP clone FGC,151289,1.132388420767888
MCAS,11404337,-0.3191442981427469
KMS-20,24180719,3.3038292759957404
TE 617.T,54678924,4.605608720275873
CA46,49793307,-4.01311922110524
NCI-N87,44632017,1.346248550233927
BT 330,UNC0638-navitoclax (1-1 mol-mol),2.829713529856627
D283 Med,9826308,-0.3808520436039156
SET-2,11647372,1.3402152078110998
Ku812,148198,-4.150507844489635
BT 330,24180125,2.435960640097673
KMRC-2,5328940,2.384373805479353
AU565,135999136,4.178255303593246
NCI-H2172,9907093,5.645738343072073
NCO2,selumetinib-UNC0638 (4-1 mol-mol),0.7842678664675523
BT 139,44462760,4.266077088931013
WM983B,JQ-1-UNC0638 (2-1 mol-mol),1.0710090735153637
PE/CA-PJ34 (clone C12),46215462,1.5577121166656367
HCC2218,10127622,4.243973317573093
CML-T1,44259,0.1754844857900887
KMS-20,5566,2.852625231328134
LoVo,25022340,4.929882293123705
Ku812,2729026,1.365537555600546
KMS-20,selumetinib-decitabine (4-1 mol-mol),0.7829332375750434
SW1573,3503,1.662872296112478
D283 Med,107970,1.5899675113879286
BT 328,57519531,5.35390801053985
BT 248,9952709,2.726522372177628
AN3-CA,piperlongumine-MST-312 (1-1 mol-mol),0.9520021063279038
SK-N-AS,462382,-0.2333401047950518
SKM-1,11626560,0.5030232412556168
BT 328,3503,3.047903158140159
NCO2,5278396,2.5703556103296004
NU-DHL-1,11964036,-0.3211090677795742
YH-13,67156097,-1.843734712267085
SK-N-AS,10296883,4.111462357552098
KP-4,24785538,0.469913223575538
MCAS,5291,3.577669160991793
HEC-151,6917907,-8.293051303885992
OAW42,24901704,4.087174271461636
BT 330,11625818,5.530530948719102
TE-15,72193861,-1.1257441377745852
Hs 683,5460769,1.3545224877290158
PE/CA-PJ34 (clone C12),24785538,-0.2008088807094913
HSC-4,6914657,-3.070952064512468
TE 617.T,73707398,0.9549107621752264
AN3-CA,11494412,0.238688631284878
LNCaP clone FGC,969516,2.7285158421956677
HARA [Human squamous cell lung carcinoma],11647372,1.8404588933860024
PaTu 8988s,285033,-3.9117222428012535
IST-Mes1,selumetinib-PLX-4032 (8-1 mol-mol),4.413511328522001
KMBC-2,613753,3.2512958056393195
TE 617.T,selumetinib-decitabine (4-1 mol-mol),4.124849218027814
SK-MEL-1,9926054,2.8910201246716403
OAW28,656346,0.8948255988542453
SK-N-AS,15547703,3.148981466991298
BT 504,168312962,2.8687881561582587
NCI-H2110,25262965,-3.5486036305483752
NCO2,969516,2.466737247840222
SNU-1033,10410894,4.578281873924552
PE/CA-PJ49,3503,2.351778774467552
CML-T1,navitoclax-pluripotin (1-1 mol-mol),-4.409543307902375
SW1990,5328940,1.5130831907204647
BT 330,11612883,3.1615690662749083
KP-4,4261,3.627604600241331
H-STS,1242560,3.458516939321499
TE-15,selumetinib-tretinoin (2-1 mol-mol),1.8436837111735784
NCI-H1092,selumetinib-GDC-0941 (4-1 mol-mol),3.727074735978538
GOS-3,9907093,6.267214731972656
BT 328,73707438,3.7767552618386087
SNU-1214,54619267,2.8943239784785817
A4/Fukuda,24821094,2.016569070962388
WM983B,6918736,-0.0813201806037856
IST-Mes1,409805,5.880779442140838
BT 330,168313200,1.8051222028456737
PaTu 8988s,57519531,4.239533170435924
SKM-1,6852167,1.599440768743568
KMRC-2,4705,3.2105980144700004
KYSE-70,11507802,1.463595053056406
EJM,6918878,1.483002003508878
HMCB,1242560,3.0802534848210947
BFTC-909,4788,5.986704833543041
SK-LMS-1,3062316,2.9928105534026774
Hep-G2,9911463,3.8113421260686735
A4/Fukuda,5282054,2.418862118344995
ML-1 [Human thyroid carcinoma],3465537,2.728802739434878
Kasumi-2,11238147,1.8873340406507049
EJM,24856436,-1.4562249201698472
KMS-20,4261,-1.121015461502452
D283 Med,9967941,4.476390135887204
NU-DHL-1,71466578,1.9656918552747795
KP-4,vorinostat-navitoclax (4-1 mol-mol),2.553754020508292
RERF-LC-Ad2,46199207,3.5588718766495564
RERF-LC-A1,piperlongumine-MST-312 (1-1 mol-mol),1.32641148018266
KYSE-70,10410894,6.372300696648814
WM983B,navitoclax-gemcitabine (1-1 mol-mol),-1.476079449126547
AN3-CA,9840324,5.532669136405244
MM1.S,12001922,1.2922454576478266
KMS-20,54596558,3.850002617797552
Hep-G2,navitoclax-gemcitabine (1-1 mol-mol),1.7377855458966929
HMCB,44185566,3.1081163889895107
MM1.S,23725625,4.074862026328633
MCAS,alisertib-navitoclax (2-1 mol-mol),1.883780422351886
TE 617.T,selumetinib-piperlongumine (8-1 mol-mol),3.275728050255235
BT 504,5287969,-1.6457769609710884
RERF-LC-A1,2733526,3.3878111587349915
CA46,216239,1.3191761483145148
BT 330,selumetinib-BRD-A02303741 (4-1 mol-mol),4.602699425351198
LCLC-103H,3062316,4.5172002478583035
HMCB,navitoclax-sorafenib (1-1 mol-mol),1.4210675529122485
HSC-4,24771867,2.9499855440491243
D283 Med,11612883,1.593543211602983
MM1.S,11964036,-0.3067716332960522
ESS-1,docetaxel-tanespimycin (2-1 mol-mol),-6.30643911780066
BT 504,3854666,0.6653491549199024
OAW28,1641662,3.6011202742070014
OAW28,73707398,1.2451215877479735
NCI-H2110,462382,1.2289410171017607
SKM-1,9936388,-5.746280121163761
PE/CA-PJ34 (clone C12),selumetinib-piperlongumine (8-1 mol-mol),3.000431938444702
OAW28,44185566,1.918306011480311
SNU-1214,11214940,0.7673101804446996
CML-T1,SNX-2112-bortezomib (250-1 mol-mol),-2.787489120690278
BFTC-909,44185566,2.75887016136311
LNCaP clone FGC,168312962,1.214226575768129
A4/Fukuda,4788,3.9402862208503753
Kasumi-2,56963564,-0.3250682085247875
OAW28,5281672,6.00346703144391
KMS-27,42642645,1.0749697510061529
NCO2,6918328,-1.999945125292113
PE/CA-PJ34 (clone C12),3854666,0.7943523247128464
HMCB,11178236,-3.675827592873557
SK-MEL-1,navitoclax-pluripotin (1-1 mol-mol),-4.305894973997605
PE/CA-PJ49,11427553,2.342569802533504
SW1990,56973724,4.7773565867531325
RERF-LC-Ad2,3854666,2.675858231607706
KYSE-410,2113511,6.262812466706523
SNU-8,52912189,2.5544077359525525
ESS-1,2945648,3.5685871452412137
HuT 78,10231331,-3.0866153075416376
LoVo,11609586,1.9215259939554383
JIMT-1,44202524,2.3987049802823464
SNU-1272,selumetinib-vorinostat (8-1 mol-mol),4.048227486527485
Raji,65064,3.2905729648450643
SNU-1272,168313047,3.3416788102138995
Aska-SS,5494449,2.854188753025021
HuT 78,71466445,0.6237805812301164
SW1990,2945648,2.974467829952507
HuT 78,44566777,1.359437800629114
HCC2218,446155,4.288252010402634
PE/CA-PJ34 (clone C12),613000,2.377303032798795
NCI-H1092,JQ-1-vorinostat (2-1 mol-mol),1.0867450445892073
WM983B,5284616,3.092445573518385
NCO2,6438330,0.5904048188838438
TE-15,9840324,5.5048533304021925
NCI-H2081,76446078,4.17311881830217
EJM,9936388,-8.624056137584708
OAW42,11507802,0.7828628930483126
HEC-151,675434,4.287380101646617
H-STS,3384730,2.3703448532527043
BT 139,53392493,1.7683203487497317
SNU-1033,44566777,1.4560071944280613
SW1990,25126798,3.59446918054184
ESS-1,3689413,-0.979855371465586
Hs 683,11455910,0.4733989942514576
TE-15,3634881,3.8214660125087394
A4/Fukuda,selumetinib-BRD-A02303741 (4-1 mol-mol),0.8807124285351838
LCLC-103H,119607,5.457614279333413
OE21,9866186,-0.2003776611728709
AN3-CA,25183872,-1.1882282616586746
GOS-3,selumetinib-piperlongumine (8-1 mol-mol),4.534264258970437
AU565,5978,-4.241011158819041
Ku812,57519531,1.8933058292523095
SET-2,56963564,0.295658155824717
KMBC-2,135928012,4.465224778976871
CML-T1,374536,2.401691970017444
NCI-N87,104842,-4.261750557946528
GOS-3,168313016,4.456848917287458
KYSE-410,89928392,1.6242803203582832
KP-4,11626560,0.2216664549729946
AU565,46199207,2.977397460043432
A4/Fukuda,44202524,1.0259860145116777
ESS-1,24821094,3.503483475384322
JIMT-1,selumetinib-GDC-0941 (4-1 mol-mol),2.201344491734076
PE/CA-PJ49,72193861,0.3864361123852703
SK-N-AS,selumetinib-UNC0638 (4-1 mol-mol),-0.1264847199848531
BT 320,11404337,0.6966185269279856
WM983B,11485656,1.9141384633865923
SNU-308,168313047,3.2453222840070324
IST-Mes1,25150857,2.301198962208278
KYSE-410,71466578,5.354766099813538
NU-DHL-1,49846579,4.101611336723351
NCI-H2110,11707110,1.745114004919136
CA46,17755052,1.7120394846678155
HMCB,6918837,-1.783371825238031
IST-Mes1,navitoclax-MST-312 (1-1 mol-mol),2.625426297409908
RERF-LC-Ad2,selumetinib-PLX-4032 (8-1 mol-mol),3.375421683976003
TE 617.T,3384730,2.113266542955424
SNU-308,44507138,2.844975712866042
HuT 78,9911830,2.253743254641726
SNU-1214,1750826,-1.2568858685348383
GOS-3,25183872,-0.8854682014750674
LoVo,5311,0.3380696500116906
TE-15,89183176,4.278773668184103
YKG-1,25183872,-1.2785338987258574
MCAS,54678924,2.1250047909510013
TE 617.T,2708,3.9220927277029505
NCI-H2172,9825149,2.304858157045072
SET-2,44607531,0.4466369484576992
RERF-LC-A1,54618164,3.9982996694871424
ML-1 [Human thyroid carcinoma],19582717,3.041392892734857
RPMI-7951,151289,0.7115875874342479
Aska-SS,11214940,1.7313506139966672
H-STS,6917907,-5.810162038338551
NCI-N87,89928392,0.9456157368763274
OAW28,navitoclax-piperlongumine (1-1 mol-mol),0.6841862022765504
HSC-4,9911830,2.7717739782698563
AN3-CA,9907093,3.670524814087886
A4/Fukuda,11427553,0.0702382308883879
HuT 78,6914657,-4.847386491977826
NCI-H1395,60750,-2.362742731537794
HARA [Human squamous cell lung carcinoma],409805,4.942295126142001
HMCB,12003241,-2.4987094510650834
NCI-N87,3081361,1.4568926260691408
Kasumi-2,24180125,1.6711646659047346
Hs 683,15953870,3.706668121424788
SW1990,322968,4.796232412021376
SNU-1033,10385095,1.019137651596638
Kasumi-2,4578,4.103424218787652
PE/CA-PJ34 (clone C12),16219061,2.427956187970103
HCC2218,71680916,4.066710263465823
PE/CA-PJ49,445643,3.8626930631521232
SNU-1033,9915743,1.252454153580825
SEM,26596,-3.506968001766276
OAW42,5978,-0.2771026188226049
MM1.S,navitoclax-piperlongumine (1-1 mol-mol),0.7235910010394726
CA46,piperlongumine-MST-312 (1-1 mol-mol),1.0820043516957718
OAW42,5291,3.8634582657192063
EJM,753704,3.6448847004253055
CML-T1,654092,-1.9909155078044125
NCI-H1395,selumetinib-JQ-1 (4-1 mol-mol),2.8235760807369177
SK-MEL-1,1750826,1.8310603638530116
WM983B,11507802,1.057697066285331
AU565,5328940,1.3384832652905083
HSC-4,54678924,3.092091974621669
EJM,11234052,4.536788140349876
NCI-H2110,2828334,6.053691532060519
PE/CA-PJ49,9887053,4.12500650202634
SW1990,45100481,5.275366410533853
HEC-151,25105715,3.437309931066462
KP-4,10410894,3.2867527282339233
HMCB,piperlongumine-MST-312 (1-1 mol-mol),1.358280026891677
EJM,selumetinib-piperlongumine (8-1 mol-mol),3.077035642814966
NCI-H2172,51037431,3.879120282151884
HARA [Human squamous cell lung carcinoma],3689413,3.203435099189031
NCI-H1092,25227462,1.0244248968881735
HuT 78,5470400,1.1962895680163173
HEC-151,409805,5.612668913895041
CML-T1,6917907,-6.247910968385368
ESS-1,16725315,4.522564141114606
NCI-H1395,107970,2.4345825548290265
A4/Fukuda,ISOX-bortezomib (250-1 mol-mol),-0.2493422793699864
SET-2,11656518,-0.7512695953696935
OAW28,4096211,1.5501495805084426
PE/CA-PJ49,9866186,0.6761684743809719
A4/Fukuda,3384730,1.825152720179272
BT 248,5311,3.0798190942417363
KMS-20,156414,1.093109837922788
NCI-N87,2749,1.4538564926114168
KMS-27,969516,1.8240446034664448
SKM-1,5978,-3.867045594927121
EJM,16736978,1.1744995972918135
YH-13,16725315,3.2502967771135096
GOS-3,11222830,1.7526889108260606
NU-DHL-1,6505803,0.0102011938996583
BT 328,9935249,3.0923830009934843
TE-15,216345,4.377731510791297
TE-15,11222830,1.763810814771804
SKM-1,654092,-1.7907532685480716
BT 248,11427553,3.5134734510694687
HEC-151,644241,2.1605297615214716
TE-15,135398516,2.5916064538875188
HMCB,53232,1.5068869536074645
MCAS,11175137,3.0218199031977324
LoVo,4259181,0.2045859597859785
Aska-SS,46398810,1.7944329951404463
NCI-H2110,969516,2.600500497982865
IST-Mes1,49867926,4.44564652397053
HMCB,25227462,1.4267273911688456
CML-T1,51039095,1.5406670560339248
NCI-H2081,446155,1.804477819432441
CA46,71466445,1.6737757590775906
NCI-N87,6505803,-6.101345662019038
SK-N-AS,navitoclax-PLX-4032 (1-1 mol-mol),3.5104240505298536
NCI-H1092,54596490,4.303629834820445
LNCaP clone FGC,10127622,5.349418794723568
Aska-SS,25183872,0.6675184537647518
KYSE-410,6184667,2.8740805650715404
HCC2218,11427553,3.731500730274806
SNU-8,selumetinib-decitabine (4-1 mol-mol),2.696466945642044
WM983B,400769,0.0024441220031393
NCI-N87,168312962,2.346349065468924
BT 320,11396600,4.5560356349666
KMS-27,53232,2.4317447026544254
NCO2,vorinostat-carboplatin (1-1 mol-mol),1.6155650859115178
NU-DHL-1,11317348,1.955778298078063
BT 248,16219061,2.5057647005845354
Ku812,5280436,2.864612594738688
PaTu 8988s,56963564,0.8100228770040716
YH-13,3025986,-1.231894259194408
HSC-4,11228183,2.0585180361700313
Ku812,11364421,-4.941394755779054
SW1990,72193861,3.365835430501514
BT 320,65064,6.551398782521052
PE/CA-PJ49,241158,3.9020503625286698
MM1.S,54619267,4.994237455053685
HMCB,51039095,2.359958278264178
D283 Med,11626560,0.0898695348441468
WM983B,navitoclax-sorafenib (1-1 mol-mol),1.6841830037696714
KMS-20,2749,1.3693937739963689
CA46,6610355,3.575030613446337
Hs 683,5284373,2.937845283028805
KMS-20,44543605,3.8968998395353784
RERF-LC-A1,BRD-K27188169-navitoclax (2-1 mol-mol),3.6651265228354855
AN3-CA,5280436,-0.2236746703993007
Hep-G2,tanespimycin-gemcitabine (1-1 mol-mol),-1.7096270961562854
TE 617.T,25195348,2.9786244092709704
A4/Fukuda,6918638,-1.9449982869755031
BT 504,15547703,2.935015149206738
SNU-1214,10385095,1.848528700998056
A4/Fukuda,10127622,0.8035335483112384
Hs 683,5978,-5.5766481174172675
KMS-27,9935249,2.590998934095406
LCLC-103H,serdemetan-SCH-529074 (1-1 mol-mol),2.340183164719549
KMRC-2,24821094,3.495546791316723
YH-13,44185566,3.169017423167434
CA46,3136844,3.7113001526336338
IST-Mes1,11404337,-0.5180157624887997
KMS-20,5287969,-1.7447232595261333
OAW28,4788,5.61832216329738
HMCB,5746,1.3604590054330616
BT 248,25195348,5.391578709053811
KMRC-2,9911463,4.365671191059928
KMBC-2,5329102,2.8485011824708133
KMS-20,100016,6.235059528000449
SEM,675434,3.717379386242577
HuT 78,24785538,1.710563314926326
EJM,322968,2.5237519299290687
BT 139,54618164,4.290643622410761
KMS-20,11507802,0.6395655511000325
Ku812,11222830,0.9056809830950744
BFTC-909,16115403,-3.993091010962378
HCC2218,11404337,1.2593455770198374
KMS-27,3503,1.5005311551351748
SKM-1,11222830,1.186229333087779
TE 617.T,9866186,0.80054695295052
H-STS,46191454,1.9033796822973523
A4/Fukuda,JQ-1-MK-0752 (1-1 mol-mol),-0.933197038878086
SNU-1272,52947716,-5.180719901739396
A4/Fukuda,3038522,1.5780319148667876
KYSE-410,4261,2.0189298285374724
SW1990,89928392,2.811800306716961
A4/Fukuda,72734382,2.815137004147321
NU-DHL-1,navitoclax-PLX-4032 (1-1 mol-mol),-1.9945668257516072
D283 Med,45279963,2.3359358447892093
NU-DHL-1,navitoclax-gemcitabine (1-1 mol-mol),-5.825890673866902
BT 248,3825829,4.117903271720201
WM983B,navitoclax-pluripotin (1-1 mol-mol),-1.737233366085975
MM1.S,5351362,1.350784459153801
NCO2,49793307,-4.859728816155666
SW1990,11364421,-1.7327127591081195
JIMT-1,36314,-4.734274822470357
OE21,72376,-3.060607188572333
NCI-H2110,5113032,4.667236952685056
BT 139,89928392,1.7039273106387889
KMRC-2,57519531,3.768608069014823
SK-LMS-1,2708,5.723768268048996
PE/CA-PJ34 (clone C12),216239,3.0316915626145726
LoVo,44202524,1.5416570481285088
RERF-LC-Ad2,216468,3.9552651527096065
Ku812,11427553,-0.0025143076889682
TE 617.T,15953870,3.1067145457473906
Ku812,selumetinib-decitabine (4-1 mol-mol),-3.2860234073960126
OAW28,11214940,1.4072727029323666
LoVo,9936388,-7.372990206557469
OE21,439501,-2.897438407377833
SK-LMS-1,216345,4.485314060512248
KYSE-70,25126798,3.963979956832577
CA46,135398516,0.7680931483587626
KYSE-410,9903786,4.00816844948711
Aska-SS,24797083,1.7745933427966527
NCI-N87,vorinostat-navitoclax (4-1 mol-mol),0.7685195358482984
SW1990,135421197,2.4673652362446887
KYSE-70,sirolimus-bortezomib (250-1 mol-mol),0.1222740684138433
SNU-308,439501,-2.437759024379206
NCI-N87,3025944,4.18610508240951
HCC2218,11455910,0.1685104412294276
NCI-H2081,UNC0638-navitoclax (1-1 mol-mol),0.8615686531760992
CML-T1,9825149,1.6129799202532635
OAW42,SNX-2112-bortezomib (250-1 mol-mol),1.3313369846260583
HuT 78,25062766,1.4308476674773298
PaTu 8988s,piperlongumine-MST-312 (1-1 mol-mol),3.25367846765047
HSC-4,46199207,3.2853086951025197
SW1573,6917907,-6.296104468024424
TE 617.T,71466445,3.56672644929392
SK-MEL-1,11228183,1.038779410701008
Ku812,168312962,-3.0210187912028075
Kasumi-2,9866186,-1.4043484015282397
WM983B,3038522,2.836940799869077
SNU-308,44607531,0.5379458517759286
KYSE-70,11497983,4.3699696445826035
IST-Mes1,25227462,1.492895446731939
NU-DHL-1,9549297,1.597119849266011
SNU-1214,2858523,2.9431030962515132
KP-4,9911830,2.4137773940538487
MCAS,400769,-0.8505604420726267
HEC-151,1641662,2.6005557069979703
SW1990,selumetinib-JQ-1 (4-1 mol-mol),1.814683670817831
SK-LMS-1,6917907,-5.745443884408125
NCI-H1092,5281672,3.7306069141641856
NCI-H1092,31703,-0.4568076370772141
MM1.S,71466445,1.6605389329514368
OE21,24753719,4.068797621390331
BT 320,439501,-1.927418392306892
BT 328,46398810,2.9413062884147014
BT 328,5287969,-1.46849607666092
HARA [Human squamous cell lung carcinoma],decitabine-navitoclax (2-1 mol-mol),1.7884131125603568
LNCaP clone FGC,16038120,2.90049903396662
NU-DHL-1,6918878,-0.9557667101081658
BFTC-909,BRD-K27188169,5.152610673434624
KYSE-70,208908,2.5295165235288004
MM1.S,135999136,4.602725766791159
LCLC-103H,49793307,-2.0847949302841324
HCC2218,JQ-1-MK-0752 (1-1 mol-mol),5.949338502006685
NCO2,10077130,2.3607747258114804
SKM-1,72734382,3.266871379316779
ESS-1,ISOX-bortezomib (250-1 mol-mol),0.2324495051743559
Ku812,387447,-5.271865105209625
Raji,5281672,3.9689768271377592
BFTC-909,11152667,-0.3524603871752078
AN3-CA,24180125,3.116324501416526
SK-LMS-1,56946209,-4.87344547296277
YH-13,216239,3.5317850372057875
AU565,11647372,-0.7623159020318493
MCAS,89928392,1.6246065994897545
NCI-H2172,11404337,1.861894071580906
YH-13,5278396,4.665825083326453
SET-2,navitoclax-birinapant (1-1 mol-mol),-1.2703950962736938
BT 504,136227924,2.4961671253802957
GOS-3,216345,3.7028655718770502
YKG-1,45279963,4.304411410062701
MCAS,8515,4.589748627719716
Hs 683,446155,2.4006976340909083
BT 504,9911463,3.2688065154654287
Hs 683,11612883,3.874361817357709
NCI-H2172,11364421,1.11334494051812
AN3-CA,462382,0.8052159492645975
AU565,71751553,3.982904849419344
KP-4,navitoclax-pluripotin (1-1 mol-mol),0.1818856971283002
KMS-27,6918289,2.2477856087325603
LoVo,25183872,-1.0423877479811554
A4/Fukuda,25102847,0.4372365282678318
H-STS,49766530,-3.13255748664254
SNU-1033,702558,5.237655466937512
RERF-LC-A1,637858,2.1829548820407165
Kasumi-2,3136844,3.733604332390159
WM983B,16659841,5.297201058465451
OAW28,327653,3.155680016062074
HCC2218,3503,1.2267358647117403
KMS-20,44137675,3.5747690218783075
ESS-1,10296883,4.371449070908232
SNU-8,11228183,3.906973897476982
HSC-4,984333,1.2474358256824072
LoVo,65628,4.171555925906434
D283 Med,753704,2.8717556024543067
SK-MEL-1,56946209,-1.1384330166680112
TE-15,241158,3.84144022719984
HSC-4,JQ-1-UNC0638 (2-1 mol-mol),5.303785757115223
PE/CA-PJ49,24771867,1.9864075317158347
BT 328,tanespimycin-gemcitabine (1-1 mol-mol),-0.0824560105444719
RERF-LC-A1,navitoclax-gemcitabine (1-1 mol-mol),-1.4596841524458946
PaTu 8988s,19582717,4.619699148190798
SK-LMS-1,16741245,3.6746390980011174
WM983B,11626927,4.291812085651598
A4/Fukuda,16065773,1.900447949816596
RERF-LC-A1,65628,4.427259211867234
TE 617.T,tanespimycin-gemcitabine (1-1 mol-mol),-4.604968382262146
NCI-H2081,65628,3.78371199726488
Ku812,16736978,-0.4990163142068329
TE-15,135928012,3.6935983275775537
CA46,4259181,0.0375174782651609
LNCaP clone FGC,56946209,-6.055306214745871
PE/CA-PJ49,462382,0.1339696850034375
H-STS,1566236,1.8552051664221092
HMCB,4917,3.7036802766341266
NU-DHL-1,3689413,-2.5727806443741836
CA46,44607530,1.320133740199814
D283 Med,168312962,2.205429971467616
OAW28,71466445,4.188405368682896
KP-4,24856436,0.6663554557266653
PaTu 8988s,JQ-1-carboplatin (1-1 mol-mol),3.780889611052604
PE/CA-PJ34 (clone C12),46907787,4.066257221145479
NCI-H1092,6852167,4.811360661328789
Kasumi-2,54613361,-0.9648217673530566
ML-1 [Human thyroid carcinoma],25150857,2.4072078224567486
SNU-8,9956119,2.4121257943102496
KMBC-2,navitoclax-pluripotin (1-1 mol-mol),-0.7787416964266355
LoVo,24856436,-0.7244956111709783
SEM,216239,-0.7466305411957983
TE 617.T,24771867,4.245459071859496
PaTu 8988s,54678924,4.2231984066275015
BT 330,60750,0.0644455877393972
HMCB,2874250,-4.802730295191432
Ku812,49836020,4.574644913995472
Ku812,3815108,1.773113304227131
HMCB,136227924,3.0347930044007643
NCI-H2110,71751553,4.36348548213894
OAW28,6918837,-3.92509053266304
HSC-4,135440466,2.2202939224472655
OAW42,60750,-4.426623140007549
TE 617.T,5280436,2.065282864017122
PE/CA-PJ49,9926054,1.8069972619127008
OAW42,4477,0.5575494840325266
SNU-8,44589607,2.595559159087893
NCI-H1092,44137675,4.14698117829052
WM983B,5460769,5.3340527249808005
A4/Fukuda,2874250,4.0164309105299685
SW1990,7326481,4.182711938657022
SNU-1214,25154868,4.088629107850921
NU-DHL-1,54626689,4.007312828770784
SEM,11214940,0.7713690657909067
EJM,decitabine-carboplatin (1-1 mol-mol),2.2378968674639363
SNU-8,15983966,2.284009944123205
RERF-LC-A1,6917907,-5.772603307313147
SNU-308,252682,6.464226744000865
NCO2,3543504,3.4407468951468094
AN3-CA,12003241,-2.637522524679412
BT 330,4917,2.9109712569166297
PE/CA-PJ34 (clone C12),71466578,5.659709650891852
RPMI-7951,421610,2.0128260125538797
NU-DHL-1,9868037,1.5827566273106026
HSC-4,10410894,2.7401570440851155
NCI-H2110,selumetinib-PLX-4032 (8-1 mol-mol),4.399430073640621
SNU-1214,SNX-2112-bortezomib (250-1 mol-mol),-1.2222009804045444
NCI-H2110,42642645,1.3057236795101204
KYSE-410,3062316,-1.640148197583731
KP-4,9903786,1.7495953596701077
HuT 78,11222830,0.3543354397865786
SK-N-AS,46191454,2.044058692745182
HCC2218,54143018,3.6519142988394098
Ku812,6918837,-4.505214094305032
ML-1 [Human thyroid carcinoma],6918289,2.565001109569917
HEC-151,5311281,4.406904152868016
NCI-H2081,285033,-4.017735387470941
NCI-H2081,53232,2.211955699015755
HSC-4,441298,2.8371907900438535
KYSE-70,135875424,3.720063911223788
PaTu 8988s,7251185,3.0647906499377964
HEC-151,5335621,6.1818969924575145
YH-13,135875424,4.585935280505426
SK-LMS-1,16725315,3.2291343894639803
BT 320,216239,3.754471265318657
HARA [Human squamous cell lung carcinoma],3025986,-0.8541128463962537
BT 328,11656518,4.018032711371447
SEM,10322450,3.0556839954997685
KP-4,135411,0.2840057840675377
HSC-4,19582717,4.479728463380205
NU-DHL-1,10231331,-1.2748802736904843
HEC-151,docetaxel-tanespimycin (2-1 mol-mol),-4.438217342936677
RERF-LC-A1,445455,5.673281127348227
OE21,6184667,1.691212727819629
SNU-308,11626560,2.3164476710661983
SNU-1214,25150857,2.4299746363214125
NCI-N87,5460769,3.352422042402732
KYSE-70,10385095,0.9665013844498838
KMBC-2,9549297,4.127496683757197
KMS-27,11427553,1.1582692146360252
HMCB,72376,-0.5022720815558697
CML-T1,JQ-1-vorinostat (2-1 mol-mol),-0.0778878507242399
A4/Fukuda,9444,3.1818692272898423
SK-LMS-1,5311281,1.8163928569648944
LCLC-103H,46191454,2.10390720157798
IST-Mes1,25022340,4.432743731061051
BT 330,216345,1.3297376378121593
OAW42,262093,3.645720807716878
LoVo,6918837,-3.586713596901602
BT 330,71729975,0.6660991074128464
NCI-N87,702558,5.013224249903468
RPMI-7951,969516,2.1642782433531225
HuT 78,2742550,1.9478816710996465
ML-1 [Human thyroid carcinoma],4788,6.371899932480547
SNU-308,44486219,4.355116140168268
RPMI-7951,46398810,2.059588562452404
KMRC-2,vorinostat-carboplatin (1-1 mol-mol),4.622831077205028
AU565,57519531,1.889615726213954
KYSE-410,54454,3.984562652045316
KMS-20,9887053,4.355785993783173
BT 328,135659046,3.8583019402961343
Ku812,11485656,2.1573639541519474
YH-13,11178236,-3.430618404279131
KYSE-410,9823820,4.309422676682165
TE 617.T,227681,2.8564980043830515
NCI-H1395,462382,1.900499609260616
H-STS,60750,-4.358992814054535
NU-DHL-1,25126798,3.605160224623971
NCI-H1092,7251185,1.5138496531623726
Hs 683,89928392,1.5985619722358693
MCAS,17759555,4.691620378552776
KP-4,9956119,3.912879801668201
NCI-H2081,613000,5.284324483502851
BT 139,637858,2.313744051526735
KYSE-70,2746,2.8005709054024224
Hs 683,11485656,3.0003726107919437
SNU-1214,11656518,1.889614069943663
OE21,tanespimycin-bortezomib (250-1 mol-mol),-1.6225844369747413
D283 Med,16736978,0.404071171344105
LCLC-103H,135411,1.3970817088756593
HSC-4,3081361,1.976322212956416
WM983B,10184653,2.331827146390807
PE/CA-PJ34 (clone C12),11427553,3.5428497677945807
SNU-8,5978,-2.8991524915618454
OE21,285033,-4.639504259676399
Kasumi-2,11152667,-1.6921100461719016
NU-DHL-1,25227462,-4.640207660582911
SNU-1033,11625818,4.277044008333248
KYSE-70,46191454,2.1451937437577575
BFTC-909,4096211,2.208598833058293
TE 617.T,54639665,4.38998607843506
RERF-LC-A1,9911463,3.9529854896489782
TE 617.T,2733526,4.048872059257863
WM983B,selumetinib-decitabine (4-1 mol-mol),-1.6443721704693546
HuT 78,navitoclax-MST-312 (1-1 mol-mol),0.598412445003022
H-STS,637858,1.1585331861261023
KYSE-410,5291,3.7055428862452673
RERF-LC-Ad2,selumetinib-GDC-0941 (4-1 mol-mol),0.4804595733416271
RERF-LC-A1,159324,3.1171864929596977
RPMI-7951,6918837,-3.6765620040448783
SKM-1,409805,3.7093603817382337
PE/CA-PJ49,2949965,2.63001949752774
MM1.S,10296883,3.0108141042121246
OE21,tanespimycin-gemcitabine (1-1 mol-mol),-1.4888613002009743
Hs 683,4096211,1.660669341815773
BFTC-909,9444,3.603329432205708
TE-15,24856436,-0.9894737380847988
TE 617.T,navitoclax-birinapant (1-1 mol-mol),2.46391001326416
BT 504,5978,-5.69782717028931
WM983B,448949,3.409519528895042
PE/CA-PJ34 (clone C12),107970,2.3192518543827476
EJM,52912189,-1.0770989556153556
KYSE-410,5284373,3.250370291088375
TE 617.T,1242560,3.2106509327260917
HSC-4,49846579,1.975916395804951
KMS-20,5113032,5.7855573183073785
HSC-4,5460769,1.9290612526481368
JIMT-1,selumetinib-decitabine (4-1 mol-mol),5.515746627851732
SET-2,5282054,2.570839430401872
LNCaP clone FGC,24821094,3.724025510090393
HSC-4,11656518,1.5757846986297326
PE/CA-PJ34 (clone C12),JQ-1-MK-0752 (1-1 mol-mol),5.182119120511875
HEC-151,54618305,4.2925699084671525
HEC-151,6918878,2.1820464530462163
MM1.S,6252,-0.7116460334368461
MCAS,53392493,2.955916127146427
KMRC-2,568763,1.556710187113669
RERF-LC-A1,selumetinib-UNC0638 (4-1 mol-mol),6.64676306020409
KP-4,24901704,1.8878672874550328
NCI-H2172,67156097,4.441497505181189
ESS-1,4378219,1.976133617597145
SK-LMS-1,15953870,4.449149497882856
KMS-20,11647372,-0.2518820801437051
TE 617.T,136227924,1.63601430884803
IST-Mes1,123631,3.330483874726673
TE 617.T,JQ-1-UNC0638 (2-1 mol-mol),0.3306309340053746
CA46,6918328,-3.721989268042841
BT 139,9911463,2.810742843963801
NCI-H2081,71466578,5.057643127393127
Kasumi-2,71680916,3.663022593238377
KMS-27,4917,2.986896806012511
Raji,6505803,2.919386850087895
SK-MEL-1,15547703,5.53534404853671
CA46,24821094,1.9467424475066963
Hs 683,53481919,3.7353029255072783
ESS-1,426756,3.7262870837192503
CML-T1,vorinostat-navitoclax (4-1 mol-mol),0.0862805898320609
BT 504,51039095,1.4699769126439928
SK-LMS-1,2742550,3.9277163858782913
H-STS,11485656,0.1079902200809361
LNCaP clone FGC,11964036,0.9277079727850748
SNU-1272,2858523,2.5104124408417157
EJM,107970,2.184437882167209
PE/CA-PJ34 (clone C12),navitoclax-MST-312 (1-1 mol-mol),0.8797788073810391
NCI-H2110,navitoclax-PLX-4032 (1-1 mol-mol),3.5351266692450256
EJM,65628,4.064740748344536
SEM,5311281,0.7085042450698669
IST-Mes1,44819697,0.965138597180618
Hs 683,135398516,3.188206567673989
NCI-H1395,navitoclax-MST-312 (1-1 mol-mol),0.8378237881754972
KYSE-410,448949,2.4860337699563906
SNU-1214,9803433,4.368496616834253
BT 330,227681,3.2986722537694715
NCI-H1395,65064,5.358143004384587
HSC-4,9911463,3.832706037448295
WM983B,24951314,1.5894160413495977
SEM,decitabine-navitoclax (2-1 mol-mol),-3.4991748591618026
D283 Med,decitabine-carboplatin (1-1 mol-mol),-0.1319093330990738
AU565,2858523,2.8415967437488443
ML-1 [Human thyroid carcinoma],55508,1.8303716396385248
BT 139,31703,-0.7978827356055225
NCO2,6918736,-3.467685718712483
IST-Mes1,6917907,-4.257425330675956
HEC-151,11404337,-0.8422867477352739
TE 617.T,44566777,0.1553719189995731
NCI-H2110,5351362,1.1999288672979518
Aska-SS,44589607,3.03884653856261
LoVo,753704,4.37626239298451
NU-DHL-1,3025944,4.128998199561555
OAW42,23725625,5.790985458028767
RERF-LC-Ad1,10302451,4.5263361411635366
BT 139,71304818,3.117060314680253
ESS-1,9911830,2.1910771619648077
KMBC-2,53392493,3.27166937772612
NU-DHL-1,49793307,-5.248785765365087
ML-1 [Human thyroid carcinoma],navitoclax-gemcitabine (1-1 mol-mol),0.4874661343054459
KP-4,5282054,3.3464630345919355
D283 Med,5460769,1.125938178392905
NU-DHL-1,24180125,2.343403566122717
CA46,4788,4.772802977698259
PE/CA-PJ49,navitoclax-pluripotin (1-1 mol-mol),-0.7727749404031732
BT 504,3543504,5.031667455207807
SK-LMS-1,navitoclax-gemcitabine (1-1 mol-mol),-2.1368284485101814
KMRC-2,24951314,2.6109807900606263
OAW28,322968,3.926433659329745
D283 Med,ISOX-bortezomib (250-1 mol-mol),-0.293421488526388
BT 139,5566,2.9967310450121816
NCI-H2110,151289,0.7148300319898179
PE/CA-PJ49,11178236,-3.28089539885458
KP-4,24771867,0.2854190310309647
TE-15,serdemetan-SCH-529074 (1-1 mol-mol),2.490682124349896
YH-13,11238147,2.49094347137922
BT 320,54649381,5.331321773509753
PE/CA-PJ49,613000,2.2856276091576704
D283 Med,3825829,1.8555624568055975
KMRC-2,4917,3.69658277533404
GOS-3,568763,1.0345737986601573
KYSE-410,3689413,0.6720370091874901
PaTu 8988s,9915743,-0.0886276947358788
PE/CA-PJ49,219104,4.033917827909158
HEC-151,9884685,0.5854860158758856
TE-15,65064,3.5266887119836428
KMRC-2,44607530,1.7376258849298154
YKG-1,16720766,0.8883100647238013
KMS-20,JQ-1-navitoclax (2-1 mol-mol),-1.501822959559956
PaTu 8988s,219104,4.155059926230293
BT 330,6914657,-4.9495639860890535
KMS-20,675434,4.108652876132496
PE/CA-PJ34 (clone C12),135440466,2.5835124352915084
MM1.S,2729026,2.344981820167116
BT 248,2828334,5.879853395133371
LoVo,navitoclax-pluripotin (1-1 mol-mol),-2.104287475086767
AU565,53232,3.892352285865555
JIMT-1,15983966,-3.2112251469332005
LCLC-103H,9911463,4.367340887441101
Hs 683,568763,1.3884888776313176
SET-2,16722836,-0.1774401414878187
SET-2,421610,1.9981144134483724
SEM,vorinostat-carboplatin (1-1 mol-mol),1.1477550395391434
BT 504,2842253,6.240466816490142
A4/Fukuda,462382,-0.2406989279082468
Raji,452548,-3.42803254084333
A4/Fukuda,5329102,0.822909221294871
SET-2,decitabine-carboplatin (1-1 mol-mol),-0.0783164861685106
Raji,11497983,3.8774717564884416
AN3-CA,11317348,1.5853926508405654
RERF-LC-A1,6918328,0.4961194490378269
AU565,1239801,6.39587237663574
ML-1 [Human thyroid carcinoma],decitabine-navitoclax (2-1 mol-mol),2.5515685650410216
NCO2,409805,3.4174299709806704
HuT 78,72376,-3.326794088490654
ESS-1,17755052,2.168026535406177
A4/Fukuda,1750826,-3.1003590099134284
NCI-H1395,36462,4.192459813965937
NCO2,6852167,3.0522218001812114
SET-2,2733526,4.122359576354569
H-STS,375860,-0.6907889018597777
OAW28,44137675,4.561686598527574
IST-Mes1,12003241,-1.7187710036837192
WM983B,5951923,6.48706363434354
YH-13,24785538,1.1754482929087915
YH-13,36314,4.085888552358508
KMS-20,51037431,4.06192441494652
KP-4,46907787,2.8983323327312185
NCO2,doxorubicin-navitoclax (2-1 mol-mol),-3.3991173013582467
CA46,409805,3.3808362620175187
LoVo,44589607,1.625549992230134
RPMI-7951,4521392,5.160488379575089
SK-LMS-1,9884685,0.6915267736542438
IST-Mes1,16659841,2.7339021092282527
KMBC-2,42642645,1.3462679167777547
BT 330,9549297,1.684631895780215
NCI-H1395,60700,0.9119898603788574
NU-DHL-1,400769,-1.0687598831956515
Raji,11964036,1.1423265876219442
HuT 78,5281321,-2.4358925400623797
KMS-20,15953870,2.7543869132459378
A4/Fukuda,9840324,5.782088483619631
LNCaP clone FGC,6450551,3.014319559444335
HEC-151,71466380,5.72488815846615
Hs 683,5287620,-3.309313653276712
PaTu 8988s,702558,6.597763482628467
BFTC-909,10385095,0.9839595624316404
RERF-LC-A1,10427712,4.263512643583032
OE21,135875424,4.2322811376256
NU-DHL-1,54765302,3.7764075919835984
RERF-LC-Ad1,3815108,3.6891446241117873
RERF-LC-A1,156422,3.7851058818185352
LNCaP clone FGC,doxorubicin-navitoclax (2-1 mol-mol),-2.264651644205161
SNU-1272,135423438,5.060183017948369
HSC-4,135875424,3.4627713632233537
YKG-1,12001922,2.2090036010272533
OE21,44462760,4.2487562361155335
SW1990,168312962,3.681678065961884
SNU-8,159324,3.7143577321129393
PE/CA-PJ34 (clone C12),5470400,-0.1416170344108112
Ku812,135421197,1.6654017400601815
CML-T1,66577038,2.0285847507138017
CML-T1,10231331,3.71504818577299
OAW28,4096211,1.5501495805084426
AU565,11625818,3.8205404098717457
RERF-LC-A1,6505803,-1.6574767095757488
BFTC-909,25062766,1.7422044094415416
PaTu 8988s,5738263,3.8037236140642454
SEM,25062766,0.2261975735754109
SK-N-AS,67156097,-2.521497927674448
NU-DHL-1,6184667,2.420250013348629
BT 330,1566236,2.4105147195149694
ESS-1,49836020,-4.193111027878734
Hs 683,5278396,3.84823350271613
OAW28,24901704,3.441244042276163
RPMI-7951,6450551,3.1050149829691787
KYSE-410,6918328,-0.1647605185632367
NU-DHL-1,2945648,1.372163089409248
SET-2,24180125,3.520791323049292
HEC-151,10113978,2.960493097461511
KP-4,5278396,3.298974733874376
D283 Med,24964624,0.6925287192814263
SNU-1272,navitoclax-gemcitabine (1-1 mol-mol),1.6228672225859768
KP-4,446155,0.7205006970910534
NCI-H2110,52912189,2.774816177157098
BT 330,ISOX-bortezomib (250-1 mol-mol),-0.1691367130870625
ESS-1,151289,1.069450318701332
SNU-308,11175137,3.154524014075145
HARA [Human squamous cell lung carcinoma],25150857,2.860855820493058
SEM,31703,-4.117081497210504
IST-Mes1,135421197,1.925463420817299
HSC-4,3825829,4.330540788358233
RPMI-7951,24856436,0.185198824753273
A4/Fukuda,7326481,2.3355820774301206
KMS-27,4261,0.5113923676120534
TE-15,57519531,1.62599243838619
MM1.S,1641662,3.76159788149762
Kasumi-2,285033,-4.713748931161676
SEM,tretinoin-carboplatin (2-1 mol-mol),1.6069371738870424
TE 617.T,11640390,3.011974342366218
KYSE-410,135398516,1.6469122862912091
SET-2,6918837,-6.044596893115915
GOS-3,7251185,3.0018815610418694
SEM,25150857,1.6285052261344466
MCAS,46191454,-0.6520538534336672
NU-DHL-1,135421197,0.761695548293036
CA46,10322450,2.6264913036213606
GOS-3,11485656,3.367022375162814
SK-LMS-1,SNX-2112-bortezomib (250-1 mol-mol),-1.3853939234705217
TE-15,3011155,4.33060770882189
CA46,5280436,1.6785665289286047
NCO2,selumetinib-JQ-1 (4-1 mol-mol),-1.9216061314069743
IST-Mes1,107970,2.9610434925705773
SNU-1272,carboplatin-UNC0638 (2-1 mol-mol),5.070275489272453
KMBC-2,navitoclax-PLX-4032 (1-1 mol-mol),-0.2513103749729587
Hs 683,11222830,1.737895244343142
KMRC-2,BRD-A02303741-navitoclax (2-1 mol-mol),3.3429469235932494
TE 617.T,60750,-7.010901382774134
SET-2,54613361,-0.3766377840861687
D283 Med,126941,-4.12717690100812
NCI-H2081,navitoclax-piperlongumine (1-1 mol-mol),0.7242013058592781
HSC-4,327653,3.5197711195347434
RERF-LC-Ad2,25102847,2.973897211120729
ML-1 [Human thyroid carcinoma],9926054,2.0491703403306056
HSC-4,10184653,-0.7296444895073179
BT 504,11222830,1.2572855515248933
SET-2,10077130,3.122391683197605
TE 617.T,24180125,2.0821537489988544
ML-1 [Human thyroid carcinoma],9444,3.622178437751676
BT 320,24797083,3.954904976663047
OAW28,4788,5.61832216329738
NCI-H2081,42642645,-0.9606541390632763
GOS-3,676352,1.7019961079374837
AN3-CA,serdemetan-SCH-529074 (1-1 mol-mol),2.3645494916379532
WM983B,25161177,1.8287777247119323
MCAS,15547703,2.7273456704873142
MM1.S,2858523,3.054704671957027
GOS-3,107970,2.255442380434802
NCO2,17759555,3.260915037065223
AN3-CA,16722836,2.609323427195484
KYSE-410,15953870,3.289472194998764
NU-DHL-1,9823820,3.2683941347540704
NCI-H2110,1566236,3.9517659227404263
OAW42,selumetinib-PLX-4032 (8-1 mol-mol),4.596123432417094
NU-DHL-1,25161177,3.575744569500696
NCI-N87,4259181,-0.3128226187706996
NCI-H1092,navitoclax-pluripotin (1-1 mol-mol),0.8124337915703985
BFTC-909,11612883,3.5324782187628827
BT 320,selumetinib-UNC0638 (4-1 mol-mol),5.097773746306877
NCI-H2081,46174525,2.628990819300419
PE/CA-PJ34 (clone C12),53392493,1.8170083800399903
SET-2,6852167,2.1824189534016556
A4/Fukuda,12001922,1.2276815023009988
KMBC-2,11625818,5.816213773261342
CA46,9935249,0.2545497442771542
Kasumi-2,5328940,0.1344355450802072
MCAS,selumetinib-decitabine (4-1 mol-mol),2.306653637135641
SNU-8,selumetinib-JQ-1 (4-1 mol-mol),-0.3445187438421354
TE 617.T,67156097,-2.0932175014499244
KMS-27,carboplatin-etoposide (40-17 mol-mol),0.9248762236277256
LCLC-103H,12001922,1.920474262728411
OAW28,15953870,5.078636607909671
SET-2,53301938,4.205096030806661
RERF-LC-Ad2,9927531,7.758899930646885
KYSE-410,156414,-0.3480069289117364
WM983B,168313200,2.0257774924558176
MM1.S,54686904,2.8702453474373315
H-STS,23635314,-4.332307696037408
H-STS,16720766,0.6181925299457043
NCI-H2081,selumetinib-GDC-0941 (4-1 mol-mol),2.2419889571626146
MM1.S,5280436,3.932437851404913
AN3-CA,23725625,6.041812493780868
KMS-20,753704,4.324043656881392
YH-13,5329102,1.6719454710321933
RERF-LC-A1,241158,3.4003643660710714
SW1990,9823820,4.425130211783221
LNCaP clone FGC,navitoclax-MST-312 (1-1 mol-mol),0.9978593113162046
BT 330,16038120,0.5396247487924652
A4/Fukuda,123631,1.573225246333458
SNU-1214,54143018,-0.2365789293950507
LoVo,10385095,1.3603816893768768
MM1.S,72193861,1.743096021733494
ESS-1,45279963,4.196559746594957
RPMI-7951,11167602,2.502155495655697
NCI-H2110,49836020,-1.7351781152481929
Kasumi-2,3025944,3.902952987709838
A4/Fukuda,89183176,1.286008536767452
GOS-3,9967941,3.548284114921986
BT 328,2729026,2.3236347104871924
OAW42,11455910,0.9169740584979637
SEM,11404337,-1.9668178292815095
IST-Mes1,46224516,1.3511239581863117
AN3-CA,40482356,5.1223591742849415
LoVo,168313016,4.599216339831628
NU-DHL-1,46191454,-0.6723674281273057
KYSE-70,54619267,5.587983352589812
NU-DHL-1,1750826,-5.605759271082352
SK-N-AS,374536,4.009524069127922
AU565,6610355,3.967539400054512
KMS-27,5278396,3.716466097320167
SEM,11612883,0.3199155998762981
RERF-LC-Ad1,6852167,4.2610431072057695
Hs 683,126941,-2.279190865540304
HARA [Human squamous cell lung carcinoma],638278,3.613202989039307
KYSE-70,107970,2.5727619321994353
SNU-8,104842,-1.0653176876921144
HuT 78,19582717,2.6899137103246327
HARA [Human squamous cell lung carcinoma],25062766,2.285935640348263
HEC-151,11719255,4.240324425597553
HMCB,285033,-1.7820394591449478
HEC-151,selumetinib-JQ-1 (4-1 mol-mol),2.04219566232124
SW1990,168313016,4.40739187693859
SK-MEL-1,9444,4.224499687401875
PE/CA-PJ49,16736978,2.0157573091231957
NCI-H1092,444795,4.269979452389004
AU565,56649450,1.7738933823843377
LCLC-103H,3689413,1.9966381223526644
SET-2,54639126,4.3899784036288825
NU-DHL-1,151289,0.4356808259590597
SNU-1033,11396600,3.651423781511848
SKM-1,51039095,1.6344221890369603
NCI-H2172,3689413,0.3383001060602208
SK-N-AS,11497983,3.822150779992109
WM983B,23725625,5.091687421204069
BT 504,24797083,0.9629716486033008
OE21,11955716,-2.430228405790455
KYSE-410,tanespimycin-gemcitabine (1-1 mol-mol),-0.2570017784424961
A4/Fukuda,6438330,0.8804707138455458
AN3-CA,6610216,4.1751650141546826
PE/CA-PJ49,10184653,1.5434849064288445
NCI-H1395,5978,1.0563157186154253
OAW28,2858523,3.071437644261336
OE21,46199207,3.110625169720766
Hep-G2,10074640,2.639791541844783
CA46,15953870,3.0438117584706164
KMS-27,11656518,2.105180970638757
EJM,JQ-1-vorinostat (2-1 mol-mol),-0.3009892531248522
KMS-20,16722836,0.7293384571450807
ML-1 [Human thyroid carcinoma],446155,2.0206180645356766
NCI-H2110,5329102,2.106537605857881
LoVo,9911830,1.9062113768292104
Hs 683,11178236,-3.3483252874095837
BT 320,6917907,3.364777316338114
SET-2,68056272,3.2451496482148716
SK-MEL-1,46224516,3.23076377202171
Ku812,568763,-0.5026436454206128
NCI-H2110,5311,1.596719721323732
SK-MEL-1,selumetinib-PLX-4032 (8-1 mol-mol),-1.072189759525611
SW1990,53232,1.76868009043537
Hs 683,2828334,6.124701184526488
BFTC-909,11455910,1.958059547603208
RPMI-7951,322968,2.854105958499618
KMS-20,119182,-0.7060386970592318
SK-LMS-1,44137675,4.668720860798916
SW1990,5351362,1.1543206548626652
NCI-H2081,11497983,-3.5541578106955516
SEM,322968,1.9591491826764695
SNU-1272,4477,1.2199769171135058
SK-LMS-1,71466445,5.876102346203037
SET-2,46926350,-5.829442769281559
BT 320,53301938,4.424260786877386
KMRC-2,crizotinib-PLX-4032 (2-1 mol-mol),1.931069342582774
TE-15,11152667,-0.8942963388788865
AU565,5280436,3.6175977861549473
HMCB,crizotinib-PLX-4032 (2-1 mol-mol),2.393956445339111
SEM,44486219,4.180288188212984
HSC-4,9907093,5.592562690426939
H-STS,JQ-1-vorinostat (2-1 mol-mol),0.6269555463342106
OE21,46191454,0.5707756581247114
TE-15,71466445,3.5922640502663077
KYSE-70,25183872,-0.2407157689495178
EJM,4705,3.167336091742425
BT 320,17755052,3.980908422662348
BT 248,4705,2.6318547262793386
BFTC-909,11178236,-2.4757289909406683
OAW42,45279963,3.9727290248443863
NCI-H1395,tanespimycin-gemcitabine (1-1 mol-mol),4.210954263258385
PaTu 8988s,selumetinib-BRD-A02303741 (4-1 mol-mol),1.64163073342872
Aska-SS,4261,1.667053994015884
YKG-1,46199207,3.7186268028334
SW1990,11455910,1.2583427289615488
TE 617.T,123631,-0.2963807875359265
TE 617.T,9825149,2.243732271836408
SET-2,9840324,5.675754316118916
TE-15,24951314,1.3185945015140828
SNU-308,6852167,3.364672579284096
HuT 78,2858523,3.1169604415364303
BFTC-909,24748573,2.672786285704278
BT 330,5329102,1.6954321581918674
BT 320,navitoclax-sorafenib (1-1 mol-mol),2.857010837113841
Hs 683,16065773,2.162457649302814
TE 617.T,151289,0.8146404071058262
HuT 78,54765302,4.2796964156487665
KYSE-70,53495165,0.5494520653774981
BT 504,selumetinib-BRD-A02303741 (4-1 mol-mol),4.78765966639542
SNU-8,9903786,3.356408381726989
OAW42,JQ-1-carboplatin (1-1 mol-mol),4.198659850424817
OAW42,42611257,3.2581311692409285
MM1.S,73707438,4.7017263774156
SK-N-AS,23582824,0.9309369623040752
Kasumi-2,JQ-1-vorinostat (2-1 mol-mol),-0.9081345169636283
HARA [Human squamous cell lung carcinoma],31703,-1.5277652674394486
SK-LMS-1,10127622,5.304754918518943
CA46,119182,-4.388833865288787
SET-2,11234052,4.522742685815237
JIMT-1,erlotinib-PLX-4032 (2-1 mol-mol),3.9516527398409993
RERF-LC-Ad1,46398810,3.150870182853183
LNCaP clone FGC,9908783,4.491876694058294
LNCaP clone FGC,53392493,2.7107691255841457
KYSE-70,71304818,1.8226881659751617
SNU-308,3384730,3.959298768658411
SK-LMS-1,piperlongumine-MST-312 (1-1 mol-mol),2.31506192799256
KYSE-410,135984461,4.6292418393207235
ML-1 [Human thyroid carcinoma],9866186,0.3108629746931657
NCI-H1092,5351362,1.059712602120236
BT 248,docetaxel-tanespimycin (2-1 mol-mol),-0.0329319446366538
OAW42,44607531,1.7938171089210322
KYSE-70,6610216,4.087252338732691
RERF-LC-Ad1,navitoclax-MST-312 (1-1 mol-mol),3.737696475545332
PE/CA-PJ34 (clone C12),54626689,4.8339545787356215
SNU-8,72193861,0.8736863386386848
OE21,44489675,3.6391121100343247
LoVo,25195348,3.880726101323461
H-STS,675434,4.034994029543359
KYSE-410,selumetinib-JQ-1 (4-1 mol-mol),1.899201390217913
H-STS,11364421,-4.998126775681505
SNU-8,6852167,2.9028412896879856
SNU-1272,15983966,2.6541351995098545
BT 248,31703,-0.7981868387763399
KMRC-2,25062766,1.716878433118612
SET-2,16741245,4.779685324729375
ESS-1,5566,3.65596879307383
KYSE-410,2746,3.332005025730893
NCI-H2081,984333,-0.4217004435784025
A4/Fukuda,637858,0.8198578842358093
NCO2,carboplatin-UNC0638 (2-1 mol-mol),1.9260372517838371
BFTC-909,JQ-1-navitoclax (2-1 mol-mol),1.710597904541152
NCI-H1395,25262965,-4.1064506045953095
HMCB,16722836,1.8505640461629969
PE/CA-PJ49,135875424,3.843300837205347
MCAS,135398516,-0.2900633713122362
HSC-4,15983966,0.1445652725334258
TE-15,3689413,0.9912236496957668
AN3-CA,11396600,4.58709626361668
HARA [Human squamous cell lung carcinoma],2945648,3.3865607820212316
HMCB,3062316,2.903029383335688
PE/CA-PJ34 (clone C12),89183176,5.81670990965372
SNU-308,123631,0.6743565736055448
MCAS,6918736,-1.7437988275136789
KMS-20,9911463,2.8485967740948284
AN3-CA,52912189,5.456100531842718
GOS-3,11964036,2.3854684921529525
NCI-H1092,53495165,1.5582645503568386
PaTu 8988s,25161177,3.043873631916992
PaTu 8988s,4259181,0.1562419703255739
BT 330,72376,-2.2798402595654643
CA46,65628,4.372814936384242
NCI-H2081,BRD-A02303741-navitoclax (2-1 mol-mol),1.572790594213783
WM983B,11657048,4.937881389626147
SKM-1,5281321,-0.4705948424838158
NCI-H1092,vorinostat-navitoclax (4-1 mol-mol),0.5832215278438359
ESS-1,44543605,4.6000400414532505
LNCaP clone FGC,104842,-4.4374315412875065
OAW42,56649450,2.9292995840941822
BFTC-909,6917907,-4.2174557642594035
RERF-LC-Ad2,crizotinib-PLX-4032 (2-1 mol-mol),1.9189852963092824
YKG-1,5951923,5.422075002317939
D283 Med,55508,1.738146449836156
SK-MEL-1,24748573,1.8885887173657103
OE21,66577038,2.109411516197842
SK-LMS-1,4096211,2.5339124248624945
KYSE-410,676352,2.3264223438557847
HuT 78,JQ-1-carboplatin (1-1 mol-mol),-2.068765124024036
HCC2218,9936388,0.977315225187753
NCI-H2110,72734382,3.9204916905436953
Aska-SS,9549297,1.144867094134784
SNU-8,11175137,2.4587616442256603
Hs 683,52947716,2.9909065947709856
HSC-4,9926054,2.0278633205902468
SEM,176870,1.5033295083802505
SKM-1,5351362,1.5652480308403496
KYSE-410,16736978,1.1524112302725302
NCI-H2081,9823820,3.6115894739916414
JIMT-1,448949,2.0856604927755633
NCI-H2172,15983966,2.0038954044857227
BT 320,54143018,4.726719249085395
BT 320,4378219,1.7610425663146678
GOS-3,4477,0.980296597324464
SW1990,11175137,2.8268727027301557
EJM,650361,3.796410138993618
KMBC-2,53481919,5.533960714974802
NCI-H2110,52947716,3.0612107252591634
SNU-308,navitoclax-piperlongumine (1-1 mol-mol),2.161495777411906
HEC-151,31703,-2.2895750216205832
Ku812,46943432,4.280814189443877
NCI-H2110,9915743,1.734073577383887
LNCaP clone FGC,462382,0.5963170764169649
Hep-G2,1242560,4.268302796379108
YKG-1,navitoclax-MST-312 (1-1 mol-mol),1.1745049441725737
BFTC-909,60700,0.4554202898414442
NCI-H2081,135984461,4.3718384438901285
PaTu 8988s,4261,3.2609853730369323
NCI-H2110,selumetinib-UNC0638 (4-1 mol-mol),5.261547030595486
BT 330,54618771,1.126600316617638
HSC-4,9956119,3.775946121479013
NCO2,5746,-1.1153710666690966
OE21,10184653,-4.387807743027572
MCAS,613753,4.7352169808443305
HuT 78,SNX-2112-bortezomib (250-1 mol-mol),-3.095377009148787
HEC-151,445091,4.618132291370935
SET-2,107970,1.5950786133470078
RERF-LC-A1,107970,2.429814394867771
NCI-H2081,71304818,1.874241739609375
HuT 78,9884685,0.1724524998439705
SEM,9887053,1.384456155351722
OE21,45100481,5.232894765925204
SEM,65628,2.5869900174043647
EJM,navitoclax-piperlongumine (1-1 mol-mol),0.8895676752169835
KMS-20,46174525,2.556560760455921
Hs 683,JQ-1-vorinostat (2-1 mol-mol),1.2290552326293391
RERF-LC-Ad1,25126798,4.287589780864176
MM1.S,219104,2.0959225509633552
A4/Fukuda,1566236,1.4071330472860828
WM983B,4477,0.2879588337655966
NCO2,56973724,0.5851182100804396
BT 248,4917,1.8494335305709009
NCI-H2081,25183872,-2.502554706433877
Ku812,doxorubicin-navitoclax (2-1 mol-mol),-2.802907461854501
SNU-8,44185566,2.3653389321238354
PaTu 8988s,44607531,1.582037029265366
SKM-1,sirolimus-bortezomib (250-1 mol-mol),0.3833247137434921
YKG-1,637858,1.419948249294149
EJM,135659046,3.4058346184663693
SET-2,89928392,0.7137402814992264
PE/CA-PJ34 (clone C12),2742550,3.898499868649933
NU-DHL-1,44819697,-0.6868539952356948
HEC-151,23582824,1.8104263678243615
CML-T1,54618305,-5.881736901302383
YH-13,10385095,0.585484965582367
NCI-H1395,3136844,4.616978313876093
CML-T1,vorinostat-carboplatin (1-1 mol-mol),1.2674452804454217
SKM-1,selumetinib-JQ-1 (4-1 mol-mol),-3.5716961442559496
NCO2,5280436,2.7735341942678757
LoVo,selumetinib-BRD-A02303741 (4-1 mol-mol),1.3489379302549531
RPMI-7951,12003241,-0.9511728924240472
SNU-8,89183176,3.903990016446917
A4/Fukuda,tanespimycin-gemcitabine (1-1 mol-mol),-4.973874531854187
SKM-1,216345,2.58392001557385
MCAS,selumetinib-BRD-A02303741 (4-1 mol-mol),1.302698878227716
NU-DHL-1,71304818,2.6808989156503467
HARA [Human squamous cell lung carcinoma],2749,1.5155233624959286
OAW42,46907787,3.3206761920396164
KMS-20,613000,1.1345541972303637
KYSE-70,66577038,3.0162273972396005
MCAS,568763,0.8857059564894935
ESS-1,126941,-4.948247383785425
OE21,4788,5.877941677977921
NCO2,54618771,-0.1705151191723565
Ku812,4521392,4.096251186969024
NCI-H2172,46224516,4.4094176842523245
ML-1 [Human thyroid carcinoma],25062766,2.2645177949682775
NU-DHL-1,6252,-2.10817374162043
Ku812,25154868,3.035500592962472
TE-15,25227462,-1.6172386739041076
KMRC-2,6918328,1.5862321115038376
TE-15,navitoclax-birinapant (1-1 mol-mol),0.1032456902871259
HMCB,252682,6.031465547355209
IST-Mes1,45279963,3.842534876522704
Hs 683,2729026,2.6302099584377534
PE/CA-PJ34 (clone C12),4705,1.0597990978306746
RERF-LC-Ad2,5460769,6.029186520623905
NCI-H2172,2729026,2.5458261586186013
OAW28,5329102,1.8792475137868745
NCI-N87,123631,-0.3933912143385343
OAW28,46843906,3.2241568449076556
SNU-1272,crizotinib-PLX-4032 (2-1 mol-mol),2.5958559456556025
KMS-27,46943432,1.1908434425451844
KMS-27,44486219,4.244516858504852
HARA [Human squamous cell lung carcinoma],676352,2.7556636695973515
MM1.S,73707398,0.3713750235386087
SK-N-AS,25062766,3.021655259446294
BT 504,12003241,-1.3815102310326015
SEM,24856436,-2.546648725851104
PE/CA-PJ49,52947716,3.1703776332713076
HuT 78,selumetinib-GDC-0941 (4-1 mol-mol),-3.8107077874530657
HCC2218,vorinostat-carboplatin (1-1 mol-mol),2.0355750419233107
D283 Med,11234052,3.767459494315311
RERF-LC-Ad1,73707398,2.698751964761458
Hs 683,67156097,-2.670852292829107
NU-DHL-1,JQ-1-MK-0752 (1-1 mol-mol),-1.024409939497564
OAW42,135440466,2.540044758140704
LNCaP clone FGC,5738263,3.2803193382868745
NCI-H2081,89928392,0.9325631325341028
OAW28,JQ-1-UNC0638 (2-1 mol-mol),1.5055699462445158
PE/CA-PJ34 (clone C12),5278396,3.888828333623774
RERF-LC-Ad2,100016,6.703705933143471
HMCB,10302451,4.070081150685941
RERF-LC-A1,5470400,2.8195640292504054
BT 330,135928012,3.687683575459301
BT 330,3136844,4.335632368425244
SW1573,selumetinib-vorinostat (8-1 mol-mol),4.856763743237327
TE 617.T,441298,4.204811776771992
AU565,25227462,0.9575642046813388
KMS-20,4521392,3.4103323634767775
KYSE-410,216468,2.8171143313107927
D283 Med,11455910,0.6480749902472364
HEC-151,6918328,-0.3993843896261924
H-STS,5329102,1.888507265760659
Hs 683,1716436,3.2273737363260286
OAW28,53495165,3.30177539085494
RERF-LC-Ad2,24901704,2.869473134456323
HARA [Human squamous cell lung carcinoma],JQ-1-vorinostat (2-1 mol-mol),2.5839829159057848
SW1573,11609586,3.686627979451031
CML-T1,135984461,1.8956927240773784
BT 330,1716436,2.18293804812622
RPMI-7951,2828334,6.2799556772556775
NCI-N87,19582717,3.5520999296373437
SNU-308,15983966,2.358099109597309
PE/CA-PJ49,448949,1.8927168169114004
GOS-3,71466380,4.9000171792124
Kasumi-2,400769,-1.337956311995758
TE-15,11485656,1.960576997256463
KMBC-2,serdemetan-SCH-529074 (1-1 mol-mol),2.458567671710058
SNU-1033,3689413,-2.6391429266703015
SK-LMS-1,53392493,3.3529874770947714
OAW42,3038522,1.940121713897555
MM1.S,9911830,2.728285435741644
HEC-151,10410894,2.649584895586281
NCI-H2081,5470400,-3.843190665542197
AN3-CA,2746,4.007834108220286
SEM,53392493,1.476252706272148
WM983B,UNC0638-navitoclax (1-1 mol-mol),4.930439890956027
HMCB,637858,1.3431818902192771
NCI-H2110,56649450,2.75917742246227
SEM,9929138,6.8273209917060145
KP-4,54618771,2.957585816818264
Hs 683,9826308,0.3200109255128864
SK-N-AS,53495165,-0.3125745311738068
BT 504,4705,3.101925484309532
HEC-151,4096211,1.0893719310707468
A4/Fukuda,54454,2.014078017992857
LoVo,31703,-2.470313869470646
NCI-H2081,tanespimycin-gemcitabine (1-1 mol-mol),-4.020630878954612
NCI-H2081,9911830,1.4932773015429426
SW1990,alisertib-navitoclax (2-1 mol-mol),1.968721211872207
OAW28,tretinoin-navitoclax (4-1 mol-mol),1.3460784377141035
BT 139,24797083,0.871050037747606
TE 617.T,54765302,3.214416792318029
NU-DHL-1,3503,1.1771125091152093
A4/Fukuda,72199292,-0.4044306818473915
NCI-H2110,alisertib-navitoclax (2-1 mol-mol),2.8711325454482988
D283 Med,89928392,0.7177145922675237
NCI-N87,375860,-0.928197184659684
TE-15,9911463,3.694434531668693
IST-Mes1,71466578,4.723128098465521
KMRC-2,2949965,2.6713021171496285
RERF-LC-A1,24964624,3.383543286133736
CML-T1,9935249,2.5956918222650507
HMCB,24951314,2.2278273113758083
KMS-20,11964036,0.567950942976561
HuT 78,44486219,3.8943973878115985
PE/CA-PJ49,568763,0.8663774214435017
PE/CA-PJ34 (clone C12),17755052,1.133637594911045
CML-T1,8515,3.304453494146528
ESS-1,374536,5.146738438727042
LNCaP clone FGC,5335621,4.370259556780433
KYSE-410,4259181,0.334687441755604
CA46,135411,0.0331424760277949
HEC-151,148198,-1.7915860378087891
BT 139,6610355,5.0488800183599825
HMCB,5566,3.160933533240533
NCO2,11497983,-3.3258592780222456
NCI-H2110,73707371,5.04412555046355
TE 617.T,11234052,4.193590791426118
HARA [Human squamous cell lung carcinoma],9926054,1.843677597683555
KMS-27,1242560,2.2003071590723007
NCO2,24856436,-0.1417663098133967
CML-T1,9911830,-1.528510322337235
PaTu 8988s,25102847,3.091699775507105
BT 504,216345,1.65390968728622
SET-2,5287620,-2.9581433175203315
OAW42,6918837,-1.0445619405898865
PE/CA-PJ49,46191454,1.6379354990764687
Ku812,72193861,-0.3622836093760774
SK-N-AS,208908,1.9164192947057883
KYSE-410,969516,2.9293638368777417
Ku812,serdemetan-SCH-529074 (1-1 mol-mol),1.0312018024481138
HSC-4,selumetinib-decitabine (4-1 mol-mol),5.3885261906416275
SEM,11152667,-6.712483327053162
TE 617.T,49766530,0.7219936029633269
OAW42,46398810,3.017100469539754
Hs 683,6917907,-5.495645682266978
OE21,15953870,1.724082394316485
SET-2,4261,-0.6443084099324052
RERF-LC-A1,984333,-0.8241147465835575
SK-MEL-1,6917907,-3.5206061971736307
CML-T1,52912189,1.3905308136477008
NCI-H1092,BRD-K55473186,3.7509315405702224
HEC-151,135398516,2.0507188798762277
NU-DHL-1,448949,-1.77397684546658
MCAS,446155,3.4124965523550586
OAW42,24180125,3.18113812065638
CML-T1,9866186,-1.0355523545849354
BT 248,15953870,3.6832035377423216
Aska-SS,676352,2.016488821538694
BT 330,tretinoin-carboplatin (2-1 mol-mol),4.791093177810098
GOS-3,9933475,1.7482363497307876
HuT 78,5566,2.7990159644878
NCI-H1092,71466445,6.1929235006275585
SEM,11455910,-0.3463344343386808
TE-15,selumetinib-GDC-0941 (4-1 mol-mol),1.395228567811366
MM1.S,10113978,2.8208205912142597
KMRC-2,136227924,3.1141635996197183
SW1990,252682,8.194560981520343
KMRC-2,9884685,0.9059778924037538
NCO2,16038120,-0.1956357909816668
SW1990,168313200,2.994110056013303
NCI-N87,65628,4.009039012864223
HSC-4,54618771,2.9865797342969564
KMRC-2,702558,5.806055725230924
LCLC-103H,4477,0.7527503872487015
Hep-G2,51037431,2.134327625147545
PE/CA-PJ34 (clone C12),navitoclax-gemcitabine (1-1 mol-mol),-0.7545233222413882
GOS-3,salermide-PLX-4032 (12-1 mol-mol),5.528835129082399
ML-1 [Human thyroid carcinoma],navitoclax-piperlongumine (1-1 mol-mol),1.771267146894677
NCI-H2172,969516,3.534921805851224
AN3-CA,135999136,1.6085173592108284
LoVo,4521392,4.145025799048703
Ku812,374536,1.5029739319713498
KMS-27,2733526,3.3995560375076663
OAW28,46398810,2.3633613380182386
OAW28,3025986,-0.5681838773369163
MCAS,54143018,-0.6447535043455573
D283 Med,5470400,-0.4295186800488584
A4/Fukuda,5291,3.6218734753047226
OAW28,227681,3.168890693964491
HMCB,46926350,-4.187449030083668
AN3-CA,24772860,-3.14166980026705
SNU-1033,carboplatin-UNC0638 (2-1 mol-mol),3.4423158884964664
SNU-308,400769,-0.6277123856254561
Aska-SS,5311,1.1143613375213084
SK-LMS-1,17755052,2.8417893313361433
LNCaP clone FGC,9911830,1.9985262700964304
SNU-1214,5351362,0.7905695196735173
SET-2,5328940,1.259459223371511
Raji,BRD-K55473186,3.4562594687437733
KYSE-410,16741245,5.350523076249508
HuT 78,5951923,5.985995138810963
HSC-4,11625818,4.485436042124793
CA46,374536,0.6029387131655304
SEM,5284616,2.3626206201017292
NCI-H1092,10127622,5.156307996468707
RPMI-7951,49850262,3.2718463669067916
KYSE-410,135999136,4.574182902915764
RERF-LC-A1,448949,2.369479885378649
AN3-CA,45279963,3.097251207724971
HCC2218,5746,1.2598379525306076
HuT 78,16659841,-0.357838633597325
SET-2,11719255,2.427527144997736
SNU-8,ISOX-bortezomib (250-1 mol-mol),1.008571676159857
LoVo,JQ-1-carboplatin (1-1 mol-mol),1.9010825713651585
PE/CA-PJ34 (clone C12),67156097,-1.858213748948673
CA46,25102847,1.8345278315547784
KMS-27,54143018,-1.1044690232436043
KMS-20,5291,3.4295110430475204
TE 617.T,6610355,3.955537249205886
PaTu 8988s,72376,-1.5914481946696195
KMS-20,UNC0638-navitoclax (1-1 mol-mol),1.0394785462110392
NCO2,65064,2.9956872970646593
NCI-N87,5281321,-1.2852273423113845
SET-2,156414,0.9354500438685124
NU-DHL-1,56946209,-8.095759228151296
KP-4,5329102,2.725759406628116
NCI-H2081,11494412,-0.0076516448343769
HARA [Human squamous cell lung carcinoma],89928392,1.691456490518517
BT 320,11485656,3.3413754154715796
SEM,46907787,-3.1211446232519178
SET-2,44491742,3.5989743077742387
A4/Fukuda,52912189,-0.8285591911559074
SK-N-AS,135999136,3.841880719801881
BT 139,51039095,2.2391406183743605
HEC-151,3676137,4.107793982328588
HuT 78,tanespimycin-bortezomib (250-1 mol-mol),-1.2620001487699233
EJM,9911463,3.809334952263978
SET-2,135440466,0.3849463595907619
ESS-1,56649450,2.890363396041127
PaTu 8988s,2871966,-0.1095165482463066
HuT 78,24753719,4.53725590635391
NU-DHL-1,24785538,1.0329892667677911
SNU-308,44241473,4.357724828152583
H-STS,119182,0.2834032478354432
HSC-4,7326481,1.9301811465772087
NCI-H2172,selumetinib-GDC-0941 (4-1 mol-mol),3.58741960121688
Kasumi-2,25126798,3.908076551751955
NCI-H2172,387447,-2.372723736293485
ESS-1,42642645,1.3351553509560612
MM1.S,322968,-0.5994478682175649
SNU-1214,11427553,2.9043841340969494
NCO2,5329102,0.6472346885413935
ML-1 [Human thyroid carcinoma],7251185,4.28899372473645
LNCaP clone FGC,selumetinib-decitabine (4-1 mol-mol),5.4258848699301225
SK-MEL-1,44507138,3.745085280013714
MM1.S,9915743,0.5251517896588939
JIMT-1,1750826,-3.177953176582802
RERF-LC-Ad2,6852167,2.3505226801926686
ML-1 [Human thyroid carcinoma],124202324,2.283804161098842
D283 Med,vorinostat-carboplatin (1-1 mol-mol),1.5123175007523422
ESS-1,46926350,-4.410058245118817
HARA [Human squamous cell lung carcinoma],carboplatin-etoposide (40-17 mol-mol),3.125998778003278
BT 139,568763,-0.0093893552495712
LoVo,6610216,4.332472846182503
KYSE-70,11175137,2.267736133904179
D283 Med,52947716,0.9658281246971616
SKM-1,66577038,3.0728529943968153
Raji,5287620,-1.5524953820622165
ML-1 [Human thyroid carcinoma],1566236,3.1920996771286783
YKG-1,46907787,4.9363681806831075
HEC-151,6852167,1.7550927798186455
NU-DHL-1,176870,2.457037183526244
NCI-H2081,9866186,-0.1809494281387173
NCO2,753704,3.723590000459205
MCAS,676352,2.173847245928757
KYSE-410,5351362,1.4338379223432771
SK-N-AS,65064,5.22731652193117
SK-LMS-1,71466578,6.071547313669305
PE/CA-PJ49,44185566,2.9892582778669503
TE 617.T,11404337,-2.8418150062947487
HARA [Human squamous cell lung carcinoma],24771867,-1.145662696893675
Raji,11640390,3.644744225679567
SK-LMS-1,25150857,3.157289421707309
HEC-151,navitoclax-sorafenib (1-1 mol-mol),2.5394801706733237
OAW42,11955716,2.731179891352535
CA46,5470400,3.727677755196873
WM983B,53232,2.3574100246554863
Raji,15953870,3.353900819495554
OAW42,carboplatin-UNC0638 (2-1 mol-mol),3.5995154157767613
NCI-N87,71304818,2.1951958800989133
PaTu 8988s,54619267,3.798156483041669
KYSE-410,9866186,2.7647131409969052
OAW42,23582824,0.8250858028039957
CML-T1,2828334,5.888296080725352
YH-13,10074640,3.684344080158783
ESS-1,67156097,-1.3750835854420782
Kasumi-2,46174525,2.7896977924424218
AU565,136227924,2.2371309282915184
YH-13,984333,1.552799653388661
Hep-G2,25062766,1.9430883989406535
BT 328,44607531,1.5766345227803793
Kasumi-2,44566777,1.2078773885517011
WM983B,10296883,3.9280678477622857
IST-Mes1,25154868,5.0412707783574735
RPMI-7951,2742550,3.350018850838408
NCO2,241158,1.6159541696435746
KMS-27,25150857,2.021589185938539
BT 320,409805,6.1406982436622
HuT 78,66577038,2.508658596603646
OE21,11228183,2.8752736860379504
SET-2,11609586,1.952463968520616
SNU-1214,44202524,1.5276984250934775
NCI-H2110,53495165,1.2696599250691445
SW1990,2828334,6.278483653876946
BT 139,5470400,0.7333090079769623
Kasumi-2,67156097,-2.3799018148926363
SET-2,445643,3.8553582166731415
NU-DHL-1,44486219,3.982254697079296
NCI-H2172,2949965,5.543762898620983
PaTu 8988s,11625818,4.462633368005334
IST-Mes1,5113032,4.841043294054768
PE/CA-PJ49,11640390,4.292577053675064
RERF-LC-A1,10127622,6.057067097911176
LNCaP clone FGC,375860,-0.5963987861231773
KMS-20,24785538,-1.6506772000571488
Raji,72193861,0.4918514187287914
YH-13,11625818,3.6537350019321897
TE 617.T,10231331,2.9787791726298183
Kasumi-2,11609586,-0.6223010091545076
HuT 78,JQ-1-UNC0638 (2-1 mol-mol),-1.5524452367081547
OAW28,16722836,1.5279923407751788
AU565,421610,2.258686960610045
Ku812,decitabine-navitoclax (2-1 mol-mol),-1.352567227704547
SNU-8,16725315,4.537611285821178
BT 248,135440466,3.298497559431859
SK-N-AS,25195348,3.8156251051829218
KYSE-410,49793307,-2.0140322893035867
SNU-1033,6450551,4.4287775672397345
NCI-H1092,2733526,5.304612787284194
KMS-20,4259181,-0.0713242382704696
KMRC-2,24856436,2.923913597668444
HSC-4,10302451,2.384078053411002
PE/CA-PJ34 (clone C12),637858,1.319722583622998
PaTu 8988s,navitoclax-gemcitabine (1-1 mol-mol),-0.1588864518233156
NU-DHL-1,BRD9876-MK-1775 (4-1 mol-mol),0.6044264218877945
H-STS,11222830,1.7144208699256454
PE/CA-PJ34 (clone C12),5460769,-0.2838566207500756
NU-DHL-1,11656518,1.0275988085654195
HSC-4,4788,5.270141450772874
SKM-1,57519531,1.204378273950668
SNU-8,5470400,-2.564132685735376
BT 320,322968,4.418694945814317
RERF-LC-Ad2,2746,5.029161088145208
OE21,6852167,2.0185127581228763
NU-DHL-1,6918837,-5.004297563636696
RERF-LC-Ad2,navitoclax-pluripotin (1-1 mol-mol),0.2360218345452729
RERF-LC-A1,702558,5.085084790342271
Aska-SS,9868037,4.2121131114727435
BT 320,11175137,3.303235141929386
TE 617.T,11507802,1.0822738369190534
GOS-3,5281672,4.273337523665355
TE-15,SNX-2112-bortezomib (250-1 mol-mol),-1.9782645389742703
KMS-27,1716436,3.601327816256154
HEC-151,6918736,-0.5117244940884614
MM1.S,44493528,4.254687888851587
RERF-LC-Ad2,1566236,1.925261747039256
HSC-4,11214940,4.953530718305131
Aska-SS,1750826,-0.901544414457822
MCAS,16013152,4.123178903224857
SK-N-AS,24856436,-1.628932436495073
RERF-LC-A1,23635314,-2.4833688664592373
KMRC-2,25183872,-0.2670953829983857
GOS-3,5738263,2.3320703610233724
CML-T1,3025944,4.207605674746215
KMS-20,5738263,2.421562414606395
BT 248,46224516,2.5816980785990875
SNU-1033,navitoclax-sorafenib (1-1 mol-mol),2.074211206681648
AU565,2871966,0.5985779022023225
SK-LMS-1,107985,-2.0791216357249054
HEC-151,24856436,0.1538040410841821
OAW28,3062316,-0.5042902382709098
OE21,135659046,3.360946677017383
OAW28,46224516,2.3854099680927523
NCI-N87,2708,3.9537199090854673
AU565,227681,3.7153411694983887
IST-Mes1,3081361,1.9096346363157353
CA46,10427712,3.800630662833656
PaTu 8988s,71304818,2.815056412385755
HSC-4,selumetinib-MK-2206 (8-1 mol-mol),1.8625647516668664
BT 248,54626689,4.44361910749143
TE 617.T,1750826,-0.8446628594544829
ESS-1,71304818,2.8292725688978986
JIMT-1,11222830,2.0554414032913324
KMBC-2,9903786,2.1846129600819353
YKG-1,25154868,5.653220601909001
Kasumi-2,11625818,2.3070585930223477
Ku812,42642645,-2.294133807161646
HEC-151,tretinoin-carboplatin (2-1 mol-mol),4.7632496996236044
Hs 683,3854666,0.633440254190545
HARA [Human squamous cell lung carcinoma],9549297,1.8946305959472185
HEC-151,104842,-2.1594012391460735
A4/Fukuda,36462,-0.7730347482869518
OAW42,BRD-A02303741-navitoclax (2-1 mol-mol),3.509186685070675
PaTu 8988s,2126,5.9287347992088355
SEM,25105715,2.97048574375964
KMS-20,4378219,1.896511565907232
LCLC-103H,54454,2.120049105724829
YKG-1,9927531,5.706988241233545
HEC-151,53392493,2.135168779555376
PE/CA-PJ34 (clone C12),16720766,1.060904595920648
EJM,11175137,3.135182491748147
SET-2,24901704,2.3825305481978907
D283 Med,3854666,0.4329488785955893
HuT 78,6852167,0.2624976594092375
PE/CA-PJ34 (clone C12),navitoclax-birinapant (1-1 mol-mol),3.3511739424223457
AN3-CA,54626689,5.185402039214214
BT 320,serdemetan-SCH-529074 (1-1 mol-mol),2.392228056514646
Ku812,6918878,1.294263756548978
PaTu 8988s,5280436,1.929961763742872
KMS-20,54618795,2.973934546624762
SET-2,107985,-4.483879722090849
ML-1 [Human thyroid carcinoma],3689413,0.6725245747839163
Hs 683,54596558,3.756343230742294
RPMI-7951,44491742,3.876790810560562
H-STS,44819697,-0.0809498053641322
PE/CA-PJ34 (clone C12),selumetinib-navitoclax (8-1 mol-mol),1.660781192604045
SNU-1214,3384730,2.1855301864131422
KP-4,60750,-3.857385032944416
Raji,208908,1.6366125751195242
KMS-20,49836020,5.970121389426133
BT 504,10113978,2.61825508760096
NCI-H2110,9933475,2.2594309830350054
OAW28,702558,5.716785737298097
KMS-27,219104,3.484553686975267
NCO2,446155,2.74859012596089
GOS-3,6918837,-2.1176912664371144
NCO2,6252,-2.058888652832414
CML-T1,9444,4.326131103147221
BT 330,9915743,0.5029117023680005
CML-T1,alisertib-navitoclax (2-1 mol-mol),-1.6309921665617133
BT 139,15547703,3.8265236987304823
HSC-4,3025986,-1.9523671858491285
MM1.S,5281321,-2.4935203757499997
ML-1 [Human thyroid carcinoma],11167602,2.9640815113410923
NU-DHL-1,decitabine-navitoclax (2-1 mol-mol),-3.2385891621120786
LNCaP clone FGC,6917907,-5.735621263633647
MCAS,25126798,3.8264410165946336
NU-DHL-1,44632017,-0.251527549613568
RERF-LC-Ad2,1641662,4.420593940976066
YH-13,11214940,1.756237854396178
SEM,selumetinib-vorinostat (8-1 mol-mol),0.5449202862000408
NCI-H2081,46224516,0.9232346266515704
OAW28,107985,-3.5497769626209217
KYSE-70,3543504,4.273044270546896
Hep-G2,46398810,2.254556195261035
RERF-LC-Ad2,126941,-4.128221669961258
KMS-27,9936388,-7.881651109846528
CML-T1,148198,-3.9003291277504526
YKG-1,3854666,1.2272418792594904
BT 139,4259181,1.714008353576017
PaTu 8988s,navitoclax-PLX-4032 (1-1 mol-mol),3.0937800000641493
SET-2,123631,1.6700754945891212
LoVo,6610355,3.962139785065475
PE/CA-PJ49,crizotinib-PLX-4032 (2-1 mol-mol),1.4047955242788717
BT 504,5287620,-2.1942468893677542
LNCaP clone FGC,5280436,1.7775351222193678
Aska-SS,44607530,3.7629974782079674
KYSE-70,11404337,0.2060464556058333
SKM-1,10302451,3.713731670018531
KYSE-410,46907787,2.6604064739007804
NCI-H1395,11485656,1.9214345391656065
NCI-H2110,9911463,4.283441783130732
AU565,11317348,4.006750700524709
SW1990,16219061,3.467469065240219
AU565,46907787,3.197599854412173
LoVo,1641662,3.111662868893329
Hs 683,208908,1.8258770070851449
Kasumi-2,53232,4.135119610512006
HCC2218,44819697,2.205591212815753
OAW42,89183176,4.957870731206607
GOS-3,44589607,2.926429501470136
HARA [Human squamous cell lung carcinoma],10385095,1.0837341672046903
CA46,24771867,-0.8036362931877258
HCC2218,176870,2.47397725704118
BT 330,selumetinib-JQ-1 (4-1 mol-mol),4.150840661532534
HuT 78,navitoclax-PLX-4032 (1-1 mol-mol),0.749332467745858
WM983B,6610216,4.015594712233716
NCO2,36462,-0.655679332462451
Ku812,24901704,-0.4203026454288152
BFTC-909,5287620,-2.871557478653834
MM1.S,selumetinib-BRD-A02303741 (4-1 mol-mol),3.755901339608387
NCI-H1395,46843906,3.1516076694809994
SNU-8,11178236,-4.432412759173127
Hs 683,3543504,5.0981277433978205
SET-2,54596558,4.29557036905182
BT 330,selumetinib-UNC0638 (4-1 mol-mol),4.0092554620462835
BT 504,navitoclax-piperlongumine (1-1 mol-mol),2.159869596294648
NCI-H2172,10184653,4.232620517792368
TE 617.T,11152667,-1.0765284818833325
IST-Mes1,462382,1.0027449292382402
PE/CA-PJ34 (clone C12),104842,-4.003781154796879
Hs 683,46926350,-4.250334489293196
BT 328,9903786,4.817171686681598
ML-1 [Human thyroid carcinoma],25126798,4.037868296097697
EJM,100016,6.634092198961092
NU-DHL-1,44202524,1.452274997974498
SK-LMS-1,71751553,5.37247176250955
NCI-N87,JQ-1-vorinostat (2-1 mol-mol),-1.1800761907808068
BT 504,11364421,-1.9089246946956964
RERF-LC-A1,216468,4.229831895560937
OE21,57519531,2.944377743454458
WM983B,5351362,1.1374404234545994
YKG-1,3038522,1.877440168253775
YKG-1,8515,4.7576372381485
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308
TE-15,6610355,3.622853234209338
SK-LMS-1,5311,2.961845688790093
SNU-1214,11175137,3.3781853792916787
ML-1 [Human thyroid carcinoma],5280436,5.01828711367565
NCI-H2081,53392493,1.9098873697280916
SK-LMS-1,66577038,3.208935464661633
OE21,168312962,2.0349973268808
HSC-4,doxorubicin-navitoclax (2-1 mol-mol),-1.2623488821486932
HMCB,4521392,4.730786278370015
MCAS,9926054,1.882674367902201
SW1573,11178236,-2.507507612037206
HCC2218,100016,5.089450081937329
ESS-1,24771867,2.6208219680257328
SNU-1033,104842,-3.0813929648763905
NCI-H2081,12003241,2.480414390654569
SET-2,568763,-0.7021275174916793
YH-13,1750826,-2.081763837802431
D283 Med,71751553,4.245405525851178
KMBC-2,71466578,4.853263312097692
NCI-H2081,6505803,1.279924414831301
RERF-LC-Ad2,selumetinib-BRD-A02303741 (4-1 mol-mol),5.235970238895281
KYSE-70,675434,4.695192974207532
TE 617.T,176870,1.0236396280936095
SKM-1,3025986,-2.206806722856398
Kasumi-2,16659841,3.619219766502468
A4/Fukuda,421610,2.9916322722523425
SK-LMS-1,26596,1.8216060443410544
SK-LMS-1,9911830,2.533802245803789
HEC-151,219104,3.6842983437818058
LNCaP clone FGC,4788,4.966129065472295
SKM-1,227681,3.1077347467323224
Kasumi-2,46215462,1.2219116069395664
Ku812,6623618,1.7016648351323582
PE/CA-PJ49,2749,1.8530825541406395
PE/CA-PJ49,148124,-8.481770349273331
SK-N-AS,42611257,3.470351548530906
CML-T1,11717001,4.07494523492724
LNCaP clone FGC,11625818,1.7203183902552397
ML-1 [Human thyroid carcinoma],135440466,2.0685655954708824
KMBC-2,selumetinib-JQ-1 (4-1 mol-mol),1.4650712581947256
A4/Fukuda,46199207,1.9027513858957976
SNU-8,carboplatin-etoposide (40-17 mol-mol),3.8322598256715543
CML-T1,2858523,2.0919777443937715
SEM,71466380,1.6371741531095363
HuT 78,8515,3.8606402282287657
PE/CA-PJ34 (clone C12),11317348,4.808081492985304
PE/CA-PJ49,56649450,2.459480943641603
ESS-1,piperlongumine-MST-312 (1-1 mol-mol),0.6128133156835777
RERF-LC-A1,9903786,4.61839139463389
KMRC-2,navitoclax-pluripotin (1-1 mol-mol),-0.9157954124950312
HEC-151,6505803,0.2052514279790806
SKM-1,168313200,4.186901063511942
NCI-H2081,JQ-1-UNC0638 (2-1 mol-mol),0.2107025154126548
PE/CA-PJ34 (clone C12),66577038,3.169631550973707
MM1.S,135411,0.4705097492243096
MCAS,9840324,5.2050043041150245
TE-15,3136844,3.713291500695178
BT 504,11485656,1.8828721795315295
OAW42,4378219,2.256269324004719
AU565,89928392,2.1536851128845904
MM1.S,168313016,2.515366642859788
PE/CA-PJ49,selumetinib-decitabine (4-1 mol-mol),5.036707112558136
SK-MEL-1,decitabine-carboplatin (1-1 mol-mol),4.4221897912824435
Ku812,11507802,0.7053087419669674
TE 617.T,JQ-1-carboplatin (1-1 mol-mol),1.6979959142929375
Ku812,11152667,-2.1041122356576127
HSC-4,5566,3.1631957469062684
NCI-H1395,11396600,4.124168749082167
KMS-20,11640390,0.2250858855689749
SW1990,24771867,2.961729646695687
RPMI-7951,sirolimus-bortezomib (250-1 mol-mol),1.5520674857207382
ML-1 [Human thyroid carcinoma],9936388,-4.434207119356507
YKG-1,24180125,3.6126357196897496
SK-N-AS,25150857,1.065175537817186
EJM,67156097,-2.836977847319536
HuT 78,675434,4.061234501182394
BT 504,3025986,2.338357492096702
LoVo,11625818,2.0848313295223844
Hs 683,10077130,6.330426980372672
AU565,navitoclax-birinapant (1-1 mol-mol),2.4267027556232836
BT 320,73707438,3.918904444875683
LoVo,12001922,1.64420677630862
CML-T1,2708,2.830885116766648
NCI-H2110,16219061,3.166955045757715
NCI-H2110,135659046,4.755266203031495
BT 330,644241,2.044782133454181
BT 139,2729026,2.333147558824636
D283 Med,24901704,2.1853171446916257
NCI-H2110,SNX-2112-bortezomib (250-1 mol-mol),-2.488327500904662
PE/CA-PJ34 (clone C12),374536,3.765928674441179
SET-2,24785538,-0.3698408856768623
SEM,56946209,-6.723586049186012
D283 Med,56973724,2.3235035869013703
BT 330,53495165,-1.711062636200042
HEC-151,73707371,4.4632705727221245
TE-15,5738263,2.473444471017114
SET-2,54618164,3.897456065397519
ESS-1,alisertib-navitoclax (2-1 mol-mol),-0.432728207962684
EJM,216345,3.6507207430679616
Ku812,11178236,-3.734217026428133
RERF-LC-A1,navitoclax-piperlongumine (1-1 mol-mol),2.413546643288704
KMS-20,25105715,2.3755676458508277
TE-15,11625818,4.172467616978408
HuT 78,10322450,2.3335862951913726
SK-MEL-1,322968,3.933922383626387
CA46,227681,1.829365253324193
CML-T1,9915743,1.9836361869709076
Hep-G2,168313016,5.1281820641860545
Raji,168312962,0.8665560177214189
KYSE-410,46843906,2.989071360754789
Raji,3634881,2.495614055557117
A4/Fukuda,400769,-1.555916482707746
SK-LMS-1,6505803,0.606445374310417
NCI-H1395,104842,-0.629937294678588
OAW28,11222830,1.7030270245193828
MCAS,11222830,1.783415446127836
NCO2,46224516,1.2023222105668852
NCI-H2081,doxorubicin-navitoclax (2-1 mol-mol),-3.331282092417488
NCI-H1395,11707110,3.0530004675688964
KP-4,10302451,4.244768589994227
MCAS,3825829,3.968162894586803
H-STS,16038120,1.2852053797527971
BT 330,68056272,3.791659523244117
AU565,16725315,3.19394291041594
ESS-1,1716436,3.7627823141372874
TE-15,BRD-A02303741-carboplatin (1-1 mol-mol),4.933510886872774
Aska-SS,135999136,2.4639426582272796
RERF-LC-Ad1,11626560,2.342625482561719
CML-T1,44589607,0.9502853682806348
MCAS,241158,4.420825214389376
Kasumi-2,BRD-A02303741-carboplatin (1-1 mol-mol),3.1733704189118894
NCI-N87,selumetinib-navitoclax (8-1 mol-mol),1.647881556522465
D283 Med,4521392,4.070852610455029
Raji,5746,1.4113173154358156
TE 617.T,12003241,-2.151805000440827
ESS-1,16722836,2.4138886266191086
ESS-1,135421197,2.603718676668537
Kasumi-2,6918878,1.1877992835952844
KMS-27,9825149,1.9092185850085857
SNU-8,5311,1.0961338625008177
SNU-8,452548,0.8743559932335202
BT 328,serdemetan-SCH-529074 (1-1 mol-mol),2.5091917299328315
SNU-308,9915743,-2.1849760358615296
HMCB,3854666,0.4980905922324143
SK-N-AS,36314,-3.61542660542322
KP-4,136227924,3.1314573836961235
BT 330,31703,-0.3476663206942247
KP-4,5311,1.654340953589235
D283 Med,441298,3.3392911841728767
KYSE-70,676352,2.557270596786296
SEM,67291369,-2.94711830511694
H-STS,navitoclax-gemcitabine (1-1 mol-mol),-4.788943462701537
SNU-308,17755052,0.6777282543616701
MM1.S,3025944,3.5237417636724215
Kasumi-2,docetaxel-tanespimycin (2-1 mol-mol),-5.507046356769771
RERF-LC-A1,3825829,3.3687382314808265
ML-1 [Human thyroid carcinoma],42611257,2.85876832372032
OE21,12003241,-2.4283256435660205
MM1.S,navitoclax-gemcitabine (1-1 mol-mol),-5.407415705446715
NU-DHL-1,JQ-1-vorinostat (2-1 mol-mol),-1.099094096725154
HuT 78,31703,-1.631625857843589
BT 330,54649381,3.7606030780580255
SEM,3465537,0.8371255640679629
Kasumi-2,5281321,-3.5035572972621916
LoVo,46191454,2.275591949439888
SNU-1214,55283,4.343343098172006
NCI-N87,3634881,3.127468365851455
GOS-3,6505803,2.171469842265414
YKG-1,decitabine-navitoclax (2-1 mol-mol),4.796036772567169
KP-4,3689413,-2.736369445880075
SEM,11485656,1.8495119352561953
YKG-1,5281321,0.1990106510793085
OE21,46943432,2.2967121363038707
MCAS,53232,1.2719461381962025
Hs 683,5328940,1.5291062612291195
LoVo,1317464,3.6287749925486743
ML-1 [Human thyroid carcinoma],selumetinib-MK-2206 (8-1 mol-mol),-0.7620404937141786
SNU-1033,5329102,1.9595624260675009
KMS-20,navitoclax-sorafenib (1-1 mol-mol),1.3745359370236474
CA46,9840324,5.575806842573594
SNU-1214,44489127,4.458368254164627
Hs 683,11707110,3.5249505522714553
HCC2218,44566777,-0.7932095979791006
A4/Fukuda,11178236,-5.149024442366163
SW1573,17759555,4.342323370433329
D283 Med,119182,-3.5504334050643314
HuT 78,53392493,1.254063263001093
OE21,10231331,0.7094072975995727
SEM,5281321,-3.2823659838346697
HuT 78,52947716,2.981697525257689
HMCB,53392493,2.956281764261595
AN3-CA,24856436,0.4687169072066183
KMS-27,3081361,3.484716209908866
YH-13,4917,3.8244363131273458
SW1990,107970,2.5044307368694687
TE-15,2746,3.020954904357082
OAW28,46907787,2.388022074777516
RERF-LC-Ad2,5329102,2.745960476689009
IST-Mes1,JQ-1-MK-0752 (1-1 mol-mol),2.655505520266403
LoVo,54618771,0.7060685526757626
KMS-20,241158,1.964058176771948
EJM,72376,-2.674765470406556
PE/CA-PJ34 (clone C12),3038522,3.0123071564783777
LoVo,piperlongumine-MST-312 (1-1 mol-mol),2.135338171440717
SK-N-AS,24901704,3.6341490648566546
BT 139,123631,1.829633498163757
PE/CA-PJ34 (clone C12),11485656,1.7983954039931191
A4/Fukuda,72193861,-0.8043632874402014
SET-2,44607530,0.9874669623772268
BT 320,46398810,3.263265417740268
CML-T1,24901704,0.2948239854297986
NCO2,4521392,3.9977763012424377
TE-15,11626560,2.719456619678878
ML-1 [Human thyroid carcinoma],262093,3.5917492591420737
HCC2218,25150857,2.4817306828124313
HEC-151,5284616,2.6847657376009484
MCAS,24889392,4.880860270636762
SK-MEL-1,10231331,-1.9528897384138784
YH-13,44137675,2.4918035822396973
CA46,2749,1.009648399882346
HuT 78,10302451,3.5523158684911764
YKG-1,3025944,4.339643197163568
KMRC-2,65064,5.247444442299946
BT 330,10296883,4.249787142782667
PaTu 8988s,44493528,4.319224054149941
ML-1 [Human thyroid carcinoma],56973724,3.438642865372283
HCC2218,5278396,3.6856174156136374
SET-2,11214940,1.520131237216913
Raji,135398516,1.6921916464598077
HuT 78,10127622,5.47630186372846
SW1573,25102847,2.4268351657646874
Ku812,51037431,1.3532968628760291
H-STS,25227462,-1.51229280635868
HMCB,44607531,1.498982144758814
HCC2218,5566,-1.3857884624884214
MM1.S,135398738,3.10215639374587
YKG-1,44589607,3.192854738782174
SNU-8,11497983,4.308002849653566
HCC2218,53495165,1.287439615302038
ML-1 [Human thyroid carcinoma],135875424,5.514442636506433
SNU-1033,3025986,-0.1134743810645725
SET-2,5284329,2.750889251948025
RERF-LC-A1,135411,0.8558941149277943
Ku812,3825829,2.937255635905749
D283 Med,462382,-0.0438075540116339
D283 Med,451668,-1.57029447939279
PaTu 8988s,52947716,2.8130648859444523
PaTu 8988s,10127622,2.65847651383055
TE 617.T,31703,-3.86675458975869
SNU-1214,1242560,3.2645993868330265
NCI-H2172,16038120,1.3227343075096445
Hs 683,4259181,-0.0189213214010426
WM983B,446155,1.9418166097390095
SW1573,selumetinib-JQ-1 (4-1 mol-mol),1.6562897469951037
HSC-4,66577038,3.591157601556467
MM1.S,46398810,1.896454943753355
OE21,selumetinib-UNC0638 (4-1 mol-mol),1.44688345450047
RERF-LC-Ad1,400769,0.0163383776885635
CML-T1,9926054,1.696565612874625
Kasumi-2,104842,-5.6475576104946565
BFTC-909,44589607,3.3115887945185496
KMBC-2,SNX-2112-bortezomib (250-1 mol-mol),-0.6016200424782262
SNU-1272,46199207,3.241167347577687
KMRC-2,71751553,4.728116551648532
NCI-N87,12003241,-2.470820657410725
NCI-H1395,selumetinib-piperlongumine (8-1 mol-mol),3.796978991433947
TE-15,9956119,3.858934118650968
TE 617.T,salermide-PLX-4032 (12-1 mol-mol),4.973897299997077
D283 Med,65064,2.891889878161975
SK-N-AS,51039095,2.0531916534025583
MM1.S,54649381,2.997921024059072
SNU-8,6505803,0.4041272460627742
KYSE-70,5460769,2.831605222646697
PaTu 8988s,5566,3.001668312879565
KMS-20,3136844,4.071065919144672
PaTu 8988s,52912189,-0.4293595588527679
A4/Fukuda,54143018,0.5698360241890451
YKG-1,tanespimycin-bortezomib (250-1 mol-mol),0.0684440375972302
BT 139,445643,3.8282789867787104
ESS-1,136227924,3.049003867547222
GOS-3,54618771,2.751038853336045
KMS-27,26596,-2.324040117520084
TE-15,ISOX-bortezomib (250-1 mol-mol),0.2495596410464286
NCI-H2081,5743,3.6602518190396616
CML-T1,1242560,3.0102013740079783
ESS-1,56963564,0.4189689637772429
ESS-1,11625818,4.257377389303946
BT 504,969516,4.846359462982436
HuT 78,3854666,0.8787104419208177
SK-MEL-1,9840324,5.508982460875605
SNU-308,11364421,1.487320429758004
CA46,carboplatin-UNC0638 (2-1 mol-mol),3.486985389348746
TE-15,carboplatin-etoposide (40-17 mol-mol),1.7247988708379622
KMS-20,selumetinib-BRD-A02303741 (4-1 mol-mol),1.4575031822908706
BT 328,72376,0.5320465754189707
H-STS,135440466,1.636722926447895
SNU-308,676352,2.958164070149424
RERF-LC-A1,vorinostat-navitoclax (4-1 mol-mol),1.5348804245708227
SET-2,25183872,-1.8828048567516271
SK-LMS-1,327653,3.1438411129584933
Kasumi-2,16219061,1.087081093705916
CML-T1,327653,2.5732071532781866
JIMT-1,navitoclax-PLX-4032 (1-1 mol-mol),3.3448945850140968
AU565,25195348,3.492226581515367
NU-DHL-1,5291,3.690421399928162
SET-2,selumetinib-piperlongumine (8-1 mol-mol),2.3759886885841293
Raji,31703,-3.5148796323259446
NCI-H2081,52912189,1.203290286041043
NU-DHL-1,11213558,3.5998210227089036
EJM,3854666,0.5770225844187807
BFTC-909,1750826,-0.1726466566192349
WM983B,51037431,4.669061776188775
ESS-1,3384730,2.888530811754609
NCI-H2110,439501,-2.2349143195011583
PE/CA-PJ49,135999136,4.298011402376219
PE/CA-PJ34 (clone C12),54618771,0.3330928840466188
PaTu 8988s,5291,3.600934363557586
NCI-H2081,262093,2.026605801788383
RPMI-7951,5566,2.3477005519736083
KMRC-2,9825149,2.7901863927657247
KMS-27,24785538,0.2071067325135329
CA46,16065773,1.8844207098737984
BT 139,decitabine-navitoclax (2-1 mol-mol),0.8812766124383217
KMS-27,vorinostat-navitoclax (4-1 mol-mol),-1.848445503822888
SNU-308,216345,4.441885405176313
MCAS,216345,4.8670475281089045
NCI-H2110,carboplatin-etoposide (40-17 mol-mol),1.3774072251808476
HuT 78,11427553,0.3947942526358813
SEM,168312962,2.860671737666069
LNCaP clone FGC,16013152,2.5423309014724076
SK-N-AS,7251185,1.8366364514171465
CA46,60700,-1.6899904219212585
YKG-1,10385095,1.6490747273170454
LNCaP clone FGC,241158,3.9934021722066784
HMCB,10385095,1.0131649772543003
PE/CA-PJ49,5351362,0.8409386836986219
KYSE-410,5328940,1.0709504499455504
YH-13,25154868,5.479535858900875
KYSE-410,387447,-4.701677943314103
HSC-4,24785538,3.772420906085344
SK-LMS-1,5281672,5.729460184884058
SK-N-AS,tanespimycin-bortezomib (250-1 mol-mol),0.7232551135734744
SNU-1214,5566,2.3887972000624296
SK-MEL-1,8515,3.632622061872653
KMS-27,3038522,3.4686403819900007
MCAS,navitoclax-birinapant (1-1 mol-mol),1.833168601601442
GOS-3,66577038,3.060096848137411
ML-1 [Human thyroid carcinoma],24748573,2.352453339172467
NCI-H1395,11656518,2.2687803518385365
SNU-1272,alisertib-navitoclax (2-1 mol-mol),1.6439535972099484
KMS-20,44462760,0.735907586100602
D283 Med,4096211,0.7263346692990906
IST-Mes1,168312962,2.5289389848934647
TE 617.T,1641662,3.175023016974929
KMS-27,5351362,0.4742016355596101
NCI-H2172,10296883,3.8919469305692256
NCI-H2081,24951314,0.5279638616093859
SK-LMS-1,6450551,3.8959522130422135
BT 328,46224516,3.135960011776331
JIMT-1,4259181,-0.6325464626851699
TE-15,46907787,0.2449943729998491
SKM-1,selumetinib-tretinoin (2-1 mol-mol),-3.0324303149575904
ESS-1,11175137,1.5326050179721749
KMS-27,44589607,2.129697097661726
HEC-151,6918837,-2.8647570458184433
NCI-H2110,25126798,3.7228045991020817
NCI-H2110,11234052,4.624815979691428
KMS-27,decitabine-navitoclax (2-1 mol-mol),-1.799686527598198
SET-2,51037431,3.918390185213242
KMBC-2,25062766,2.4834909036700203
KYSE-410,42611257,2.6736806454935276
TE 617.T,3552672,4.636158960130362
LoVo,erlotinib-PLX-4032 (2-1 mol-mol),1.656921727064621
Ku812,10385095,1.0609410330256543
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
NU-DHL-1,3465537,0.9340526955418934
KMRC-2,9903786,3.847767222952075
Kasumi-2,3634881,1.9476495169521624
HSC-4,6918289,2.856015155241233
CML-T1,54618771,0.285641515878807
NCO2,JQ-1-navitoclax (2-1 mol-mol),-1.1320267901313352
AU565,17755052,-0.9729531204394496
IST-Mes1,9903786,2.7623614356082458
ESS-1,decitabine-carboplatin (1-1 mol-mol),5.337587299103004
SNU-308,11427553,3.899753909319736
RPMI-7951,52947716,3.0759598541034796
SNU-308,16722836,1.6160846911951356
TE-15,53392493,3.2221529579805983
HCC2218,10077130,4.346327682406917
SKM-1,19582717,2.678138329760968
HMCB,6438330,1.909471735352977
AN3-CA,tretinoin-carboplatin (2-1 mol-mol),6.598989461225886
WM983B,4788,5.883402228923509
Kasumi-2,46199207,3.5720995907025803
NU-DHL-1,erlotinib-PLX-4032 (2-1 mol-mol),2.559491717642415
OE21,24901704,3.8910537982527673
SNU-1033,15983966,1.6057150130260425
SW1990,5278396,4.36316707507952
Hs 683,11647372,1.1270075140835378
ML-1 [Human thyroid carcinoma],126941,-2.044263255039902
HCC2218,2733487,6.357125769523036
EJM,10113978,3.070208700221595
Hs 683,3081361,1.8007329789984097
OAW28,6610355,6.153508691776863
SW1573,9866186,2.2605214925080035
A4/Fukuda,46224516,1.3171235816864948
LoVo,46398810,1.578557668618055
PE/CA-PJ49,4521392,3.9756678286917775
HMCB,11404337,-1.2429546984634874
Kasumi-2,11507802,0.0513516992758086
BT 504,135659046,3.5842907457354376
KMBC-2,selumetinib-PLX-4032 (8-1 mol-mol),3.916029133492093
D283 Med,selumetinib-PLX-4032 (8-1 mol-mol),5.220725051966228
SK-LMS-1,6914657,-2.5359699625386685
KMS-20,5311,0.5424141236542899
OAW28,285033,-1.6788024908058845
A4/Fukuda,9903786,0.7546004224414102
HuT 78,969516,2.200953925383129
ML-1 [Human thyroid carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.127776457092234
NCI-H2081,10410894,3.3787731123867464
KMBC-2,alisertib-navitoclax (2-1 mol-mol),-0.3408409494439297
A4/Fukuda,11647372,-0.68075141177871
Kasumi-2,9927531,4.453654232617923
A4/Fukuda,119607,3.918640768426122
SK-N-AS,216239,2.0759045042725837
MM1.S,44202524,1.2152140209200315
PE/CA-PJ34 (clone C12),4788,5.839985662068601
BT 328,3825829,4.625111565622426
RERF-LC-Ad1,51039095,3.4667294063138407
SK-MEL-1,11612883,3.2645007615915933
OAW42,156414,1.8124502035679988
TE-15,26596,-3.7197158754991615
D283 Med,16722836,1.0096131047253871
BT 328,9936388,2.1535847087745386
MCAS,10127622,1.8277619446104008
NCI-H2081,6917907,-5.960779404992594
KYSE-410,9927531,5.048506934315496
KMBC-2,9956119,4.710694162970388
NU-DHL-1,selumetinib-JQ-1 (4-1 mol-mol),-0.9508883032540202
SET-2,5460769,3.4880653417656022
PE/CA-PJ49,135411,0.8247523784493911
YKG-1,crizotinib-PLX-4032 (2-1 mol-mol),1.242537511199376
YKG-1,56649450,3.459902550410693
SKM-1,3025944,3.5406886531793225
KMS-20,208908,1.6387060547766314
LoVo,56949517,2.258326270055845
HARA [Human squamous cell lung carcinoma],60700,-1.6734694813518207
YKG-1,11497983,4.151175156243401
KMS-20,3062316,-0.0467041684401502
MCAS,SNX-2112-bortezomib (250-1 mol-mol),-2.5445813038175222
JIMT-1,10074640,3.5044675599028414
SK-MEL-1,66577038,3.3885639497610205
OAW42,9907093,4.193554498080869
HEC-151,3025986,-2.169802753575252
MCAS,10302451,3.470287420983729
ESS-1,444795,3.9723378710264985
SK-MEL-1,6610216,4.20996876122129
D283 Med,5291,3.8993292084473814
RPMI-7951,carboplatin-etoposide (40-17 mol-mol),2.086794328183726
NCI-H2081,72376,-1.7545095760528466
TE 617.T,5282054,2.832126943240028
SNU-308,11609586,3.686939237017378
D283 Med,135659046,3.420100505846104
OAW42,66577038,2.770725183059622
SNU-8,11404337,-0.4750422228003279
NCI-H2110,31703,-2.3083076582256083
KMRC-2,23635314,3.8772911931885568
AN3-CA,6914657,-5.228653700421252
NCI-H2081,44607530,1.5089413575069657
SET-2,UNC0638-navitoclax (1-1 mol-mol),-0.0926361698206657
RERF-LC-A1,16115403,-3.2935296690861846
PE/CA-PJ49,71466380,4.6952219405725435
SEM,148198,-7.106649826649242
SNU-308,selumetinib-navitoclax (8-1 mol-mol),2.9333493766077
MM1.S,16741245,2.4226245621755016
SNU-1214,135875424,3.75117609732274
JIMT-1,4917,3.0160122946878656
SNU-8,135398516,0.7053023430063577
KMRC-2,122327,4.0267787578359835
LoVo,71466578,1.8530080227063717
NCI-H2081,4788,5.364194014939799
EJM,44487872,4.364141533871357
ESS-1,676352,2.507808041358265
SK-N-AS,2113511,5.855864872818787
PE/CA-PJ49,72734382,4.152703498048938
ML-1 [Human thyroid carcinoma],11640390,3.608850000621235
IST-Mes1,54618771,0.8929247318821524
NU-DHL-1,2742550,3.0949121408680886
KMS-27,SNX-2112-bortezomib (250-1 mol-mol),-3.169114693760398
TE 617.T,selumetinib-MK-2206 (8-1 mol-mol),1.3573740232103315
BT 248,navitoclax-MST-312 (1-1 mol-mol),0.9766831627739164
OAW42,6438330,3.312666565514621
BT 320,72193861,4.258668508473769
H-STS,119607,5.558084402470166
AU565,navitoclax-piperlongumine (1-1 mol-mol),2.020927074963466
OAW42,11178236,-2.3093374546462053
WM983B,erlotinib-PLX-4032 (2-1 mol-mol),-0.0727602327646141
D283 Med,89183176,3.347036918603312
NCI-H2172,322968,4.774024266828323
RERF-LC-Ad2,4378219,2.030697080387384
LNCaP clone FGC,6610216,3.917804193778173
OAW28,216345,3.8770767977792913
BT 248,5278396,3.9189937549477545
KMS-20,25227462,-3.9594980981183534
D283 Med,carboplatin-etoposide (40-17 mol-mol),0.662788733652507
KYSE-410,7326481,3.59147835328922
Ku812,156422,3.166038236669379
HARA [Human squamous cell lung carcinoma],7326481,3.3732570103291657
BFTC-909,56946209,-2.8280109825858943
TE-15,doxorubicin-navitoclax (2-1 mol-mol),-2.2072480277972355
NCI-H1092,4917,2.811199240132262
NCI-H2110,11404337,1.6337523371229576
OAW42,4705,4.623217521868117
KMS-20,9868037,2.1280335543005293
BT 504,54596558,4.115488020149132
A4/Fukuda,selumetinib-UNC0638 (4-1 mol-mol),0.1859137838774149
NCI-H2110,446155,3.203285885476125
BT 328,322968,2.861041928630023
MM1.S,vorinostat-carboplatin (1-1 mol-mol),1.8626350946674588
Ku812,49793307,-4.102016019806379
RPMI-7951,navitoclax-piperlongumine (1-1 mol-mol),1.5386843401965045
HuT 78,135411,-0.1860381511558323
Hs 683,9911830,1.9641699230536744
OAW28,10296883,4.314409366833216
Aska-SS,3854666,3.7773042948558726
OE21,31703,-0.5136116587785329
BT 328,262093,2.379096363022233
OAW42,3465537,3.409740302129575
MM1.S,654092,-1.4935807523777964
TE 617.T,2949965,2.1108985425245796
HMCB,24856436,0.4140973737290317
Raji,54626689,5.170364825272944
HCC2218,24797083,0.8276710015239062
A4/Fukuda,24964624,-0.76967256635286
KMS-20,3025986,-0.9941815226128248
BT 320,53495165,1.9791180905331631
KP-4,salermide-PLX-4032 (12-1 mol-mol),5.008447458182367
SEM,156422,3.246663813247162
HEC-151,23725625,4.932869099588327
SNU-1214,2828334,5.794331402319802
RERF-LC-Ad1,6623618,2.970461552664049
Ku812,9823820,0.8448235439574285
HMCB,11626560,3.142721320668581
Kasumi-2,25183872,-1.7482434423211834
TE 617.T,6918736,-0.5588786583625035
H-STS,53232,2.3734460475104275
SET-2,6918328,-2.5220109859531497
BT 330,11175137,2.2159250165553175
RERF-LC-Ad2,11497983,4.777328214496428
NCI-H1092,ISOX-bortezomib (250-1 mol-mol),0.1294529339414141
NCI-H2081,selumetinib-piperlongumine (8-1 mol-mol),2.382828726466422
SNU-1033,5287620,-4.078658633318351
NCI-N87,navitoclax-PLX-4032 (1-1 mol-mol),1.558715689605079
RERF-LC-Ad2,107970,2.022505659566407
BT 248,400769,-0.0166923245796401
Aska-SS,1716436,2.2467196259646114
PE/CA-PJ49,46907787,3.401972170810614
IST-Mes1,676352,1.6027795070012942
NCO2,16115403,-5.444087936708219
SET-2,409805,5.152205992309063
BT 139,168313016,5.38709248356601
KMS-20,tanespimycin-gemcitabine (1-1 mol-mol),-4.135890410106922
HARA [Human squamous cell lung carcinoma],445091,4.978549366904043
KMS-20,3025944,3.4740880117517974
RERF-LC-Ad2,11167602,5.947765325830758
MCAS,9884685,0.0580097672331096
KMRC-2,5738263,3.9706624221369617
ML-1 [Human thyroid carcinoma],49846579,3.632639122540709
EJM,135999136,1.6782155584907743
SET-2,71751553,3.975724095102093
SEM,104842,-5.92078969792144
SNU-1033,44607531,1.915061497650475
PaTu 8988s,selumetinib-MK-2206 (8-1 mol-mol),0.9064049603975098
AU565,44819697,-0.774785052988496
Ku812,135398516,0.808826921913188
Hep-G2,216345,3.0800650649903436
Ku812,73707398,0.2962870044778456
SKM-1,selumetinib-vorinostat (8-1 mol-mol),-1.297292884672553
Hs 683,6450551,2.938905151489075
RPMI-7951,159324,3.4055874402556725
JIMT-1,5281321,-0.643402655781002
NCI-H2110,12003241,-0.2811614102315782
AN3-CA,11455910,0.3745394880525272
KYSE-410,55283,1.8179347719355985
SK-LMS-1,4378219,1.9539135587059129
SEM,carboplatin-etoposide (40-17 mol-mol),-1.5762350099115583
NCI-H2110,448949,2.5547306967217605
OE21,9823820,3.998720921326037
SNU-1214,5287620,-2.0712575071030326
CML-T1,9936388,-6.3994005254305995
EJM,44566777,-0.1727976349601711
MM1.S,JQ-1-MK-0752 (1-1 mol-mol),-0.6005566068077197
Hep-G2,6610216,4.162282260552703
Kasumi-2,107985,-4.524149027848321
MM1.S,65628,3.725915125304722
BT 330,49793307,-4.038045129216892
YH-13,serdemetan-SCH-529074 (1-1 mol-mol),3.0020411747572098
HARA [Human squamous cell lung carcinoma],10113978,3.460603354098383
Ku812,89928392,0.3085887086853859
SNU-308,SNX-2112-bortezomib (250-1 mol-mol),-1.4321385103419753
LoVo,46943432,3.050109964187685
OE21,46174525,4.431848508923809
AU565,46174525,5.4998307146624255
HuT 78,135423438,1.6811720044411254
TE-15,decitabine-carboplatin (1-1 mol-mol),5.90574027638704
ESS-1,9956119,4.049525614029127
MM1.S,3503,2.4888642007911175
BT 330,5311,1.7603481679347692
AN3-CA,16736978,1.2131559252663011
SW1990,11485656,1.987828191145096
HSC-4,53495165,1.6708694504220498
RERF-LC-Ad1,selumetinib-JQ-1 (4-1 mol-mol),3.573516405475977
RERF-LC-A1,9868037,1.4970424039127654
NU-DHL-1,selumetinib-tretinoin (2-1 mol-mol),1.2606436334910045
SK-MEL-1,tretinoin-navitoclax (4-1 mol-mol),0.8672158796156537
SK-LMS-1,31703,0.7910398871556167
BT 320,9825149,2.6279121601862676
RERF-LC-Ad2,4477,2.027795326183103
JIMT-1,375860,-0.7058390896374014
KMS-27,327653,2.9836297632664905
OAW28,11485656,3.2643123414600645
MM1.S,60750,-5.284473024198937
LoVo,selumetinib-JQ-1 (4-1 mol-mol),-1.8361098312254576
ESS-1,SNX-2112-bortezomib (250-1 mol-mol),-1.8592325691556872
SW1990,6918328,1.0030891487677016
PE/CA-PJ34 (clone C12),piperlongumine-MST-312 (1-1 mol-mol),1.2365607449836908
KMRC-2,3081361,1.5624883528172209
LCLC-103H,12003241,-0.4608233539243975
ML-1 [Human thyroid carcinoma],vorinostat-carboplatin (1-1 mol-mol),2.0705525470951587
NCO2,25150857,0.4912470555986215
ML-1 [Human thyroid carcinoma],5335621,2.3456257872682933
ESS-1,11977753,-1.6513872956899434
BT 504,1716436,2.231722818879149
Raji,5351362,1.8284566296891975
OAW28,BRD-A02303741-navitoclax (2-1 mol-mol),1.4319695403367312
LoVo,9926054,1.9069881185353632
NCO2,44819697,-2.412627486311444
Kasumi-2,11647372,-1.94314797775666
ESS-1,36314,-8.425270671395753
BT 330,107985,-2.041993977074398
KMRC-2,11497983,5.325556261162262
PE/CA-PJ49,11222830,1.7141113097768597
BFTC-909,135411,0.8518885281649031
EJM,16038120,0.4172376538699918
Kasumi-2,6252,-4.69021119640851
OE21,11167602,2.1998769764079884
RERF-LC-Ad2,66577038,3.292062541665056
SNU-1033,10184653,1.4967757543250255
KMS-20,6436223,-4.921746279888799
RERF-LC-Ad2,tanespimycin-gemcitabine (1-1 mol-mol),1.644525077585294
BFTC-909,carboplatin-UNC0638 (2-1 mol-mol),3.28125381181505
D283 Med,46174525,1.3652890399217403
SNU-8,1750826,-4.897790030937784
SKM-1,3543504,4.073022036864239
SK-MEL-1,2733526,2.8314406365269047
PaTu 8988s,selumetinib-navitoclax (8-1 mol-mol),0.853510092858617
EJM,49766530,-0.6352274600767028
SEM,409805,3.7048315559445575
AN3-CA,3385,5.79126133100466
CML-T1,salermide-PLX-4032 (12-1 mol-mol),4.618653772046038
NCI-H2110,285033,-2.9077531500214953
NU-DHL-1,5351362,0.683345885255648
AN3-CA,10427712,3.685891925367644
KP-4,11612883,2.230891969991632
RERF-LC-Ad2,135999136,4.345961129852593
MCAS,6918878,0.9071397786754258
KMBC-2,72376,-0.7788588244541385
KMS-27,4788,5.2861405054010975
BT 320,vorinostat-navitoclax (4-1 mol-mol),3.086351264141679
NCI-H1395,56649450,3.261892320114533
PE/CA-PJ34 (clone C12),9956119,3.8571372412004954
LNCaP clone FGC,9907093,1.5996607378578112
SET-2,11717001,4.260121463162566
NCI-H2081,JQ-1-vorinostat (2-1 mol-mol),-0.2017741262953333
HCC2218,107970,1.4999859497279118
OAW28,11404337,-1.5682838378564492
BT 248,53392493,1.7075191079379444
NCI-N87,25150857,2.476373943211786
HARA [Human squamous cell lung carcinoma],44185566,2.9912273208606552
SK-MEL-1,selumetinib-tretinoin (2-1 mol-mol),-0.7499311401821994
NCI-H1092,753704,4.364704525984801
SEM,46943432,-1.9096552724661455
KMRC-2,9866186,4.373631240679055
HCC2218,16741245,2.792602257727281
CA46,67156097,-2.616833441535583
KMS-27,5328940,1.8509249776552708
Hep-G2,3038522,4.124890793702152
MCAS,72193861,0.5600268291929783
MM1.S,15953870,5.481933437473156
Kasumi-2,4261,-0.415942894249068
SET-2,6917907,-5.85452555473126
SK-MEL-1,24964624,3.0419798026176323
SK-LMS-1,9825149,2.845623074931724
NU-DHL-1,2729026,2.5099936780211674
JIMT-1,6918289,2.923454600612105
ML-1 [Human thyroid carcinoma],JQ-1-navitoclax (2-1 mol-mol),0.5559974390910295
NCI-H1092,JQ-1-MK-0752 (1-1 mol-mol),3.999675305705296
SK-MEL-1,1242560,3.617042809512809
HMCB,3825829,4.05483266037916
KP-4,11228183,3.542329746983204
SNU-308,2858523,3.05429804839885
RERF-LC-Ad2,168313200,4.3712795765743255
SNU-1033,227681,3.718667619088726
EJM,5329102,1.5761634875262642
MM1.S,JQ-1-carboplatin (1-1 mol-mol),-0.259196457141764
Kasumi-2,151289,0.8385264971723331
Raji,16736978,1.1642856059975797
LNCaP clone FGC,45279963,3.0791910503127533
KP-4,16725315,3.490304952293189
CA46,9933475,1.582522184359856
Ku812,24785538,1.196998208063896
NCO2,5566,2.1008615340089305
Aska-SS,9444,4.284255356775216
CA46,9915743,0.7447060154867644
SEM,135398516,2.1523456379103028
OAW42,54618771,1.2241554078015442
H-STS,6918878,0.8588702567283845
RPMI-7951,24951314,1.154817681866478
HMCB,11238147,1.8414836223135087
RERF-LC-Ad2,navitoclax-piperlongumine (1-1 mol-mol),2.1145246572038565
OE21,208908,-0.200539873809521
SNU-1214,navitoclax-gemcitabine (1-1 mol-mol),-0.6659452983720491
SW1990,216239,3.0623929345543215
NCI-H1092,24856436,2.3450141967184233
GOS-3,navitoclax-piperlongumine (1-1 mol-mol),2.852873715439821
PE/CA-PJ34 (clone C12),24821094,-0.2762581028984301
SK-MEL-1,73707398,1.2021958708063876
CML-T1,selumetinib-tretinoin (2-1 mol-mol),2.254120654073675
SKM-1,53392493,1.9339863901276448
KYSE-410,72376,-2.171020985776524
PaTu 8988s,tretinoin-carboplatin (2-1 mol-mol),4.870625870132988
SET-2,5311281,5.420440730186175
Ku812,6450551,-2.2531779420040694
PE/CA-PJ34 (clone C12),156414,-2.3095911483351004
SNU-1272,969516,3.722830166507094
HSC-4,10127622,4.548794444843462
TE-15,5287969,-2.182793092465143
KMRC-2,72734382,5.924709157089256
AU565,3503,2.743681155949089
AN3-CA,11485656,-0.8274044857319752
LNCaP clone FGC,16065773,2.0959712633138423
BT 504,753704,4.931350289967595
RERF-LC-A1,135999136,1.9235315107843012
JIMT-1,135875424,5.902712544312733
YH-13,3552672,4.052352129280503
H-STS,10113978,4.065703828677869
OE21,44202524,1.341863747335709
RPMI-7951,654092,-0.1798670044623603
TE 617.T,9915743,-4.6063841978227
KYSE-410,441298,2.439581525248614
SNU-8,11364421,0.2778138033460223
ESS-1,3062316,-1.8450260242136765
RERF-LC-Ad2,16722836,3.0439182676210965
GOS-3,4259181,0.7347951046145877
KYSE-70,24964624,1.4483005111507754
OAW28,11625818,4.459236282412159
JIMT-1,452548,1.0642288296928477
KMS-20,5351362,0.6433164049464225
LCLC-103H,selumetinib-tretinoin (2-1 mol-mol),5.386262557976758
SW1990,9825149,2.486018157354109
SEM,23635314,-3.712591806997875
SNU-308,322968,4.604014460202124
HSC-4,BRD-A02303741-carboplatin (1-1 mol-mol),4.481505642686289
BFTC-909,24180125,2.699370118217823
SK-LMS-1,4521392,5.319177274757583
EJM,119182,0.4247713532004813
CML-T1,67291369,-1.213032955096986
EJM,24951314,0.9397817217373432
HuT 78,5284373,3.1403236788776314
OE21,selumetinib-MK-2206 (8-1 mol-mol),1.5228521171431184
TE 617.T,15547703,3.0129955014018237
TE 617.T,tretinoin-navitoclax (4-1 mol-mol),4.714029382854611
HSC-4,9952709,2.643320259436509
PaTu 8988s,168312962,3.50119634211369
Aska-SS,65064,5.347065069795541
KMS-20,3689413,-1.644811207648459
PaTu 8988s,9933475,1.5392829753432309
JIMT-1,3634881,4.430819529657494
NCI-N87,6918837,-4.459129390963203
Aska-SS,107970,1.9510492684161391
HuT 78,2708,0.286348811973392
SK-LMS-1,selumetinib-decitabine (4-1 mol-mol),6.678783247365014
MM1.S,44607531,1.436632189629932
CML-T1,6914657,-6.7918120052462685
OAW42,241158,4.137379643985406
Ku812,151289,0.0229500128579697
OE21,4521392,4.107626345506232
KMS-20,54618164,3.4319678497850705
RERF-LC-Ad2,45279963,4.603927979704453
BT 330,3384730,0.3611580582543141
TE 617.T,16720766,0.6194685193213763
YH-13,5113032,4.871050749600929
MM1.S,52947716,-4.198321546878978
NCI-N87,327653,3.392428289503534
PaTu 8988s,6184667,2.9190065631966173
SK-MEL-1,51037431,2.40466151350701
NCO2,445455,3.418963952391156
LNCaP clone FGC,11609586,0.8127524529146487
SNU-1272,11427553,3.4052745190282305
SNU-1272,56946209,0.3273283438568876
BT 504,444795,4.894377759650745
Aska-SS,6918638,1.1582390446838242
CML-T1,216345,1.8584843601432488
SNU-1214,selumetinib-PLX-4032 (8-1 mol-mol),2.398477274128209
BT 330,246676,6.180038418715505
D283 Med,15547703,2.9787798550877476
CA46,3025944,4.264528242833472
EJM,89928392,0.7789703373466773
BT 330,6610355,5.532780791196112
JIMT-1,5284329,5.143303137167667
AN3-CA,24901704,1.906570785391895
KP-4,11152667,0.9201986867468503
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
SW1573,216468,2.7570678542174294
KMBC-2,24180719,5.106392241669845
OAW28,219104,3.640461878438656
NU-DHL-1,71466445,1.452037118148276
Hep-G2,9840324,5.75050852869845
Hs 683,57519531,2.6846964890948875
OAW28,374536,3.018534312402979
KYSE-410,119607,5.136595755641417
Aska-SS,3503,3.4369193911145732
TE-15,2742550,3.96805077868976
SK-LMS-1,25102847,2.448614110794131
KMS-27,51039095,2.4502408780185903
D283 Med,24753719,3.1316348069328357
Kasumi-2,46926350,-4.426429724391801
KP-4,49793307,-3.288276813506919
MCAS,44137675,2.939638990664671
Aska-SS,11626560,-3.0218589475675226
NCI-H2081,10302451,3.961972444166296
OAW42,6918328,1.2418785321861934
KYSE-410,9911830,2.598803177921042
SNU-308,44137675,3.0382663195493382
NCI-H1092,64971,4.337644758899671
SNU-1214,46398810,2.1577623807495745
KMS-20,6918837,-5.417214970743668
NCI-N87,5280436,4.116578666931142
GOS-3,11178236,0.4111622236569117
EJM,42642645,0.830143723901443
OE21,5291,3.3087584466891813
BT 328,24951314,3.0926880274607753
NCI-N87,16722836,0.5704530263405226
HuT 78,11719255,1.766568320704254
JIMT-1,5329102,3.296068102927955
Hs 683,675434,4.367936233685233
BT 328,135398744,6.520469371663204
WM983B,5291,4.148723454710633
JIMT-1,11152667,0.2510787979057463
SK-N-AS,148124,-5.963448683076425
NCI-H2110,3689413,0.5131338822863976
PE/CA-PJ49,119607,5.897126928878016
SW1573,16741245,2.047879460545898
NCI-H1092,24964624,2.2870226351654637
SEM,erlotinib-PLX-4032 (2-1 mol-mol),2.337772510139529
RERF-LC-Ad2,54619267,4.920908972450122
EJM,44137675,3.342808530148661
KMS-27,3136844,4.048697620753124
NCI-H1092,tanespimycin-bortezomib (250-1 mol-mol),0.328880127360426
NCI-N87,11228183,1.1576925814137384
Kasumi-2,1716436,2.2552230484948477
HARA [Human squamous cell lung carcinoma],24180125,3.640570848683534
Aska-SS,568763,0.920290507458521
OAW28,71751553,5.303505748888211
ML-1 [Human thyroid carcinoma],452548,-2.1962617612927375
MCAS,107985,-3.860765706660282
PaTu 8988s,5278396,3.9928047507799698
Ku812,81146,4.292819669950478
HMCB,46843906,3.827430396412732
AN3-CA,46174525,4.153257771053101
HARA [Human squamous cell lung carcinoma],441298,0.3301976976056055
MM1.S,17755052,-0.7145946453467518
RERF-LC-Ad2,4259181,0.9500738030007112
NCI-H2110,5311281,2.5750016799213564
PE/CA-PJ34 (clone C12),crizotinib-PLX-4032 (2-1 mol-mol),2.0573857462256124
OAW42,8515,4.937675036123391
SK-MEL-1,25105715,2.6177296004409185
HuT 78,24771867,-2.8492074914531407
HSC-4,4917,3.66079963002401
SK-N-AS,3025944,4.250148957941627
OE21,16013152,5.5838435912248015
GOS-3,24785538,1.563454655561809
RPMI-7951,148198,-2.190615440736015
CML-T1,71304818,1.5782846307483736
KYSE-410,151289,3.1282412096438477
BT 248,navitoclax-PLX-4032 (1-1 mol-mol),1.075952259913776
AN3-CA,3503,0.812908549205794
NCO2,135398516,0.1825544870983551
KMRC-2,5278396,4.273818300386133
SNU-8,2708,5.486542141379691
Aska-SS,11364421,-3.32672774799048
SK-LMS-1,2729026,3.0741249685189564
SK-LMS-1,11507802,1.4126896513922915
OAW42,10113978,4.352704606876751
HCC2218,135875424,1.4940742692763715
KMBC-2,5281321,-1.9570835424627304
BT 328,selumetinib-PLX-4032 (8-1 mol-mol),4.625572383999939
NCO2,selumetinib-vorinostat (8-1 mol-mol),0.8624505474898547
BT 328,89928392,1.451353651421501
KYSE-410,7251185,4.107605175954228
MM1.S,136227924,2.5395832269167027
PE/CA-PJ49,123631,1.961042341269847
LNCaP clone FGC,selumetinib-MK-2206 (8-1 mol-mol),2.0330759913309437
NCI-N87,1242560,3.6090545678814983
WM983B,637858,2.6617865393922906
NCI-H1395,3634881,3.864261643428736
HEC-151,3038522,3.9401881104716527
SKM-1,44507138,-0.8724707362135841
YKG-1,11364421,-5.418729498974909
ML-1 [Human thyroid carcinoma],vorinostat-navitoclax (4-1 mol-mol),0.5480043604957033
D283 Med,46191454,0.4881415464041219
SET-2,11396600,3.171295781716927
SK-LMS-1,25154868,3.229783914350985
LoVo,3854666,1.417426416420887
Hs 683,2742550,3.2253237968684134
HSC-4,tretinoin-navitoclax (4-1 mol-mol),4.058213789004076
RERF-LC-A1,6914657,-5.396629710467322
SET-2,6610355,3.64487356976899
IST-Mes1,tanespimycin-bortezomib (250-1 mol-mol),0.5343992581220592
ML-1 [Human thyroid carcinoma],17755052,4.154119256233629
OAW42,71680916,4.388668067052255
YH-13,262093,3.0071094341497826
RERF-LC-A1,3025944,4.319044268162594
ML-1 [Human thyroid carcinoma],89928392,0.0943028098974214
KMRC-2,11485656,3.489579667056433
JIMT-1,JQ-1-MK-0752 (1-1 mol-mol),5.1552416103255565
Ku812,crizotinib-PLX-4032 (2-1 mol-mol),-1.188059714033302
RERF-LC-Ad2,4521392,4.328503056699229
KYSE-410,46215462,2.1860497248848074
SW1573,31703,0.7694714266266048
LCLC-103H,400769,-0.2327707833195369
YH-13,54618771,3.881155680896358
SNU-308,5113032,5.401232227004145
D283 Med,6918878,0.6524959368526162
SK-LMS-1,7251185,3.044185157926379
Kasumi-2,9907093,3.255145953057051
GOS-3,16722836,1.9168472063673057
Ku812,5281321,-2.365774247469062
RERF-LC-A1,2749,1.8227713818128584
RERF-LC-A1,11167602,2.3879562150409788
BT 504,44819697,-2.40755703862291
BT 504,JQ-1-UNC0638 (2-1 mol-mol),2.7294851811604786
ML-1 [Human thyroid carcinoma],2126,5.801287401499987
RPMI-7951,6918736,-2.0199101963947608
HSC-4,16725315,4.164866459292326
HARA [Human squamous cell lung carcinoma],SNX-2112-bortezomib (250-1 mol-mol),-1.7614271905544292
KMS-27,selumetinib-navitoclax (8-1 mol-mol),-2.014253215631696
SNU-1272,navitoclax-sorafenib (1-1 mol-mol),0.9627190131227148
HuT 78,135440466,0.5263420458199721
NCI-H2110,72193861,1.5303088787695434
PE/CA-PJ49,9825149,2.059569205901066
PE/CA-PJ34 (clone C12),1239801,5.087439693870939
AN3-CA,444795,3.791626271347074
MM1.S,11612883,1.791748337852018
JIMT-1,1242560,4.292772737764005
D283 Med,70680404,3.701093742955501
RERF-LC-A1,65064,5.187705806393217
LCLC-103H,73707398,1.1679839843019937
H-STS,5281672,5.306153738631839
Hep-G2,3689413,1.297693127771037
EJM,4917,3.5272313521273415
SW1573,selumetinib-PLX-4032 (8-1 mol-mol),4.4065207246272005
AN3-CA,36314,3.30264317359827
NCI-H2110,44185566,2.8955090963041696
KMBC-2,24964624,3.269942985008608
ESS-1,53232,1.8155260046975692
KMS-27,9926054,0.4648817543416692
HSC-4,25262965,-0.4495508061813805
HEC-151,selumetinib-tretinoin (2-1 mol-mol),3.175453438392023
SNU-8,54618771,-0.2346938322915562
AN3-CA,51039095,-0.7477898547965632
KMS-27,5329102,1.2754691026352412
TE-15,11213558,2.2393015872709663
RERF-LC-A1,49766530,-2.6105960143319487
NCI-H2081,5329102,1.7214489652710063
BT 139,6852167,2.565632709988516
KMRC-2,erlotinib-PLX-4032 (2-1 mol-mol),3.2851821343888137
BT 330,54618164,3.911280393833352
HSC-4,9866186,0.7177643600632182
PE/CA-PJ34 (clone C12),46398810,2.398216250372749
SEM,navitoclax-pluripotin (1-1 mol-mol),-2.998871592273369
SK-MEL-1,31703,-0.6768611040979032
YH-13,tanespimycin-gemcitabine (1-1 mol-mol),0.5639208789602934
AU565,3825829,3.6732705699214105
SNU-8,6438330,2.278299075946909
IST-Mes1,3634881,3.096696127840678
NCI-H2110,3025944,4.089971841145756
KP-4,65628,4.537508539882641
RERF-LC-Ad2,16725315,5.240836708334476
CA46,SNX-2112-bortezomib (250-1 mol-mol),-3.5188600200549507
WM983B,135398744,6.927047773444745
SNU-308,4788,6.043537780465283
LCLC-103H,JQ-1-vorinostat (2-1 mol-mol),1.8490344501092353
NU-DHL-1,3025986,-0.9340926836685216
TE 617.T,25183872,-1.615385706309996
OAW28,5351362,2.5555782345102407
TE 617.T,4917,2.465000151468364
HCC2218,6918878,2.7353588630987686
TE 617.T,25062766,1.6641802399549648
Kasumi-2,11222830,0.4757152299010318
PaTu 8988s,136227924,2.43354349220747
SET-2,49766530,-3.130186221857788
Hs 683,serdemetan-SCH-529074 (1-1 mol-mol),1.0183404300099244
OAW28,3503,2.6573145013500743
TE 617.T,135440466,2.798852052515524
RERF-LC-Ad2,4788,6.022465947744937
KMS-27,49850262,2.9709310853441524
PE/CA-PJ34 (clone C12),44507138,2.9484181855986704
SK-MEL-1,49836020,3.8417397632517143
SEM,5280436,2.6493290705242636
NCO2,89928392,-0.5521265574818192
EJM,135398516,2.3604347567100965
HEC-151,crizotinib-PLX-4032 (2-1 mol-mol),2.750322812792129
SW1990,vorinostat-carboplatin (1-1 mol-mol),4.185330295794131
RERF-LC-Ad2,136227924,3.207411157267862
HCC2218,44589607,2.315850455563168
SET-2,3038522,2.442853150165528
TE 617.T,24821094,-3.6157652796729094
RPMI-7951,5281672,4.014017945800659
A4/Fukuda,46943432,-0.0927442133672991
PE/CA-PJ49,11485656,1.6473553373420289
NCO2,3385,2.684693871399256
BT 320,5280436,4.79134990721052
KP-4,9911463,4.220672229227994
HMCB,selumetinib-vorinostat (8-1 mol-mol),3.744114804484371
BT 330,16219061,2.713050419726025
Hs 683,56649450,2.9783836223956097
GOS-3,54596558,4.225745385987354
BT 139,11609586,2.914596514513223
HARA [Human squamous cell lung carcinoma],2858523,2.980861882613042
NCO2,46191454,-1.519487193767707
OE21,25154868,5.314720620107449
BT 139,53495165,1.1666373701090846
SK-N-AS,10427712,4.505749060089054
TE 617.T,11964036,1.464476618126061
RPMI-7951,20959075,-3.4556844315099338
LCLC-103H,5281321,-0.160992403838045
D283 Med,4705,3.1008912872866325
NCI-H2110,25195348,2.492831292074008
A4/Fukuda,6917907,-6.123586781218294
OAW42,navitoclax-gemcitabine (1-1 mol-mol),-2.8873665866917673
RPMI-7951,446155,0.7290278361931649
RERF-LC-Ad2,44819697,-0.974294728440346
ESS-1,11455910,0.1046831634026344
ML-1 [Human thyroid carcinoma],73707386,3.645367416812384
HARA [Human squamous cell lung carcinoma],navitoclax-MST-312 (1-1 mol-mol),0.8639589641874816
TE-15,44607531,0.6290395295712479
OAW28,16725315,3.4000122970226196
KP-4,6914657,-4.054574917998354
A4/Fukuda,3634881,2.7004024711225596
KYSE-70,54649381,4.140433754758901
BFTC-909,crizotinib-PLX-4032 (2-1 mol-mol),2.7598509436067906
NCI-H2081,44197249,1.2499480792075393
OE21,107970,2.067715024549662
BT 139,4261,3.718644080720644
KYSE-410,16720766,2.451225960087191
SNU-308,5329102,2.481111150286444
SKM-1,4477,0.924139002455618
AU565,doxorubicin-navitoclax (2-1 mol-mol),-1.8766069789082105
WM983B,11626560,1.6946680451066254
EJM,71466445,3.872070794685453
NCI-H2081,16038120,0.2763554915628486
SW1990,erlotinib-PLX-4032 (2-1 mol-mol),3.1505138932188994
NCI-H2110,25062766,2.323703238743529
PE/CA-PJ49,2871966,-1.0203219249186255
SNU-8,123631,2.432481388718517
RERF-LC-Ad2,docetaxel-tanespimycin (2-1 mol-mol),0.5061822490526904
NU-DHL-1,65064,2.7159461046068545
D283 Med,448949,1.5195328538607995
AN3-CA,168312962,2.1984376085167057
SNU-1033,322968,2.479712039507349
IST-Mes1,5282054,4.276236228318484
AN3-CA,3025986,-1.5680744465077654
KMRC-2,5566,3.121461088888439
KYSE-410,25105715,3.37078451111397
BT 330,25062766,3.0536121535083587
SEM,24821094,2.5010829781969774
NCI-H1092,135411,1.4198261476430412
KMS-20,5494449,2.3670693825128164
HCC2218,676352,1.7082186018348895
NU-DHL-1,10184653,1.6775776447141315
RERF-LC-A1,644241,2.932089965738435
ESS-1,135875424,3.182582939188363
JIMT-1,446155,3.558519974390135
BT 248,46398810,1.9244684206215508
NCO2,219104,1.3592981600655467
ML-1 [Human thyroid carcinoma],17759555,4.838019485799326
KYSE-410,176870,1.6923860408993845
SK-LMS-1,1641662,3.82758028546174
NCI-H2172,24785538,3.3212479615271366
SEM,44507138,-0.6979596604838103
NCI-N87,3062316,-1.4174361948917271
RERF-LC-A1,119182,-1.0992354118533822
NU-DHL-1,44491742,4.098367852004394
A4/Fukuda,8515,2.244185004641864
BT 248,6450551,3.394353011187604
HARA [Human squamous cell lung carcinoma],11317348,1.2268055094863417
YH-13,9903786,3.849279075978848
Raji,753704,4.744566564298066
Hs 683,16722836,1.639377356168815
OAW28,24964624,1.7856613849766505
SNU-1033,BRD-K55473186,3.698407793853298
HEC-151,24964624,2.1072074781623207
Hs 683,71751553,4.288998179151866
OAW42,46199207,3.6972984140580336
OAW42,46224516,2.821776088390658
CML-T1,135999136,1.353337094400064
Aska-SS,11152667,-1.72297256980761
Hs 683,12001922,1.3488364585339865
HuT 78,11626560,-0.0583952728146231
Aska-SS,2746,3.0488180575917463
KMBC-2,5351362,2.0199902229891356
YKG-1,4578,4.349355625393761
NU-DHL-1,11167602,2.239253055046329
HARA [Human squamous cell lung carcinoma],54613361,-1.6613115011598742
NCI-H2110,10410894,3.887521181440491
YKG-1,6610355,5.888296552052047
SEM,135984461,1.5883939694151252
YKG-1,25126798,4.0055488213659185
TE-15,54613361,-1.0416432703799845
BFTC-909,66577038,2.856590203747272
Ku812,46191454,1.1353148896243908
ML-1 [Human thyroid carcinoma],89183176,4.271882086089193
LNCaP clone FGC,selumetinib-PLX-4032 (8-1 mol-mol),4.8180087843942045
SK-N-AS,44819697,-0.3799973811764388
NCI-N87,46191454,1.700307220457573
SK-MEL-1,1716436,3.820132210959846
JIMT-1,67156097,-0.0861691385919231
KMS-27,24951314,0.3454296251372741
KMRC-2,135398516,3.3839358458345012
Aska-SS,10113978,3.4814618544469664
Kasumi-2,451668,-1.101171086852316
SNU-308,156414,-0.0512353312380724
D283 Med,6917907,-6.043720587150759
SET-2,19582717,2.274143567405833
KYSE-70,44202524,1.884457998669868
SEM,3503,1.134942375896238
NCI-H2172,4259181,0.413697798920579
IST-Mes1,piperlongumine-MST-312 (1-1 mol-mol),2.506000344733661
AU565,24748573,1.9131971710517224
ESS-1,49766530,-0.3205579652733103
Aska-SS,11396600,4.186494523446212
RPMI-7951,ISOX-bortezomib (250-1 mol-mol),0.1773808939731821
NCI-H2081,16720766,0.6801529058840203
Aska-SS,11257553,-0.3673169428608714
RERF-LC-Ad2,5311281,2.9510769338472542
KYSE-70,3062316,0.8461927752800795
PE/CA-PJ49,71466578,3.4798185838256424
SKM-1,5291,3.5671310197846267
CML-T1,selumetinib-vorinostat (8-1 mol-mol),2.04753807538672
RPMI-7951,51039095,2.6069304996363964
NCI-N87,52947716,-3.473486168283201
TE-15,5746,-0.1886497101513132
HuT 78,navitoclax-birinapant (1-1 mol-mol),-0.5043518643676743
A4/Fukuda,72376,-3.4342601152101473
Hs 683,9444,4.314878154306634
KMBC-2,4259181,1.3883022744442572
Hep-G2,9915743,2.3547256655946542
ML-1 [Human thyroid carcinoma],426756,5.157831333984941
OAW42,5738263,3.978980729619564
HEC-151,navitoclax-gemcitabine (1-1 mol-mol),-2.2394249546056972
HEC-151,5329102,2.7051876594578887
D283 Med,9866186,-1.70229195873881
D283 Med,68056272,-6.774567480474886
BT 248,327653,3.4402013175237394
OE21,selumetinib-BRD-A02303741 (4-1 mol-mol),1.5962384018267015
Hep-G2,navitoclax-pluripotin (1-1 mol-mol),-0.1847699337637438
HSC-4,44491742,4.173988284907792
HCC2218,23582824,1.521937184875748
HEC-151,1242560,2.9912281070430815
EJM,9927531,5.060130602494636
KP-4,26596,-2.006035898797214
HuT 78,9933475,1.6695706910823258
SK-MEL-1,5291,4.035708227942067
WM983B,5328940,1.6482757135749386
KMS-20,5281672,3.173673228263361
SNU-1033,448949,2.2538788240200724
AN3-CA,11609586,3.731629186042926
Ku812,3136844,4.770484958270985
Ku812,637858,1.0891915977996414
BT 330,119607,5.997382672500204
RERF-LC-A1,54626689,4.363358001048379
NCI-N87,54613361,-1.4178620324204825
SEM,1566236,0.4832736150587708
D283 Med,54618771,1.215604089870786
D283 Med,5351362,0.7934624245547425
WM983B,46843906,2.3355241232328785
OE21,5113032,4.566089749491281
SNU-1214,969516,2.1576653261965917
A4/Fukuda,10074640,2.009206402328629
PE/CA-PJ34 (clone C12),409805,3.8621146596524087
BT 504,11152667,1.2887357418273375
Hep-G2,159324,2.69530902129888
Aska-SS,25227462,1.0052150561481492
PE/CA-PJ49,selumetinib-tretinoin (2-1 mol-mol),4.909206986371302
SEM,11317348,-1.664715379633235
D283 Med,10302451,2.6795990859409695
OAW42,11964036,1.1297202111412792
Aska-SS,3025986,-1.1269382472860745
SEM,11626560,-0.667786957756766
KP-4,5351362,1.0460255800913
NCI-H1395,637858,2.3715473340173774
SW1990,25105715,3.6419570585511063
CA46,3825829,3.8503527939376583
KMS-20,44202524,1.4561593053704711
HCC2218,216468,2.074728004381242
BT 248,3038522,2.764297682711703
OAW28,49793307,-1.8076729764727852
HSC-4,24964624,2.5086826728272538
SNU-1214,46907787,-0.1476900319760525
Ku812,2828334,5.359664398174482
KP-4,24180719,5.26371468545235
H-STS,BRD-K55473186,4.025612277112804
NCI-H1395,11364421,1.3628820394407153
SK-MEL-1,11364421,0.213035643297777
NCI-H1395,52912189,3.2257776206607205
AN3-CA,148124,-1.73779448723161
RPMI-7951,2842253,5.693868632906147
HuT 78,navitoclax-pluripotin (1-1 mol-mol),-0.0445825989521908
KMBC-2,23725625,6.983046906431785
TE-15,11612883,2.028874235885918
LNCaP clone FGC,24753719,4.279348645230378
LNCaP clone FGC,11228183,3.180943323557888
SEM,44589607,1.526364309080405
SEM,25154868,5.025601551325329
SNU-1214,44607531,-0.2478501514076817
Kasumi-2,11427553,1.2029720763459597
Ku812,54618164,2.681700331746246
OAW42,126941,-0.9644696778639646
NCI-H2110,24772860,-1.5922871326648207
HCC2218,49766530,-1.6679502221604972
KP-4,selumetinib-navitoclax (8-1 mol-mol),3.470743491394599
KP-4,3543504,4.022018926398087
PE/CA-PJ49,5335621,5.293467271056006
NCI-H2110,6918837,-3.807984438873097
NCI-H1092,piperlongumine-MST-312 (1-1 mol-mol),1.5005628811138385
SK-LMS-1,135875424,4.759949001069946
KMS-20,11178236,-2.952639968854244
NU-DHL-1,46224516,2.2701616013146655
OE21,15547703,2.5365503437817263
EJM,24772860,-3.292775584200783
GOS-3,135411,0.9391696009475228
SW1990,1474550,4.493069593499753
HuT 78,navitoclax-piperlongumine (1-1 mol-mol),-0.4618726000146174
AU565,446155,4.298434988536317
KP-4,25102847,0.8930602765096312
BT 330,49867930,4.445743606373579
PaTu 8988s,439501,-3.8776790772528864
Ku812,5335621,4.179509612142592
OAW28,71304818,3.062868675930112
Hs 683,24753719,4.249788601430605
ESS-1,BRD-A02303741-navitoclax (2-1 mol-mol),4.070395472210358
A4/Fukuda,10231331,-0.0070700765814584
NCI-H1395,44607531,1.6381567273877196
H-STS,6918736,-3.6487860531030702
SW1990,676352,1.910648708099832
HSC-4,123631,0.7882754974693414
HuT 78,6450551,0.5524678941583652
NCI-N87,54649381,3.6397596564561487
SNU-1214,selumetinib-navitoclax (8-1 mol-mol),0.7432927168918613
PaTu 8988s,1239801,3.962308527881551
SNU-1214,9911463,3.639683247778992
LoVo,navitoclax-gemcitabine (1-1 mol-mol),0.8957448181446594
ML-1 [Human thyroid carcinoma],53392493,2.260380394132801
H-STS,9927531,5.457961831541725
SNU-8,5278396,3.766037951677824
KYSE-410,44543605,4.220068383699119
GOS-3,73707398,2.285638026393688
NCI-H1395,71680916,4.653034119360089
OE21,selumetinib-vorinostat (8-1 mol-mol),1.753596194788317
KMS-27,19582717,2.129982519189229
SW1990,71466445,5.525497338974383
CA46,1239801,3.4142476342729817
HARA [Human squamous cell lung carcinoma],vorinostat-navitoclax (4-1 mol-mol),1.9090977342000552
YKG-1,71304818,3.690747374674459
A4/Fukuda,16741245,4.963846947143099
JIMT-1,57330099,6.3115160926516305
NCI-H2110,216345,4.506742036788765
BT 320,400769,-0.2737977451215982
TE 617.T,3025986,-2.9533377775399376
MCAS,44819697,-0.3897995387059051
CML-T1,6252,-3.9112690302721265
LoVo,5335621,4.644708398315867
HARA [Human squamous cell lung carcinoma],11364421,-4.71423157944935
PE/CA-PJ49,42611257,3.1679792717367263
NCO2,68056272,2.7830900587315277
RERF-LC-A1,9952709,2.7957300597766905
Aska-SS,BRD9876-MK-1775 (4-1 mol-mol),1.635899844987541
RERF-LC-Ad2,2858523,3.25558003658132
KYSE-410,5746,2.8569470687695184
ESS-1,23635314,-3.6853445659402704
AN3-CA,24748573,1.2496269403470617
SNU-1272,6852167,2.886842068916118
NU-DHL-1,5328940,1.0877052650240928
MCAS,176870,4.086443000813508
BT 330,11396600,1.7759393171748088
Raji,24180719,5.292771843313121
HARA [Human squamous cell lung carcinoma],3503,1.5305596721968624
LNCaP clone FGC,6610355,3.563130598931258
Raji,51039095,3.3155695679488355
BT 330,10302451,3.8668829581904944
D283 Med,2858523,2.945286331512549
NCI-H1395,135421197,1.2810683988074232
OAW28,89183176,4.823946494889004
KMS-27,613753,2.615432098108357
OE21,5978,-4.237509886719093
RPMI-7951,tanespimycin-bortezomib (250-1 mol-mol),-3.2107041108384524
OAW42,89928392,1.6468274692145377
A4/Fukuda,11640390,-1.5428779369431247
WM983B,285033,-0.7438423653812216
KMS-27,5470400,0.9858362981297084
YKG-1,3081361,3.493822674928686
Hs 683,56963564,0.3272394235462448
RPMI-7951,54626689,4.364725309097019
GOS-3,5351362,2.3365334015432686
OAW42,25227462,2.55423994960915
OAW42,168312962,4.046404782948286
LoVo,107985,-3.583734032756361
Kasumi-2,24779724,5.733659143451784
NCI-H1395,6252,1.808154322431175
SNU-1272,11175137,2.9649563467216207
TE-15,crizotinib-PLX-4032 (2-1 mol-mol),1.7250862743662545
HEC-151,6184667,3.0163898402014597
WM983B,675434,4.272507315923553
KMS-27,24748573,1.0763276764001952
PaTu 8988s,11977753,-2.9446150832886815
PaTu 8988s,1750826,1.0085664751094332
SEM,25227462,-4.562496215443916
KYSE-410,73707398,1.149006405026039
HMCB,vorinostat-carboplatin (1-1 mol-mol),3.689100478232481
AU565,46926350,-5.126810871510528
KYSE-70,656346,0.9492660515895844
HuT 78,5282054,1.191616800468705
D283 Med,53392493,1.8196798066611335
A4/Fukuda,71466445,1.4546499284121797
BT 330,10410894,4.0887660018271905
SNU-1214,5280436,3.8026602944252184
SNU-1272,5311,1.8395995002993613
HSC-4,44607531,1.5153971496977892
HEC-151,11625818,3.876789656510256
KMBC-2,16722836,1.9787417702056784
BT 328,6438330,1.8463189750437397
SEM,BRD-A02303741-navitoclax (2-1 mol-mol),-2.0492341390598368
CA46,122327,3.963727711050333
TE 617.T,11427553,1.9207461631378344
MCAS,219104,3.9637771027882662
NCI-H1395,46199207,3.5912826317512136
MCAS,9825149,2.8412530080010874
Hep-G2,31703,-1.2144454026470897
YH-13,54143018,0.7752211198324802
KMS-20,57519531,0.5319259109001735
CA46,24856436,-0.7056093623802927
PE/CA-PJ49,107985,-3.897981701971708
SNU-8,vorinostat-navitoclax (4-1 mol-mol),1.1947638066550503
SK-N-AS,100016,6.379811774246359
SW1573,124202324,3.209850220678193
ESS-1,73707398,0.9452333213652502
WM983B,1242560,3.619503438458267
NU-DHL-1,49766530,-4.7275009055236445
KMRC-2,2945648,3.792915068350856
NCI-H2172,serdemetan-SCH-529074 (1-1 mol-mol),2.3503290461711424
NCI-H2110,navitoclax-MST-312 (1-1 mol-mol),0.9913337300457437
OAW42,JQ-1-MK-0752 (1-1 mol-mol),4.966576724518682
BT 504,36462,3.8166909345932383
A4/Fukuda,53392493,1.8640822641046917
NCO2,3062316,-6.803724492401588
CML-T1,68056272,2.531220488236934
NCI-H2081,9549297,1.131692292209531
HSC-4,135659046,3.804399419736421
RERF-LC-A1,5351362,1.0421798162906604
RPMI-7951,5978,-4.041450293577184
Aska-SS,219104,2.9804042619186433
HMCB,65064,5.473995129472351
GOS-3,crizotinib-PLX-4032 (2-1 mol-mol),1.48580275068934
SNU-1272,241158,4.382370259171122
A4/Fukuda,17755052,-0.6813796549781841
AU565,375860,-0.7785666069738753
SK-LMS-1,374536,5.368903896661628
NCI-H2081,60750,-4.420786299204752
HEC-151,1566236,1.8834874590606951
SEM,36462,-2.7360640601525845
PE/CA-PJ34 (clone C12),135411,0.6306768615973338
GOS-3,44819697,0.5869793417455883
NCO2,54613361,-1.6641899597334342
SW1990,5746,1.3748376932131507
OE21,3081361,0.1199830515991339
PaTu 8988s,selumetinib-tretinoin (2-1 mol-mol),2.1087968884942057
TE 617.T,168313016,4.349421247778161
SET-2,4917,3.2769010357827
YH-13,46215462,1.6135517915003736
TE 617.T,selumetinib-navitoclax (8-1 mol-mol),2.626941630887623
LoVo,104842,-3.39586805089817
KP-4,44819697,-1.3019658221659052
ML-1 [Human thyroid carcinoma],24889392,3.5627585346619712
BFTC-909,71304818,3.116417285157316
LNCaP clone FGC,6505803,-1.5170131166658098
PE/CA-PJ34 (clone C12),753704,4.689094474093603
CA46,44819697,-3.819793103454841
ML-1 [Human thyroid carcinoma],3081361,2.035617561629102
SET-2,25126798,-2.3352287177137443
BT 328,10385095,1.6482003129933624
SET-2,5280436,1.6179366010145249
KMS-20,426756,4.256968107104022
NCI-H1092,216239,1.663382184966008
PE/CA-PJ49,11647372,1.87277527539183
SNU-8,44202524,1.4999626286569303
RERF-LC-Ad2,10296883,4.240676300513298
RERF-LC-Ad2,448949,1.713494552366947
SK-LMS-1,5287620,-0.2129368820184852
LoVo,JQ-1-vorinostat (2-1 mol-mol),0.1759239316074218
NCI-H2081,6918736,-2.652468008724762
BT 139,vorinostat-navitoclax (4-1 mol-mol),2.3090973995678232
ML-1 [Human thyroid carcinoma],67156097,-0.9782117982072136
HuT 78,107970,1.6472037116063474
KMS-27,16115403,-5.455837565599094
LCLC-103H,446155,2.7010460448050075
SK-N-AS,11214940,1.545355221750456
AU565,selumetinib-BRD-A02303741 (4-1 mol-mol),5.383276880115408
NCI-H1395,navitoclax-PLX-4032 (1-1 mol-mol),3.577675870608842
HARA [Human squamous cell lung carcinoma],6610216,4.810637550807952
HARA [Human squamous cell lung carcinoma],135421197,2.918907943246249
Hs 683,44491742,3.840304182439804
SNU-1214,9825149,1.427253874883519
KMS-27,8515,4.078018494843081
Raji,9866186,0.6262664347859852
SET-2,8515,2.781692301096623
BT 330,navitoclax-MST-312 (1-1 mol-mol),0.9583669176517168
NCI-H2081,11609586,0.9464908978048564
HMCB,11955716,-0.0705026992658857
KP-4,52947716,-8.46314108741909
KMRC-2,9935249,5.014843219573403
KYSE-410,219104,4.514421987123987
EJM,9866186,0.2932895588367603
NCO2,9911463,2.9393398457743163
PaTu 8988s,676352,1.727843425986356
PE/CA-PJ49,25126798,3.8968500748458794
ESS-1,25150857,2.554300661987261
CA46,119607,3.9558807366301374
Raji,159324,2.512472945563818
BFTC-909,51037431,4.63288955594681
HEC-151,4261,1.908115663505495
BT 504,6914657,-4.893950720703537
OAW42,100016,6.607597097790758
NCI-H2172,5329102,2.0139014487546567
KP-4,11364421,-3.997085257757438
Hep-G2,44607531,2.793402038765765
SW1573,3025986,2.659291536752942
BT 328,4378219,2.241353375973062
SET-2,11178236,-0.8349720594026627
PE/CA-PJ34 (clone C12),2858523,2.9495363309542126
KMBC-2,2746,3.623005517857566
NCO2,100016,5.1199760357582385
NCI-H1092,selumetinib-vorinostat (8-1 mol-mol),2.4548144613596885
YH-13,selumetinib-piperlongumine (8-1 mol-mol),4.547014115194958
AN3-CA,10184653,1.4748604510160417
BT 504,4259181,0.909538881723855
NCI-H2081,16736978,1.7422337137610255
AN3-CA,9911830,-0.0740885579254531
H-STS,5328940,1.248159196656948
A4/Fukuda,11234052,3.83864189929063
H-STS,piperlongumine-MST-312 (1-1 mol-mol),1.017162018251856
NCO2,15547703,2.314916895862008
NCO2,36314,4.1049870669682775
Ku812,107970,1.4051912271786118
NU-DHL-1,3385,1.8377112991123596
NCI-H1395,148124,3.756905797674181
LNCaP clone FGC,10322450,2.7673995360058954
OAW42,54618164,4.146300677714183
SKM-1,46199207,3.0713623583857257
HSC-4,5278396,3.3910828172613128
Aska-SS,56946209,-4.162847997331869
LoVo,10074640,2.9851259451828476
SK-MEL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.7049789212673134
ML-1 [Human thyroid carcinoma],15983966,-5.2151360937473
NCO2,3825829,2.543330928254624
HuT 78,2130404,3.85812044436517
KMBC-2,JQ-1-vorinostat (2-1 mol-mol),1.1085928462642851
HuT 78,54618305,4.369358935790669
LNCaP clone FGC,53325874,5.102870442920095
CML-T1,409805,3.5817002644537683
CML-T1,262093,1.3151134240668207
OAW28,24753719,4.434201172795376
EJM,426756,4.346205416348047
KMS-20,9825149,0.2596001529902395
SNU-1214,168313047,1.8606762103685877
SKM-1,3136844,3.4979321802253356
Ku812,135423438,-2.2335088833738146
PaTu 8988s,400769,-0.9091228865005044
SW1573,54678924,1.9184875438403524
BT 330,46907787,5.374973233157415
NU-DHL-1,126941,-5.231246874864336
SNU-308,24180125,4.244524360791015
Ku812,selumetinib-navitoclax (8-1 mol-mol),-2.189866116629726
Kasumi-2,11175137,1.5162390215690418
SET-2,72376,-3.832573157030871
TE 617.T,241158,3.7218678617090046
TE 617.T,3825829,3.961501634657472
SNU-8,3689413,-3.353074674655615
SK-LMS-1,3025944,4.18904978597071
BT 248,salermide-PLX-4032 (12-1 mol-mol),3.4628856053275623
HMCB,10113978,4.0112336544376435
NCI-H1092,2113511,4.75362905375034
BT 248,9825149,2.247604687491298
HEC-151,3854666,1.712269153838878
Hep-G2,25154868,4.6149046547070816
HuT 78,119607,5.154111912943426
MM1.S,JQ-1-vorinostat (2-1 mol-mol),-1.2519551841274497
NCI-H2110,168313016,5.8271641700116215
NCI-H1092,56649450,3.409643738416104
KMRC-2,11717001,4.303274746092272
HuT 78,carboplatin-etoposide (40-17 mol-mol),1.9720174218366708
PE/CA-PJ34 (clone C12),11977753,0.3576222008658177
MCAS,57519531,3.520827392578698
NCI-N87,135421197,1.227136310912881
D283 Med,11609586,0.9542779203239456
WM983B,selumetinib-GDC-0941 (4-1 mol-mol),-4.627362213665692
Aska-SS,serdemetan-SCH-529074 (1-1 mol-mol),2.1099409470519777
AN3-CA,327653,2.9289784088078177
MCAS,448949,2.981446658298907
KYSE-410,44507138,1.6682479458112085
TE 617.T,72193861,0.4830435506885093
OAW42,2949965,2.6013258041500107
JIMT-1,89928392,2.9352190027043754
NCI-H2172,135421197,1.3346129669572484
KMS-27,5280436,3.782674761872888
PaTu 8988s,46191454,6.477602463627896
BT 320,57519531,6.301542560729613
BFTC-909,107970,2.2861723254681774
NCI-H1092,11640390,3.833743684940511
RERF-LC-A1,doxorubicin-navitoclax (2-1 mol-mol),-1.3673628554052226
PE/CA-PJ49,375860,-0.7510752719204733
NU-DHL-1,BRD-K55473186,1.794195588089048
H-STS,5566,3.25870422892361
NCI-N87,44819697,-2.3159908553894932
Aska-SS,9803433,4.290162471771147
RERF-LC-A1,9840324,5.185069567131442
AN3-CA,carboplatin-etoposide (40-17 mol-mol),3.7641975222911057
SNU-1272,5281672,5.145020952556211
CA46,9866186,-0.3275085520058725
BFTC-909,650361,3.8112149600795706
HMCB,44566777,1.6890977945598695
HARA [Human squamous cell lung carcinoma],1641662,3.0207416829742058
LoVo,1750826,-1.736017877496402
BT 328,65064,5.830382460342701
MM1.S,navitoclax-sorafenib (1-1 mol-mol),3.1642933402407705
HCC2218,selumetinib-piperlongumine (8-1 mol-mol),3.6814989837566183
OAW28,53392493,2.314719178940984
AN3-CA,44491742,4.617223070127138
ESS-1,24797083,1.4472359872095728
RERF-LC-A1,42642645,1.655315386787829
EJM,11656518,1.6048868934870253
BT 248,76446078,4.2307608716074565
IST-Mes1,44202524,3.78616908386864
SNU-1033,5282054,3.1260262048593246
NCI-H1092,5746,1.1584970745481975
A4/Fukuda,6505803,0.0348674492980193
KMRC-2,10231331,3.7445529235865895
Hep-G2,6918328,-0.5211746327374635
PE/CA-PJ34 (clone C12),448949,2.311723632816614
BT 139,4096211,3.1155400909396973
SNU-1214,docetaxel-tanespimycin (2-1 mol-mol),-4.931471584468297
EJM,65064,5.323795448913802
NCI-H1395,11238147,4.343547830393109
CML-T1,54686904,3.622967709931094
BT 248,3384730,2.3830241448741987
HSC-4,11609586,5.018303752842559
BT 330,11955716,-1.5122245117562267
BT 139,9933475,1.3002583684708735
CML-T1,49793307,-4.188413118061572
KP-4,51039095,3.2736205630042736
LNCaP clone FGC,9444,4.43168901353623
BT 320,15547703,5.516273739658597
PaTu 8988s,44589607,1.86453426836221
JIMT-1,10184653,1.86420751297937
MM1.S,44632017,1.7374394851414656
KMS-20,piperlongumine-MST-312 (1-1 mol-mol),0.9360765316980608
BT 330,BRD-A02303741-carboplatin (1-1 mol-mol),5.354371330024741
BT 504,11396600,2.364157912442885
BT 248,16038120,1.7409517230791791
IST-Mes1,navitoclax-gemcitabine (1-1 mol-mol),-2.5828122357465144
SK-N-AS,11485656,1.7301696835910343
NCI-H2110,serdemetan-SCH-529074 (1-1 mol-mol),2.3998932290242765
CML-T1,serdemetan-SCH-529074 (1-1 mol-mol),0.193373711840136
SNU-1272,25150857,3.4753548117910853
TE 617.T,23582824,1.0106934298284411
AN3-CA,119607,5.088034337896445
D283 Med,tretinoin-navitoclax (4-1 mol-mol),6.584931144825414
OAW42,36314,2.620535088466105
NCI-H2081,11234052,3.237478562823228
OAW42,54143018,1.5933683489692032
SNU-8,JQ-1-vorinostat (2-1 mol-mol),0.5470628080695262
WM983B,selumetinib-vorinostat (8-1 mol-mol),-1.7225741889279806
ESS-1,11640390,3.6623137422227607
NCI-H1395,984333,2.1058514684040373
HEC-151,2746,2.893075641123897
HCC2218,salermide-PLX-4032 (12-1 mol-mol),3.4023873677480343
HSC-4,11364421,-0.0916399418549534
SW1990,44589607,3.43879529956881
JIMT-1,9926054,3.6367846725262543
SEM,24771867,-2.7357477254631744
HEC-151,selumetinib-UNC0638 (4-1 mol-mol),5.224989415390747
HSC-4,60750,-5.118377280037083
AN3-CA,11719255,3.633331051172675
OAW42,5278396,3.781361707376392
PaTu 8988s,2858523,3.066235891558281
SK-LMS-1,sirolimus-bortezomib (250-1 mol-mol),0.2757332914045335
A4/Fukuda,11717001,3.8123333180630103
HSC-4,17755052,1.8179922614483863
PaTu 8988s,9903786,1.8009975173036927
Ku812,216468,0.540361244163346
PaTu 8988s,49793307,-4.962170953630436
Kasumi-2,vorinostat-navitoclax (4-1 mol-mol),-2.345570206946048
BT 330,2858523,3.0506576949933844
HEC-151,BRD-K99584050,4.400631541046007
AN3-CA,6438330,1.0525165882785603
EJM,JQ-1-MK-0752 (1-1 mol-mol),0.8699252378567319
HSC-4,262093,2.780665409693215
HSC-4,9967941,3.0274642479334215
SNU-308,selumetinib-BRD-A02303741 (4-1 mol-mol),5.178063267003013
A4/Fukuda,11317348,1.1392337694005448
CA46,5335621,3.676802077981384
SKM-1,8515,1.7539525603020008
SNU-8,54619267,3.9617652458857777
Raji,3384730,0.7697959861519768
SK-MEL-1,16722836,1.8617367112497776
SNU-308,1716436,5.086826833735244
CML-T1,11609586,-0.1617986940719625
KMS-20,176870,2.605197587383483
A4/Fukuda,9915743,-0.3554458205966057
H-STS,387447,-5.130568890460207
SET-2,11455910,-0.0425011411311434
GOS-3,6918638,1.663921744527482
TE-15,12003241,-1.6215722433150963
NU-DHL-1,9927531,5.134600574788464
OAW42,285033,-1.0022229866256522
SK-N-AS,5335621,5.443345020792538
KMRC-2,11396600,3.609897485717139
OAW42,5284373,3.0420721511021314
BT 328,11178236,-3.1111942702784092
SK-MEL-1,44489367,4.41779299292988
SW1990,45279963,4.327475403633366
SEM,11656518,-0.9335747644896384
Hs 683,168313200,1.8001064604931507
HARA [Human squamous cell lung carcinoma],107985,-4.031127583701494
RERF-LC-A1,446155,1.6878899595701953
SKM-1,selumetinib-decitabine (4-1 mol-mol),-0.7515820525024105
BT 139,11485656,3.131336333287838
HSC-4,16741245,1.7716610997683242
OE21,54618771,-0.7908986466721764
SKM-1,67156097,-2.558709086141829
RERF-LC-A1,2729026,3.044350513676348
NCO2,71304818,1.188015373679632
BT 330,57519531,2.9868357975460564
HSC-4,6918878,5.2813290465493505
SK-MEL-1,tretinoin-carboplatin (2-1 mol-mol),4.80072740524702
HMCB,54678924,1.6823171066105604
A4/Fukuda,5281321,-4.090150251628595
SNU-1033,BRD-A02303741-navitoclax (2-1 mol-mol),3.0862137384300015
HEC-151,11977753,-1.2526892648552814
OAW28,11455910,2.4986666790908583
YKG-1,navitoclax-piperlongumine (1-1 mol-mol),3.397056870192574
PaTu 8988s,docetaxel-tanespimycin (2-1 mol-mol),-3.736117907039699
SK-N-AS,72193861,-0.0582823609479615
SEM,6610216,3.5318840364079302
ESS-1,selumetinib-PLX-4032 (8-1 mol-mol),4.921474213039296
SEM,9967941,3.0889750042554267
SEM,navitoclax-MST-312 (1-1 mol-mol),-2.7304049147303764
NCI-H2081,24901704,2.205959847838861
IST-Mes1,selumetinib-piperlongumine (8-1 mol-mol),4.502033014563436
PE/CA-PJ34 (clone C12),40482356,5.160347507354427
BT 330,tanespimycin-bortezomib (250-1 mol-mol),-1.5657589280340811
OAW42,462382,1.1956032934756198
TE 617.T,6918638,0.5415631808582457
BT 330,23725625,5.635337028270855
YH-13,426756,4.439847465268924
AN3-CA,219104,2.4655837884379626
SK-N-AS,135411,0.3173917962022085
LNCaP clone FGC,9843750,5.190823020080022
HMCB,2828334,6.16899162002209
KP-4,104842,-4.083786519426226
Aska-SS,44566777,0.3208847613888042
CML-T1,4788,4.608482830288328
LCLC-103H,159324,3.784520620712173
SET-2,erlotinib-PLX-4032 (2-1 mol-mol),2.8695240779606936
BT 248,44607531,1.181861447118321
AN3-CA,selumetinib-MK-2206 (8-1 mol-mol),2.0426489986894265
BT 139,selumetinib-JQ-1 (4-1 mol-mol),2.342972128639262
KYSE-70,selumetinib-UNC0638 (4-1 mol-mol),3.25629169074294
CML-T1,241158,2.0968023336421227
TE 617.T,2729026,1.8529578734685528
HARA [Human squamous cell lung carcinoma],44607531,1.5873617953354324
MM1.S,4477,1.1148587916452
PE/CA-PJ49,25154868,5.401962162415612
SW1990,3854666,4.405402240089115
BT 139,969516,2.3517673922237003
KMS-27,10113978,3.1128677638338274
LoVo,5278396,2.046108484267772
RPMI-7951,73707398,0.5772291594495476
BT 330,44491742,4.367748851083318
SEM,15983966,-4.919276038332578
HCC2218,9549297,1.4476788481664282
SNU-1272,4788,6.041801756981533
IST-Mes1,11427553,1.720147340773497
H-STS,216239,0.9162079464609584
LCLC-103H,67291369,2.0170444485862196
OE21,11234052,4.474728947098881
HCC2218,72376,-1.8929847607660144
KMBC-2,53393127,4.084787929931407
NCI-H2172,107985,-3.1793632305275836
RPMI-7951,1750826,-2.4322694777109453
RERF-LC-Ad1,5746,2.3313775446459326
HuT 78,4578,4.42076549518963
IST-Mes1,49793307,1.120791830462594
SNU-1214,6918328,-0.2873228341432076
SK-MEL-1,67291369,2.2157293082234935
HMCB,2749,2.739693517527312
TE-15,5284616,3.380011015586448
KMS-20,36314,4.071326540312212
HuT 78,4477,0.82836425534414
Hs 683,UNC0638-navitoclax (1-1 mol-mol),1.040409655043311
KYSE-410,5281672,5.403053592840652
NU-DHL-1,5311,-0.0484251150139828
HuT 78,3689413,-1.8719775604380453
OE21,4705,-2.1528136210817324
NCI-H2110,2733526,4.313644509385281
NU-DHL-1,carboplatin-etoposide (40-17 mol-mol),0.2003297158995997
Ku812,644241,-5.729959790836442
RPMI-7951,9915743,0.6767769344324703
KMS-27,100016,3.811410813700335
AU565,6610216,3.647426232490327
KYSE-70,5282054,4.279196842795529
Hep-G2,285033,2.524821694424631
NCI-H1395,5470400,-0.4743897093415642
NCI-H2110,5287969,-1.8120859549958457
OAW42,613753,3.5213979370539255
LNCaP clone FGC,11167602,1.6735547882241617
LNCaP clone FGC,55283,3.3025309781827565
SNU-1272,15953870,3.4362338657153835
LNCaP clone FGC,613000,2.5473993264791424
YKG-1,123631,3.7325814546092873
OAW42,23635314,-1.0386835952997526
NU-DHL-1,262093,0.667372891927881
BFTC-909,60750,-1.7298046099952136
HARA [Human squamous cell lung carcinoma],6918328,1.494996835192892
AU565,11494412,-0.7938994603064
SNU-308,11964036,0.9815562264956836
SNU-1033,219104,3.456953215141336
OAW42,16065773,3.1960612801505546
MM1.S,11626560,0.5945750260073711
KMS-20,24772860,-2.355954669463017
D283 Med,BRD-K55473186,4.203896885474867
KP-4,sirolimus-bortezomib (250-1 mol-mol),1.5699611904925963
BT 248,72376,-0.6579483524735774
ESS-1,2729026,3.152936804917953
OAW28,9825149,1.8591620922463772
SW1573,9956119,4.0915863238100645
OE21,119607,5.383595951688716
AU565,52947716,0.8422274137680903
YKG-1,5311281,1.228854081788957
Ku812,1641662,2.247994905759536
NCI-H2110,45279963,4.041141728653127
SKM-1,44819697,-2.7532924214144727
SK-LMS-1,salermide-PLX-4032 (12-1 mol-mol),5.327577924761485
SNU-8,25062766,1.5846373572086123
SNU-1272,10322450,4.07877256776116
KMS-20,11257553,0.1864785625212487
OAW28,24785538,1.1869022382798196
AU565,JQ-1-UNC0638 (2-1 mol-mol),2.17780253884304
SNU-1033,56946209,-4.811007379199089
Kasumi-2,73707398,-0.974822208153436
KMS-20,24889392,-0.8715030564449404
NCI-N87,168313047,2.984513904409232
KMRC-2,selumetinib-PLX-4032 (8-1 mol-mol),3.8526523658363248
KYSE-70,135999136,5.194226724950964
H-STS,24785538,0.7812018408159317
Hep-G2,11485656,-0.7210069253709863
TE-15,446155,1.2346950535383283
SKM-1,25183872,-3.4899394684902947
A4/Fukuda,5351362,0.320845740356061
KMS-20,11238147,1.9305174496673645
SK-N-AS,5291,3.772954146986624
LNCaP clone FGC,46174525,4.178946718976701
NCI-H2172,10127622,5.854674318699288
AN3-CA,168313200,3.821120909855463
NCI-H2110,25102847,2.7229918825923276
SEM,241158,3.04470395214072
SK-N-AS,16013152,4.281794932367084
Hs 683,5351362,1.147088427149933
H-STS,67156097,-2.7564383026884345
Hs 683,11396600,3.438921740314131
Kasumi-2,168312962,2.3104598884340515
NCI-H2081,462382,-0.5652785498949985
LoVo,100016,6.001395250082881
PaTu 8988s,46224516,1.391714663581103
SET-2,42611257,3.1945148983849943
MM1.S,46943432,0.8040935349772499
TE 617.T,2113511,5.005683090438257
NCI-H2081,10074640,2.3874549358623756
SNU-1033,selumetinib-vorinostat (8-1 mol-mol),2.0856562296145187
CML-T1,71466445,2.0221424049362033
CA46,25183872,-1.226882585953409
NCI-H1092,53392493,1.721482373156668
MCAS,24797083,1.7533121756428505
RPMI-7951,decitabine-carboplatin (1-1 mol-mol),3.5510906298045937
NCI-N87,5311,0.9556802173694716
WM983B,53495165,2.779403825416632
AU565,carboplatin-etoposide (40-17 mol-mol),1.7469100851636217
Kasumi-2,4788,5.288898541322949
NU-DHL-1,136227924,1.2519389073848997
BT 330,73707438,1.741057691577743
HARA [Human squamous cell lung carcinoma],11175137,1.814800704414418
MCAS,46224516,4.169683625614388
D283 Med,3689413,-5.066385831563446
GOS-3,60700,-0.2943345936745988
SNU-1214,702558,4.805377717438986
RERF-LC-A1,568763,0.046296829837636
AU565,44462760,4.31661778136252
BT 504,53495165,0.454493953018445
PE/CA-PJ34 (clone C12),53325874,4.873665514097965
LNCaP clone FGC,1242560,3.3033179259269887
BT 248,5479543,3.7849708026150406
KP-4,selumetinib-GDC-0941 (4-1 mol-mol),0.6661339772202117
OAW42,107970,2.320375917331678
OAW28,11964036,1.3272537866850969
CML-T1,11238147,1.550777100551064
Kasumi-2,67291369,1.3044869974839717
PE/CA-PJ34 (clone C12),5284616,3.3084044044013017
HMCB,26596,-1.2966092010554455
SK-MEL-1,23635314,4.225056109773594
A4/Fukuda,374536,-1.0311095755670416
NU-DHL-1,10322450,3.582925513183909
Hep-G2,11625818,5.989869211242665
CA46,327653,2.398308016277815
RERF-LC-A1,5281321,-0.2734888925335224
EJM,613753,3.047876123022861
KMRC-2,navitoclax-sorafenib (1-1 mol-mol),2.1673044240978374
IST-Mes1,71751553,5.350652566949457
NCI-H1395,219104,2.9305329834901768
BFTC-909,54649381,4.487285574329416
SK-LMS-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.250412004550364
SW1990,216345,4.764095840089945
TE-15,16722836,1.2676445254840203
SEM,carboplatin-UNC0638 (2-1 mol-mol),2.079018969490806
D283 Med,15983966,-4.384389226245483
Ku812,445455,5.7620239049284505
PE/CA-PJ49,25262965,-1.5780417973805605
EJM,11494412,-0.937899289743814
OE21,JQ-1-vorinostat (2-1 mol-mol),-0.1835803700202176
SNU-1214,11609586,3.0218291311347145
NCI-H2172,241158,6.148791775116968
SW1573,10026128,4.237670104162456
AU565,6918638,0.3564513775218086
Kasumi-2,selumetinib-tretinoin (2-1 mol-mol),7.516580529144076
NU-DHL-1,5738263,2.6843790569826536
HMCB,alisertib-navitoclax (2-1 mol-mol),1.9380444383575808
BT 248,54454,4.901618168416747
BFTC-909,702558,5.601571619782522
BT 330,9935249,0.442722317267438
AN3-CA,5335621,4.80855208441781
RERF-LC-Ad1,24785538,2.8640497838765824
OAW42,409805,5.898373871499896
Kasumi-2,5311037,4.15499666746129
Ku812,1750826,-2.479099984818899
HARA [Human squamous cell lung carcinoma],104842,-3.702627319243614
KMS-27,60750,-4.266224763393727
SK-N-AS,9956119,4.091105737324408
ML-1 [Human thyroid carcinoma],107970,2.5074769228196025
SNU-1214,135398516,2.563377227960364
WM983B,5566,2.9480739003165133
PaTu 8988s,5287969,-2.4599396728047176
JIMT-1,60700,3.113818148728579
PaTu 8988s,24856436,-1.8823090138598328
TE 617.T,11485656,1.686521614831033
BT 504,6918837,0.7435345592902766
KYSE-410,3038522,3.5021634739591088
BT 248,448949,1.935087924253196
EJM,71304818,1.7741690400196457
HSC-4,969516,2.6364274978390703
BT 248,1750826,0.7778964775949998
RERF-LC-A1,selumetinib-navitoclax (8-1 mol-mol),4.532411285596849
A4/Fukuda,BRD-A02303741-navitoclax (2-1 mol-mol),4.161880654149954
TE 617.T,46398810,1.6357636391747654
NCI-H2081,9926054,1.7325996665522785
EJM,piperlongumine-MST-312 (1-1 mol-mol),0.9890593099361664
SK-N-AS,16725315,3.1707572347880837
A4/Fukuda,49793307,-5.572580515048152
KMS-27,57330099,4.453875165878117
RERF-LC-Ad1,navitoclax-pluripotin (1-1 mol-mol),-0.2842869888478678
PaTu 8988s,5460769,4.375147735669684
MM1.S,selumetinib-vorinostat (8-1 mol-mol),1.8050138059594567
SNU-1272,1716436,3.918709850381952
SET-2,5281321,-3.932606276737236
SK-N-AS,104842,-2.0601973897979375
IST-Mes1,446155,1.803889787209672
AU565,9935249,2.085801217703038
A4/Fukuda,387447,-5.631039688913266
YKG-1,65064,5.3416215480655875
YH-13,selumetinib-MK-2206 (8-1 mol-mol),3.53074146528381
NCI-H1395,navitoclax-birinapant (1-1 mol-mol),3.789667753469327
BT 328,4788,5.982911703327575
SW1990,11178236,-3.6963335662856016
NCI-H2110,2729026,3.135711176833809
NCI-H2110,5311037,4.07771587308812
NCI-H2172,11396600,4.171717068415809
HEC-151,126941,-2.3305220825243533
KYSE-410,6610355,5.169195393353756
KMS-20,71466380,4.301818086320641
SNU-1214,25183872,-1.2283957727376138
SNU-1033,11152667,-1.2864641909035752
NU-DHL-1,148198,-4.718908672184396
RPMI-7951,656346,-0.3467317873475116
AU565,51039095,3.3315580468624795
SK-MEL-1,46199207,3.029001134650959
OE21,54765302,4.254324559348036
KMBC-2,6852167,2.897354350199853
SET-2,44632017,1.0717539740379156
Hs 683,24951314,1.6027905117261754
SET-2,53232,1.7911172891332965
RERF-LC-A1,selumetinib-JQ-1 (4-1 mol-mol),1.0639220525759086
LNCaP clone FGC,crizotinib-PLX-4032 (2-1 mol-mol),2.1211203614787912
SNU-1214,11640390,2.9297550209160343
Raji,46191454,-0.7209725963204677
NCI-N87,53232,3.890681715203442
HSC-4,2842253,4.76622062087716
KMBC-2,10410894,2.9583144658422578
IST-Mes1,3025944,4.475795844293571
KMS-20,67291369,0.8651776622015213
BT 328,24748573,3.666462316296569
OAW42,4578,5.3167746978593255
BT 139,11222830,1.7868119636115656
HEC-151,11427553,3.4373448447885098
ESS-1,54765302,4.90712121180697
HSC-4,2708,2.9878251305615477
GOS-3,6918328,0.9203199321907972
HARA [Human squamous cell lung carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),1.441529788664552
YKG-1,36462,2.1375754999523915
CML-T1,568763,0.104759642693247
KYSE-70,216345,3.953496119268799
YH-13,25062766,1.542076592026761
LNCaP clone FGC,119182,-0.8257267598050168
SEM,208908,2.0616953187944835
HSC-4,11427553,3.1625220487182193
KP-4,vorinostat-carboplatin (1-1 mol-mol),3.567594716721618
HuT 78,erlotinib-PLX-4032 (2-1 mol-mol),4.780125064629265
NU-DHL-1,9911463,3.294428726772871
SNU-8,11222830,1.589804664349569
SNU-8,24901704,4.345339239210362
NCO2,JQ-1-carboplatin (1-1 mol-mol),-0.8378761962661548
SET-2,462382,0.4973532947572526
AN3-CA,71466445,5.096273299698095
PaTu 8988s,2742550,4.064177152940504
Hep-G2,71304818,2.021799775788192
A4/Fukuda,216239,1.5760740052804734
SNU-8,5280436,3.657328810288953
SEM,676352,1.684382877039761
Hs 683,JQ-1-UNC0638 (2-1 mol-mol),1.243801160638627
BT 504,72193861,1.4878827206684468
SNU-1033,374536,2.1253296894333595
OE21,3543504,4.324385832552226
TE 617.T,156414,-2.5018662250676713
SET-2,11612883,1.412102181509034
KMS-27,9887053,2.6639337999908728
KMS-20,72199292,0.0792134976648957
RERF-LC-A1,216239,2.2403205408836104
BT 330,53481919,5.743905569728565
OAW28,25262965,-0.9519808245592094
NCI-H2081,216345,3.6466668059147054
KMBC-2,11234052,4.545716332187808
CML-T1,24753719,1.910679313408318
PE/CA-PJ49,12001922,2.488213828418306
D283 Med,9935249,1.011376298828927
NCI-H1395,16736978,1.0598222504477564
RPMI-7951,24180125,2.9670273769283506
NCO2,73707398,-1.0010123602704273
AN3-CA,selumetinib-JQ-1 (4-1 mol-mol),3.4953796840918763
HMCB,9935249,3.1054191675254064
AU565,52912189,3.2475583793468994
MCAS,44185566,2.861754795019825
BT 330,9952709,2.8069341569894304
RERF-LC-Ad2,16736978,1.4486111986027184
SNU-1272,135421197,2.338787330458388
KMRC-2,16038120,1.2280873757091175
EJM,19582717,2.2813420198916057
HCC2218,tanespimycin-gemcitabine (1-1 mol-mol),-2.850540092805532
GOS-3,sirolimus-bortezomib (250-1 mol-mol),0.3031881482046261
YKG-1,11152667,0.85211892000732
BT 504,9933475,1.7588692918725246
HARA [Human squamous cell lung carcinoma],11497983,-2.5330413808054333
SW1990,ISOX-bortezomib (250-1 mol-mol),0.2814121129638218
PE/CA-PJ34 (clone C12),10231331,3.045773235767836
HMCB,5113032,4.37953106967478
D283 Med,tretinoin-carboplatin (2-1 mol-mol),0.0098310122185737
KMS-20,322968,1.9273054184406155
BT 330,8515,4.407994026323292
RERF-LC-Ad2,72193861,4.063600666642819
MCAS,16741245,1.8524285811133965
PE/CA-PJ34 (clone C12),1641662,3.2339299238694066
KYSE-70,selumetinib-JQ-1 (4-1 mol-mol),2.626623407119128
Hep-G2,439501,-0.8010222698535624
HMCB,409805,5.980176460908731
BT 504,16659841,2.250495507970734
Kasumi-2,7326481,4.035955767547482
A4/Fukuda,5311,-0.1264358008137528
HCC2218,52947716,-6.603303596955929
NU-DHL-1,11647372,-0.5414932497737441
SET-2,613000,2.447046938208336
OAW42,9903786,3.91324183381597
Hs 683,46843906,3.630992092073276
SNU-1033,262093,2.351645391909522
SW1990,7251185,3.0840272669149384
YKG-1,15953870,4.202012318992034
PaTu 8988s,24951314,1.7139060752195443
NCI-H1092,2871966,-0.9629545155853874
EJM,3062316,1.2217642247890057
SKM-1,selumetinib-UNC0638 (4-1 mol-mol),-0.1462150618543426
OAW28,46907787,2.388022074777516
BT 139,46215462,1.8129684234410115
JIMT-1,vorinostat-navitoclax (4-1 mol-mol),2.104430606981258
KMS-20,10113978,2.317809443763058
SNU-8,5281321,-1.1560578240990744
RPMI-7951,25126798,3.405375688978992
NCI-N87,4261,0.8200487533079858
SK-N-AS,5282054,3.4987335478086568
NCI-N87,11683005,3.6426598339920297
YKG-1,11717001,4.560589494626805
PE/CA-PJ34 (clone C12),JQ-1-UNC0638 (2-1 mol-mol),1.4419134854320173
KYSE-70,11609586,2.827625452517046
MCAS,44543605,3.819118149951799
MCAS,56946209,-4.611204773415356
HEC-151,49850262,3.872671430576316
NCI-N87,vorinostat-carboplatin (1-1 mol-mol),2.026584102601564
CA46,613000,1.1767209163070167
OAW28,5311281,1.8509970799423736
SNU-1033,12003241,-0.6294445516416565
PE/CA-PJ34 (clone C12),10322450,3.5530253232214664
Kasumi-2,9935249,-0.6704419087402653
SK-N-AS,11152667,-2.6826642832146126
SEM,4521392,4.258271706242731
HCC2218,6610355,4.312691214632914
NCO2,24951314,-0.1649882872383479
OAW42,6914657,-3.8246834413384145
HCC2218,439501,-2.1463275405716495
HuT 78,67156097,-1.4779973758207117
NCI-H2110,135984461,4.3368706411004325
SKM-1,54619267,4.249968374064052
Ku812,54618305,3.744773275517672
PaTu 8988s,9444,3.623021044997965
NCI-N87,71466578,5.1108247117444865
WM983B,10127622,-0.801964249021768
BT 139,44137675,3.208547495705803
BT 328,42642645,1.526904383487112
OE21,9908783,4.434588884510805
SET-2,11625818,3.966078974132002
EJM,9907093,4.11164993118498
NCO2,selumetinib-PLX-4032 (8-1 mol-mol),1.5431307842016615
OAW28,JQ-1-vorinostat (2-1 mol-mol),0.5545971801402327
ESS-1,2874250,4.555685369292356
BT 328,5566,3.1707222601804803
TE-15,135411,-0.3374771976719254
JIMT-1,656346,1.7864284058366129
HMCB,tanespimycin-bortezomib (250-1 mol-mol),1.0972296557807748
LCLC-103H,71466445,3.510295389264131
ESS-1,46174525,4.298251988925839
HMCB,327653,2.816846205013027
CA46,56973724,2.349278499068081
HSC-4,11175137,3.5997845208099797
SNU-1214,656346,0.878147723418443
NCO2,322968,2.0386374535640286
SNU-8,4788,5.895963539155099
HARA [Human squamous cell lung carcinoma],5311,2.3146371221244184
TE 617.T,25154868,2.46272579601567
IST-Mes1,54454,3.4404607016766264
HuT 78,55508,4.04712313060397
CA46,25227462,-5.088225796968986
ESS-1,54626689,4.894766460355583
BT 139,navitoclax-pluripotin (1-1 mol-mol),-1.6784448507193144
D283 Med,3634881,2.480961702066835
SNU-8,219104,4.134632076675879
HCC2218,25183872,0.3170535790676645
RERF-LC-A1,44241473,5.145911228951114
SK-N-AS,1716436,3.256457603512173
PE/CA-PJ34 (clone C12),119607,5.593400059439999
A4/Fukuda,71466578,0.6387062903604859
KMBC-2,9868037,4.318288154925569
EJM,44607531,1.4254236431935456
KP-4,BRD-A02303741-navitoclax (2-1 mol-mol),3.6233365394469175
SNU-1272,10074640,3.618892542136291
AN3-CA,JQ-1-carboplatin (1-1 mol-mol),4.617910971387189
PE/CA-PJ34 (clone C12),15953870,4.1853998040231595
OAW42,25062766,2.037116724358972
AU565,374536,-0.7311314672583101
OAW28,10302451,2.68651474445359
BT 248,387447,-5.028656036950466
SNU-8,16736978,2.3395746599285214
OAW28,24753719,4.434201172795376
NCI-H2081,219104,2.665049667127658
ESS-1,24889392,3.924374920251665
LoVo,4378219,2.040258922351895
MM1.S,6505803,-0.1841114080814497
SW1990,11977753,-2.174403412887458
Hs 683,4578,4.4950914970661175
NCI-H2081,9915743,0.926591953046768
BT 248,BRD-K55473186,1.6909762369263868
HuT 78,71466380,2.9398406998655395
TE 617.T,vorinostat-carboplatin (1-1 mol-mol),2.8187064409728806
OAW28,168313016,5.164256635335989
KYSE-410,54678924,2.767561148050687
OAW28,67291369,5.503883029091299
SNU-8,20959075,-3.095305417381531
NCI-H2110,168313200,2.986185729607549
SET-2,carboplatin-etoposide (40-17 mol-mol),1.454768246911245
NU-DHL-1,25154868,3.3783021431332085
OE21,148198,-3.484738735179186
PaTu 8988s,selumetinib-decitabine (4-1 mol-mol),2.721971536386784
SEM,navitoclax-PLX-4032 (1-1 mol-mol),-1.6228685659579063
YH-13,89183176,4.032829383808348
YKG-1,3465537,3.622087306802616
OAW42,2874250,4.970102332812981
YKG-1,10127622,4.916424628114341
NCI-H2081,55508,1.4698718095491496
NCI-H2081,9927531,2.933726437844289
WM983B,219104,4.633425827171367
SNU-1033,208908,1.8154583109832951
NCI-H1395,alisertib-navitoclax (2-1 mol-mol),4.525296331369141
OAW28,89928392,1.6809049325642302
KMRC-2,5978,6.823148875955023
EJM,54596558,4.61440332017562
RERF-LC-A1,9907093,5.222629356289204
TE-15,JQ-1-carboplatin (1-1 mol-mol),0.1114942232553469
MM1.S,327653,2.336208515323047
OE21,25062766,1.2859206682836428
BT 139,5281321,0.9957709719611229
WM983B,36314,-5.20144562383542
EJM,44486219,4.513652355820563
NCI-H2081,44632017,0.6530598645266015
SET-2,126941,-5.930398504442238
TE 617.T,BRD-K55473186,4.156036847499281
OAW42,5311281,2.788704178536122
CA46,11609586,1.0102139081655188
HEC-151,JQ-1-MK-0752 (1-1 mol-mol),1.1160938672676726
LCLC-103H,5746,3.1287643224929735
YKG-1,60700,3.1326853541806603
WM983B,15547703,5.421896513172421
HuT 78,serdemetan-SCH-529074 (1-1 mol-mol),1.8219869196237213
OAW28,9935249,3.684332158484572
KMS-27,6918328,-1.1796709912308914
RPMI-7951,24753719,4.344653463611892
NCI-H2172,6852167,4.795805811514927
HuT 78,23635314,-3.2203205513382023
RERF-LC-A1,5566,3.0693258457595305
ESS-1,439501,-2.0978778954241215
NU-DHL-1,73707398,-1.134131669743868
YKG-1,11175137,1.824320383587359
A4/Fukuda,5278396,2.678829799859676
BT 504,doxorubicin-navitoclax (2-1 mol-mol),-2.431628544998373
NCI-N87,selumetinib-tretinoin (2-1 mol-mol),6.374104250530425
YH-13,tanespimycin-bortezomib (250-1 mol-mol),-0.5369599682458667
YH-13,sirolimus-bortezomib (250-1 mol-mol),0.2727627020521754
NCI-H2081,3825829,4.196645416863087
D283 Med,67156097,-2.9733455385355803
SET-2,135984461,1.767736462015104
OAW42,6918736,-0.8171492266133866
PE/CA-PJ34 (clone C12),51037431,4.093871362794514
SNU-1214,126941,-4.3908189021889665
BT 330,57330099,5.445552954780525
Hs 683,4788,6.010266672743516
OAW28,135928012,4.847644989583831
KYSE-410,11317348,4.323305036717103
TE-15,448949,1.444286373082681
OAW28,16065773,3.4526029247448973
SW1990,54618771,1.819696432191247
MM1.S,selumetinib-navitoclax (8-1 mol-mol),2.538303509958093
HuT 78,387447,-5.436092440743046
NCI-H2172,44607530,2.4860384239384605
WM983B,5738263,4.195605323585238
YKG-1,3552672,2.1988515508502764
A4/Fukuda,selumetinib-tretinoin (2-1 mol-mol),0.1306282538246569
MCAS,9911463,3.99734234256231
ML-1 [Human thyroid carcinoma],176870,3.163449715300446
BT 320,71304818,2.914725517037444
SW1990,53392493,2.7839355508070773
CA46,46398810,1.9636985074186508
EJM,24797083,0.92088604751269
SET-2,44507138,2.8272213268552218
OAW42,151289,1.5068907411227557
KMS-20,12003241,-1.6984779188581272
NCI-H2110,72376,-1.2241994360828286
CML-T1,11497983,1.5281324652658594
TE-15,24180125,5.117300850152298
Ku812,16038120,-0.3334823664980552
EJM,107985,-4.84255557894517
BT 139,9868037,3.9588523345635376
SET-2,753704,4.217890366544489
Hep-G2,44507138,3.1613379759015845
BFTC-909,ISOX-bortezomib (250-1 mol-mol),1.0929987126714282
Raji,17759555,4.490622135010783
HuT 78,9927531,5.1568522769540674
Ku812,2126,4.384485550053496
NCI-H1395,11175137,3.230418109330353
Ku812,6852167,2.7508092991832016
YH-13,6914657,-1.321976768912636
HuT 78,46224516,1.0193234135657596
SNU-8,67291369,1.4328430830200354
BT 328,156414,4.0443464949872645
OAW42,5328940,1.84091572430057
NCI-H1395,89928392,1.518159514357362
LoVo,675434,4.114717976727459
SNU-1214,4477,0.8623778747742765
BT 320,11152667,2.8584362453350427
TE 617.T,426756,4.479031808281675
H-STS,9840324,5.735130502734432
SK-MEL-1,216239,1.8227691011772231
NCI-N87,SNX-2112-bortezomib (250-1 mol-mol),-4.305728707352715
KYSE-70,375860,-0.042936769343065
KMS-27,262093,2.820550232220946
Ku812,8515,2.860455557749638
SW1990,24753719,4.9557561363455624
IST-Mes1,5738263,4.045528078129119
NCI-H2081,5978,-4.744970810463312
NCI-H2081,24785538,-0.1890476398389944
HuT 78,9967941,3.6248756588046382
AU565,navitoclax-gemcitabine (1-1 mol-mol),-2.716980570642507
KMBC-2,24856436,1.133565283278238
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997
HEC-151,10074640,3.1058867670982924
ESS-1,6610216,4.607428871946369
ESS-1,46843906,3.355969876815747
PE/CA-PJ49,19582717,2.9784501499232414
TE-15,3854666,-0.2434846174212646
CA46,11167602,1.6890466560929325
EJM,11238147,1.5865276508772588
SK-MEL-1,3634881,3.721058287123139
Hs 683,24901704,3.2629232057843467
SKM-1,613753,2.904024053377545
SNU-1272,448949,3.345262663923222
NCO2,navitoclax-MST-312 (1-1 mol-mol),0.1429204193513858
LoVo,73707386,4.416344333605744
BFTC-909,5311,1.6846521587280363
SEM,25161177,4.0488319816215
KMS-27,11717001,3.99777903159406
Kasumi-2,JQ-1-navitoclax (2-1 mol-mol),-2.2721346445712896
BT 139,3689413,1.1435542954681734
YKG-1,11485656,3.6397536658143865
EJM,navitoclax-sorafenib (1-1 mol-mol),1.3600415783658448
HMCB,2708,5.151962818613397
H-STS,56963564,-0.0472332493661748
KMS-20,148124,-6.52302823792501
SET-2,285033,-4.01065883021271
HSC-4,4705,3.95336427523857
BT 504,25150857,2.453674944336693
SKM-1,11507802,0.9251203923511582
D283 Med,5978,-3.0503373024803557
WM983B,salermide-PLX-4032 (12-1 mol-mol),1.4766033758194694
SKM-1,400769,-3.7567993571091063
BT 139,72193861,3.223416508879562
CML-T1,451668,-2.1837981176470738
Hep-G2,5328940,1.8827970950468589
SEM,23582824,0.9375364224327816
RERF-LC-Ad1,12001922,2.2096549629967424
BT 139,selumetinib-navitoclax (8-1 mol-mol),2.4007286553519833
PaTu 8988s,2729026,2.6444658169673914
SNU-308,vorinostat-navitoclax (4-1 mol-mol),1.528170211925988
SK-LMS-1,11626560,2.695648756973684
NCI-N87,72376,-2.7230406051655676
ML-1 [Human thyroid carcinoma],selumetinib-JQ-1 (4-1 mol-mol),1.6383064835611996
KMRC-2,25195348,4.278954150940016
CA46,25262965,-5.196703638661911
PE/CA-PJ34 (clone C12),10074640,3.6571343520395794
PE/CA-PJ34 (clone C12),73707398,0.9457530769963428
MM1.S,10385095,0.5772741744912003
HARA [Human squamous cell lung carcinoma],44259,0.8184068416156438
NCO2,57330099,3.4888864913972593
BT 504,5460769,2.119344247070391
NCI-H2110,55283,3.522352390292201
KYSE-70,11364421,-0.2598881855214042
AN3-CA,16725315,2.970185923367207
BT 330,11238147,1.6995695818769838
OAW28,6610216,3.9661844518771185
OAW42,16722836,1.232521656555263
Kasumi-2,6436223,-4.213376684231403
RPMI-7951,11656518,3.155761627261377
SNU-8,navitoclax-piperlongumine (1-1 mol-mol),2.452305783836848
BT 139,16065773,1.9490897684890804
SW1573,104842,-2.57352069349058
RERF-LC-A1,262093,2.373838000571716
SK-N-AS,5278396,3.646251183086581
KMBC-2,135398516,3.1820927081241392
AU565,6436223,-4.706952881213825
Ku812,168313047,1.6186365472773052
SK-MEL-1,12003241,-1.7363712573149035
A4/Fukuda,5311037,4.577970147235868
SNU-1214,4788,5.152440404862343
CA46,10385095,0.6992054873225039
NCI-N87,208908,-2.7799590207113014
SNU-8,2729026,3.1220208939977097
BT 248,serdemetan-SCH-529074 (1-1 mol-mol),1.089631188997332
SK-LMS-1,9911463,4.31771461226135
Ku812,9926054,1.5145588468111315
TE 617.T,53232,0.6252760379465637
Raji,11175137,2.7969423133493025
BFTC-909,57519531,3.2286550647211025
SK-N-AS,71751553,4.378274889288709
BT 248,10385095,1.1706577035646757
D283 Med,9803433,2.2263192458664767
HEC-151,439501,-1.7100799573978192
RERF-LC-Ad2,11214940,1.66425243656515
LNCaP clone FGC,2746,2.220031738697338
ESS-1,5287969,-2.291544510973284
D283 Med,2113511,4.840177237246556
Kasumi-2,2742550,3.256021563602066
NU-DHL-1,44589607,1.1355203141192094
NCI-H2081,9907093,4.181981134504412
SK-LMS-1,44486219,4.327912998611937
ML-1 [Human thyroid carcinoma],24797083,1.931228349809168
SNU-8,25126798,3.883778707085978
YH-13,2113511,5.759844147331347
BT 328,24775005,3.5424710463828624
MCAS,24753719,3.982586102388834
KP-4,11317348,2.67436986374534
PaTu 8988s,4521392,4.128256043423252
Aska-SS,25062766,3.8645676552270865
SK-LMS-1,71304818,1.7309088009251954
BT 504,7251185,1.8323101338027723
WM983B,JQ-1-carboplatin (1-1 mol-mol),2.7485302033318084
RERF-LC-A1,carboplatin-UNC0638 (2-1 mol-mol),4.848016640225387
PE/CA-PJ49,46843906,3.0340645343525954
CML-T1,9887053,1.7753443459725933
HMCB,135423438,4.419625220654583
KMBC-2,vorinostat-navitoclax (4-1 mol-mol),-0.0695917806099074
CML-T1,5113032,5.118103556540756
KYSE-410,11238147,4.798531583653568
LNCaP clone FGC,JQ-1-navitoclax (2-1 mol-mol),-1.107225810907736
PaTu 8988s,44462760,3.684376374134235
ESS-1,445455,4.4559986013916815
Ku812,navitoclax-sorafenib (1-1 mol-mol),0.8229949370688716
HMCB,10427712,4.183996317253481
RERF-LC-A1,3038522,3.971368715365633
OE21,53481919,3.671898939631697
SEM,46843906,-1.2667030420519347
EJM,12003241,0.5402616975347148
EJM,serdemetan-SCH-529074 (1-1 mol-mol),2.152068500257776
LCLC-103H,168312962,2.4705597448172822
BFTC-909,erlotinib-PLX-4032 (2-1 mol-mol),4.45664321306644
HSC-4,5335621,5.235604448739508
NCO2,56946209,-5.073194752215529
HSC-4,11167602,1.6360881716966182
AU565,4521392,3.744925242939049
YH-13,vorinostat-navitoclax (4-1 mol-mol),1.848157138564096
ESS-1,24951314,1.795276006384557
OE21,selumetinib-PLX-4032 (8-1 mol-mol),2.235556808561001
CA46,25150857,1.719157108492683
HEC-151,10127622,3.4193086476491814
HuT 78,54649381,3.65840256094047
BT 139,11626560,2.3775074493494284
SW1990,piperlongumine-MST-312 (1-1 mol-mol),1.0885797655495495
RPMI-7951,135440466,2.2545531481236014
PE/CA-PJ49,11497983,3.7994521825167302
SK-N-AS,49793307,-2.9221578355478655
Kasumi-2,6610216,3.59110037414398
KYSE-70,446155,3.830415114438346
JIMT-1,126941,-2.9107515148587404
IST-Mes1,448949,2.0697752718967677
IST-Mes1,4578,4.452023444310014
PE/CA-PJ49,5479543,3.6121733345315503
OAW28,51037431,5.214608262969992
SEM,11175137,1.2728559618828204
GOS-3,71304818,3.432284958440276
Ku812,25105715,2.5153812758141902
EJM,16722836,1.936156340232378
Hs 683,5329102,1.6753697513688257
LNCaP clone FGC,72376,-1.8461779553879152
TE 617.T,148198,-5.570836708197065
KMS-20,5311037,3.3328695016599132
RERF-LC-A1,3081361,3.61758571221608
NU-DHL-1,984333,0.6343201948214459
ESS-1,119607,5.640066336706725
WM983B,148124,-4.219347286004686
BT 320,5738263,4.511639431207419
RERF-LC-Ad2,702558,5.435441193828656
RPMI-7951,676352,1.7068328683549538
NU-DHL-1,11175137,1.9777455594143565
TE-15,36462,0.8303129579402212
OAW28,navitoclax-birinapant (1-1 mol-mol),0.270639577142551
WM983B,252682,6.201263112556364
SW1573,23582824,0.5044187481506299
SK-N-AS,44493528,4.35131115030736
OAW42,11707110,4.305063832457843
HSC-4,3676137,3.997252050059137
KMBC-2,piperlongumine-MST-312 (1-1 mol-mol),2.5373712464665767
PE/CA-PJ34 (clone C12),11175137,2.637065754924562
SNU-8,676352,2.994743080679249
NCO2,3634881,2.512945578603333
KP-4,9868037,2.659555107849518
Ku812,11238147,1.619388725534285
KMS-27,11178236,-5.969829351072696
YH-13,navitoclax-pluripotin (1-1 mol-mol),0.1454276161313981
SEM,3634881,2.315957933723583
HEC-151,171352865,4.287251049554932
KMBC-2,54678924,1.7845836529906036
LNCaP clone FGC,6918878,1.6855471667539077
HuT 78,241158,3.345962703014529
SW1573,51039095,4.568767182944777
BT 504,2858523,2.965212021791349
SET-2,decitabine-navitoclax (2-1 mol-mol),-2.129700586239786
Ku812,5284616,-4.419466580952263
NCI-H1092,9935249,2.293612828813301
TE 617.T,tretinoin-carboplatin (2-1 mol-mol),4.888045737134101
HMCB,3081361,2.917485308140701
KYSE-70,452548,2.3575041584151637
BT 330,46398810,2.0838726617109575
OE21,9903786,3.8183922804943298
CA46,11656518,1.817934601803022
NCI-N87,49793307,-2.95740399691262
AN3-CA,148198,-4.708662281337999
RERF-LC-Ad2,15547703,3.0920288807988245
Hep-G2,3081361,2.5045314139497723
SNU-308,3038522,4.08288745774994
SK-N-AS,44589607,2.325162409761716
NCI-H1395,25195348,3.618629950214112
NU-DHL-1,crizotinib-PLX-4032 (2-1 mol-mol),1.8134352324623328
BT 139,24821094,1.6610897074199305
KYSE-70,24772860,-1.2328668610311222
TE-15,tanespimycin-bortezomib (250-1 mol-mol),-0.6249388884216994
NCI-H2110,409805,5.766269272797009
RERF-LC-Ad2,148198,-4.2716837580451825
Hs 683,BRD-A02303741-navitoclax (2-1 mol-mol),3.3943725578287376
PE/CA-PJ34 (clone C12),9933475,1.703658812980445
JIMT-1,5328940,1.6826511785825409
ESS-1,462382,0.8866034659436756
Kasumi-2,11364421,-5.792134203695654
IST-Mes1,5311,2.113640627204962
KMBC-2,2749,1.7206137145305835
CA46,25161177,3.91788686206549
BFTC-909,16038120,1.74161234898449
SNU-1272,216468,5.738566915129053
SNU-1272,24951314,2.1913708545239543
SET-2,54678924,1.2764107286462951
EJM,selumetinib-UNC0638 (4-1 mol-mol),4.085374328127957
YH-13,selumetinib-tretinoin (2-1 mol-mol),4.993849877011519
KMBC-2,5460769,1.880103554481412
AU565,6918328,-1.0169109160359904
D283 Med,3503,1.294693501027344
CML-T1,5746,-2.1549173035879803
LoVo,227681,3.064150517180394
SK-LMS-1,5282054,4.21562772528494
SKM-1,doxorubicin-navitoclax (2-1 mol-mol),-1.9778957551235763
BFTC-909,9868037,3.24226767674478
H-STS,57519531,1.7536520840543603
HCC2218,9868037,3.0911136075501253
KP-4,16741245,4.517888599440113
Hs 683,73707371,5.528718161611099
KYSE-70,11214940,1.7563649507227177
OAW28,42642645,0.9360886571737812
KP-4,24964624,3.280275889697183
BT 320,16038120,1.884341751706396
SNU-1272,6610355,5.209635935326743
Hep-G2,16722836,1.3885604192453562
PaTu 8988s,11719255,3.3536118584296086
TE-15,52947716,3.120902835565105
SET-2,252682,6.247375005107577
CA46,selumetinib-BRD-A02303741 (4-1 mol-mol),5.304542005494123
KYSE-410,123631,1.1616708404794314
HuT 78,5335621,4.006139745042012
EJM,136227924,2.8681258655198367
SEM,selumetinib-BRD-A02303741 (4-1 mol-mol),2.811165590219853
AU565,serdemetan-SCH-529074 (1-1 mol-mol),1.652601677572969
AN3-CA,24771867,0.3006367782170145
NU-DHL-1,19582717,3.0772227336893505
NCI-H1395,11404337,2.1973197619817832
OAW42,54678924,2.7713628918347983
TE-15,9884685,1.0908801329755264
KMS-20,JQ-1-vorinostat (2-1 mol-mol),-0.6306779482230097
PaTu 8988s,24901704,4.07044278536804
CML-T1,107970,1.8137988275945616
SK-MEL-1,navitoclax-piperlongumine (1-1 mol-mol),-2.531275183811392
SNU-308,11625818,3.828888868418273
SK-MEL-1,selumetinib-navitoclax (8-1 mol-mol),-1.9711761755036088
Kasumi-2,135440466,2.9310364314773376
MCAS,20959075,-2.7430469730457077
EJM,11396600,3.800195279839431
HMCB,12001922,1.7530973363803413
NCI-H2081,613753,3.0014003602908392
HuT 78,15953870,2.5576152772998832
HuT 78,71751553,4.273670469751914
NCI-N87,crizotinib-PLX-4032 (2-1 mol-mol),2.5035050425609673
NCO2,6184667,2.869230122449572
Hs 683,3634881,3.3169012356271574
Ku812,176870,1.7235761174633464
KMBC-2,11955716,1.186326617820705
PE/CA-PJ49,3136844,3.894534312555505
D283 Med,12003241,-3.4539176227720794
IST-Mes1,16038120,1.0913997834143612
YH-13,16720766,0.962389750080769
KP-4,JQ-1-UNC0638 (2-1 mol-mol),4.144719102429264
SNU-1033,54619267,4.351275427505696
BT 139,JQ-1-vorinostat (2-1 mol-mol),1.3408990308759607
ESS-1,60750,-3.419429492485854
KMRC-2,11167602,4.424264905666824
Kasumi-2,135421197,0.8154486687594628
SW1990,25062766,1.7290899582352826
IST-Mes1,8515,4.272788297141445
KMRC-2,613753,3.2501406467499536
KYSE-70,3081361,2.4267899196210982
OAW28,11485656,3.2643123414600645
HSC-4,selumetinib-BRD-A02303741 (4-1 mol-mol),4.233119251645935
RERF-LC-Ad1,24889392,4.514749379565269
HCC2218,168312962,-2.061497863171819
RPMI-7951,vorinostat-navitoclax (4-1 mol-mol),1.0109262347877594
BT 248,2858523,2.3138600326756436
ESS-1,JQ-1-vorinostat (2-1 mol-mol),1.066705942118914
BT 248,11175137,2.43855252671782
LNCaP clone FGC,25227462,-2.764949583578387
Kasumi-2,selumetinib-UNC0638 (4-1 mol-mol),3.1045685976717623
RPMI-7951,16219061,3.1411295377528297
MM1.S,46174525,3.3961962324765764
TE 617.T,107985,-4.218073473743226
Ku812,68056272,1.369253541918081
NCI-H1395,568763,0.9321190773221452
ML-1 [Human thyroid carcinoma],1750826,-1.3031865689994189
MM1.S,3062316,1.4627062032317144
EJM,6917907,-6.067792190523033
Kasumi-2,11257553,-0.3952076481824682
RERF-LC-Ad2,JQ-1-vorinostat (2-1 mol-mol),2.137541513249455
NCI-H1092,285033,-2.138341448649312
HEC-151,400769,-0.8964791777115502
KMS-27,11609586,0.8561260403457472
RPMI-7951,441298,2.363553637102318
Hep-G2,71466380,3.1584053277092696
NCO2,12001922,1.2398854630234812
TE 617.T,25227462,-3.549528235544154
Kasumi-2,3854666,0.5999676074569762
KMBC-2,5287969,-1.6235944200251051
RPMI-7951,24785538,2.5562188747130645
WM983B,24748573,2.6134328151260755
SET-2,71466445,1.5490156865471134
RPMI-7951,6623618,1.951581302772224
KMS-27,54613361,-1.5890909260641095
LNCaP clone FGC,135421197,1.5055395740527522
KMBC-2,57519531,3.989886284892741
SEM,135411,-1.7060706905647656
SNU-1214,11238147,1.933777148058132
RPMI-7951,11507802,1.523521389260421
NCO2,5328940,-1.3429523096826288
KYSE-410,2708,5.464005595955719
PaTu 8988s,UNC0638-navitoclax (1-1 mol-mol),1.233216645790841
NU-DHL-1,71729975,0.4748567113914174
SK-MEL-1,carboplatin-UNC0638 (2-1 mol-mol),3.929950532064666
KMBC-2,25022340,2.3366821677333114
TE 617.T,24180719,3.6567645960116497
SKM-1,984333,0.5121971220732339
SW1573,71680916,4.0865163925225385
SNU-1033,53392493,1.6848356880137518
WM983B,3062316,-0.2827262503403948
SNU-1214,3038522,3.5904170903489585
PE/CA-PJ49,11656518,1.2217707692377924
LCLC-103H,676352,1.9880979903313516
KYSE-410,11222830,1.660607012947518
LoVo,3081361,0.9226789940369008
KMBC-2,421610,4.1276517367028545
BT 139,9866186,3.845827958746893
A4/Fukuda,4705,2.104501352907832
PE/CA-PJ49,alisertib-navitoclax (2-1 mol-mol),-1.398570786240834
D283 Med,44493528,4.1397828788754465
HuT 78,448949,0.4485717539901531
SW1990,46191454,3.835132075792151
SKM-1,11427553,1.4023933333008194
H-STS,5278396,2.5022643900173707
EJM,11640390,1.8430526894462032
SEM,56649450,3.981802014132025
WM983B,1566236,4.024003638692175
JIMT-1,4477,0.2034805009722897
NCI-H2110,119607,5.439167297599681
SKM-1,216239,2.5216092374481716
CML-T1,selumetinib-PLX-4032 (8-1 mol-mol),3.463736211464864
SNU-308,44819697,2.1321699487878245
NCO2,123631,1.4748338877724372
Hep-G2,168312962,-0.8172908968582097
NCI-H1092,46843906,3.6069684847393666
SW1573,3062316,2.075650426956439
KP-4,375860,-0.9518603940694028
SK-MEL-1,3854666,3.1088864044713747
KMS-20,5280436,3.104525764611907
YH-13,JQ-1-MK-0752 (1-1 mol-mol),1.712752654360266
TE 617.T,navitoclax-PLX-4032 (1-1 mol-mol),3.682311343585133
LoVo,navitoclax-sorafenib (1-1 mol-mol),2.5511515051305893
SNU-1214,2749,1.7868446846610977
KYSE-70,46907787,2.9670215892594793
KMS-20,19582717,1.3096306305639924
KYSE-410,446155,3.849504807442918
Aska-SS,57519531,2.1807971197736946
KP-4,9825149,2.986048802019184
SEM,45279963,3.71935630000701
LNCaP clone FGC,445091,4.232041657449121
SK-N-AS,crizotinib-PLX-4032 (2-1 mol-mol),1.24464227923661
NCI-H2110,11626560,1.8725648928578935
RERF-LC-Ad2,16038120,1.0723160205223616
NCI-H1092,65628,3.8308798172666183
SNU-1033,alisertib-navitoclax (2-1 mol-mol),1.8441105793255037
PaTu 8988s,135999136,4.429569126789119
Kasumi-2,56973724,0.9281139851854971
KP-4,11396600,3.580302793635078
IST-Mes1,9926054,1.778703370274458
HSC-4,168313047,3.0036663016787015
Hep-G2,2746,2.5421699123058383
HMCB,sirolimus-bortezomib (250-1 mol-mol),0.2910880989689153
KMS-20,5746,-0.3166262639193328
NCI-H2110,2113511,5.920003848385286
HCC2218,51039095,3.70801925853649
KP-4,docetaxel-tanespimycin (2-1 mol-mol),-6.012613986523793
SK-N-AS,5311281,1.8121550647491944
OAW28,409805,4.888216855585461
SET-2,44137675,2.73543784848982
Raji,54678924,0.89459864851051
BFTC-909,644241,3.062866082016443
ML-1 [Human thyroid carcinoma],24772860,0.5673209260643837
TE 617.T,5311,1.3477335510320705
KMS-20,71466578,2.1821979344467537
HEC-151,15983966,-2.399363351088112
HuT 78,carboplatin-UNC0638 (2-1 mol-mol),1.5408742669191249
Aska-SS,53392493,1.884177786668172
KYSE-410,135659046,3.770855239455897
SK-LMS-1,46398810,3.17940895755664
CA46,JQ-1-vorinostat (2-1 mol-mol),-0.7880767442206768
PE/CA-PJ49,53392493,2.005132316425773
TE-15,JQ-1-MK-0752 (1-1 mol-mol),0.2653870098950329
ML-1 [Human thyroid carcinoma],71304818,3.0426605111728517
NCO2,644241,3.59504052771079
SW1573,4261,3.544037815747042
SW1990,6610355,4.5884758329623825
BFTC-909,3038522,3.685618431455981
Hep-G2,5311,0.6170411040071866
A4/Fukuda,46907787,-1.6446005772830188
SNU-1272,5470400,5.593661886100306
EJM,46926350,-5.52167397488298
ESS-1,7251185,2.2330805866433834
PE/CA-PJ34 (clone C12),45279963,3.8312353498990785
PaTu 8988s,3038522,2.9710508112698983
SK-N-AS,44486219,4.259683695397055
NCI-H2172,168313200,3.683168062347926
PaTu 8988s,46215462,1.30654538565013
PE/CA-PJ34 (clone C12),9926054,1.748247929323894
A4/Fukuda,44543605,3.1271044447490235
AN3-CA,25126798,3.0603028688799077
EJM,46943432,3.619668904272789
JIMT-1,613753,3.3557000645012134
SK-LMS-1,6918837,-1.8023788120750237
SKM-1,2746,1.6032420730880204
BT 504,6438330,2.064426586822408
OE21,54596490,5.298200205444942
SEM,5287969,-1.544606693116113
KMS-27,11485656,2.096815262793708
SK-LMS-1,5328940,2.5570935904048606
NCI-H1092,216345,3.5494296383445105
BT 248,53232,4.253838861384023
NCI-H2110,11167602,4.9824234878437395
MCAS,4261,1.8522605558000784
NCI-H2081,11222830,0.8960915766388172
SKM-1,375860,-0.6747488513339966
NCO2,119182,-1.6950498558242229
NCI-H2081,54618164,3.631207373775394
HEC-151,44819697,0.1746671006919519
BFTC-909,3815108,3.5118939741133075
GOS-3,262093,3.1165245547903804
YKG-1,31703,-1.4076263674107627
CML-T1,25150857,1.621602747179882
KYSE-70,285033,-2.195981319752621
Raji,25150857,2.2556333838390388
CML-T1,219104,2.3392357294314055
LoVo,4096211,0.5868958804653562
NCI-H1395,12003241,1.698262392733821
AN3-CA,BRD-A02303741-navitoclax (2-1 mol-mol),4.701391126937182
SW1573,89183176,3.862510153781557
SEM,216345,1.9480472657729433
TE-15,44493528,4.216402167585121
SNU-8,124202324,2.521017615962926
BT 330,119182,-0.5764948998791074
NCI-H2081,4477,0.6401046576729016
SEM,168313200,1.52373638401344
KMS-20,5281321,-3.543869904687322
ESS-1,11507802,2.580294278940104
H-STS,6450551,1.5253926760198298
BT 328,piperlongumine-MST-312 (1-1 mol-mol),1.83335233808469
D283 Med,135984461,1.545115225409391
TE-15,5282054,3.1485256365752914
KMS-27,46398810,2.309866347447312
MCAS,12003241,0.5308085719616568
NCI-H2172,400769,-0.2846387856986963
H-STS,2729026,3.2634172065243656
SET-2,2746,0.8916395455775363
KP-4,3825829,3.2044690277521592
KYSE-70,168312962,-0.2970816131627225
PE/CA-PJ34 (clone C12),salermide-PLX-4032 (12-1 mol-mol),5.538851904722065
GOS-3,16725315,5.248800956635294
RERF-LC-A1,11647372,2.6977994550896365
NCI-H2081,54143018,0.6248059952712489
MM1.S,44589607,1.0331036343158948
KMS-20,135875424,2.456374257858295
LoVo,selumetinib-piperlongumine (8-1 mol-mol),1.883455735434258
PE/CA-PJ49,tretinoin-navitoclax (4-1 mol-mol),4.444657287953014
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084
OAW42,25154868,5.410881914669428
CA46,JQ-1-carboplatin (1-1 mol-mol),-0.7040949114758062
SEM,400769,-1.6212646015616712
RPMI-7951,60168763,3.264006929182048
BFTC-909,6918289,3.427790661189136
NU-DHL-1,44462760,1.663932260819044
JIMT-1,3689413,-1.7375587293018775
NCI-H1395,5291,4.092601973794721
SW1990,9927531,5.3345214594202695
NU-DHL-1,44566777,0.8504751325231436
BT 328,2708,7.776890663910961
SNU-308,89928392,3.511225244541038
BT 504,25105715,3.27017572632137
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
D283 Med,44607531,2.0088553908095954
ML-1 [Human thyroid carcinoma],5746,-1.0436745341015816
Kasumi-2,JQ-1-carboplatin (1-1 mol-mol),-0.6879782047787374
PaTu 8988s,44607530,2.1258058161075226
PaTu 8988s,11214940,1.9051514433442307
HuT 78,439501,-3.2848313932186315
NCI-H1092,16065773,1.6948884921799936
HARA [Human squamous cell lung carcinoma],navitoclax-gemcitabine (1-1 mol-mol),-0.596107332987684
SW1990,241158,4.5746267223156085
KP-4,tanespimycin-bortezomib (250-1 mol-mol),-2.4280197504959107
YKG-1,51039095,2.966618349513072
Hep-G2,25126798,4.0487954098404755
TE 617.T,46843906,2.8177440726942797
SK-LMS-1,445643,5.376306507638801
BT 139,219104,4.509107206389703
SNU-1033,44137675,3.659599107185258
BT 320,3062316,3.917549487062472
KMS-20,54618771,0.3177440488164709
PE/CA-PJ34 (clone C12),44632017,0.8623565218793319
RERF-LC-Ad2,54618771,1.6045253072760792
SKM-1,5287620,-2.0310276882381633
KYSE-410,24771867,2.1573021034498705
KMS-20,9967941,3.626187423361352
AU565,44507138,1.5217719455679517
KMS-27,9549297,2.0072526603834464
SNU-1033,25183872,-1.222439470478559
NCO2,alisertib-navitoclax (2-1 mol-mol),-2.125466999585316
Hs 683,8515,4.507985509607111
KMBC-2,9866186,-0.8646710770131696
A4/Fukuda,445643,2.2110077600401996
H-STS,46843906,3.4319919456792296
ESS-1,6184667,3.505716491924749
WM983B,66577038,3.2925740679756585
MCAS,60700,0.1584567285823285
HMCB,4096211,2.0391547918713626
KMS-20,carboplatin-etoposide (40-17 mol-mol),1.5141675555174716
BT 330,25154868,5.299931833551549
HSC-4,56949517,4.34052816497715
Ku812,44185566,0.7020078390558537
YKG-1,54618305,4.389332697073838
NCI-N87,119182,-3.621619524843969
CA46,24775005,3.732581966598925
RERF-LC-A1,44137675,4.267374816283445
TE-15,5329102,1.929411101964923
MM1.S,vorinostat-navitoclax (4-1 mol-mol),0.234201323226823
Hs 683,11977753,-2.3238360318004747
NU-DHL-1,9952709,2.663459796321655
LNCaP clone FGC,44202524,1.406144438084138
KMS-20,3465537,0.9285591790497558
TE-15,23725625,5.9431267639026375
NU-DHL-1,3676137,5.3250743483320395
KYSE-410,53232,3.7629368703278208
MM1.S,452548,-3.3591080388586816
NCI-H2110,25150857,3.0611564298156315
LNCaP clone FGC,5329102,2.7055412464817823
Kasumi-2,753704,4.42700120937948
A4/Fukuda,56973724,1.7857996527787343
SNU-8,44241473,4.763385234005065
RERF-LC-A1,654092,-1.2602553133835417
YKG-1,25262965,-2.8273978219835416
Hs 683,421610,2.270321909677873
NCI-H2172,446155,4.098751908168383
D283 Med,BRD-A02303741-carboplatin (1-1 mol-mol),4.587928026591079
CA46,25195348,1.4184238486273535
OAW28,753704,4.708152366597851
CML-T1,2729026,1.0181320426336582
BT 248,24748573,2.3039416185334556
PE/CA-PJ49,16722836,1.703221716045444
NCO2,9956119,2.055283655836574
OAW28,11612883,3.952715585132085
OE21,17755052,1.0095449688943243
KMBC-2,56946209,-4.199826885472946
SKM-1,11455910,-0.0252675410510007
YKG-1,9887053,4.276479175493701
CML-T1,89183176,3.024950752568636
ML-1 [Human thyroid carcinoma],25102847,2.935986325205898
GOS-3,carboplatin-UNC0638 (2-1 mol-mol),3.2409123088113194
PE/CA-PJ34 (clone C12),11955716,-2.415491990969517
OAW28,JQ-1-UNC0638 (2-1 mol-mol),1.5055699462445158
KYSE-410,6852167,1.749610623919313
Hep-G2,selumetinib-MK-2206 (8-1 mol-mol),-0.3910940132297484
NCI-H1092,4261,0.9195387417672236
CML-T1,3854666,0.73725489161191
HuT 78,selumetinib-PLX-4032 (8-1 mol-mol),-3.310365038603551
Kasumi-2,439501,-3.441659601561783
KP-4,16722836,2.23507470757676
Kasumi-2,445455,4.224989809831099
RPMI-7951,448949,0.8690324871561279
BFTC-909,11364421,-5.034674750215906
RPMI-7951,56946209,-3.4543929986035717
AU565,36314,-7.774521242942876
SEM,11719255,1.9160664785241357
MM1.S,135398516,0.5060788410645305
SNU-8,6918837,-2.3006259406352023
OAW28,119607,5.347849335106357
Aska-SS,241158,3.805565217473049
SNU-308,44589607,4.7032544289207125
HEC-151,375860,-0.8046156329798803
KMRC-2,135875424,4.786513298485674
A4/Fukuda,54618305,3.964460418875751
D283 Med,216239,2.1724575702857
SKM-1,219104,2.5131596943012053
HuT 78,11647372,0.6475379223076121
ML-1 [Human thyroid carcinoma],selumetinib-UNC0638 (4-1 mol-mol),-2.912510210684258
BT 330,44607530,0.8480949545139396
Hs 683,11507802,1.064006368361757
KMS-20,46224516,1.6732996169077097
BT 330,tanespimycin-gemcitabine (1-1 mol-mol),-0.7395806919705037
AN3-CA,36462,2.7690899161359774
LNCaP clone FGC,374536,-0.7618428530873494
ESS-1,44566777,0.5104790978676739
YKG-1,46215462,1.7714075060920065
SET-2,11213558,-0.1598016097823202
CA46,9927531,3.0223750820915978
PaTu 8988s,navitoclax-birinapant (1-1 mol-mol),1.2530315595122747
SK-LMS-1,44462760,4.2317756310447106
IST-Mes1,16725315,5.212250641781058
OAW42,644241,1.8292706332656063
BT 504,9903786,2.1257740171546717
BT 504,44507138,4.182635948744125
BT 330,7251185,1.8500952657054732
TE 617.T,4096211,1.584959611515095
SW1990,10184653,1.79028114395006
MCAS,17755052,1.3855879628381012
TE-15,19582717,3.5124908558846353
SKM-1,71466445,1.6319589215508703
EJM,54618771,0.5366367501744294
PaTu 8988s,44486219,4.497877862030564
SNU-1033,4378219,1.9830509373994671
BT 320,2126,5.543243224179777
Kasumi-2,123631,2.0188728462797885
KMS-27,6914657,-3.8444502413551658
RERF-LC-Ad2,tanespimycin-bortezomib (250-1 mol-mol),0.3910876035437155
Ku812,3384730,0.3528763049585885
OE21,24180125,3.3854112835406625
BT 504,168313200,1.7545727786068688
RPMI-7951,6252,4.663548083399878
SET-2,60700,-2.9666676909447496
NCI-H2110,decitabine-navitoclax (2-1 mol-mol),4.889337790333301
NCI-H2110,4477,0.6632295370187135
TE-15,6505803,-1.869936847714552
RERF-LC-A1,148198,-3.1102576281385654
KP-4,25154868,4.218317877549878
OAW42,selumetinib-navitoclax (8-1 mol-mol),2.7251033379638807
SNU-8,9936388,-5.172305126613517
CA46,44632017,0.5480853683486498
YKG-1,52947716,3.285514356728494
MCAS,9936388,-6.436874065356807
TE-15,9933475,1.5084956369379665
SW1990,9884685,1.028509429358882
ESS-1,selumetinib-GDC-0941 (4-1 mol-mol),2.1616208595010966
Aska-SS,11609586,2.144286749456431
SNU-1214,selumetinib-tretinoin (2-1 mol-mol),0.5457033843008748
AN3-CA,54618771,2.457771155909442
SNU-308,107970,2.9327058246303483
HEC-151,11626560,2.4585377057566613
PaTu 8988s,60700,-0.3114042731507669
NCO2,6917907,-6.364188718429011
BT 320,BRD-K55473186,3.858960180173933
Hep-G2,135875424,4.631021258019282
SNU-1214,56963564,0.6024580482919216
TE-15,216239,2.79028848933855
HuT 78,2945648,3.150096975155089
SNU-8,151289,1.199400027159569
SEM,51039095,0.5318115856558748
AN3-CA,753704,4.635041156511698
KYSE-70,6918328,0.2213620303324437
CA46,23725625,5.582899861703026
NCI-H1092,11214940,3.734775459591196
SNU-1033,568763,-0.247393300871531
BFTC-909,73707398,1.325657316242966
KMS-20,54626689,3.7959086868633016
MCAS,40482356,5.123729097421837
PE/CA-PJ34 (clone C12),11494412,-0.047975107536018
WM983B,126941,-4.105276153405101
KP-4,9926054,2.5953636784587877
BT 330,11317348,1.5954032915726168
SK-N-AS,5566,3.025086689743236
Ku812,54454,3.828644257456088
MM1.S,71680916,5.174704169094283
SW1990,11707110,-2.3904983782670164
Hs 683,54765302,3.844319739814382
OAW42,2749,1.5900605969459
Aska-SS,45279963,4.287982423003227
Hs 683,3025944,4.195696476989441
SNU-1214,15953870,3.760154168645951
ESS-1,969516,2.694807880886465
Ku812,11612883,2.6120187815621128
BT 248,25105715,2.686391114115495
SET-2,53481919,3.738136134081667
LoVo,216468,2.992200557668688
SKM-1,969516,2.2754030412406774
CA46,11485656,1.2289823963881294
GOS-3,49836020,5.837697611269413
HSC-4,445091,4.370395830414555
SK-MEL-1,387447,-2.6389063498741225
OAW42,10172275,4.377921817794679
SK-LMS-1,71680916,5.050337566069936
EJM,5311,0.5955107958606237
SK-LMS-1,136227924,4.704854352606181
RERF-LC-Ad1,selumetinib-piperlongumine (8-1 mol-mol),4.22277875723884
A4/Fukuda,11485656,1.5130746228374388
HSC-4,3011155,4.427149856421904
SK-LMS-1,alisertib-navitoclax (2-1 mol-mol),1.0295022331839287
HuT 78,446155,1.49234207270104
HARA [Human squamous cell lung carcinoma],selumetinib-JQ-1 (4-1 mol-mol),3.6659251122276015
BT 248,25183872,-1.6442953183353304
KMS-27,44819697,-2.444267674030988
NCI-N87,serdemetan-SCH-529074 (1-1 mol-mol),1.7996053995650736
NCI-N87,654092,-0.6954721735465327
Hs 683,10172275,4.903981746071532
HMCB,439501,-1.1140754693945072
RERF-LC-Ad2,11640390,3.4027791820615665
NCI-N87,100016,7.118039999797619
OAW28,44493528,4.631141764792384
NCI-H1092,1716436,2.458293295551776
PE/CA-PJ34 (clone C12),60750,-1.7641821181444215
OAW28,2729026,2.5871569751548047
Raji,4521392,4.1619167727464665
PE/CA-PJ49,2858523,3.1407591199690144
BT 504,25227462,1.6424817770724798
NCI-H2110,tanespimycin-gemcitabine (1-1 mol-mol),-2.8428766738251965
H-STS,107985,-3.371812219101193
OAW28,15983966,1.5707780698474574
LCLC-103H,3634881,3.188262499934553
KMS-20,262093,1.6065117070445694
SK-N-AS,46215462,1.5582727610065583
SW1573,16722836,2.4665820842388606
BT 139,16725315,3.2723557113557105
ML-1 [Human thyroid carcinoma],375860,0.003862862725961
SNU-1033,11222830,1.785225605711629
LoVo,176870,1.1282563754131285
EJM,selumetinib-MK-2206 (8-1 mol-mol),2.5520093937916144
BT 139,3543504,5.470750216796982
AU565,46191454,1.308540851634407
KMBC-2,5311,1.615987624610291
PaTu 8988s,5281321,-0.5973180568257009
SNU-1033,11955716,-0.1266857479332317
A4/Fukuda,BRD-K55473186,4.020373973875239
BT 328,ISOX-bortezomib (250-1 mol-mol),1.5922800813403362
TE 617.T,421610,1.5744665942554643
D283 Med,54618305,4.176148849074149
EJM,5351362,0.5946464682501855
H-STS,2749,1.0388085008681336
Hs 683,1566236,3.857796471842603
HEC-151,107970,2.3284041079322497
AN3-CA,46215462,1.512809957192001
BT 139,3503,1.158588418080293
EJM,4477,0.4259147068963801
BT 504,49793307,-4.126084893763906
TE-15,6438330,2.635469606386231
SET-2,9866186,-1.6231732696202446
WM983B,104842,-2.7837032939510635
SNU-8,5328940,1.340184233172612
NCI-N87,3854666,1.2679317332294615
PaTu 8988s,16065773,2.5223841177009083
NCI-H2172,119607,4.988984400900318
BFTC-909,11167602,2.8757137848929006
WM983B,10231331,-2.8464070849273755
OAW42,tretinoin-navitoclax (4-1 mol-mol),4.130962933720272
BT 139,navitoclax-sorafenib (1-1 mol-mol),0.7413129484728741
SNU-1033,5287969,-1.852663004526358
CA46,448949,1.4123991312197492
RERF-LC-Ad1,24964624,3.310681300814033
KMRC-2,219104,4.226334553448108
SK-MEL-1,11396600,3.732963338182352
OE21,219104,4.351276400343982
NCI-H2110,16065773,3.6504121328768937
SK-MEL-1,11656518,-1.4263780627799514
AN3-CA,11234052,3.789167280312416
Ku812,216345,2.75636919454375
SKM-1,53495165,-0.711725561210763
WM983B,4261,1.5967514950630737
HSC-4,65064,5.180183799352401
OAW42,12001922,2.4464310473843667
HARA [Human squamous cell lung carcinoma],969516,2.3775549977258836
SKM-1,9826308,-1.0931344277451622
KMBC-2,446155,4.099966375118705
HMCB,16065773,1.8456110367577696
A4/Fukuda,3385,2.3595203579832553
NCI-H2081,10113978,3.1143213489087755
BT 328,2126,6.023692748820712
OAW28,44819697,-1.5562690526140308
EJM,3634881,2.858173041625091
AN3-CA,11427553,1.8420889337174475
Aska-SS,11977753,-0.7258583648361356
Aska-SS,126941,-2.750768473215521
AN3-CA,9803433,6.356257322204903
D283 Med,322968,2.541378119684702
LNCaP clone FGC,100016,6.505127339133147
HEC-151,6610216,4.488226027984822
ESS-1,crizotinib-PLX-4032 (2-1 mol-mol),2.558730455952703
BT 504,448949,1.766062180385496
SW1990,11427553,2.629768269739627
KYSE-410,2742550,3.0781954877880797
BT 248,644241,1.8454939937856112
TE-15,17755052,1.65002415158768
Kasumi-2,676352,0.386616578071509
Hs 683,9907093,3.927023043212742
ESS-1,2749,1.483117566277163
LNCaP clone FGC,tanespimycin-gemcitabine (1-1 mol-mol),-0.8170997409283122
MM1.S,285033,-2.3858654705971
NCI-H1395,216239,1.7586314171989954
IST-Mes1,66577038,2.5150906013236423
IST-Mes1,navitoclax-pluripotin (1-1 mol-mol),-0.6633970571557571
Ku812,selumetinib-tretinoin (2-1 mol-mol),-1.3123873210444326
KMBC-2,11485656,2.7390953396220588
NCI-H2110,11612883,2.552146272408435
Raji,322968,2.716304325933968
KMRC-2,ISOX-bortezomib (250-1 mol-mol),0.1988664338872188
LNCaP clone FGC,24797083,1.6504551610378324
KYSE-410,16013152,4.977584509485277
Kasumi-2,57330099,4.668594265491518
LCLC-103H,969516,2.7736350304467483
AU565,crizotinib-PLX-4032 (2-1 mol-mol),2.690947224555452
OAW28,135398516,2.0767833136681437
SK-MEL-1,piperlongumine-MST-312 (1-1 mol-mol),2.0200202022493547
OAW28,25262965,-0.9519808245592094
RERF-LC-A1,60750,-3.8438002969304694
KMS-20,10074640,2.509346004952602
KP-4,36462,0.4570460544879974
SKM-1,6610355,3.573663853963525
RPMI-7951,2949965,2.7750243079239016
GOS-3,89928392,1.6340555670682608
CA46,46843906,1.200591966763502
CA46,44137675,2.206940954689562
ESS-1,49793307,-2.776813429548929
RPMI-7951,387447,-4.73850592434981
Hep-G2,11612883,2.6533620783645935
LoVo,123631,1.2882244486240189
SET-2,24748573,2.5163254367643515
Kasumi-2,984333,-0.6107639841292208
HMCB,246676,5.779204987667754
AU565,9933475,1.5968241540352486
RERF-LC-Ad2,15953870,4.58156365468759
NCI-N87,navitoclax-birinapant (1-1 mol-mol),2.0087616801931953
PE/CA-PJ34 (clone C12),11497983,5.068239933837802
MM1.S,navitoclax-pluripotin (1-1 mol-mol),-0.4741986975069364
PE/CA-PJ34 (clone C12),11178236,-3.1085754379858175
HuT 78,25126798,3.93002512253093
YH-13,6450551,2.0238267614967644
SKM-1,168312962,0.8747361111835986
H-STS,216468,0.2818757493359613
SNU-1214,6918837,-2.7432806587125085
BT 330,selumetinib-vorinostat (8-1 mol-mol),2.5092548953484184
Hep-G2,23582824,2.7643164311321584
NU-DHL-1,5335621,3.760222495124576
PaTu 8988s,68056272,3.766790890647225
PE/CA-PJ34 (clone C12),151289,0.5971679831137401
OAW42,44202524,4.031270648001562
AU565,5281321,-1.6701173206544262
KYSE-70,107985,-3.298359335305578
Ku812,6438330,1.0615071756734653
SEM,168313016,1.967017226052083
Hs 683,16038120,1.3403020790788895
HuT 78,168313016,3.837657248427472
NCI-H1395,17755052,2.034281994914555
YKG-1,439501,-3.197548465236136
ML-1 [Human thyroid carcinoma],3854666,0.5957604923029644
BT 139,16659841,4.09372938961613
ESS-1,25126798,3.845580054250281
RERF-LC-Ad2,24964624,2.450772716957221
SK-LMS-1,11364421,1.259648760009216
SEM,54618771,-1.6874791122177024
LoVo,5460769,-2.1468642890382412
KYSE-70,9915743,1.2522553618909642
SEM,24951314,-1.2286603360441832
SEM,89928392,-0.8606001711517224
EJM,52947716,-8.188732553251715
KMBC-2,5284616,2.9519587458655057
NU-DHL-1,9911830,2.5877421671517578
IST-Mes1,24901704,2.6411672165981965
AU565,1750826,-0.6805778178680736
PaTu 8988s,navitoclax-sorafenib (1-1 mol-mol),2.036825737456502
Hs 683,26596,-1.91567083647516
NCI-H2110,262093,4.10340668622513
SKM-1,11640390,1.3825660672186588
LNCaP clone FGC,piperlongumine-MST-312 (1-1 mol-mol),-0.3549600707438295
GOS-3,3689413,-2.185831490776692
HEC-151,55283,3.4756802706250154
Raji,241158,1.7953871388242486
SNU-1214,10074640,2.7352407476720084
RERF-LC-A1,11238147,3.1238243156990273
NCI-H2081,23725625,3.532612655790426
OAW28,148198,-3.8662210541116977
BT 248,54618164,4.1848059637542585
TE 617.T,9967941,2.6679963163569647
SK-N-AS,5328940,1.54015893442402
NCI-N87,25126798,3.678424158745535
BT 330,135999136,1.458475788495572
KP-4,6610216,4.774737819722466
RERF-LC-Ad2,tretinoin-carboplatin (2-1 mol-mol),5.31055335503166
Hs 683,3689413,-0.4207741938701824
Ku812,11656518,-1.0903190853859568
TE 617.T,16736978,1.1800461581216122
AN3-CA,JQ-1-vorinostat (2-1 mol-mol),2.0099922232895473
CML-T1,3025986,-2.237853890359125
Hs 683,71466380,4.422250293269032
OAW28,5278396,3.588828047742794
SEM,25126798,3.9463817961224215
Kasumi-2,1714884,3.668347649937234
HEC-151,JQ-1-vorinostat (2-1 mol-mol),0.8892638871442682
WM983B,navitoclax-MST-312 (1-1 mol-mol),0.5670082678352489
SNU-1272,selumetinib-piperlongumine (8-1 mol-mol),5.23378922409154
MCAS,JQ-1-MK-0752 (1-1 mol-mol),0.9287029380340656
EJM,11213558,2.5134733614994778
BT 504,262093,2.380431698547906
Kasumi-2,2746,1.0036072682129122
BT 504,119607,5.960381090687712
RERF-LC-Ad2,11494412,5.090684169686155
HuT 78,9868037,2.4738144029909908
NU-DHL-1,11404337,-3.826325924415509
KYSE-410,6438330,2.783614791976934
SW1990,135984461,4.558882799669272
Kasumi-2,6852167,0.8229890671000598
Aska-SS,JQ-1-carboplatin (1-1 mol-mol),-0.8718657257645913
SK-LMS-1,46224516,4.235136579585433
OAW28,107970,2.4537130721494105
RERF-LC-A1,11404337,-0.8149390042058701
JIMT-1,11609586,3.6644245329261618
AN3-CA,176870,2.4166207171941214
KMRC-2,53495165,1.7829529769899184
HuT 78,11455910,0.0216709312460527
SNU-1272,24856436,1.090216568071402
BT 139,10410894,2.5885383837649765
BT 328,4917,3.0980779681660375
Raji,2874250,4.412187435297027
LNCaP clone FGC,676352,1.626838759048587
MM1.S,11485656,1.9684027845110144
MCAS,135398744,6.37399282177603
RPMI-7951,400769,-0.4881987174819877
Kasumi-2,2729026,2.278256361901275
NCI-H1092,148124,4.484868615111272
SW1990,56946209,-5.150132867799484
PE/CA-PJ49,2729026,3.098127456645034
H-STS,tretinoin-carboplatin (2-1 mol-mol),3.744726554678935
RPMI-7951,11152667,-2.388321573678012
OAW42,2945648,3.1266200349845317
IST-Mes1,19582717,4.57770755362997
LCLC-103H,selumetinib-navitoclax (8-1 mol-mol),5.009751197634793
D283 Med,46398810,1.668520426721307
A4/Fukuda,alisertib-navitoclax (2-1 mol-mol),-3.158247130795727
ML-1 [Human thyroid carcinoma],6252,2.036085666454029
HMCB,54613361,-0.6563978019622596
BT 139,11404337,0.9723364970795382
BT 330,12003241,-0.9920089469814386
AU565,26596,-1.0644098452654434
CML-T1,54143018,-0.824314936779772
D283 Med,3062316,1.834992436946839
HSC-4,12001922,2.169357927696289
WM983B,2828334,6.1146993372866625
NU-DHL-1,46174525,2.6554261934954546
NCI-H2081,6184667,2.212797142714644
RPMI-7951,119607,5.588441079801166
KMS-27,44507138,1.0396730145947588
H-STS,36314,2.0613869853420685
SK-MEL-1,439501,-2.4358325657169035
RERF-LC-A1,107985,-2.1483108523550287
LNCaP clone FGC,23635314,-4.3206947518061325
CA46,969516,2.1845952347247306
SK-N-AS,navitoclax-birinapant (1-1 mol-mol),3.213470998576584
SNU-1033,3384730,1.7215428531280956
SK-LMS-1,568763,0.9265341496938512
HARA [Human squamous cell lung carcinoma],19582717,3.08314824082211
Hep-G2,selumetinib-JQ-1 (4-1 mol-mol),-0.7772498513580158
BT 328,6450551,3.790902491385394
HSC-4,25154868,3.1331848354363063
NCI-N87,969516,2.8189934287936733
SNU-1033,60750,3.4861545004254597
ESS-1,11719255,3.627821400565806
LoVo,23582824,-0.7966748622900964
SET-2,16720766,0.4971129747207303
A4/Fukuda,148198,-4.99238512913244
KYSE-70,44137675,3.4677446622108925
BT 504,54618305,4.42433904701444
H-STS,24821094,1.6491011840853225
CML-T1,44493528,3.9716542826771297
KYSE-410,132971,2.959826431509786
OAW42,135421197,2.0874020814941643
PE/CA-PJ49,89183176,3.640347103490525
KMS-20,44819697,-0.2921256349223009
OE21,44819697,0.3428124471506664
BT 330,decitabine-carboplatin (1-1 mol-mol),4.09556937223759
SET-2,11640390,2.674485343113428
BT 139,6918638,0.9412017663716644
ESS-1,2858523,3.2684495269565703
WM983B,46191454,2.167446632287678
AU565,carboplatin-UNC0638 (2-1 mol-mol),2.4152389485219503
AU565,9911830,3.457946854316075
SW1990,44489675,3.717324941296481
KMS-27,11612883,2.155507394778575
BT 328,11175137,3.2083588182965705
YKG-1,25227462,2.1847299491854533
SKM-1,9935249,2.0831236560196147
OAW28,3025986,-0.5681838773369163
HSC-4,navitoclax-PLX-4032 (1-1 mol-mol),2.8756909366575023
MM1.S,71466380,2.0255927209587545
NCI-H1092,doxorubicin-navitoclax (2-1 mol-mol),-2.111052945986695
SNU-308,selumetinib-MK-2206 (8-1 mol-mol),1.728929604870732
ESS-1,3385,5.777226471096733
KMBC-2,2945648,2.6298767117226256
OE21,24797083,1.6133510569110745
ESS-1,44589607,2.6194620218883116
SNU-308,JQ-1-vorinostat (2-1 mol-mol),-1.218615882412746
KMS-27,135398738,6.313619028269227
SK-LMS-1,71466380,6.298027250001301
SK-MEL-1,44197249,3.702910884570759
KMRC-2,462382,1.077906580919196
SNU-8,6610216,4.841964372920672
NCI-N87,72193861,-0.2047514956394879
NCI-N87,5566,2.8110881508350567
PaTu 8988s,12001922,1.9011418575580596
BT 248,11228183,2.0159399448324065
LoVo,9956119,3.291456775833892
A4/Fukuda,9884685,-2.10728676228506
SK-N-AS,6917907,-5.459166837245398
MM1.S,6918328,-1.8285057660481956
Hs 683,4477,0.8459227550326421
HuT 78,5280436,3.170358590810086
SEM,24797083,0.5724609501787771
EJM,135875424,3.8151689174566665
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683
PaTu 8988s,122327,4.239534425754978
SK-LMS-1,25195348,3.6018133416826283
YKG-1,5328940,2.878150949986743
NCI-H1092,9907093,4.298683896140943
NCO2,67156097,-2.3355167587147845
BT 504,5494449,1.976448465519641
BT 328,16722836,1.9860843246282325
ML-1 [Human thyroid carcinoma],46174525,4.296155307906125
BT 330,56649450,4.0940833334268225
BT 504,25161177,2.9144147392529263
SW1990,salermide-PLX-4032 (12-1 mol-mol),5.451252695389819
Kasumi-2,16722836,0.3444985018145829
EJM,5287620,-2.617076608456458
BT 248,selumetinib-BRD-A02303741 (4-1 mol-mol),5.279106159978606
SEM,426756,3.493351005002034
LoVo,11178236,-1.6059359070935737
CML-T1,11228183,0.9343365693589996
SNU-1214,piperlongumine-MST-312 (1-1 mol-mol),3.1129983440518294
KMRC-2,2742550,3.727908257312414
A4/Fukuda,107970,1.5574682195612295
OAW28,piperlongumine-MST-312 (1-1 mol-mol),2.526870142360867
AU565,11719255,4.218610599596327
KMS-27,135984461,4.260058247162953
OE21,24772860,-2.401866774595391
SK-LMS-1,11404337,0.6927873506119244
NCI-H1092,54618164,3.7504442983527104
D283 Med,71466578,4.625574960038893
TE-15,11955716,-2.743936917090752
OAW28,675434,4.444033298399729
SK-N-AS,66577038,2.928707617971436
RERF-LC-A1,73707398,1.0933643071146293
YKG-1,613753,3.3129091754262827
SNU-308,25062766,3.067179561733296
BT 330,10385095,1.0976852552783771
NCI-H2110,5566,3.0568513878110712
HuT 78,49867926,4.101314288502533
KMRC-2,135999136,5.684896477141993
BFTC-909,2842253,5.585220688564769
PE/CA-PJ49,2828334,6.088984241737005
LNCaP clone FGC,1750826,0.7741819365239112
OAW42,4259181,0.8701798956954508
SK-LMS-1,15547703,4.5011010864651135
MCAS,15953870,3.8672859313011614
OAW28,docetaxel-tanespimycin (2-1 mol-mol),3.524507000700441
OAW28,54619267,3.96587417417148
CA46,15547703,2.518572103836232
SNU-1214,11964036,0.7123256395160985
PE/CA-PJ49,9826308,0.3040528028280299
CML-T1,JQ-1-MK-0752 (1-1 mol-mol),0.6034690158877323
Hs 683,9935249,2.3161488384728575
HCC2218,445455,5.240101293913752
HARA [Human squamous cell lung carcinoma],5113032,5.077717215414557
NU-DHL-1,7251185,0.290516417532148
NCI-H1395,9915743,5.704472879097531
Hs 683,1750826,-1.5393828247496997
OE21,25102847,2.68958768038217
SET-2,5284373,2.6486368029968377
OAW28,1750826,-3.338956149870334
KMBC-2,49766530,0.6316468025143787
HMCB,56963564,0.3861475037431977
KP-4,JQ-1-vorinostat (2-1 mol-mol),2.215951107023166
SK-MEL-1,25154868,3.766314035314364
SK-N-AS,45279963,3.4688192061516463
BT 139,46398810,1.8221701592535624
SK-LMS-1,51039095,3.185085491657033
KMBC-2,4261,1.386030908381011
KP-4,9927531,4.133132471869078
NCO2,54619267,3.010440501212102
EJM,25150857,1.0881005690844914
KMS-20,tretinoin-carboplatin (2-1 mol-mol),3.6685354299569486
AU565,54596558,3.073830584555768
SNU-1272,doxorubicin-navitoclax (2-1 mol-mol),1.2550263816124974
Raji,11485656,1.8853842234896017
KMS-20,2828334,5.046366077488849
KMS-20,71304818,2.1480627398937284
PE/CA-PJ49,400769,-0.7520887247331347
SNU-1214,alisertib-navitoclax (2-1 mol-mol),-1.2524210364186528
CML-T1,5460769,1.000954417912476
D283 Med,44632017,0.7172381887934464
H-STS,ISOX-bortezomib (250-1 mol-mol),0.4695504712696665
NCO2,54686904,3.942776995517741
Hs 683,10231331,6.307100182412671
HSC-4,11404337,-0.2351979780524762
EJM,24771867,4.483722434089688
RERF-LC-A1,46191454,2.064734251261712
SET-2,2729026,2.5950867985485813
BFTC-909,5738263,3.1091802601858185
SEM,selumetinib-UNC0638 (4-1 mol-mol),3.022170285595094
SNU-308,BRD-A02303741-carboplatin (1-1 mol-mol),1.672049819506349
BT 504,65064,5.3718028645854385
BFTC-909,104842,-1.584917163766509
JIMT-1,10113978,3.830844564734344
OAW28,23725625,6.509051762822527
Kasumi-2,49846579,-4.472892287565064
SNU-308,UNC0638-navitoclax (1-1 mol-mol),1.6647275742348495
BFTC-909,vorinostat-navitoclax (4-1 mol-mol),1.5579626952552863
GOS-3,4261,3.5553215793215185
HSC-4,24753719,5.996217074466553
CML-T1,15953870,2.3626237456804025
OE21,6918837,-3.6471584113226534
KMRC-2,12001922,2.386008364335044
CA46,644241,2.374325583681648
PaTu 8988s,46199207,3.3376100430192808
SK-N-AS,5951923,6.13431251894796
BT 139,25183872,-0.4307176707233577
SW1573,12001922,2.294011710402099
BT 320,24771867,4.382883452747231
PE/CA-PJ49,salermide-PLX-4032 (12-1 mol-mol),5.445436027747134
SEM,serdemetan-SCH-529074 (1-1 mol-mol),1.7105647593027902
KYSE-70,9840324,6.215387239369238
SNU-1214,52947716,-4.751256114565385
NCI-N87,6914657,-3.795056001746233
CA46,8515,3.648186715161825
NCI-H2081,11317348,1.2192738417019382
TE 617.T,selumetinib-vorinostat (8-1 mol-mol),2.763602035928325
SNU-8,2874250,4.080390541790942
AU565,11609586,0.8886557909894768
RPMI-7951,54686904,4.071763535806967
AN3-CA,71304818,2.4203683950062493
KMS-27,36314,-5.123625139779761
D283 Med,24951314,-0.1478123596184988
BT 330,11626560,1.856341325054047
MCAS,119607,3.997130409644658
SET-2,67291369,1.628396214067084
LoVo,124202324,1.6089295836770297
SEM,52912189,-3.2555480793236713
IST-Mes1,49836020,4.276541253138442
KYSE-410,9825149,2.609127213924351
SNU-1033,135875424,3.081818614002125
MCAS,6184667,3.214386090956169
BT 320,44486219,4.486546687955142
ML-1 [Human thyroid carcinoma],6918328,-0.1732040518011542
OE21,11213558,0.6907970625707129
CA46,71680916,4.255070441315874
SNU-1033,2742550,3.4354448610207555
SET-2,JQ-1-carboplatin (1-1 mol-mol),-0.9059473366978348
KMS-27,44491742,4.7290458888071765
IST-Mes1,107985,-3.865584471784785
KYSE-70,44819697,2.67312291481412
SW1573,51037431,1.8928004764191728
NCI-H2081,2742550,2.443856607923171
NU-DHL-1,246676,5.479524719053534
GOS-3,126941,-1.2183252312090715
NCI-H1092,10113978,3.439379415042978
SNU-8,168312962,2.7450687253779025
Kasumi-2,3825829,3.3479634665685167
KMS-27,446155,1.6717794193167046
PE/CA-PJ34 (clone C12),168312962,3.0603880546719537
TE-15,6918837,-3.951124038573147
SW1990,3689413,-1.271257676680656
BT 330,400769,0.3388217199631021
HARA [Human squamous cell lung carcinoma],44819697,3.9048868362328264
SET-2,selumetinib-JQ-1 (4-1 mol-mol),-0.4291738156644369
CML-T1,31703,-3.375342626899218
EJM,2708,5.071772468532641
BT 139,6918328,2.0359102713275528
YKG-1,selumetinib-GDC-0941 (4-1 mol-mol),1.6719516399203749
RERF-LC-Ad1,44185566,3.2196778571318356
NCI-H2110,56973724,3.970636480100385
ESS-1,753704,4.74318722205844
HuT 78,11609586,3.1698799239466857
LNCaP clone FGC,73707398,1.3422598428306614
KMS-20,46907787,-1.3444114814530854
NCI-H1395,16725315,5.329149992697811
NCI-N87,135999136,4.294797881105147
OAW28,9915743,2.8675584787684456
CML-T1,100016,5.302267949835527
OAW42,53495165,0.7210192087089266
AN3-CA,54143018,1.288994178377089
Hs 683,168312962,3.719183345738996
NCI-H2081,15953870,2.893627667573686
SK-N-AS,16065773,2.22396757563583
RERF-LC-A1,53481919,3.91916671478165
BT 504,322968,2.4738129696708073
Kasumi-2,36462,-1.2000537391874553
YH-13,11626560,1.8964713919919112
SEM,1242560,2.9052555910824025
NCI-H2110,24748573,2.8560245780031255
NCI-H2110,984333,1.8873693488549352
RPMI-7951,selumetinib-vorinostat (8-1 mol-mol),2.1108488039083775
ML-1 [Human thyroid carcinoma],24771867,3.392643461506865
MM1.S,444795,4.170246109552412
BT 330,25161177,3.61492722125511
RERF-LC-Ad2,9911463,4.319203395941844
Aska-SS,11964036,-0.6557208412964481
HSC-4,452548,-1.2537746146037845
TE 617.T,445091,4.633106606112208
NCI-H1092,11178236,-2.084013708263219
H-STS,navitoclax-piperlongumine (1-1 mol-mol),0.9655635349297744
NCI-H2110,selumetinib-GDC-0941 (4-1 mol-mol),1.414956690857524
PaTu 8988s,5328940,0.4052921421822181
SKM-1,5394,3.370864501723167
Hs 683,54618164,4.101275609218899
NCI-H1395,2828334,6.054247002865052
CA46,9907093,3.753589195065423
NCI-H1092,25154868,3.3407457586417566
KYSE-410,445643,4.18343809737397
LCLC-103H,piperlongumine-MST-312 (1-1 mol-mol),1.477002143093837
BT 504,10302451,4.044770274527245
HuT 78,10074640,2.6664319662154625
AN3-CA,2749,1.5883837990648886
SNU-1033,46907787,1.4215977745383968
OAW28,carboplatin-UNC0638 (2-1 mol-mol),3.4332779723405182
ESS-1,5329102,1.725733095868152
TE-15,2708,3.2297865949089024
PE/CA-PJ49,JQ-1-navitoclax (2-1 mol-mol),1.311184957137478
PE/CA-PJ49,1716436,3.7947980371388854
NCI-H1092,salermide-PLX-4032 (12-1 mol-mol),5.357754410384337
SNU-1272,serdemetan-SCH-529074 (1-1 mol-mol),2.457882821768218
NCI-N87,doxorubicin-navitoclax (2-1 mol-mol),-2.375472287210564
LCLC-103H,24753719,4.521159399126971
EJM,10302451,3.688285722224437
PE/CA-PJ34 (clone C12),65628,4.231511653332105
HCC2218,445643,3.270243804562818
NCO2,11167602,0.0770809640123331
BT 504,6610216,4.285733774392814
KYSE-70,10302451,3.1884398798129525
BT 248,2749,1.3146464590197295
KYSE-410,selumetinib-vorinostat (8-1 mol-mol),2.854769391791397
YH-13,107985,-2.561016282380613
HCC2218,10427712,4.297430574502978
OAW28,25150857,2.5691026408672957
MM1.S,44185566,2.164095245238619
HMCB,446155,0.6240619426088403
SK-LMS-1,9956119,3.722389147017188
Kasumi-2,24180719,3.447908092121991
HARA [Human squamous cell lung carcinoma],9884685,2.402658407469787
ML-1 [Human thyroid carcinoma],53495165,2.320007555236624
KP-4,322968,4.0363585521291965
WM983B,11494412,2.4978869334252143
SK-MEL-1,11175137,3.336864796523492
OAW28,72193861,2.7871547903709266
SW1990,11626560,2.077334834203954
SEM,3543504,3.2145269894533315
ML-1 [Human thyroid carcinoma],3815108,2.9979183689426723
RPMI-7951,252682,6.468448714439519
HEC-151,2842253,4.840261523994017
EJM,6252,2.286416731528207
ESS-1,613753,3.280704528327703
OAW42,9935249,3.0438491704796076
SNU-8,49766530,-3.645853792041198
NCO2,selumetinib-tretinoin (2-1 mol-mol),-0.5111518790261063
Hs 683,2746,3.210764654839646
H-STS,613753,2.542792713259053
BFTC-909,2841722,4.3094465275997536
Hs 683,10113978,2.3708319863373
NU-DHL-1,24180719,3.951276464233685
RERF-LC-A1,452548,-0.2095835567662839
SW1573,6918328,0.8267852089643692
MM1.S,6623618,2.4719369503455257
BT 320,9926054,4.941319925063275
NCI-H2110,25154868,5.090581289250825
KMBC-2,73707398,1.4795418187244096
KMBC-2,46907787,3.4975434896929674
NCI-N87,6184667,4.346047693042568
HCC2218,16720766,-1.1445454517220572
KYSE-70,9903786,2.353212274658888
PE/CA-PJ34 (clone C12),24748573,1.6796934908276056
EJM,5287969,-2.456057382836623
SET-2,5394,4.234029843739517
AN3-CA,51037431,3.642744967178951
Kasumi-2,9823820,3.05022407511669
HARA [Human squamous cell lung carcinoma],9825149,2.481612932411
ESS-1,salermide-PLX-4032 (12-1 mol-mol),5.510207558856386
NCO2,6450551,-1.8088387094117775
BT 330,54678924,1.905713263173462
TE 617.T,44620216,3.671019031819898
OAW42,decitabine-carboplatin (1-1 mol-mol),6.17001335417031
OE21,selumetinib-piperlongumine (8-1 mol-mol),2.027180738703513
RERF-LC-A1,71304818,1.6425871342093996
SK-N-AS,3825829,4.113120296702569
RPMI-7951,3025986,-2.5294219808590888
IST-Mes1,439501,-2.4971864822052767
Hs 683,2842253,5.180053846927469
RERF-LC-A1,5328940,2.218085249970747
SK-LMS-1,10296883,4.497007332627828
PE/CA-PJ49,374536,1.0284025610078626
TE-15,135659046,3.5275305939343884
SNU-308,sirolimus-bortezomib (250-1 mol-mol),1.6825510481181765
ESS-1,25105715,3.705428666019564
HSC-4,9908783,6.127900398037499
TE 617.T,72734382,4.397534859865898
RPMI-7951,piperlongumine-MST-312 (1-1 mol-mol),1.6179236321332118
SNU-308,208908,1.459414363933131
OAW42,56946209,-4.655280960776341
Kasumi-2,426756,1.7072417198911318
RERF-LC-A1,44202524,1.4308011652172037
SET-2,9444,4.37195818926585
D283 Med,135411,-1.9342059509823124
RERF-LC-Ad2,44589607,1.764039142360227
PE/CA-PJ34 (clone C12),3025986,-1.608443242420705
EJM,156414,1.801807158025587
PE/CA-PJ34 (clone C12),2871966,-0.2106632494105586
Hep-G2,613753,3.545634028634973
ESS-1,24964624,3.0338116933926735
HCC2218,4378219,3.99128981890596
SK-N-AS,4578,4.574646503593068
NCI-H1092,984333,-1.1758296018465422
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649
PE/CA-PJ49,54618164,4.029217614638186
MCAS,148198,-2.0312221156390717
TE-15,5311,1.424175872597402
NCI-H2110,24856436,-0.06908715109082
WM983B,6918328,0.4830837833629592
OE21,10127622,2.1709622508475657
PE/CA-PJ34 (clone C12),11238147,2.027181576861032
NCO2,carboplatin-etoposide (40-17 mol-mol),-0.0016305250211093
PaTu 8988s,doxorubicin-navitoclax (2-1 mol-mol),-1.420841461356717
NCI-N87,9444,3.5890718830627923
D283 Med,selumetinib-vorinostat (8-1 mol-mol),2.011575118738352
MCAS,5328940,1.99827020232334
HSC-4,11238147,3.6589845000918504
OE21,2945648,3.0380681902240254
NCI-N87,156414,-4.435299577962505
BT 139,5738263,3.7831987912460505
YKG-1,6505803,-0.4747915631752394
SNU-8,6918289,2.2992452702949495
NCI-N87,selumetinib-decitabine (4-1 mol-mol),3.433626364692319
WM983B,9967941,2.244765575020048
Hs 683,5282054,4.0736692861931205
BT 320,9840324,5.908905325340882
ML-1 [Human thyroid carcinoma],54143018,-0.4485048931823356
RPMI-7951,5311281,1.1032843350695771
NCI-H2172,637858,5.647730401907311
SNU-1033,72376,-2.494714641053571
D283 Med,409805,5.788391613893814
A4/Fukuda,2729026,2.569130626356953
HCC2218,216345,3.0948922650331303
SNU-1272,3503,2.878382710922879
MM1.S,11640390,-0.5885267923488479
NCI-H1395,675434,4.314501346602578
CML-T1,753704,4.085313154725238
SW1990,selumetinib-PLX-4032 (8-1 mol-mol),2.638465998633568
KMBC-2,7251185,2.346374978663141
WM983B,11222830,1.7092478703597698
PE/CA-PJ34 (clone C12),49766530,5.059286998332617
PaTu 8988s,2945648,3.478517867509888
NCI-H2110,44632017,1.4132924038310986
MM1.S,23582824,0.1697868743152248
TE-15,12001922,2.3177412223130496
Aska-SS,selumetinib-BRD-A02303741 (4-1 mol-mol),5.7728850622560755
SK-N-AS,6914657,-3.248141557165595
RERF-LC-A1,25183872,-2.3060707321542924
Aska-SS,11485656,2.660522165344914
CA46,52912189,-0.9978651387823436
MM1.S,9887053,3.7557116412340568
Kasumi-2,10302451,2.501538159290375
KMBC-2,vorinostat-carboplatin (1-1 mol-mol),3.723920308466531
BT 139,5978,4.457671126786022
SK-LMS-1,tanespimycin-gemcitabine (1-1 mol-mol),0.8145609085201625
CA46,10296883,3.259152671675197
BT 248,9936388,1.117792201973615
TE-15,135421197,1.6096072932868513
BT 328,46199207,1.7290666248648392
HARA [Human squamous cell lung carcinoma],445455,6.075035505832661
KYSE-410,selumetinib-PLX-4032 (8-1 mol-mol),2.7618648700335213
PaTu 8988s,11427553,1.984096358783623
SKM-1,24772860,-3.5610280198331705
PE/CA-PJ34 (clone C12),46843906,2.5839561879544775
BT 248,675434,4.340673839490162
BT 248,11497983,5.371692371312494
RERF-LC-A1,2841722,3.2217223058979996
SW1990,6450551,3.4368390730521203
TE-15,10184653,-1.8330433827490031
KMBC-2,60700,0.1804497253264331
Kasumi-2,15547703,3.1022786704275394
SNU-1214,24964624,2.2699672227084435
ESS-1,135398516,2.488999023139088
ML-1 [Human thyroid carcinoma],4521392,4.335063435629941
BT 330,6918837,-1.1383844113587298
AN3-CA,5978,-3.3545327463272256
TE 617.T,16013152,3.960391652735795
OAW28,123631,1.649178742735097
YH-13,6918328,0.5686815123232866
EJM,44632017,0.4808977509287103
TE-15,selumetinib-piperlongumine (8-1 mol-mol),3.655752274712541
OAW42,6917907,-5.7208568379829305
HEC-151,11222830,1.1889668864862717
NU-DHL-1,24775005,3.519869888834562
Kasumi-2,10385095,0.5473944457717855
PE/CA-PJ49,piperlongumine-MST-312 (1-1 mol-mol),1.2466935058482151
CML-T1,55283,-0.0221984323925449
Hs 683,644241,2.1182711597047277
BT 328,71729975,3.0990455270892365
BT 328,12001922,1.7973322325176817
SK-N-AS,serdemetan-SCH-529074 (1-1 mol-mol),1.0500598222341275
ML-1 [Human thyroid carcinoma],54618164,4.279062995535924
RERF-LC-Ad2,44185566,2.7611278525459872
HuT 78,4788,5.194344825774489
OE21,15983966,-4.016701447888591
AU565,12001922,1.255153902569356
SNU-1272,2828334,5.899475603043714
SNU-1272,9936388,1.7321766128233604
JIMT-1,3384730,3.025610795975883
LNCaP clone FGC,9840324,4.693814425253386
PaTu 8988s,23582824,0.5896367967334025
NCI-H2081,2729026,2.0154063962132676
ESS-1,135411,0.5252983253091638
RERF-LC-Ad1,selumetinib-decitabine (4-1 mol-mol),6.00514087254069
RPMI-7951,9956119,1.9401474518949864
A4/Fukuda,44607531,1.1783204907000706
RERF-LC-A1,SNX-2112-bortezomib (250-1 mol-mol),-2.481271550036836
NU-DHL-1,navitoclax-MST-312 (1-1 mol-mol),-2.4981273247607696
IST-Mes1,sirolimus-bortezomib (250-1 mol-mol),2.2264590257726704
BT 139,66577038,2.708472891460834
RERF-LC-Ad1,carboplatin-etoposide (40-17 mol-mol),3.9878410003386
BT 328,11609586,3.6463226315951225
NCI-H2172,11427553,4.648186022805162
SNU-308,36462,4.516059663616316
PaTu 8988s,72193861,3.4773628322581605
Raji,16722836,1.1339708179404666
SK-N-AS,44185566,2.614006736173609
OAW42,11485656,1.8505528524867976
SNU-1214,262093,2.99372726902227
PE/CA-PJ34 (clone C12),selumetinib-MK-2206 (8-1 mol-mol),1.6855089164633987
EJM,49836020,4.362565190709962
BT 328,11612883,4.649689158242477
D283 Med,2126,1.5971545854650095
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245
SK-LMS-1,44185566,3.1100046298830035
HARA [Human squamous cell lung carcinoma],5329102,2.385019760073336
NCO2,31703,-2.9093466293226693
Kasumi-2,262093,1.7604912977671856
HSC-4,2130404,3.512147769522711
HCC2218,252682,6.509393450799849
EJM,JQ-1-navitoclax (2-1 mol-mol),0.2111319026515788
Aska-SS,31703,-1.1205597197123982
H-STS,6184667,4.225407258507326
CA46,26596,-3.5845712744961324
BT 248,4788,5.6007343352714605
NCI-H2081,JQ-1-carboplatin (1-1 mol-mol),1.838328263048474
BT 328,216239,3.5186612290950148
KMRC-2,3062316,-0.0725608563984309
MCAS,126941,-2.2746618054427548
Kasumi-2,637858,0.3812755763700117
RERF-LC-A1,54686904,5.5884657542841705
JIMT-1,6914657,-4.528779020330571
SK-MEL-1,crizotinib-PLX-4032 (2-1 mol-mol),1.0429380572123352
NCI-H2081,10184653,0.9038087955146576
AU565,3552672,1.7684242008913282
PaTu 8988s,9825149,-0.4385958210811754
SW1990,5311281,1.7301970935112505
SK-N-AS,5738263,2.4427311368116285
HARA [Human squamous cell lung carcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.7875744304636512
TE-15,3384730,5.002634362664369
NCI-H2110,16013152,4.230924821724543
SW1573,6623618,2.3278245092002936
BT 328,52947716,2.920977634750811
EJM,25126798,3.659135720159963
Raji,3854666,1.2627673053798778
Kasumi-2,44185566,0.8464196954941686
Hs 683,6438330,3.1088945001228945
NCO2,89183176,3.9554250635729886
Hs 683,selumetinib-tretinoin (2-1 mol-mol),6.040363001093622
SW1990,tanespimycin-gemcitabine (1-1 mol-mol),-2.0275719671324577
SW1573,25126798,4.147065453172024
BT 248,89928392,0.7552276073317185
KYSE-410,6450551,3.839411878776235
SNU-1272,54618359,4.4674166850323624
PE/CA-PJ49,107970,2.309472784516984
BT 139,168312962,3.392986151792307
ML-1 [Human thyroid carcinoma],53232,3.218931075380609
SK-LMS-1,25227462,2.3062795616243643
HSC-4,400769,-0.948607557046086
SNU-308,serdemetan-SCH-529074 (1-1 mol-mol),2.985440600627557
OE21,44491742,3.708692446594154
KMS-20,10322450,3.2597318465423353
MM1.S,446155,2.5979306804829463
AN3-CA,53392493,1.9117238552893072
HuT 78,6184667,-1.7510976513907253
ML-1 [Human thyroid carcinoma],4477,0.6808915512553289
Hs 683,46398810,1.6710254432947709
LCLC-103H,2828334,6.353673046539711
PE/CA-PJ34 (clone C12),1716436,3.718741146894734
BT 320,24821094,3.905918214519909
BT 320,387447,-3.873135040539017
PaTu 8988s,11213558,1.0290753699028068
PaTu 8988s,54618771,-1.1165982816182902
YH-13,5311281,1.1254096591203009
H-STS,6918638,-0.6396360846494638
PaTu 8988s,15953870,3.81421509052964
RERF-LC-A1,11656518,2.259994417070033
BT 248,6438330,0.9229397913759128
HARA [Human squamous cell lung carcinoma],8515,3.1956320485149265
NCI-H2110,6505803,-2.3425437188382587
PaTu 8988s,1641662,3.5300797376584305
GOS-3,24951314,2.597884619205853
TE-15,56946209,-4.477662549081909
NCI-H2081,9903786,1.5566694513779922
LNCaP clone FGC,4096211,1.3967324251081952
SET-2,9967941,2.243909136307081
SK-N-AS,9933475,1.6401288056862575
RPMI-7951,262093,2.547304876719483
CA46,984333,-2.431082434536014
SNU-308,6918736,-1.7889919897338664
CML-T1,46191454,-1.3100798451488396
BT 504,6436223,-4.919343717511096
D283 Med,23582824,-0.1827482787925018
KP-4,135875424,3.69718795810946
KMS-20,5287620,-2.1955252828905745
PE/CA-PJ34 (clone C12),23582824,0.3149365494632303
H-STS,6252,1.236462961602802
NCI-H1395,46907787,2.4653160178838354
HuT 78,9866186,-0.7405908316391746
CA46,4705,3.1649236354970154
SEM,374536,-3.4278771787335107
PE/CA-PJ49,25102847,1.7536968430646858
A4/Fukuda,5281672,3.917758560865086
H-STS,12003241,-1.720451684377523
LoVo,66577038,2.852951614414874
KMS-20,25183872,-1.3231637510750665
RPMI-7951,6505803,-3.4302306957343434
SNU-308,53232,3.288372850050381
PaTu 8988s,135875424,4.807406911194583
H-STS,89928392,0.800005419398714
NCI-H2172,46191454,4.392012035479809
SNU-1214,72376,-2.4971526141185043
SNU-1033,23582824,0.7558818085524805
NCO2,984333,-1.1474501426514436
LoVo,5978,-0.9838296745754056
KMRC-2,6610355,3.6681341689584928
Hs 683,135423438,3.058302675128977
NCI-H1092,51037431,6.3894384839452725
OAW28,11175137,3.6697867992343607
NCO2,54618305,3.6684730669441152
CA46,11955716,-2.7152267118714204
Ku812,44137675,4.859064076132382
PE/CA-PJ34 (clone C12),4096211,1.8873047656462525
SKM-1,24856436,-0.4445096015127717
TE 617.T,9911830,2.045260681155165
BT 139,25126798,4.1512134868113435
WM983B,24180125,2.8843311676242345
KMBC-2,tanespimycin-bortezomib (250-1 mol-mol),0.8255558863308646
SNU-8,44607531,1.6077512156664846
KMS-20,54678924,1.6750524513499827
NCI-N87,5335621,4.88881532131479
Kasumi-2,23582824,0.0696466908969853
HSC-4,107985,-2.2656284906222144
SW1990,9952709,3.369520781827838
LCLC-103H,23635314,-1.3522299115808438
SEM,6610355,4.764894277791875
SNU-8,selumetinib-navitoclax (8-1 mol-mol),0.997902568577224
SET-2,3062316,1.708959853761753
Hep-G2,676352,2.2206143636349287
ESS-1,100016,6.502595194480242
KYSE-70,5311281,3.780874632943925
PaTu 8988s,54626689,4.835984760777768
HEC-151,24785538,3.133591967449538
PE/CA-PJ49,5284616,3.20238900002261
KMS-27,24771867,-2.8070025091368054
RERF-LC-Ad2,216239,1.8867785835820676
TE 617.T,71751553,3.9067894428896928
SNU-8,6623618,2.2752999138216103
BT 139,7251185,1.9571958886017575
KMRC-2,60700,1.5834227754610717
PE/CA-PJ49,16219061,3.15705369329154
HARA [Human squamous cell lung carcinoma],119182,-1.5549760643936197
EJM,selumetinib-decitabine (4-1 mol-mol),1.790992102358079
Hs 683,25102847,1.227616215801813
NU-DHL-1,702558,5.1708042133042875
Hs 683,56946209,-4.267470222354378
D283 Med,11964036,0.8770173052283631
ESS-1,54596558,5.727088950348892
BT 248,5978,2.367827241369892
BT 504,11427553,2.1605317215993707
OAW28,3025944,4.579278298637093
OE21,11626560,1.5106981785877758
KMS-20,73707398,-1.0592725192615595
BT 248,5287620,-3.0713737356172484
SNU-8,31703,-0.3398671923044067
BT 248,6914657,-2.576788872604972
TE 617.T,11175137,1.2522835808510424
SW1990,10074640,3.349164976711024
SK-N-AS,89183176,4.41320750882091
NU-DHL-1,31703,-3.2392931195383756
HuT 78,BRD-A02303741-carboplatin (1-1 mol-mol),3.8369942625366
HMCB,19582717,4.963972584535481
HEC-151,5281321,-0.7091237619824996
LoVo,3815108,2.2685826541267615
KMS-20,24779724,4.331285550613222
SKM-1,135421197,1.6359213938027426
RERF-LC-A1,246676,4.379402832179336
PE/CA-PJ49,5738263,3.49385120973068
NCI-H2081,11214940,0.770060608501173
SNU-1033,10302451,2.931783952664607
KMRC-2,11625818,5.255718414133251
LCLC-103H,11152667,0.8142627496272367
JIMT-1,46199207,3.2650152561926418
OAW28,4477,1.0036814180565996
HEC-151,56649450,3.3632660336882436
BT 248,2871966,0.7814721484275546
OE21,vorinostat-navitoclax (4-1 mol-mol),1.0661063456279147
BFTC-909,400769,-0.3884900564724624
BFTC-909,5278396,3.473037688340168
HSC-4,124202324,2.961748327308983
BT 330,46224516,1.677739394435492
NU-DHL-1,9803433,4.595964480668706
HCC2218,5291,3.9239941781881216
PaTu 8988s,vorinostat-navitoclax (4-1 mol-mol),1.0724018274153246
PE/CA-PJ49,15983966,-4.430083817298675
IST-Mes1,10113978,3.525341044523829
KMRC-2,16736978,2.3097236282239413
RPMI-7951,72193861,-0.4754821102951712
ESS-1,16038120,1.529167469529828
HSC-4,9884685,0.6492053944574516
PaTu 8988s,50905018,6.329104593069708
SW1573,11228183,1.3544411199442492
OAW28,9926054,1.976123345191561
SEM,11707110,1.3401031193099515
NCI-H2110,2749,2.4653527623396947
Kasumi-2,11656518,-0.8040408639715576
BT 139,44197249,5.019770619603963
SW1990,984333,1.0677771030068235
MCAS,10074640,3.1296292298776716
SKM-1,1242560,3.2805801288992296
NCO2,49766530,-4.92824321728858
A4/Fukuda,11396600,-8.215434514364686
LNCaP clone FGC,54596490,4.35808730811733
GOS-3,5278396,3.876962723891849
Kasumi-2,16038120,1.393585308421038
AU565,15983966,1.7541662071439053
BT 504,4261,4.422416432922366
CML-T1,selumetinib-decitabine (4-1 mol-mol),-0.3389481007221296
RERF-LC-A1,67156097,-1.8492136986669632
NCI-H1092,3854666,1.7831562708521254
HSC-4,JQ-1-navitoclax (2-1 mol-mol),3.2016872805134025
SNU-1214,135411,0.9910284163381392
BT 320,71729975,3.655690084257896
LNCaP clone FGC,selumetinib-navitoclax (8-1 mol-mol),4.604637822418501
BFTC-909,selumetinib-vorinostat (8-1 mol-mol),1.99531584260594
PE/CA-PJ49,6438330,2.0005684835219633
HEC-151,selumetinib-PLX-4032 (8-1 mol-mol),3.4450740625580956
LNCaP clone FGC,10385095,0.9687144663796518
SK-LMS-1,carboplatin-UNC0638 (2-1 mol-mol),4.686207896901682
SET-2,selumetinib-vorinostat (8-1 mol-mol),0.6611589487965128
LoVo,2749,2.494181165729376
JIMT-1,11626560,2.461460350130894
AN3-CA,1242560,3.3233723476682115
JIMT-1,9911463,4.046723460616858
KYSE-70,6918736,-3.61435843984592
PE/CA-PJ34 (clone C12),439501,-1.4242244228812553
NCI-H2172,9936388,1.8105409817982183
Hep-G2,selumetinib-navitoclax (8-1 mol-mol),0.9270338424772362
WM983B,JQ-1-vorinostat (2-1 mol-mol),0.7376112423099928
Hs 683,23582824,0.6802419635855828
KMS-20,5278396,2.5832332460860328
TE 617.T,49793307,-4.415420925878237
ML-1 [Human thyroid carcinoma],6610355,5.061552725322464
NCI-H2110,4578,4.455232001542883
TE 617.T,73707438,3.845277218747361
D283 Med,148198,-7.782574988452476
Ku812,15983966,-4.686318445484671
NCI-H2081,2749,0.7188111553916358
PE/CA-PJ34 (clone C12),navitoclax-pluripotin (1-1 mol-mol),-0.3375022038968858
CA46,2842253,3.7037662444842696
LNCaP clone FGC,5278396,3.111775886688035
KMRC-2,5746,3.1834045914700155
CML-T1,126941,-3.100237153288417
OE21,2871966,-1.4442396602428826
CA46,vorinostat-carboplatin (1-1 mol-mol),1.5433198119850344
BT 328,1750826,2.2772741974811637
SNU-1033,123631,2.4204782637043616
SW1990,1716436,3.676749796387318
KMRC-2,doxorubicin-navitoclax (2-1 mol-mol),0.532546220972544
BT 248,123631,2.103805835203493
PE/CA-PJ34 (clone C12),31703,-1.629082926616254
KP-4,4788,5.576487975798441
NCI-H1395,5311281,3.3268012915389047
TE 617.T,11647372,2.975388477244594
SNU-308,selumetinib-piperlongumine (8-1 mol-mol),6.364021070075463
Kasumi-2,11955716,-2.6016781088205665
Raji,3062316,2.8888075900479007
PE/CA-PJ49,387447,-5.239888509178112
PaTu 8988s,JQ-1-UNC0638 (2-1 mol-mol),1.1829021924496204
SNU-1214,446155,1.554024884222307
KMRC-2,11609586,3.050903259712864
SNU-308,9903786,2.008516122429012
JIMT-1,51039095,3.729831712562254
ML-1 [Human thyroid carcinoma],5311,0.3887425314777955
KP-4,alisertib-navitoclax (2-1 mol-mol),0.7704039917355672
LoVo,44137675,-1.419079349485425
HARA [Human squamous cell lung carcinoma],1716436,3.773793106717324
NCO2,selumetinib-navitoclax (8-1 mol-mol),-1.091956630375411
KP-4,5978,-4.324853556330347
CML-T1,selumetinib-navitoclax (8-1 mol-mol),1.8946920670328231
SEM,2858523,2.9325299148032413
AU565,135398516,2.596290086865212
SK-MEL-1,navitoclax-birinapant (1-1 mol-mol),-0.6286234029712032
BT 248,crizotinib-PLX-4032 (2-1 mol-mol),2.0944776626354145
BFTC-909,11647372,1.2423847125416496
LNCaP clone FGC,6914657,-3.0837607942450553
AU565,9952709,2.716124716701941
LNCaP clone FGC,11396600,3.414051330907707
HCC2218,11238147,2.0840075714063833
RPMI-7951,216239,2.699311777327497
KMS-20,11494412,0.3854055603119042
IST-Mes1,11178236,-2.2337214332221023
HARA [Human squamous cell lung carcinoma],2733526,3.2699742840947414
Aska-SS,44507138,3.8617946638708545
SW1990,24785538,-0.3480071895354156
SK-LMS-1,3552672,1.8445236305168005
KYSE-70,322968,3.381611542483835
LoVo,5281672,4.34355838965171
KMS-20,42611257,2.1874354470841366
NCI-H1092,11964036,2.0347322907537624
AU565,25161177,3.67389505129512
PaTu 8988s,BRD-A02303741-navitoclax (2-1 mol-mol),1.8909548429371676
KMRC-2,24180125,1.140997225837335
NU-DHL-1,135398738,5.717285469146395
PE/CA-PJ34 (clone C12),6252,1.334555273604778
HuT 78,44607530,0.9490207020575367
KMBC-2,11222830,1.8438762755647733
SK-N-AS,15983966,4.085655823293015
LCLC-103H,51039095,3.3288484115108825
CML-T1,navitoclax-piperlongumine (1-1 mol-mol),0.6324311645871261
MM1.S,selumetinib-GDC-0941 (4-1 mol-mol),0.5513447190034949
KMRC-2,selumetinib-JQ-1 (4-1 mol-mol),3.693514223055559
SNU-1214,16720766,0.4119762972677722
NCO2,5284616,-1.3822115848747645
WM983B,9952709,3.8765138130801344
SKM-1,ISOX-bortezomib (250-1 mol-mol),-0.1246400707539527
RPMI-7951,5278396,2.740047026102501
SNU-1272,5746,2.042902676289699
Ku812,selumetinib-PLX-4032 (8-1 mol-mol),-1.0900745107339422
RERF-LC-Ad2,3689413,-2.3718681179327143
MM1.S,navitoclax-birinapant (1-1 mol-mol),0.4533704477118982
NCO2,11234052,2.610672193810511
HSC-4,selumetinib-PLX-4032 (8-1 mol-mol),3.794219924107932
BFTC-909,100016,5.8134150302243865
H-STS,alisertib-navitoclax (2-1 mol-mol),-1.762059403403842
HMCB,36462,1.7096647665785494
TE-15,89928392,1.3476165657557055
RPMI-7951,BRD-K13185470,4.283548482725321
BT 248,6184667,2.4270302543682307
NCO2,selumetinib-GDC-0941 (4-1 mol-mol),-0.0014559865533413
LNCaP clone FGC,2113511,4.114352668379086
NCI-H2081,24964624,2.0878863741822395
SNU-1033,44607530,1.187440277371415
OE21,100016,6.577886119924336
SNU-8,654092,-2.3977544496906624
Kasumi-2,navitoclax-pluripotin (1-1 mol-mol),-2.9755028456871866
NCI-H2110,73707398,1.6375647309525496
HuT 78,6918638,-1.8650927856269544
HMCB,ISOX-bortezomib (250-1 mol-mol),0.174785181826403
Ku812,11609586,1.4051049600539705
Aska-SS,5287620,-1.825079293822929
TE 617.T,44589607,1.763754723578897
KMRC-2,6450551,2.739677229756094
EJM,3038522,1.9147262325597951
TE 617.T,25105715,3.234039412199738
KYSE-410,44137675,3.6487631222802337
SW1573,3854666,2.927116287337192
KMS-20,44491742,3.719914001289463
PaTu 8988s,148198,-4.140903608928441
HMCB,2113511,5.752921913122264
Ku812,11626560,-1.6024532092090518
LNCaP clone FGC,5328940,2.0473459597054258
HMCB,66577038,3.152546562192711
H-STS,10385095,1.1550393753572457
BT 330,65064,5.135566827612043
OAW28,5329102,1.8792475137868745
HEC-151,navitoclax-birinapant (1-1 mol-mol),2.919110430192298
LNCaP clone FGC,2871966,-0.8616364754610153
SK-LMS-1,11707110,3.3466757840367656
SW1573,52912189,3.9296893768173065
OAW42,vorinostat-navitoclax (4-1 mol-mol),1.2218880200267044
D283 Med,285033,-3.580408991915884
NCI-N87,tanespimycin-bortezomib (250-1 mol-mol),-5.300963645653278
OAW28,24951314,0.5571772807313425
LoVo,16741245,3.141864677583783
NCI-H2110,crizotinib-PLX-4032 (2-1 mol-mol),1.801559524212287
RERF-LC-Ad2,11626560,2.11718882124061
KMS-20,439501,-3.5751856752548985
PaTu 8988s,11609586,3.1640342250274194
KMS-20,6610355,3.4776734350028784
NCO2,445643,2.984424761816817
HEC-151,56963564,-1.301366231241759
KMBC-2,119607,5.19926943709357
NCI-H2110,135440466,1.5580785055019832
ESS-1,11494412,1.0604335653802026
BT 504,66577038,2.6800889871615485
SW1990,5280436,2.285966065927425
A4/Fukuda,5328940,-0.5379688872377596
TE-15,4578,3.931578799636627
Kasumi-2,UNC0638-navitoclax (1-1 mol-mol),-2.8195604802601197
HEC-151,4705,2.9357366805195735
KP-4,44507138,4.316938927291668
SNU-308,107985,-2.764112061523982
Aska-SS,46191454,1.788346033353313
NCO2,60700,-1.256096242773144
KMS-20,11167602,1.9500667412435135
SNU-1214,9911830,2.476886366604881
Ku812,24771867,-1.2789053732108495
BT 320,25227462,3.0496366497602025
SKM-1,60700,-2.303999469511284
BT 330,9884685,0.2489393167095227
KMS-27,65628,3.4273380344864233
SK-MEL-1,6918289,2.8155269741231885
PE/CA-PJ49,148198,-3.4268639622300516
OE21,5311,1.919322978011042
YH-13,168312962,3.022410497071698
BT 330,navitoclax-piperlongumine (1-1 mol-mol),1.7947014353724977
CML-T1,11317348,-0.5508465073970409
GOS-3,6917907,-5.627090987822961
RERF-LC-Ad1,124202324,3.7772146428282385
SW1990,568763,-0.2089680591537602
KMS-27,49836020,5.305149991763679
HuT 78,16219061,1.2984020773766147
BT 330,11656518,2.0366659236710825
SK-N-AS,252682,6.458616558231519
SNU-1214,100016,6.334633199659308
OAW28,5311,0.8600755425080211
HSC-4,135928012,4.241462346184107
AN3-CA,24753719,4.3754867797298544
AU565,2842253,5.995707097044385
Hs 683,44589607,3.229038489255208
KMS-20,23725625,4.884759798123119
HMCB,5311,2.1964407346203627
LoVo,2729026,2.166128688763036
EJM,168313200,3.7804211641471097
OE21,11719255,3.641646729629715
HSC-4,decitabine-navitoclax (2-1 mol-mol),3.5629592535507557
HMCB,24797083,1.265825872563084
PaTu 8988s,55283,2.9199595680280455
NCI-H2081,9967941,3.827989580994779
D283 Med,44589607,0.7733689758035397
HCC2218,6505803,-2.0723621071637788
NCI-H1395,54678924,1.3168571915404212
NCI-H2110,6610216,4.402528376622354
HARA [Human squamous cell lung carcinoma],448949,2.536052822584039
NCI-H1092,9911830,2.3624309911243313
BT 330,4261,3.0560809505668365
KMS-20,135984461,4.215331371407202
KYSE-410,6918878,3.650985342430235
YKG-1,tretinoin-carboplatin (2-1 mol-mol),6.38208471298272
NCI-H2110,104842,-3.248883005108901
SW1573,656346,0.5263129478884733
TE-15,9866186,-1.021801869424804
JIMT-1,6918837,-1.8559995146428456
HSC-4,46224516,3.389129888163455
HCC2218,11175137,2.387225353328728
CA46,71304818,1.9606514180280712
H-STS,16722836,2.295773784833407
TE-15,56963564,-0.9589446957937114
NU-DHL-1,salermide-PLX-4032 (12-1 mol-mol),3.6957030880466544
Kasumi-2,56649450,1.224051068091054
SNU-1214,135999136,5.40108770784267
KYSE-70,44486219,3.9722791166403657
SEM,46224516,1.5959166317590987
Hs 683,3025986,-1.4982466986527858
BT 504,3552672,1.5894861440747878
PaTu 8988s,56649450,1.242344926252794
EJM,11647372,1.0355727686672764
CA46,9887053,1.048475441216289
AN3-CA,6505803,-3.3327049528719312
LoVo,46843906,2.381362357237743
D283 Med,9825149,0.299021869301145
MCAS,36462,1.655496509759999
ML-1 [Human thyroid carcinoma],219104,3.7281299088831386
AN3-CA,675434,4.408623418183415
MCAS,5460769,1.176961037581758
HEC-151,8515,4.452182396163437
BT 328,1716436,3.653949071950038
NCI-H2081,56963564,0.1641201817536982
NCI-N87,navitoclax-gemcitabine (1-1 mol-mol),-3.6490042770502815
Ku812,156414,-0.0936884682974776
CA46,168313200,1.9493207867170304
MM1.S,3634881,3.159855284524507
OE21,135398738,5.932843920060456
SNU-1272,637858,3.0444768805463465
OAW28,navitoclax-gemcitabine (1-1 mol-mol),-0.0926576582551772
KYSE-70,49793307,-3.275020883815728
HARA [Human squamous cell lung carcinoma],44202524,1.300312464104863
SNU-1033,6610216,4.08331616990365
CML-T1,4259181,-0.9247208790621684
PE/CA-PJ49,navitoclax-birinapant (1-1 mol-mol),2.417341355887914
KYSE-410,11626560,1.963091480584616
NU-DHL-1,445455,3.2773220789700397
SET-2,vorinostat-navitoclax (4-1 mol-mol),-1.0463472428768836
SK-LMS-1,vorinostat-navitoclax (4-1 mol-mol),0.9355333025959492
PaTu 8988s,9952709,4.520443732339643
KYSE-70,969516,2.5944329315988552
NCI-N87,24180125,2.059368273959215
SW1990,JQ-1-carboplatin (1-1 mol-mol),4.363911496200424
KMRC-2,46215462,1.5871375052382457
YKG-1,16736978,1.5030984389697135
IST-Mes1,327653,2.848745693869025
TE-15,2749,1.2362405825112004
BT 330,9840324,5.89658505539565
CA46,46191454,-0.333651418813281
IST-Mes1,54618164,4.8538718291352945
SK-LMS-1,selumetinib-tretinoin (2-1 mol-mol),5.22300202696497
KMS-27,tanespimycin-gemcitabine (1-1 mol-mol),-4.329009308752247
SNU-1214,selumetinib-BRD-A02303741 (4-1 mol-mol),2.175511889017324
HSC-4,9915743,0.765957034876682
SW1573,docetaxel-tanespimycin (2-1 mol-mol),2.3053158054818077
ML-1 [Human thyroid carcinoma],52947716,-0.2471601623530622
YH-13,11455910,2.765771134789071
AN3-CA,42642645,-0.9169147434440384
SK-MEL-1,5329102,1.8797340956963695
HSC-4,387447,-4.060952426407354
YH-13,409805,5.8043407056117395
KP-4,erlotinib-PLX-4032 (2-1 mol-mol),3.77182029997156
BT 504,3634881,1.876902363154123
A4/Fukuda,23635314,-5.004930640559638
MCAS,445091,5.5986001063773365
KMRC-2,11404337,1.481375710238033
HCC2218,65628,6.436563943794135
ESS-1,6918878,4.817127721204009
BT 248,decitabine-navitoclax (2-1 mol-mol),1.3496925152518875
SK-N-AS,56949517,4.567665223015802
CML-T1,6610216,3.6071739537574863
MCAS,24901704,3.384328232240074
HuT 78,9825149,1.9871661414815665
Ku812,654092,-1.4885664585268723
KMRC-2,44137675,4.642823566259911
MCAS,9908783,6.190374698999782
AN3-CA,46843906,4.15372068511724
EJM,16725315,4.889333996088531
KMS-20,carboplatin-UNC0638 (2-1 mol-mol),2.6820630100068197
SK-MEL-1,decitabine-navitoclax (2-1 mol-mol),-0.2306856878490712
BT 328,44819697,-1.602072753607262
Aska-SS,52947716,3.0851875163999067
LoVo,11507802,0.9778049572121082
SET-2,24964624,2.5464611805916326
HSC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.9348378913345816
Kasumi-2,6918638,-1.1951505869280743
PE/CA-PJ49,119182,-1.5966059849702965
SNU-308,387447,-4.108149171712701
MM1.S,126941,-0.9459288946859304
YH-13,16038120,1.3752099545726146
NCI-H1092,675434,3.921847980999154
LNCaP clone FGC,19582717,2.7383506613575745
SNU-308,219104,5.365013057580392
PaTu 8988s,53232,5.199955962685543
Raji,16720766,-0.0176101372134706
HuT 78,702558,5.694592487661442
Hs 683,387447,-4.17962939881664
PaTu 8988s,644241,1.4748860636178889
OAW28,46199207,3.397949359639469
HCC2218,44491742,3.8267338846087497
KP-4,72193861,-0.3045152868469126
KYSE-70,46174525,4.613744209458669
KP-4,25105715,3.790415010169424
LCLC-103H,3384730,4.225305457137805
MM1.S,6918837,-5.0481223249904525
KMBC-2,216345,4.370874186588204
CML-T1,selumetinib-JQ-1 (4-1 mol-mol),0.8733678884698052
PaTu 8988s,9936388,0.6570193749634515
SK-MEL-1,selumetinib-JQ-1 (4-1 mol-mol),-2.2090163573526653
SET-2,9826308,0.9008531739680242
BT 320,6918837,0.518825985636162
KP-4,65064,5.182181693304659
NU-DHL-1,16720766,-1.0246097126306042
GOS-3,969516,3.7661148918393823
KMS-27,5287620,-2.957381061466462
NU-DHL-1,409805,5.5181498055430565
CA46,11719255,3.04595311036835
SET-2,5470400,-1.759000400814145
SKM-1,6505803,-1.0817481083509812
AU565,selumetinib-MK-2206 (8-1 mol-mol),1.4284909775011103
BT 328,9825149,2.1820811004987126
GOS-3,24797083,1.855899364684227
HMCB,46907787,2.4282883374132256
SK-LMS-1,1750826,-2.158580742507532
CA46,2949965,2.263314804434843
NCI-H2172,9911830,3.117247767846657
SK-MEL-1,24775005,3.916732480100824
CML-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.4350289295501254
SNU-1214,serdemetan-SCH-529074 (1-1 mol-mol),2.0689906007106376
MM1.S,6610355,3.8482790769850017
PE/CA-PJ34 (clone C12),3081361,0.8218652425695582
KYSE-410,49867926,3.884487882273441
SET-2,JQ-1-vorinostat (2-1 mol-mol),-1.920843385058424
RERF-LC-Ad1,5328940,2.4316696035248153
PE/CA-PJ34 (clone C12),119182,-0.6317231418312041
LCLC-103H,65064,5.179389446108673
MCAS,44202524,1.49697239773081
KMBC-2,11152667,1.3012621029988305
RERF-LC-Ad1,44819697,0.2089459186593415
LNCaP clone FGC,25161177,4.947661929093119
KMS-27,72734382,3.649380634189348
LNCaP clone FGC,erlotinib-PLX-4032 (2-1 mol-mol),2.8127712400378737
SK-MEL-1,5566,2.370137827997764
RERF-LC-A1,3689413,-2.1513750225162114
IST-Mes1,selumetinib-UNC0638 (4-1 mol-mol),3.472834598034016
RERF-LC-Ad2,15983966,2.6001101676234644
Hs 683,vorinostat-carboplatin (1-1 mol-mol),3.528980222681868
SET-2,676352,1.571456304153482
RERF-LC-A1,JQ-1-carboplatin (1-1 mol-mol),5.6290359475230725
OE21,9840324,7.130440725429134
HMCB,16736978,1.7637750571409103
BT 504,ISOX-bortezomib (250-1 mol-mol),0.697055524521774
SNU-8,241158,1.5874400033719902
LoVo,49836020,1.6927786584323
SNU-1214,16741245,4.00897301492853
Aska-SS,327653,3.2557442863738033
A4/Fukuda,11625818,2.700159842549232
JIMT-1,piperlongumine-MST-312 (1-1 mol-mol),2.984180410142684
OAW28,11152667,0.0990704789630026
AN3-CA,24951314,1.3705311595438758
CML-T1,selumetinib-piperlongumine (8-1 mol-mol),3.07705446138146
NCI-H2081,135398738,4.309612048348404
OAW28,25126798,4.214847534438453
SNU-8,107970,2.3224728440298814
PE/CA-PJ49,carboplatin-UNC0638 (2-1 mol-mol),3.667372427911613
RPMI-7951,42642645,1.1114872828283802
YH-13,46191454,1.7299937465263655
Ku812,7326481,1.3104376334560923
SK-N-AS,71680916,4.462736242885828
Kasumi-2,208908,2.161160996454662
NCO2,4788,4.213224009752897
SNU-1033,24901704,3.4309079022670472
SNU-8,JQ-1-carboplatin (1-1 mol-mol),1.6259891864743636
BT 330,docetaxel-tanespimycin (2-1 mol-mol),-2.1739850279343433
SKM-1,135440466,0.5492238324239911
TE-15,piperlongumine-MST-312 (1-1 mol-mol),1.329292927903699
NU-DHL-1,135398516,0.2609599699484601
HSC-4,salermide-PLX-4032 (12-1 mol-mol),5.175495928614886
ESS-1,51039095,3.5660815776575228
SEM,3136844,3.235068436368959
LNCaP clone FGC,navitoclax-pluripotin (1-1 mol-mol),-1.5517628792513285
NU-DHL-1,4788,5.7470913378244
NU-DHL-1,tretinoin-navitoclax (4-1 mol-mol),-1.9043556508131567
SNU-1272,1641662,4.135361121218487
PaTu 8988s,675434,4.44028682039976
KYSE-410,10302451,1.6161895544560456
HuT 78,156422,4.343521315297441
KYSE-70,159324,1.7590392520862297
KMBC-2,6918878,5.016118473072515
ML-1 [Human thyroid carcinoma],44507138,2.4759759240399206
AU565,24951314,-0.2220635763258615
RERF-LC-A1,219104,3.9809048408812706
KYSE-70,135411,1.9014599224142343
RERF-LC-Ad2,11222830,1.7233775029483531
RERF-LC-Ad2,104842,0.4265236360414571
SK-MEL-1,11455910,2.3970626759922418
D283 Med,9915743,1.368920834577302
HCC2218,44241473,4.43561890592857
BT 320,selumetinib-GDC-0941 (4-1 mol-mol),2.4654879652784447
SEM,vorinostat-navitoclax (4-1 mol-mol),-1.6904002163702885
BT 504,9444,3.891973824319471
AN3-CA,81146,4.350886008377241
KMRC-2,5287620,-2.766433271422092
Aska-SS,53232,-5.775078503604418
SK-N-AS,11178236,-3.28030469150885
H-STS,73707398,1.2106724937411937
AN3-CA,6610355,3.5783077725767853
BT 139,11427553,3.113347058526198
KYSE-410,10074640,2.973181094557615
A4/Fukuda,11152667,-2.4230854517211977
OAW28,52912189,1.8010258653688298
OE21,10074640,2.6390698783302025
MM1.S,25126798,3.74177726744656
NCI-H2110,44566777,0.634528654722784
ESS-1,36462,-0.1255368808432747
HMCB,6914657,-4.177401359592738
HCC2218,5311,0.3074156467085373
BFTC-909,2113511,5.65564772398506
IST-Mes1,42642645,0.3467837133172653
SEM,3384730,-0.188183167842947
A4/Fukuda,6610216,3.4719570509087445
SKM-1,3634881,1.6208942767524477
KYSE-70,1750826,1.0050628158627442
SKM-1,11214940,2.1069577398563415
SNU-1033,11404337,-1.419235655385228
TE 617.T,24785538,1.222197390283284
NCI-H2172,25195348,4.702714064642265
BFTC-909,9907093,4.635414583134371
LNCaP clone FGC,4917,3.636523890997274
KMRC-2,5351362,1.4627270802530556
NCI-H2110,613000,2.499144712249598
SK-N-AS,54619267,3.9785801078591594
KYSE-70,2729026,2.877153539650856
MCAS,24771867,2.4778802536032045
CML-T1,11455910,-0.3388293365451558
Kasumi-2,71466445,1.815897736576068
JIMT-1,5351362,1.1516040675086128
RPMI-7951,60700,-1.191819439472768
NCI-H2081,5738263,3.7116939105777687
RPMI-7951,11228183,2.9012784360869492
KYSE-410,23635314,-1.9771165162186872
Aska-SS,262093,2.4925778805334975
SKM-1,9840324,5.371011979568873
OE21,421610,2.7409789844233385
LoVo,54626689,4.759845357486115
RERF-LC-A1,72734382,5.92142815159328
A4/Fukuda,9549297,1.6255879909683784
Kasumi-2,16720766,-0.2515973340383426
LNCaP clone FGC,16659841,3.8088119567527903
HuT 78,46398810,2.0725080388247927
RERF-LC-Ad2,969516,2.8404089798962646
HMCB,49793307,0.2477875655449162
KYSE-70,17759555,3.816264723168541
NU-DHL-1,53495165,-3.4420511548934973
LNCaP clone FGC,11719255,3.490071444575551
RERF-LC-Ad2,navitoclax-sorafenib (1-1 mol-mol),3.4815256316040006
KYSE-70,4096211,2.254549645630953
IST-Mes1,9884685,0.6527999920478087
NCI-H1395,16038120,3.027555805242751
ML-1 [Human thyroid carcinoma],9915743,-0.6180546405493912
NCI-H2110,5460769,2.6451142093153326
SNU-308,5351362,1.2731127244632512
YH-13,168313016,4.37029301578321
RERF-LC-Ad2,9907093,4.485338642207398
SNU-308,11178236,-0.1870535511193118
LNCaP clone FGC,2729026,3.004810986448101
RERF-LC-A1,441298,1.1515457636883657
MCAS,selumetinib-JQ-1 (4-1 mol-mol),0.5693027943347815
OAW42,JQ-1-vorinostat (2-1 mol-mol),1.522053021347644
SEM,JQ-1-vorinostat (2-1 mol-mol),-2.448022035749378
TE-15,9903786,2.5325936452806723
SNU-308,alisertib-navitoclax (2-1 mol-mol),0.6832132242815244
NCI-H1092,462382,0.0075448360840851
HARA [Human squamous cell lung carcinoma],25126798,3.0348047735223935
NCI-H2110,3854666,1.2202267080403588
H-STS,tanespimycin-bortezomib (250-1 mol-mol),0.0434064671940078
OAW28,216345,3.8770767977792913
D283 Med,11175137,1.7894441907886798
BT 139,9903786,4.553274987644657
NCI-H2081,6438330,1.5625660396683954
RERF-LC-A1,45100309,5.869505145889965
Hs 683,135659046,3.747937151940255
LNCaP clone FGC,675434,3.938004078494452
OAW42,navitoclax-pluripotin (1-1 mol-mol),0.0566000348721316
KMRC-2,25262965,-2.17943777957922
HCC2218,1641662,5.2445396499203865
OAW28,carboplatin-UNC0638 (2-1 mol-mol),3.4332779723405182
TE 617.T,56973724,2.843269444748679
CA46,2746,0.9501634288999758
PE/CA-PJ34 (clone C12),11707110,-0.098789156222797
YH-13,ISOX-bortezomib (250-1 mol-mol),0.2310542886202235
OAW28,crizotinib-PLX-4032 (2-1 mol-mol),2.110933622393645
HEC-151,54613361,-0.1055371916059164
HMCB,JQ-1-UNC0638 (2-1 mol-mol),1.877058831391371
WM983B,6917907,-5.474948571359277
ML-1 [Human thyroid carcinoma],11222830,1.0897337620982457
OE21,24951314,1.194971489666842
HARA [Human squamous cell lung carcinoma],6918289,2.581505632245523
BT 328,568763,1.8540976735744827
AN3-CA,31703,0.3464960160255474
CA46,54618164,3.845436645537388
NCI-H2110,445643,3.9404850685978334
KP-4,241158,1.8280076583022216
YKG-1,67156097,0.6160547787763923
CML-T1,selumetinib-GDC-0941 (4-1 mol-mol),2.3571897890829323
MCAS,navitoclax-pluripotin (1-1 mol-mol),0.5016754306809756
SNU-8,67156097,-1.3396461393156114
BT 320,9952709,2.926036005886834
RERF-LC-Ad2,4917,5.168503342508482
Raji,6918328,-2.1612103654061516
NCI-H2172,5351362,3.0006177485677044
SET-2,71466380,3.2876551416058337
H-STS,selumetinib-piperlongumine (8-1 mol-mol),2.659030814623116
KMS-20,navitoclax-MST-312 (1-1 mol-mol),0.8684749204516451
KYSE-70,9936388,-4.915846401119174
D283 Med,9907093,3.62208828367571
Hs 683,9952709,3.6516209267387914
SW1573,11427553,4.057369297610019
ESS-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.581305001836425
AN3-CA,969516,2.05001504854235
LNCaP clone FGC,17755052,0.9231030927826008
NCI-N87,5746,-2.0970985848352837
HuT 78,54626689,4.7254586853376175
YKG-1,2828334,6.412348563007059
PE/CA-PJ49,10231331,4.972087269175424
SEM,sirolimus-bortezomib (250-1 mol-mol),-0.6909485025943941
NCO2,17755052,2.2517535272786016
KMRC-2,52947716,3.2403383849187195
OAW42,7326481,4.26616283909166
KMBC-2,navitoclax-birinapant (1-1 mol-mol),-2.0894974372494612
RERF-LC-Ad2,doxorubicin-navitoclax (2-1 mol-mol),0.6418385821919341
TE-15,10302451,0.955725633878595
YKG-1,26596,0.9408189524000934
HCC2218,2949965,2.5969904614047485
PE/CA-PJ34 (clone C12),9840324,5.6753199284891505
SEM,11647372,1.226548693223236
HSC-4,sirolimus-bortezomib (250-1 mol-mol),1.2607817332731768
TE 617.T,19582717,4.16014564583822
ESS-1,navitoclax-gemcitabine (1-1 mol-mol),-3.147832073684123
BT 330,426756,3.999579288506848
BT 139,1716436,2.2745354204675667
HCC2218,46843906,4.781522984776227
A4/Fukuda,4378219,1.9024946719152895
SK-N-AS,11222830,1.5458794401066622
RERF-LC-A1,serdemetan-SCH-529074 (1-1 mol-mol),2.388459895447403
MM1.S,51037431,1.8715826956664352
NU-DHL-1,6610216,3.849394820990355
BT 504,2742550,3.507515217857391
HMCB,44137675,3.1016831628423542
OAW28,135421197,1.4901490212875883
SNU-308,452548,3.317512043570676
SNU-8,44819697,-0.5709611370205837
SNU-1214,67156097,-1.7976268412329377
SK-N-AS,selumetinib-PLX-4032 (8-1 mol-mol),0.6936138679831568
ML-1 [Human thyroid carcinoma],5328940,1.048806619411155
HSC-4,54619267,4.093335991980471
NCI-H2110,44607531,1.2211196147146048
AN3-CA,navitoclax-MST-312 (1-1 mol-mol),0.2700125726217607
ML-1 [Human thyroid carcinoma],25183872,1.7816002858265556
LoVo,3503,2.2987332704820016
NCI-N87,9911830,2.159086109533926
TE-15,6450551,2.7867234571621804
KP-4,2828334,6.089733529975997
D283 Med,selumetinib-decitabine (4-1 mol-mol),-0.3297766379520341
PE/CA-PJ34 (clone C12),25183872,-0.4619037978479324
HMCB,241158,3.538321708116031
NCI-H2110,1239801,4.6745645972191685
Kasumi-2,5351362,0.8391907710572402
NU-DHL-1,11228183,-3.596114572397512
TE-15,11396600,3.8567248680954056
D283 Med,44607530,0.9211029721085632
SK-MEL-1,72376,-1.616089423157278
A4/Fukuda,24951314,0.2081517019188384
Hs 683,11175137,1.575737295771595
Ku812,9803433,4.326144725372532
RERF-LC-Ad2,73707398,1.2471079254460122
ML-1 [Human thyroid carcinoma],10231331,4.187669502210677
SNU-1214,navitoclax-birinapant (1-1 mol-mol),1.6796123920432815
BFTC-909,54143018,0.6300785047889099
HSC-4,24797083,0.9836127584085878
NCO2,11507802,0.4438358583588965
SNU-1214,168312962,-0.9399527642901874
Ku812,JQ-1-navitoclax (2-1 mol-mol),-1.1866145933539507
OAW28,53495165,3.30177539085494
KMRC-2,3503,3.1235286594556007
TE 617.T,44491742,3.9684227449531697
KMRC-2,135440466,2.172644324172392
BT 504,46901937,5.731455079229945
KMS-27,10184653,1.6525430220853072
RPMI-7951,11612883,2.6435847430306696
HuT 78,637858,0.0090449520272635
IST-Mes1,9911830,1.5716425903239464
KMRC-2,675434,5.987792180737955
BT 139,46843906,3.701995296517631
BT 328,15983966,3.6622955294931865
YH-13,71466578,4.92268847622802
D283 Med,12001922,1.043249882837814
GOS-3,6852167,4.136996914293619
SW1990,4477,0.8261455578387246
OAW28,208908,1.9779710002494069
H-STS,15983966,-4.061111130827075
NCI-H2172,159324,3.4766300457250416
NCI-H2081,54618771,1.045855982244366
HuT 78,44607531,1.3859547211867245
KP-4,SNX-2112-bortezomib (250-1 mol-mol),-2.729591666452361
SET-2,439501,-3.519167585481613
Hep-G2,24964624,2.457583201626236
Aska-SS,24951314,0.8841010020541346
MM1.S,53392493,1.575283610163411
SET-2,3503,1.2013280353182436
CA46,135659046,2.986085914123542
LCLC-103H,16219061,5.306010014393872
TE-15,42642645,0.6450047304037199
HEC-151,46191454,-0.1634405658392589
PaTu 8988s,82146,4.315487161713906
WM983B,25062766,2.468624930010441
TE-15,11175137,1.7379507922596151
SNU-308,navitoclax-MST-312 (1-1 mol-mol),1.9474762449323673
BFTC-909,16219061,3.736019824418232
MM1.S,11609586,-0.4904496149826149
KMRC-2,72376,2.0798917005863617
MCAS,11214940,1.0484190061593228
KYSE-410,JQ-1-MK-0752 (1-1 mol-mol),2.863101776499217
SNU-8,vorinostat-carboplatin (1-1 mol-mol),2.8875335842096077
SW1990,637858,2.6354229615266447
CA46,salermide-PLX-4032 (12-1 mol-mol),5.07380877764379
NCI-H2110,16722836,2.5325989448324493
NCI-H1395,25227462,2.331405873777041
KMRC-2,56973724,4.033388480468852
SW1990,selumetinib-GDC-0941 (4-1 mol-mol),1.2183464614228592
Aska-SS,67291369,3.382785717613604
LNCaP clone FGC,123631,3.551253848409697
KMBC-2,23582824,0.4991820200879616
JIMT-1,168312962,3.711924405294868
MCAS,25262965,-2.666466085626817
H-STS,sirolimus-bortezomib (250-1 mol-mol),0.1241794019468204
EJM,salermide-PLX-4032 (12-1 mol-mol),5.466360284353834
OAW28,6918328,-0.6493981710218658
RPMI-7951,SNX-2112-bortezomib (250-1 mol-mol),-2.272647558916823
IST-Mes1,3062316,-4.79181247277669
OAW28,25062766,3.2225198305631464
CML-T1,36314,-5.131510797683319
BT 504,65628,4.716972580704197
SK-MEL-1,JQ-1-navitoclax (2-1 mol-mol),-1.8917140408224469
YH-13,4096211,1.7553390235947497
HCC2218,969516,2.8110779148383616
KP-4,navitoclax-birinapant (1-1 mol-mol),2.981041559584989
AU565,11960529,4.91307375329511
HCC2218,11152667,3.74490271643498
NCI-H2110,135875424,4.423682476800295
YKG-1,7326481,5.641592853625606
SNU-8,doxorubicin-navitoclax (2-1 mol-mol),0.6886100127038397
ESS-1,selumetinib-vorinostat (8-1 mol-mol),3.369239403980627
KMS-27,441298,2.670154019123105
ESS-1,9887053,4.577592103187429
HSC-4,2874250,5.810325396532396
RERF-LC-A1,9823820,4.369021532343093
KMS-20,selumetinib-PLX-4032 (8-1 mol-mol),2.2500774116215196
TE-15,11455910,-0.076849872958893
EJM,11214940,4.2208595782990965
YH-13,12003241,-0.7443010060517422
SKM-1,44493528,3.979629908351757
A4/Fukuda,11497983,-1.0595923666648657
LCLC-103H,11507802,2.208399559850935
Kasumi-2,tanespimycin-gemcitabine (1-1 mol-mol),-5.446919177897971
RPMI-7951,44607531,1.5066320786781766
LCLC-103H,23725625,5.147048491846708
KP-4,53232,2.3027476870683756
AN3-CA,5746,2.1305977985768085
EJM,56649450,2.621369128509505
BFTC-909,16725315,4.495652912061774
D283 Med,9911830,1.6953738838285617
LNCaP clone FGC,24951314,1.1304514947758728
JIMT-1,doxorubicin-navitoclax (2-1 mol-mol),0.9576674640627898
Ku812,16720766,-0.9300961810556406
HuT 78,25150857,0.8929430868058179
Kasumi-2,25262965,-2.503194884241619
BFTC-909,262093,3.5924629632259792
KP-4,ISOX-bortezomib (250-1 mol-mol),0.4690866749839671
SNU-1033,5311,1.072248134793335
RERF-LC-Ad2,24821094,4.198014955346009
PaTu 8988s,salermide-PLX-4032 (12-1 mol-mol),6.000347868731987
OE21,2733526,4.086815697024987
KMS-27,168313047,2.6565282166568034
ML-1 [Human thyroid carcinoma],7326481,3.5221044039257037
RERF-LC-A1,selumetinib-piperlongumine (8-1 mol-mol),4.628606505838462
HCC2218,selumetinib-decitabine (4-1 mol-mol),6.205354195390442
A4/Fukuda,10113978,1.900139268592958
CA46,45279963,3.66447519946476
NCI-H2081,46926350,-4.428589866932994
GOS-3,107985,-2.049266528770901
OE21,123631,-1.0243580930173388
NCI-N87,5311281,2.449994968111211
CML-T1,3543504,3.744639287704583
NCI-H1092,6450551,2.2597381563726433
NCI-H2081,vorinostat-carboplatin (1-1 mol-mol),1.7925408533831422
SW1990,16736978,1.235642463151611
OE21,11364421,-5.654768870517808
EJM,9967941,2.872620425548139
NCI-H2081,135440466,3.0899746157429173
RERF-LC-Ad2,71304818,2.712854683480008
HSC-4,31703,-2.446577735650292
PE/CA-PJ34 (clone C12),9884685,0.3333327844016708
PaTu 8988s,46843906,2.1796914916961865
NU-DHL-1,46215462,1.671878123602452
SW1573,5113032,6.532830278238065
Hs 683,docetaxel-tanespimycin (2-1 mol-mol),-6.250654311863999
SW1990,11228183,3.7055348049186354
YH-13,52947716,-5.569011726742263
KMS-20,53495165,-4.499917260073859
RPMI-7951,644241,2.388085399534529
HEC-151,6438330,1.1738977407400153
Hs 683,107985,-3.457154115132212
OAW42,5746,-0.2152334314410869
ESS-1,2113511,5.741051028329071
NCI-N87,60750,-4.457686499395666
CA46,135875424,2.985562686352135
Ku812,5278396,2.880964948790695
GOS-3,9825149,2.947863727591062
OE21,613000,2.5457180338251533
HCC2218,docetaxel-tanespimycin (2-1 mol-mol),-2.41898448454828
OAW42,selumetinib-GDC-0941 (4-1 mol-mol),2.1178159599202626
KP-4,984333,0.8072210644040998
TE 617.T,6438330,2.7353087025620377
OAW42,82146,3.9418767021752337
Raji,44137675,4.0530836304331475
OE21,3025986,-1.6199199531853583
AN3-CA,5738263,2.4424476879393193
YKG-1,5479543,3.551055937780437
BT 328,53393127,6.034881823049704
KMS-20,135411,-0.1800034953276003
BT 139,448949,1.7108312586402246
HSC-4,6610216,4.241818899552939
SNU-308,54613361,1.3783530680753424
NCI-H1395,135984461,4.376761136039875
Hs 683,44607531,1.496524141296035
PE/CA-PJ49,3634881,3.4602619031598945
BT 139,9952709,2.4160089059178107
CML-T1,216468,0.1350088901202253
RERF-LC-A1,5460769,2.531170153978
RPMI-7951,119182,-2.106125598677035
SK-N-AS,4261,1.8457207553532595
TE-15,462382,1.115995338445578
KMS-27,5746,-0.3772523731080616
NCI-N87,60700,-1.3451868063168757
HCC2218,3062316,3.0327849170125254
SNU-8,tanespimycin-bortezomib (250-1 mol-mol),1.1303799126997314
YKG-1,4259181,0.3868166013965885
SEM,11977753,-1.3254464144533478
OAW42,119607,6.102469755511117
D283 Med,5281321,-4.405439498584387
SK-MEL-1,135421197,3.405543423729856
BT 139,208908,1.2301436422365457
SEM,969516,-0.0005595502936996
HMCB,24964624,3.0929732847658613
MM1.S,656346,0.8966007785283742
NCO2,2874250,3.7531238378575136
EJM,1641662,2.9948072583311567
SKM-1,44543605,3.543477995326012
AN3-CA,selumetinib-BRD-A02303741 (4-1 mol-mol),5.034678301732505
LNCaP clone FGC,10302451,3.7109646115457418
AN3-CA,11507802,0.6411944159694901
SK-LMS-1,9933475,2.3657628336253396
NCO2,44632017,-0.2331627468664847
SK-MEL-1,25150857,2.2780461365667284
NCO2,56963564,-1.4633100692621936
NCO2,107985,-5.5165771909272046
MCAS,6918328,0.5035344277026522
Hep-G2,446155,4.188968045550805
LNCaP clone FGC,216239,1.7260872019236435
KP-4,54143018,-0.6876943348633362
PaTu 8988s,10385095,1.7438856573412385
NCI-H2081,5746,-1.1331646162653188
HMCB,53495165,0.9664452371473048
CML-T1,4096211,0.5897034084412636
SEM,446155,3.622162137038395
OAW28,navitoclax-sorafenib (1-1 mol-mol),1.7172583203628091
NCI-H1395,25126798,4.167853501092747
HSC-4,23582824,-0.585849233367442
KMRC-2,2871966,3.883506418529128
RERF-LC-A1,selumetinib-MK-2206 (8-1 mol-mol),3.776506759434963
HuT 78,selumetinib-piperlongumine (8-1 mol-mol),-3.245208706353043
BT 504,24821094,3.4957106800035116
NCO2,42642645,-2.6055941527545228
PE/CA-PJ34 (clone C12),56949517,4.317826888670926
OAW28,11396600,3.5740319462685535
SNU-1214,44819697,-2.330970176435049
KMS-27,54454,1.928881135788404
HARA [Human squamous cell lung carcinoma],176870,3.342277724847585
PaTu 8988s,73707398,1.72539191163247
NU-DHL-1,3634881,1.5922727518374944
A4/Fukuda,3011155,4.269088750580724
OAW42,5351362,1.116523998911409
HCC2218,3543504,0.7583357638948873
CML-T1,46943432,2.522264418529326
GOS-3,25150857,1.9006273010690065
HCC2218,24180719,3.079134814722543
NCI-H2081,24753719,4.037731991107883
SNU-8,2749,2.2827839907899645
BT 248,11960529,3.73553983344596
AU565,568763,-0.2996152351915113
SEM,702558,2.631789406831085
TE-15,24821094,-0.055231882311639
Kasumi-2,5743,-2.32743694805066
SNU-1214,613753,2.649500579698431
Kasumi-2,selumetinib-PLX-4032 (8-1 mol-mol),4.8744745414665145
Kasumi-2,JQ-1-MK-0752 (1-1 mol-mol),-0.4470190343146605
Ku812,25126798,3.6375519347650047
JIMT-1,11964036,1.6728727984787053
SW1990,selumetinib-MK-2206 (8-1 mol-mol),1.7059513810078966
A4/Fukuda,19582717,0.7629696429231957
OAW28,66577038,2.5027239379183666
NCI-H2110,46907787,2.692877404772462
OE21,carboplatin-UNC0638 (2-1 mol-mol),3.28101335426984
KMRC-2,54596490,5.045398582154487
Raji,24772860,-3.1428664616860615
OAW28,11178236,-3.057015425639644
Ku812,56946209,-4.665200171711114
NCI-H1092,5951923,4.507769777348797
KMRC-2,selumetinib-vorinostat (8-1 mol-mol),3.246916366131707
RERF-LC-A1,46199207,2.990561207653277
HEC-151,selumetinib-navitoclax (8-1 mol-mol),2.5500574298476657
WM983B,54143018,1.7088932938334722
YKG-1,doxorubicin-navitoclax (2-1 mol-mol),-1.1717417104097605
Hs 683,sirolimus-bortezomib (250-1 mol-mol),1.0884212532476678
SNU-308,tanespimycin-gemcitabine (1-1 mol-mol),-0.7443975463839722
OAW28,53232,2.960609854482466
LCLC-103H,24964624,3.0934102496012565
NCI-H1092,54618771,1.961811722948082
BT 504,7326481,4.137514831698377
KMS-27,4259181,-1.1469286160575058
Raji,136227924,2.5188827267380116
KMRC-2,400769,0.9397643729925782
NCI-N87,124202324,1.1856737577999816
Hs 683,51037431,4.463172397129538
SW1990,60700,-0.8541147195402934
KYSE-70,54143018,-0.2928055682999507
TE 617.T,613000,3.3643329298161935
EJM,44543605,3.7217729651907825
NCI-H2110,5746,0.0974100097723131
SNU-8,9887053,4.177655211283038
D283 Med,135875424,3.0041212409823053
PE/CA-PJ34 (clone C12),selumetinib-PLX-4032 (8-1 mol-mol),2.847954484086583
CML-T1,637858,1.454745710944211
SET-2,11238147,1.9393035585687608
WM983B,selumetinib-piperlongumine (8-1 mol-mol),-1.7593896741971775
Hep-G2,2828334,6.110325188036079
HSC-4,24775005,4.677905847548428
AU565,123631,0.0519428975879534
SK-N-AS,2949965,2.6344324584451053
LNCaP clone FGC,16741245,4.9091514043929605
KP-4,44632017,0.4169327779251814
LNCaP clone FGC,9887053,1.6596295171491997
SW1573,285033,-0.3175288260868649
RPMI-7951,44589607,2.5685754653743724
BT 139,navitoclax-birinapant (1-1 mol-mol),0.9139278911158232
BT 504,decitabine-navitoclax (2-1 mol-mol),5.00949456237649
BT 320,11427553,4.124967356317301
MCAS,navitoclax-MST-312 (1-1 mol-mol),0.7888327520655
NU-DHL-1,10410894,0.6654652153011242
KMRC-2,216239,3.7115665542039302
OE21,1750826,1.9997604925130417
JIMT-1,135440466,3.0312778929774264
SKM-1,9907093,3.8598781273482983
EJM,23939,4.39619028953138
SK-LMS-1,JQ-1-vorinostat (2-1 mol-mol),1.295857635010565
NCI-H2110,67156097,-1.093207704220165
BT 320,3854666,3.86904800273952
D283 Med,46215462,1.5827854676989337
ML-1 [Human thyroid carcinoma],carboplatin-UNC0638 (2-1 mol-mol),3.254418532258765
Kasumi-2,erlotinib-PLX-4032 (2-1 mol-mol),2.6918027963335827
BFTC-909,15953870,3.192835350037467
NCI-H1395,10302451,4.201114377039751
SK-MEL-1,327653,3.0009528841881283
Hep-G2,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1901606503524278
MM1.S,60700,-1.118985990176223
YKG-1,11238147,1.8492898998590992
YH-13,navitoclax-piperlongumine (1-1 mol-mol),2.7253521934801217
SK-LMS-1,11657048,4.444916823006313
BT 330,25183872,-1.681997867633064
NCI-H2172,54618164,4.006615708933043
SNU-8,23635314,-1.998431310162353
BT 320,135875424,3.1120862947515255
Hs 683,9911463,3.853379830397607
AU565,24797083,1.2091873523376886
SET-2,9956119,1.6747796641968389
IST-Mes1,67291369,1.9412797776758044
OE21,selumetinib-JQ-1 (4-1 mol-mol),-0.1930020472631329
BT 139,285033,-0.1387265291417826
NCI-H1092,11507802,0.7710347538539816
NCI-H1092,46926350,-4.274443636172462
PE/CA-PJ34 (clone C12),446155,2.4621784911192317
NCO2,675434,3.3955636985812294
D283 Med,BRD-A02303741-navitoclax (2-1 mol-mol),4.100647340597535
NCI-H2081,7251185,1.1327722028105756
EJM,9926054,1.7534790705740089
Ku812,6914657,-6.377173707713946
TE 617.T,16741245,4.1592195625423845
TE 617.T,selumetinib-PLX-4032 (8-1 mol-mol),2.1990487798939764
OAW28,11497983,4.916879328733168
NCI-H2172,11455910,3.487096997214958
NCI-H2081,136227924,2.7498424735477913
PaTu 8988s,11178236,-3.993619119148662
KYSE-410,54618164,4.094546226578619
YKG-1,11609586,3.3937959596704523
SK-LMS-1,2871966,-0.1812763074571703
KMBC-2,25227462,1.5498003806223235
LNCaP clone FGC,selumetinib-piperlongumine (8-1 mol-mol),4.580403937531623
OAW42,135411,0.7410867506657871
Hs 683,10184653,1.5587127969041623
RERF-LC-Ad2,56649450,3.379867439418164
Raji,24797083,0.986652540468224
KYSE-70,24821094,5.190593902676824
GOS-3,11609586,2.254603724376055
NCI-H2110,4259181,-0.2511035825060961
PE/CA-PJ49,57519531,2.123608665735884
HuT 78,24964624,-2.2262621005839813
YH-13,6505803,-0.6394660445903715
SNU-1033,2746,3.071869125008986
HSC-4,322968,4.636798889333657
BFTC-909,55508,3.078625314561866
NCI-H2110,44507138,3.030476898815104
YKG-1,216239,3.3317563893959377
KMS-27,448949,2.041269365132705
SNU-8,5335621,4.415032779411775
WM983B,24775005,3.5501914368343344
KMBC-2,44507138,2.985904055733976
SNU-1033,16736978,4.192553953720477
Hep-G2,sirolimus-bortezomib (250-1 mol-mol),1.7771755554565365
SK-MEL-1,56963564,5.753230149562826
BT 248,11955716,-0.8129800870812356
SEM,71751553,4.239243086655999
WM983B,49766530,2.209591976361656
RERF-LC-Ad2,SNX-2112-bortezomib (250-1 mol-mol),-1.0932359303566324
KMS-20,2945648,2.3119596630463657
ML-1 [Human thyroid carcinoma],49850262,3.5297334075235245
SNU-1033,46926350,-3.712986003015726
NCO2,crizotinib-PLX-4032 (2-1 mol-mol),-0.7152592164948813
OAW42,piperlongumine-MST-312 (1-1 mol-mol),2.378996038917939
A4/Fukuda,navitoclax-gemcitabine (1-1 mol-mol),-5.146642660406073
Hs 683,44620216,3.795198661592088
PE/CA-PJ49,409805,3.747059655038111
YKG-1,54618771,1.607640245193468
ML-1 [Human thyroid carcinoma],11612883,2.523942692100722
NCI-N87,9936388,-5.070095106907016
Kasumi-2,9933475,1.7570111474767809
CML-T1,176870,2.5950096151434345
HCC2218,15953870,3.7305294656594623
BT 328,984333,0.810991187703125
HMCB,4788,5.563501322279771
MCAS,11977753,-2.438590361715294
CML-T1,6852167,0.9836314645814764
NCI-H2110,6917907,-5.621291047180246
KMS-27,36462,-0.3122628984401899
PE/CA-PJ49,11494412,-0.4920931569097222
ESS-1,57519531,1.5158364649894671
HSC-4,3543504,3.922868331711394
PE/CA-PJ34 (clone C12),9952709,3.276837469660591
NCI-H1092,107985,-3.3152950865622564
OAW28,46398810,2.3633613380182386
NCO2,168313047,-0.0929183677697479
CA46,16720766,0.453567173389679
NCI-H2081,31703,-2.720849472293294
TE-15,6918878,1.5398675408353943
SK-LMS-1,selumetinib-navitoclax (8-1 mol-mol),2.476280866882333
NCI-H1092,46174525,3.656769194454104
Hep-G2,374536,1.5546394927769718
HCC2218,46907787,2.570368749578335
RERF-LC-A1,24856436,0.7969021162233922
SK-N-AS,24771867,2.5012979508837696
IST-Mes1,4521392,4.383284740471391
NCI-H1395,6852167,3.4323108551980748
PaTu 8988s,9866186,2.7260374250505808
TE-15,11494412,-1.732621371792193
YKG-1,25150857,2.66438292717209
Raji,1242560,3.207248077218254
KMS-27,10385095,0.2784313447424752
SEM,24964624,1.6218762857386917
SET-2,selumetinib-navitoclax (8-1 mol-mol),-0.7080378803323621
SET-2,53325874,4.5663395365380355
Ku812,3634881,2.5120056948653
Kasumi-2,selumetinib-vorinostat (8-1 mol-mol),0.9890334474484956
SW1573,53232,-0.4627324496874346
HARA [Human squamous cell lung carcinoma],9911830,2.811378702432749
RERF-LC-A1,ISOX-bortezomib (250-1 mol-mol),0.187830447634388
RPMI-7951,7326481,3.2368064282682076
SK-LMS-1,5951923,4.520329928618062
TE-15,11647372,1.9040962473693783
EJM,navitoclax-MST-312 (1-1 mol-mol),0.9135656796063774
SK-N-AS,JQ-1-navitoclax (2-1 mol-mol),0.7481886179343493
OAW42,67156097,0.2562316976125848
SW1990,navitoclax-gemcitabine (1-1 mol-mol),-1.7958308660531992
NU-DHL-1,53232,2.540653358624638
RERF-LC-A1,24771867,3.1832932078828335
HSC-4,119182,0.0150561689419209
YKG-1,6918328,0.8877093194372333
TE-15,navitoclax-gemcitabine (1-1 mol-mol),-0.4700203817880856
HuT 78,71729975,0.9717002340056357
PaTu 8988s,16725315,5.295606501066723
NCI-H1092,6610216,4.21553350442545
NCI-H2081,11955716,-2.042301690942712
BT 504,JQ-1-vorinostat (2-1 mol-mol),1.6152459526378566
KYSE-410,67156097,0.065853882181778
HEC-151,24797083,1.0438718877064863
OAW42,119182,-1.0523055553220644
SNU-308,decitabine-navitoclax (2-1 mol-mol),1.4439981820169328
KMS-20,11625818,3.818760510140028
SEM,11625818,5.278130050580437
AN3-CA,46398810,2.836151148830735
YH-13,10113978,4.558059650015548
IST-Mes1,11717001,4.337000636344965
HuT 78,navitoclax-sorafenib (1-1 mol-mol),1.735834872159947
EJM,15953870,3.026448270110203
PE/CA-PJ34 (clone C12),44486219,4.215930684165307
D283 Med,44489675,3.5231335030624855
KYSE-410,5282054,4.0043320693852
Aska-SS,2729026,2.2940081648522246
EJM,3689413,-2.394173462666658
ESS-1,10302451,3.294150768882909
Kasumi-2,9826308,-0.3836015857314186
TE 617.T,10296883,3.758267174754907
SEM,135398738,-0.4705480766315878
PaTu 8988s,241158,4.442566432866993
KMRC-2,6914657,-1.6241038444290086
NCI-H1395,11234052,4.314713395827009
OAW28,25062766,3.2225198305631464
KMS-27,135875424,3.062949478876591
D283 Med,25262965,-4.463192676637634
GOS-3,JQ-1-UNC0638 (2-1 mol-mol),2.0742730655318233
BT 139,5287969,-1.5925638100844708
KP-4,421610,4.182899126160872
HuT 78,16736978,-0.4405557775162137
HARA [Human squamous cell lung carcinoma],5328940,0.878974684606101
BT 504,9911830,2.9079127670616978
CA46,25154868,4.248651634430963
BT 504,53232,5.370075511163261
BT 328,17755052,2.7457916392526247
LNCaP clone FGC,53232,3.656268546746555
TE 617.T,navitoclax-sorafenib (1-1 mol-mol),2.2031906036417883
EJM,6918328,-1.265460040313133
BT 248,navitoclax-pluripotin (1-1 mol-mol),-1.2956772624371633
RPMI-7951,66890843,4.6499131615758635
ML-1 [Human thyroid carcinoma],56649450,4.029501942502391
KMS-27,20959075,-3.466163882395625
SNU-8,5281672,3.454491420991977
A4/Fukuda,448949,1.1686862984883333
PE/CA-PJ49,9927531,5.215467759359
TE 617.T,135928012,3.262303401406854
SK-MEL-1,5287620,-2.8655306110259287
SK-LMS-1,9967941,5.011647610882007
ESS-1,12003241,-1.211695248693708
NCI-H2110,9927531,4.774812830583443
SK-LMS-1,2733526,5.0233438877930645
PE/CA-PJ49,24901704,4.643738871205813
SK-N-AS,4917,2.891570782750972
KYSE-410,135423438,1.615361831673466
RPMI-7951,71466445,5.865470046063986
TE 617.T,5738263,3.651421569462811
SNU-1033,9868037,4.1632978097237014
WM983B,387447,-4.220808963695924
H-STS,25126798,3.914537201699023
HuT 78,135875424,3.0458075465752694
H-STS,5291,3.872294840120784
OAW42,6610216,4.144894228463558
TE 617.T,16725315,3.1542877991652656
IST-Mes1,SNX-2112-bortezomib (250-1 mol-mol),1.249422428379272
MCAS,4477,1.7344664635493
BT 504,46224516,2.0219276163534388
SK-N-AS,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.2098595134860778
LoVo,2858523,2.923658201852042
NCI-H1395,9884685,-0.0679636269907438
NCO2,navitoclax-gemcitabine (1-1 mol-mol),-4.624432749142179
SK-N-AS,selumetinib-GDC-0941 (4-1 mol-mol),-0.6593922451468693
SNU-1033,156414,1.6354285292334745
Ku812,9908783,4.70753642591378
OAW42,11175137,2.882975918230224
SEM,selumetinib-decitabine (4-1 mol-mol),-1.996234931247303
OAW28,9911463,4.007690751229585
SK-N-AS,5311,0.9753912650822524
NCO2,6610355,4.708354648506394
Ku812,sirolimus-bortezomib (250-1 mol-mol),-4.706863759104448
KYSE-410,24964624,2.5855367861983365
TE-15,6918328,-0.394350388862967
A4/Fukuda,168313200,2.9572494196719723
NCI-H2081,11167602,4.408206719858069
CML-T1,carboplatin-etoposide (40-17 mol-mol),-0.8203492199596885
NCI-H1395,24180719,5.770511312321668
D283 Med,71466445,1.8844109066317911
KMBC-2,3503,1.2413837341976814
Aska-SS,ISOX-bortezomib (250-1 mol-mol),0.9403464673165612
SNU-1214,60700,1.0859962451574008
KMS-20,9444,4.5404933780509635
NU-DHL-1,156414,1.5243299906287209
BT 328,136227331,5.061934875267611
BT 504,3689413,0.2401102984502228
SEM,7251185,0.9533100433474536
TE-15,4477,0.8329048028922312
KMBC-2,3038522,3.0239147751029
JIMT-1,17755052,2.000553425167253
HEC-151,16013152,4.101963115676647
ESS-1,1566236,1.5560500313895365
PE/CA-PJ34 (clone C12),5566,3.075370246500284
SNU-308,72193861,2.7866488099422693
PaTu 8988s,11647372,1.5690311428117751
SNU-1214,navitoclax-piperlongumine (1-1 mol-mol),1.9032666953627455
GOS-3,8515,4.692167574261379
TE 617.T,387447,-4.6885019632323255
NCI-H1092,serdemetan-SCH-529074 (1-1 mol-mol),2.0594961272701453
SEM,11717001,4.301730945883233
HMCB,tanespimycin-gemcitabine (1-1 mol-mol),0.8879400812338334
BT 139,46224516,3.3567883234175406
KYSE-410,66577038,3.1075620073245624
KYSE-410,46199207,3.362816327601518
LoVo,11364421,-3.7348040522268624
OAW42,122327,4.408237851345783
LoVo,SNX-2112-bortezomib (250-1 mol-mol),-2.7337701225380786
BFTC-909,24771867,4.730369684143592
CML-T1,49850262,2.3003389318393404
NCO2,navitoclax-PLX-4032 (1-1 mol-mol),0.2793291180673107
RERF-LC-Ad1,168313047,3.647095781351058
ESS-1,9927531,5.52249907084491
Kasumi-2,15953870,2.7617758274096404
TE 617.T,45279963,3.525595804474129
SNU-308,5566,3.3108470564797225
RERF-LC-Ad1,11364421,2.25691448448964
BT 139,2742550,2.665128125190364
ML-1 [Human thyroid carcinoma],49766530,-1.1158595986885904
SK-MEL-1,613753,2.672623593009721
LNCaP clone FGC,46199207,2.5599085856747323
KYSE-410,11152667,-0.1422079620328849
SNU-8,selumetinib-piperlongumine (8-1 mol-mol),1.802133871907447
HuT 78,10410894,2.2762155045304295
SNU-1033,2708,5.22281661109988
Hep-G2,452548,1.6597392394544144
NCI-H1092,104842,-3.256755572593022
KMBC-2,675434,4.8268210565645076
BT 139,5278396,3.8835862216023194
ESS-1,carboplatin-etoposide (40-17 mol-mol),0.969659746088125
WM983B,9866186,0.3265428169121327
SEM,11238147,1.513546731102789
RERF-LC-A1,72376,-1.716207143868092
OE21,135421197,1.5054570422138
EJM,56963564,0.0358307292912413
YH-13,135984461,4.0881390777757245
BT 248,24951314,2.138284126904765
OAW42,11317348,4.403816769714154
SK-LMS-1,6918328,0.6345903625341753
H-STS,SNX-2112-bortezomib (250-1 mol-mol),-2.995018705819844
SNU-1033,439501,-2.7458935942411085
OE21,5951923,5.242575680046821
HSC-4,17759555,2.4253306074953978
HARA [Human squamous cell lung carcinoma],12001922,1.8002757111950325
KP-4,57519531,2.7718546379882154
HMCB,444795,4.365001038195376
PE/CA-PJ34 (clone C12),7326481,3.1862405320000606
AN3-CA,selumetinib-UNC0638 (4-1 mol-mol),3.959828908489292
WM983B,42611257,0.4066154620712524
RPMI-7951,5351362,0.7294605148676923
PaTu 8988s,9884685,3.7069578425529257
YKG-1,6610216,4.705494965359816
TE-15,3825829,1.985318153826467
HCC2218,44197249,3.83159054202454
CML-T1,702558,3.0833664933254235
H-STS,262093,1.3358664140686949
PaTu 8988s,24978538,1.7094830128151086
A4/Fukuda,9927531,3.7257201794253776
EJM,10026128,6.2528613872855
CA46,5284616,-8.167802056045408
HSC-4,49793307,-1.7279713732228117
WM983B,9907093,4.634368442809879
TE-15,9926054,1.8189889434505215
NCI-N87,36462,0.3600781388020123
OAW42,11238147,2.0498966286897993
KMS-20,5328940,1.431090406795279
SNU-1272,11656518,1.8045520914389075
CA46,11494412,-0.1540181126177876
YKG-1,11228183,3.6918030107166784
SW1990,135440466,2.3978591257913218
SK-N-AS,3081361,2.839267079991696
SK-MEL-1,51039095,3.122033336327695
SEM,11507802,-0.3844502911192904
MM1.S,54143018,0.2857202786050064
SEM,11213558,-1.899887205353697
RPMI-7951,9907093,4.278738901234216
RERF-LC-Ad1,9936388,2.559895364863056
HuT 78,selumetinib-tretinoin (2-1 mol-mol),-3.3029302026602125
NCI-H1092,6918328,-0.0864293010170715
NCI-H1395,54618164,4.0783729987601225
CML-T1,135928012,3.921778036516406
HuT 78,7326481,3.898377103940941
RERF-LC-A1,7251185,3.5661928656880377
AU565,1242560,3.5510894145829286
SK-MEL-1,9952709,2.9758990850799556
JIMT-1,44632017,2.67516355498133
CA46,9926054,1.6892727173627182
NCO2,44202524,-0.4878982628038839
LNCaP clone FGC,1641662,3.3792685969663716
BT 328,3543504,5.231432946006072
OAW28,24964624,1.7856613849766505
BT 248,11640390,5.783520002908773
GOS-3,31703,-1.1173409595108883
NCI-H2081,25062766,3.110506006448837
PE/CA-PJ34 (clone C12),107985,-3.5683543961091138
LoVo,637858,1.5179613366947162
HCC2218,53245473,4.390880482928817
SK-MEL-1,5738263,3.4879999199998135
YKG-1,selumetinib-tretinoin (2-1 mol-mol),4.056935710637763
SNU-1272,89928392,2.766641438672422
PE/CA-PJ49,11214940,4.441072373529905
LNCaP clone FGC,46398810,3.373306144767874
SK-LMS-1,89928392,1.5380179268332728
NU-DHL-1,227681,1.656422659669183
PE/CA-PJ34 (clone C12),5291,4.131665147466615
SW1990,11625818,5.124392007984169
RERF-LC-A1,carboplatin-etoposide (40-17 mol-mol),3.079332352135714
RERF-LC-A1,56946209,-2.007898981246181
MM1.S,49793307,-4.457847663527619
SK-N-AS,5479543,3.4187450326971605
SKM-1,73707398,0.3700517012219515
TE 617.T,60700,-2.179954799206808
AN3-CA,10385095,0.1159584530929505
RPMI-7951,3815108,2.5391159267765144
BT 248,9884685,-0.279602051509792
KP-4,9935249,4.396743844440814
RERF-LC-A1,421610,3.516192065471449
BFTC-909,374536,2.594742723017773
HARA [Human squamous cell lung carcinoma],9840324,5.741888919857564
WM983B,54619267,4.441939237180739
BT 328,44566777,0.5494237323450607
WM983B,119607,5.910727936946644
SK-N-AS,10385095,0.6911222834259994
NU-DHL-1,11222830,0.1401036768079258
Hs 683,5284616,3.1798422053690394
SK-N-AS,135984461,4.344661124927598
SET-2,56649450,3.1911301169821367
KMS-20,11455910,0.7957422642794928
HEC-151,73707398,0.6503268944686523
PE/CA-PJ34 (clone C12),25105715,3.6718860986285975
LNCaP clone FGC,71466380,4.233263325075632
TE-15,54678924,2.061678703135273
HuT 78,docetaxel-tanespimycin (2-1 mol-mol),-5.471210221464332
TE 617.T,6917907,-5.978561156381877
SEM,selumetinib-MK-2206 (8-1 mol-mol),0.6180470677405737
D283 Med,23635314,-3.5786484067215545
HEC-151,57519531,2.365873229813937
RERF-LC-Ad2,6918638,1.8472690467547748
BT 328,5494449,3.740729289137561
Kasumi-2,4477,0.978376283081578
Kasumi-2,2749,0.3805959448623131
SW1990,3503,1.938053759615162
LNCaP clone FGC,8515,4.149767079879017
HuT 78,60750,-3.915840643388668
KP-4,5335621,5.265120466379572
TE 617.T,16722836,1.5288602103234736
GOS-3,72376,-1.137393114335449
KYSE-410,25154868,4.70403816905794
SNU-8,71466445,3.518025690097915
SK-MEL-1,5328940,2.4862595383145827
SNU-308,selumetinib-vorinostat (8-1 mol-mol),3.2167042029880264
MM1.S,5282054,2.5945944982730538
SNU-8,375860,-0.8346021123643971
OE21,25126798,3.6194882522456098
BT 248,4259181,0.8166391520482507
D283 Med,navitoclax-pluripotin (1-1 mol-mol),-1.8329751159945813
SK-LMS-1,11612883,4.463968607595997
SKM-1,4259181,-0.1122232838107409
NCI-H2110,2742550,3.917163865497912
BT 248,107970,1.564508535325896
WM983B,2733526,4.1306506013362405
LNCaP clone FGC,2874250,4.6479769678530385
SK-N-AS,6505803,0.8631817321203803
LNCaP clone FGC,11222830,1.7946004031282303
KYSE-70,25150857,2.5963104301055258
SW1990,16725315,3.443689747487624
NCI-H2110,9840324,5.768286236692181
BT 248,9868037,3.916296675967623
OAW28,2746,2.637952220594215
RPMI-7951,10302451,2.662563983337758
NCI-N87,tretinoin-navitoclax (4-1 mol-mol),0.6005709555160592
SK-N-AS,16038120,-0.0578440929246991
NU-DHL-1,3825829,3.145887822053552
MCAS,19582717,5.177441348034704
KMS-20,selumetinib-UNC0638 (4-1 mol-mol),0.6726182150265286
BT 504,6610355,5.165972467563183
TE 617.T,44632017,0.816965431655708
OAW42,11222830,1.3027823633605535
KP-4,54454,1.6581389243409257
SK-MEL-1,JQ-1-UNC0638 (2-1 mol-mol),-0.549212264797066
KMS-27,selumetinib-MK-2206 (8-1 mol-mol),-1.32719530265033
KYSE-70,3854666,1.6457032232411275
CA46,11238147,1.5462987380530164
KMS-20,11626560,1.153431092647739
SET-2,9933475,1.8182440705609093
TE 617.T,676352,1.4740706229451386
AU565,54613361,-1.6068695222158444
Hep-G2,selumetinib-decitabine (4-1 mol-mol),0.775371272875809
PE/CA-PJ49,5278396,3.6420002374977294
IST-Mes1,54613361,2.804102088673467
A4/Fukuda,44632017,0.3391160528514481
SET-2,55508,1.782724659965198
CML-T1,71466380,3.6658800118854673
NU-DHL-1,36314,-4.32042645892424
MCAS,3854666,1.0662273712961947
SNU-1272,46901937,3.721598697481184
Kasumi-2,6918837,-5.725087899258232
OE21,44607530,0.5174164350757162
KP-4,10427712,4.668928673169826
SKM-1,208908,3.3298351666258763
WM983B,23635314,-1.7239155383839546
H-STS,60700,-2.8002918740934044
PE/CA-PJ34 (clone C12),25262965,-2.594783363003755
D283 Med,alisertib-navitoclax (2-1 mol-mol),-3.1585358120838825
RERF-LC-Ad2,3025986,-1.6334496295077816
SNU-308,selumetinib-tretinoin (2-1 mol-mol),4.936945882415517
BT 248,54613361,5.122685224165604
KMRC-2,16725315,5.308613938847766
SET-2,82146,3.921079503064887
KMS-27,10322450,3.3921429038631707
NCI-N87,11626560,1.9254713694635637
BT 330,10231331,3.9874659396467793
BT 320,2729026,2.399631543883215
NCI-N87,16720766,-1.168414694473064
KP-4,252682,6.9364694268072435
MM1.S,JQ-1-navitoclax (2-1 mol-mol),-0.6640240653642139
NCI-H2172,11964036,2.255348451727483
SW1573,5479543,3.675213844165782
YH-13,327653,3.132127686900927
KYSE-410,selumetinib-navitoclax (8-1 mol-mol),3.3378568723711286
MCAS,119182,0.7383136380888948
BT 248,9927531,4.7076279917818225
CA46,123631,1.9024335998312112
SNU-1033,71751553,4.333449645170772
NCI-H1092,10296883,3.8260798051213376
KYSE-410,6505803,-1.395116732641888
LNCaP clone FGC,262093,3.5120752927452803
Hs 683,11625818,3.859187506214817
Hep-G2,56946209,4.656180413694649
Raji,53392493,2.607166976359352
H-STS,11609586,0.7770634294621763
OE21,alisertib-navitoclax (2-1 mol-mol),1.9539668690079708
RPMI-7951,6918289,2.8870775780311924
SNU-1214,72193861,0.8767959746030513
Kasumi-2,5284616,2.846557055185116
PaTu 8988s,9887053,3.932226470782735
Kasumi-2,44589607,0.7324041454669186
IST-Mes1,4917,3.386112443694605
Aska-SS,10427712,3.984050891681042
NCI-H2081,46398810,2.7782565224728537
KMS-20,24753719,3.26753514652521
SKM-1,119182,-3.439658099339246
HMCB,135421197,2.011360494635396
LNCaP clone FGC,7326481,2.6276779263247136
MCAS,67156097,-1.87014679044215
KMS-27,16725315,0.8036221388012417
SEM,100016,5.238818929389881
KP-4,10127622,5.552568613540639
NU-DHL-1,15983966,-4.432229151645776
SKM-1,10385095,0.5930890296191716
Raji,25126798,3.979032960527878
BT 139,65064,5.271614365528748
PE/CA-PJ34 (clone C12),5328940,0.4121607573919046
NCI-H2110,65064,5.718221272891953
TE 617.T,25126798,3.397946475866573
RERF-LC-A1,5335621,5.80713809196862
NCI-H2110,24180719,4.287105919201185
KP-4,638278,3.287352596500583
YKG-1,135398516,1.8406212394581116
KMS-27,JQ-1-MK-0752 (1-1 mol-mol),-3.7311302166854903
H-STS,docetaxel-tanespimycin (2-1 mol-mol),-7.723560174899757
MCAS,168313200,3.057905648422764
KYSE-410,400769,-1.024882871497729
Raji,5311,0.5368749929335932
Kasumi-2,54618771,-0.6876381814105375
Kasumi-2,4705,3.579279614719375
HSC-4,5351362,1.6988999536887646
SNU-8,JQ-1-UNC0638 (2-1 mol-mol),0.8314654213146081
Aska-SS,5329102,2.307959348285351
OAW28,3081361,1.8855664708831448
NCI-H2110,327653,3.7242823172188815
YH-13,126941,-0.9334172609353208
Ku812,3385,4.251256683389901
MCAS,44241473,5.035889660055443
TE-15,vorinostat-carboplatin (1-1 mol-mol),3.032439168473077
SET-2,16736978,1.494285339412499
AU565,10385095,1.377392665812461
SET-2,25062766,-0.8634965177329965
JIMT-1,6450551,4.001452562661689
AU565,54678924,2.5293429329053763
NCI-H2081,docetaxel-tanespimycin (2-1 mol-mol),-5.990158626012855
SNU-308,23725625,7.126867792374974
OAW42,11625818,4.411671928740385
D283 Med,3543504,2.346861617384035
KP-4,6918736,-1.4678476306173975
KMS-27,51037431,3.195812814283898
NCI-H2081,24856436,-0.1244268039061882
TE 617.T,25150857,1.1400030971124389
ESS-1,54618771,1.2318880484657342
LoVo,5566,2.507145044552918
SNU-8,carboplatin-UNC0638 (2-1 mol-mol),3.5048949040947512
MCAS,44632017,1.1533505396576618
HCC2218,16725315,2.471471872055809
D283 Med,5479543,3.66909557584616
NCI-H1092,2708,5.052405164442807
TE 617.T,9927531,4.756324122053051
NCI-H1092,11152667,0.3392565176972865
Hs 683,6852167,1.768664782954411
CML-T1,16115403,-5.689263243746957
AN3-CA,3689413,0.1719288482065274
NCI-H2081,4096211,1.423515993754231
SK-N-AS,135659046,4.543052332569712
NCI-H2110,5282054,4.116451043017715
OAW28,44607531,1.5392912313773788
NCI-N87,11485656,1.873926788766734
MM1.S,119607,4.277227419584953
ESS-1,71466578,4.727259089012869
Ku812,24772860,-3.654878232310525
YH-13,25126798,3.838421818647453
HCC2218,10302451,2.366058376925374
Ku812,11717001,2.262913045686641
BT 504,alisertib-navitoclax (2-1 mol-mol),-2.322595010962812
Ku812,25062766,1.6116262467918423
MCAS,46215462,2.85395044792557
HEC-151,4917,3.5509211593087904
KMRC-2,19582717,5.701776985219262
HEC-151,6610355,3.6251776557221542
TE 617.T,11960529,3.773275701050975
SK-N-AS,11707110,-5.565911326125377
BT 320,9444,6.119535049609411
NCI-H2081,JQ-1-navitoclax (2-1 mol-mol),0.0671859130804495
NU-DHL-1,navitoclax-birinapant (1-1 mol-mol),-2.6009930383173465
RERF-LC-Ad1,12003241,-0.821513059069255
MM1.S,5281672,3.0676410234065745
SK-LMS-1,148124,-4.355018265532959
HMCB,613753,3.1872639599039188
ML-1 [Human thyroid carcinoma],carboplatin-etoposide (40-17 mol-mol),0.3624432437862623
KYSE-410,9444,3.8448275957909983
Ku812,452548,-0.7948570640360005
NU-DHL-1,11612883,1.5610668318918748
NCI-H1092,2945648,2.0700638140292256
SNU-8,656346,1.5871868754593337
Ku812,46224516,1.585603002633456
KMS-20,46398810,1.6452638403183906
HARA [Human squamous cell lung carcinoma],6918736,-1.65788247009277
ESS-1,8515,4.728832630346152
ESS-1,11427553,2.850757771456098
H-STS,navitoclax-sorafenib (1-1 mol-mol),1.7549262144899889
NCI-H2110,107985,-2.7030092125020713
NCI-H2110,3503,1.6749548080811365
A4/Fukuda,24785538,-4.18833617701787
LoVo,322968,3.2361743048313536
YH-13,10296883,4.196539709790054
Kasumi-2,9825149,1.9223862209950433
BFTC-909,49867926,6.076136735210805
NCI-H2081,19582717,3.032200893690187
NCI-H2172,11152667,1.0620592795126853
HuT 78,123631,3.101357526527429
SW1990,11612883,3.6109216532509985
HMCB,375860,-0.2087542288186852
OAW28,46191454,1.726492969979986
BT 139,135999136,1.5889963250911243
TE-15,navitoclax-piperlongumine (1-1 mol-mol),2.8674602106602527
TE-15,16720766,1.0189208524673423
NCI-H1092,5335621,4.115542911112419
HMCB,10296883,4.337758420607625
NCI-H1092,25150857,2.120015833074409
LCLC-103H,135421197,1.2256317024766628
Kasumi-2,227681,1.7835466743963533
H-STS,24772860,-2.67708885899535
HEC-151,9887053,2.104759905960382
NCI-H1092,15547703,3.51736308964877
Kasumi-2,5280436,2.9235164089126884
HCC2218,72193861,2.2032780830216483
SK-N-AS,5978,-3.4727408846406354
WM983B,16038120,0.9083191509415924
BT 248,carboplatin-UNC0638 (2-1 mol-mol),3.451491217767034
NCI-H1092,16038120,0.7864664240058443
D283 Med,613753,3.0929826878056135
PE/CA-PJ34 (clone C12),selumetinib-GDC-0941 (4-1 mol-mol),0.7203053018358525
RERF-LC-Ad1,107970,2.434538597740863
NCI-H1395,409805,5.969168563416671
JIMT-1,24753719,5.242052344798916
RPMI-7951,44185566,2.293538209282658
NCI-H1395,11317348,4.623534055604914
OAW28,46199207,3.397949359639469
ESS-1,10231331,5.566440371270769
H-STS,439501,-3.713409181758543
IST-Mes1,135398516,1.9830137838908624
CA46,7251185,0.9564015595877396
NCI-H2081,vorinostat-navitoclax (4-1 mol-mol),0.2731238832512092
NCO2,11640390,2.877866680216141
HEC-151,135423438,1.588330635557561
SK-LMS-1,16736978,2.241037962984953
Raji,11455910,3.338513112420112
D283 Med,444795,-3.2845998018022775
HSC-4,2949965,3.8536489984175097
RERF-LC-A1,9927531,4.243256542635893
NCI-H1395,11178236,-3.24243996776791
SNU-1214,11455910,3.3877834337363124
NCI-N87,JQ-1-navitoclax (2-1 mol-mol),0.0624511044953225
LNCaP clone FGC,753704,4.7408710893467525
SNU-308,9444,4.413415053457932
TE-15,44632017,0.1469612223098825
NCI-H1395,selumetinib-PLX-4032 (8-1 mol-mol),5.142160466217897
TE-15,6852167,2.5993041449635794
BT 328,11626560,2.3893583978213617
TE 617.T,5311037,3.706459212786118
KMRC-2,navitoclax-PLX-4032 (1-1 mol-mol),2.3753142298233576
NCO2,8515,2.809674810948928
OE21,3385,1.6130767225067393
NCI-H1395,31703,-0.5933376727422321
PaTu 8988s,44566777,2.3336781645980573
BT 504,11612883,2.4726052301960273
NCI-H2081,135875424,3.067653141346589
KMRC-2,9952709,4.468026604525415
TE-15,445643,3.9755663234454
A4/Fukuda,6918878,-0.3411937140873722
KMBC-2,1716436,2.8982733087308095
EJM,2858523,3.0050440424582554
KP-4,4378219,5.374060110087321
SNU-308,selumetinib-GDC-0941 (4-1 mol-mol),1.3521020528190912
KMRC-2,8515,5.486198436058084
BT 330,sirolimus-bortezomib (250-1 mol-mol),0.7092263662862476
Aska-SS,11625818,3.428731184802555
HMCB,123631,3.130302719689839
NCI-H2110,10074640,3.26088943592308
AU565,11977753,-1.5018138963846497
KYSE-410,5284329,3.558631935754952
SNU-1214,ISOX-bortezomib (250-1 mol-mol),-0.0324388048428389
KYSE-410,60700,0.1592027393358413
A4/Fukuda,67156097,-3.3575882698535526
TE 617.T,46901937,3.882810689943171
SEM,44566777,-0.7801941037699254
PE/CA-PJ34 (clone C12),4578,4.231677990703362
OAW42,10184653,1.9449987359914496
SEM,262093,0.379936046646312
YH-13,51039095,2.0739005868490983
NCI-H2081,selumetinib-UNC0638 (4-1 mol-mol),2.5188590507358177
KMRC-2,9911830,1.0904583461694266
HARA [Human squamous cell lung carcinoma],219104,4.732621852676119
BT 330,71466578,4.426885768144453
HCC2218,216239,1.3361151410076062
BT 330,36314,3.842656257622534
Ku812,JQ-1-vorinostat (2-1 mol-mol),-1.169942743430711
RERF-LC-Ad2,23582824,1.2595931522328652
BT 320,selumetinib-PLX-4032 (8-1 mol-mol),4.7621521702079175
SNU-1033,19582717,3.722098743560197
NCO2,selumetinib-piperlongumine (8-1 mol-mol),0.1203084501494281
HCC2218,16038120,1.660255245191623
NCI-H1092,9936388,1.337118908669493
HuT 78,3025986,-0.0982635511462348
RPMI-7951,26596,-1.730558618097036
NCI-H2081,135411,-0.7766989256852646
SNU-1214,12001922,1.6320434938041075
Raji,5284616,-3.4327724662437853
SW1990,44185566,2.9867132370015037
RERF-LC-Ad2,2729026,3.074324067766426
Kasumi-2,54649381,3.5158481033233593
HEC-151,72193861,1.157153344552763
BT 330,piperlongumine-MST-312 (1-1 mol-mol),1.6726335041341065
TE-15,451668,4.643080759774818
JIMT-1,23635314,-1.4785878110109518
HEC-151,71466578,3.9461658446284753
CML-T1,tanespimycin-gemcitabine (1-1 mol-mol),-3.893519256585349
LoVo,11396600,2.965288622606591
NCI-N87,3503,2.784967297602414
NCI-H2110,11427553,2.892862784296617
WM983B,31703,0.0742837904776236
BFTC-909,24951314,2.3445794180209565
TE 617.T,11955716,-2.720710291099432
TE-15,9935249,2.05768814929574
KYSE-410,5566,3.1176802766209772
LNCaP clone FGC,107970,2.7706506032666067
NCI-H1395,11640390,4.861591383833504
SET-2,135398738,4.079297463223511
AN3-CA,1716436,2.9241172946515963
OAW28,135928012,4.847644989583831
PE/CA-PJ49,44589607,2.270791693100932
Ku812,15953870,2.600365830737877
OAW28,44566777,2.367961844085161
SK-N-AS,6918638,-0.3067046964839828
SEM,72734382,1.9390760938253868
BFTC-909,984333,1.0937084793466407
RERF-LC-A1,445643,3.795739377078709
OAW28,selumetinib-navitoclax (8-1 mol-mol),1.984152872487984
SKM-1,selumetinib-PLX-4032 (8-1 mol-mol),-3.711046707808481
YH-13,5351362,2.4271787200041066
HMCB,1566236,1.7394312384979265
KMBC-2,46926350,-3.492426009474656
HARA [Human squamous cell lung carcinoma],72376,-2.3262904878865083
ML-1 [Human thyroid carcinoma],2708,2.4589573831191633
D283 Med,9936388,-6.8022099816120605
BT 139,2949965,2.7755159833580554
OAW42,10385095,1.3430576612490104
Kasumi-2,675434,3.537694279705698
AU565,168312962,1.8906319972872971
HuT 78,65628,5.4520261644264165
SEM,54649381,3.0580730250658283
NCI-H1092,568763,-0.3741146279376747
NCI-H1395,44819697,2.3149017923532607
BT 320,25150857,3.33324545252111
BT 330,46174525,4.328901662443132
KMBC-2,11238147,3.862409359846617
KP-4,445091,3.9007514105638186
HSC-4,11234052,4.4583786214563865
NCI-H1092,11404337,-0.107357005094737
CA46,3465537,3.345448990020783
H-STS,selumetinib-BRD-A02303741 (4-1 mol-mol),5.187355615985605
RERF-LC-A1,54649381,3.742824120436759
HARA [Human squamous cell lung carcinoma],15547703,3.5023955614710633
SW1573,53495165,2.229023421141798
AU565,3136844,3.8072298284959385
BT 330,44632017,3.9619858214951726
Ku812,135984461,1.927355885078453
BT 330,4521392,4.71297125211208
BT 248,16736978,2.1942612442020484
KYSE-70,10074640,3.109810551584267
LCLC-103H,navitoclax-piperlongumine (1-1 mol-mol),2.283715788771616
LoVo,135875424,3.182508442374063
OAW28,44491742,4.754653012158477
HEC-151,11717001,4.773206045150148
OAW28,3634881,3.2370607224140473
NCI-H2172,409805,5.805224348451236
KMS-20,5329102,1.4165548971793418
MCAS,1716436,3.309095084683311
Kasumi-2,1641662,2.7685254402742183
SW1990,135411,0.6325357507232034
ML-1 [Human thyroid carcinoma],107985,-3.3059977696559204
SNU-1214,984333,-0.2882399666487046
LCLC-103H,6914657,-3.562706144669992
PE/CA-PJ49,5287969,-2.1626090287701114
SEM,24901704,-0.5071793762146407
HuT 78,122327,5.365599791501648
NCO2,selumetinib-decitabine (4-1 mol-mol),-2.697615497657135
HMCB,3634881,3.192903309408832
BT 330,123631,2.474720312975102
BT 330,9868037,3.503197969188101
KYSE-70,piperlongumine-MST-312 (1-1 mol-mol),2.4573232964304506
SNU-308,44185566,2.4594712559167204
RERF-LC-Ad2,135398738,6.149274102093841
YKG-1,7251185,2.916667385040177
NCI-H2081,1641662,3.083642159017046
OAW28,12001922,1.8847589611064504
ESS-1,54678924,1.5705216909139783
Aska-SS,135875424,5.860449274469886
BT 320,11364421,3.2966905188906717
NCI-N87,selumetinib-BRD-A02303741 (4-1 mol-mol),3.924319992587928
SK-N-AS,52947716,2.988552784346086
H-STS,107970,1.855553720240211
YKG-1,4261,2.958862922267848
NCI-H2081,23635314,-3.63845546552979
RERF-LC-Ad2,241158,4.786001291187356
NCI-H2081,119607,5.212257732916615
MCAS,3634881,3.1690679925110357
AU565,11964036,0.1505437081667179
EJM,71466380,4.304951400979373
EJM,11609586,2.8527211576187925
SNU-1033,969516,2.8339819827255326
BT 248,24978538,0.997787879795877
YKG-1,vorinostat-carboplatin (1-1 mol-mol),4.05575271660812
A4/Fukuda,tretinoin-navitoclax (4-1 mol-mol),2.572216751068698
BT 328,168312962,4.074485851514308
PaTu 8988s,17755052,-0.2693936600995607
SK-MEL-1,11222830,1.181093495483479
SW1990,374536,2.916783298582251
AN3-CA,11222830,1.3124942675480578
NCI-H2110,11719255,4.204925011456819
MCAS,11717001,2.616335887582357
SNU-1033,6852167,3.058956873768391
LCLC-103H,crizotinib-PLX-4032 (2-1 mol-mol),2.3424806360589625
AN3-CA,1750826,-1.203263132000608
LNCaP clone FGC,89928392,1.3426249945041528
TE 617.T,24964624,3.0326403472888988
HuT 78,45279963,3.999861167525814
KMS-27,6623618,2.322817398104662
PE/CA-PJ34 (clone C12),675434,4.380294227135041
HARA [Human squamous cell lung carcinoma],11228183,1.9492387662676105
SEM,tanespimycin-bortezomib (250-1 mol-mol),-2.121594680168012
SK-LMS-1,675434,4.534585488298608
PE/CA-PJ34 (clone C12),5426,4.4355205896905225
RERF-LC-Ad2,262093,2.9385372389092197
GOS-3,16736978,3.431687375441577
KMS-20,148198,-4.371887061655697
BFTC-909,54619267,3.991913685478571
TE-15,4705,1.329912019407035
NU-DHL-1,5287969,-2.616412522743469
SK-LMS-1,2749,1.6237086623457104
SEM,6918736,-2.5690877985953566
GOS-3,selumetinib-vorinostat (8-1 mol-mol),4.505292657728925
IST-Mes1,JQ-1-UNC0638 (2-1 mol-mol),0.9628638270224468
MM1.S,carboplatin-etoposide (40-17 mol-mol),0.4992373169000672
IST-Mes1,36462,4.9786696220654845
NCI-H1395,piperlongumine-MST-312 (1-1 mol-mol),1.204552153931692
MCAS,56963564,0.4121061980618511
PE/CA-PJ34 (clone C12),219104,4.13429787847428
NCI-H2110,4705,2.9559067422385494
SNU-1272,452548,2.9795464172377923
SKM-1,72376,-5.080407432720659
OAW28,11625818,4.459236282412159
HEC-151,navitoclax-pluripotin (1-1 mol-mol),-0.5891321923863233
NU-DHL-1,11640390,3.61397071522667
OE21,5311281,1.796992451946629
Kasumi-2,613753,2.4327594137588235
KMBC-2,72193861,3.090412546181339
BFTC-909,6918736,-1.9066217610366931
KMS-20,11152667,-1.0661904813825076
SK-MEL-1,123631,2.331202925626899
SNU-1272,11178236,-2.3936924408182265
GOS-3,71751553,4.284016393111424
NCI-H2081,67291369,3.286816150820097
NCI-H2081,2708,2.8987838262857264
KMS-20,11485656,2.050412836201762
HCC2218,613753,1.639284692925763
SNU-8,208908,3.1333693959692033
CA46,4261,-0.8863355705331979
Hs 683,1242560,3.640721837691029
D283 Med,54678924,1.845714700786355
NCO2,20959075,-3.882859537837438
WM983B,439501,-2.1469095584384608
LCLC-103H,72376,-1.8791119747944676
MCAS,3384730,1.4801567541736018
CA46,156414,1.2808873732328336
YH-13,676352,1.7621508381493205
SET-2,445455,4.086945585806047
PE/CA-PJ49,11152667,-0.7755260151132314
SNU-1272,71466445,5.534293199033029
ML-1 [Human thyroid carcinoma],54619267,4.278122085164484
KMS-20,crizotinib-PLX-4032 (2-1 mol-mol),1.622375633570859
BT 504,327653,3.327628019841459
NCI-H2110,11977753,-0.363959983784443
NU-DHL-1,selumetinib-PLX-4032 (8-1 mol-mol),3.261247948908544
SK-LMS-1,285033,-0.1351823927020098
NCI-H2081,135421197,1.057518505455496
A4/Fukuda,56649450,0.8497740308893211
SET-2,46191454,2.4902419082362677
SNU-8,135984461,1.5881449503105405
OE21,3503,1.8943716488769395
EJM,11955716,-2.8070580374393073
LNCaP clone FGC,31703,-2.79397639751077
CA46,42642645,0.1424242949920916
CML-T1,16038120,0.5708889366464743
OAW42,doxorubicin-navitoclax (2-1 mol-mol),0.0056958918584985
RERF-LC-A1,66577038,3.784227034929813
Hs 683,50905018,4.377501260447325
RPMI-7951,2841722,4.243352466432455
OAW28,71466380,4.3449274646859495
NU-DHL-1,11152667,-2.1433741052472493
PE/CA-PJ49,24748573,1.2565986822042992
NCI-N87,72193870,2.948099148236623
LCLC-103H,alisertib-navitoclax (2-1 mol-mol),3.34324855950724
SET-2,24821094,2.79989362054305
SKM-1,100016,4.336407790429152
BT 139,262093,2.8481987129285256
HARA [Human squamous cell lung carcinoma],5287620,-1.762699468398793
BFTC-909,49850262,4.237463012213885
Hep-G2,24901704,2.3159858819340817
SNU-1272,400769,-0.1796926060476786
WM983B,24856436,-0.0265731359121475
HSC-4,5479543,4.052409111099337
RERF-LC-A1,20959075,-3.5172156955146616
YH-13,doxorubicin-navitoclax (2-1 mol-mol),-1.2809581142975497
OAW28,54649381,3.786658613217657
BT 248,doxorubicin-navitoclax (2-1 mol-mol),-1.9120530478094175
PE/CA-PJ34 (clone C12),11234052,4.957821880358116
KMS-20,151289,1.001427412715124
SK-N-AS,5281672,4.4239035086612395
NCI-H1395,119182,1.588983658397695
OAW42,salermide-PLX-4032 (12-1 mol-mol),5.364246156559443
SK-LMS-1,46215462,2.820393358220259
JIMT-1,10302451,2.8331671466366957
HSC-4,5287620,-1.917371788332746
BFTC-909,126941,-2.0975077483758415
MM1.S,24856436,-0.1487659765377816
AN3-CA,46926350,-5.100633637937967
SET-2,72734382,2.7143918769890543
IST-Mes1,vorinostat-navitoclax (4-1 mol-mol),2.4210379040593972
YH-13,JQ-1-carboplatin (1-1 mol-mol),2.725669158848688
Kasumi-2,24771867,-3.1023362721742607
GOS-3,3503,2.7215232573825605
Raji,46224516,3.459730704149693
LoVo,5287620,-2.196691557023958
NCI-H2081,selumetinib-PLX-4032 (8-1 mol-mol),4.306569856872656
LNCaP clone FGC,448949,1.9163701600156855
Kasumi-2,445091,5.553993217061133
SNU-1214,46199207,2.239067133840438
JIMT-1,selumetinib-piperlongumine (8-1 mol-mol),4.727586377395606
HMCB,135999136,1.9344485879492248
RERF-LC-Ad1,10184653,2.5913648583184905
H-STS,decitabine-navitoclax (2-1 mol-mol),1.503430207514452
Hep-G2,docetaxel-tanespimycin (2-1 mol-mol),-1.6535454004195396
YKG-1,5282054,4.677565101895448
AN3-CA,262093,3.1058426937478036
NCI-H2110,4521392,4.271379132375328
SK-LMS-1,241158,4.676834411951693
D283 Med,6918638,-2.490498776882626
CA46,5311,-0.1889513685103653
PE/CA-PJ34 (clone C12),123631,-0.1749534582660772
OAW42,16013152,3.77909219849116
YH-13,8515,4.054803825976401
HMCB,10074640,3.711732352742634
KMBC-2,135421197,1.90199423292403
A4/Fukuda,25126798,3.529395374343333
YH-13,6918638,0.7209706519949683
MCAS,44489675,3.667641612730395
A4/Fukuda,11507802,0.3746235533355334
OE21,53232,2.5328108907893734
YH-13,16736978,1.9226883316273975
NCI-H1395,57519531,3.1803418993490715
AN3-CA,2828334,6.144729082437511
PaTu 8988s,448949,1.7496601969177892
SW1573,54454,1.176648172779268
BT 320,navitoclax-piperlongumine (1-1 mol-mol),3.22781533773438
PE/CA-PJ49,65064,5.397337839278479
BFTC-909,24978538,2.589526114093726
LNCaP clone FGC,24856436,-0.0092886398073457
ML-1 [Human thyroid carcinoma],9927531,5.643924198323062
H-STS,1750826,-4.772155717820538
Kasumi-2,176870,2.2683953361762166
IST-Mes1,11175137,3.00105789094782
HuT 78,67291369,-1.2460432819903486
Kasumi-2,71304818,2.3604520648914136
KYSE-410,44589607,3.0538156762263435
Hs 683,25150857,1.0448555959679475
KP-4,5566,3.0849581277118157
KMS-20,4788,3.707173211304455
NCI-H1395,9926054,1.836702615994444
ML-1 [Human thyroid carcinoma],24180125,2.9342502769836263
MCAS,11152667,-0.1014639738878534
NCO2,16722836,0.0579621950117729
TE 617.T,11625818,4.430228460646322
HEC-151,969516,2.437486238076301
WM983B,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.6718503574539278
HMCB,89928392,1.1617926857836482
Hs 683,vorinostat-navitoclax (4-1 mol-mol),0.8152340271221348
HEC-151,44491742,3.809390131450424
BT 248,24772860,-1.8114686790878316
NCI-H1395,24901704,3.973165668688871
TE 617.T,54618305,4.435147460279245
SNU-308,tanespimycin-bortezomib (250-1 mol-mol),-1.0172716653448413
MM1.S,2113511,3.813209914161712
WM983B,selumetinib-navitoclax (8-1 mol-mol),-2.384983739080848
NCI-H2110,135928012,4.809338380726518
NCI-H2110,49793307,-2.5859284275056114
PE/CA-PJ34 (clone C12),56946209,-4.043732138060434
CA46,148198,-5.7845042531785
Kasumi-2,9926054,1.3771704127752784
ESS-1,219104,3.183003735039725
ESS-1,6610355,4.793916265981142
SW1990,136227924,4.2742525725591864
ESS-1,16736978,2.6908591982967645
SW1573,46398810,3.5765453048302933
BT 330,4259181,0.5985885076364172
YKG-1,1716436,3.7130114389790982
SK-MEL-1,4477,-0.4887370671356128
SKM-1,374536,2.026505336627946
KMRC-2,66577038,2.988810152223179
AU565,salermide-PLX-4032 (12-1 mol-mol),3.909685759147712
TE 617.T,2858523,3.0924364714944192
KYSE-410,selumetinib-piperlongumine (8-1 mol-mol),4.297006093363548
HARA [Human squamous cell lung carcinoma],11964036,1.505983259630614
SK-N-AS,6918328,0.149425114056405
HARA [Human squamous cell lung carcinoma],6917907,-4.425737266076785
NCI-H2081,73707438,4.181676139303675
D283 Med,16659841,2.7868909453303337
OAW28,6852167,2.294169410796982
ESS-1,23725625,4.356874799520387
SKM-1,54143018,-1.6863423462272775
SET-2,448949,1.065059148438568
SK-N-AS,24772860,-2.9182773308806644
YKG-1,5738263,3.956639283215739
RPMI-7951,tanespimycin-gemcitabine (1-1 mol-mol),-4.333052092080868
SK-LMS-1,2113511,5.626213244355371
OAW28,15983966,1.5707780698474574
CA46,24901704,2.114836921018661
RPMI-7951,10184653,1.226360085792303
Hs 683,262093,3.4514070525670295
HuT 78,sirolimus-bortezomib (250-1 mol-mol),-0.0760803060705267
IST-Mes1,5311281,1.4883568311904505
HCC2218,navitoclax-sorafenib (1-1 mol-mol),1.2983575402034089
SET-2,969516,2.6708400521609788
NCI-H1395,selumetinib-GDC-0941 (4-1 mol-mol),2.3368578075304463
A4/Fukuda,89928392,-0.3543848103605003
Hs 683,10322450,2.9588176453624766
BFTC-909,4259181,-0.0277162117211437
Hep-G2,46191454,0.5545112986492189
OAW42,24951314,2.416381431715157
Hs 683,9933475,1.6882466578728266
YKG-1,docetaxel-tanespimycin (2-1 mol-mol),-4.349420995381951
AU565,6505803,-0.7592801042803803
OE21,46926350,-5.252070355990055
Hs 683,9866186,1.1103968225648688
D283 Med,67291369,-1.3976379586601873
SEM,5394,4.006285802204493
Ku812,67291369,1.446502731333229
RERF-LC-A1,6918736,-1.6667385291970562
BT 504,446155,4.2665574261289745
HEC-151,25126798,3.8095237719017048
KMS-27,alisertib-navitoclax (2-1 mol-mol),-3.3119680885741314
IST-Mes1,doxorubicin-navitoclax (2-1 mol-mol),-0.5203692654605504
KMS-20,6450551,1.8183077034001904
YH-13,selumetinib-decitabine (4-1 mol-mol),4.949176752890973
LCLC-103H,148198,-1.3742012361346914
SEM,docetaxel-tanespimycin (2-1 mol-mol),-4.77446001640726
AN3-CA,4259181,-0.2663396960548074
KMRC-2,44185566,2.9985969521540805
PE/CA-PJ49,6852167,2.2001528743044094
OAW42,44486219,4.403545257864686
SNU-1214,9926054,3.9057313084396656
EJM,sirolimus-bortezomib (250-1 mol-mol),0.0278018018083393
SW1990,10127622,2.690812065092725
OE21,24821094,-1.6479639852881638
Ku812,6505803,-1.520866948509506
AN3-CA,49793307,-2.78420396185601
PaTu 8988s,5287620,-2.2711432055313874
RERF-LC-A1,44632017,1.017781023879169
HMCB,148198,-4.3449695976370055
BT 248,285033,1.6288115150650024
HMCB,135411,0.3409472589453896
Hs 683,3136844,4.024059328221529
OAW28,5280436,5.165372214799318
KMBC-2,3543504,4.210942018618952
MM1.S,2749,2.045600082739513
BT 330,25126798,4.221457017188824
AU565,49766530,1.448288738772077
RERF-LC-A1,25126798,3.9092544824799713
PaTu 8988s,ISOX-bortezomib (250-1 mol-mol),0.2755393634191515
A4/Fukuda,71680916,4.641498651595925
OE21,56946209,-6.583786952065454
HEC-151,9840324,5.659644401752755
RPMI-7951,9911463,4.017661136446782
PaTu 8988s,carboplatin-etoposide (40-17 mol-mol),4.348077475366244
SKM-1,637858,0.6023395164344832
SK-N-AS,JQ-1-vorinostat (2-1 mol-mol),0.3883104058783083
HARA [Human squamous cell lung carcinoma],6450551,1.1333007709837388
JIMT-1,12003241,-0.563362100663344
A4/Fukuda,54618771,0.259551202975953
KP-4,9826308,0.2172163721214547
SNU-308,ISOX-bortezomib (250-1 mol-mol),0.4354606210952242
A4/Fukuda,25105715,3.290295740743095
CML-T1,tretinoin-navitoclax (4-1 mol-mol),0.9331911225781374
SK-N-AS,72376,-2.1190609581260196
RPMI-7951,156414,1.6471654307541064
SET-2,135411,-1.5084865108910783
D283 Med,445455,1.4902396217257328
BT 330,23582824,1.1075472955671075
SEM,6184667,1.572697662015749
RPMI-7951,71304818,2.808506833737362
HuT 78,11964036,-0.1137295311814781
AN3-CA,6852167,1.7401945713297349
Hs 683,216345,3.130540481909432
SK-LMS-1,5287969,-1.7845602058689602
BT 248,5280436,3.4551701194558935
PE/CA-PJ34 (clone C12),24771867,1.6845259930692984
KMBC-2,1566236,2.626882312986064
RERF-LC-Ad1,doxorubicin-navitoclax (2-1 mol-mol),0.6040282925735914
LCLC-103H,24951314,1.7436429589603968
Hep-G2,6917907,5.1054062498915025
SNU-8,25183872,-1.2856044424153128
TE-15,675434,4.749290653711745
TE 617.T,72376,-3.1403158194387175
BT 320,25183872,-0.2453721787274933
WM983B,44137675,3.997585569822008
MM1.S,tretinoin-navitoclax (4-1 mol-mol),4.414459370094276
RERF-LC-Ad2,2708,5.54880563564346
HCC2218,9444,3.687872411544604
PE/CA-PJ34 (clone C12),25161177,5.151345189753289
NCO2,10385095,0.8572094806219551
RERF-LC-Ad2,675434,4.722753673129772
KMRC-2,9907093,4.749987652272065
RPMI-7951,11647372,-0.0231097705626451
BT 330,25105715,3.681400132695821
SNU-1214,11234052,4.291999723646573
KMRC-2,89928392,1.7780290135771808
RPMI-7951,15547703,1.8715095189683175
KP-4,3025944,4.776864859188652
SNU-1033,375860,2.3566426851273063
SET-2,50905018,4.146383712792895
KMBC-2,11626560,2.4975919030328155
RERF-LC-A1,24772860,-2.54974532107594
SK-N-AS,9936388,-8.947501416398147
WM983B,54596558,4.116293812728796
HEC-151,9967941,3.6318712214056705
BT 328,11955716,-1.056274858719932
OAW28,JQ-1-vorinostat (2-1 mol-mol),0.5545971801402327
NCI-H2081,5351362,0.7138229961516296
RPMI-7951,135984461,1.8350083594586524
HSC-4,46191454,1.405754738797376
HuT 78,400769,-0.7325888332601455
BT 248,148198,-3.920391313180545
SW1990,11494412,3.8548639457314184
KMS-20,docetaxel-tanespimycin (2-1 mol-mol),-5.71277411020647
RERF-LC-Ad1,6918837,-0.1903099145343919
MM1.S,11222830,1.7404282204181818
OAW28,44607530,1.1070032957823266
NCI-H1092,374536,2.5568939719400707
EJM,vorinostat-carboplatin (1-1 mol-mol),2.441111900525166
ESS-1,9936388,3.356877818481439
Kasumi-2,42642645,-0.9002721123779656
HSC-4,135398516,2.2759469773851224
RERF-LC-Ad2,sirolimus-bortezomib (250-1 mol-mol),2.075251911083675
TE-15,11364421,-6.1192537543756576
SKM-1,10296883,3.074274434558128
Ku812,262093,1.3423418533813145
RERF-LC-A1,49850262,4.321710930976986
NCI-H1395,5328940,2.584315328897391
ML-1 [Human thyroid carcinoma],3676137,5.53606210778591
YH-13,11494412,0.8602319711686647
ESS-1,24856436,-0.1726658691519087
SK-LMS-1,24821094,3.80492364683607
BT 504,54619267,3.8113570299406136
KYSE-410,16038120,0.9720900860952146
NCI-H2172,55283,3.100636399415034
SNU-1214,387447,-4.544627243417016
HARA [Human squamous cell lung carcinoma],9952709,3.695976506837269
Raji,46398810,2.4304525112151074
SEM,5479543,1.9736510753778953
SK-MEL-1,11152667,1.128621157478479
PaTu 8988s,409805,3.706044847536148
D283 Med,navitoclax-MST-312 (1-1 mol-mol),0.7013282040570831
NCI-H2081,72734382,3.7264145222957
OAW28,24797083,1.7501511491860735
LNCaP clone FGC,44543605,4.499692025996323
SW1990,2708,4.958099509571108
KYSE-70,3689413,0.9447440025313596
BT 139,2842253,7.121896255124089
AU565,5311,0.7700744364318666
BT 139,16038120,1.5236761382209176
Ku812,71680916,4.360628354999314
SNU-1272,4259181,2.0481969958420683
MM1.S,10427712,3.559662100834844
Aska-SS,16065773,3.860549946793715
Kasumi-2,10127622,5.115736544584973
BT 139,6450551,2.676401003884647
KYSE-410,salermide-PLX-4032 (12-1 mol-mol),5.1075765861504
CML-T1,12001922,1.44047939392769
LoVo,11214940,1.900565531770479
SKM-1,126941,-2.265408392302096
AU565,9887053,5.902090445564702
WM983B,676352,1.7617404668534022
TE-15,56646779,4.168404632635053
SNU-1214,36314,0.8573482666662119
KYSE-410,11396600,3.754375595740645
KMRC-2,3136844,4.810057568138529
BT 320,89928392,3.842726131224359
RERF-LC-Ad2,374536,3.127585092037682
HEC-151,9907093,4.173038055291299
KMBC-2,45279963,3.9581668191157706
SET-2,3025944,3.2400035641971514
Kasumi-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.6309006264211411
SKM-1,JQ-1-navitoclax (2-1 mol-mol),-0.3773904973177986
KYSE-70,71466445,4.079477869375345
CML-T1,638278,3.0153915179905098
KYSE-70,11625818,4.1356453826336965
Raji,9825149,2.621015556442004
BT 330,637858,2.906999129152924
HARA [Human squamous cell lung carcinoma],23635314,-1.642514653884031
BT 504,426756,5.401070091180918
OAW28,5311281,1.8509970799423736
A4/Fukuda,2945648,2.3216808345706035
SW1573,3543504,3.864321270652805
OAW28,68056272,3.642995313586114
KP-4,11625818,5.13819427873932
OAW42,11977753,0.6333554572255577
NCI-H2110,5280436,2.8304700563547014
SNU-8,44486219,6.2061810000984465
SNU-308,1750826,-0.3400503245695513
LNCaP clone FGC,9926054,1.750086860049474
CML-T1,25262965,-1.9815055926190612
BT 139,3038522,2.270920869321994
NCI-H2081,11178236,-4.898241631670769
CA46,71751553,4.222934016329145
NCI-H2110,67291369,3.7100617261641826
SET-2,3465537,3.762273356710905
HuT 78,44491742,3.833204810123411
RPMI-7951,3689413,-1.832371720912868
OAW42,36462,2.75457574041248
BT 328,doxorubicin-navitoclax (2-1 mol-mol),-0.3035540353070404
RERF-LC-A1,15547703,3.300362780129702
LCLC-103H,3503,2.9910654808261614
HEC-151,46224516,3.6184851885623592
KMS-20,10427712,4.433037209532288
RERF-LC-A1,9549297,4.257530324921654
BT 328,11404337,1.5843001055688009
LoVo,135411,-0.4629764704945864
KMS-20,54649381,1.58560475565201
GOS-3,2871966,0.5648988653696159
HSC-4,637858,2.398043952194309
BT 139,676352,1.9837722344026232
SNU-8,60700,1.740675186077755
NCI-H2110,156422,4.257541093107017
NCI-H2081,crizotinib-PLX-4032 (2-1 mol-mol),0.7820959087513495
BT 330,3552672,1.5304127335233928
PE/CA-PJ49,9956119,3.948810633072343
ML-1 [Human thyroid carcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.412069402111766
KMBC-2,24951314,1.4260955032902127
SET-2,5287969,-2.330112107554474
SNU-308,4261,2.7469296008750845
SEM,54618795,1.733111871979466
KMS-20,54618305,3.8048007259852543
Hs 683,25105715,3.2975436946067407
HSC-4,4261,2.7283942469645424
AN3-CA,vorinostat-carboplatin (1-1 mol-mol),3.9446751303054097
HuT 78,piperlongumine-MST-312 (1-1 mol-mol),0.3660386442956273
Hep-G2,SNX-2112-bortezomib (250-1 mol-mol),-2.874949452723731
JIMT-1,20959075,-2.913205598183445
EJM,23582824,0.4180774571431987
SK-N-AS,135398516,2.2311808624841993
SNU-1272,5278396,3.8944923273965113
OE21,71466578,4.389757659452917
CA46,53495165,-3.0280125025934495
SNU-308,216239,3.170566655617644
LNCaP clone FGC,JQ-1-MK-0752 (1-1 mol-mol),-0.0461588421219478
BFTC-909,44493528,4.370300807083883
HSC-4,25183872,-0.8460464512297751
HMCB,6505803,-1.40903466994972
LoVo,71466380,3.017013363980257
RERF-LC-Ad1,2858523,3.2226795457282735
AN3-CA,46901937,3.742113645268159
Raji,216345,3.9745931055166257
KMS-27,17759555,3.6183556062757263
HSC-4,4521392,4.744801099229743
Ku812,10302451,-2.0253572962014617
BT 504,23635314,-1.703100531873441
ESS-1,19582717,4.154053780498712
ML-1 [Human thyroid carcinoma],11364421,-5.159158552339723
Kasumi-2,25227462,-2.512802493882235
KMS-20,2733526,2.652352860912795
PE/CA-PJ49,6505803,-1.5018082269654205
D283 Med,72734382,2.7546451144628756
EJM,285033,-3.245893351127227
OAW28,72376,-0.5739552302850919
SNU-8,1716436,3.464795989893741
KMS-20,637858,0.4496747428654858
YH-13,24772860,-1.8932225377928673
SNU-1033,JQ-1-navitoclax (2-1 mol-mol),0.4519309992600058
OAW28,71304818,3.062868675930112
BT 320,10410894,4.180150860885228
OAW28,49766530,-0.5315014966120291
NCI-H1092,73707398,1.109051456829637
KMRC-2,selumetinib-piperlongumine (8-1 mol-mol),3.7705043206304496
SNU-1214,11497983,4.859477926792302
D283 Med,54619267,3.614000477543864
OAW28,135999136,1.5944266420299655
RERF-LC-A1,sirolimus-bortezomib (250-1 mol-mol),0.1484412834683056
NCI-H1395,44486219,4.094426397743146
NU-DHL-1,451668,-1.5883202608860565
Ku812,54618771,-0.0049031848150657
KMRC-2,11175137,2.6874128471774865
TE-15,16725315,3.528829604172264
MCAS,49850262,3.7303738254171046
SKM-1,36314,2.437591695433872
AN3-CA,16659841,1.6671523013965392
A4/Fukuda,11228183,1.827405863351363
SNU-8,tretinoin-navitoclax (4-1 mol-mol),4.661127606592348
CML-T1,5291,-1.725219795873105
BT 139,439501,-2.1565169223075062
HMCB,11609586,3.5550453810468094
D283 Med,1239801,3.514118708957111
SNU-1214,JQ-1-carboplatin (1-1 mol-mol),3.0225618728899675
RPMI-7951,984333,0.6667231329572814
KMS-27,444795,4.486378633657878
Aska-SS,11238147,2.181555993543122
RERF-LC-Ad2,1750826,-3.0175803273525004
Hep-G2,60700,1.3225339846103372
KP-4,5287620,-1.8879437684025624
SK-MEL-1,156414,2.027107668574744
BT 504,24180125,2.722819243904145
OAW42,60700,-0.9744011007995004
OAW28,9911830,2.567685352724645
BT 248,72199292,1.1105829108074048
HCC2218,3025944,4.040560692551885
LoVo,selumetinib-UNC0638 (4-1 mol-mol),1.1151231376311057
NCI-H2110,135398738,4.827884640911211
WM983B,24180719,-0.3073697815298015
SKM-1,2858523,3.0530773935068836
Kasumi-2,JQ-1-UNC0638 (2-1 mol-mol),-0.8323708292538591
PaTu 8988s,25195348,4.4301827617344
RPMI-7951,3503,3.303373344392616
BT 504,11257553,3.701533851501363
NCI-N87,navitoclax-pluripotin (1-1 mol-mol),-2.6023370603895337
YH-13,9911463,4.412003433189975
Ku812,selumetinib-MK-2206 (8-1 mol-mol),-1.6716664417855296
BT 504,9803433,4.404552176959332
HMCB,JQ-1-carboplatin (1-1 mol-mol),2.516859123575671
SW1990,71751553,4.1573307972574485
SET-2,5311,-0.0842412480168777
HEC-151,54686904,4.134628252363428
A4/Fukuda,15953870,2.701018205920996
NCI-H2081,11626560,1.2362543076571495
BT 328,2858523,3.1475044170181996
PaTu 8988s,44819697,0.2776197966694109
SEM,10074640,2.905756912957373
BFTC-909,26596,-1.7437210940555867
KP-4,11175137,3.1941644849091024
SNU-8,4096211,2.394279422586692
SK-MEL-1,107970,2.4240588929392715
Hs 683,448949,1.593482361717585
NCO2,400769,-1.4333992099130242
KMBC-2,6918837,-1.8660869153498012
TE 617.T,126941,-4.418116621588743
PaTu 8988s,15547703,3.1329587275782935
NCO2,9868037,0.9893364674462136
BT 139,441298,3.6889162663460406
SW1990,navitoclax-sorafenib (1-1 mol-mol),2.681169669736164
Aska-SS,selumetinib-GDC-0941 (4-1 mol-mol),-0.3966051454003071
NCO2,44241473,4.08733028399539
WM983B,16720766,0.3932392842737714
KMS-27,44202524,0.9115909799659608
Hs 683,637858,2.5544628931589166
ML-1 [Human thyroid carcinoma],5287620,-1.9113881956575816
HMCB,6918328,1.0614857704066594
ESS-1,3025986,-1.587368137911761
SEM,7326481,2.7655671912091933
NCI-H2110,selumetinib-decitabine (4-1 mol-mol),5.0796744346099345
KP-4,1285940,4.496309170142005
NCI-H2081,5278396,2.9598770747140435
RERF-LC-Ad1,carboplatin-UNC0638 (2-1 mol-mol),3.9915096293079912
NCI-H1395,448949,2.6579762505133915
HEC-151,25183872,-1.059402099425215
SNU-1272,selumetinib-MK-2206 (8-1 mol-mol),4.6345162541062495
HuT 78,49793307,-3.123496799876953
NCI-H2081,4917,1.6033986047844857
NU-DHL-1,439501,-3.591448694271343
SNU-1033,9825149,1.4317957372190675
KMRC-2,11647372,1.1574311998836746
Kasumi-2,navitoclax-PLX-4032 (1-1 mol-mol),-2.139769926295153
SNU-1033,216345,3.944827364524943
OAW28,11214940,1.4072727029323666
BT 139,322968,3.0519168490050377
MM1.S,ISOX-bortezomib (250-1 mol-mol),-0.3446289417675626
RERF-LC-A1,12003241,-0.839480669213789
GOS-3,45279963,4.315465934949481
RERF-LC-A1,16722836,1.9400564712078383
WM983B,6450551,3.5533890395991428
PaTu 8988s,2733526,4.194013495733503
KMS-27,docetaxel-tanespimycin (2-1 mol-mol),-5.169430287476713
SNU-308,25126798,3.9253752381206346
NCI-N87,25102847,3.5806366762623645
TE-15,2945648,2.9214028652347146
CA46,12001922,1.4868064190708767
SET-2,46199207,3.0903312204608464
NU-DHL-1,9935249,0.0276338554577939
HEC-151,168313016,4.881545929029312
H-STS,49793307,-5.0868612084063995
BT 504,9907093,4.372954080817687
BFTC-909,docetaxel-tanespimycin (2-1 mol-mol),0.450361572300305
NCI-H2110,selumetinib-vorinostat (8-1 mol-mol),2.8227636055377565
GOS-3,409805,3.6304586799066967
LNCaP clone FGC,selumetinib-GDC-0941 (4-1 mol-mol),1.7020146925511015
BT 328,6505803,-1.1568571975604598
SET-2,10127622,3.4186773553125827
LNCaP clone FGC,25195348,3.417298777907315
GOS-3,selumetinib-MK-2206 (8-1 mol-mol),3.670573645172849
OAW28,44607531,1.5392912313773788
YKG-1,11494412,2.049778246411874
CA46,60750,-0.9269398092944348
D283 Med,51037431,2.0998452060410484
GOS-3,56946209,-4.9562360028209795
PE/CA-PJ49,44491742,3.950119634705539
NCO2,654092,-3.498430696051644
HuT 78,5311,-0.4427844433748262
SW1990,selumetinib-decitabine (4-1 mol-mol),2.063456443553195
Raji,decitabine-carboplatin (1-1 mol-mol),2.814088522434008
NCI-H1395,168312962,2.594728459229535
KMS-20,135440466,0.075801610820689
SNU-1214,6610355,4.339610066840723
YH-13,73707398,1.2587835012572517
KMS-20,9903786,1.7377090782754483
MCAS,piperlongumine-MST-312 (1-1 mol-mol),1.212907637048482
PE/CA-PJ34 (clone C12),5329102,2.622202287503012
KYSE-410,3815108,3.2500534674852743
AU565,54618305,4.305835133395234
EJM,24889392,5.896592144374216
BT 248,24797083,0.3482207661961916
SNU-1214,JQ-1-MK-0752 (1-1 mol-mol),-3.5080834664420006
HMCB,54619267,4.162576667162129
SW1990,9936388,2.7870062891486613
SNU-1033,72193861,3.2223717057340493
TE 617.T,675434,4.316914924358703
SNU-308,25262965,-0.0197220188097323
OAW42,156422,4.361918049077773
KYSE-410,crizotinib-PLX-4032 (2-1 mol-mol),1.8110357932791312
GOS-3,5566,2.9543896668680287
TE 617.T,10322450,3.863383234066746
BT 248,6918837,-0.6138774965830072
BT 248,5282054,3.4340814823816324
RERF-LC-A1,docetaxel-tanespimycin (2-1 mol-mol),-5.501717383852979
HuT 78,25183872,-2.0170798191492634
Hep-G2,9926054,1.3870503906392218
TE-15,168313016,4.315144290531877
KYSE-410,72199292,2.115453552605538
SNU-8,44259,1.3502886518318586
D283 Med,serdemetan-SCH-529074 (1-1 mol-mol),1.078221364588871
D283 Med,16725315,3.6263864453470993
D283 Med,44462760,4.193275636143645
LNCaP clone FGC,46215462,1.62932026806228
OE21,25105715,3.1274779018732213
AN3-CA,56946209,-4.582764500182781
CML-T1,11427553,0.3447104584156399
SK-N-AS,navitoclax-gemcitabine (1-1 mol-mol),-4.491825639716861
NCI-N87,54686904,4.2918164398278815
HEC-151,selumetinib-vorinostat (8-1 mol-mol),2.0752491992861537
CA46,135423438,1.6657304721140649
PE/CA-PJ34 (clone C12),4917,3.437342838485429
KMS-20,448949,1.7182131870831587
NCI-H2110,25105715,3.722215242768395
RPMI-7951,3690,3.5557452100063123
SET-2,5351362,0.9152088249518402
SET-2,426756,2.384993708171705
GOS-3,65064,3.2866798747983585
PE/CA-PJ49,11719255,3.701933769080067
Hs 683,10074640,2.88569633331329
LoVo,11612883,2.4190290931093954
ESS-1,2746,2.6118901158900423
PE/CA-PJ49,156414,1.3413488116629748
MM1.S,26596,-1.4234323398175248
D283 Med,6918837,-6.563523505293122
HuT 78,11497983,0.3896895605416182
CA46,44462760,4.878030903037556
MCAS,65064,5.2677124531317245
Hep-G2,107985,-3.632879499618416
KYSE-70,25195348,5.534160735777195
SNU-1272,3689413,0.1489687776606243
SNU-1272,vorinostat-navitoclax (4-1 mol-mol),1.588620831694009
WM983B,9911830,2.107261735137238
NCI-H2110,5738263,3.5819945608358053
NCI-H2081,selumetinib-tretinoin (2-1 mol-mol),6.041656888825654
SET-2,444795,4.329364706689898
HCC2218,15983966,1.8414905081063295
SKM-1,44632017,0.051151225180369
NCO2,72376,-3.7754024287715615
PE/CA-PJ49,25227462,0.930346704481828
HCC2218,11609586,2.605015214107852
KYSE-70,2828334,5.886367586734188
RERF-LC-A1,5278396,3.346165465420988
SW1573,16013152,3.6979705228045354
RERF-LC-Ad2,5328940,1.9140374587439275
SW1990,docetaxel-tanespimycin (2-1 mol-mol),-4.562574826687001
ESS-1,4788,5.85778957294441
EJM,3543504,5.026142247155409
RERF-LC-Ad2,984333,1.0605681508803593
SEM,12003241,-3.075217153076431
IST-Mes1,44566777,1.465871694296859
SNU-1214,44241473,4.767389445416476
SW1990,6438330,2.378775688549145
RPMI-7951,2733526,3.292724930535778
SK-N-AS,11609586,3.065672369709663
D283 Med,71680916,4.275278855129835
MM1.S,46907787,-0.8682718758201811
KMS-27,3815108,2.4440705350233856
JIMT-1,5738263,3.5892254589132664
Aska-SS,4259181,1.378146825762795
BT 330,9936388,0.9619236718444248
KYSE-410,11234052,4.03136586306223
PE/CA-PJ49,7326481,3.2892077928478294
AU565,31703,-1.2264921928318224
WM983B,4259181,-0.5261677537027811
PE/CA-PJ34 (clone C12),5311,2.204084588588605
SNU-1033,9967941,3.6129070478106367
BT 248,9911830,3.0671224453630326
KMS-27,1641662,3.015780749094616
SET-2,9935249,0.876527985665801
KYSE-70,navitoclax-piperlongumine (1-1 mol-mol),2.418726808753935
BT 139,71466578,5.495328241613025
D283 Med,9884685,0.4652080192462777
NCO2,25183872,-2.0467014421756984
Ku812,5328940,-1.8378811939347264
OAW42,24964624,2.3042413931427705
LNCaP clone FGC,SNX-2112-bortezomib (250-1 mol-mol),-2.9814353159230778
ML-1 [Human thyroid carcinoma],46215462,1.6577528274030604
HuT 78,10184653,1.1494734571444012
Hep-G2,vorinostat-navitoclax (4-1 mol-mol),1.3069749829657018
HARA [Human squamous cell lung carcinoma],1242560,4.08747373250943
TE-15,5351362,0.7885319665169142
Ku812,613753,2.440420613478445
D283 Med,135398516,0.8377293343644862
TE-15,46199207,2.907714368540411
HARA [Human squamous cell lung carcinoma],54618164,4.558968644978708
HCC2218,46199207,3.4003371329104475
KMBC-2,5738263,3.5623230616489647
Raji,44589607,2.4455053114760084
NCI-H2110,vorinostat-carboplatin (1-1 mol-mol),3.477235305894441
Ku812,6918328,-1.271327436604222
SNU-1272,11485656,2.6947903691441795
LNCaP clone FGC,2858523,3.0735622516163175
Hep-G2,5287620,-1.53536683394514
BT 330,54596558,4.033632071999387
CML-T1,decitabine-navitoclax (2-1 mol-mol),-1.9117963719087396
LCLC-103H,36462,3.06746452433931
YKG-1,6450551,3.4208466602547833
MCAS,54619267,3.7434418919533656
SW1990,65628,4.249281655519801
NCO2,5738263,2.30194361835568
OAW42,navitoclax-PLX-4032 (1-1 mol-mol),2.8919608300321387
PE/CA-PJ49,675434,4.546524265845795
RERF-LC-A1,6918289,2.260257520656188
SK-MEL-1,9927531,4.509159168037888
KYSE-410,5479543,3.752161213938342
KYSE-410,SNX-2112-bortezomib (250-1 mol-mol),-2.4286427831534767
Hs 683,5311,1.7997560518290772
KMBC-2,15547703,2.177108839879538
KP-4,444795,4.300956807365333
AN3-CA,568763,0.8013749082806687
SK-MEL-1,24978538,-0.0707021947478328
EJM,11719255,2.3281018448944195
H-STS,2113511,5.446449899751943
SW1990,446155,2.0061093369202285
HEC-151,4788,4.697494958927593
ESS-1,24779724,4.457445117995274
NCO2,ISOX-bortezomib (250-1 mol-mol),-0.6807063021400231
ML-1 [Human thyroid carcinoma],46907787,2.3673247902218804
Kasumi-2,24964624,-0.4292953548999766
CML-T1,6438330,0.4811462042672619
BT 330,11507802,1.5671604794200418
SNU-1033,46398810,2.1751402205560972
SKM-1,46943432,0.4553858331231263
SNU-8,6914657,-3.408955584236779
OAW42,11234052,4.0534893565938965
IST-Mes1,16722836,0.916062842065302
SW1990,613753,3.313749610505739
JIMT-1,5470400,0.5897480207784117
SKM-1,carboplatin-etoposide (40-17 mol-mol),-0.1005652278487919
HuT 78,46215462,0.912768914225953
Hs 683,66577038,2.871437721836891
SK-LMS-1,2126,5.096957646919912
TE-15,100016,6.263488161224716
Kasumi-2,3385,2.4314400955221576
BT 504,44607530,0.8883726385830908
SW1990,4788,5.859060109553269
NCI-H1092,3689413,-0.2231155414175143
LoVo,446155,3.732759169917468
BT 504,227681,3.2543020665959363
TE 617.T,984333,-0.2626607268984583
NCI-H2172,51039095,3.282312932514956
Hs 683,53392493,3.1941471527840237
OAW28,25195348,5.036760517156048
BFTC-909,11222830,1.7098036316197358
YKG-1,3825829,4.427024688096871
Kasumi-2,9903786,1.7296917357536032
PE/CA-PJ34 (clone C12),6610216,4.323795888758034
KMS-20,9929138,5.867169727564362
CA46,11404337,-2.4021967063511434
SNU-1214,selumetinib-UNC0638 (4-1 mol-mol),2.031739596740135
EJM,9823820,4.691178108469771
D283 Med,navitoclax-gemcitabine (1-1 mol-mol),-5.0092480687610035
NCO2,54143018,-1.4492412836146171
CA46,11640390,3.3312213559791397
Ku812,5329102,0.560653568662338
BT 248,vorinostat-navitoclax (4-1 mol-mol),1.3262626080799325
OAW28,135421197,1.4901490212875883
Kasumi-2,445643,3.712609595977314
Aska-SS,56649450,2.4139610587567115
BT 504,1566236,1.844513919380763
LoVo,10113978,1.9718639606113115
OAW42,148198,-4.166593370065839
NCI-H2110,89928392,2.605019986825885
CA46,crizotinib-PLX-4032 (2-1 mol-mol),1.0865859048820203
D283 Med,60750,-5.2447634258495155
SKM-1,46174525,2.564354179427139
CA46,5278396,3.312720557512005
HSC-4,6438330,1.0116267584860468
MM1.S,10127622,5.107569305905412
ESS-1,6918638,0.5362706870956574
HSC-4,11222830,1.068056053085511
OAW28,54618771,1.1011370240470315
YH-13,4578,5.582049884276352
JIMT-1,66577038,3.4273306589230064
EJM,6610355,4.327559225261186
Ku812,208908,2.1856881030512043
NCI-H2110,11222830,1.6504638716126514
D283 Med,2828334,5.77841146939239
KMBC-2,tretinoin-navitoclax (4-1 mol-mol),1.1343859495127468
SEM,5743,-3.3598270412643347
ESS-1,148198,-4.109415572856481
BT 504,9868037,3.967723190943412
LCLC-103H,107985,-2.4603139026976213
SNU-1033,11707110,-1.6713761677122163
TE-15,5287620,-3.110015038357965
OAW42,4096211,1.8226989658243649
Hs 683,16659841,2.9598539767719507
TE-15,JQ-1-vorinostat (2-1 mol-mol),-1.090745465541189
IST-Mes1,322968,3.0930404941453933
LoVo,67291369,1.4516021942624118
PE/CA-PJ34 (clone C12),11612883,2.848187742516691
NCI-H1092,19582717,5.304024438034291
OAW42,9933475,1.908294370679977
EJM,9903786,2.5710642236856818
BT 328,tanespimycin-bortezomib (250-1 mol-mol),-1.4953584261079875
YKG-1,11656518,3.2950724236560456
RERF-LC-A1,5738263,3.1282409831273
Hep-G2,89183176,5.542677270745169
BT 139,11507802,3.556283958105639
HCC2218,10385095,0.9355515453003532
ML-1 [Human thyroid carcinoma],2746,-1.478438692576885
LoVo,36314,1.7018910931264415
KP-4,151289,0.3587584967433216
HSC-4,5328940,0.4436918358674775
NU-DHL-1,322968,1.8618584947977044
JIMT-1,6917907,-2.0800933801080945
AU565,24180125,2.1910645714042634
SEM,salermide-PLX-4032 (12-1 mol-mol),4.3063302243904085
SNU-308,9926054,1.9749915644839853
HARA [Human squamous cell lung carcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.5629845870291592
HEC-151,JQ-1-navitoclax (2-1 mol-mol),0.7409991193456812
PaTu 8988s,12003241,-0.9111494781164662
RERF-LC-Ad1,serdemetan-SCH-529074 (1-1 mol-mol),2.637264034786848
Ku812,31703,-2.031411479408016
ML-1 [Human thyroid carcinoma],387447,-2.817858817217488
BT 330,135398516,1.8910897394720865
OAW42,5282054,4.609146955550685
RPMI-7951,15953870,2.308533676595083
NCI-H2110,71466578,5.140572162086394
SKM-1,1641662,2.105508221547458
LNCaP clone FGC,6918736,-2.2970648149141475
CA46,462382,0.6475442737717811
A4/Fukuda,3136844,3.333855932915555
BFTC-909,6610216,4.898578232775107
Ku812,44259,0.671540597620678
HMCB,vorinostat-navitoclax (4-1 mol-mol),1.320679048022774
Aska-SS,16736978,2.0956913570631976
LoVo,12003241,-2.8621949377385465
PE/CA-PJ49,23635314,-4.290211790654201
YKG-1,676352,1.798762675179312
KP-4,107970,2.3974989228996586
IST-Mes1,11609586,2.670649923207088
HSC-4,9840324,5.223554072523372
CML-T1,1716436,3.108020123675437
BT 320,6918638,3.210777195522013
MCAS,3025944,4.53185196548215
WM983B,navitoclax-PLX-4032 (1-1 mol-mol),-0.8456105909983045
HuT 78,selumetinib-navitoclax (8-1 mol-mol),-3.3209959202803323
Hs 683,119182,2.9030188000592947
BT 330,46199207,1.6849129944487666
KMS-27,49793307,-4.722985009136323
SK-MEL-1,UNC0638-navitoclax (1-1 mol-mol),-0.6906136435096342
NCI-H2172,1750826,-0.2815484633093131
SEM,1750826,-0.892835267111722
LNCaP clone FGC,6918837,-4.306681175333808
HSC-4,3038522,3.958216901800584
KMS-27,9823820,3.714575222743397
OAW28,65064,5.229460149894731
CML-T1,11656518,-0.3565307280161567
IST-Mes1,24964624,2.9505066533460464
NCI-N87,17755052,-1.4521000328048816
NCI-H2081,54639701,4.415769472543696
IST-Mes1,135999136,4.360333625305844
SK-N-AS,BRD-A02303741-navitoclax (2-1 mol-mol),4.127041881610321
KMS-20,49793307,-3.879201058014154
PE/CA-PJ34 (clone C12),42642645,1.4632083376153606
Aska-SS,piperlongumine-MST-312 (1-1 mol-mol),2.035630717741488
GOS-3,60750,-1.363518575342279
AN3-CA,26596,-3.5868272426759584
ML-1 [Human thyroid carcinoma],6184667,3.426764234055379
NU-DHL-1,24951314,-0.7364467941633237
KP-4,6184667,2.1864211393774684
SW1573,BRD-A02303741-navitoclax (2-1 mol-mol),1.994158389176884
PE/CA-PJ49,JQ-1-vorinostat (2-1 mol-mol),0.4372186827616553
Kasumi-2,25102847,1.9985292692576584
SK-MEL-1,9911830,3.4534417148400145
JIMT-1,docetaxel-tanespimycin (2-1 mol-mol),-4.468665029147565
Hep-G2,11497983,4.251359027932584
SNU-308,445091,4.634958976950105
RPMI-7951,5280436,3.8526287980581264
CA46,44566777,-1.0409480025289963
SW1990,11640390,3.421819562355846
OE21,7251185,3.300385841415819
H-STS,24771867,-2.0225510536358353
MCAS,vorinostat-carboplatin (1-1 mol-mol),4.095044355949227
LNCaP clone FGC,72193861,0.7655554184680992
PaTu 8988s,387447,-4.143715999712614
BT 330,44819697,-2.7674730539604453
D283 Med,5278396,2.633233418079239
A4/Fukuda,serdemetan-SCH-529074 (1-1 mol-mol),0.8122212024039632
SK-N-AS,9884685,0.5788482092816835
OE21,navitoclax-MST-312 (1-1 mol-mol),0.9127482024320372
OAW28,5460769,4.044755256654475
BT 504,11167602,1.7922968046934435
NCI-H1092,3038522,3.1295884700931182
BT 504,2729026,1.2282846763144355
NCI-H2110,11640390,3.118244527452471
SK-LMS-1,5351362,1.0221811076234175
Raji,10410894,0.2321339045385242
BT 330,11640390,1.9167810634257632
KMS-27,151289,0.3978275019277482
GOS-3,53392493,2.045340494319027
SW1990,126941,-4.292570667373939
RERF-LC-A1,9826308,0.1197535217057311
HEC-151,44137675,3.543841403432853
TE-15,31703,-1.9709825874210252
SW1990,42642645,0.6858937551923172
NCI-H1092,135421197,1.379439810077043
PE/CA-PJ49,135984461,4.387949775407799
SK-N-AS,salermide-PLX-4032 (12-1 mol-mol),5.472055736140025
RERF-LC-A1,1641662,3.0719688089781565
BT 328,16219061,3.835550220565251
MCAS,135411,0.3992258142971907
SET-2,644241,4.42349249378709
LoVo,11152667,-3.1828514843907967
BT 504,10427712,4.398644038175613
KYSE-410,navitoclax-sorafenib (1-1 mol-mol),1.8928817442562549
SW1990,11656518,2.0447972596662
SK-N-AS,46843906,2.210011287581428
NCI-H2110,4788,5.467246455417277
SNU-1214,9915743,-3.00050567913294
BT 504,135875424,2.85163619011477
KMBC-2,984333,5.617764060349004
PE/CA-PJ49,54618305,4.991417436766986
KYSE-410,124202324,2.809951119195219
SW1990,5287969,-2.232579195364531
BT 248,156422,4.367304785746438
YKG-1,462382,0.3807695493955695
SK-N-AS,25161177,3.7765569892092063
TE 617.T,216468,4.057012823522719
LoVo,65064,4.389937632551182
KMRC-2,10074640,3.080783314535937
HSC-4,654092,0.2566378579351391
SNU-8,11485656,2.474151094807621
SW1573,5328940,2.8151731448483424
Kasumi-2,15983966,-4.769110499873103
AU565,637858,2.0174799842455364
LCLC-103H,46199207,3.173752217609666
KP-4,6918837,-1.774783385584419
YH-13,89928392,1.3765832739802537
SNU-1214,54618771,-0.4857643216446591
Raji,9935249,3.258166700499432
MM1.S,10074640,2.540679060778685
OE21,5470400,-0.382943496610633
SNU-1033,11364421,-0.0634614398116834
ESS-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8573739995038356
MM1.S,3385,3.993221582004266
ML-1 [Human thyroid carcinoma],11609586,2.006327876020203
Ku812,JQ-1-carboplatin (1-1 mol-mol),-1.5108430449944463
KYSE-410,9915743,-1.3205440456701116
SW1990,16038120,0.769493188570446
LoVo,51037431,2.9518330914759043
A4/Fukuda,6918328,-3.9252329494253586
PE/CA-PJ34 (clone C12),44566777,1.0686416610033969
SEM,151289,0.5470981042649448
SNU-308,selumetinib-PLX-4032 (8-1 mol-mol),4.004313994841309
D283 Med,11427553,4.872458207858214
LoVo,11626560,0.8234069861143318
SNU-1033,1566236,1.8581490134242764
LCLC-103H,44507138,1.7459518533167655
SNU-1214,51037431,3.8670550149268146
A4/Fukuda,216345,2.739557201577506
KMS-20,216345,3.908471127762827
NCI-H2081,3038522,1.7557154711324474
PE/CA-PJ34 (clone C12),erlotinib-PLX-4032 (2-1 mol-mol),0.5526794928208874
BT 330,6450551,1.8703937125350776
SK-MEL-1,49793307,-0.2584958218568318
IST-Mes1,6918878,2.524010054300984
OE21,9926054,1.7334869398194368
OE21,46398810,2.840841233000916
OAW42,selumetinib-MK-2206 (8-1 mol-mol),2.354488125030172
BT 328,439501,-3.1360046964577983
SK-N-AS,navitoclax-sorafenib (1-1 mol-mol),2.7950141791052276
SNU-1214,44137675,2.73058467391687
KMS-27,409805,3.6220211323899782
HuT 78,445455,2.369844577955314
KYSE-70,119607,5.065055719995064
SET-2,9823820,3.5307586058920397
PE/CA-PJ34 (clone C12),9911830,2.0683867467094657
NCI-H1395,JQ-1-carboplatin (1-1 mol-mol),2.36945639284839
EJM,25062766,1.6809786410493317
AN3-CA,23582824,-0.662849754096843
YKG-1,1566236,3.4432239781359577
HuT 78,54618771,-0.2261201753145263
SK-N-AS,vorinostat-carboplatin (1-1 mol-mol),1.8957301810258111
HCC2218,675434,3.068178566954701
BT 504,25062766,2.629228237764604
PE/CA-PJ49,25183872,-2.3917341598703232
SEM,9952709,2.504756008215234
SNU-308,448949,2.712847357418782
MM1.S,5278396,3.253514832421593
KYSE-70,31703,-0.0860185315527888
NCO2,135411,-0.0942193787788768
NCI-H2081,375860,-0.0986689884250349
YH-13,5281321,-2.463748915985143
NCI-H2172,44543605,3.7462839501403256
AN3-CA,selumetinib-vorinostat (8-1 mol-mol),3.509818575986226
LoVo,5351362,1.2957137522113673
MM1.S,753704,4.513964984168999
EJM,11178236,-6.131326848580391
SK-MEL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.1247246947880956
MM1.S,5978,-3.473474877410116
SNU-1033,JQ-1-UNC0638 (2-1 mol-mol),0.3734309129675442
KP-4,9866186,0.3799463798053679
NCI-H2081,227681,2.433511689406021
PaTu 8988s,3136844,4.247292724797891
KP-4,60700,-2.446672768416198
Hs 683,122327,4.192242521314138
BT 504,44607531,1.5091820328409666
LoVo,3025986,-0.1762115912359206
RERF-LC-A1,4378219,1.8089871114360447
SK-N-AS,vorinostat-navitoclax (4-1 mol-mol),0.859434660114792
ESS-1,31703,-3.4275082307518807
SK-MEL-1,docetaxel-tanespimycin (2-1 mol-mol),-0.1173336391223231
SEM,10296883,-0.6538100941325019
MM1.S,124202324,0.7291888929578118
SEM,82146,3.5358695310229704
KMS-27,25062766,1.8620246532604927
KMBC-2,11175137,3.4182731043572847
NCI-H1395,4917,3.698580311776931
D283 Med,46943432,1.9673056187100668
Aska-SS,119607,6.144068607625952
BT 248,56963564,4.0439806336642175
NCI-H2110,44137675,2.993470299595554
WM983B,11178236,-5.687753408941692
D283 Med,23725625,2.5008033134469647
AN3-CA,9967941,2.1371429863242692
TE-15,8515,2.4630178987516564
SK-N-AS,SNX-2112-bortezomib (250-1 mol-mol),-2.8881942444955233
NCI-H1092,11234052,4.115847054230737
SK-N-AS,46907787,2.030774624984343
LoVo,60700,-0.3967380120150421
GOS-3,navitoclax-gemcitabine (1-1 mol-mol),-2.24576809498804
PaTu 8988s,10302451,4.079091129858146
KMS-20,25195348,3.35080522486854
A4/Fukuda,5738263,2.3624425097256676
BT 330,3062316,2.567282780734098
CML-T1,ISOX-bortezomib (250-1 mol-mol),-0.7676441178316211
RERF-LC-A1,selumetinib-GDC-0941 (4-1 mol-mol),3.459186933832629
OAW28,446155,3.9986810531407486
HEC-151,selumetinib-decitabine (4-1 mol-mol),4.407861516510348
HCC2218,448949,2.479128950709568
SNU-8,3025986,-0.8610390713696733
IST-Mes1,44491742,4.903550558956352
BT 248,9549297,1.6274014594604191
HuT 78,11717001,2.148899417206966
KYSE-410,24856436,0.3863800848702762
OE21,sirolimus-bortezomib (250-1 mol-mol),-0.2095744240897051
PaTu 8988s,JQ-1-navitoclax (2-1 mol-mol),0.4387961323167006
TE 617.T,56946209,-5.04642023755872
BT 328,3689413,2.3836323832860673
RERF-LC-Ad2,135440466,2.5121012258931295
ML-1 [Human thyroid carcinoma],156414,1.0547615836858202
HMCB,54143018,0.6781529714604165
TE 617.T,6852167,3.448270243983474
KP-4,107985,-3.0581190073780524
OAW42,3676137,5.465473843263381
CA46,5978,-7.34958411963843
HMCB,644241,4.490422282614611
D283 Med,selumetinib-piperlongumine (8-1 mol-mol),2.4396148018972585
A4/Fukuda,decitabine-navitoclax (2-1 mol-mol),-0.552282956789893
LNCaP clone FGC,5291,3.697238645744427
RERF-LC-A1,2130404,3.5580498448115376
BT 504,selumetinib-decitabine (4-1 mol-mol),5.919221923738227
TE-15,2729026,3.117170834129398
LNCaP clone FGC,16736978,0.4632149160261901
KP-4,6623618,1.8349774868149575
KMBC-2,24748573,2.0825637158480457
SEM,tretinoin-navitoclax (4-1 mol-mol),-1.6039122831909487
NCI-H2110,15953870,3.912079483220952
KYSE-70,73707438,4.323396479680616
H-STS,16736978,1.4661636218515657
Hep-G2,46224516,1.405645809008333
EJM,25183872,-1.9531773899114209
NCI-H1092,72376,-1.2021536382065705
PE/CA-PJ49,31703,-1.3164543555016257
KYSE-410,BRD-K27188169-navitoclax (2-1 mol-mol),3.7266510041041463
ESS-1,25022340,0.9618153764188746
PE/CA-PJ49,44566777,0.2729786276106425
NCI-H1395,24771867,4.164021178387528
ML-1 [Human thyroid carcinoma],421610,2.367130129227347
AN3-CA,322968,2.7400100761512967
Aska-SS,7251185,1.843675489494185
SET-2,11977753,-1.6200324397994894
AN3-CA,409805,5.126415304640116
KP-4,decitabine-navitoclax (2-1 mol-mol),3.393653330674042
KMS-27,135411,0.1575765990656979
CML-T1,55508,2.709114480954857
LCLC-103H,637858,2.882745745429834
Ku812,25102847,-0.2981237407146331
PE/CA-PJ34 (clone C12),6505803,-2.153335195822847
KP-4,5738263,3.4470838399922297
GOS-3,10074640,3.609406723020456
LCLC-103H,4788,5.950660347049977
SET-2,11494412,0.7084758030554381
SEM,16736978,3.717756753629991
HuT 78,JQ-1-navitoclax (2-1 mol-mol),-0.7968607943270343
NCI-H1395,72376,-0.6047916144496074
SNU-1033,49766530,-1.347246040659949
SEM,49836020,0.2207243584754971
HARA [Human squamous cell lung carcinoma],5311281,2.4258881489706217
WM983B,3025944,4.370041800407228
SK-LMS-1,4261,1.4846635416850682
NCI-N87,119607,4.916125105909822
SKM-1,9903786,0.91314187591027
KYSE-70,6610355,4.961596413135767
LCLC-103H,11364421,-3.1628974948140405
Kasumi-2,119607,5.143919911790516
BT 504,sirolimus-bortezomib (250-1 mol-mol),1.7161873277095432
SK-MEL-1,JQ-1-MK-0752 (1-1 mol-mol),-3.660502478026094
AN3-CA,53232,2.110237276491864
SEM,11427553,-0.9142896779989294
Kasumi-2,11719255,0.7919357371697194
SKM-1,15983966,-6.231443096361553
CML-T1,89928392,0.2335848320544615
KMRC-2,45279963,3.8727204027924103
OE21,9911463,3.2233291636106727
NU-DHL-1,44185566,1.0271500895351358
YH-13,24797083,1.5819702777514613
SNU-308,66577038,3.0438550827272457
RERF-LC-Ad1,3854666,3.753707482876592
HCC2218,vorinostat-navitoclax (4-1 mol-mol),0.8970155470733918
WM983B,15983966,3.994577962518255
HMCB,3025986,0.04435044447406
SNU-1272,4917,3.2346611590060608
KMS-20,9823820,3.101769645887986
HuT 78,445091,4.391722157853981
SNU-308,6610216,4.383994283569161
LNCaP clone FGC,9911463,2.657029606210989
SNU-1272,11683005,3.754967611266652
AN3-CA,9926054,1.8039265956503063
NCI-H2110,doxorubicin-navitoclax (2-1 mol-mol),-2.638354806422936
Kasumi-2,3465537,0.5812514796989715
OAW28,carboplatin-etoposide (40-17 mol-mol),4.113933024401999
TE 617.T,448949,1.7221444457220252
SET-2,219104,2.1406118345364877
TE-15,6184667,1.875027670900844
Kasumi-2,72193861,0.1525951303543335
NCI-H1092,42642645,1.4285528009484267
EJM,11404337,-0.4702991542329423
GOS-3,135999136,4.682109520485855
Kasumi-2,5282054,2.4598760030877553
BT 328,9956119,4.461775202302022
CML-T1,3011155,1.2837041284349135
HEC-151,322968,3.0831168321133147
KMS-27,46199207,2.868672970964164
AN3-CA,15547703,2.8402798062083496
KMS-20,selumetinib-vorinostat (8-1 mol-mol),-0.0574541449020858
ML-1 [Human thyroid carcinoma],5311281,2.103239185945236
TE 617.T,71466578,5.5404489464924165
NU-DHL-1,71680916,3.5275093347477795
SW1990,448949,1.3238938068231705
SK-N-AS,4259181,-0.3147022482615397
BT 330,66577038,2.74568444462768
OAW28,148198,-3.8662210541116977
JIMT-1,25262965,-1.6655167234101924
SNU-1214,44632017,1.3603108487912077
HMCB,462382,0.5929109293335464
Kasumi-2,31703,-3.912318367279324
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015
NCI-H1092,53232,4.715701338222689
H-STS,3689413,-4.4758570940331515
CA46,selumetinib-PLX-4032 (8-1 mol-mol),4.812160149058309
KP-4,613753,3.0855452721954326
LoVo,11485656,1.8604760547282393
KP-4,3676137,3.93966074498979
Ku812,19582717,3.1020544900029297
KMBC-2,2828334,6.082053545971173
ESS-1,navitoclax-pluripotin (1-1 mol-mol),-0.2560996080158209
Hs 683,65628,4.4952708080724495
BT 328,613753,3.4687194971891184
MCAS,11640390,3.637750239974848
JIMT-1,135999136,4.503963053903458
HSC-4,5311,1.8002123285320597
EJM,53392493,1.8417186959189336
KMS-27,72193870,3.4384796192922877
SNU-1272,25126798,4.058669238010608
NCI-N87,409805,4.5069551273823585
HuT 78,6918736,-0.9922912481789786
H-STS,vorinostat-navitoclax (4-1 mol-mol),1.152799818591655
HMCB,doxorubicin-navitoclax (2-1 mol-mol),-1.216514285353257
HCC2218,selumetinib-vorinostat (8-1 mol-mol),2.1332099474977455
SNU-308,piperlongumine-MST-312 (1-1 mol-mol),3.701215910216338
SK-N-AS,sirolimus-bortezomib (250-1 mol-mol),0.1203472334672894
KYSE-410,selumetinib-tretinoin (2-1 mol-mol),5.436574012517174
HEC-151,2708,4.535952513422743
LoVo,52912189,0.3784309245329977
TE-15,11404337,-0.7391616924820064
NCI-H2110,11955716,-2.3591682548088273
BT 504,216239,2.15959954576467
KMBC-2,2708,4.865695204708852
BT 328,11238147,2.054089677039581
AU565,3465537,1.0667310492419344
EJM,3025944,4.146188688594528
EJM,46174525,3.426446737452036
SK-N-AS,8515,4.55115290186792
MM1.S,46843906,0.846343121160042
SK-MEL-1,9967941,3.289843931438621
AU565,613000,0.5241513608694668
MM1.S,3025986,-1.7222159842477116
Ku812,54613361,-1.6579291545050676
SK-N-AS,2742550,3.823682171563052
KMBC-2,salermide-PLX-4032 (12-1 mol-mol),4.16483239560193
Hs 683,11719255,3.697399434664443
PE/CA-PJ49,5282054,3.6745843820414312
HCC2218,445091,4.1052384856024515
TE 617.T,71304818,1.441601624929096
TE-15,3062316,-2.853969144385318
KMS-27,5281321,-2.6329785941906367
Kasumi-2,5335621,4.247176943532892
HuT 78,24821094,3.2631800653476017
MM1.S,46199207,3.245764113166512
SEM,44484893,-1.5339295370272434
BT 504,11455910,0.316004589079872
CML-T1,docetaxel-tanespimycin (2-1 mol-mol),-5.351471523499181
KMRC-2,135659046,5.230232657074779
MCAS,1641662,3.2767625761066643
JIMT-1,969516,3.10963992150901
SNU-1033,2945648,1.3952035242940846
SW1990,4578,4.588770076265956
KMS-27,9866186,-0.3625285569835875
BT 320,10074640,3.68399538142115
KP-4,11640390,4.34325096954633
Hs 683,erlotinib-PLX-4032 (2-1 mol-mol),3.209711945439973
YH-13,5311,2.0479305445727083
NCO2,613753,2.8764818135504924
WM983B,67156097,0.9365483599690656
MM1.S,11238147,1.6949017998059208
RERF-LC-A1,9444,6.465540340308158
KMBC-2,44185566,3.018196319024016
NCI-N87,54454,3.669804409798402
NCI-H2110,selumetinib-BRD-A02303741 (4-1 mol-mol),4.4516534452427505
KMS-27,17755052,2.27081295525487
YH-13,135411,1.4167541971469908
SK-N-AS,6610216,4.189892588331561
BT 330,9933475,1.5908629116386517
PE/CA-PJ34 (clone C12),71751553,4.188621560003168
EJM,11964036,1.6770560082105996
PE/CA-PJ49,11238147,2.578263887023537
KYSE-70,11964036,0.6479741930424838
EJM,4259181,-0.0332233948997356
D283 Med,24771867,-2.2450737191486883
WM983B,2858523,3.0806083097472805
NCI-H1092,5282054,2.5552812504046742
WM983B,54626689,4.781491968938461
NCI-H2081,11152667,0.3314648978290519
SET-2,25150857,1.6478785174653998
PE/CA-PJ34 (clone C12),25126798,3.781683390757729
Ku812,24180125,2.3184854542342217
BT 504,54678924,1.9232760728761469
SNU-8,400769,-0.7541255884015454
BT 320,51039095,3.427316698358292
Raji,44607530,2.3705151094198387
NCO2,46398810,0.8964237611975863
SKM-1,65064,4.990027609519168
TE-15,51039095,1.9253122960428968
A4/Fukuda,carboplatin-etoposide (40-17 mol-mol),0.4853632935092173
NCI-H1395,3025986,0.7160390395986832
ML-1 [Human thyroid carcinoma],6450551,2.5869852554462622
BT 248,445091,5.158109648340294
RERF-LC-Ad1,44507138,3.8186397004948343
YKG-1,2949965,2.7570477718162367
NCO2,5281321,-6.552879113351198
PE/CA-PJ49,71304818,2.6794491158142386
WM983B,11364421,-6.839587537434616
HuT 78,73707398,-1.0733102034167783
SET-2,11228183,-0.1721778083662545
KMBC-2,11657048,4.986417986707535
D283 Med,54765302,3.826457537496404
RPMI-7951,219104,3.3269736194785193
HEC-151,2828334,5.830320904671621
OE21,2858523,3.0662483175538444
BT 139,JQ-1-navitoclax (2-1 mol-mol),0.5774680712043125
Ku812,46199207,2.6759001741675372
AN3-CA,10302451,3.617635565971862
KMBC-2,25154868,4.277573934530614
NU-DHL-1,2828334,5.350284710579576
HCC2218,10410894,2.581995329678069
OAW42,9927531,5.261343543721406
RPMI-7951,doxorubicin-navitoclax (2-1 mol-mol),-2.741205682713804
LoVo,9911463,2.8816718818913176
BT 320,5311,2.686412240878293
KMS-20,tanespimycin-bortezomib (250-1 mol-mol),-0.2140039466554119
NCI-H2172,16065773,3.3027567277795513
LCLC-103H,vorinostat-carboplatin (1-1 mol-mol),3.3120163118812687
KMS-27,2828334,5.834788512638451
NCI-H2081,676352,1.7285025773311848
SK-MEL-1,3025944,4.409445366935466
EJM,44819697,1.6195788474548276
Kasumi-2,65628,2.2018759133614987
SNU-1033,3503,1.5718890329009363
NCI-H1395,11612883,3.2235820919891256
KMBC-2,52912189,4.619437750179636
KP-4,2708,3.142602714561915
SNU-8,3384730,2.821449347547462
RERF-LC-A1,navitoclax-sorafenib (1-1 mol-mol),2.738424491171132
SK-N-AS,1323703,4.860005530056665
OAW42,25183872,0.2517529296042449
BFTC-909,148198,-2.03933057080943
H-STS,5460769,1.2422964505231244
MCAS,10184653,2.7840829057514753
SK-LMS-1,6610355,6.064160984405766
MM1.S,16722836,0.4655451922698376
LNCaP clone FGC,11178236,-2.8738158193146575
TE-15,navitoclax-sorafenib (1-1 mol-mol),3.1467908177063686
CA46,5746,0.6077367646083516
SEM,UNC0638-navitoclax (1-1 mol-mol),-2.575766799282578
IST-Mes1,6610216,4.781215155625892
RERF-LC-Ad1,10074640,3.528026148983471
CA46,3689413,-3.563387503989764
BT 328,11427553,3.9535129095984054
YKG-1,400769,0.2933301417342049
SNU-308,11640390,4.99720907789617
YKG-1,53232,1.050815302448319
KP-4,52912189,3.5083218883418272
GOS-3,44486219,4.351702661257634
KMRC-2,2729026,2.995912943656125
BT 139,5291,3.770783503503458
YH-13,216345,4.472180809621783
SKM-1,6918878,-0.8378415751208989
RERF-LC-A1,erlotinib-PLX-4032 (2-1 mol-mol),3.805837801387939
NCI-N87,10410894,1.83413876253328
OAW28,5287969,-1.4958665626980858
SNU-1214,navitoclax-pluripotin (1-1 mol-mol),-3.219384330131526
LNCaP clone FGC,3385,1.984048991307278
SW1990,17755052,2.187799447368803
RPMI-7951,16115403,-4.771621646391644
NCI-H1395,46398810,3.2237740665235495
H-STS,15953870,3.89259126645257
NCO2,tanespimycin-gemcitabine (1-1 mol-mol),-4.979379636954008
SKM-1,46224516,2.679988010860087
SNU-308,262093,4.9932279379660764
NU-DHL-1,6438330,0.0083524547313942
KYSE-70,46398810,2.5990171625416916
YH-13,107970,3.012104980277858
BT 248,10074640,2.9402331094049265
AN3-CA,448949,1.3403771585742368
OAW42,31703,0.7042261926311711
SNU-8,44632017,1.3384899891643445
EJM,selumetinib-GDC-0941 (4-1 mol-mol),1.950719382616822
Kasumi-2,5978,-3.933681438293164
A4/Fukuda,JQ-1-navitoclax (2-1 mol-mol),-1.310646692558982
NU-DHL-1,23582824,0.4052084507324015
PE/CA-PJ34 (clone C12),3503,2.1595052777982437
YH-13,5746,2.3705459380305256
NCI-H1395,11964036,2.245588880269689
PaTu 8988s,selumetinib-piperlongumine (8-1 mol-mol),2.380469190147341
KMRC-2,17755052,2.40271888708834
SET-2,24753719,3.747338164648229
NCO2,9929138,5.425530092389558
BT 248,3552672,1.5840638178238662
RERF-LC-A1,387447,-5.173995922750218
NCI-H2081,2113511,5.887523874573183
OAW42,9887053,3.1515627670394992
MM1.S,selumetinib-JQ-1 (4-1 mol-mol),-0.6106024148084398
SK-N-AS,11234052,4.282570528517073
H-STS,12001922,1.5454673867103017
HSC-4,135423438,1.814117839489682
PE/CA-PJ34 (clone C12),11657048,5.70613373367465
HuT 78,15547703,4.385354526396273
Raji,23582824,3.0012319575717092
PE/CA-PJ34 (clone C12),5351362,0.8158998641281501
KYSE-410,navitoclax-PLX-4032 (1-1 mol-mol),1.8859543476529048
KYSE-410,3025944,4.432706614143299
GOS-3,5281321,1.1585317053456523
SET-2,135398516,1.449792598541135
OE21,24180719,4.795188480973195
GOS-3,3025944,4.406147026305863
NCI-H2081,151289,0.7108361073513202
OAW28,4259181,0.9119817479539226
RERF-LC-Ad2,168312962,3.944293822864603
CA46,25126798,3.582571225160254
NCI-H2110,5287620,-2.255110543638233
NCI-H2110,9956119,4.294829796278382
CA46,16736978,0.453820731366511
KMBC-2,24772860,-1.3622286012164393
HuT 78,4259181,-0.3142311669352864
SW1573,168313200,1.7327341920391253
SNU-1272,49850262,4.293787638544132
Kasumi-2,5460769,1.467216518279754
SK-MEL-1,168312962,-2.673328538535636
HSC-4,25062766,1.8609848482730849
SET-2,4705,3.0557910229077554
Ku812,5311281,1.497944921969674
D283 Med,24821094,1.9076821647913431
ESS-1,2871966,0.4858563694283366
TE 617.T,219104,2.7498102062256464
MCAS,9866186,0.5994154394418661
Raji,107970,1.9902567284357284
BT 320,60700,5.739551872199599
KMS-20,445643,3.538778449687995
LCLC-103H,6917907,-4.211388264656449
AU565,151289,0.4389765151464501
HSC-4,409805,5.399675964474335
SNU-1272,675434,6.21056389373631
CML-T1,5281672,4.316508820409711
IST-Mes1,54596558,4.6034089904468125
NCI-H1395,JQ-1-vorinostat (2-1 mol-mol),1.5410924011287808
Hep-G2,16736978,0.6632271469742936
Raji,11626560,2.140916450876962
BT 330,9967941,3.1248823788428
KMBC-2,6610216,4.214797525140246
HMCB,5978,-3.0634075828231757
SK-LMS-1,3634881,3.6033137231613055
PE/CA-PJ34 (clone C12),53495165,-1.0427588967994468
HuT 78,44202524,1.902464587959626
KYSE-70,16722836,1.4327625680833322
Aska-SS,44819697,-2.0300758660488984
D283 Med,9903786,1.479416225891386
JIMT-1,42642645,1.596095812784991
YKG-1,24821094,3.8775145827770703
OAW28,387447,-4.631995500074297
ESS-1,5351362,1.0632420043003554
KMS-20,navitoclax-pluripotin (1-1 mol-mol),-1.7464713167457526
LoVo,26596,-4.043483931746528
SK-MEL-1,36462,2.966778719187199
SKM-1,6918837,-4.5219646789618455
LNCaP clone FGC,168313016,4.233748238876194
RERF-LC-Ad1,25183872,4.290443599779795
NU-DHL-1,89928392,-0.986320160270056
MCAS,15983966,-5.308386091607527
RERF-LC-Ad2,409805,3.938022823911279
SET-2,5566,3.01113622374019
GOS-3,6914657,-2.554831261851343
GOS-3,navitoclax-pluripotin (1-1 mol-mol),1.020256272208372
HARA [Human squamous cell lung carcinoma],25262965,-0.7160848382234604
HCC2218,4705,1.2825749224447869
OAW42,44607530,2.9491702112654257
Ku812,327653,2.6105949863285436
SKM-1,4096211,0.188033132168566
KMRC-2,676352,1.733053022246691
RERF-LC-A1,alisertib-navitoclax (2-1 mol-mol),0.7395937605869288
H-STS,7251185,1.0219328536539296
NCO2,11625818,4.018319606454172
OAW28,5335621,5.136061685098042
NCI-H2110,168312962,3.2702691603373437
Hep-G2,54618771,-1.2901934533941846
KMBC-2,5494449,3.5619976172577967
WM983B,9956119,4.113977728570892
KYSE-410,71466445,4.5751159315788055
BT 504,2828334,6.024354146475064
CA46,3384730,2.283076300956678
D283 Med,2874250,4.322597187496923
SKM-1,3825829,2.28297195030611
RPMI-7951,11175137,0.94409588176426
HEC-151,135659046,3.7740160846468
NU-DHL-1,25150857,0.917723720261522
PE/CA-PJ34 (clone C12),285033,-2.1264465291275476
SK-N-AS,5281321,-0.9525802476570496
KYSE-410,11175137,2.5904994526857994
LCLC-103H,4259181,1.0955663651185623
MM1.S,6438330,0.7925484040145825
NCI-H1092,UNC0638-navitoclax (1-1 mol-mol),0.7964927017699627
YH-13,57519531,2.0380151734661185
AU565,44137675,3.533476650788096
RERF-LC-A1,11396600,3.681688949161253
SNU-1033,9936388,0.9211545103072076
SEM,navitoclax-gemcitabine (1-1 mol-mol),-6.263167217210504
D283 Med,JQ-1-MK-0752 (1-1 mol-mol),0.6628276308701311
HMCB,6917907,-5.7267155149499915
RPMI-7951,erlotinib-PLX-4032 (2-1 mol-mol),2.7568128654498363
NCI-H1395,5281321,-3.249479550606142
HEC-151,676352,2.204105817499985
KMS-20,7251185,1.0924387988239983
YH-13,3825829,4.007616735103447
Ku812,4261,0.3259044550005565
KMS-20,25102847,2.4151614593065687
ESS-1,322968,2.8286903155082137
KMRC-2,selumetinib-decitabine (4-1 mol-mol),3.5803480958076315
Kasumi-2,9444,3.998890232290453
LNCaP clone FGC,navitoclax-PLX-4032 (1-1 mol-mol),3.229192012291585
SW1990,148124,-0.559061851738452
KP-4,42642645,-0.9361975871435074
NCI-H2081,208908,1.5488690353253576
AN3-CA,439501,-3.229124904343767
EJM,3825829,3.923583211439946
AN3-CA,9933475,-1.822781591064649
PE/CA-PJ49,168313016,4.508662039314565
SNU-1033,49793307,-3.819770558923537
Kasumi-2,49766530,-3.7396811929647513
TE 617.T,107970,1.5986795918546095
SEM,JQ-1-navitoclax (2-1 mol-mol),-3.2274870101256306
IST-Mes1,11494412,3.57589790392084
KP-4,25062766,2.0544826822763604
BFTC-909,2130404,3.366307483642889
Aska-SS,216468,2.623048745293118
KMBC-2,3689413,-0.0193871140642154
SK-MEL-1,9868037,2.6521511264174493
Ku812,navitoclax-pluripotin (1-1 mol-mol),-5.237528282763509
TE 617.T,navitoclax-piperlongumine (1-1 mol-mol),1.3861842012788683
BT 248,55508,3.993579478299883
AU565,107970,1.9067452119355752
HARA [Human squamous cell lung carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.4213259806317335
RPMI-7951,42611257,2.919657953778153
OAW42,46191454,3.570654848685792
PaTu 8988s,53392493,2.9230199935224213
SKM-1,24797083,0.9734913560698324
ML-1 [Human thyroid carcinoma],54649381,4.324070376451948
NCI-H1092,24748573,1.407040997377024
HuT 78,3062316,2.376024867755132
YH-13,46224516,2.974421814944524
PE/CA-PJ49,66577038,2.894241408654739
Hs 683,5281321,-2.3150031498918495
OAW28,44493528,4.631141764792384
CA46,11396600,2.515122226404857
EJM,439501,-2.5591027297640565
ML-1 [Human thyroid carcinoma],51039095,1.326261900002616
CA46,11707110,2.876405562319207
Hep-G2,44607530,1.8246078375377963
MCAS,16722836,2.5171913283956613
NCI-N87,73707386,2.4106113659233723
SEM,53393127,4.163322375685533
KMS-27,4096211,0.8812731296424201
SEM,6252,-2.7487715463047926
SNU-1272,selumetinib-PLX-4032 (8-1 mol-mol),6.285014325142589
SNU-1272,10184653,2.951340324734288
ESS-1,135984461,4.427051677708814
KMRC-2,262093,3.029643780288338
OE21,piperlongumine-MST-312 (1-1 mol-mol),1.2426960927906567
Hs 683,4378219,5.423312148170216
SNU-1033,10127622,1.9510135134483133
GOS-3,tanespimycin-gemcitabine (1-1 mol-mol),3.128044986938021
SNU-308,46398810,3.035178089819383
SET-2,11964036,0.2316148322598224
CML-T1,67156097,-2.1928175380469477
LoVo,44185566,1.1715497148164364
KMS-27,124202324,1.1714757425485065
MCAS,25195348,2.845282760757658
KMBC-2,9967941,1.9178199848644633
ML-1 [Human thyroid carcinoma],3025986,-0.9166044093803444
AU565,119182,0.402305157716339
ML-1 [Human thyroid carcinoma],36314,-4.393977809452653
CA46,tretinoin-carboplatin (2-1 mol-mol),4.700900152183415
RPMI-7951,3081361,2.390832718109946
SNU-1214,selumetinib-vorinostat (8-1 mol-mol),1.1139893258531253
SKM-1,25195348,1.6929147684241908
GOS-3,9926054,2.0544356724695776
PaTu 8988s,3503,2.76867417170209
Ku812,17755052,2.1126549747307535
EJM,carboplatin-etoposide (40-17 mol-mol),1.4421874233068297
OE21,448949,1.634533405585945
TE 617.T,44543605,4.234759992226973
NCI-H2110,5278396,3.9686122668770416
HuT 78,3025944,4.291408043863783
HuT 78,984333,1.4807762289322746
OE21,24748573,1.791064623837087
CA46,11612883,1.866301185217262
SNU-1272,54618164,4.215546778710406
BT 248,2945648,2.911977762170341
A4/Fukuda,navitoclax-pluripotin (1-1 mol-mol),-2.9042967889462408
ESS-1,5282054,2.6666271713695906
PE/CA-PJ49,135398516,2.6308812592012467
ESS-1,selumetinib-decitabine (4-1 mol-mol),5.708912466990789
OAW28,UNC0638-navitoclax (1-1 mol-mol),1.4894889011779118
SKM-1,42642645,1.502866726077564
SW1990,12003241,-1.6004272332343192
BT 248,25126798,4.2564362718884965
NCI-H1395,crizotinib-PLX-4032 (2-1 mol-mol),2.536780809037994
NCO2,3503,1.449577551391915
PE/CA-PJ34 (clone C12),11222830,1.6303913144002309
RERF-LC-A1,71680916,4.452837016645261
HEC-151,6623618,2.715792717872131
BFTC-909,carboplatin-etoposide (40-17 mol-mol),3.649517561488253
SW1990,5460769,2.4608974418371017
SNU-8,9866186,3.3154856187317643
ESS-1,135398738,5.75744142626397
YH-13,44241473,5.475816552188209
KMS-20,4477,-0.4884463728422688
Kasumi-2,navitoclax-birinapant (1-1 mol-mol),-3.1912080416511355
SNU-308,12001922,2.139310360120992
ESS-1,25102847,3.139039712214138
HSC-4,5282054,3.7951129778884822
NCI-H2172,ISOX-bortezomib (250-1 mol-mol),1.8546920872964217
KMS-20,navitoclax-PLX-4032 (1-1 mol-mol),2.7801553034248543
YKG-1,carboplatin-etoposide (40-17 mol-mol),2.9316391165537943
NCI-H1395,72199292,3.1887982930787575
HEC-151,sirolimus-bortezomib (250-1 mol-mol),0.8769904812641561
KYSE-70,46843906,3.5210263801871498
NCI-H2081,24748573,1.609194979965708
BT 248,53481919,4.127258509947241
RPMI-7951,100016,4.945357769827656
BFTC-909,11427553,2.7610941057010754
IST-Mes1,6918837,-3.247555275823077
JIMT-1,6852167,4.253888723725077
Aska-SS,12001922,1.1901080826215733
NCI-H2172,16722836,1.8466753686021025
PE/CA-PJ49,9823820,3.972273865868368
TE-15,445091,4.176775577912737
TE-15,10074640,3.669455422609935
NCI-H1395,4477,0.6354024043517065
GOS-3,56649450,5.993657371981695
A4/Fukuda,5746,-1.1009867615741116
BT 504,navitoclax-pluripotin (1-1 mol-mol),-1.46370438861848
KP-4,11427553,2.2511460729021224
AU565,135875424,4.732736146663846
HCC2218,navitoclax-piperlongumine (1-1 mol-mol),2.0551255289167893
WM983B,vorinostat-carboplatin (1-1 mol-mol),3.825571176347783
SNU-1033,45279963,3.891384028776156
OE21,44137675,3.048058416075801
PaTu 8988s,3062316,1.0456910406995648
Kasumi-2,5470400,-0.4099593110944021
KYSE-410,136227924,3.831866760516254
NU-DHL-1,2733526,3.27744677089757
SNU-308,9866186,2.6206872366175302
SNU-308,135875424,4.501679724510711
NCO2,6918289,-0.1788871390168953
HSC-4,216239,1.6239220207771676
SNU-8,6918328,-0.0298959396904497
HSC-4,serdemetan-SCH-529074 (1-1 mol-mol),2.5503350460616505
H-STS,327653,2.5353230161110014
SNU-308,3815108,4.426401095088581
SK-N-AS,56963564,-0.2708005966820242
IST-Mes1,216239,2.2087908746431517
SW1990,969516,2.8420789096313057
NU-DHL-1,327653,2.351197542951544
SK-N-AS,10322450,4.76025598295129
A4/Fukuda,119182,-4.160589878424858
Hs 683,navitoclax-PLX-4032 (1-1 mol-mol),2.4517865371866163
SKM-1,BRD-A02303741-carboplatin (1-1 mol-mol),3.2500648097928524
KMBC-2,decitabine-navitoclax (2-1 mol-mol),0.1268287752394686
IST-Mes1,11364421,-1.7965673619245748
NCI-H2172,6918837,-1.0151074573651029
Raji,54618771,-0.1378575615243227
BFTC-909,selumetinib-navitoclax (8-1 mol-mol),4.610305702630868
KP-4,10113978,3.65058716470038
LCLC-103H,3815108,3.704858926741837
NCI-H1395,42642645,1.8763678628327745
SET-2,135659046,3.4006834919950006
KYSE-410,753704,5.6578219631905435
MM1.S,262093,0.96316485237803
HuT 78,613000,1.4786721028886782
BFTC-909,selumetinib-JQ-1 (4-1 mol-mol),1.1253035869238386
SK-LMS-1,44491742,4.239159149665423
SET-2,46943432,0.0852924787187384
HEC-151,984333,1.4845970451786328
KP-4,3503,1.291142260744515
SET-2,9903786,0.1058309934713531
NCI-H2110,126941,0.8722085310593726
JIMT-1,10385095,3.3257762843711913
NCI-H2081,6450551,1.1680905848909615
HEC-151,3825829,3.2794548774754384
KYSE-410,17755052,0.637998239137264
SW1990,serdemetan-SCH-529074 (1-1 mol-mol),2.760960145814768
PE/CA-PJ34 (clone C12),262093,3.186494210920842
GOS-3,51039095,2.831868271027857
D283 Med,168313200,1.8321011656642825
CA46,11977753,-4.21997551918338
TE 617.T,5460769,-1.488012889612994
TE 617.T,5329102,1.5061058549942548
LNCaP clone FGC,445643,3.690270900500078
RERF-LC-Ad2,11238147,1.9847745124514788
LNCaP clone FGC,10113978,2.438610206970959
KMS-27,11396600,3.3340163467465573
NCI-H2172,219104,5.178074654865666
SK-MEL-1,568763,0.7330272131368595
Ku812,JQ-1-UNC0638 (2-1 mol-mol),-1.3299079938073646
HEC-151,selumetinib-piperlongumine (8-1 mol-mol),2.3699584185565836
OAW28,654092,-1.8070222863139416
Hep-G2,25150857,1.869528617252537
JIMT-1,49766530,-0.5672366381322033
OE21,4917,1.8464114079840808
HuT 78,11955716,-3.02864832586091
SW1990,135398516,1.7693870648731356
TE 617.T,JQ-1-vorinostat (2-1 mol-mol),1.0614147730739114
OAW42,6184667,3.3333432418091067
NCO2,23635314,-4.061610187164504
HCC2218,9887053,4.291749578436511
HARA [Human squamous cell lung carcinoma],2113511,5.545523050638764
KYSE-70,135440466,2.892957215680813
MM1.S,119182,-3.364464438003169
TE-15,49836020,0.684840592082847
SNU-8,5287620,-2.974029721204148
AN3-CA,168313307,4.649989431692814
PaTu 8988s,5284616,5.504271391115589
MCAS,71304818,1.9599377919200471
Kasumi-2,11455910,-0.3707966959989963
YH-13,5287969,-1.6680517760665383
Ku812,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.5255380430209794
NCI-H1092,24785538,0.314823204123774
SNU-1033,4521392,4.048046804000424
HEC-151,448949,2.014658447928665
HuT 78,9549297,1.1531452884135298
NU-DHL-1,23635314,-3.800545586452872
EJM,9935249,2.9209217117855903
RERF-LC-A1,3676137,4.204225736275773
HuT 78,23582824,1.377489502141806
SNU-8,969516,2.7797463612145017
KMS-27,11228183,-4.318717214987111
IST-Mes1,51039095,1.641675506171098
KMBC-2,53232,2.737414991179705
MM1.S,15547703,2.467235317270649
WM983B,3081361,1.8201189631058072
CML-T1,60168763,3.1201048573104395
SNU-308,73707398,3.5686803185694327
SNU-1033,135398516,1.7537770421704515
PE/CA-PJ49,26596,-2.486533753867605
RERF-LC-A1,11640390,3.672330098997642
KYSE-410,10427712,5.99349260924601
OAW42,11427553,3.2697444811707417
NCI-N87,navitoclax-MST-312 (1-1 mol-mol),0.8705289738440536
SEM,25102847,-1.3835697041248178
A4/Fukuda,11719255,2.014724282446697
PaTu 8988s,24772860,-3.347769561665238
NCO2,216468,-1.9272741493225116
H-STS,vorinostat-carboplatin (1-1 mol-mol),1.9243801953461248
ML-1 [Human thyroid carcinoma],10127622,2.646237824428173
NCI-H2110,9935249,3.1608776626158432
BT 328,5311,4.9120281347164525
YKG-1,24753719,4.608335607306647
SK-MEL-1,24772860,-1.586354225256687
YKG-1,135421197,3.1079510852519343
SNU-1214,tanespimycin-gemcitabine (1-1 mol-mol),-2.56698732074714
NCI-H1395,6918638,1.485308761584704
IST-Mes1,1566236,1.9315527075511711
KMBC-2,327653,3.602242571352684
TE 617.T,54619267,3.894645588668696
SEM,5738263,2.206097409243099
SET-2,135421197,1.735218850040683
HMCB,4578,4.2642752613227435
SNU-1214,11404337,-1.0088442164692528
SK-N-AS,11427553,1.9310385215970292
BT 504,49766530,1.1284892746391262
CA46,5351362,0.7524287969492447
TE 617.T,10427712,3.9181007930072855
TE 617.T,445643,3.920587629900857
YH-13,4259181,0.5149162893859401
SK-N-AS,613753,2.9493524558952755
RERF-LC-A1,44607531,1.5568125430876705
SNU-1033,66577038,2.1226133896065815
KP-4,6505803,-3.0608028116863464
JIMT-1,107970,2.57313135077594
NU-DHL-1,26596,-3.470221600864271
NCI-N87,5287620,-2.9994225662437928
HARA [Human squamous cell lung carcinoma],tretinoin-navitoclax (4-1 mol-mol),0.6020182307201102
JIMT-1,serdemetan-SCH-529074 (1-1 mol-mol),2.4138688145797227
RERF-LC-Ad1,alisertib-navitoclax (2-1 mol-mol),3.5290493102127045
SNU-8,136227924,2.992589463119238
H-STS,3543504,2.597342605893142
SEM,crizotinib-PLX-4032 (2-1 mol-mol),0.5423441096655561
PE/CA-PJ34 (clone C12),9823820,3.875484528440309
SK-MEL-1,3815108,3.1523911920687726
YKG-1,4378219,2.059610902750737
SW1990,54626689,4.474747694138227
SK-N-AS,49766530,0.7065822517646133
A4/Fukuda,107985,-4.34456564276242
KMS-20,3825829,3.171752203706611
RERF-LC-A1,54454,2.441914131777335
SNU-1033,51039095,2.869483479494676
ML-1 [Human thyroid carcinoma],24785538,0.9232201957937346
HuT 78,2126,1.4144801662515558
OE21,3689413,1.0863405783683666
TE 617.T,119182,-1.0028967690047823
KMS-20,44566777,-0.0659077616958368
SNU-1272,11507802,4.459274197083698
SW1990,3025944,4.28252811259168
HuT 78,24797083,1.4167690374824495
PE/CA-PJ34 (clone C12),10127622,3.216554947417576
JIMT-1,6623618,2.4293910823732228
LoVo,3825829,3.571391318080427
NU-DHL-1,2949965,1.9624818198288896
BT 330,421610,2.3539293685640357
SW1990,11152667,-1.371942963553871
D283 Med,5328940,1.7071399155082068
HCC2218,6918837,-4.224202625927703
BT 504,11955716,-1.702392653725734
CA46,9956119,2.2503821303322864
PaTu 8988s,24889392,4.7009950355781065
HCC2218,31703,-0.3143133536876616
NCI-H2110,16038120,0.9199508274522638
WM983B,16725315,5.135366057077512
BFTC-909,3025986,-2.0399601309440336
PaTu 8988s,11222830,1.69695662081358
Hs 683,135421197,1.945110581550152
HuT 78,6918328,-2.2367447807827405
OAW28,227681,3.168890693964491
KYSE-70,56946209,-4.444419695204879
HEC-151,54678924,1.55404668159995
SNU-1272,11234052,4.3028185789263045
YH-13,piperlongumine-MST-312 (1-1 mol-mol),1.341145556901202
SK-N-AS,9866186,-0.3414073865337838
BT 248,navitoclax-sorafenib (1-1 mol-mol),1.2094722993885498
NCI-H2110,107970,2.6685379556569297
TE-15,selumetinib-BRD-A02303741 (4-1 mol-mol),4.531240951960659
KMS-20,216468,1.0997828740051716
Ku812,71466445,2.9617943038056858
HEC-151,54618771,1.151174886462992
PaTu 8988s,11234052,4.024340086805705
HuT 78,16065773,1.7912473078063993
ESS-1,1750826,-1.919918883471636
SNU-8,24771867,0.819050595072537
SK-N-AS,119607,5.899021904297609
PE/CA-PJ34 (clone C12),11647372,1.7004397362424115
Raji,25195348,4.486887099265514
SKM-1,675434,4.4448031338395655
KMBC-2,11178236,-2.9069382083568733
SK-N-AS,2871966,0.7994619805433452
BT 320,156414,4.178952757446285
D283 Med,5287620,-0.8821442485679016
BT 248,445643,3.6752138638176057
ESS-1,25262965,-1.850856990715792
RPMI-7951,3552672,2.1891148728288363
CML-T1,2733487,8.178067655910914
NCO2,24901704,-0.4886675797845647
IST-Mes1,tanespimycin-gemcitabine (1-1 mol-mol),1.7121373731851923
HMCB,16038120,1.4836068881756783
HARA [Human squamous cell lung carcinoma],49766530,5.57937649881164
H-STS,9907093,4.221434191899145
AN3-CA,72376,-2.2485185205059985
BT 328,25126798,5.564385085332987
SK-N-AS,4788,5.926383462651949
SNU-308,9911463,4.030831002886429
RERF-LC-A1,216345,4.045144681969048
BT 504,12001922,1.1383643597706272
KMS-27,6252,0.0348439734292254
LNCaP clone FGC,10296883,3.861229612453215
KMS-27,445091,4.415439646433754
Ku812,984333,-1.8126254994765352
MCAS,46943432,2.7452690797646553
GOS-3,46398810,2.269718225041391
HuT 78,148198,-3.964995663982544
EJM,3503,2.0967076650635543
KYSE-410,56946209,-4.266724774825525
HuT 78,4261,-0.4546763762816934
RERF-LC-Ad2,1242560,3.853205903260469
SNU-1033,65628,4.326862310201289
RERF-LC-Ad2,71466445,6.028378172033726
SNU-308,vorinostat-carboplatin (1-1 mol-mol),4.300379627893463
KP-4,148198,-2.7737316499717353
SW1990,5281672,4.431148411532364
KYSE-70,135398744,6.338938630156892
WM983B,168312962,2.390159684164899
SNU-1214,49793307,-3.442501742996358
NU-DHL-1,4096211,0.6464919825454908
BT 330,11719255,3.5995815229972488
SK-N-AS,4477,0.9089749928412676
NU-DHL-1,72193861,-0.4414983831950781
AU565,11234052,4.466615830851295
SNU-8,11507802,1.7250586009549282
Aska-SS,439501,-3.4608963825976686
SET-2,1750826,-1.8928364956090873
NU-DHL-1,3081361,1.944566373471897
Kasumi-2,135999136,3.771420948620172
OE21,carboplatin-etoposide (40-17 mol-mol),4.891272299916478
BT 139,11257553,1.1662278460307622
SK-N-AS,216468,2.6100436950053845
NU-DHL-1,11657048,4.264544687406424
BT 328,15953870,4.378443753461669
CML-T1,9823820,1.5491308586448294
OAW28,JQ-1-carboplatin (1-1 mol-mol),2.7763585253391625
CML-T1,15547703,2.6642294109203823
SNU-8,216468,3.852480687275417
SKM-1,54618771,0.6725959366795358
SEM,selumetinib-PLX-4032 (8-1 mol-mol),4.899213225344207
RERF-LC-Ad2,44566777,0.7222536941065739
YKG-1,JQ-1-UNC0638 (2-1 mol-mol),2.7051806168218153
ESS-1,23582824,0.5465688177901259
NCI-H2081,decitabine-navitoclax (2-1 mol-mol),1.4988648347854454
AN3-CA,44202524,2.221803011886496
Hep-G2,9936388,0.9252852669938214
ML-1 [Human thyroid carcinoma],36462,0.3533243941090192
OAW28,10296883,4.314409366833216
KYSE-410,53301938,-5.993806788421289
RERF-LC-Ad2,44607531,1.5056793765283658
LoVo,6623618,1.7195113979524326
GOS-3,42642645,0.8540004409462456
A4/Fukuda,285033,-4.063528792592557
HEC-151,4378219,2.401235967325108
SET-2,10172275,5.003847259947949
BFTC-909,23725625,7.000464253417552
NCI-H2081,25154868,4.423306661705061
BFTC-909,2949965,3.0294119536880197
RERF-LC-A1,3854666,0.6720221481756725
NCO2,11152667,-1.862283935437442
BT 248,11257553,3.3794437157400754
HARA [Human squamous cell lung carcinoma],5470400,2.3733756266777037
Hs 683,7326481,2.8848658644574803
HSC-4,676352,2.328446260179327
KMBC-2,9933475,1.7459888748592547
AN3-CA,1566236,1.2128002285671464
Aska-SS,216345,4.469243610618642
ESS-1,135440466,2.7026954574197424
D283 Med,24748573,1.2146097740205386
SK-N-AS,984333,1.2966454176671267
HSC-4,navitoclax-birinapant (1-1 mol-mol),2.9615241748083907
PaTu 8988s,421610,3.586133279881709
NCI-H2110,15547703,2.9800613541020633
HCC2218,6852167,2.7413890151562543
EJM,selumetinib-navitoclax (8-1 mol-mol),3.474694147708575
D283 Med,72193861,-0.1483015304434956
KMBC-2,44462760,4.169877786786469
LoVo,6505803,-0.2027234925460443
SNU-1214,44259,0.5042401155612436
NCI-H2110,89183176,5.1726369191381165
OAW42,104842,-3.272911588630791
PaTu 8988s,1716436,2.523682098033693
NCI-N87,6252,-1.400414082532842
KYSE-70,71466578,3.801340757329347
SET-2,65628,4.139593667952883
YH-13,6610216,4.911134346587397
KYSE-70,24785538,1.5800117539652696
KMS-20,3081361,1.7600848114221452
Aska-SS,49793307,-2.549218823655417
AN3-CA,67291369,4.137326776444439
NCO2,216345,3.2715449791190596
ESS-1,9915743,1.8900363437156489
NCI-N87,5470400,-1.6354434063399317
CML-T1,4477,-0.6676342393752774
SNU-1033,445643,4.458031896103707
SKM-1,24785538,-1.0651885035802942
SK-N-AS,5287969,-2.116222931677428
OE21,25022340,4.370946816483807
CA46,selumetinib-tretinoin (2-1 mol-mol),4.988677002369049
SK-N-AS,969516,2.8216499712220027
RERF-LC-A1,16038120,1.8586255302614336
Kasumi-2,sirolimus-bortezomib (250-1 mol-mol),-0.078386775418122
HARA [Human squamous cell lung carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.8572824243778725
H-STS,9887053,3.8773696813734246
A4/Fukuda,2871966,-1.2628046939905593
CA46,3543504,2.8823298921776717
BT 248,135411,2.4646623802818577
MM1.S,1750826,-2.8354438151746972
IST-Mes1,5287620,-1.7840398419727848
Hs 683,156414,1.79593868877012
NU-DHL-1,23725625,1.761495354377978
HSC-4,57519531,1.2769425534379089
NCI-H2081,15547703,3.0939456177037945
HuT 78,216345,3.2083234120467004
KYSE-410,24901704,3.119564924115497
KMRC-2,10184653,2.3551240861075473
ESS-1,9935249,3.3777402733386617
HMCB,4477,0.1906220265974898
AU565,400769,-0.800888344050601
AN3-CA,10113978,0.3124355863019905
LNCaP clone FGC,9927531,4.548275216558741
A4/Fukuda,65064,3.1077716650538707
KMRC-2,15547703,4.90562893778179
BT 328,16038120,0.9793977548017024
Raji,46907787,-0.4930919590495862
SW1573,11238147,3.4967804964098517
HARA [Human squamous cell lung carcinoma],46907787,3.600628557962214
LNCaP clone FGC,7251185,2.5221179443574493
GOS-3,44137675,4.312209162350938
SNU-308,54618164,4.492572736691696
PaTu 8988s,11404337,-0.6739371473320328
NCI-H1395,9967941,3.3785918920686924
Raji,135411,0.5014739051384897
SNU-8,10074640,3.140800903715358
D283 Med,16065773,1.947977492056464
NCI-H2110,carboplatin-UNC0638 (2-1 mol-mol),5.586200860655614
HEC-151,72199292,1.439503600932236
BT 504,16219061,3.029811270539528
D283 Med,5335621,3.872227054379363
SKM-1,15953870,2.3750866132882305
A4/Fukuda,24180719,2.900503133545593
SK-LMS-1,2828334,6.288537675968613
Raji,24856436,0.5760631088144806
LoVo,448949,1.89047161937067
NCI-H2172,25262965,2.237724096784882
H-STS,selumetinib-MK-2206 (8-1 mol-mol),2.3802158766857935
KYSE-70,3385,2.7043091028991175
SKM-1,46398810,2.0273283297042712
SKM-1,serdemetan-SCH-529074 (1-1 mol-mol),2.2169498527480664
NCI-N87,44486219,4.180509732108111
HuT 78,16725315,3.3290051312719284
D283 Med,9444,3.79519909230311
NU-DHL-1,5282054,2.5574961270689887
OAW28,11364421,1.0555351676055402
H-STS,25195348,4.556158906706763
D283 Med,11396600,2.9109671183024983
KP-4,17755052,3.700899087296149
IST-Mes1,53232,2.11135293708232
KMRC-2,3634881,3.0472209218282407
HCC2218,carboplatin-UNC0638 (2-1 mol-mol),3.781070783372361
AU565,5335621,4.583819394214033
Kasumi-2,107970,1.3663131605888186
KMBC-2,19582717,5.005649239927271
MCAS,439501,-1.7764971276715424
KMS-20,89928392,-0.4430373670813298
BT 504,25183872,-1.3672603639210117
HuT 78,219104,1.1531069030640524
LNCaP clone FGC,56963564,-0.1269898531988885
HSC-4,15953870,4.269670192757531
Kasumi-2,409805,3.7279902229812114
Kasumi-2,selumetinib-piperlongumine (8-1 mol-mol),1.718006716449046
Aska-SS,60700,-1.5034109982704524
OE21,12001922,1.590204471841314
BFTC-909,25126798,3.8219929141120166
SNU-8,56963564,0.0574253000889037
IST-Mes1,selumetinib-GDC-0941 (4-1 mol-mol),2.032921854049634
Ku812,tanespimycin-gemcitabine (1-1 mol-mol),-4.681338743201834
LoVo,11964036,-0.4950100771581299
PE/CA-PJ49,9935249,3.146155709540263
AN3-CA,24964624,1.438954699001727
HMCB,25154868,4.752941970603395
AN3-CA,46907787,4.249089743528786
Hs 683,9884685,-0.0613437771219763
BT 248,3503,0.874016545693445
SNU-1272,54618771,3.136436186338116
Aska-SS,docetaxel-tanespimycin (2-1 mol-mol),-1.5084400255004682
KMBC-2,44237094,3.0834774593122924
SK-MEL-1,10184653,1.984161935201279
OE21,9927531,4.992848693668257
NU-DHL-1,5281321,-2.700321539992985
LNCaP clone FGC,25062766,1.6324812543548115
NCI-H1092,navitoclax-sorafenib (1-1 mol-mol),1.0021052217425306
KMBC-2,448949,2.9773081298124726
MM1.S,6610216,4.132453161575956
BT 504,BRD-K55473186,1.8217785263443804
TE-15,tanespimycin-gemcitabine (1-1 mol-mol),-0.1853120012449584
RERF-LC-A1,11214940,1.4159869162167165
KMS-27,9907093,4.633224131705679
Hs 683,3503,2.6166989682892483
SNU-308,104842,-0.6964578064926701
Hs 683,135928012,3.6982239425483887
CML-T1,24856436,-1.6072060020086385
SW1573,107970,2.0608182724975266
HuT 78,3038522,2.0525522612169813
AU565,71304818,2.0398490425817144
YKG-1,1750826,0.4616022986658529
SNU-8,568763,0.2503555108357383
NCI-H1092,227681,1.9884114901843049
BT 139,17755052,0.3641484354126661
SW1990,2749,1.9109779661146389
SKM-1,54678924,0.9652165480263206
KP-4,16720766,-1.213576786632785
NCI-H2110,24821094,3.684367762026687
YKG-1,151289,1.726340360462664
D283 Med,72199292,-0.0739367415470992
KMRC-2,2126,5.828846038780047
ESS-1,7326481,3.8932312053689873
Raji,119607,5.398499611687464
SK-N-AS,72734382,4.25660887919325
MCAS,9956119,4.084833721760423
Kasumi-2,tanespimycin-bortezomib (250-1 mol-mol),-1.599342036270796
SK-LMS-1,54618305,4.344599681263995
TE 617.T,9907093,4.051637713465443
KMBC-2,4578,5.794411776152561
KMS-27,11507802,0.7171665546072066
CML-T1,24785538,1.8797614633691848
OE21,9911830,2.128262086485743
HSC-4,25150857,3.233332545340528
BT 504,SNX-2112-bortezomib (250-1 mol-mol),-2.8994878905257253
CML-T1,72193861,-0.1877801569331633
Kasumi-2,216468,0.9994844042695143
BT 330,89928392,0.2679954207172777
RERF-LC-A1,3025986,-0.0701931499801226
AU565,23582824,-0.1593812680979049
PE/CA-PJ49,322968,4.844964817248369
CA46,66577038,2.896384523521911
TE 617.T,10127622,2.9715092422586324
SNU-1033,5278396,3.240191745193955
KP-4,JQ-1-carboplatin (1-1 mol-mol),3.935772405145619
HSC-4,4259181,1.301377168384764
A4/Fukuda,navitoclax-piperlongumine (1-1 mol-mol),0.9145762959476356
SET-2,135423438,1.6244153608303664
NCI-H2081,36462,-1.2215520528836945
EJM,11717001,5.2726365511414475
NCI-N87,10231331,4.183605147658756
LoVo,135928012,4.12079355273469
KMS-27,72193861,-0.2876549963756236
D283 Med,tanespimycin-gemcitabine (1-1 mol-mol),-4.72619951673043
HEC-151,42642645,2.0154759097446875
RERF-LC-Ad1,selumetinib-GDC-0941 (4-1 mol-mol),2.261809192633126
RPMI-7951,JQ-1-navitoclax (2-1 mol-mol),1.5648934807647052
HMCB,salermide-PLX-4032 (12-1 mol-mol),5.107969579791182
LCLC-103H,10184653,2.9582533974514433
ESS-1,46907787,0.8695499024183594
KMS-27,126941,-3.059494952153393
OAW42,24785538,2.4058899171670327
NCI-H2081,135659046,2.9715500062667455
AU565,JQ-1-carboplatin (1-1 mol-mol),2.695919157809604
CML-T1,5470400,-2.3275269381266326
RERF-LC-A1,11427553,2.9426624918133615
SET-2,54619267,3.644282553207176
KMRC-2,3689413,-1.0505298927618916
SNU-8,navitoclax-PLX-4032 (1-1 mol-mol),4.548524240325165
HCC2218,24951314,0.6107555519957106
RPMI-7951,8515,4.057754260895621
OE21,24856436,0.030233909527142
KYSE-70,3634881,3.4536977245329363
PE/CA-PJ34 (clone C12),10302451,1.6517506382371558
HARA [Human squamous cell lung carcinoma],selumetinib-vorinostat (8-1 mol-mol),4.369788913914824
NCO2,4259181,-1.6856701146210389
NCI-H1092,16659841,4.30883248177806
MM1.S,25062766,2.021817164392542
LNCaP clone FGC,6438330,2.9794054600880013
D283 Med,selumetinib-UNC0638 (4-1 mol-mol),5.192185535679209
TE 617.T,23635314,-3.733388930400156
LCLC-103H,16115403,-4.4820283098337805
NCI-H2172,148198,-0.2534137859754289
A4/Fukuda,44819697,-1.7397384839387715
AU565,5284616,2.6982931675931914
SNU-1214,216239,2.540927485180012
PE/CA-PJ34 (clone C12),6438330,2.354249023140132
YH-13,6918837,-2.973076414332095
HEC-151,9903786,2.765131251863377
Hs 683,71304818,2.49706068927472
WM983B,72193861,2.2054227981405465
SNU-1033,piperlongumine-MST-312 (1-1 mol-mol),1.4896523298912026
Raji,ISOX-bortezomib (250-1 mol-mol),0.7576291321089732
BT 330,16736978,2.4354691948516636
BT 248,selumetinib-piperlongumine (8-1 mol-mol),3.781064018131383
YKG-1,3136844,4.395647151601772
Hs 683,31703,-1.3519603121797323
SNU-8,navitoclax-MST-312 (1-1 mol-mol),1.2469420286948325
TE-15,676352,1.8572191068197632
TE 617.T,11364421,-5.700379248879762
TE-15,54143018,0.5513791553368855
MCAS,2113511,4.790363283284617
Aska-SS,4917,2.9830188607886856
RPMI-7951,11683005,2.9377231655803526
KP-4,445643,3.533968483343183
SK-MEL-1,ISOX-bortezomib (250-1 mol-mol),1.490586324643071
NCI-H1092,11228183,0.9840040358909228
Hs 683,676352,1.7883450519966615
BT 320,vorinostat-carboplatin (1-1 mol-mol),4.235025979591699
LNCaP clone FGC,387447,-4.3744425710670685
KP-4,439501,-3.618807292682963
LNCaP clone FGC,24771867,3.412877398053759
KMS-20,2126,4.021349157282486
HEC-151,64971,3.070504643309202
ML-1 [Human thyroid carcinoma],11647372,1.3935699525801049
BFTC-909,alisertib-navitoclax (2-1 mol-mol),3.1464879320843635
NCI-H1395,100016,6.569605836811141
KMS-20,9884685,-0.8480553066997102
NCI-N87,alisertib-navitoclax (2-1 mol-mol),-1.7331970522410185
RERF-LC-A1,72193861,-0.0328319220759964
KYSE-70,51039095,3.5490987853947247
PaTu 8988s,alisertib-navitoclax (2-1 mol-mol),-0.4124098932275182
SW1990,selumetinib-vorinostat (8-1 mol-mol),3.2800234723001016
EJM,46215462,1.2684837092951116
KP-4,156414,1.731574968381172
OE21,11396600,3.3249407167750284
AN3-CA,5311,1.952423788364144
KMS-20,9549297,1.1298438503478845
KYSE-410,64971,2.2623618573953035
SET-2,11152667,-2.526707061700353
JIMT-1,vorinostat-carboplatin (1-1 mol-mol),3.798404753650721
Hep-G2,46199207,3.164086950692396
EJM,1566236,1.0332712944799087
NCO2,11626560,-1.177437754050202
SK-N-AS,46398810,2.143383015137399
Hep-G2,selumetinib-UNC0638 (4-1 mol-mol),0.8728537208894
SET-2,3543504,3.7201819667077176
H-STS,JQ-1-carboplatin (1-1 mol-mol),1.6767150892638072
Ku812,piperlongumine-MST-312 (1-1 mol-mol),1.051865706808779
MCAS,5311,1.443638775726388
NCI-H2081,26596,-1.5856459484869678
Ku812,168313016,4.091505378923506
RERF-LC-A1,5291,3.937522324630336
LNCaP clone FGC,426756,4.29389408705882
HMCB,2858523,3.340163049950989
KYSE-410,9926054,2.1669765108653483
KP-4,2126,3.9104129832919545
BT 328,5738263,4.558527530025055
SNU-1272,6917907,-2.5782962145708295
HARA [Human squamous cell lung carcinoma],262093,3.694607099499911
OAW42,969516,2.569990089969391
A4/Fukuda,navitoclax-sorafenib (1-1 mol-mol),1.3354427361603598
CML-T1,65628,2.7154825762494057
YKG-1,126941,-4.127185813066353
BT 330,11257553,2.5811561366626816
KMS-20,135999136,4.473937191041351
SET-2,selumetinib-BRD-A02303741 (4-1 mol-mol),3.5961531213512834
LoVo,6918328,-0.3156299102516719
Raji,46843906,1.86954144818753
HuT 78,BRD-A02303741-navitoclax (2-1 mol-mol),0.2900830981041313
NCI-H1092,613753,3.151391695683802
BFTC-909,3854666,1.1654585644167257
YH-13,54454,3.0632699075103926
OAW28,2746,2.637952220594215
Raji,71466445,2.2613596218999295
NCI-H2172,11625818,5.408752687191274
HSC-4,crizotinib-PLX-4032 (2-1 mol-mol),2.8141472051881076
RPMI-7951,5311,1.014545329666132
OAW42,2742550,3.9256565797202776
PE/CA-PJ34 (clone C12),alisertib-navitoclax (2-1 mol-mol),-0.593506063139588
HuT 78,2733526,3.230584673721713
OE21,36462,4.517672973298236
NCI-H2081,4259181,0.351932807704407
HCC2218,5460769,-0.600250204778271
SNU-8,5460769,4.64495536055113
EJM,16720766,0.882880765643151
GOS-3,168312962,3.853513662902144
A4/Fukuda,136227924,1.9204852137512072
PaTu 8988s,11317348,4.902981978815887
PE/CA-PJ34 (clone C12),12003241,-0.6178639171957262
ML-1 [Human thyroid carcinoma],46191454,1.5014607148772898
ESS-1,1242560,3.6553625997250143
BT 330,5287620,-3.02332319898901
LNCaP clone FGC,24772860,-1.3292601865972158
MM1.S,3815108,1.971538783457294
A4/Fukuda,tretinoin-carboplatin (2-1 mol-mol),3.3716994915899945
KYSE-70,20959075,-2.927604227069557
YKG-1,44491742,4.005192115909779
HARA [Human squamous cell lung carcinoma],20959075,-3.3968163713216657
OAW42,49846579,1.7625330891329691
A4/Fukuda,135440466,-0.9873079875011114
HMCB,24901704,3.7054734278526986
RPMI-7951,JQ-1-vorinostat (2-1 mol-mol),1.1154559644743227
Kasumi-2,6505803,-2.445084849944434
TE-15,4917,3.684614793750609
HMCB,9907093,4.430209797884857
NCO2,9823820,0.7086921452062875
GOS-3,216239,2.237593713178657
AN3-CA,374536,2.9665572949501775
HMCB,448949,2.7592399466934516
RPMI-7951,16720766,-0.004796168701453
NU-DHL-1,67156097,-2.718460958664846
HEC-151,135411,-0.0260657506821276
BT 328,71751553,4.608962030519419
SW1573,JQ-1-vorinostat (2-1 mol-mol),2.32143209708559
SKM-1,135875424,3.1648969740603095
SNU-8,4917,3.3493519367479396
RERF-LC-A1,9887053,6.112452950263811
GOS-3,6610216,4.739620593848468
SK-LMS-1,9866186,2.47967074493931
SK-LMS-1,462382,0.9703247285669422
KYSE-410,216345,4.526779821165723
EJM,16013152,4.173303948908386
TE 617.T,57519531,1.7478555944414165
BT 328,25105715,3.784465780287459
BT 248,9935249,2.246614582121965
SNU-1214,JQ-1-vorinostat (2-1 mol-mol),-1.44187466676985
PE/CA-PJ49,176870,2.630140398370365
CML-T1,crizotinib-PLX-4032 (2-1 mol-mol),-0.082010794969092
SNU-1272,44486219,5.3170939881808605
NCI-H1395,9933475,2.0762479324148435
ML-1 [Human thyroid carcinoma],11626560,2.2482240841306123
SNU-1033,11178236,-4.360978702778772
KYSE-410,3465537,2.783776931016741
KMS-20,31703,-1.639291403660424
RPMI-7951,6918328,-0.3826949167276244
BT 504,11178236,-2.8422722013672037
JIMT-1,6505803,0.7397672871240382
SEM,16219061,1.294188336335581
MM1.S,11625818,2.94126991090669
BT 248,57519531,6.254880017804167
OAW28,serdemetan-SCH-529074 (1-1 mol-mol),2.2159278934374416
H-STS,25262965,-3.423231216338223
SK-MEL-1,24951314,1.8160222030940336
TE-15,sirolimus-bortezomib (250-1 mol-mol),0.9127775689721958
RPMI-7951,36314,-5.69556054736906
BT 248,alisertib-navitoclax (2-1 mol-mol),-0.6283307077190651
EJM,1716436,2.8546888693070818
TE 617.T,selumetinib-UNC0638 (4-1 mol-mol),1.935672721822544
BT 320,3025944,4.750339696858045
SET-2,16038120,0.992903996663106
SK-LMS-1,54619267,4.473937340383362
NCI-H2081,67156097,-1.7291479863882548
PaTu 8988s,252682,7.221235451439796
NCI-H2110,23635314,-3.755634787992258
KP-4,15983966,-3.659286023589941
ML-1 [Human thyroid carcinoma],654092,0.5372247724983673
AN3-CA,216239,1.4123950124016178
YKG-1,44566777,0.971285441188688
BT 504,10074640,3.017335694436595
KYSE-410,11656518,2.307112216885876
BT 320,52947716,3.1695176437652757
BT 330,3465537,1.066825715550645
KMBC-2,25262965,0.9196876948223344
RERF-LC-Ad2,25126798,4.1724068761038104
NCI-H1395,vorinostat-carboplatin (1-1 mol-mol),4.5909845476881905
PE/CA-PJ34 (clone C12),445091,4.329153580227635
LoVo,148198,-1.1147075342847712
RPMI-7951,135411,0.7923410936868759
NCI-H1395,5460769,5.87662281780079
LNCaP clone FGC,46926350,-4.319899748167567
NCI-H2110,71466380,5.718855140716474
KYSE-410,serdemetan-SCH-529074 (1-1 mol-mol),2.1526193639948015
ESS-1,JQ-1-navitoclax (2-1 mol-mol),-0.1704578961514246
SW1990,44491742,4.13198674266079
TE-15,selumetinib-vorinostat (8-1 mol-mol),2.423276654507223
SET-2,6914657,-8.835137306174536
MM1.S,crizotinib-PLX-4032 (2-1 mol-mol),1.0198368521760113
HARA [Human squamous cell lung carcinoma],159324,3.9851922367796937
HARA [Human squamous cell lung carcinoma],10427712,4.036967432982734
PE/CA-PJ34 (clone C12),72376,-1.7240853207922306
RERF-LC-A1,4917,2.996858395229378
OAW42,3854666,1.601770174817354
Hs 683,11317348,3.009129007427486
NCI-N87,tanespimycin-gemcitabine (1-1 mol-mol),-4.9778446176040845
RERF-LC-Ad2,12001922,1.5702211119337048
NCI-H1395,44566777,1.012205213932494
HSC-4,16720766,-1.6245250648624636
NCI-N87,3543504,4.249309596150935
KP-4,6918289,2.3270563261529276
RPMI-7951,25102847,2.7186548604055725
RERF-LC-A1,5746,0.8497297098985078
A4/Fukuda,56946209,-6.395954164738885
MCAS,654092,-1.435173669526354
SNU-308,168313016,4.41321855315878
KMRC-2,23582824,0.4728362426959734
RPMI-7951,168313047,1.8853313482329883
AU565,5351362,0.5336942302969934
SEM,3385,2.486221343421728
SET-2,262093,0.9752595476876692
SET-2,alisertib-navitoclax (2-1 mol-mol),-1.6726061008876394
BT 328,5281321,2.1998966981580073
Aska-SS,navitoclax-MST-312 (1-1 mol-mol),1.6298710816433473
HARA [Human squamous cell lung carcinoma],9826308,0.352829852370258
NCI-N87,11238147,1.7339284670687316
LoVo,135999136,5.7154474843469565
OAW42,444795,4.960287089839776
CML-T1,6450551,-1.1017942434712815
KYSE-410,52947716,2.8858360152094695
SNU-308,10427712,4.3610615678797595
AU565,44620216,3.755834453350393
SNU-1214,73707398,0.3322136890505088
SNU-1272,16725315,4.676116134552396
ML-1 [Human thyroid carcinoma],5351362,1.4214743835970418
Hs 683,219104,4.201816269396338
SNU-1033,3552672,1.8370323194969735
SNU-308,crizotinib-PLX-4032 (2-1 mol-mol),2.800363734120127
YH-13,15983966,-4.17863717198839
SK-N-AS,3689413,-1.598597846908754
SK-N-AS,9825149,1.6986340964255513
KYSE-410,65064,4.338133496704831
AN3-CA,25150857,3.292765254129613
BT 504,409805,3.844578236593203
MCAS,5281321,-0.2583959641541334
A4/Fukuda,409805,3.596796639089143
RPMI-7951,409805,3.607253520959431
OAW28,446155,3.9986810531407486
IST-Mes1,9936388,2.2275468363886763
YH-13,322968,2.764039711973652
KP-4,44493528,4.395451461814576
BT 248,10302451,3.817813130063646
CA46,241158,1.6221144264981358
BFTC-909,54618164,4.281231487810877
PE/CA-PJ49,44137675,2.9964477729791787
A4/Fukuda,3854666,-0.0838776105349313
HCC2218,72734382,3.781656999997794
WM983B,16219061,3.3781658288780085
OE21,11647372,1.281241297693498
KP-4,11214940,0.8001776072875577
MM1.S,25154868,3.9012655265230127
BT 504,6505803,-4.714346364333315
BT 330,3634881,2.0146150726773637
H-STS,44202524,1.3266978322273313
NCI-H2172,46215462,1.890508970942278
NCI-H1092,25183872,-0.0477909858083303
SNU-308,5470400,-1.2304202061174676
BT 328,11152667,1.7027658226426858
LCLC-103H,322968,4.113300289497368
BT 330,3025986,-0.5037878900572669
BT 330,753704,4.468894642288355
MCAS,969516,1.3336911200408736
HEC-151,36462,3.471634124285656
RERF-LC-Ad2,5311,3.206144053941421
SW1990,25154868,5.078344865125208
HMCB,15547703,2.756722106244236
SNU-1033,11626560,1.7306664010056585
RERF-LC-Ad1,11222830,1.8540425304510488
PE/CA-PJ49,52912189,2.038214782345057
BT 248,10184653,1.5665149744328004
Ku812,24753719,3.51384685300995
GOS-3,135421197,1.697146176044067
IST-Mes1,25102847,1.8280194065910471
SK-LMS-1,3136844,4.349436037935601
TE-15,322968,4.717017848015086
BT 504,5470400,-1.7258555212468338
OE21,10113978,3.4201681643891413
CML-T1,5280436,4.11670865979611
BT 504,2949965,2.5682252119160185
JIMT-1,2828334,6.49148801011018
RERF-LC-A1,100016,6.9126876628990885
MCAS,selumetinib-MK-2206 (8-1 mol-mol),0.565829170882376
NU-DHL-1,6918638,-1.28362156468715
SET-2,54143018,0.6103556076462618
OAW42,5281321,-2.445150420997909
BT 330,613753,3.615021864677912
NCI-N87,107985,-3.2122311985508136
SET-2,5281672,4.329689350067033
SW1990,65064,5.293704077887717
SET-2,168313307,4.480873522233062
A4/Fukuda,25150857,1.0832866246256998
KP-4,46199207,2.668096838486965
SET-2,216239,1.8893520946498368
HCC2218,2733526,3.8936387665194423
OAW42,3136844,4.152260977947288
Hs 683,54619267,4.24261582571363
CA46,89928392,0.0283947615438792
SET-2,24978538,-1.67699540287414
KMS-27,135421197,2.249002810195298
SET-2,36462,0.7834835963268753
OAW28,11178236,-3.057015425639644
OE21,3038522,1.96217261831384
KMS-27,56963564,-0.7436339869905211
OAW28,445455,5.326899909172617
KMS-27,6610216,4.611195004957726
KMS-27,57519531,1.5676211644937377
NU-DHL-1,375860,-1.1724229979544771
TE-15,1641662,2.6442257340275495
OE21,637858,2.675555960290433
NU-DHL-1,637858,-0.1721952663561851
AN3-CA,9936388,-6.467722299824651
HMCB,3689413,1.1423939419443525
MCAS,16725315,3.3168898128798676
IST-Mes1,10184653,1.5276072056435492
NU-DHL-1,25102847,3.3147943558623916
HuT 78,24772860,-3.0726220135578353
PaTu 8988s,54618164,4.048235772282788
KMS-20,6918878,1.3372822623967346
BT 328,53392493,3.725538863996033
NCI-N87,52912189,1.61892272115858
OE21,71466380,5.2862149479921205
NCI-H2110,11494412,1.0397098548542971
EJM,44491742,4.208016925641279
NU-DHL-1,6450551,1.9014057000217284
OE21,1716436,3.782733753033253
Kasumi-2,135423438,1.5853456579896534
KYSE-410,5311,1.569986205030131
SK-MEL-1,10127622,-1.1875907450684648
HuT 78,24978538,1.2584289097403791
A4/Fukuda,56963564,-0.5107551488404702
RPMI-7951,4261,1.656871275640203
HCC2218,12001922,1.1879364076303054
SKM-1,11178236,-3.008392774513597
HuT 78,tanespimycin-gemcitabine (1-1 mol-mol),-3.1990435340994043
PE/CA-PJ34 (clone C12),135421197,2.056271924404355
TE 617.T,carboplatin-etoposide (40-17 mol-mol),1.132049095306285
SNU-308,3689413,0.3406956707675037
OAW28,44137675,4.561686598527574
AN3-CA,156414,1.36110068717594
BFTC-909,JQ-1-carboplatin (1-1 mol-mol),5.2410563732595845
Hep-G2,24797083,1.3035755936637026
NU-DHL-1,4259181,-0.8877351143250455
A4/Fukuda,71751553,4.0599050322296995
CML-T1,24180125,2.207667320892802
Hep-G2,387447,-2.9195151512018427
CA46,24951314,-0.0442972386064399
KMS-20,42642645,0.7493716009663114
NCI-N87,54619267,3.778794485594146
NCO2,10231331,-0.4964087143893907
MCAS,66577038,3.1755673384775656
KYSE-410,107985,-2.92528025460227
SEM,3038522,-0.4118927159500882
Hs 683,9927531,5.316569157291169
OAW28,322968,3.926433659329745
ML-1 [Human thyroid carcinoma],6917907,-7.443362541349426
KMBC-2,52947716,2.968056555180957
HuT 78,51039095,2.102033530869646
HCC2218,navitoclax-pluripotin (1-1 mol-mol),-0.2294031857545135
PE/CA-PJ49,216345,4.295730817362929
PaTu 8988s,24797083,1.7671088655864275
Hs 683,15983966,4.053767211388769
KMS-27,46224516,2.4008723262948353
SEM,444795,1.9334021981472231
KYSE-70,24951314,1.3178292218062186
LCLC-103H,49850262,3.834081254838611
NU-DHL-1,44507138,1.6307410381746317
SNU-1214,5278396,3.4697021692694325
GOS-3,4788,6.125814579723799
SK-LMS-1,448949,2.3077393619428186
CA46,decitabine-carboplatin (1-1 mol-mol),2.864981631125043
NCO2,44493528,3.738913102707939
HCC2218,219104,2.9510043871026643
NCI-H2081,45279963,2.492987124324476
H-STS,100016,5.985929376611731
EJM,9956119,3.780866112721705
H-STS,11404337,-0.7903033287308603
A4/Fukuda,135421197,1.440002399326734
Raji,9444,3.612558099704484
OAW42,6918878,4.7005705812756045
PE/CA-PJ34 (clone C12),16741245,6.228519168048979
CML-T1,4521392,4.044943461780163
LoVo,9887053,2.8676927346989265
HMCB,67156097,-0.9353963085848984
SET-2,serdemetan-SCH-529074 (1-1 mol-mol),1.260779700034802
LCLC-103H,2733526,4.623781011828813
OE21,2113511,5.973000294010022
BFTC-909,421610,2.763760389372973
EJM,25102847,3.2089639074549123
SNU-308,6917907,-4.778384146649152
NCI-H1395,2858523,3.2706223313658445
KMS-27,11152667,-0.6309596217329284
YKG-1,44185566,3.0761735678069884
TE 617.T,5746,-1.809843384603936
IST-Mes1,613753,3.190229377917506
BT 320,12001922,1.695610420399754
HuT 78,54613361,-0.8401705547778511
OE21,9907093,3.967532299255402
A4/Fukuda,135411,0.1560078623072997
SK-LMS-1,4788,5.52968576004321
EJM,6852167,1.8935710220557025
RPMI-7951,JQ-1-carboplatin (1-1 mol-mol),3.054924141826928
PaTu 8988s,51037431,3.954345324731351
KP-4,9936388,-5.247407210845399
Kasumi-2,241158,2.967162139629707
Hs 683,6914657,-2.788485470689341
PE/CA-PJ49,24180125,3.249476496714235
OAW28,168313047,2.064989846569142
IST-Mes1,24951314,2.196137261882708
BT 330,11455910,-0.0355958099114693
HARA [Human squamous cell lung carcinoma],24889392,3.022552356394008
BFTC-909,9825149,2.463033939289578
OAW28,46174525,4.143540766033049
TE-15,23635314,-5.216893508037696
IST-Mes1,alisertib-navitoclax (2-1 mol-mol),2.2852376454563896
KMRC-2,25126798,4.178838935050268
KMBC-2,15983966,3.0423394947967526
CA46,5282054,2.3254868404716755
NCI-H2110,1641662,4.22097007378697
KYSE-410,9935249,4.016740976439891
CML-T1,60700,-4.046906202956944
NU-DHL-1,6436223,-6.457204193178952
SET-2,9907093,3.6028257763126144
KYSE-410,36314,-5.691724228748092
SW1990,46907787,4.845912107981417
RPMI-7951,3025944,4.282884400108956
KMBC-2,sirolimus-bortezomib (250-1 mol-mol),0.4292158066242218
HARA [Human squamous cell lung carcinoma],45100309,5.833200435543825
SKM-1,SNX-2112-bortezomib (250-1 mol-mol),-3.517071278236208
CA46,1641662,3.144498035259472
EJM,9826308,-0.8928202360474983
CA46,72734382,3.577472012209052
KMS-27,24753719,3.911687472760716
SNU-1214,42642645,1.0103419328558412
PaTu 8988s,46907787,4.297293150577968
NCI-H2110,54618771,2.4596551535175504
BT 328,9908783,5.49619417239086
HuT 78,6438330,0.788518681331833
BT 504,46843906,3.7045959838451945
BT 248,44589607,2.2150317514642635
BT 328,11257553,2.5148124289145217
NCI-N87,56946209,-4.157058230951839
D283 Med,374536,-5.802881326036661
BT 330,448949,2.2489092778248856
CML-T1,11234052,1.4016611587884042
Aska-SS,72193861,0.8225136305229684
WM983B,107970,2.073106798570593
SKM-1,selumetinib-navitoclax (8-1 mol-mol),-0.63098338976802
KYSE-410,285033,-2.1152693669169924
BT 139,54618795,3.673895729151394
KMBC-2,104842,-3.307712782526657
A4/Fukuda,241158,1.407426277414268
OAW28,10184653,1.1706980363621209
SNU-1033,11640390,3.12906001854956
LNCaP clone FGC,3634881,3.3768985687237683
CML-T1,5328940,-0.6883003462747955
YKG-1,10322450,5.46076367923885
TE-15,4788,5.841864344946093
PE/CA-PJ49,57330099,4.42307803385474
IST-Mes1,11955716,-2.3343063309165095
NU-DHL-1,4578,4.105143209459994
KMS-27,11175137,1.4645453009817528
SK-LMS-1,24771867,4.309064190513273
HARA [Human squamous cell lung carcinoma],46191454,0.0255281814012309
OAW28,selumetinib-BRD-A02303741 (4-1 mol-mol),5.828946434943108
ML-1 [Human thyroid carcinoma],15547703,3.133536230544004
NCI-H2110,2708,5.257811785679327
HEC-151,72734382,4.52120073933795
GOS-3,44566777,1.372759140356778
AN3-CA,44566777,-1.0212204802664189
Kasumi-2,136227924,1.9658135956042504
SK-N-AS,3038522,1.5985736981548817
HuT 78,5494449,0.26098093907273
TE 617.T,409805,3.5642990209893024
SKM-1,54649381,3.9349803004412496
H-STS,9866186,-0.0944353973133468
AN3-CA,25154868,4.426580057954225
TE-15,44486219,4.017048995117067
BT 504,selumetinib-PLX-4032 (8-1 mol-mol),5.423322412934704
SNU-8,10184653,1.6550353804349267
HARA [Human squamous cell lung carcinoma],vorinostat-carboplatin (1-1 mol-mol),4.151404263307493
NCI-H2081,16741245,4.790981336180039
SK-MEL-1,11238147,1.9053152500687955
OAW42,selumetinib-UNC0638 (4-1 mol-mol),4.767658389208469
TE 617.T,135999136,4.164047799222283
RPMI-7951,9903786,2.3675771120862485
SK-LMS-1,3081361,3.433881373314138
Ku812,16115403,-5.456092150194313
A4/Fukuda,selumetinib-piperlongumine (8-1 mol-mol),1.1723483513994604
AN3-CA,docetaxel-tanespimycin (2-1 mol-mol),-5.191099882644974
BT 330,322968,2.4204114649278092
KMBC-2,51037431,2.8141584353563736
TE 617.T,11626560,1.8832957884579664
Hs 683,11609586,2.3962325200102317
NU-DHL-1,11364421,-5.372844831594239
SEM,9884685,1.4949119152013906
D283 Med,9823820,3.71007725808951
KMRC-2,tretinoin-navitoclax (4-1 mol-mol),2.3072936502607884
NU-DHL-1,72376,-4.025213511339456
BFTC-909,UNC0638-navitoclax (1-1 mol-mol),2.418146384904106
SNU-1272,124202324,3.3198251305185975
PaTu 8988s,11152667,-2.740642733850453
WM983B,25227462,1.1827541037160172
PE/CA-PJ34 (clone C12),4261,2.8870037717787307
SNU-308,erlotinib-PLX-4032 (2-1 mol-mol),3.159344954008492
YKG-1,2126,5.813283713723567
WM983B,156414,1.573204920480929
HSC-4,119607,3.948608575005578
MCAS,23635314,-2.30522753278216
D283 Med,11214940,-0.7958287739094837
CA46,72193861,0.1338517787347367
NCI-N87,135440466,2.814988966864087
HEC-151,46199207,3.1847539015673307
SNU-308,54618771,1.0411941789938453
ML-1 [Human thyroid carcinoma],54613361,1.1529799235720395
Hep-G2,serdemetan-SCH-529074 (1-1 mol-mol),1.77689814586136
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933
AN3-CA,44632017,0.5090157762596916
KP-4,15953870,3.4462713281416697
YKG-1,10427712,4.433579193557295
SET-2,71466578,1.6940206430792373
Kasumi-2,65064,2.9473106091456467
BFTC-909,71466380,5.267829049221599
KMBC-2,219104,4.201311649898133
SKM-1,54454,1.9004592108781224
HSC-4,71304818,1.898043557267106
KMRC-2,23725625,7.2890345118236
SNU-8,3854666,0.7475509647190202
SKM-1,448949,1.85245067746411
H-STS,crizotinib-PLX-4032 (2-1 mol-mol),1.0847078558510623
SK-MEL-1,11964036,1.6345292749152505
BT 504,5282054,4.613434492128775
RERF-LC-Ad1,16722836,2.166524022697494
CML-T1,2874250,4.926765314452629
PE/CA-PJ34 (clone C12),168313200,2.559397227720179
HCC2218,10113978,2.8653467839209448
Kasumi-2,8515,3.2781378887974775
IST-Mes1,10074640,3.5425729050518053
CML-T1,9907093,3.685523679081733
NCI-H2081,10026128,5.597175491927259
MM1.S,637858,1.1030416488426389
AU565,9915743,-3.6885201415408098
NCI-H1395,9444,4.051341414153912
SNU-1033,25161177,3.7481241199091953
ESS-1,24772860,-2.7433674764679097
SNU-1033,3062316,-0.0877910405089985
NCI-H2110,3825829,4.046505267673778
NU-DHL-1,piperlongumine-MST-312 (1-1 mol-mol),0.314430194898088
SK-N-AS,241158,4.128008478186768
LNCaP clone FGC,11977753,-4.293415372510932
RPMI-7951,2126,3.125954532463681
WM983B,selumetinib-PLX-4032 (8-1 mol-mol),-2.06788007054237
IST-Mes1,2874250,4.337377448058327
OAW42,11214940,4.326951836281865
PE/CA-PJ49,11964036,1.1031989419108066
RERF-LC-Ad2,46215462,1.8550618153186036
AN3-CA,107970,2.2532094276604115
JIMT-1,3503,3.910684306251534
HSC-4,15547703,3.6362413258054063
CML-T1,6918837,-4.73728443815153
LNCaP clone FGC,navitoclax-piperlongumine (1-1 mol-mol),2.2980400101036045
HSC-4,44486219,5.375029781512573
Hep-G2,4705,3.661377424610174
OAW28,carboplatin-etoposide (40-17 mol-mol),4.113933024401999
HuT 78,54678924,2.190206987497857
AU565,753704,4.59624742359194
SK-N-AS,216345,3.920081649583527
AU565,5329102,2.0441914674842008
OAW28,JQ-1-MK-0752 (1-1 mol-mol),2.4765621370980875
KYSE-410,3825829,3.948132670947577
HSC-4,selumetinib-vorinostat (8-1 mol-mol),2.2215922063973648
HCC2218,25102847,3.5244982698311396
Kasumi-2,alisertib-navitoclax (2-1 mol-mol),-2.881127323252466
LoVo,1242560,3.2639930925900305
KMRC-2,25154868,5.42308156728812
KYSE-70,12003241,-1.4257688129039825
BFTC-909,613000,3.1980696015333137
Kasumi-2,5311281,1.4543587988632989
AN3-CA,44185566,2.983350323486881
TE-15,25126798,3.521201926251703
SNU-1033,navitoclax-birinapant (1-1 mol-mol),0.0075865215090206
CA46,53232,2.437328600755792
BT 330,selumetinib-tretinoin (2-1 mol-mol),5.330829076137418
SW1573,24951314,1.273840217876839
YKG-1,16722836,2.573532003620113
KYSE-410,421610,3.494907211126446
MM1.S,decitabine-navitoclax (2-1 mol-mol),0.5929032240981287
KMBC-2,25102847,2.042822848975917
OE21,135411,0.4173817790505238
NCI-H1092,12001922,1.6370209009668415
MCAS,56649450,3.7534424582376222
KMS-27,66577038,3.2035364529332298
PE/CA-PJ34 (clone C12),5113032,5.000018786320908
D283 Med,9911463,2.6227366888943986
H-STS,135421197,1.21674084203813
OAW28,44491742,4.754653012158477
WM983B,selumetinib-tretinoin (2-1 mol-mol),-1.8992831067573617
KYSE-410,5978,-3.3770169672228416
HCC2218,5113032,5.565941219612929
KP-4,452548,-1.9659972775465684
TE 617.T,53495165,-2.1817272104035537
EJM,5335621,4.269621462989024
D283 Med,10410894,2.0006248450880912
NCI-N87,selumetinib-MK-2206 (8-1 mol-mol),0.3550893984048577
AN3-CA,54619267,3.846991016326593
NCO2,60750,-5.730709932045554
YH-13,selumetinib-PLX-4032 (8-1 mol-mol),4.578081619399974
KMBC-2,11364421,2.175132064190205
MM1.S,159324,2.619931466693083
SKM-1,9444,4.064416967836726
SW1573,9936388,3.0507391751654698
AU565,5278396,3.257778157431963
Raji,168313047,1.9706216654470443
KMRC-2,11228183,2.3872134310173103
SET-2,navitoclax-PLX-4032 (1-1 mol-mol),-0.4800202266033647
BT 248,676352,1.654368845250315
CA46,5291,2.960224941202677
HMCB,72193861,1.1610146616364858
BT 139,42642645,1.0499068063196206
HEC-151,2729026,2.502599167536784
SNU-1033,10074640,3.1442232102828407
CML-T1,441298,0.5187670078326817
PE/CA-PJ34 (clone C12),445455,5.711009055392974
HEC-151,100016,5.913951457428463
ML-1 [Human thyroid carcinoma],42642645,0.1882919364816784
SK-LMS-1,44589607,3.255128289291538
HARA [Human squamous cell lung carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-1.5170547368842298
ML-1 [Human thyroid carcinoma],656346,1.1399678324227185
KYSE-70,6918837,-2.6267197721971582
EJM,1242560,2.98578545305507
BT 139,4378219,1.2549106486924078
RERF-LC-Ad2,65064,5.3005897391207375
AU565,9927531,4.912755977802547
SK-LMS-1,11719255,5.678568573801583
PaTu 8988s,24821094,3.32561092177269
YKG-1,sirolimus-bortezomib (250-1 mol-mol),0.0311399701967428
NU-DHL-1,54143018,-3.6528405777406743
JIMT-1,11485656,3.0502841230880327
SK-MEL-1,11609586,3.1227060779186013
NCI-H2110,navitoclax-piperlongumine (1-1 mol-mol),2.9971394291703675
RERF-LC-A1,444795,5.084978113439599
KMRC-2,navitoclax-birinapant (1-1 mol-mol),0.645706108158614
H-STS,5335621,4.075403306660697
TE 617.T,piperlongumine-MST-312 (1-1 mol-mol),1.050582795400428
SK-MEL-1,3081361,3.2801710313910175
LNCaP clone FGC,135398516,1.4914387819371897
SK-MEL-1,2858523,1.977348892510004
HARA [Human squamous cell lung carcinoma],52947716,4.13690029570622
OAW28,5281672,6.00346703144391
OAW28,JQ-1-MK-0752 (1-1 mol-mol),2.4765621370980875
PaTu 8988s,6918328,-0.474247394227878
Kasumi-2,4096211,1.078024917290252
YH-13,JQ-1-UNC0638 (2-1 mol-mol),2.8302570708443757
ML-1 [Human thyroid carcinoma],2113511,5.6174346670931286
NCI-H1395,25062766,3.463916813883382
KMS-27,vorinostat-carboplatin (1-1 mol-mol),1.7514374465473277
KMRC-2,46398810,2.7180589797423167
EJM,51039095,2.802911331082466
BT 504,148198,-4.360319644130701
BT 504,11213558,1.0348170371236436
AN3-CA,16720766,0.5918360933191997
Kasumi-2,2858523,3.136381143278692
Hs 683,doxorubicin-navitoclax (2-1 mol-mol),-1.8748809062125371
KMS-27,10231331,-2.582639088661463
CA46,11178236,-6.883102305003874
YKG-1,51037431,4.372919308418105
NCI-N87,11964036,0.5275056986755973
Kasumi-2,10427712,4.152130511624211
MM1.S,serdemetan-SCH-529074 (1-1 mol-mol),-0.1591683949873749
H-STS,56946209,-4.578784798240611
SK-LMS-1,3825829,4.897973293918553
SET-2,5329102,1.4152351029185346
RERF-LC-A1,46398810,3.1088523753724893
KMRC-2,6852167,1.9056104142520949
SNU-308,16038120,2.1179451909693445
NCI-H2110,ISOX-bortezomib (250-1 mol-mol),1.2567543792582585
SKM-1,5311281,1.1395980087167572
PE/CA-PJ49,3038522,2.615741330384697
PE/CA-PJ49,9840324,5.81623015366044
BT 320,selumetinib-vorinostat (8-1 mol-mol),4.325017392219319
SNU-1272,3025986,2.0429499224913927
NCO2,5460769,1.276478801243687
TE-15,10322450,3.2140192626835313
H-STS,15547703,3.2281511582174875
NCI-H1092,72193861,1.411805795615286
LCLC-103H,10302451,4.471526391535591
SET-2,2871966,-0.0579957240311698
NCI-H1092,439501,-3.60207444945155
OAW42,10074640,3.881457200020669
NCI-N87,10113978,2.582247145825502
ESS-1,10074640,3.3924948891566995
BT 504,4578,5.422523652338587
IST-Mes1,15547703,3.097349866450655
SK-N-AS,46199207,3.163036202585008
TE-15,46398810,2.257588086332498
BT 320,448949,3.0267975144627894
HSC-4,6918837,-1.8301723200742368
Hs 683,25183872,-0.3449669069687002
WM983B,11964036,1.529997392242979
KMS-27,23635314,-3.235668153489761
SK-LMS-1,11234052,4.728333340623987
ESS-1,44202524,1.7594814112354966
TE-15,44566777,-0.1580764360549867
Kasumi-2,9803433,4.641295101837652
D283 Med,252682,6.563125255029891
OAW28,400769,-1.4620594490922918
HCC2218,241158,2.2086061733116615
KYSE-410,5280436,3.0983343367538447
HSC-4,216345,4.5807127841732775
OAW42,navitoclax-sorafenib (1-1 mol-mol),1.983412280087654
Ku812,9967941,3.019856322262854
ESS-1,25227462,-2.235408931429562
ESS-1,6918736,-1.7029949901876988
OAW42,erlotinib-PLX-4032 (2-1 mol-mol),3.0931730437944105
KMRC-2,selumetinib-GDC-0941 (4-1 mol-mol),1.6802426748833608
EJM,3136844,3.6340399610084537
HARA [Human squamous cell lung carcinoma],3038522,4.1452744027346045
JIMT-1,crizotinib-PLX-4032 (2-1 mol-mol),2.3168806717912487
SW1573,2729026,2.4001203305493397
LNCaP clone FGC,11427553,3.334144293197662
SEM,650361,3.800745597928697
NCI-H2110,navitoclax-birinapant (1-1 mol-mol),-4.382676347082387
OAW28,24821094,3.6183900250040497
IST-Mes1,119182,0.8525106306178227
Hs 683,46174525,4.3348734308118715
KMBC-2,46843906,4.6430675158298715
PE/CA-PJ34 (clone C12),16013152,4.240449393705453
EJM,9444,4.350025057986223
HCC2218,6918736,1.572834496313944
KP-4,1716436,3.507941691131362
BT 320,navitoclax-gemcitabine (1-1 mol-mol),3.195871969497656
RPMI-7951,docetaxel-tanespimycin (2-1 mol-mol),-5.319642676447243
NCO2,5351362,0.3480332583034318
NCO2,9887053,2.509790456363511
HMCB,carboplatin-etoposide (40-17 mol-mol),3.2976351954293324
NU-DHL-1,24772860,-2.0670136915752395
RERF-LC-A1,selumetinib-PLX-4032 (8-1 mol-mol),4.806399432618583
LoVo,9935249,1.1872155844887071
BT 139,9956119,4.207916626823982
BT 328,25062766,3.0045654818886507
BT 330,53392493,1.8521619405922451
HARA [Human squamous cell lung carcinoma],16736978,1.7495486591528322
PE/CA-PJ34 (clone C12),5280436,1.7888326138899853
RPMI-7951,650361,3.986097803134267
BT 248,25262965,0.9142276489527752
HuT 78,50905018,2.5901860875051144
PE/CA-PJ49,46215462,1.5914258688265177
MM1.S,sirolimus-bortezomib (250-1 mol-mol),-3.4112466986615475
LCLC-103H,vorinostat-navitoclax (4-1 mol-mol),1.2532375191006415
BT 330,135875424,2.80821579250056
CA46,46215462,1.3062506059575565
PE/CA-PJ49,serdemetan-SCH-529074 (1-1 mol-mol),2.62655069783554
NCI-H2110,322968,4.098165258163528
NCO2,53232,3.277628613997438
HARA [Human squamous cell lung carcinoma],24856436,-1.2762108597510684
NCI-H1395,BRD-A02303741-navitoclax (2-1 mol-mol),5.774765873736903
LCLC-103H,navitoclax-MST-312 (1-1 mol-mol),0.7799818365238729
TE-15,6610216,4.337725089015336
SK-LMS-1,12001922,2.30628088963523
SEM,6450551,0.3475016834415761
YKG-1,9926054,2.005416681797869
ML-1 [Human thyroid carcinoma],72193861,1.5092085092070135
MM1.S,9926054,1.5897504862532963
AU565,5566,3.0303294385930584
Aska-SS,25150857,1.346839871610819
BT 248,23582824,0.3842375588836932
RERF-LC-A1,navitoclax-PLX-4032 (1-1 mol-mol),3.0064010451247634
TE 617.T,89928392,0.9742163708877738
Raji,9911830,2.8944128431666636
KMS-20,613753,2.7781873523971687
RERF-LC-A1,135398744,8.259619126952485
PE/CA-PJ49,65628,4.299223683644022
ESS-1,9933475,2.1540018278931448
SKM-1,2708,3.277988117116173
LoVo,49793307,-4.412709808216002
H-STS,72734382,4.174468427359164
OAW42,52947716,2.929944332333208
MM1.S,54618164,3.790511096311708
SEM,tanespimycin-gemcitabine (1-1 mol-mol),-6.855613835545683
SW1573,24821094,3.391149888356164
SET-2,tanespimycin-gemcitabine (1-1 mol-mol),-4.691670704779648
HuT 78,1716436,2.3325786548339207
SKM-1,3689413,-2.418262014134033
OE21,10410894,3.4125906572250027
SEM,11167602,1.6764895293096356
Kasumi-2,44489675,3.5763019986617106
D283 Med,11625818,3.5261927376586626
SNU-1214,71466578,5.469763615942432
Hs 683,6918328,0.6076463522681637
A4/Fukuda,676352,1.592410759121419
Hs 683,5281672,4.193849409575692
MM1.S,BRD-A02303741-navitoclax (2-1 mol-mol),2.21025426960287
A4/Fukuda,11364421,-5.769651092108399
SNU-1214,25195348,3.027248087174678
KYSE-70,89183176,4.766828638924323
OAW42,568763,2.190645405694584
Hep-G2,3825829,5.065822708326793
RERF-LC-A1,15953870,3.4479949128076592
BT 320,11625818,5.9690326446968935
KMBC-2,24821094,3.5283056158301997
KMS-27,31703,-3.2755995749362214
LNCaP clone FGC,984333,2.4697165737254516
NCO2,2742550,2.371256887035148
KMS-27,serdemetan-SCH-529074 (1-1 mol-mol),1.3619921594172788
D283 Med,446155,1.3640842146375642
Hep-G2,54618164,4.2874336189086115
MM1.S,11977753,-3.342519732711574
SK-N-AS,135875424,4.067320794930689
SKM-1,25126798,2.9337562009187192
TE 617.T,119607,4.923325938404837
ESS-1,6252,2.853454302970564
HuT 78,3676137,4.565046002929079
KMS-20,68056272,3.2246681172521083
KMBC-2,9840324,5.999315503440774
LNCaP clone FGC,carboplatin-UNC0638 (2-1 mol-mol),3.3387312482974214
SKM-1,46843906,1.3113663495190937
SW1573,4259181,2.0061423198913766
KYSE-410,71304818,2.5026339556272994
BT 504,6918736,-2.3412943418843075
SK-LMS-1,16722836,2.5423254088501044
MCAS,16038120,1.8985243383940775
KYSE-410,ISOX-bortezomib (250-1 mol-mol),0.8932927534344921
Ku812,5291,-2.2328806497489437
HCC2218,246676,3.234854854561146
SKM-1,656346,0.2148623299853773
KMS-20,9907093,3.4459916472834644
AU565,148124,-5.63717967948206
NU-DHL-1,5287620,-2.1832991437877056
YKG-1,11222830,2.3027831380451342
SNU-8,3503,2.811796896000335
SW1573,9911463,3.734935340044018
NCI-H2172,6610355,5.133393026581665
SNU-8,3552672,5.071932913496887
CML-T1,60750,-4.308471121020489
HARA [Human squamous cell lung carcinoma],5282054,3.837128949835148
ESS-1,4521392,4.16442971067231
LNCaP clone FGC,BRD-K55473186,4.308577924788359
Raji,sirolimus-bortezomib (250-1 mol-mol),0.8276284938593903
BFTC-909,3385,6.578023483143935
BT 248,208908,1.7719462620560902
KYSE-70,6918878,2.8589087884624673
BFTC-909,42611257,4.384387627976705
EJM,24785538,0.370264402749186
KMS-20,navitoclax-birinapant (1-1 mol-mol),1.2609328237028008
KMBC-2,71304818,2.1221045201066935
KMS-20,24748573,1.7452169384063008
Ku812,56963564,-0.7269120722317722
KYSE-410,56963564,1.1375859752415496
SET-2,446155,1.37850534523749
YH-13,9933475,1.504253268653492
MM1.S,9911463,3.396498541948332
GOS-3,26596,5.630360863540023
OE21,5282054,3.887024213871436
WM983B,9840324,5.917023374673904
BT 504,3025944,5.235519881497847
SNU-308,3854666,3.849126427296356
OAW28,439501,-0.9322268226633188
SET-2,46843906,0.6075290988488133
RERF-LC-Ad2,11955716,-2.482304442016354
RERF-LC-A1,49867926,4.243503433126498
NCI-N87,11656518,1.4544081811160725
ESS-1,46199207,3.803521594847931
BT 248,73707398,1.2475621750333084
SK-MEL-1,4261,1.1260722981757716
GOS-3,100016,7.242262816552233
ML-1 [Human thyroid carcinoma],122327,4.584045367066115
BT 139,3101542,5.0506373944633
KMRC-2,51039095,2.899193634556031
ESS-1,5738263,3.9330786709823986
BT 330,25195348,3.573752454944967
LNCaP clone FGC,44185566,2.784372312754108
Aska-SS,46174525,4.195549448751143
NCI-H2081,5311281,1.3336176865333822
PaTu 8988s,11640390,0.9509340120197388
HMCB,9915743,1.6080279846600372
BT 504,45279963,4.153260827257106
BT 330,4788,5.911635060219132
SET-2,52912189,-0.82180039451398
CA46,navitoclax-birinapant (1-1 mol-mol),3.397408717118992
KP-4,24951314,1.4509565754370062
PaTu 8988s,11167602,2.4534499550927653
NU-DHL-1,446155,2.7819424460824274
SNU-8,4378219,2.1792585601727468
LCLC-103H,216345,4.50439896685364
Ku812,9907093,3.786730640592808
CML-T1,73707440,4.384977554594534
GOS-3,JQ-1-vorinostat (2-1 mol-mol),1.826489490547508
NCI-H2081,3136844,3.846689018483167
OE21,5278396,3.185832182245697
KMS-27,89928392,0.4366769270858706
HSC-4,6252,1.1187983220422375
PaTu 8988s,11396600,3.1820503715354276
GOS-3,11364421,2.246503341599216
CML-T1,24771867,0.0964586614823225
NCI-H2081,6252,0.369666564038939
ML-1 [Human thyroid carcinoma],3062316,-4.511354956700351
SW1990,3825829,4.305269855808273
YKG-1,2733526,4.337499984532551
PE/CA-PJ49,216239,3.0310910275366663
LNCaP clone FGC,4261,0.6571905831455885
RPMI-7951,9887053,3.65793605994431
GOS-3,119607,5.92961228058127
RERF-LC-A1,9936388,-6.729312283369553
HCC2218,10184653,-4.3566068193330505
Ku812,52947716,-6.670771231809934
BT 504,piperlongumine-MST-312 (1-1 mol-mol),2.008051118952179
PaTu 8988s,262093,3.243938357884203
KYSE-410,5738263,3.814535171181479
HCC2218,1750826,-2.5526345061979208
Ku812,3038522,2.027577923639431
SNU-8,2733526,4.815147828958365
PE/CA-PJ49,5291,3.890813201298036
Ku812,44507138,1.5251260017472812
KMBC-2,10385095,2.342587870752789
KMS-20,168312962,2.0534985084126895
KYSE-410,25150857,3.210005156084859
Hep-G2,16720766,4.874988016159793
HMCB,54618771,0.8772324111806863
BT 248,5738263,3.817096252163507
ESS-1,1285940,5.086751580497306
SEM,4705,3.2789499070594816
EJM,9915743,0.880814312418276
D283 Med,71304818,2.1992785048974577
A4/Fukuda,9935249,-4.132944592984893
CML-T1,322968,2.5082577681036473
SET-2,208908,3.114087339668993
KMS-27,4521392,4.241946733625076
NU-DHL-1,66577038,2.8657572180523823
LoVo,11427553,2.604805449600099
SNU-1214,9903786,2.1258190574569955
Aska-SS,JQ-1-vorinostat (2-1 mol-mol),0.3568016982520641
ESS-1,serdemetan-SCH-529074 (1-1 mol-mol),2.6491539318106514
RERF-LC-A1,44486219,3.773429291575219
LoVo,46199207,2.62459096292295
SKM-1,navitoclax-piperlongumine (1-1 mol-mol),0.8307338644583981
OAW28,969516,2.7253654251657573
SET-2,17755052,1.2918452501265123
HCC2218,26596,-0.1880453521462128
HCC2218,46224516,2.8034252567283557
ML-1 [Human thyroid carcinoma],9868037,3.639883526106939
BFTC-909,3503,3.411270469206907
OAW28,66577038,2.5027239379183666
Kasumi-2,613000,1.0071641049539857
TE 617.T,637858,1.1275370402381546
Hep-G2,3025944,3.632600142557463
YKG-1,72376,-2.105331743762953
NU-DHL-1,9887053,0.6312128826435269
OE21,16741245,4.961434938976918
SEM,5287620,-2.250994542245304
Hs 683,selumetinib-GDC-0941 (4-1 mol-mol),2.318747786701251
KMBC-2,44137675,3.7082057495512095
HCC2218,3825829,3.8059808455027704
JIMT-1,322968,4.55525060723241
SEM,119182,-4.118292279963464
A4/Fukuda,46398810,1.5683404384737003
PE/CA-PJ34 (clone C12),9903786,2.211143495082886
KMS-27,16722836,0.7458247417063953
HARA [Human squamous cell lung carcinoma],55508,3.1590088041564752
RERF-LC-A1,2858523,3.015069372087202
A4/Fukuda,9911830,0.8865121451383732
NCI-N87,16038120,-0.0105690503285029
OAW28,73707398,1.2451215877479735
NCI-H1395,676352,2.20823720680155
AN3-CA,3543504,4.592926404158275
PE/CA-PJ49,4788,5.915803154330926
RPMI-7951,9826308,0.480723158605391
NCI-N87,44137675,2.149558923433186
KYSE-410,23582824,0.2536678029172985
LCLC-103H,66577038,3.6128741464935423
SK-LMS-1,crizotinib-PLX-4032 (2-1 mol-mol),2.072496392258814
Kasumi-2,19582717,2.3340571924025326
CML-T1,25062766,1.440222571379222
Raji,654092,-1.8737175642963104
OE21,104842,-2.9568269236985416
IST-Mes1,5328940,2.5729000547912397
SW1990,104842,-4.21160579314145
YH-13,52912189,2.2271959636109693
NCI-H1092,3062316,3.749220976786342
BT 330,5282054,3.965299812309079
NCI-H1395,66577038,3.726458763342507
BT 139,selumetinib-UNC0638 (4-1 mol-mol),5.570827080630345
KYSE-410,53495165,1.4811388636079783
BT 328,387447,-3.18043057197166
OAW28,49793307,-1.8076729764727852
SNU-1272,409805,6.302573635067764
RERF-LC-A1,44819697,-2.918408428097085
OAW28,31703,0.1585101679236112
SEM,15547703,1.7172948756521211
NCI-H2081,445643,4.277637250227414
HARA [Human squamous cell lung carcinoma],57330099,4.527264318285619
HARA [Human squamous cell lung carcinoma],216239,2.4828561148565256
NU-DHL-1,JQ-1-navitoclax (2-1 mol-mol),-1.983484883677281
NCI-H2110,24797083,1.6464918448849135
Hs 683,400769,-0.3737887426285373
D283 Med,JQ-1-navitoclax (2-1 mol-mol),-0.3504935844901085
KMS-20,selumetinib-JQ-1 (4-1 mol-mol),-2.1329666207384124
GOS-3,49793307,-1.7592424650384757
MCAS,24772860,-3.031835508256121
WM983B,122327,5.7092758269003685
PE/CA-PJ34 (clone C12),44607531,-0.1890255077191596
NCI-H2110,46926350,-4.246677806016688
NCI-N87,73707398,0.9429301881187698
SW1990,19582717,5.28624367684453
AN3-CA,44607531,1.3300471520029256
HEC-151,44185566,1.247652658298612
KMS-20,54143018,-0.774941821803654
WM983B,136227924,4.383113443662036
CA46,613753,2.777360120502711
D283 Med,151289,0.5549046196657793
Hep-G2,168313047,1.9779091798447304
MCAS,52912189,1.8684628256786515
LoVo,16725315,3.2447595903434627
TE-15,6917907,-5.750854284737166
MCAS,54649381,4.395413097110276
KMBC-2,445091,4.27135106704316
TE 617.T,8515,3.600809985804118
PaTu 8988s,selumetinib-UNC0638 (4-1 mol-mol),1.5979017868409875
OAW42,selumetinib-vorinostat (8-1 mol-mol),4.452734121336326
PE/CA-PJ49,5287620,-1.2687739751971734
CA46,702558,3.0016875761250383
KMRC-2,439501,-1.138228475309333
NCI-H2081,11977753,-1.86082433815017
RERF-LC-A1,9911830,2.8330661508640542
SK-N-AS,11175137,1.7393012407400996
NCI-H2172,44202524,4.914031503934329
CML-T1,9911463,2.5893115421622737
OAW42,12003241,1.2884936123543242
ML-1 [Human thyroid carcinoma],969516,2.8184901812435923
CML-T1,984333,-1.4387494949343358
KYSE-410,656346,1.720425099616191
H-STS,11396600,3.334455384541719
LNCaP clone FGC,5978,-3.7743504448066583
D283 Med,3025944,3.966000560385046
KMS-27,6505803,-0.687237988201334
NCI-H2110,10427712,6.255261988959236
Ku812,49850262,3.2075768806895324
BT 139,tanespimycin-bortezomib (250-1 mol-mol),-4.226590067496966
HARA [Human squamous cell lung carcinoma],9868037,3.8920643368101713
NCI-H1395,216468,5.017239605699041
BT 504,8515,3.6274381992503786
HEC-151,135440466,2.8083122233217335
H-STS,24856436,0.4197930634847036
MCAS,25102847,3.243219999349448
AU565,54618164,4.092787142183454
LCLC-103H,44607531,1.705045272122037
SEM,71576739,-1.1799480290235729
KMS-20,67156097,-1.6945401630297232
LNCaP clone FGC,JQ-1-UNC0638 (2-1 mol-mol),-1.7433469805632364
KYSE-70,53232,3.7067207893488017
SNU-8,638278,3.4785573806437036
SNU-1033,54618164,4.351406762339218
SK-N-AS,9927531,4.866192814831014
OAW28,10184653,1.1706980363621209
H-STS,26596,-2.569417697964928
EJM,11977753,-2.8981828943560255
JIMT-1,10127622,5.6036579427281925
ML-1 [Human thyroid carcinoma],1716436,2.512454049061402
SK-N-AS,42642645,0.9617810876109002
AN3-CA,73707398,0.9328233137559012
YH-13,24901704,3.58648266528955
AN3-CA,135440466,1.9764681400731403
LNCaP clone FGC,25126798,3.669964822378694
TE 617.T,1239801,3.896236456079403
SW1573,navitoclax-piperlongumine (1-1 mol-mol),1.792577527221854
WM983B,44491742,4.283339353588083
KMS-27,piperlongumine-MST-312 (1-1 mol-mol),3.135425545454246
JIMT-1,5311,1.9033401574994544
A4/Fukuda,36314,4.126705075384559
BT 330,285033,0.8091924542559932
RPMI-7951,6914657,-4.365510801369332
PE/CA-PJ49,11396600,3.5050583522874637
SNU-1214,168313016,6.364459074383153
SNU-8,26596,-0.6710039843025739
SK-N-AS,448949,1.997748105989846
HCC2218,11214940,1.0598485229259995
SW1990,1566236,1.8608127009436903
WM983B,46926350,-4.3427957401240445
YKG-1,selumetinib-PLX-4032 (8-1 mol-mol),3.9991996258306384
Ku812,241158,2.509231607325934
RERF-LC-Ad2,5291,3.84133804155984
OAW28,5460769,4.044755256654475
SNU-1214,17759555,2.7745156093905043
OAW28,11626560,1.7877294085158288
SET-2,5284616,3.130528148118791
NCI-H1395,135411,0.822890110332085
YKG-1,148124,-3.4477323343219637
A4/Fukuda,4578,3.815086457915261
HARA [Human squamous cell lung carcinoma],2729026,2.992927693558788
NCO2,25126798,3.087210292443575
BT 248,9933475,1.8575466823142976
LCLC-103H,5278396,3.620640513148108
Hep-G2,11178236,-2.211780590989946
BT 248,3081361,2.663958705985954
SEM,10302451,1.800985187016429
NCI-H2110,11228183,3.5598870695262215
PE/CA-PJ49,6918837,-5.282958299099714
EJM,135421197,1.4211538659692204
SW1573,navitoclax-MST-312 (1-1 mol-mol),-1.0459858342436132
HEC-151,11364421,-4.903162292093641
KYSE-70,613753,3.646356391333843
BT 139,3552672,1.636250898601629
SNU-308,72376,-1.526423190812565
HARA [Human squamous cell lung carcinoma],119607,5.240910567943734
Kasumi-2,11977753,-3.013388327331023
KMS-27,2749,1.0570748312778857
WM983B,doxorubicin-navitoclax (2-1 mol-mol),-0.8127091516816888
ESS-1,3854666,1.0692309253016814
WM983B,216345,4.002752392671331
HARA [Human squamous cell lung carcinoma],navitoclax-sorafenib (1-1 mol-mol),1.2625473684238606
HEC-151,10184653,0.244741697598772
TE 617.T,6610216,4.021742193250995
BT 320,6610216,4.229919303269505
Aska-SS,carboplatin-UNC0638 (2-1 mol-mol),1.782130723144459
OAW42,10296883,4.103500664094552
NCO2,107970,0.4926308981227985
SNU-308,6918328,0.4613782583679794
KMS-27,25262965,-2.6525185132842406
KMBC-2,9911830,3.153897570043922
NU-DHL-1,16065773,1.845713529586983
CML-T1,135875424,3.5304182343940935
HuT 78,5287969,-1.62674651410725
NCI-H1092,11719255,3.2848713677183334
KP-4,5281321,-2.10713627328183
HEC-151,11647372,1.208008316206568
YH-13,16659841,3.3586443316598675
BT 139,24964624,1.9176050283121209
SNU-8,613753,3.0857459456597804
A4/Fukuda,selumetinib-PLX-4032 (8-1 mol-mol),2.453113132843287
ML-1 [Human thyroid carcinoma],119607,6.010030667993389
HSC-4,selumetinib-UNC0638 (4-1 mol-mol),3.54677113858736
Raji,1714884,4.147818206483101
NCI-H2110,6918736,-0.92711542269103
BT 504,11656518,1.1568253891115663
Kasumi-2,387447,-5.322857892005912
SEM,JQ-1-UNC0638 (2-1 mol-mol),-2.509155551335313
MM1.S,67291369,-0.2087334312967911
PE/CA-PJ34 (clone C12),44819697,-1.5115898426437493
NCI-N87,44486093,4.414725106733636
KYSE-410,2949965,3.144048608876155
MCAS,159324,3.426184358584357
LNCaP clone FGC,10074640,3.1868639923318516
KYSE-410,4917,3.010113303817647
OE21,53392493,3.130106350947806
Raji,6610216,4.035753851614817
IST-Mes1,decitabine-navitoclax (2-1 mol-mol),4.382542969117623
KYSE-410,BRD-A02303741-carboplatin (1-1 mol-mol),3.200574814178471
BT 248,156414,1.4948422332158926
HSC-4,71466445,6.061667629347064
BT 139,54649381,3.76760719227815
Hep-G2,89928392,3.967748323767258
RERF-LC-A1,BRD-A02303741-navitoclax (2-1 mol-mol),3.5227012634184933
CML-T1,9908783,6.154706718384333
SET-2,5426,5.550203665060653
EJM,46224516,1.5336479152215143
WM983B,11455910,0.7348895690575076
MCAS,24779724,4.433406171067244
WM983B,6918837,-2.917672410167883
OAW28,11609586,2.8574541529278883
HuT 78,57519531,1.7150629071467791
NU-DHL-1,241158,2.9356865238845313
H-STS,3503,1.3838886795992438
LoVo,46174525,4.300656487428364
SK-LMS-1,selumetinib-JQ-1 (4-1 mol-mol),2.2731779644264645
TE 617.T,5284373,2.9344966923010047
SW1990,44202524,5.184894737297559
LCLC-103H,25183872,-0.5465174194125176
YH-13,148198,-2.7695139562786526
TE 617.T,11497983,3.60730452568753
Kasumi-2,3038522,2.07744827479205
NU-DHL-1,24901704,2.6374466424788356
SNU-8,11455910,1.7503640063904615
PE/CA-PJ49,5329102,2.072056563609684
NCI-H1092,3025986,-1.5280995504056256
KYSE-410,11427553,3.390914778571702
CA46,10113978,2.0547387812543425
IST-Mes1,3552672,2.081532957284865
AU565,4788,5.691461260554478
PE/CA-PJ49,24753719,4.080575528970359
TE-15,5278396,2.640029564459249
PaTu 8988s,445091,4.284103172399486
SET-2,984333,-2.9081310934556868
OAW42,54619267,4.420376034097867
RERF-LC-Ad1,selumetinib-PLX-4032 (8-1 mol-mol),4.111152215390761
KMRC-2,44241473,4.436801876335884
KMRC-2,67156097,4.44150811979282
HEC-151,49766530,-0.2709325293810298
SET-2,5335621,3.8169137961967534
HARA [Human squamous cell lung carcinoma],16115403,-4.2638303939611335
PE/CA-PJ34 (clone C12),25102847,1.9967626307461543
JIMT-1,44137675,3.726785357167399
ESS-1,44137675,3.2480943550658576
EJM,7251185,1.248669965280625
BT 139,11612883,3.441320456022431
NCI-H2172,5282054,5.216564599238412
BFTC-909,49793307,-2.946331542038894
SNU-1214,15983966,-3.997780013419944
WM983B,3854666,2.4188126448912075
Aska-SS,selumetinib-UNC0638 (4-1 mol-mol),3.105844363432866
KMRC-2,decitabine-navitoclax (2-1 mol-mol),1.6162271998356526
Aska-SS,11455910,2.343634234167196
RPMI-7951,5329102,1.587417345703683
RERF-LC-A1,44259,0.5096046614892119
RERF-LC-A1,JQ-1-navitoclax (2-1 mol-mol),2.5712725297870658
Hep-G2,3503,2.878453369176515
MCAS,5311281,4.0403014636627805
BFTC-909,navitoclax-PLX-4032 (1-1 mol-mol),3.5024450661652153
TE 617.T,11609586,0.4827523694476935
BT 320,168313200,3.0477072720221936
NU-DHL-1,60700,-4.437717551634179
SEM,11494412,-0.8044371012013913
Ku812,10427712,4.412501870743701
SW1990,49766530,-0.1486325613650474
JIMT-1,11238147,3.9266369976937106
BFTC-909,2749,2.0212973698927184
IST-Mes1,9866186,0.9671533169607398
SNU-1272,107985,-3.786570861641408
EJM,16659841,3.8654950259269056
TE-15,637858,1.9944393508197875
SNU-1033,136227924,2.5540912421490387
Ku812,73707386,3.1917387110464666
TE 617.T,5351362,0.9742264058795986
SET-2,5702613,2.94601164461312
D283 Med,11977753,-2.8972996135138565
RERF-LC-Ad1,66577038,3.626450370462214
SK-LMS-1,docetaxel-tanespimycin (2-1 mol-mol),-3.362972367128596
Hep-G2,6623618,1.7960151363036378
JIMT-1,3038522,4.191305282087918
Hep-G2,5351362,2.6024956401093684
BT 320,25105715,3.591126909496077
NCI-H2081,11640390,3.2499982344751994
NCI-H1092,56946209,-3.79263403316681
LNCaP clone FGC,72734382,4.201277780294119
ML-1 [Human thyroid carcinoma],5329102,1.4103281602713895
KP-4,3634881,3.205031601431634
NCI-N87,6918878,2.817621762559668
SNU-1272,54619267,4.134812215155654
SNU-1214,4521392,3.48771925693952
CA46,72376,-3.3789820311778764
HMCB,31703,-0.0757887186951435
AU565,5287969,-1.6574542255158256
NU-DHL-1,serdemetan-SCH-529074 (1-1 mol-mol),1.6055293417204113
LoVo,969516,2.402995535890804
SKM-1,44202524,0.4961794817988646
BFTC-909,5280436,4.2143472852581025
MM1.S,11427553,1.612283358238567
BT 139,10113978,3.580002932334986
ML-1 [Human thyroid carcinoma],11719255,2.5461185366109453
OAW28,2828334,6.258958244852924
PE/CA-PJ34 (clone C12),54613361,0.0290460408179859
JIMT-1,16722836,2.261251019484351
SEM,9908783,4.605938150893541
HARA [Human squamous cell lung carcinoma],375860,-0.967052520231088
BT 320,44566777,1.538730078733798
CML-T1,1641662,2.8295390269831464
HEC-151,3689413,0.5850952885102259
IST-Mes1,selumetinib-JQ-1 (4-1 mol-mol),0.7556363714344752
PE/CA-PJ34 (clone C12),5738263,2.3523932159562144
NCI-H2110,6438330,3.101663821546876
NU-DHL-1,9903786,2.0090459538270298
PE/CA-PJ34 (clone C12),5287969,-2.1859806545337888
SNU-8,54686904,4.436891017984491
LCLC-103H,5287620,-0.2007412781628433
BFTC-909,5335621,5.263558209813896
SNU-1214,46191454,1.616623098413041
AN3-CA,selumetinib-decitabine (4-1 mol-mol),5.583042753450803
NCI-H1092,76446078,4.704982368459853
GOS-3,5329102,1.5794439698416267
CA46,252682,5.8821335535914905
NU-DHL-1,navitoclax-sorafenib (1-1 mol-mol),-1.6614414384749498
TE 617.T,44486219,4.035845763911834
BT 139,10127622,4.956470394935132
HARA [Human squamous cell lung carcinoma],36314,-5.79294260923826
MCAS,637858,2.160945503625874
HSC-4,10074640,3.187745953835862
Kasumi-2,16725315,3.214174294489856
NCI-H2172,285033,0.6169104755063226
NCI-N87,15983966,-4.100894125332804
HARA [Human squamous cell lung carcinoma],4261,3.400371454492322
SNU-1033,decitabine-navitoclax (2-1 mol-mol),1.6958517813828735
HARA [Human squamous cell lung carcinoma],135875424,5.177992671051203
Hs 683,613753,3.2727608242534827
SEM,135440466,0.4390195175312653
TE-15,11719255,3.003827280691082
SEM,11955716,-2.9812698149685626
KMS-20,8515,3.454893590517526
RERF-LC-Ad1,46199207,3.6404487316358014
SK-N-AS,64971,4.5028339026139435
HARA [Human squamous cell lung carcinoma],5738263,3.6004475982525825
LoVo,24797083,1.0858534416002044
MM1.S,15983966,1.9540047876230984
LNCaP clone FGC,5282054,2.507461271717801
WM983B,44202524,1.872789372284009
PE/CA-PJ49,docetaxel-tanespimycin (2-1 mol-mol),-6.834195493556901
SK-N-AS,15953870,3.313993154958585
ESS-1,568763,-1.0434791743348584
BT 248,11494412,3.557230805764516
Raji,51037431,3.299758359424842
OAW28,123631,1.649178742735097
BT 139,176870,5.347456474975529
A4/Fukuda,65628,3.8428022223998366
SEM,24775005,3.6246781660471794
KYSE-410,208908,1.6043849793411151
SNU-308,6918837,-2.0367306099029587
LNCaP clone FGC,3854666,0.694335956852511
BFTC-909,9936388,1.702123766125507
HARA [Human squamous cell lung carcinoma],25105715,3.4880191589222966
JIMT-1,44491742,4.195591062798884
NU-DHL-1,10113978,2.330797013945373
HEC-151,17759555,2.8737027606890875
SNU-308,25150857,2.5138578868567913
H-STS,216345,2.2143657283557854
BT 248,6610216,3.912037893092857
CA46,selumetinib-GDC-0941 (4-1 mol-mol),2.557872196645032
YH-13,SNX-2112-bortezomib (250-1 mol-mol),-1.3355072923544795
D283 Med,25195348,2.687944983140332
BFTC-909,2708,5.254338200716292
AU565,piperlongumine-MST-312 (1-1 mol-mol),1.980808732390433
TE 617.T,46224516,0.8374598863695136
Aska-SS,16720766,-0.4517051678184295
HCC2218,9825149,2.6814610531710223
NCI-H2110,10231331,4.807632795755959
OAW42,10322450,4.813249082593069
HEC-151,637858,1.4744237971842309
A4/Fukuda,6852167,0.513003696591474
TE 617.T,156422,3.304932757225741
KMRC-2,44491742,3.971638428490517
HEC-151,12001922,2.1072309594101086
SEM,9935249,-3.4494441375925153
TE 617.T,3025944,3.9487310185301534
SNU-1214,9826308,0.0838633230560196
LNCaP clone FGC,11640390,3.376526738931285
ML-1 [Human thyroid carcinoma],20959075,-2.269435131540743
SK-LMS-1,3503,2.124140890470344
SK-LMS-1,tanespimycin-bortezomib (250-1 mol-mol),0.2402445839028043
TE-15,126941,-2.159611946288151
YKG-1,984333,1.4105650913207732
PaTu 8988s,6505803,-2.1809975101024417
SNU-1033,24821094,3.577851437010747
NCI-H1092,navitoclax-gemcitabine (1-1 mol-mol),-1.9058386314503173
HSC-4,2729026,2.4603123985812276
KMBC-2,navitoclax-sorafenib (1-1 mol-mol),0.8722120803993443
AU565,6852167,0.824199435407992
SNU-308,3543504,4.589142587467719
NCI-H2081,54613361,-0.0228941732183183
HARA [Human squamous cell lung carcinoma],2841722,4.596341456340547
SEM,3676137,4.192581322448915
CML-T1,3634881,2.472630922180769
RPMI-7951,54143018,-0.6464494976945091
Ku812,navitoclax-birinapant (1-1 mol-mol),0.1805704585034357
SK-LMS-1,16065773,3.944700611122238
YH-13,439501,-2.216859157731525
AN3-CA,11175137,1.6731689264439218
SNU-8,23725625,5.695206402753821
HCC2218,44137675,3.038492049158943
NCI-H1395,9936388,2.8582059793440964
YH-13,374536,3.765039330811098
OAW28,51037431,5.214608262969992
HCC2218,1566236,1.7509931914659491
TE-15,4261,1.1705616568389658
SNU-1214,5978,-1.5940747604494143
A4/Fukuda,44489675,3.3968348796203003
Kasumi-2,44632017,0.7335001301015701
BT 248,44566777,-0.50911829246694
IST-Mes1,46398810,2.0674819997592406
EJM,tanespimycin-gemcitabine (1-1 mol-mol),-4.796041108961502
OAW42,44185566,2.9689995043339215
NCI-H1395,46191454,1.8704386563260864
Hep-G2,JQ-1-vorinostat (2-1 mol-mol),1.308980455848885
SKM-1,451668,-2.063833274943064
ESS-1,54143018,0.807928117545995
HuT 78,36314,-5.690425807572839
ML-1 [Human thyroid carcinoma],11507802,1.1504003941708354
NCI-H2110,9903786,2.318107893964858
KYSE-410,4705,2.1516675380518953
PE/CA-PJ49,9884685,0.5185977592735194
D283 Med,1716436,2.988422279265608
SK-N-AS,71304818,2.9186350347132968
NCI-H1092,49793307,-5.3090977764299145
RPMI-7951,25262965,-1.858765534488669
SW1990,2858523,3.108665147059129
OAW42,135398516,3.2740489100961714
JIMT-1,11175137,3.2175551147102786
H-STS,11612883,2.0759775526312096
SEM,9915743,-2.2587042117517284
KMS-20,72376,-2.953076031643005
PE/CA-PJ49,67291369,1.7434258549595576
IST-Mes1,11152667,-0.1137559634255308
HEC-151,71304818,2.2040931123668357
SNU-1214,24180719,2.9494589381604026
NCI-H1395,374536,5.636718886348253
HMCB,54618164,4.179643558652394
BT 248,11222830,0.9088188698521174
KYSE-410,9956119,3.754635391401796
NCI-H2081,135999136,1.634974352928294
SKM-1,JQ-1-MK-0752 (1-1 mol-mol),-0.3579798637205856
SK-LMS-1,11175137,3.0563983886925485
PE/CA-PJ49,11404337,0.0513303948007028
TE 617.T,54613361,0.91605087523289
KYSE-410,4096211,2.054863080467891
CA46,6918638,-2.155597959241919
GOS-3,selumetinib-PLX-4032 (8-1 mol-mol),5.581542151485772
NCI-N87,135398516,0.1780104282584799
SET-2,49867926,3.721151379814877
AU565,11257553,-0.514738811981399
OE21,71680916,4.326553499160839
HCC2218,9927531,0.7764965952119703
PE/CA-PJ49,54143018,0.3953698783249076
YH-13,1242560,3.390662173618847
SK-LMS-1,51037431,1.890462199856316
SK-N-AS,107985,-4.041624187442296
SK-MEL-1,alisertib-navitoclax (2-1 mol-mol),-2.1096090631604225
CA46,3038522,1.2076902647573031
NU-DHL-1,vorinostat-carboplatin (1-1 mol-mol),1.348913294016227
RERF-LC-Ad2,400769,-0.9539605441189488
RERF-LC-Ad1,ISOX-bortezomib (250-1 mol-mol),1.1789049180677365
IST-Mes1,216345,3.619183672475448
SNU-8,1242560,3.383210455618013
BT 320,11178236,-2.5149680405736095
LoVo,4705,1.5085236639058903
ESS-1,82146,4.445932191029335
SK-N-AS,12001922,1.350346132693266
BT 328,10184653,3.731010322665131
KMS-27,10410894,2.595057582613953
BT 330,3503,1.007043340813608
BT 248,216345,4.501699374414374
Ku812,676352,0.8509371863711478
EJM,11152667,-2.5425383772209393
SEM,BRD9876-MK-1775 (4-1 mol-mol),-0.9190635288333102
AU565,6184667,2.5363760520525247
HEC-151,16065773,3.119237421704228
Kasumi-2,24951314,-0.5780068322267972
D283 Med,4578,4.258576085653485
RERF-LC-Ad2,selumetinib-navitoclax (8-1 mol-mol),1.7872800947486227
A4/Fukuda,5113032,4.450145517718883
Kasumi-2,6918328,-2.1918789082401355
KMS-27,171352865,4.770366680942233
MM1.S,24785538,-3.291318943306552
Hep-G2,24951314,0.9482365858167474
SNU-1272,3854666,4.252561459564198
SW1990,9903786,3.346032701157222
KMS-27,375860,-1.142960082705596
GOS-3,1566236,2.0611902912111013
AN3-CA,387447,-4.801616318597083
TE-15,55508,6.278494515493491
SK-LMS-1,10385095,1.8771783160907216
SW1990,navitoclax-pluripotin (1-1 mol-mol),-0.9911428992903798
JIMT-1,6918736,-1.4744098430927444
RPMI-7951,selumetinib-JQ-1 (4-1 mol-mol),1.1039196671614755
D283 Med,SNX-2112-bortezomib (250-1 mol-mol),-3.2108691902220317
Kasumi-2,168313016,3.99242446715415
KMRC-2,54618305,4.826508920504646
HCC2218,5287620,-0.7427500488535822
LoVo,16736978,-0.2277330125842315
KP-4,8515,3.507883744965969
EJM,327653,3.072072044008088
SET-2,42642645,1.5716650325889971
SET-2,46215462,1.341717099433842
MCAS,9826308,0.2385151370335357
SK-LMS-1,navitoclax-MST-312 (1-1 mol-mol),0.8198989880129489
BT 320,5329102,3.0266079626967928
SET-2,44493528,4.2834335976641205
CML-T1,19582717,1.9595186711365948
H-STS,24797083,1.5630657554706655
Hs 683,135440466,2.999728684300055
KMS-20,3676137,4.822799342742389
LCLC-103H,135875424,4.227127244707997
HARA [Human squamous cell lung carcinoma],42611257,3.5357302300548716
NU-DHL-1,24856436,-1.132887458167272
JIMT-1,3025944,4.686835567443059
KYSE-70,23725625,6.518030965677853
YKG-1,119607,6.023388476770122
OE21,1566236,3.330797910783387
NCO2,11222830,1.2298042990940938
SNU-1272,11626560,2.412334917468919
KP-4,637858,2.2303750130637163
CML-T1,11152667,-2.6898641024331584
OAW28,374536,3.018534312402979
KYSE-410,26596,0.1189340940832646
NCI-H2081,445091,4.108892916064877
KYSE-410,9907093,4.226995518045274
NCI-H1395,72193861,3.743948008436619
KMS-20,446155,2.015814928352595
SK-LMS-1,11222830,1.0823072578010553
YH-13,selumetinib-GDC-0941 (4-1 mol-mol),2.117878884448022
KMS-27,9840324,5.417982870639934
BT 139,2858523,3.519149173207282
MCAS,9444,3.993377815466736
SNU-1033,25154868,4.9583601903631855
LCLC-103H,6918736,-1.2879755952577534
Kasumi-2,135398744,8.02054113805855
NCI-H2172,24180719,4.347081195006066
Kasumi-2,tretinoin-carboplatin (2-1 mol-mol),2.8935059772434792
HCC2218,25227462,0.9757651959327488
OAW28,11977753,-1.87780111267196
MCAS,135421197,1.955288267695935
BT 139,24180719,5.457784024295298
EJM,67291369,1.7499501988378825
Hs 683,136227924,2.524769704566026
Hs 683,24821094,3.6507321764392806
NCI-H1395,3689413,-2.5246792207692073
LNCaP clone FGC,3062316,2.5314062575910383
KP-4,19582717,5.485304590763591
Hs 683,5311281,1.0766329567459891
NCI-H2172,46199207,3.6599874133069337
HEC-151,68056272,4.055262002994441
NCI-H1092,3081361,3.870512478612
NU-DHL-1,16736978,-0.1858099364077559
NU-DHL-1,navitoclax-piperlongumine (1-1 mol-mol),-2.603408624311022
PE/CA-PJ49,36462,0.5276653245054587
KP-4,56946209,-3.866030178778536
Hs 683,10296883,3.967060059444981
NCI-N87,4917,2.911504588829893
TE 617.T,44493528,4.329408184341151
BT 330,51039095,2.347210430351482
MM1.S,9903786,2.841249590923514
WM983B,tanespimycin-gemcitabine (1-1 mol-mol),-1.6286675768894772
SW1573,25154868,3.281093993360062
Ku812,navitoclax-piperlongumine (1-1 mol-mol),-0.4247050049516961
RPMI-7951,56963564,-0.4899477969524511
KYSE-70,docetaxel-tanespimycin (2-1 mol-mol),-4.718411789937545
LNCaP clone FGC,53495165,-3.058468218132953
KMS-27,3384730,0.3724984048412317
SKM-1,9549297,1.2494873676183296
SNU-308,44489675,3.6982483700429816
NCO2,73707386,2.320986142131463
IST-Mes1,5281321,-0.504099135222913
PaTu 8988s,46398810,1.9991090660302973
TE-15,25062766,1.200635335183344
RERF-LC-Ad1,54454,3.700489737063693
NU-DHL-1,68056272,3.3268540806967493
HuT 78,11625818,3.646817685983461
H-STS,46215462,1.7095245533302474
BT 320,54618795,3.6611780989616514
Ku812,451668,-0.4735095751840026
RPMI-7951,439501,-2.4869379045692313
BFTC-909,decitabine-navitoclax (2-1 mol-mol),5.107856917496857
SW1573,11404337,-1.3449252751203844
BT 504,9825149,2.098338156974242
KMS-20,5470400,3.66095099823791
NU-DHL-1,15547703,3.0121998321464805
RERF-LC-A1,vorinostat-carboplatin (1-1 mol-mol),2.4343200147790744
KYSE-410,4788,5.897202503975128
ML-1 [Human thyroid carcinoma],44632017,3.256506939906626
PE/CA-PJ34 (clone C12),6852167,2.080023831418778
SKM-1,3385,1.1892530781163966
IST-Mes1,135411,1.0362911335756892
SK-MEL-1,4917,2.925765826226466
PaTu 8988s,445643,4.25778743866418
OAW42,5280436,2.3865244736877824
KP-4,5311281,0.5350208098377819
NCI-H2110,54618305,4.481600360500252
KMBC-2,322968,4.513420316222048
JIMT-1,5282054,4.362342663864306
BT 248,73707438,3.693804860778579
NU-DHL-1,387447,-5.01713614563577
SNU-8,24856436,0.3445950257327131
NCI-H2081,241158,4.1289817617864575
HCC2218,2828334,5.476104905446887
NCO2,44259,0.5020620033285452
OAW42,11152667,-1.0580201050498812
YKG-1,24180719,3.9983429760657265
NCI-H2110,54613361,-0.3026858846945739
KYSE-70,51037431,6.2873914521382765
SNU-1214,16722836,0.6993060369104132
JIMT-1,44589607,3.223672220298868
Kasumi-2,5311,-0.335738593661984
LCLC-103H,135999136,4.479345177933151
SEM,1641662,2.508220365497951
NU-DHL-1,2858523,3.2387233611606945
SNU-1214,216468,0.5120468457029691
NCI-H1395,24951314,2.24574697242026
CML-T1,46199207,2.0991647549590304
Ku812,11234052,3.043132602643913
ML-1 [Human thyroid carcinoma],9967941,2.6659391926085183
KMS-27,6438330,1.5142340540628925
KMS-27,168313016,5.514189836939729
KMBC-2,9825149,2.796829820387343
RERF-LC-A1,5282054,3.983591345567895
AN3-CA,400769,-1.610122578962545
ML-1 [Human thyroid carcinoma],JQ-1-carboplatin (1-1 mol-mol),0.7562453345428342
HSC-4,148198,-2.795908666323494
A4/Fukuda,15547703,2.4441609561923547
OAW42,11656518,3.104019641918633
JIMT-1,135984461,4.835908287513633
KYSE-70,400769,-0.6610715268602807
HSC-4,9823820,4.434899642824078
Aska-SS,9956119,4.259319664009723
OAW28,159324,2.7212056331712584
SET-2,2949965,1.3064818811189056
SW1990,5738263,4.0408382975361965
PE/CA-PJ49,11609586,3.094343334038443
SK-MEL-1,11640390,4.907415921825892
AU565,54596490,4.681317358630495
MCAS,25105715,3.2707078341625837
KMBC-2,441298,2.4144420207612094
NCI-H2110,9444,4.512884732727542
NCO2,BRD-K58730230,4.288151219140436
HARA [Human squamous cell lung carcinoma],656346,-0.3153592740671193
BT 139,11955716,-1.697910651443111
SW1990,5291,3.846713865326283
Kasumi-2,4259181,-0.4186991216348978
TE 617.T,462382,-0.1040217351692691
AU565,135440466,3.093480574806016
NCO2,25062766,1.6487899850071774
Hs 683,53232,2.407041443710606
LoVo,16065773,3.0239362353443195
PE/CA-PJ34 (clone C12),25227462,0.7769258738291116
BT 328,11167602,4.034112762840579
CML-T1,3038522,2.3382153755761372
D283 Med,107985,-4.659724680199273
WM983B,441298,3.230892781989705
NCO2,24180719,2.363595427996926
HEC-151,9956119,3.45656253081276
NCO2,decitabine-carboplatin (1-1 mol-mol),-2.08696402237591
Ku812,5351362,0.738272453823816
HuT 78,3136844,3.938412897897032
AU565,11656518,2.4577765871660353
H-STS,5282054,2.573359833272533
KYSE-410,613753,3.317152261963387
BT 320,66577038,3.2847085574393557
PE/CA-PJ49,carboplatin-etoposide (40-17 mol-mol),1.478939712667842
BT 504,5328940,1.8205122683465604
HMCB,11175137,3.661072098195176
BT 320,3503,3.052625173384868
PE/CA-PJ34 (clone C12),676352,1.767200093931116
KMRC-2,119607,5.905550906408889
MCAS,5738263,3.7529999834247545
Aska-SS,10074640,2.970727178654189
LCLC-103H,9936388,2.1573494470182593
OAW42,1716436,3.6467595531417833
NCI-H2110,26596,-0.8689069076907829
KYSE-70,JQ-1-vorinostat (2-1 mol-mol),1.448223728209247
NCI-H2110,136227924,4.625762146403413
PE/CA-PJ49,3854666,0.40608223824848
PE/CA-PJ49,49867926,3.991551266826087
IST-Mes1,3854666,2.0681561223579075
NCO2,BRD-A02303741-navitoclax (2-1 mol-mol),0.998277867970351
BT 320,44607530,2.9331646844346015
ML-1 [Human thyroid carcinoma],65064,4.907366569161651
TE-15,1716436,2.6611332853088316
LCLC-103H,11427553,2.9009004188890546
ML-1 [Human thyroid carcinoma],25154868,4.839556149748317
YKG-1,navitoclax-PLX-4032 (1-1 mol-mol),5.471845288851878
MM1.S,5113032,5.133627737640779
KMS-27,168312962,-1.5157440270086788
NCI-H1395,6918837,-1.563832795621605
IST-Mes1,11485656,3.5408910362273835
BT 139,crizotinib-PLX-4032 (2-1 mol-mol),1.8615105842920296
HCC2218,4917,2.6450259941081535
D283 Med,1242560,3.0255302054486797
KP-4,5284616,2.9251067954202243
BT 330,selumetinib-MK-2206 (8-1 mol-mol),2.398235060247757
SEM,selumetinib-JQ-1 (4-1 mol-mol),-1.6081049960911422
SW1990,11955716,-2.6949226775920745
BT 139,2828334,6.284593174469785
SW1990,6918638,1.2411625887645945
NU-DHL-1,6918736,-3.063185007693412
AN3-CA,54678924,1.6198465889937177
HCC2218,9933475,1.682361828234478
MCAS,11964036,1.9381780562903528
NCI-H2110,54678924,1.637714485165824
EJM,9825149,1.9985799603893497
RPMI-7951,3465537,-0.2413225331247042
SEM,72193861,-0.1864351946405744
OAW42,25105715,3.468531429058693
OAW28,168313200,4.298133692275281
MCAS,5278396,3.716598283508606
SNU-8,46398810,2.415375163446902
PE/CA-PJ34 (clone C12),462382,1.1999827824546994
OAW28,25183872,-1.003855010480259
AU565,tretinoin-navitoclax (4-1 mol-mol),4.550367433205839
NCO2,10410894,1.627512769076185
JIMT-1,5278396,3.920863267492461
NCI-H2110,6610355,4.409375445265295
NCO2,71466445,2.6517435517023284
KYSE-70,44493528,4.735176242945038
Ku812,11167602,0.0017995666708742
BT 139,24180125,3.745397640720988
AU565,2746,2.9112036552039737
Ku812,44487061,4.391820137967094
CML-T1,9927531,3.1672020542525674
YH-13,5282054,3.978961263004533
SK-N-AS,2733526,4.201236340961212
ESS-1,25195348,3.4553614671814903
BT 328,9444,4.598160630608248
SNU-1214,2113511,7.01646304826078
HSC-4,89928392,1.9678897287961257
KYSE-70,selumetinib-navitoclax (8-1 mol-mol),3.975968679943077
KP-4,135421197,2.59268452027494
TE 617.T,3465537,1.2174694198208424
RERF-LC-A1,tretinoin-navitoclax (4-1 mol-mol),3.6182985795411566
RPMI-7951,46907787,2.690496694685834
PaTu 8988s,11364421,-4.526893014804376
SEM,5494449,-4.399827227621216
KYSE-410,24748573,1.6083529001862935
Aska-SS,3025944,4.227311720651848
SNU-8,119607,5.799968666397276
AU565,vorinostat-carboplatin (1-1 mol-mol),2.4881642304307463
BT 248,72193861,2.013908806167315
KMRC-2,1716436,3.689982087798527
OE21,5284616,-5.631337139904208
NCI-N87,24901704,2.2078626603453664
CA46,16722836,1.2778374610309875
IST-Mes1,637858,2.1376990366589905
SNU-1033,erlotinib-PLX-4032 (2-1 mol-mol),3.2989071401635344
MCAS,451668,-1.085007175694647
KYSE-70,5311,1.3049127753558711
YH-13,4788,5.883867811277833
NCI-H2110,docetaxel-tanespimycin (2-1 mol-mol),-5.357361865620825
SW1573,126941,-1.0305779796426808
Kasumi-2,54596558,4.023508952920703
MCAS,54613361,0.0059907932342909
NCI-H2110,24771867,3.185032011648231
ML-1 [Human thyroid carcinoma],2733526,3.914729894927785
SNU-8,49793307,-2.730453416599212
OAW42,26596,0.2521816339620648
LNCaP clone FGC,107985,-3.945098238572166
H-STS,decitabine-carboplatin (1-1 mol-mol),5.177792515700317
BT 328,JQ-1-vorinostat (2-1 mol-mol),3.553838421661415
NCO2,387447,-5.467195701538589
SET-2,9825149,1.617033396612476
MCAS,9549297,1.7154224156023905
TE 617.T,322968,2.4970078464973255
SK-LMS-1,54618164,4.255927554001473
AN3-CA,6918638,0.8350174262489668
HEC-151,5282054,3.4640113624850435
Ku812,3503,1.4349303332326306
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943
OAW42,11612883,3.868938887834983
KP-4,122327,4.232816492077044
RERF-LC-Ad1,44202524,4.3484891149380696
YH-13,71751553,4.865573337264169
HSC-4,11612883,3.5946567658341197
AN3-CA,11404337,1.5621280335523782
KMBC-2,637858,2.3795290977842014
SKM-1,23582824,1.1838260126790126
SW1990,54596490,5.639139126471044
KP-4,82146,3.3218041213797185
CML-T1,3384730,0.9879066704986152
NCI-H1092,44819697,-2.585083012775511
KMS-20,246676,4.441835225578849
YH-13,54613361,-0.2526246447247056
SEM,44632017,-0.1291219027701855
SK-N-AS,327653,3.714692783839888
RPMI-7951,3543504,4.334732090077199
A4/Fukuda,9911463,2.417745886609146
PE/CA-PJ49,11213558,1.0158445908271905
SK-N-AS,439501,-3.01819280603901
SNU-8,327653,3.195636469676862
NCO2,135440466,1.1781134590171525
HMCB,107985,-2.41132307847832
SK-LMS-1,60700,-0.2851766330643205
H-STS,219104,3.0414715393637937
EJM,5738263,3.5762426266629617
KMS-20,3384730,1.352817423261366
SET-2,322968,2.0480585516644014
NCI-H2081,6610216,3.784534117796005
BT 320,6438330,2.745053768259143
A4/Fukuda,67291369,-0.3870993856905487
Hs 683,72376,-1.5249898832053124
LCLC-103H,71466578,5.036508948431935
LNCaP clone FGC,selumetinib-tretinoin (2-1 mol-mol),5.335442917701662
NCI-N87,9952709,5.048469263792704
Raji,9840324,5.728026147182044
KYSE-410,2828334,6.400513638299557
KMBC-2,135440466,2.5056800348952053
TE-15,46191454,1.606865712982689
MCAS,60750,-2.5665145901984943
LCLC-103H,selumetinib-JQ-1 (4-1 mol-mol),2.2778723422083886
BFTC-909,11214940,1.666026285351028
KMS-27,9967941,3.184631883228521
SK-LMS-1,24180719,4.466013942579335
Kasumi-2,5287969,-1.8638241340536708
MM1.S,56649450,0.693428636347353
Ku812,44589607,1.98424939843821
SEM,5282054,2.754283213849225
HEC-151,selumetinib-GDC-0941 (4-1 mol-mol),1.9023911399430904
SNU-1272,16038120,1.164758471385012
SW1573,tanespimycin-gemcitabine (1-1 mol-mol),5.2364436023498815
AN3-CA,46199207,3.4912031216021906
KMRC-2,4788,6.118095865877025
MCAS,selumetinib-PLX-4032 (8-1 mol-mol),1.4461333725450911
SK-N-AS,4096211,1.8858030653415112
KYSE-410,54618305,4.463720756901811
SNU-8,15953870,4.687237129335348
SK-N-AS,135398738,4.843654534830111
Ku812,carboplatin-etoposide (40-17 mol-mol),2.1492601350964606
Aska-SS,selumetinib-MK-2206 (8-1 mol-mol),1.267914479489374
NCI-H2081,25227462,-3.2054871570484114
RPMI-7951,24978538,2.2131570624667978
BT 330,219104,3.3915993444029047
NCI-H2110,24964624,2.4930185559615947
SEM,6438330,0.6807940195950141
BT 330,71680916,4.818271109302731
Ku812,2708,3.4695310575636262
ESS-1,26596,-1.5335330182559344
CA46,doxorubicin-navitoclax (2-1 mol-mol),-1.6756299291036936
CA46,24753719,4.040239779097469
SK-LMS-1,49766530,-1.7559370930712266
BT 248,24964624,0.9785580517881716
Kasumi-2,135984461,1.6284116850001094
D283 Med,5287969,-2.6386701555560466
SNU-1272,12001922,1.7945381645240002
Aska-SS,carboplatin-etoposide (40-17 mol-mol),4.007794441531432
NCI-H1092,11485656,1.8493866648869597
LCLC-103H,11609586,3.0072473444370904
TE 617.T,10385095,0.7381710373926665
LNCaP clone FGC,5351362,1.275923514869112
HEC-151,11214940,3.7969879904558073
ESS-1,9866186,0.1543463253926908
NCO2,25262965,-2.4397903309002884
BT 328,11396600,3.7528560222461858
BT 248,erlotinib-PLX-4032 (2-1 mol-mol),2.9999117563905497
LoVo,vorinostat-carboplatin (1-1 mol-mol),2.43633518664014
LCLC-103H,selumetinib-vorinostat (8-1 mol-mol),2.6611498366022763
YH-13,navitoclax-MST-312 (1-1 mol-mol),0.5038954748118908
ESS-1,11626560,2.39928314153679
SEM,2708,2.117173016792575
KMBC-2,73707438,4.383844764052632
H-STS,66577038,3.1923549200255796
Kasumi-2,135411,-1.6102115279025644
CA46,5311281,1.0891225881142432
KMS-27,sirolimus-bortezomib (250-1 mol-mol),0.0328786954835015
PaTu 8988s,135440466,1.1893530670174288
GOS-3,81146,4.428248018506032
JIMT-1,44507138,1.853052345828243
NCI-H2081,10296883,3.746053952557345
SEM,24772860,-3.2932991831821767
NCI-H1395,44493528,4.373197971838804
YH-13,11609586,3.847087958422487
SK-N-AS,156414,1.537017755514308
SNU-8,11612883,2.730749090245882
OAW42,208908,3.493947163240246
KMS-20,71751553,3.937106268474675
MCAS,10296883,3.979435703813419
SW1990,10427712,4.382583740281089
SET-2,docetaxel-tanespimycin (2-1 mol-mol),-5.191672273029725
PE/CA-PJ34 (clone C12),56646779,4.7380779869722565
NU-DHL-1,11955716,-1.5402141200018542
NCI-H2081,44137675,3.995852216137384
SK-N-AS,3465537,3.1460094304770387
SEM,327653,3.0255719016474605
CML-T1,5978,-4.3443825686600785
PE/CA-PJ49,doxorubicin-navitoclax (2-1 mol-mol),-1.9478418148635344
Hep-G2,107970,2.033740391106035
TE 617.T,16659841,3.927285951195876
SNU-1033,135421197,1.1443309651958211
KYSE-70,6852167,2.2981101713941814
HSC-4,16038120,1.7232268235274473
HMCB,71466380,3.936881687634452
AU565,9956119,3.3766215860348368
NCI-H2172,56946209,2.15106765647146
D283 Med,2708,2.7389036189058156
JIMT-1,ISOX-bortezomib (250-1 mol-mol),1.6729086499502406
SNU-308,11234052,4.284422221510759
SET-2,16219061,2.3262981001473912
SNU-1033,60700,0.4874108250457245
YH-13,637858,2.290172126875016
LNCaP clone FGC,9952709,2.4492721163211333
ESS-1,216345,4.629850284617237
Hep-G2,selumetinib-GDC-0941 (4-1 mol-mol),-0.4461378228189951
OAW28,54618164,4.207465894202405
SK-MEL-1,sirolimus-bortezomib (250-1 mol-mol),1.7691939182804728
HuT 78,426756,2.038203464685228
YKG-1,44607531,1.7314965452309146
HuT 78,72193861,0.6888403740474174
SET-2,44486219,4.176423413472714
BFTC-909,1641662,3.805506520632872
NCI-H1092,6914657,-5.953361692198434
OAW28,984333,0.3792215902143511
CML-T1,168312962,-0.7219792388324245
BT 330,49766530,-1.7517349908544686
GOS-3,5328940,2.3255367780793432
TE-15,44137675,2.7760233846096845
ML-1 [Human thyroid carcinoma],46398810,2.1486791434985344
ML-1 [Human thyroid carcinoma],73707398,0.9772448893034968
SET-2,24889392,4.339903723354472
HuT 78,3543504,5.689885557286378
ML-1 [Human thyroid carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),-0.2880991888537167
ESS-1,445091,4.768128875501155
SK-MEL-1,452548,2.1265146221847666
HCC2218,56946209,-1.8093732345555749
A4/Fukuda,753704,3.7176461109746897
SET-2,6918878,0.2720159878545329
JIMT-1,JQ-1-vorinostat (2-1 mol-mol),2.2220323520293324
Kasumi-2,navitoclax-gemcitabine (1-1 mol-mol),-5.447760787137567
KMS-27,2841722,4.033827389929099
BT 330,387447,-5.2185859135267405
NCI-N87,24180719,3.957157119616887
NCI-H2081,753704,4.35902455138568
RPMI-7951,23635314,-1.518044786135355
GOS-3,6438330,5.388884852572475
SET-2,11707110,0.8817247620057471
BT 139,44607531,0.6267654065816637
SET-2,selumetinib-PLX-4032 (8-1 mol-mol),3.6485530309859406
HMCB,navitoclax-gemcitabine (1-1 mol-mol),-1.404873290232393
HCC2218,3689413,-1.7582350299108729
TE 617.T,5281672,4.03972695843784
PE/CA-PJ49,54626689,4.62395369924922
PE/CA-PJ49,11955716,-2.5163887082114753
BT 330,5738263,3.980318493089423
KMS-20,11717001,3.5596278173639835
SET-2,4259181,0.1167213945949705
OAW28,67291369,5.503883029091299
HCC2218,1716436,1.618358710169954
RPMI-7951,126941,-2.8571002343127354
SK-N-AS,89928392,1.3267587142072523
KMS-27,6918878,3.015060659774869
SNU-1272,selumetinib-GDC-0941 (4-1 mol-mol),3.373247687277942
HSC-4,vorinostat-navitoclax (4-1 mol-mol),1.9548576859286355
MCAS,46907787,1.67067233253558
SNU-8,10127622,1.517621881090038
NCI-H1092,11497983,4.878334634479546
CML-T1,11178236,-2.7580162479970634
Kasumi-2,10184653,1.2356790109659648
D283 Med,5282054,2.5822291305993064
NCI-H2110,10113978,3.4332805714710157
KMBC-2,carboplatin-etoposide (40-17 mol-mol),4.395543758735
BT 330,10322450,4.515837789997584
Kasumi-2,44202524,1.2131871054756846
Ku812,selumetinib-JQ-1 (4-1 mol-mol),-3.4448372792658857
SNU-1272,JQ-1-vorinostat (2-1 mol-mol),1.5021778679128583
NCI-N87,400769,-1.2757727144105298
PE/CA-PJ34 (clone C12),135984461,4.299717419292052
CML-T1,46907787,-0.5465083296094366
SK-LMS-1,446155,0.540245442261307
YH-13,11612883,3.2122521691176975
SW1990,5311,2.4410720341542977
LCLC-103H,89183176,5.182939632216163
HARA [Human squamous cell lung carcinoma],54618771,1.4449475826214635
SK-N-AS,2749,1.8917197763310865
SEM,24978538,-3.458194735771583
PaTu 8988s,4705,3.38811272412219
KMS-27,24856436,0.2038546195429807
HSC-4,46398810,3.0881815243810897
AN3-CA,104842,0.1693347049630243
Hs 683,tanespimycin-gemcitabine (1-1 mol-mol),-0.667566647901776
JIMT-1,409805,5.21285843677131
LNCaP clone FGC,445455,4.814735127711645
OE21,54619267,3.756831032565462
LNCaP clone FGC,5460769,1.4769173176739367
HSC-4,2749,1.8453067540575636
KP-4,serdemetan-SCH-529074 (1-1 mol-mol),2.40284921565821
OE21,49836020,4.665936469802933
KP-4,46398810,3.1557442071121606
EJM,25154868,4.2554852921408415
Aska-SS,11497983,4.298236057631577
Aska-SS,3825829,4.613612651673856
HuT 78,11317348,2.425204796310932
AU565,9908783,4.7252597511686965
TE 617.T,9823820,3.4486564121687695
BT 330,6438330,0.9073034139929264
SNU-1214,156414,-3.2304362437665812
CA46,126941,-4.174426911659592
OE21,54626689,4.586584726224223
SK-MEL-1,2828334,6.092303367135549
JIMT-1,11234052,4.517099917796713
ESS-1,262093,3.0427773228942057
KMBC-2,4477,1.229312067583003
LoVo,11175137,1.7419612548831422
NCI-H2172,44185566,3.129392327597959
Ku812,135875424,4.708872885868404
SK-MEL-1,54649381,4.230171165309088
WM983B,5282054,4.483342547372228
Hep-G2,10296883,3.682570839684776
KP-4,4917,3.466459044932804
OE21,374536,3.562547341164509
KMRC-2,10127622,3.879900327054352
NCI-H2172,1716436,2.3088273241910686
PE/CA-PJ49,selumetinib-vorinostat (8-1 mol-mol),1.4585612568832638
NCI-H2172,16720766,4.787872984188638
WM983B,71466380,5.163630916772624
SNU-8,19582717,3.8862122891629425
SKM-1,2749,1.349204961084549
SNU-1214,71466380,4.053214344929856
BT 320,9935249,2.6939509810826294
NCI-H2081,60700,-2.8603020139497115
SEM,JQ-1-MK-0752 (1-1 mol-mol),-2.5626704583038276
TE 617.T,24856436,-0.0598938558590973
GOS-3,637858,2.327239346274226
PE/CA-PJ34 (clone C12),46926350,-5.351224463970161
OAW28,135440466,2.5697421477630273
KMBC-2,445643,3.749158738502044
CML-T1,44491742,2.876043803936746
SK-LMS-1,613753,3.286520760006206
BT 504,6450551,1.2836569274030185
NCI-H2110,sirolimus-bortezomib (250-1 mol-mol),0.8725557491519701
SK-LMS-1,5566,3.6003036251951195
ESS-1,10385095,0.0154495368261296
JIMT-1,navitoclax-gemcitabine (1-1 mol-mol),2.527846181835564
SK-MEL-1,46398810,2.5132560090727454
IST-Mes1,49867930,4.491137344342606
BT 139,135875424,2.659641868559938
NCI-H1092,24821094,3.179628760987399
Ku812,5281672,3.8217692077235
KYSE-410,5329102,1.9540391850066523
BT 328,11455910,1.1431162062454217
SNU-8,439501,-2.494664293068585
HCC2218,16659841,4.361072089276897
SK-LMS-1,65064,5.781704969284795
IST-Mes1,9935249,3.876611894197404
TE-15,53495165,0.1275569462567273
EJM,24821094,3.662751413369248
HEC-151,2749,0.6701627119421153
SK-N-AS,46926350,-4.132726643488665
RERF-LC-A1,4259181,-0.0269897105807535
BT 139,6505803,-5.215267056081471
Kasumi-2,6438330,0.3381981879114322
CML-T1,54649381,3.615747973120369
Aska-SS,11222830,1.885220624165585
HARA [Human squamous cell lung carcinoma],11222830,1.4006503885864872
SEM,5278396,2.924280160734611
SK-MEL-1,24856436,0.8151207655749367
HARA [Human squamous cell lung carcinoma],navitoclax-birinapant (1-1 mol-mol),1.3986072497708624
CML-T1,135398516,1.062716502546658
TE 617.T,54618164,3.769426855939867
NCI-H2110,753704,5.759547446476079
NCI-H2110,3062316,1.6416396765359922
HEC-151,216239,1.8200014424297823
SW1990,46926350,-4.013688074453093
BT 320,11214940,4.494237160276683
KP-4,71304818,2.4172206525635316
KMBC-2,66577038,3.542721508364004
SK-LMS-1,11625818,4.800925756736957
KMRC-2,UNC0638-navitoclax (1-1 mol-mol),2.5258787536181515
SNU-8,4521392,4.562248393821206
SW1990,9915743,2.956888864284862
KYSE-70,4788,5.890959200463747
Raji,44507138,1.1959829987130275
BT 330,702558,5.305426703437462
NCO2,3815108,0.944486956694321
GOS-3,11427553,2.487045066954577
NCI-H1092,6917907,2.9110687137698443
HCC2218,9926054,1.6047846197702569
HMCB,24821094,3.404555238372124
KMRC-2,49867926,5.18700499218569
PE/CA-PJ34 (clone C12),24951314,2.349740240636077
Ku812,9911463,3.2535027234043428
NCI-H2110,9908783,4.433738876921207
RERF-LC-A1,54619238,5.777627081986452
NCO2,46943432,0.3319797897009531
OAW42,2733487,3.105594965269564
NCI-H1092,selumetinib-navitoclax (8-1 mol-mol),4.937762967371625
KMBC-2,24753719,5.4446471977662245
HEC-151,11455910,-0.546024976491568
OAW28,56946209,-4.450705744661636
PE/CA-PJ34 (clone C12),65064,5.4596992338484664
KP-4,3025986,0.0232409556769203
SEM,73707398,-1.1402705015945305
Hs 683,navitoclax-gemcitabine (1-1 mol-mol),-1.976153895418953
SNU-1272,9926054,2.4790221898932283
SNU-308,54649381,3.890823095113657
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487
JIMT-1,selumetinib-vorinostat (8-1 mol-mol),2.6253101469518136
IST-Mes1,72376,0.3576615812024088
OE21,salermide-PLX-4032 (12-1 mol-mol),4.851200282788362
SW1990,23582824,0.8486087379824238
OE21,67291369,1.9144842745200683
SW1990,148198,-3.981392088661051
SNU-8,176870,3.005143293310265
CA46,11455910,-0.2967360934235351
TE 617.T,4705,0.0619159999462867
SNU-308,8515,4.888482056700149
SNU-1272,2733487,6.387054792356426
ESS-1,11656518,2.306800559161758
RERF-LC-Ad1,9911830,3.638980358065119
HEC-151,piperlongumine-MST-312 (1-1 mol-mol),1.456707300994177
KMS-27,11404337,-1.6812910673716006
Kasumi-2,54619267,3.817493003311882
TE 617.T,selumetinib-tretinoin (2-1 mol-mol),2.362320733514288
KMRC-2,1566236,2.2234157510538832
MCAS,9929138,6.918248380879042
NU-DHL-1,16013152,3.387087199942325
PaTu 8988s,25154868,5.292132269319359
AN3-CA,135875424,2.655467292479818
KP-4,JQ-1-navitoclax (2-1 mol-mol),2.383966273580647
RERF-LC-Ad1,49793307,-0.0254634862960308
SK-N-AS,44607531,1.4343173293691498
SKM-1,54618164,3.978394394327194
CML-T1,71466578,2.784294880886227
KMBC-2,676352,2.118156688654481
SNU-1214,676352,1.8003199215115635
SW1573,1750826,-4.895155026964416
KYSE-410,168312962,3.075670045651394
SK-N-AS,erlotinib-PLX-4032 (2-1 mol-mol),3.5519171442480517
LoVo,2708,4.2308362163689415
BT 330,selumetinib-GDC-0941 (4-1 mol-mol),1.903493951226084
Raji,44202524,1.2005931973805375
RPMI-7951,568763,-1.4306382653254477
TE-15,11640390,3.6556981227113634
Ku812,3689413,-1.935767376067546
MCAS,25154868,4.061191249717254
TE-15,439501,-2.48025284068881
SK-MEL-1,25126798,4.366214869223187
BT 330,374536,3.220978821427871
Aska-SS,10302451,3.2025437422649796
PE/CA-PJ34 (clone C12),6917907,-5.874012893273867
HuT 78,10113978,2.521071548009062
Hep-G2,3543504,4.31839273313728
A4/Fukuda,9825149,-2.050748608979426
KYSE-410,11647372,0.147715793237346
LCLC-103H,selumetinib-GDC-0941 (4-1 mol-mol),3.056154104463145
KMBC-2,156414,2.2596369338990976
NCI-H2081,3552672,1.4004455642024622
NU-DHL-1,selumetinib-UNC0638 (4-1 mol-mol),1.2848172177454842
SET-2,6252,-3.154531220963429
CML-T1,119182,-4.6073645657146285
HEC-151,5738263,3.5405750813790373
WM983B,36462,1.7671342918989796
IST-Mes1,12001922,2.6228240364869113
EJM,selumetinib-tretinoin (2-1 mol-mol),5.075808196107974
SK-LMS-1,11238147,1.9919735936136431
ML-1 [Human thyroid carcinoma],selumetinib-decitabine (4-1 mol-mol),4.367801531941202
AU565,81146,6.247262332137589
PaTu 8988s,135423438,2.605491208286135
A4/Fukuda,piperlongumine-MST-312 (1-1 mol-mol),1.0662246579823889
HMCB,5470400,-3.7060636680278
KMS-20,9936388,-8.248983770505305
PE/CA-PJ49,11612883,2.5815525377879553
RERF-LC-Ad2,46191454,2.0010974670681083
NCI-H1395,25161177,5.627463134287728
BT 320,5494449,4.096191424375148
SNU-1272,49766530,0.1675221070029884
BFTC-909,11609586,2.9417391320909134
HuT 78,56649450,2.503642191453737
A4/Fukuda,24771867,-3.7385177445932585
MM1.S,selumetinib-UNC0638 (4-1 mol-mol),1.889294879744257
OAW28,60700,1.95920843974679
Hep-G2,409805,4.627773602187177
CML-T1,10410894,3.3337757256136245
CML-T1,3689413,-2.671933251411637
EJM,46398810,2.702595853434399
A4/Fukuda,44185566,1.3030950937163224
BT 328,969516,3.8664962726625416
Raji,9868037,1.949547656703084
NCO2,JQ-1-MK-0752 (1-1 mol-mol),-0.9342312470361546
SW1990,JQ-1-MK-0752 (1-1 mol-mol),3.1533696321662243
RERF-LC-Ad2,219104,4.076519133645829
EJM,5278396,3.1726685526501357
HCC2218,71304818,0.9959138044887994
PE/CA-PJ49,71466445,3.0052586534681645
YKG-1,56946209,-4.319334777154593
IST-Mes1,24797083,1.4429650511590184
BT 328,44589607,2.897724961441205
EJM,24180719,3.679957283710777
SK-MEL-1,71304818,1.792445561686164
OAW28,11964036,1.3272537866850969
OE21,53495165,-2.7243301708474603
IST-Mes1,3384730,4.026476803757859
HEC-151,25102847,3.323993310168594
PE/CA-PJ34 (clone C12),3552672,5.59200043016104
Raji,54618164,3.808171022146071
Hs 683,11364421,-5.723594219866352
KMS-27,452548,-2.159096065325925
KMBC-2,12003241,-0.070536665370705
NCI-H2081,44486219,4.417324221540856
NCO2,676352,1.1561489724786105
D283 Med,73707398,0.757498039182734
SNU-1033,2858523,2.909769226528934
KMRC-2,11152667,0.1110471147886436
TE 617.T,9887053,1.3952225168172891
SK-LMS-1,44819697,-0.0573849235807142
AN3-CA,246676,4.36497705352595
Kasumi-2,selumetinib-MK-2206 (8-1 mol-mol),1.1378728727000402
SET-2,6505803,0.5122894661821437
BFTC-909,969516,2.723005004244225
KMS-20,sirolimus-bortezomib (250-1 mol-mol),-0.3833823463346493
SET-2,SNX-2112-bortezomib (250-1 mol-mol),-2.5339305074195804
LoVo,17759555,2.3197484044750905
TE 617.T,docetaxel-tanespimycin (2-1 mol-mol),-7.03188292749413
BT 139,60700,1.6721898683127974
NCI-H2110,36462,0.5226581571760742
RERF-LC-Ad2,11977753,-1.321500951988714
SK-MEL-1,46907787,0.0749929399397362
NCO2,44507138,1.147448391229369
Hep-G2,67291369,4.476639132471762
NCI-H2110,9887053,6.172725359065793
HARA [Human squamous cell lung carcinoma],9956119,4.138225192842101
RERF-LC-A1,54618305,5.82239682454832
SET-2,56973724,3.3542907589691913
WM983B,9926054,1.9818225106954688
PaTu 8988s,4917,3.2992563846024128
PE/CA-PJ49,sirolimus-bortezomib (250-1 mol-mol),0.2701469855669
HARA [Human squamous cell lung carcinoma],46199207,3.289640650109998
PE/CA-PJ49,erlotinib-PLX-4032 (2-1 mol-mol),1.642024654705514
EJM,54143018,0.5914638722228845
NCI-H1395,71304818,2.2994001148699414
MM1.S,216345,1.7407707889539985
HARA [Human squamous cell lung carcinoma],5278396,3.775794457804869
NU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.8169816306561488
LNCaP clone FGC,285033,-4.262367843729107
JIMT-1,6918328,0.7869245169808525
KMRC-2,984333,1.7771942339470834
SKM-1,46215462,1.429596205296915
SEM,1239801,2.628378122820145
SK-MEL-1,11427553,3.211974912715107
KMRC-2,6438330,3.135955348186537
H-STS,1641662,3.378445220211116
LNCaP clone FGC,5281321,-3.3435432641320957
SEM,57519531,1.3518150272189275
SK-N-AS,44607530,1.35852755154074
ESS-1,11364421,-5.252170636700316
LoVo,crizotinib-PLX-4032 (2-1 mol-mol),1.6425571440672022
IST-Mes1,10385095,2.3784865098232255
NU-DHL-1,25262965,-2.025747961233056
SKM-1,2828334,5.763127700268427
NU-DHL-1,148124,-5.1269699362990195
BT 248,5460769,4.810999932000391
SNU-1272,51037431,3.3764674616808734
NU-DHL-1,16659841,3.4914634927740456
CML-T1,44185566,0.9347798856606148
KP-4,100016,6.84348879863886
LNCaP clone FGC,4477,0.4038376941880343
HuT 78,vorinostat-carboplatin (1-1 mol-mol),1.4699381378496317
SNU-8,10385095,1.1888093081137228
Aska-SS,9843750,4.126997970153608
NCI-H2081,7326481,2.574676844247029
JIMT-1,2113511,7.0250565126488915
YH-13,26596,-1.6020780091570677
PE/CA-PJ34 (clone C12),16038120,0.98561045029006
AN3-CA,135398516,0.9039138069149286
IST-Mes1,1242560,3.612096070768593
WM983B,6184667,3.089627833549022
NCI-H1395,2871966,-1.8514751727384056
AU565,11178236,-4.26632575473861
RERF-LC-A1,19582717,4.162408386700002
A4/Fukuda,9926054,1.7963505717751411
NCI-H2110,60750,-4.5848595647563695
NCI-H2172,24964624,2.6919837814589926
JIMT-1,9935249,3.6195859739992544
RERF-LC-A1,51039095,3.1367076151025315
NCI-H2110,44486219,4.2907180414461195
CML-T1,4917,2.5218741140394476
NCI-H2110,9826308,1.0215113237989006
BT 328,2749,4.811351487491957
BT 504,54613361,-1.791349240523618
Ku812,135999136,1.6073024160366625
PaTu 8988s,4096211,2.074974909140277
NCI-H1092,66577038,3.0171960065263077
SNU-1214,54618164,3.4998200252029257
RPMI-7951,3825829,3.4221940030653903
D283 Med,46907787,-0.0797634926932206
Kasumi-2,57519531,1.2182883326717542
KMRC-2,44589607,3.5490328249670164
ML-1 [Human thyroid carcinoma],navitoclax-MST-312 (1-1 mol-mol),1.8932386957075495
NCI-H2110,6450551,1.873911800645245
BT 504,613753,3.308278918610588
MCAS,100016,6.4909883414165135
YKG-1,25105715,3.7815729862100578
OAW28,5287620,-1.6233190690502424
BFTC-909,10302451,3.622269240471498
Kasumi-2,11494412,-0.1140662522158316
HCC2218,5328940,1.3666058898247246
KP-4,11404337,0.6488423054091234
BT 139,54626689,5.014806632611532
RERF-LC-Ad2,erlotinib-PLX-4032 (2-1 mol-mol),4.9635698805638535
SET-2,44202524,1.8632476825063649
PE/CA-PJ49,10302451,1.2868329863340626
SNU-1033,54596558,4.298942732542006
HMCB,54626689,5.696553588626368
SW1990,9967941,3.0043140523429512
SEM,6918328,-4.219248553628803
OAW28,44486219,3.976522680156617
CML-T1,1750826,-4.284831191139796
SW1990,122327,5.6524077873763385
SNU-1033,11977753,-3.95491254834697
YH-13,5287620,-2.012457236382429
SK-LMS-1,4917,3.7233760792032338
AU565,11175137,1.8234152921093247
Ku812,44632017,0.624416259441737
HARA [Human squamous cell lung carcinoma],10302451,4.803964333247322
LCLC-103H,71304818,2.281745913631909
OAW28,12003241,-0.542287488877267
LoVo,9903786,0.6551100591729495
ESS-1,3825829,4.02803833382595
ML-1 [Human thyroid carcinoma],31703,-3.706133682115605
PE/CA-PJ49,11977753,-0.1070031812883785
Raji,44543605,4.342270551881589
TE 617.T,selumetinib-JQ-1 (4-1 mol-mol),1.4912652874419787
BT 504,25262965,1.3321141466698254
BT 504,9956119,4.075034176762701
WM983B,216239,2.674397179372425
Ku812,24180719,2.5562197151601413
CA46,31703,-2.2435350155349023
HARA [Human squamous cell lung carcinoma],10074640,3.2082861236873814
LoVo,68056272,4.365145786196869
BT 139,11152667,1.692404589023897
TE 617.T,5284616,3.1382086796806954
NU-DHL-1,9884685,-1.1010004281847865
NCI-H2110,613753,3.1736011398703226
Ku812,72376,-3.225507267019729
RPMI-7951,3634881,2.27691218047639
HCC2218,44607531,-1.2799819817909714
YH-13,16065773,2.7841843870151086
RERF-LC-A1,6918837,-2.4332554136811897
SW1573,11640390,3.5338327701281176
YH-13,11152667,0.725065654418547
SNU-8,25195348,3.807920536715813
SNU-308,71304818,2.6626259183515706
PE/CA-PJ49,11317348,4.262539229938768
IST-Mes1,5746,2.704326416379231
A4/Fukuda,6918837,-6.1208599704470865
Kasumi-2,46398810,1.7112254413455064
PE/CA-PJ34 (clone C12),9915743,-2.2300833448892985
D283 Med,44185566,1.0704577587111352
BT 139,11175137,3.339566250291237
HEC-151,654092,0.4022245307281385
NCI-H2172,11485656,2.8163630892876212
NCI-H2110,36314,-7.893561115183718
HuT 78,72199292,0.6737146382384092
HuT 78,JQ-1-vorinostat (2-1 mol-mol),-2.017178846521955
GOS-3,46843906,3.599659815664158
KMS-20,11612883,1.7611738578766285
SK-LMS-1,25126798,3.9652724672274746
OE21,2729026,3.0182002409216606
TE-15,107985,-3.356146031116269
TE 617.T,11238147,1.8250112009941364
RERF-LC-Ad2,676352,1.8513721102027352
CML-T1,44489367,4.494553632990814
KMS-27,6918837,-4.653515944209293
HCC2218,73707398,1.2835282527544178
SK-N-AS,168313200,1.823483037418336
OE21,969516,2.6445480444615375
OE21,5329102,1.6646243395280815
Aska-SS,445643,4.692347461031462
RERF-LC-A1,44185566,2.6917735020169022
HSC-4,5738263,3.918173826320675
AU565,JQ-1-vorinostat (2-1 mol-mol),0.9003268678800701
RERF-LC-A1,5284373,3.754194249320464
NCI-H2172,5311,2.4884362345426045
TE-15,49793307,-3.104697903925981
SK-LMS-1,6918878,4.8128232448975705
NU-DHL-1,17755052,-0.6529178657406193
SK-MEL-1,3543504,4.226847392266549
BT 320,71751553,4.331550413851084
KMS-27,3543504,3.911589713227349
KMS-20,4705,2.611307391977677
OAW28,3854666,2.969576020962734
JIMT-1,3543504,4.357534697165237
KMS-27,656346,-0.3984160294388325
SK-LMS-1,navitoclax-pluripotin (1-1 mol-mol),-0.4259364139119853
SK-N-AS,56973724,3.7594555237426297
JIMT-1,3854666,1.22286835521865
RPMI-7951,54613361,-0.7956260293060785
OE21,6505803,-1.9429365414296416
HuT 78,12003241,-1.0527217193191982
Aska-SS,136227924,2.71481465035111
PE/CA-PJ49,11364421,-5.75476179784462
RPMI-7951,11497983,3.9908718874763065
A4/Fukuda,5284616,3.229953451024844
MCAS,6914657,-2.7470677358412714
SKM-1,tanespimycin-gemcitabine (1-1 mol-mol),-1.8087612580761447
PaTu 8988s,11228183,1.465741521328901
JIMT-1,11427553,4.133147125432285
CML-T1,navitoclax-sorafenib (1-1 mol-mol),0.8856526530243491
NCI-H1092,24951314,0.6671727176626792
Ku812,44202524,1.0653964547956452
KMS-20,10302451,2.7224697614535662
HEC-151,72376,-3.726090784979559
CA46,246676,4.699933053014099
SW1573,tretinoin-navitoclax (4-1 mol-mol),3.744579099862024
PaTu 8988s,44185566,2.1261231703862324
Hs 683,selumetinib-UNC0638 (4-1 mol-mol),2.56808468223834
Hs 683,462382,0.4916010012762787
Hs 683,9956119,2.9988441581599967
H-STS,5280436,0.3080604203440315
NCI-H1395,9907093,4.0773524584978285
IST-Mes1,6918328,0.8508470020259952
CML-T1,57330099,4.076691821950742
PaTu 8988s,4788,6.041968744796845
AU565,3634881,4.304518749556461
Aska-SS,446155,3.3770877945361444
WM983B,4578,6.26363220861669
NCO2,11404337,-0.941549986556875
KMS-27,54649381,3.6361143349419898
KP-4,9823820,4.4368014972500065
Hep-G2,ISOX-bortezomib (250-1 mol-mol),0.639259182735851
Kasumi-2,322968,1.3079365029289678
KMRC-2,53392493,1.967193449511117
BT 328,168313200,2.3539430397400523
BFTC-909,25183872,0.7872065650622051
BT 320,9549297,2.275077325933936
D283 Med,5280436,0.4701684330621582
PE/CA-PJ34 (clone C12),71576739,4.786546039193674
Hs 683,4917,2.526590822315022
BT 248,JQ-1-UNC0638 (2-1 mol-mol),2.2588808320886917
YKG-1,11955716,-0.8727721700650264
KMS-27,navitoclax-gemcitabine (1-1 mol-mol),-3.3144752374157007
Ku812,36314,-5.058801255345217
NU-DHL-1,5460769,0.1990382783266381
SET-2,5311037,4.060144880616426
RERF-LC-Ad2,9887053,4.334988147698079
MM1.S,6917907,-7.99628431454436
SNU-1033,2828334,6.270288536823683
BT 328,51039095,3.5315864754377735
SEM,753704,2.726890937341564
NCI-N87,5282054,3.4882884399441125
BT 139,44589607,2.7431100811702227
AN3-CA,tretinoin-navitoclax (4-1 mol-mol),4.798194863439803
OE21,25183872,-1.0362554321418709
MM1.S,11175137,1.6497782551400215
PE/CA-PJ49,9952709,3.470273688977996
NCI-H2110,9952709,3.429953856124601
BT 139,25150857,2.51891884617669
SNU-1214,10427712,5.041454770133842
SW1990,5284616,3.332802592112085
OAW42,6610355,5.233101358631048
HSC-4,613753,3.3632883902358715
PE/CA-PJ49,89928392,1.256692231129512
OAW42,387447,-3.273094128668254
LNCaP clone FGC,2708,4.692892865043915
OE21,9884685,-0.6560236160170761
NCI-H2081,9887053,1.079075391336974
BT 504,selumetinib-GDC-0941 (4-1 mol-mol),0.4660055972927751
HuT 78,135398516,3.648200603857496
JIMT-1,JQ-1-carboplatin (1-1 mol-mol),6.316159128553351
ESS-1,46215462,2.1404151141829986
PaTu 8988s,6610355,3.7428320904728607
KYSE-70,ISOX-bortezomib (250-1 mol-mol),1.0092839144289247
NCI-H1092,16013152,3.726585488555384
RPMI-7951,107985,-3.3094239868135467
LCLC-103H,56946209,-1.892634070265406
D283 Med,3385,1.9589527474544168
CA46,BRD-A02303741-navitoclax (2-1 mol-mol),3.6671520767068095
Kasumi-2,3062316,1.0772152233383698
HSC-4,11396600,3.0766488056466104
BT 330,17755052,1.654973830147732
WM983B,25102847,2.081119299309081
MCAS,16065773,3.0834384026968453
CA46,49867930,4.292641096024632
NCI-N87,49850262,3.22497182450996
NCI-H1092,crizotinib-PLX-4032 (2-1 mol-mol),1.757742083775381
PE/CA-PJ49,44202524,1.2298795357846335
Hep-G2,6914657,-1.7030868105501842
A4/Fukuda,3552672,1.9607713184754867
CML-T1,151289,0.34759640697574
NU-DHL-1,11455910,-0.2130419418137634
SNU-1033,54618795,3.158688402051182
SEM,72376,-3.684920591192524
SKM-1,135398738,0.0508084825394364
LCLC-103H,20959075,-3.1548980278620657
HSC-4,11977753,4.574500022269399
NCO2,15953870,2.09569549914886
SEM,285033,-4.419553075317265
BT 504,9926054,1.7523750045888775
SKM-1,6610216,3.825535401377457
HuT 78,24775005,3.660301435771245
Aska-SS,3689413,-0.2828072846638814
Hs 683,selumetinib-JQ-1 (4-1 mol-mol),3.498842094614085
HARA [Human squamous cell lung carcinoma],15983966,-4.087930187377121
KMS-20,17755052,-0.5934612903297498
JIMT-1,carboplatin-UNC0638 (2-1 mol-mol),4.097383640177536
OE21,selumetinib-decitabine (4-1 mol-mol),1.7352766036003722
HSC-4,3465537,2.7025414883497443
OAW42,9936388,-0.5306764798725707
BT 504,702558,5.523068628105272
SNU-1272,5329102,2.930087391403409
OAW28,17759555,2.4276686354020223
Aska-SS,54596558,3.9801722385312694
TE-15,3385,3.4864316011439844
NCI-N87,676352,1.7095816234371617
SK-LMS-1,5281321,0.0710073739545425
YKG-1,19582717,5.492201151442481
OAW28,11626560,1.7877294085158288
OE21,67156097,-2.1300652740102963
RERF-LC-Ad2,753704,5.049271110646248
NCO2,124202324,1.1484680593102412
SNU-8,erlotinib-PLX-4032 (2-1 mol-mol),3.5567070048816367
SK-N-AS,10113978,3.4699319172236107
ML-1 [Human thyroid carcinoma],54618771,2.3801125351223105
BT 504,9952709,2.927056746643298
NCI-N87,salermide-PLX-4032 (12-1 mol-mol),5.428528810612746
KP-4,119607,5.316399817953364
RERF-LC-Ad2,selumetinib-tretinoin (2-1 mol-mol),5.38502918958907
KP-4,24180125,3.869043701331771
YKG-1,46224516,1.3693431765841828
YH-13,135421197,2.4430977346174165
RERF-LC-A1,60700,-1.6145881087866414
HSC-4,71466380,3.6804948915169784
OAW42,2828334,6.040529733546275
Kasumi-2,11396600,2.2579616248243495
SET-2,400769,-1.0052037587602156
KMBC-2,17755052,1.0782212674471028
BT 320,135440466,3.8135283916877625
NCI-H2172,2113511,6.262003489120703
HSC-4,23725625,4.12890848458229
ESS-1,327653,3.2040700098938837
Hs 683,12003241,0.8693905406704602
AN3-CA,2708,5.218139570683085
AU565,3689413,0.8257687517728082
OAW42,2871966,0.0508212128653839
OAW28,24180719,4.377592888188756
SNU-1033,107985,-3.3872017086874924
JIMT-1,12001922,2.0583785152306247
MCAS,135440466,2.9955528767437234
SK-MEL-1,4259181,0.7052646872097644
NCI-H2110,navitoclax-sorafenib (1-1 mol-mol),3.278080215599179
HuT 78,11612883,1.5245291666063423
Aska-SS,374536,3.2564720470478887
KMRC-2,2733526,4.229027911025838
NCI-H2081,9825149,1.369929435911088
SEM,55508,1.472940159532621
SNU-1033,676352,1.6833566564961218
SNU-8,3634881,3.482703451635013
SEM,54613361,-1.7157995235006995
EJM,44462760,3.937355169319973
HuT 78,5287620,-2.72818029260661
SEM,68056272,3.037181097799154
HSC-4,10322450,4.749470049467763
YH-13,3854666,0.9588236597385832
Ku812,375860,-0.7042833930454624
BT 248,637858,2.256250159493538
WM983B,2945648,3.2594216355685
WM983B,JQ-1-navitoclax (2-1 mol-mol),-0.1283732064164572
NCI-H1395,5746,0.9154814139320177
SNU-1214,11152667,-0.0787501334473708
TE 617.T,613753,3.0355308718279304
KMS-20,72734382,2.4480499103893707
SET-2,2858523,3.0609077413924175
PaTu 8988s,7326481,2.917044511474032
KYSE-70,439501,-1.7979650249976522
LNCaP clone FGC,16722836,2.225690900484634
HMCB,11612883,2.765209617636502
HEC-151,6450551,3.129732127763604
SNU-1272,44489675,3.6917039980316297
TE 617.T,753704,4.601983889014857
Ku812,441298,2.016526434026497
HEC-151,135875424,3.433906350348657
TE 617.T,26596,-3.5782456619220246
SNU-1272,16722836,2.182874461062422
AN3-CA,5351362,1.5175170648938876
HARA [Human squamous cell lung carcinoma],16720766,-0.0810608938508249
ESS-1,89183176,5.005336079724086
KMS-20,10385095,0.7360105255887816
WM983B,2113511,5.959043535925875
KP-4,262093,2.717667187094357
HuT 78,25105715,3.229078580605203
NCI-H2172,675434,4.445738285070077
KMS-20,erlotinib-PLX-4032 (2-1 mol-mol),2.78905431504454
HuT 78,9915743,-0.3205464670121912
HCC2218,156414,-3.7494092331236497
Kasumi-2,11234052,3.910537949204277
BT 504,89928392,0.7434243731612172
NCI-H2110,122327,5.56586564748931
RERF-LC-Ad1,262093,3.285321037103647
NCI-H1395,135999136,4.46612092216275
JIMT-1,3825829,5.589584621729448
BT 504,151289,1.3085497128348884
H-STS,25183872,-1.8884511256941123
OAW28,9884685,1.3567472374362477
A4/Fukuda,54596558,4.022693113590735
Kasumi-2,148198,-6.27183434225638
SNU-1214,44486219,2.005328572002171
OE21,11707110,-4.185918719413557
OAW28,124202324,1.9264961190623875
HMCB,11222830,1.7352561808770213
BT 504,439501,-3.1394850364876907
BT 328,148198,-4.14614868661324
AU565,24775005,3.4802015368768657
KMBC-2,36314,-0.0772216792920631
KYSE-410,16722836,1.4110627130753524
JIMT-1,54649381,3.9069207568617346
KYSE-410,135875424,4.192963545953549
BT 139,4917,2.8777452549817086
BFTC-909,7326481,3.4905195575106527
LNCaP clone FGC,44607530,2.55645338869262
RERF-LC-A1,445091,4.20154293148248
LoVo,445455,4.556737788306169
LNCaP clone FGC,24964624,0.1008168217168594
H-STS,4917,3.714262795675703
HARA [Human squamous cell lung carcinoma],11404337,-1.2743672881567891
PaTu 8988s,25183872,-0.8462493694428076
SNU-308,168312962,3.315997972235471
OAW28,216239,4.152270593115834
HARA [Human squamous cell lung carcinoma],51039095,3.2872110498619573
LNCaP clone FGC,49836020,4.788899602776088
AU565,JQ-1-MK-0752 (1-1 mol-mol),3.9179209493370175
LoVo,53392493,2.4765619401689154
KMRC-2,637858,2.4993405738331216
GOS-3,285033,-3.584870880949546
SNU-308,6610355,5.243493388653266
SW1573,10074640,3.956421484938757
D283 Med,241158,3.4452599332241616
BFTC-909,16720766,-0.0189955240044846
LNCaP clone FGC,25102847,2.2619247724264695
Hs 683,11494412,0.4021600423895013
RERF-LC-A1,2708,3.8751525126166113
Kasumi-2,25105715,3.2709711323954536
SET-2,BRD-K55473186,3.87067567297909
BT 330,5460769,2.587250000288721
RPMI-7951,serdemetan-SCH-529074 (1-1 mol-mol),1.952151609806006
HMCB,23725625,4.742834994685236
SK-N-AS,25183872,-2.8601020664891927
Kasumi-2,9884685,-1.7492969798518767
NCI-H1395,9903786,3.8864807174358984
NCI-H2081,selumetinib-vorinostat (8-1 mol-mol),1.9423097889386416
SNU-8,168313016,4.339041813764209
Hep-G2,262093,4.425755335049499
NCO2,5311,0.6301202898049395
BT 248,613753,3.1927723368663976
NU-DHL-1,45279963,-1.229232320472187
NCI-H1395,168313016,6.368341181188219
LoVo,56946209,-4.467950537911531
BT 139,72376,0.534950921160439
HEC-151,135421197,1.9024476201303135
NCI-H1395,vorinostat-navitoclax (4-1 mol-mol),3.530315000383913
SK-LMS-1,45279963,4.128111500577442
ML-1 [Human thyroid carcinoma],6918736,-3.4697519345619843
ML-1 [Human thyroid carcinoma],675434,4.374805668496918
Ku812,5978,-3.250465069954706
Raji,387447,-4.438252130288484
WM983B,11152667,-1.3678163730800454
HEC-151,ISOX-bortezomib (250-1 mol-mol),1.0155875831574754
KMS-27,216239,2.2357433386354613
OE21,11494412,-0.1422694910703912
TE 617.T,44185566,1.73921904272988
NCO2,25195348,0.8584625997805441
HARA [Human squamous cell lung carcinoma],24748573,1.9169510591730587
KP-4,carboplatin-etoposide (40-17 mol-mol),1.5121979530808032
NCO2,erlotinib-PLX-4032 (2-1 mol-mol),1.9708379169116392
YKG-1,selumetinib-JQ-1 (4-1 mol-mol),2.6528510984038864
OAW42,72193861,1.8989535166735485
KMS-20,89183176,2.765105860834293
NCO2,5978,-4.986623409525635
SW1990,24772860,-2.504887320110065
OE21,16725315,4.952658677155423
BT 504,123631,2.360743669151397
NCI-H2110,51039095,3.0637434644856283
BT 504,26596,-1.373211017914528
KMBC-2,10074640,3.129680306387812
AN3-CA,24785538,1.050781031507658
HEC-151,SNX-2112-bortezomib (250-1 mol-mol),-1.2486822284520165
SNU-8,selumetinib-MK-2206 (8-1 mol-mol),0.7228558487827623
LNCaP clone FGC,navitoclax-gemcitabine (1-1 mol-mol),-1.7581802216256437
NCI-H1092,11612883,3.1486493902012858
BT 139,11213558,5.051121416587095
OE21,5287969,-2.513381714637816
Hep-G2,241158,4.703758837360285
NCI-H2081,selumetinib-navitoclax (8-1 mol-mol),3.86740666902644
OAW28,327653,3.155680016062074
NU-DHL-1,42611257,3.173167598663498
CA46,11497983,3.715862022418827
BT 139,984333,5.086302666222492
NCI-H2110,11175137,3.0426764679724383
LNCaP clone FGC,44819697,-0.1546779845051894
RERF-LC-Ad1,89928392,3.1512603653574653
HEC-151,9868037,0.6566472366149405
SNU-1033,44491742,3.84113608449774
Raji,17755052,2.273004041581242
MM1.S,navitoclax-MST-312 (1-1 mol-mol),0.8830386124411814
OE21,10385095,0.8074841582682157
KP-4,676352,2.009740808043753
PE/CA-PJ49,24951314,0.8809030509786389
GOS-3,1750826,-2.070069963305823
CML-T1,piperlongumine-MST-312 (1-1 mol-mol),1.169857653831876
NCO2,148198,-4.272732589139003
SK-LMS-1,53495165,1.3391504782497183
YH-13,9911830,3.324457602349572
JIMT-1,navitoclax-pluripotin (1-1 mol-mol),0.1197186633594077
TE 617.T,5291,3.75733559146497
PE/CA-PJ49,54765302,4.945952388263716
NCI-H2172,107970,2.7119922666869276
SNU-1033,navitoclax-pluripotin (1-1 mol-mol),0.0916869526510523
AN3-CA,5281321,-1.191778330255899
MCAS,72734382,4.82541753834805
LoVo,135398744,6.330186357549225
RPMI-7951,31703,-2.081328284525375
HuT 78,9903786,-0.2471360619469426
KYSE-70,3025986,-0.3454993097331295
RERF-LC-A1,54618771,2.031168626063029
BFTC-909,12003241,-0.8371396827795129
JIMT-1,439501,-2.416769885537428
MM1.S,10410894,1.8770933860256032
SNU-1214,3825829,4.190729041400542
SKM-1,5280436,3.132311342282295
HEC-151,1239801,4.069177380185276
YKG-1,navitoclax-sorafenib (1-1 mol-mol),3.836400183478217
BT 248,JQ-1-vorinostat (2-1 mol-mol),2.5830463890167064
NU-DHL-1,36462,-1.7187718695601946
NU-DHL-1,11609586,2.2389796491819345
HCC2218,6252,3.535836962146142
HSC-4,241158,3.797905223062241
YH-13,16722836,2.280757149111382
HSC-4,navitoclax-pluripotin (1-1 mol-mol),0.2476370471109345
EJM,168312962,1.0850962961178168
BFTC-909,4917,2.929839520827846
SET-2,navitoclax-sorafenib (1-1 mol-mol),0.424225685100551
KMRC-2,2746,4.010185211314044
SNU-8,448949,2.187581111481743
PE/CA-PJ34 (clone C12),1566236,1.827252089315036
RERF-LC-Ad2,25150857,2.115621654267039
TE 617.T,7326481,2.496151388001922
SKM-1,10074640,3.0692754490442975
PE/CA-PJ34 (clone C12),208908,0.4778342169619697
AU565,5470400,-3.0594075513818995
YH-13,25150857,2.985150336849829
NCI-H1092,11955716,0.959637304928072
NCO2,10427712,4.234159050289118
OAW42,19582717,4.972754164199746
NCI-H2110,54596558,4.350803568816045
Kasumi-2,9952709,2.8950386128563985
Ku812,36462,1.322759060978493
KMS-20,53232,2.383010797318735
KMS-27,25154868,4.068393562898578
NCI-N87,24951314,0.3588892807295563
ML-1 [Human thyroid carcinoma],piperlongumine-MST-312 (1-1 mol-mol),2.022291985496103
PE/CA-PJ34 (clone C12),10184653,-3.1495831813545165
BT 504,107970,1.546603565945837
YKG-1,25161177,5.080655083918658
SEM,10385095,0.8510184643991832
CA46,1242560,2.637858421223904
SW1573,65628,4.136448104244246
NU-DHL-1,216345,1.6023590479795808
SKM-1,11497983,2.969155076814477
OAW42,4261,3.200245516379668
KMRC-2,selumetinib-tretinoin (2-1 mol-mol),4.708089069928908
RERF-LC-Ad2,60700,1.5764321460020152
AN3-CA,5113032,4.840828582249248
AN3-CA,5328940,2.159766358768341
HARA [Human squamous cell lung carcinoma],445643,3.755641736641804
Hs 683,2858523,3.209008362776473
SK-LMS-1,16659841,5.969922386844165
HMCB,46191454,1.8598325801790512
SW1990,11404337,0.292005149466272
LNCaP clone FGC,23582824,1.140271679671597
KMS-20,6252,-0.1616795629584481
BT 504,11494412,1.1419728911910534
MM1.S,9866186,0.3210827277460168
Hs 683,42611257,2.9373074107201167
RPMI-7951,44507138,1.9104854997841585
SW1990,25150857,3.0075549163777437
SEM,984333,-2.6792255714981295
SNU-1272,5282054,4.2528231243793755
OAW42,5470400,0.4599816117015621
SK-LMS-1,5746,3.2197222747815877
YH-13,9935249,4.648604322917456
Kasumi-2,17755052,-2.6649013271346744
Ku812,selumetinib-vorinostat (8-1 mol-mol),-1.7038187664037243
AU565,156414,-1.7188953203880928
SET-2,3825829,4.044328892203194
WM983B,3503,2.34264901212528
HCC2218,7251185,1.522693086843718
Ku812,400769,-1.4290125405795582
PE/CA-PJ34 (clone C12),72734382,5.58441698552576
KMRC-2,24889392,4.392694488278391
D283 Med,JQ-1-carboplatin (1-1 mol-mol),3.772418054249175
RPMI-7951,5281321,-2.0914965293356516
PE/CA-PJ49,126941,-1.2096415189212373
KMS-27,60700,-3.1346357302250403
Aska-SS,71304818,3.0417210051705417
CML-T1,5351362,1.0869507822739353
Kasumi-2,42611257,3.9292605095902857
TE 617.T,10302451,0.2926739718102283
SK-LMS-1,16038120,2.334826379041828
NCI-N87,selumetinib-GDC-0941 (4-1 mol-mol),-0.1269197084307303
LCLC-103H,46398810,3.30785767002878
BT 504,2708,4.541496394952082
NU-DHL-1,57519531,1.3873329303321325
NCI-H2081,navitoclax-birinapant (1-1 mol-mol),2.3090613202793473
D283 Med,135928012,2.2283751237398906
HEC-151,135398738,3.56789949879182
AN3-CA,2729026,3.165325615874287
AU565,68056272,3.4490660549666425
RERF-LC-A1,11497983,4.740247514881125
NCI-H2110,3011155,5.273512703845773
HuT 78,25262965,-1.2447606076305184
Hs 683,6918878,3.497965846629707
SNU-1214,selumetinib-MK-2206 (8-1 mol-mol),1.1524923685822592
Hep-G2,5470400,-2.8506942607066943
GOS-3,11626560,1.8119824279577827
A4/Fukuda,11175137,1.0544671313881684
LoVo,6852167,1.8421975016001388
KMBC-2,10184653,1.7602800183814515
SW1990,262093,3.247926984778252
AU565,119607,5.010456243294951
TE 617.T,3854666,0.5346166749411773
SW1573,navitoclax-sorafenib (1-1 mol-mol),1.0822173392973782
OAW42,72376,-0.2932001621679146
OE21,5328940,-0.4875133080521308
TE 617.T,11178236,-8.147664069324303
NU-DHL-1,71466380,3.774747568676896
Hep-G2,73707398,1.4703050959367814
NCI-H2081,56946209,-6.444502083933019
OAW28,navitoclax-birinapant (1-1 mol-mol),0.270639577142551
NU-DHL-1,216468,0.3012450032871305
LCLC-103H,11404337,0.85397290991948
SNU-308,25154868,5.193874635622483
BT 328,60700,3.9480451882670424
Hs 683,44137675,2.697665290818916
Hs 683,navitoclax-piperlongumine (1-1 mol-mol),2.5400999036687617
IST-Mes1,4096211,2.0722665154973052
OAW28,168312962,3.352489814007426
EJM,11625818,4.5052460488071935
SK-LMS-1,107970,3.0105847397664403
LoVo,9908783,4.437010992006648
KYSE-70,9967941,5.193135802047497
NCI-H2081,56649450,3.184734939652862
MM1.S,piperlongumine-MST-312 (1-1 mol-mol),1.4350664876301185
ESS-1,9967941,4.268050907247004
MCAS,31703,-0.84361495393889
KMS-27,54618164,3.8128826777039047
OE21,16659841,4.657122972409507
D283 Med,16741245,4.294298413876073
Kasumi-2,serdemetan-SCH-529074 (1-1 mol-mol),0.2929627524168506
PE/CA-PJ49,16065773,2.3241222859602964
BFTC-909,676352,2.5282943369079818
NCO2,54454,3.2116421498190255
CA46,6505803,0.7805822725654986
CA46,56949517,4.303265452215328
BFTC-909,3676137,5.055523871435828
Ku812,107985,-3.8161281001358778
SEM,9868037,2.0923686689232137
D283 Med,11167602,1.7563320025634743
KYSE-410,984333,2.6992528768199313
SNU-1033,24753719,4.01001604133428
CML-T1,2113511,4.359369559056824
SK-N-AS,16722836,1.4107220769890365
OAW28,11364421,1.0555351676055402
BFTC-909,6450551,3.0302116860685886
YKG-1,135440466,3.3595523458828582
MM1.S,216468,1.1892471991509614
Hep-G2,11427553,2.5788240600315686
NCO2,selumetinib-BRD-A02303741 (4-1 mol-mol),0.4968282558437219
SET-2,navitoclax-gemcitabine (1-1 mol-mol),-4.7544354875080055
LCLC-103H,9967941,4.405924448673719
SEM,5566,3.255060505668301
NCI-N87,23725625,5.7035859672182125
H-STS,tretinoin-navitoclax (4-1 mol-mol),4.079592330676085
HARA [Human squamous cell lung carcinoma],6852167,2.790696024551457
KMS-20,44632017,0.8974421618736498
SNU-1214,16038120,-0.3379155033922369
RPMI-7951,71466380,3.6712055122760665
Aska-SS,216239,3.237488227144498
RPMI-7951,5738263,2.8494549417989035
CML-T1,53232,4.305570613336498
Hep-G2,selumetinib-vorinostat (8-1 mol-mol),-0.2891046147054946
SK-LMS-1,4259181,1.6246211060463709
SK-MEL-1,448949,2.8481383578029527
BT 139,44607530,0.8538745326791171
BT 139,45279963,3.959806384472248
HEC-151,25262965,-1.7922976694301076
KMS-20,11427553,1.7901611501195382
CA46,25105715,3.628482142858773
NU-DHL-1,107970,1.0254507421459336
NCI-N87,10184653,-5.297353828317573
KMS-20,2871966,0.6331264046561579
AN3-CA,2871966,-0.11726525014801
RPMI-7951,16722836,1.3566033726121791
Aska-SS,1566236,2.835493117782545
BT 330,56963564,0.9178396039866584
HEC-151,11609586,3.2288944152185515
EJM,135440466,1.184398396955965
AN3-CA,637858,1.3761527435149865
MCAS,124202324,3.0914896284438225
JIMT-1,31703,1.0142161437444384
JIMT-1,16038120,2.0088741094665026
OAW28,135411,2.218427323792269
LCLC-103H,16722836,1.9541378773145208
NCI-N87,148198,-3.7864178683693774
IST-Mes1,53392493,1.914417087858707
MCAS,49766530,-0.3094916991443784
LoVo,3025944,2.9449078290251256
GOS-3,25227462,1.8095270845710951
BT 504,16725315,3.2911826567354967
AU565,selumetinib-PLX-4032 (8-1 mol-mol),5.080870453516365
RERF-LC-Ad1,322968,3.2350252408465843
H-STS,5281321,-2.5049759040326616
BT 320,54678924,3.6890866492224106
EJM,6918736,-2.1636905167867355
SW1990,675434,4.671519194492311
AU565,4378219,1.7809295710052302
PE/CA-PJ34 (clone C12),46191454,1.75087551478746
HuT 78,54143018,-1.655797975805756
HCC2218,JQ-1-carboplatin (1-1 mol-mol),4.076746377800596
NCI-H1092,selumetinib-PLX-4032 (8-1 mol-mol),4.373059758392111
NU-DHL-1,6852167,1.5672236440525231
KYSE-70,vorinostat-navitoclax (4-1 mol-mol),1.6518262185005994
OE21,44632017,0.6503868556767491
BT 330,10184653,1.5334712264974883
SET-2,3634881,2.666088197706586
SNU-1272,25154868,3.807572464361502
NCI-H2081,decitabine-carboplatin (1-1 mol-mol),5.393040193886032
RERF-LC-Ad2,12003241,0.07971757119013
WM983B,11175137,3.4509522159439148
KYSE-70,56963564,0.3897414986371327
KYSE-410,navitoclax-gemcitabine (1-1 mol-mol),1.688863056737806
KMS-27,439501,-2.6111087383065597
SKM-1,6917907,-8.026488311304904
SNU-8,44507138,2.862034957014357
OAW28,4521392,4.353680801577448
GOS-3,5746,1.4150119127186604
LNCaP clone FGC,9825149,3.2345733372350463
BT 328,73707398,2.390014521827579
OAW28,24856436,0.1607500363529794
KMBC-2,25161177,4.427519408575105
BT 248,409805,5.374494739188799
OE21,4261,1.6765399274629706
D283 Med,5329102,2.0804491951462323
SNU-1033,doxorubicin-navitoclax (2-1 mol-mol),1.1038361673569406
AU565,46215462,1.837951563203271
HSC-4,42611257,3.4394582921614933
SK-MEL-1,262093,3.2518519489587785
NCI-H1092,3503,1.0568837915666558
SK-MEL-1,15983966,0.7131137038664938
KMBC-2,10296883,4.242347433736866
KMS-20,11396600,3.251276500206743
SKM-1,11404337,-1.0204518416697923
SKM-1,24771867,-3.0651139758567068
KMS-20,66577038,2.524317684477447
SET-2,176870,1.8171058168649483
YKG-1,9866186,4.262068146062729
BT 328,selumetinib-navitoclax (8-1 mol-mol),1.1111417470564258
BT 504,72376,-3.086447460160276
OAW42,375860,0.01569674815874
HEC-151,25154868,3.9891461634357657
TE-15,969516,2.4646441907015464
YKG-1,15547703,3.315188658721057
NCI-N87,46224516,3.4075734240800624
D283 Med,44137675,1.6630116690363648
TE 617.T,16038120,0.6774481293525906
KYSE-70,7251185,4.369311092923008
NCI-N87,docetaxel-tanespimycin (2-1 mol-mol),-6.128008635109833
HARA [Human squamous cell lung carcinoma],322968,4.828098936758316
Ku812,216239,0.9318176026438576
SNU-1272,5284329,5.057648103020769
ESS-1,4261,0.7524787521612106
H-STS,52912189,1.096529678362862
IST-Mes1,136227924,2.313131576565863
Hs 683,46224516,1.0817542389140755
HARA [Human squamous cell lung carcinoma],11455910,0.2072973533181662
MM1.S,4788,5.213003022570621
SEM,60700,-4.28197010474707
OAW28,selumetinib-JQ-1 (4-1 mol-mol),2.156145443592261
KMS-20,445455,4.148068578484743
CA46,11507802,0.4399982092061076
IST-Mes1,24180125,3.710624760267412
NCI-H2081,24771867,-2.330318084024509
RERF-LC-Ad1,JQ-1-vorinostat (2-1 mol-mol),2.719518134337945
RERF-LC-Ad2,10184653,1.8467582375287743
KMS-20,56649450,1.446370800321743
SW1990,100016,6.759971253936254
RERF-LC-Ad1,crizotinib-PLX-4032 (2-1 mol-mol),2.9408300097194013
KYSE-410,8515,3.4355456987988666
HuT 78,5328940,1.35372142133129
BT 248,2742550,4.585670765822412
SK-N-AS,5311037,3.9746928455475
Kasumi-2,decitabine-navitoclax (2-1 mol-mol),-3.2819175731867927
Hs 683,104842,-1.7592192025796949
TE-15,119607,5.472454895282724
D283 Med,11507802,0.4939974977002742
Hs 683,969516,2.6625175796891174
HARA [Human squamous cell lung carcinoma],208908,3.016531266929929
AU565,54626689,4.66017141288812
SNU-1214,54613361,-1.50350179537693
HEC-151,5460769,2.7656616945667
SNU-308,11222830,2.6372387279798706
BFTC-909,44819697,-0.8003395289407239
PaTu 8988s,51039095,2.4568329937012123
OAW42,15983966,0.6996023859015763
HEC-151,262093,2.667137080366997
BT 504,613000,0.8877999957958356
RERF-LC-Ad2,56946209,-4.743349890760071
ML-1 [Human thyroid carcinoma],56963564,0.9868520726565888
IST-Mes1,31703,-0.6384703159849433
BT 330,54618795,3.387856446050376
RERF-LC-A1,3384730,0.4358153468642078
SNU-1214,3081361,0.6983035837467504
BT 248,44491742,4.160095989296475
NCI-H2110,11656518,2.991078235347568
SNU-1214,44507138,1.7676229984085725
BT 139,piperlongumine-MST-312 (1-1 mol-mol),0.9398262944577864
NCI-H2081,44566777,0.9156481361850354
BT 504,2945648,4.32935040918594
OAW42,3081361,1.769939802462963
LCLC-103H,36314,1.8560888005110956
GOS-3,alisertib-navitoclax (2-1 mol-mol),5.122405699516746
TE 617.T,135411,1.06145621929179
D283 Med,tanespimycin-bortezomib (250-1 mol-mol),-0.3446270457541043
Raji,16065773,3.8590792328782095
SK-LMS-1,216239,1.7029023614878849
NCI-H2081,969516,2.499381781732552
HSC-4,navitoclax-gemcitabine (1-1 mol-mol),-4.75214371637746
SW1990,25183872,-1.894552114448352
WM983B,sirolimus-bortezomib (250-1 mol-mol),1.0166833684300536
SEM,25195348,3.192775666849986
ESS-1,54618305,4.255754792589274
Kasumi-2,11317348,0.9834435800612674
ML-1 [Human thyroid carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-2.7240522304333763
NCI-H2081,16065773,2.352319766762804
SKM-1,753704,3.832130750350089
RERF-LC-Ad2,5281321,-1.005629212662992
A4/Fukuda,49766530,-0.1813275565198268
HuT 78,374536,0.782001012085031
WM983B,carboplatin-etoposide (40-17 mol-mol),3.5089299568990677
ESS-1,107970,3.021792385864846
NCI-N87,219104,3.2437824126869415
Raji,44632017,1.4331486298315164
NCI-H1092,navitoclax-PLX-4032 (1-1 mol-mol),1.5069536319364394
BT 330,3081361,3.42309290402186
PE/CA-PJ49,11175137,3.1314905920742455
SK-LMS-1,72734382,5.544812622658924
HEC-151,10302451,3.224057282004677
TE-15,613000,2.1764101144480437
ML-1 [Human thyroid carcinoma],171352865,2.7298814774275435
KMRC-2,4096211,2.549532275475938
SET-2,9911463,3.8788092570896184
BT 139,10302451,2.4564119741984785
BT 320,44241473,4.3699389688619945
LNCaP clone FGC,82146,3.546858803484303
KMS-20,vorinostat-carboplatin (1-1 mol-mol),1.9283897088416788
MCAS,9967941,2.033273226216494
KMS-20,2746,0.7437630311682376
KP-4,46191454,1.4148922556494763
A4/Fukuda,60700,-1.3381290141173086
SET-2,6610216,4.10264033472901
HSC-4,selumetinib-JQ-1 (4-1 mol-mol),3.950475054879744
SEM,71729975,0.1111350195233953
TE 617.T,5284329,5.532660063790676
TE 617.T,24753719,3.744070928960869
KMS-20,44607530,1.038063034852437
OAW28,6918878,3.220005605820797
HMCB,24753719,4.311459213197197
SK-LMS-1,10322450,5.260294901094195
CA46,selumetinib-JQ-1 (4-1 mol-mol),0.1147444107016205
BT 328,12003241,0.43959296828198
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176
OE21,9915743,-2.7713034399639
BT 139,SNX-2112-bortezomib (250-1 mol-mol),-3.0018202826250033
BT 504,119182,-0.3659750575164796
CML-T1,3825829,3.084807192466588
SKM-1,31703,-4.0248884095114965
PE/CA-PJ34 (clone C12),BRD-A02303741-navitoclax (2-1 mol-mol),3.842627181356933
SNU-308,56963564,3.1096793012002615
MM1.S,135984461,3.1063926235928703
Kasumi-2,54454,5.727506476700654
SK-MEL-1,23725625,4.962386758561049
EJM,637858,1.0127573104049012
D283 Med,6914657,-8.666743136315109
NCI-H2110,60700,-0.2930949286274902
SET-2,11364421,-3.965823711365274
Kasumi-2,decitabine-carboplatin (1-1 mol-mol),-0.2922568730993647
SW1990,387447,-5.224232089189946
TE-15,navitoclax-MST-312 (1-1 mol-mol),1.0157748808045457
YH-13,4521392,4.421044887945657
EJM,71751553,6.47545049455161
BT 330,navitoclax-pluripotin (1-1 mol-mol),-1.4987783148891678
Ku812,6610355,4.836489952876677
HARA [Human squamous cell lung carcinoma],11167602,3.2969276962649823
AU565,56946209,-4.483098881483793
MM1.S,44819697,-1.023018126505823
RERF-LC-A1,BRD-A02303741-carboplatin (1-1 mol-mol),4.46515516596552
RERF-LC-A1,675434,5.022200324366915
RERF-LC-A1,6623618,2.092672726766252
BFTC-909,53232,2.9810373365160316
RPMI-7951,66577038,2.619905734292419
PaTu 8988s,16722836,0.5018089977346094
ESS-1,15953870,4.251182517456194
RERF-LC-Ad1,72193861,4.30689015133483
HSC-4,alisertib-navitoclax (2-1 mol-mol),1.936953944798388
PE/CA-PJ49,156422,4.985705106414774
KYSE-70,15983966,-0.1847866067827735
D283 Med,44566777,0.6704743507952735
KYSE-410,BRD-A02303741-navitoclax (2-1 mol-mol),3.215352374876829
MCAS,tanespimycin-gemcitabine (1-1 mol-mol),-1.1647059970883398
KP-4,159324,2.838161812781853
D283 Med,969516,2.332007147829158
SNU-1214,3025944,3.789459190734729
HuT 78,54618164,4.24138057284203
NU-DHL-1,46926350,-4.283271721572929
AU565,selumetinib-GDC-0941 (4-1 mol-mol),0.6894235176740465
YKG-1,448949,3.5998670928110745
KYSE-410,16065773,3.1689596022377136
KMBC-2,46191454,1.5534245999123084
NCI-H2172,6918878,5.33332551521151
TE 617.T,36462,-0.1303372273364364
SEM,156414,0.3224280721453019
SKM-1,24753719,3.966974937988049
KMRC-2,71466380,5.319728082628547
OAW42,9884685,1.2574804791084064
BT 320,42642645,3.0201339489728563
BT 248,6852167,2.795606288509473
OAW42,25102847,3.0265993278659677
CA46,3062316,1.4079672687586804
Raji,67156097,-2.169522461967466
SNU-1033,11494412,3.797369316086489
RERF-LC-Ad1,49766530,-0.8755533009144216
HEC-151,5978,-5.356059517955617
RPMI-7951,452548,-0.2922706234765502
NCI-H1092,387447,-4.501071900555183
WM983B,19582717,4.5518064177416235
HARA [Human squamous cell lung carcinoma],644241,2.250939574369427
LCLC-103H,10074640,3.5983752788795287
TE-15,2828334,6.064569260089426
NCI-H2110,11152667,-0.5579192362236717
KMBC-2,31703,0.6113888072956629
KYSE-70,3503,4.330341802091645
AN3-CA,73707371,5.974433333213384
SKM-1,9926054,1.2950133266657913
SW1573,4096211,3.236722527011662
RPMI-7951,selumetinib-tretinoin (2-1 mol-mol),4.9955187390569105
MM1.S,6918289,-3.2114710937619635
MCAS,5978,-2.806072841189786
KMS-20,135928012,3.091470628632976
EJM,60750,-5.8267895844580515
KP-4,1750826,-3.809159063509498
KMBC-2,6917907,-6.447748478018451
RPMI-7951,44259,0.2296299118102286
NCI-H1395,216345,3.4712022210886824
HSC-4,11640390,4.10313790521596
Hs 683,327653,4.055715527758498
CML-T1,JQ-1-navitoclax (2-1 mol-mol),-0.3838204075177596
BT 139,5394,4.451617966192458
EJM,24748573,1.377291094457539
NU-DHL-1,119182,-3.6416118406759863
TE-15,54618771,1.8265153099983404
HMCB,969516,2.786872605358725
KYSE-70,23635314,-2.258343718513796
NCI-H1092,3136844,4.087353218769457
KMS-20,285033,-4.372488793803924
BT 504,17755052,2.509843108772955
SEM,9444,3.4451798115030705
Hep-G2,5278396,5.277054746379456
KMRC-2,3854666,3.8888485200781377
KMBC-2,12001922,2.090180788791515
KYSE-70,216468,2.031191966418552
BT 320,11626560,2.4160208902080713
AN3-CA,241158,3.592519055568355
SNU-1272,11964036,3.162546122356154
KMS-20,11955716,-2.0378008092304323
OAW28,3062316,-0.5042902382709098
EJM,46907787,1.3360205419537388
SK-N-AS,selumetinib-MK-2206 (8-1 mol-mol),0.2609089936940424
TE-15,24785538,-0.3031970560139655
ESS-1,60700,-2.9575309810678414
NCI-N87,ISOX-bortezomib (250-1 mol-mol),-0.226060851576525
BT 504,serdemetan-SCH-529074 (1-1 mol-mol),1.9371344063908635
Kasumi-2,crizotinib-PLX-4032 (2-1 mol-mol),1.093787578488076
LoVo,46907787,0.5340804086119918
BT 248,71576739,6.051378362255083
OE21,9952709,2.641418469624622
CML-T1,439501,-2.361432010025089
Kasumi-2,5278396,3.160923329427041
CML-T1,216239,1.5759445467703133
NCI-N87,11152667,-0.2953714197447944
KMBC-2,10302451,4.200978616748967
Hep-G2,4096211,2.329353731718805
LCLC-103H,136227924,3.302464114309801
SET-2,216468,-1.8966500344526072
JIMT-1,11507802,1.9961533548176555
KP-4,11656518,1.3199340179722183
KYSE-70,9926054,2.326174845830733
SK-LMS-1,375860,0.2604054406638652
CML-T1,71680916,4.411758468982172
MM1.S,6918736,-2.225977964273826
KMBC-2,3025986,-0.1359583035560626
H-STS,11955716,-2.312998810387399
HARA [Human squamous cell lung carcinoma],44137675,4.310894105428011
AU565,9936388,-7.122590364363415
LCLC-103H,654092,0.5307026796707454
SK-MEL-1,5280436,4.541983942914961
Hs 683,252682,6.537137149473829
RPMI-7951,BRD-K27188169-navitoclax (2-1 mol-mol),3.4218571512591915
NCI-H2110,8515,3.3908091407293433
A4/Fukuda,675434,3.712142385749843
HCC2218,24964624,1.465719307350961
CA46,4917,3.2539126844885757
H-STS,44632017,0.7308222143683922
LNCaP clone FGC,54613361,0.3300056652080663
RERF-LC-A1,24951314,1.256725864686236
SW1573,135421197,1.3915330004591782
BT 504,carboplatin-UNC0638 (2-1 mol-mol),3.4156664873255833
NCI-N87,carboplatin-UNC0638 (2-1 mol-mol),3.4159981227624394
BT 248,piperlongumine-MST-312 (1-1 mol-mol),1.560142448953329
HMCB,10184653,1.7690843609902929
RERF-LC-A1,4788,5.055487008869457
SW1990,72376,-1.0379449828245817
SET-2,241158,3.0184145193600807
NCI-H2110,9884685,0.5868574340900204
SK-MEL-1,12001922,1.2584341541482038
Aska-SS,44137675,1.3416422792711555
KYSE-410,19582717,4.791336864447624
D283 Med,11717001,4.89268752114943
NU-DHL-1,52912189,-0.4578007756599072
HSC-4,6184667,2.683776581109496
Aska-SS,16038120,1.63587187826233
OAW28,5311,0.8600755425080211
Hs 683,89183176,4.93147502343302
MM1.S,65064,3.292120648020702
RERF-LC-Ad2,51039095,3.0886162133744173
NCI-N87,10074640,2.8038201142488504
SW1573,selumetinib-navitoclax (8-1 mol-mol),2.299465388888248
SW1990,44607531,1.5230636151558157
Ku812,702558,3.01939584442747
KMBC-2,11640390,3.92986275287967
KMRC-2,42642645,1.3665066587462662
HMCB,216345,4.536008903536929
BT 320,969516,5.171798432399237
H-STS,11625818,2.7941108082935755
SK-LMS-1,JQ-1-navitoclax (2-1 mol-mol),0.6994679974610346
KMS-20,navitoclax-gemcitabine (1-1 mol-mol),-5.120550360626937
Aska-SS,JQ-1-MK-0752 (1-1 mol-mol),-0.7931575716583488
OAW42,49867926,4.3240599929818
OAW28,4521392,4.353680801577448
OAW28,24978538,-0.39276463694641
EJM,6450551,3.4833257379535967
LCLC-103H,107970,2.8448254128571224
PE/CA-PJ34 (clone C12),3025944,4.287194818492555
PE/CA-PJ34 (clone C12),11507802,0.6950078471538325
OAW28,24978538,-0.39276463694641
Hs 683,SNX-2112-bortezomib (250-1 mol-mol),-2.0866722674927876
SET-2,24180719,3.6007624988079696
SW1990,4521392,5.488917399959202
HARA [Human squamous cell lung carcinoma],36462,1.692464431977034
Hs 683,445091,4.264347039677046
MM1.S,66577038,3.082546058901061
Ku812,25150857,2.8984825229110207
NCI-N87,446155,3.321702095578996
BFTC-909,6918328,0.6354681535452512
SKM-1,24901704,2.156402770369734
NCI-N87,3825829,3.9513849877108207
PE/CA-PJ34 (clone C12),2729026,3.095265123820331
SK-MEL-1,400769,0.1238816240592742
LNCaP clone FGC,10427712,4.507515988092667
Raji,9803433,5.319356572768684
SKM-1,1716436,1.3420802961199974
NCO2,4261,-0.2695802264403172
H-STS,11455910,0.6438795438543947
RERF-LC-Ad2,5280436,1.929463914653169
KMRC-2,49766530,0.0425057620545657
ML-1 [Human thyroid carcinoma],322968,3.685498672876688
NCI-H2081,11238147,1.888813561617346
HARA [Human squamous cell lung carcinoma],613000,1.7145271439199108
OAW28,UNC0638-navitoclax (1-1 mol-mol),1.4894889011779118
OE21,6610216,4.168001578531245
RERF-LC-Ad1,54618771,3.6047591405088673
BT 504,375860,-0.0376175483747626
SK-N-AS,25105715,3.645763781041004
SNU-308,3081361,2.4730065598640247
Kasumi-2,568763,-0.985189730983464
OE21,7326481,2.85473988539988
MM1.S,20959075,-2.7728358796049
NCI-H2081,11175137,1.6715050081020637
JIMT-1,65064,5.150534277875595
SKM-1,36462,-0.9664350566951958
NU-DHL-1,54618795,3.1409617958317613
KP-4,16115403,-5.804045861316924
TE 617.T,568763,-0.1373542498055761
TE 617.T,44137675,3.915947346314195
NCI-H2081,carboplatin-etoposide (40-17 mol-mol),0.0768376373319903
PE/CA-PJ34 (clone C12),60700,-0.5177392228311933
LNCaP clone FGC,3676137,4.985186216409979
SW1990,2871966,0.595244082749687
SKM-1,24821094,1.9211007905225637
BT 328,25227462,1.995910036473872
KMBC-2,11977753,-0.8687302027295553
AN3-CA,3634881,3.1259393094548065
LNCaP clone FGC,24785538,2.385782397443259
BT 248,135398516,2.090653291947233
SET-2,387447,-5.133141904857513
RPMI-7951,11427553,2.3286341602705596
Hep-G2,135440466,2.0493223992937653
KYSE-410,6918837,-2.3211819523697947
SNU-1272,65064,5.250850515288352
SNU-8,135440466,2.5469173905619
NCI-H1395,45279963,4.172255756410215
HMCB,3503,1.423228329049259
SK-MEL-1,44819697,2.816733975799563
AN3-CA,3825829,3.633283861365007
ESS-1,46191454,2.1127704272389805
H-STS,44486219,3.861225962485261
SW1990,10385095,0.931801208429433
BT 248,3465537,1.7130202551321618
Ku812,44607531,1.394726431566783
SNU-1033,1716436,2.198719748586455
KMS-27,72376,-2.9843864470588533
SKM-1,53301938,-5.946970566996532
KMBC-2,3384730,3.00741450377378
PaTu 8988s,9840324,5.988728279946886
KYSE-70,3038522,4.319477989558539
ML-1 [Human thyroid carcinoma],3025944,4.339456842576773
KP-4,54649381,3.8790856388273776
HMCB,10127622,5.814733445969234
LoVo,71466445,2.646256567071358
WM983B,11228183,2.7206209973942572
GOS-3,387447,-4.946086426612472
KMS-20,107985,-4.802194252756391
KP-4,31703,-2.3064637721928745
KMS-20,5311281,0.7208695610939495
BFTC-909,5281321,-1.6266730162675118
NCI-H2081,6918878,1.3213602453376416
Hep-G2,11609586,2.605308217008377
HMCB,2746,4.319833835287885
KMS-20,40482356,4.999111533237927
SK-MEL-1,44185566,2.9227775132692524
H-STS,42642645,0.4333051661235175
LoVo,241158,4.012317425862525
HEC-151,119607,4.186956957695685
AU565,44489675,4.101715930322606
SEM,6918638,-1.2521894984782256
AU565,71729975,2.800801196457704
HARA [Human squamous cell lung carcinoma],11625818,4.840804819194981
SK-N-AS,375860,-0.8530557147031617
ML-1 [Human thyroid carcinoma],49793307,-2.0238665574613024
OAW28,12001922,1.8847589611064504
PE/CA-PJ34 (clone C12),5287620,-1.7203346154702173
HEC-151,156422,4.178129409325859
NU-DHL-1,9866186,-1.5869624207218205
MCAS,49793307,-3.621287740472224
BT 328,25183872,0.4527606216465452
YH-13,11640390,4.546437350580995
SNU-8,36462,2.8022982828339957
D283 Med,60700,-2.552297119661109
AN3-CA,11238147,2.9794087759771664
NCI-N87,20959075,-3.4539866912118784
KP-4,5328940,2.0031094895324486
KP-4,3815108,1.1665243369015572
MCAS,selumetinib-navitoclax (8-1 mol-mol),1.918251839366345
SKM-1,17759555,3.1390325960457264
KP-4,54626689,4.142456533396149
TE-15,9826308,-0.7362911274714742
OAW28,44185566,1.918306011480311
LoVo,9840324,5.061772266378942
KMBC-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2152983894179389
LCLC-103H,44489367,4.479979959570128
Kasumi-2,3689413,-2.6905586087263043
SKM-1,16065773,1.0791751756996522
WM983B,445643,3.951328542822672
BT 330,JQ-1-vorinostat (2-1 mol-mol),2.3888509552963773
AN3-CA,selumetinib-piperlongumine (8-1 mol-mol),3.440054563675044
CA46,135421197,1.13174100448049
SK-N-AS,65628,4.296687684289776
AU565,42642645,1.544546710659079
SK-LMS-1,10427712,5.025364154165243
OAW42,25195348,3.89818724628196
SNU-8,49850262,3.672071843328665
SET-2,119182,-4.272117935787393
OAW42,53232,2.321189597225101
SET-2,11507802,0.9446717198166472
TE-15,46943432,2.615867274491135
MCAS,44589607,3.464520884676177
JIMT-1,6438330,3.0598982298247885
LCLC-103H,31703,0.1335140851269586
Ku812,44543605,3.7520401009891504
HARA [Human squamous cell lung carcinoma],122327,4.478573115200279
TE 617.T,5278396,3.459688739570118
NCO2,5335621,3.837614322037597
BT 328,selumetinib-BRD-A02303741 (4-1 mol-mol),6.07719627140778
WM983B,1750826,0.8152920510414666
NCI-H1092,44185566,2.7664666060668104
Hs 683,45100481,4.462551987037815
NCI-H2110,selumetinib-piperlongumine (8-1 mol-mol),4.320159489938801
KYSE-70,5278396,3.1929088159597656
HuT 78,16722836,0.3632946203875747
AN3-CA,16065773,1.8864857102144683
TE 617.T,2749,1.8684574452896128
OAW28,71466445,4.188405368682896
CA46,2871966,-1.7971239931694716
OAW28,5282054,3.6220988157242946
MM1.S,9935249,3.6617301245150498
SK-MEL-1,36314,4.185658205201081
HuT 78,selumetinib-MK-2206 (8-1 mol-mol),-3.652138343341758
Kasumi-2,54143018,-2.3900299530010405
PE/CA-PJ49,42642645,0.7462290895329329
OAW28,selumetinib-JQ-1 (4-1 mol-mol),2.156145443592261
ESS-1,168313200,3.675041672586614
RERF-LC-Ad1,16038120,1.845587377613844
KMBC-2,71466445,4.930861718344141
ESS-1,16659841,3.2976235988863554
YH-13,49766530,-0.8723369372860722
CML-T1,9956119,2.073633266475815
Ku812,24889392,3.503331691270094
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688
NCI-H1092,1566236,1.754245151236072
Hs 683,navitoclax-sorafenib (1-1 mol-mol),2.3387746809474823
BT 320,16065773,4.123538520669632
LoVo,selumetinib-decitabine (4-1 mol-mol),1.6918156459461149
KMS-27,selumetinib-JQ-1 (4-1 mol-mol),-2.808360563321437
NCI-N87,3385,5.19418058853999
SW1573,9926054,3.1618263718643513
PE/CA-PJ49,4917,3.662887432440365
KMBC-2,5470400,-2.1674218484821446
ESS-1,11152667,-1.1144895141014577
KMRC-2,2749,6.275179909532919
EJM,11427553,2.2799246122967674
H-STS,400769,-1.1927584059737322
NCO2,151289,-1.3886335739441034
SK-N-AS,9887053,3.99593782577667
AN3-CA,135421197,1.808403236431818
SK-LMS-1,carboplatin-etoposide (40-17 mol-mol),4.22674999899941
H-STS,5287969,-2.1266541754976513
NCI-H2081,5287620,-2.511505650083613
PaTu 8988s,decitabine-navitoclax (2-1 mol-mol),1.4226472466211717
YKG-1,carboplatin-UNC0638 (2-1 mol-mol),3.500732763699647
TE-15,71466380,4.275249385620416
KMBC-2,135411,-0.2962045954833053
EJM,2945648,1.6647438664441567
HEC-151,568763,1.1606004827121237
BT 328,44185566,3.0844866112877916
KMBC-2,selumetinib-piperlongumine (8-1 mol-mol),4.480680006962565
RERF-LC-Ad1,219104,4.500436139497514
KYSE-410,vorinostat-carboplatin (1-1 mol-mol),3.364608717554743
KMS-27,984333,-0.7104374674124097
ML-1 [Human thyroid carcinoma],SNX-2112-bortezomib (250-1 mol-mol),0.4585620616557309
SW1573,53392493,3.256582971351183
KMBC-2,doxorubicin-navitoclax (2-1 mol-mol),0.0494170582755545
BT 139,5282054,3.3062021280481657
SNU-1272,6252,5.637284212439003
IST-Mes1,24821094,3.7341606082149776
SK-N-AS,2874250,4.402544674342518
CA46,676352,1.5563040092860552
SW1990,selumetinib-piperlongumine (8-1 mol-mol),2.742013369961323
ML-1 [Human thyroid carcinoma],568763,0.2556406277244685
ESS-1,10322450,4.730793151305824
SNU-1033,docetaxel-tanespimycin (2-1 mol-mol),0.7558284849800709
PE/CA-PJ49,4261,1.1092622946797217
TE-15,51037431,4.673386377362048
NCI-H1092,24889392,4.210253207752649
PE/CA-PJ49,6450551,3.0510152388664435
TE 617.T,49836020,3.775264114601375
PaTu 8988s,216345,2.7185919890283525
KMBC-2,11396600,3.805651469243142
HARA [Human squamous cell lung carcinoma],16741245,4.4624437574750955
CA46,19582717,2.2741322004032716
PE/CA-PJ49,3025986,-1.5535145146447582
HuT 78,6918837,-5.480154932078149
KMS-20,60700,-2.172769530417687
RERF-LC-Ad2,216345,4.614438011082231
SKM-1,53232,2.0648261510736576
SNU-1214,4261,1.9825839440071136
BT 248,45279963,3.7107289938294135
KMS-27,24901704,2.134456940081379
AU565,4705,1.275846161151896
ESS-1,24901704,3.989977980383822
Hep-G2,17759555,2.554294160836156
ML-1 [Human thyroid carcinoma],2949965,3.680012286367402
SKM-1,decitabine-navitoclax (2-1 mol-mol),-1.0300252512758497
D283 Med,carboplatin-UNC0638 (2-1 mol-mol),3.6189692606648016
MM1.S,5311281,2.465283429832392
Hs 683,135411,0.700670072035792
NCI-H1395,56946209,-3.045135926894346
YKG-1,24785538,1.7282682094095363
BT 139,erlotinib-PLX-4032 (2-1 mol-mol),1.3072437000876354
BT 248,46199207,1.879415157386071
SNU-1214,148198,-3.317197477709626
BT 139,76446078,5.753374932108957
OE21,JQ-1-navitoclax (2-1 mol-mol),0.2592566821270753
HEC-151,12003241,-1.83751972949174
HSC-4,753704,4.983094182740762
TE 617.T,11396600,3.161779711193339
A4/Fukuda,53495165,-3.058270414187161
CA46,selumetinib-UNC0638 (4-1 mol-mol),4.090188755292698
BT 328,9952709,3.885158695523131
NCI-H2081,54596558,4.74743870920133
BT 504,46398810,1.7646327642146833
KP-4,selumetinib-decitabine (4-1 mol-mol),6.119216280482745
WM983B,54618164,3.908984274872335
AU565,11152667,-0.8659767610796402
PaTu 8988s,72734382,4.314558303317818
BT 248,sirolimus-bortezomib (250-1 mol-mol),0.4320618504093114
CML-T1,5329102,0.8946748960608596
MCAS,16736978,0.5390207570846622
Hs 683,45279963,3.956345863658136
NCI-H2172,9929138,5.835125788077067
SNU-8,16038120,1.656867017929408
PaTu 8988s,42642645,0.9870759100571196
NU-DHL-1,55508,4.248888595165198
KP-4,2858523,2.9879328846735036
OE21,1641662,3.2639680960542012
KYSE-410,sirolimus-bortezomib (250-1 mol-mol),0.4997693160347982
RERF-LC-A1,navitoclax-birinapant (1-1 mol-mol),2.9459043683140087
IST-Mes1,44607530,1.064599314990069
NCI-H2081,73707371,5.9412545737381075
NCO2,637858,0.6185034167656125
BFTC-909,5746,0.5111824642409613
NCI-H2081,156414,1.7676788858922157
ML-1 [Human thyroid carcinoma],168313016,5.516575315061805
HSC-4,12003241,-0.0373048915881231
BT 248,11396600,1.9236183524788075
KMS-20,1716436,2.462007785368903
MCAS,54626689,5.742619105162711
Kasumi-2,44486219,4.4104720165674145
BFTC-909,46907787,2.3649992203474515
JIMT-1,25062766,2.931235858902796
D283 Med,10184653,1.6755426612344793
OAW28,9825149,1.8591620922463772
KP-4,25150857,3.3627851710641177
RPMI-7951,selumetinib-navitoclax (8-1 mol-mol),3.6622736037580506
LNCaP clone FGC,3136844,3.761028710298216
Raji,5278396,3.201743093215407
SEM,3081361,1.342967789482049
BT 320,5281321,2.315886758261944
BT 320,5281672,4.443718212515123
NU-DHL-1,alisertib-navitoclax (2-1 mol-mol),-2.593164821561062
WM983B,44185566,2.594308843507664
SK-N-AS,alisertib-navitoclax (2-1 mol-mol),-1.054047842906362
Kasumi-2,44462760,0.6612462691358557
KMBC-2,BRD9876-MK-1775 (4-1 mol-mol),1.3624664038852188
YH-13,2871966,0.9039362697940406
SK-LMS-1,10231331,6.028475115684305
H-STS,4261,-1.5298596443260053
Ku812,446155,2.2243145788030496
LoVo,439501,-1.7683171506776545
KYSE-410,11977753,-2.672714604263493
YH-13,44566777,0.4820262026960841
PaTu 8988s,11455910,0.872430488696118
EJM,5470400,-0.5536603917301139
KMS-20,984333,0.9930989474187464
NU-DHL-1,selumetinib-navitoclax (8-1 mol-mol),-0.984371811473836
KMS-27,tretinoin-navitoclax (4-1 mol-mol),0.2143181167810407
IST-Mes1,5978,0.1624820602578698
LNCaP clone FGC,15547703,2.930829356369123
KYSE-70,11427553,3.0124804015996185
SEM,67156097,-2.63166512459064
SNU-308,5287620,-2.917824809068675
OE21,navitoclax-birinapant (1-1 mol-mol),1.1957116946433446
HSC-4,25195348,4.125902627491381
Aska-SS,11717001,4.629967554850357
OE21,11152667,-1.518661040860189
KYSE-410,24821094,1.0715044163214813
A4/Fukuda,3025944,3.254701794903189
Ku812,10074640,-0.7535750701578889
YH-13,5978,-2.977787383275712
AN3-CA,selumetinib-PLX-4032 (8-1 mol-mol),3.6699680325080615
MCAS,docetaxel-tanespimycin (2-1 mol-mol),-7.434901685148422
LNCaP clone FGC,119607,4.062147707063417
BFTC-909,piperlongumine-MST-312 (1-1 mol-mol),1.831832453388112
ESS-1,3503,2.154082374677134
HMCB,9866186,-0.3805378738701598
D283 Med,25161177,4.21580762062299
KMS-20,JQ-1-UNC0638 (2-1 mol-mol),-0.883173015839936
BT 504,9826308,0.0839790839570829
SNU-1272,19582717,3.9947115976130423
BT 139,119607,5.955834117102029
CA46,10127622,5.462644164632326
HEC-151,serdemetan-SCH-529074 (1-1 mol-mol),2.434687006434136
SET-2,4578,3.7108744301164305
BFTC-909,6184667,3.207156937684644
TE 617.T,71680916,4.955345580180031
CA46,BRD-A02303741-carboplatin (1-1 mol-mol),6.48045136918117
SNU-8,serdemetan-SCH-529074 (1-1 mol-mol),2.5370176550442705
BT 139,9935249,2.9068190210975975
ESS-1,5479543,3.502329300494909
ESS-1,6917907,-5.9598430612808455
SET-2,5479543,3.7570504136940346
Kasumi-2,68056272,3.4308739954935867
SK-MEL-1,3503,2.840684134189015
D283 Med,73707438,3.9956281889573697
KMS-27,JQ-1-navitoclax (2-1 mol-mol),-1.2384478741336744
WM983B,10302451,3.572135082387995
KMS-27,selumetinib-tretinoin (2-1 mol-mol),-0.6348542440418741
BT 139,54618771,0.6654274606551459
SNU-1272,10385095,3.7094210277095274
PE/CA-PJ34 (clone C12),3689413,1.240876822848384
OAW42,439501,-3.627774271274344
RERF-LC-Ad2,9915743,1.500109019763864
D283 Med,100016,3.728925578699804
BFTC-909,54626689,4.365294423210906
NCI-H1092,36314,4.877889816324306
Hs 683,16013152,4.045589709203498
Raji,9915743,1.7375595717981451
BFTC-909,tretinoin-navitoclax (4-1 mol-mol),5.193173988671874
BT 328,44607530,2.310615312338521
HARA [Human squamous cell lung carcinoma],25195348,4.01900560130828
HARA [Human squamous cell lung carcinoma],4259181,-0.0825087225465529
Raji,6610355,4.317478015710172
KMS-27,11238147,1.891228711270113
OAW28,49766530,-0.5315014966120291
OE21,11214940,4.133615389454758
RERF-LC-Ad1,54649381,3.845102321657733
RPMI-7951,54649381,3.585382450251425
Aska-SS,25262965,-1.93819336627009
Aska-SS,16722836,0.7336063119016827
SNU-1033,46215462,1.934389008047672
HSC-4,11964036,1.64347500999081
SET-2,selumetinib-UNC0638 (4-1 mol-mol),2.5429931364421603
HEC-151,11485656,2.368331048173754
MM1.S,56946209,-4.843485824557046
LNCaP clone FGC,71466445,3.001006325551692
MCAS,JQ-1-vorinostat (2-1 mol-mol),1.0555725464616676
IST-Mes1,11214940,2.2228722379077857
KYSE-410,216239,2.2242703671059405
Kasumi-2,9915743,-0.5759730647314978
LNCaP clone FGC,44491742,3.7255423914895776
SNU-308,44489367,4.856356872192214
BT 504,10296883,3.915758265808419
CA46,5479543,2.004846411807367
WM983B,11404337,0.2030951424899205
OAW42,56963564,0.7473360361871326
H-STS,446155,2.3675618978932924
HuT 78,4521392,3.8389754666454254
A4/Fukuda,135875424,2.943838777845953
YKG-1,4705,3.5798209595137247
KP-4,409805,5.81471054655713
MM1.S,11404337,0.2422934532029092
ML-1 [Human thyroid carcinoma],53481919,4.335778865313171
PaTu 8988s,637858,2.70031319298971
LoVo,24821094,2.523288695365458
PaTu 8988s,6918837,-3.581272315150156
IST-Mes1,135875424,5.039969018342982
CML-T1,selumetinib-UNC0638 (4-1 mol-mol),2.45517668205048
NCI-H2081,4261,0.6223961435689531
SEM,421610,2.11087969336726
RPMI-7951,36462,0.7881901219926554
SNU-308,4917,2.9791418397771485
HMCB,6918736,-3.5722803082985064
LCLC-103H,2729026,3.1579084327212277
BT 248,12001922,0.9128950259060647
KMS-20,53392493,1.7021821857252477
KMRC-2,445643,4.176265931710495
SNU-1033,4261,1.9972549014264789
ESS-1,11213558,1.497271752916858
PaTu 8988s,tretinoin-navitoclax (4-1 mol-mol),3.29267564859743
LoVo,168312962,0.7059894109575258
SEM,16659841,1.8965739479385648
AN3-CA,53495165,0.5423429810700756
TE-15,136227924,4.530652264188515
KMS-20,23582824,0.2531987788293798
NCI-H2110,erlotinib-PLX-4032 (2-1 mol-mol),2.7310792101368175
SNU-1214,17755052,0.132624780404394
NCI-N87,24753719,4.36387060101307
H-STS,4096211,0.7701877892455814
EJM,56946209,-6.334554937515429
NCI-N87,46174525,4.699807035348161
SKM-1,176870,1.6834487076214133
YKG-1,tretinoin-navitoclax (4-1 mol-mol),5.641897635503529
MCAS,selumetinib-GDC-0941 (4-1 mol-mol),0.6896207239253057
SK-N-AS,11640390,4.49421820362924
TE-15,24748573,2.303795360135107
SW1573,42642645,1.1024283721976142
BT 330,262093,1.7469148441543585
BT 248,5284373,1.9481267041892785
NCI-H1395,selumetinib-MK-2206 (8-1 mol-mol),2.294517762393479
PE/CA-PJ49,5460769,0.8323029326456293
SK-N-AS,123631,3.0959708550789964
NCI-N87,selumetinib-piperlongumine (8-1 mol-mol),3.3316492796689112
PE/CA-PJ49,44607530,1.6054664418105014
MCAS,6918837,-1.9488611085333296
SW1990,46398810,2.5994928983733847
D283 Med,136227924,2.613464686393682
SNU-1033,24856436,0.766095970885635
HuT 78,2749,0.3933024099015727
RERF-LC-A1,656346,0.9431826131553396
JIMT-1,9444,3.6116498134371833
TE-15,10296883,4.422841947508094
HuT 78,104842,-4.970305265327912
Ku812,49766530,-2.390671573618507
SNU-1214,20959075,-3.1846059902986075
BT 248,11612883,3.485439835170839
CML-T1,104842,-6.467154894462458
GOS-3,16659841,4.90242511664039
RPMI-7951,89928392,0.592794462037715
MCAS,49836020,4.94613909678053
EJM,2746,1.455612839065016
TE 617.T,374536,1.0085284501370833
BT 139,4578,3.0697168430814874
AU565,9926054,0.9817648939808896
SW1990,25102847,2.030149124763984
KMS-20,selumetinib-GDC-0941 (4-1 mol-mol),-0.2221231396150395
SEM,44202524,1.290193172725863
D283 Med,54618164,3.747562396348618
HMCB,5738263,2.6270115747347993
OE21,60700,0.0279601434033075
KYSE-70,6505803,-1.025033993677824
PE/CA-PJ34 (clone C12),252682,7.281153515089364
OAW28,9911830,2.567685352724645
OE21,11238147,1.5648824179168512
PaTu 8988s,327653,3.661431131961154
Raji,72734382,4.449789381323658
PE/CA-PJ49,7251185,2.6979125423033743
SK-LMS-1,637858,2.4121207019199074
HuT 78,24856436,-0.4041118949053068
IST-Mes1,11612883,3.500237916670588
KYSE-410,25262965,-2.4471071962998683
KYSE-410,erlotinib-PLX-4032 (2-1 mol-mol),1.7965080867279632
HSC-4,25102847,2.881629074853979
RERF-LC-Ad1,568763,-0.0216703206795301
SEM,navitoclax-sorafenib (1-1 mol-mol),-3.0874607200488975
SK-N-AS,11719255,3.0037364912382563
EJM,11626560,1.3808062425150147
Kasumi-2,2842253,5.767696299842194
BT 330,2130404,4.448251197584531
EJM,135984461,5.02990169097732
HEC-151,15547703,3.1775490487943148
TE 617.T,46215462,1.4610108551553505
KYSE-410,53392493,3.1169004046390443
SNU-1272,49793307,0.8482167940358369
MCAS,4259181,0.6276233805104566
A4/Fukuda,46215462,1.453707580765341
LNCaP clone FGC,25150857,2.3178859166041126
SET-2,56946209,-6.2120441469274175
WM983B,12001922,1.1321510020540164
CA46,46926350,-5.311040218420036
NCI-H2110,445091,4.470444523586047
MM1.S,24951314,0.1961256505054842
ESS-1,3081361,3.291100160208869
MM1.S,5284616,-5.860014911973016
SNU-8,168313047,1.8430166286557448
PE/CA-PJ49,6918638,-0.873109094603626
OAW28,969516,2.7253654251657573
SK-N-AS,1566236,2.45590112845104
CA46,decitabine-navitoclax (2-1 mol-mol),3.2544479904294383
SNU-8,17759555,3.801939868692788
RPMI-7951,9866186,1.0352873659033723
AN3-CA,57519531,4.872501979365299
SW1990,9935249,3.469784483732877
LCLC-103H,241158,3.440238106244061
NCI-H1395,25102847,3.3934069433864953
LCLC-103H,54618771,0.2983505798341654
SET-2,11222830,1.0396150805320925
MM1.S,3543504,4.234419040105733
RERF-LC-A1,168313047,2.0051932552233613
BT 328,5328940,3.187680057709996
OE21,11178236,-2.3861824388467676
CA46,11427553,1.0834968953052575
TE 617.T,4788,5.030017330062183
Kasumi-2,9887053,0.7760357688642865
WM983B,5978,-2.187982149363718
Hep-G2,969516,2.730535591005145
LNCaP clone FGC,26596,-2.187376252798695
PE/CA-PJ49,24964624,2.6604502143456865
TE 617.T,10184653,-4.213351698818198
HuT 78,44137675,1.3553085189057965
TE-15,387447,-4.257900705403723
BT 248,5328940,2.875094995002875
KMRC-2,5311281,2.8027596223007136
HEC-151,10427712,4.368252042828018
SKM-1,1750826,-4.975588841995149
PaTu 8988s,11485656,1.7881493862367523
NU-DHL-1,208908,2.2448533414134864
OE21,crizotinib-PLX-4032 (2-1 mol-mol),1.31959608862987
HARA [Human squamous cell lung carcinoma],654092,0.0602204093244996
BT 139,11238147,5.399490650973942
NCI-H1395,19582717,5.560683797956257
BT 504,tanespimycin-gemcitabine (1-1 mol-mol),-4.023275821549625
RERF-LC-Ad2,carboplatin-etoposide (40-17 mol-mol),4.970817395675663
PaTu 8988s,vorinostat-carboplatin (1-1 mol-mol),4.004118413507522
NCO2,54618164,3.044626652273742
MM1.S,9956119,2.8192181838045354
Hs 683,285033,-2.9773704601582636
Hep-G2,66577038,2.115823311856728
MM1.S,3038522,4.409032122825541
AU565,445455,4.9301368045011955
PaTu 8988s,24771867,5.513171941040546
NCI-H2081,1750826,-1.4408995085202256
Raji,11396600,3.2888358336472496
SK-LMS-1,9927531,4.694028683387814
SET-2,6918736,-1.0474538730050982
Aska-SS,11427553,2.7743154007573287
RPMI-7951,JQ-1-MK-0752 (1-1 mol-mol),5.357089232557581
CML-T1,11396600,3.3654395371867425
NCO2,6914657,-6.0179460767419775
CA46,54596558,4.227379600712383
TE 617.T,54626689,4.601521502493687
ML-1 [Human thyroid carcinoma],5291,4.042812106600411
MM1.S,4096211,2.0079042529830673
YH-13,10410894,5.153853208310613
BT 139,5280436,3.140631305966164
KMRC-2,10427712,5.134156935709105
CML-T1,644241,-4.543158274485358
NCO2,JQ-1-vorinostat (2-1 mol-mol),-0.2766713422424477
NCI-H2081,3503,1.8029989394083912
RERF-LC-A1,11222830,1.4291722923459769
WM983B,1716436,3.668602444293646
OAW42,9866186,0.9125897826032336
KYSE-410,alisertib-navitoclax (2-1 mol-mol),1.3779189641202882
Raji,25262965,-2.39728180513871
KMS-27,9884685,-0.4174100202309531
SK-N-AS,2729026,2.713089087181556
HARA [Human squamous cell lung carcinoma],54686904,4.432396143260886
SW1990,9911830,1.8136131351030251
SW1990,10302451,2.528677635613451
OE21,676352,1.691810166684416
MM1.S,52912189,-0.6988954799800143
HCC2218,11222830,1.644249013842661
HEC-151,374536,2.760377421474409
WM983B,25183872,-0.4632281341383422
NU-DHL-1,1641662,2.8640618258666626
EJM,11497983,5.0496561241094895
LoVo,444795,4.8141558651213145
ML-1 [Human thyroid carcinoma],6852167,2.7131700239928316
YKG-1,71466578,5.303115926973424
BT 139,navitoclax-gemcitabine (1-1 mol-mol),-0.6679699098523508
OAW42,1566236,3.718309855470026
LNCaP clone FGC,613753,3.2056954535425235
TE-15,3081361,0.3815937966647346
LCLC-103H,11964036,1.7530296482857253
SNU-1033,6918328,-0.3254583453090335
RERF-LC-Ad1,5566,3.2885825128552857
OAW42,11404337,-0.3833970130425348
MM1.S,49850262,1.6998908770625267
BT 504,31703,-2.203650695784953
GOS-3,3062316,3.7135401373010426
BT 504,285033,-2.5782996829526597
OAW28,5281321,-1.4060991234994806
NCI-H2081,11396600,3.4950774921622174
BT 320,46199207,1.7709687668778378
RERF-LC-A1,1750826,-2.3805483756717103
TE-15,5460769,-0.6910051691918724
ML-1 [Human thyroid carcinoma],10302451,5.152653454280482
CML-T1,44819697,-2.8753334506591504
BFTC-909,selumetinib-MK-2206 (8-1 mol-mol),3.672772019831091
NCO2,72734382,3.534118076859574
A4/Fukuda,42642645,-1.373677794386147
SKM-1,3503,1.2893215840676688
NCI-H2081,387447,-5.408009728713125
SW1990,135875424,4.251787213143329
A4/Fukuda,44486219,1.5854911698245977
H-STS,2858523,3.0091153865210103
HARA [Human squamous cell lung carcinoma],49793307,-3.043253960744797
D283 Med,4477,-0.1925528209177479
AU565,15547703,3.2970552657128325
HuT 78,9926054,1.4431118641564118
SEM,3025986,-1.9982195321080336
ML-1 [Human thyroid carcinoma],6918837,-4.218663166819277
Aska-SS,54618771,0.6758112733038071
KYSE-70,5978,-0.772629381148284
SKM-1,5278396,2.594174785730779
NCI-H1395,7251185,2.615518868498986
HuT 78,16038120,0.7817739501159142
Hs 683,44486219,4.222974779104732
LNCaP clone FGC,sirolimus-bortezomib (250-1 mol-mol),-6.240208819655782
LCLC-103H,6918328,-0.1793000285029838
JIMT-1,168313047,3.4076717441947344
OAW28,11494412,4.413959214794941
LNCaP clone FGC,11234052,3.9715237356820032
KYSE-410,25126798,3.4955563392448203
HMCB,11964036,1.8216984030595027
PaTu 8988s,10074640,3.467954722409322
KMBC-2,5278396,3.553356906982777
NCI-H1395,10296883,4.692616973111803
Hs 683,5287969,-2.018977265327553
HuT 78,9444,3.580412600741262
HuT 78,46191454,0.2646394750770171
NCI-H1395,5280436,0.4598531683399105
OAW28,25150857,2.5691026408672957
SNU-1033,25262965,-0.5666439209435467
NCO2,24180125,1.8902157789920653
SNU-308,3825829,4.765268226018265
PE/CA-PJ34 (clone C12),11717001,4.9585803256068655
HSC-4,1242560,3.572222416741055
OAW42,11609586,2.9444425578324975
CML-T1,49766530,-2.849769761760908
Kasumi-2,119182,-4.8733294561059255
PaTu 8988s,31703,-0.3659547951330301
HARA [Human squamous cell lung carcinoma],65064,5.174523602274789
BFTC-909,452548,0.7682850038212578
SEM,11657048,5.137852973890356
NCI-H1092,navitoclax-MST-312 (1-1 mol-mol),0.5756040063373493
LNCaP clone FGC,1566236,3.496775804541155
NCO2,11175137,0.1353004241042472
RERF-LC-Ad1,5329102,2.5838260577458754
SKM-1,9929138,6.747336348801134
TE 617.T,JQ-1-navitoclax (2-1 mol-mol),1.0175639846758282
WM983B,11656518,-0.7097016039908027
CA46,71466578,1.7711352492213497
AN3-CA,4096211,1.3018433501999591
OE21,23582824,0.2325595193496268
ML-1 [Human thyroid carcinoma],24180719,3.042356764984187
OE21,151289,0.7158800492725989
BFTC-909,navitoclax-gemcitabine (1-1 mol-mol),0.1512584221412147
A4/Fukuda,23582824,-0.7377224087572002
SNU-308,navitoclax-birinapant (1-1 mol-mol),2.87220330029568
SK-LMS-1,49867930,5.7921489783233655
BT 330,65628,3.9363187212664488
WM983B,24964624,3.0977043903129804
OAW28,10074640,2.8656652346665545
PE/CA-PJ34 (clone C12),52947716,2.849675512601996
GOS-3,439501,-3.404828566068769
MCAS,11612883,2.389047416071472
KP-4,20959075,-3.667563654536924
SW1990,24180719,3.37776868647363
YKG-1,6184667,4.226622972803886
TE 617.T,439501,-4.266247423790402
PE/CA-PJ34 (clone C12),24964624,2.1602822275221354
KP-4,216239,1.917012450499876
CML-T1,168313016,4.15358640853123
HuT 78,53495165,-2.7087413418511135
SET-2,9927531,4.801393694643548
H-STS,JQ-1-UNC0638 (2-1 mol-mol),1.212466073546629
EJM,375860,-0.4454409247993169
NCI-H1092,alisertib-navitoclax (2-1 mol-mol),0.2122885178318103
SW1990,5287620,-2.5079972796899295
PE/CA-PJ49,46926350,-4.40046738056835
SW1573,60700,0.5293530759970745
Raji,6918736,-3.4853704580797618
Aska-SS,selumetinib-vorinostat (8-1 mol-mol),2.5241370498286373
NCI-H2172,10302451,4.417347550930714
SNU-8,446155,3.2136300084900493
SEM,11609586,1.7151177095712813
HMCB,navitoclax-piperlongumine (1-1 mol-mol),1.137064859390896
SNU-1033,44507138,3.678827909971226
NCI-N87,54143018,-0.5822633828546482
NCI-H1395,25154868,5.12981371240632
BT 330,107970,1.6746237285504426
HEC-151,3081361,3.322855731838992
RERF-LC-A1,44589607,3.4605211533530036
LoVo,135440466,2.5900307411888357
PE/CA-PJ49,11507802,0.6371620778932344
NU-DHL-1,6918328,-1.9544594496437568
HuT 78,decitabine-navitoclax (2-1 mol-mol),0.5260270362971856
SNU-1033,46191454,1.3939518639330748
HMCB,445455,4.664999175026341
SK-MEL-1,9903786,3.576716533884559
BT 139,11455910,0.9756266505311688
BT 139,11396600,2.700615833267889
KMBC-2,969516,3.745806938603398
IST-Mes1,44607531,1.530053859314775
BT 248,5494449,3.476308084030369
D283 Med,2742550,3.5680258108109975
RERF-LC-Ad1,selumetinib-UNC0638 (4-1 mol-mol),4.185176714709013
SET-2,10322450,3.4472789227229925
NCI-H1395,54626689,4.483963070109989
YKG-1,72193861,1.638693395639398
MCAS,6917907,-8.091541669459648
NCI-H2081,6852167,2.954622232439069
BFTC-909,serdemetan-SCH-529074 (1-1 mol-mol),2.384231187993096
SW1573,5282054,2.2636648441362417
ML-1 [Human thyroid carcinoma],439501,-1.5032891627146094
OE21,65064,5.246498479818922
SK-MEL-1,72193861,3.6118802929996146
Aska-SS,9936388,1.048322458845263
NCI-H1092,selumetinib-MK-2206 (8-1 mol-mol),4.303588531613232
Aska-SS,44185566,1.9962460513423377
NCI-H2110,123631,2.3500505332428956
OAW42,tanespimycin-bortezomib (250-1 mol-mol),2.1968698973757257
H-STS,135999136,1.636218584553822
Aska-SS,135411,1.2728425883633323
BT 139,25062766,2.3114298765215815
Raji,54613361,-0.2783635116202357
BT 248,322968,2.9090533378149535
RERF-LC-Ad2,11178236,-2.8552723706215812
RPMI-7951,11964036,0.1825580846818816
ESS-1,selumetinib-JQ-1 (4-1 mol-mol),2.1651949829821353
YKG-1,serdemetan-SCH-529074 (1-1 mol-mol),2.571956215465782
OE21,44487872,4.4115983844674185
JIMT-1,100016,6.5721980857327935
H-STS,10410894,3.204211008569323
NCO2,2708,3.570381614353573
Hs 683,135984461,3.956952055268157
CA46,7326481,2.91557869092902
JIMT-1,alisertib-navitoclax (2-1 mol-mol),2.971708432566902
CA46,11364421,-6.636542851208846
NCI-H1395,53392493,1.9985896329089852
MM1.S,5460769,2.129502129742311
TE 617.T,9935249,2.123679604144266
ML-1 [Human thyroid carcinoma],11427553,2.643507576643823
JIMT-1,selumetinib-MK-2206 (8-1 mol-mol),3.9718782916737023
PE/CA-PJ49,135398738,5.508952518580779
PE/CA-PJ49,25105715,3.847811291545487
OAW42,15953870,3.465465294716235
SK-MEL-1,637858,2.061096838595509
CML-T1,decitabine-carboplatin (1-1 mol-mol),-0.978509690631207
Aska-SS,6610355,5.371993731345703
SK-MEL-1,46943432,2.617200117528874
WM983B,46907787,1.5249847323988268
EJM,24964624,2.1494935456800524
ESS-1,11485656,1.966597488234831
SEM,216468,-1.0998833452832146
HuT 78,445643,3.9069827228558234
LNCaP clone FGC,637858,2.004669804836901
SEM,navitoclax-birinapant (1-1 mol-mol),-3.1404014425166777
KMS-20,11977753,-3.0017304932885525
Ku812,44489367,4.131127961346879
KMS-27,9868037,2.1445614612253614
HSC-4,16013152,3.4985623845199956
NCO2,11609586,1.0709661291756476
IST-Mes1,11626560,1.5280230569409714
Hs 683,10127622,4.848321205774742
NU-DHL-1,16038120,1.471185196159862
LCLC-103H,16741245,3.52039564689902
IST-Mes1,JQ-1-carboplatin (1-1 mol-mol),0.3758398512274805
HCC2218,227681,1.686522402811817
YKG-1,2113511,6.330776905666784
LNCaP clone FGC,5746,-0.0567096076106954
NU-DHL-1,11396600,1.7686570539993816
BT 248,71751553,4.279070264679743
RERF-LC-Ad2,25227462,1.2556396259269138
YKG-1,71751553,4.894394979371257
EJM,25105715,3.7124435653326984
A4/Fukuda,252682,6.117343290485243
SKM-1,10127622,-2.6973341706863567
TE 617.T,216239,1.6591385885716896
SW1573,SNX-2112-bortezomib (250-1 mol-mol),0.5082376174745985
JIMT-1,984333,1.5534973761008484
KYSE-70,68056272,3.571583007543391
LNCaP clone FGC,9866186,1.1737969172744749
BT 248,9956119,4.3886748820117925
BFTC-909,54613361,0.5481358040879688
A4/Fukuda,702558,5.147225783500614
NCI-H1092,9967941,1.8935629998367884
HCC2218,49793307,-3.7920850700069857
BT 248,46907787,3.027762940742573
PE/CA-PJ49,252682,6.272416242169432
SET-2,6918638,-1.854101300935
SK-LMS-1,5278396,4.082188120612068
RERF-LC-Ad1,72376,-0.2773768081931954
OE21,11612883,2.14911442236508
RERF-LC-Ad1,52912189,6.211834521603204
NCI-H2172,16741245,4.1711298858904176
RERF-LC-Ad2,285033,-1.387708870392153
AU565,24772860,3.3222909323637455
BT 504,568763,-0.811950664912034
NCI-H2110,24901704,3.0781208675388028
AU565,216345,2.670108206329082
EJM,72193861,-0.1961911914583163
LoVo,serdemetan-SCH-529074 (1-1 mol-mol),1.6319978332110785
NCI-N87,51039095,3.189774410902983
HCC2218,5287969,-1.5340225232782678
Hs 683,9887053,4.217541093528145
PE/CA-PJ49,23582824,0.0936319598104117
YH-13,1566236,1.6600939078751014
IST-Mes1,11213558,3.9887472477266215
BT 139,10385095,0.5327849644676411
SK-MEL-1,9936388,1.368356716964437
KMS-27,navitoclax-sorafenib (1-1 mol-mol),-1.216948658463341
IST-Mes1,24753719,4.106786270688489
MM1.S,49836020,3.8296017324588942
KYSE-70,navitoclax-MST-312 (1-1 mol-mol),1.2159582620106
LoVo,44607531,1.302221694572025
SNU-1033,BRD9876-MK-1775 (4-1 mol-mol),1.5655773369442785
TE 617.T,4521392,3.683082254263588
Kasumi-2,3025986,-2.1480582997040325
SET-2,2945648,2.8777449925198924
RERF-LC-A1,3634881,3.532974436832557
EJM,54613361,-0.1468563757258991
KMS-20,1242560,1.3747443997814042
CA46,56963564,-0.0544830399645368
NCI-H1395,25150857,3.355605487128081
SK-MEL-1,3384730,4.170740043765026
AN3-CA,8515,3.3149085250291632
WM983B,10113978,4.663798051397116
LoVo,JQ-1-MK-0752 (1-1 mol-mol),1.4055408884057283
JIMT-1,tanespimycin-gemcitabine (1-1 mol-mol),1.079650274958838
Kasumi-2,doxorubicin-navitoclax (2-1 mol-mol),-4.049414259936193
MCAS,4096211,1.525593887066156
HSC-4,23635314,4.118860430098142
SET-2,2742550,3.6204915074122814
AN3-CA,25227462,0.2372085595528866
GOS-3,72193861,3.4413196800383044
CML-T1,navitoclax-birinapant (1-1 mol-mol),0.167080687914587
HSC-4,5281321,1.7816899121848235
HCC2218,navitoclax-gemcitabine (1-1 mol-mol),1.3997049625477047
SNU-8,tanespimycin-gemcitabine (1-1 mol-mol),0.1281015518683249
D283 Med,4917,2.940199279345652
SET-2,25154868,3.772116503437056
BT 330,BRD-K55473186,1.816667001967137
KMS-20,24821094,3.078317328475283
CA46,46943432,1.2105530921386296
WM983B,107985,-4.2173502785895245
ML-1 [Human thyroid carcinoma],3384730,3.994618489141425
KMRC-2,selumetinib-MK-2206 (8-1 mol-mol),3.0125560396841786
LNCaP clone FGC,54618771,1.2210181091381391
RERF-LC-A1,400769,-0.9782659975890554
ESS-1,2126,5.022491020211577
BT 248,25161177,3.821794472212993
HEC-151,123631,3.074698137891114
Hs 683,9926054,1.7064216062537565
BT 139,serdemetan-SCH-529074 (1-1 mol-mol),1.800882656670933
TE 617.T,6252,-1.5755479268254928
SEM,135421197,0.5141119166667375
Kasumi-2,vorinostat-carboplatin (1-1 mol-mol),1.2501182531177977
IST-Mes1,JQ-1-navitoclax (2-1 mol-mol),-0.6205173891711487
AN3-CA,89928392,1.072961640369582
SW1990,6917907,-5.702121739351915
RPMI-7951,44202524,0.9827362400760508
HSC-4,675434,4.235689784331333
MCAS,6852167,1.7021529696000626
SKM-1,10113978,1.631549527430136
OE21,25150857,1.931299408890093
WM983B,11707110,-8.44114961057356
KP-4,2729026,3.051860412513106
PE/CA-PJ49,24785538,0.8106468414354372
PE/CA-PJ49,53232,2.090832638191268
SET-2,9887053,1.5615374832251925
Aska-SS,JQ-1-navitoclax (2-1 mol-mol),-0.8890863860184747
KMRC-2,5282054,5.119210462309406
SET-2,3011155,5.360962728041406
LCLC-103H,72193861,0.0534091586183563
BT 320,2949965,3.703585539882772
Aska-SS,tanespimycin-bortezomib (250-1 mol-mol),-0.5241440221117086
KMS-27,11222830,0.7896621936309496
JIMT-1,1716436,3.8024353465464182
PE/CA-PJ49,9907093,4.805229613005566
SKM-1,5566,3.0901148412654877
NCI-N87,241158,3.56045646229574
NCI-H1092,BRD-A02303741-navitoclax (2-1 mol-mol),2.482084229088134
CA46,10302451,0.2515382956842912
RERF-LC-Ad1,selumetinib-navitoclax (8-1 mol-mol),2.177276245480509
ESS-1,5284616,3.0410604134986405
SK-LMS-1,54626689,5.075089494785208
NU-DHL-1,6914657,-3.9631462733451426
EJM,2749,0.9568555282188456
BT 248,5329102,2.143317374155595
TE 617.T,55508,2.646830647843717
A4/Fukuda,navitoclax-MST-312 (1-1 mol-mol),0.8742444067839383
Raji,11507802,0.5089576366408277
D283 Med,docetaxel-tanespimycin (2-1 mol-mol),-4.966560181844395
NU-DHL-1,2871966,-1.1503582820032332
RERF-LC-A1,10074640,3.1296467091457703
KMBC-2,2874250,4.938053140379258
Aska-SS,10184653,1.785047997544531
RERF-LC-Ad2,51037431,5.373275241569261
KMS-27,crizotinib-PLX-4032 (2-1 mol-mol),2.7895791268037966
SW1573,JQ-1-UNC0638 (2-1 mol-mol),2.8948762578833667
LNCaP clone FGC,44489675,3.4266240607626397
EJM,6610216,4.116260512201503
SEM,135423438,-3.9763751688577527
Aska-SS,navitoclax-gemcitabine (1-1 mol-mol),0.2099132566273462
BFTC-909,568763,0.745825262149274
GOS-3,24821094,3.805948767285243
NU-DHL-1,11178236,-4.241745516668476
Ku812,11964036,0.5319973253616799
PaTu 8988s,56973724,3.426395169348298
OE21,216345,4.272499716080272
MCAS,23582824,0.7882424561758696
MM1.S,11396600,2.9620457472616533
GOS-3,25262965,-1.0893957364274085
TE-15,67291369,1.930417695564843
SKM-1,446155,3.079957129001659
SW1990,navitoclax-piperlongumine (1-1 mol-mol),3.4843269276509883
D283 Med,2871966,-1.8966862089774792
PaTu 8988s,10296883,3.673245902839484
SNU-8,SNX-2112-bortezomib (250-1 mol-mol),-0.8626352202634525
SET-2,9926054,1.6776501813643687
RERF-LC-Ad2,613753,3.2848773144154384
BFTC-909,10410894,3.671861694905457
AN3-CA,44819697,-1.7532717318545563
OAW42,16725315,5.234259808131484
LCLC-103H,44259,1.180570415475234
NCI-N87,11507802,1.464328650743575
SEM,9911463,3.141152403249145
EJM,4096211,1.0165645953400952
SKM-1,9868037,0.7505046314280106
SW1990,54618164,4.162528357630221
CML-T1,2841722,3.5416474270082796
PE/CA-PJ34 (clone C12),126941,-0.8332093183770951
RERF-LC-A1,3136844,4.0825258667497515
KYSE-410,4521392,4.26682708750012
NCI-H2110,4261,0.3587441913958428
KMRC-2,5280436,2.5305591566490504
Hs 683,5470400,1.8519340134725737
KYSE-410,tretinoin-navitoclax (4-1 mol-mol),3.820486237274089
OE21,156414,-3.0417448997848857
ESS-1,72376,-3.01301826130781
Kasumi-2,BRD-A02303741-navitoclax (2-1 mol-mol),-1.941760845574772
SET-2,10074640,2.793690603615292
OAW42,10427712,4.471208478859963
NCI-H2172,71304818,2.48630822535131
NCI-H2081,3384730,2.313537319887304
KMS-20,11707110,-4.269527722527802
LoVo,11222830,1.6500045227885836
SW1990,24797083,1.929762568379247
PaTu 8988s,25126798,3.8731761859174
Ku812,969516,1.9833816835003693
WM983B,vorinostat-navitoclax (4-1 mol-mol),1.4946308334035394
AN3-CA,375860,-0.4575105157706771
HARA [Human squamous cell lung carcinoma],44491742,4.175098575791361
RPMI-7951,124202324,2.0500814967899355
OAW28,25183872,-1.003855010480259
HCC2218,135411,2.314880593616264
SNU-308,51039095,3.440816334307095
NCI-N87,262093,3.0008468279122607
OAW42,46215462,1.7931860355954778
SEM,49867930,5.348327492184154
LCLC-103H,44185566,3.1345538089673273
EJM,445091,4.2359621817187225
CA46,46199207,1.8825158344658808
OAW42,alisertib-navitoclax (2-1 mol-mol),0.9891726531310198
SEM,219104,1.121871934400501
MCAS,selumetinib-UNC0638 (4-1 mol-mol),1.217839285065653
BT 504,54618795,3.580621083247689
CML-T1,656346,-0.3506831167953311
BT 504,5311,2.9123506028547075
Hs 683,49793307,-2.867673541770698
TE 617.T,54454,1.1275583619704346
RERF-LC-Ad2,5281672,4.4185435462263625
HCC2218,6610216,3.6192910247057113
PE/CA-PJ34 (clone C12),11228183,3.283497353043469
SW1573,409805,6.568626512075582
TE 617.T,168313200,1.7162313923101786
SW1573,24180125,4.83914798243841
OAW42,5566,3.124194417019172
PaTu 8988s,25062766,1.061864368687882
OAW28,285033,-1.6788024908058845
KP-4,9887053,1.9086083825489089
YKG-1,44486219,4.265701062085959
LNCaP clone FGC,ISOX-bortezomib (250-1 mol-mol),0.3163092256046704
PaTu 8988s,2113511,6.134434442381108
HuT 78,71576739,-3.3283921388984155
SK-LMS-1,selumetinib-MK-2206 (8-1 mol-mol),2.784478857426877
SET-2,104842,-5.7974789199415655
D283 Med,4261,0.5418403862812319
SNU-8,2841722,2.136956824320515
HMCB,51037431,1.7476286222602764
OAW42,123631,2.9918704741346094
EJM,11228183,2.3693057708406005
A4/Fukuda,44491742,3.3943913096556444
KMBC-2,24771867,3.814811761513654
HARA [Human squamous cell lung carcinoma],alisertib-navitoclax (2-1 mol-mol),-2.092897901371494
KMBC-2,25126798,3.948124515247498
BT 330,6505803,-1.6088860696930485
RPMI-7951,3038522,3.102178458058184
LNCaP clone FGC,60750,-2.9424370829616056
RPMI-7951,5328940,1.4476277745678563
KMS-20,JQ-1-MK-0752 (1-1 mol-mol),-0.7766502176752437
KMS-27,5460769,1.7009983096984826
D283 Med,sirolimus-bortezomib (250-1 mol-mol),0.1311503224086672
TE 617.T,66577038,2.256585489002928
KYSE-410,148198,-1.166924431681682
OE21,5738263,2.69040689736045
HCC2218,6918638,-0.2279728548913661
RERF-LC-Ad1,3689413,-1.7788688033713365
RERF-LC-Ad2,135875424,4.566580865948674
ESS-1,4917,3.7890836888483626
D283 Med,11364421,-5.590051926548293
RERF-LC-Ad2,24951314,2.804595086569925
SNU-1214,439501,-2.3459859921965793
NU-DHL-1,24748573,1.9153474255246443
RERF-LC-A1,151289,0.7053307673930717
Hs 683,11964036,1.2536165923644558
A4/Fukuda,9967941,2.4411204768161983
NCI-H2081,12001922,1.0080325544819035
A4/Fukuda,3825829,2.918538307685252
HARA [Human squamous cell lung carcinoma],9866186,-0.525705997781229
CA46,44493528,3.81061502276679
BT 320,JQ-1-UNC0638 (2-1 mol-mol),3.976442415564575
Raji,2828334,5.860428709895134
KMS-20,23635314,-2.706306797828618
RERF-LC-A1,36314,-5.096231554209256
BT 330,10427712,4.8242407419217095
NCO2,9444,3.0874630672958627
Hs 683,JQ-1-navitoclax (2-1 mol-mol),1.5815341723355376
SEM,451668,-2.438792361971123
BT 328,11485656,2.729036955069127
YH-13,carboplatin-UNC0638 (2-1 mol-mol),3.6332761748484255
Raji,15983966,-4.617791465019002
SW1990,9933475,2.2226971177902275
NCI-H2081,16725315,3.0839899254921095
NU-DHL-1,72199292,-0.8745527817020163
KMRC-2,JQ-1-vorinostat (2-1 mol-mol),1.361951420268354
JIMT-1,123631,2.702895241412351
BT 248,568763,0.252168352363544
RERF-LC-Ad2,10410894,5.556064790125131
SNU-1214,25102847,1.6586626773857935
LNCaP clone FGC,400769,-1.0721127446992365
Kasumi-2,44484893,-1.5195002495763423
AN3-CA,10074640,3.604671853947176
KMRC-2,107970,2.5476750010931446
TE-15,16659841,2.5822649021931396
NCI-H1092,23582824,0.4041583076972229
SEM,5284329,1.6736323396864567
NCI-H2110,6914657,-2.218161327784245
Raji,2708,4.369088535017227
Raji,10296883,3.544688579045074
HEC-151,16720766,-1.4304595515774003
KYSE-70,11612883,2.3570058511886396
SET-2,168313200,1.9017333660597997
PaTu 8988s,9927531,5.1297297992623605
Ku812,9911830,-2.227591069329418
Raji,11719255,3.479182830951447
KMRC-2,10385095,2.7581688365802917
BT 139,2708,5.853118570413443
OE21,4578,4.816064750618817
NCI-H2110,219104,4.835277347970067
Kasumi-2,49793307,-4.053216594075624
SNU-1272,71304818,2.26244025747745
TE-15,16219061,3.3101039470688125
TE-15,navitoclax-pluripotin (1-1 mol-mol),-0.7527292133388892
OAW28,16722836,1.5279923407751788
BT 320,9936388,1.7913306244505192
KMS-27,JQ-1-vorinostat (2-1 mol-mol),-1.434696398320996
Raji,46215462,1.6816639746084328
SK-N-AS,2126,5.5487230535866106
AN3-CA,676352,1.6503096620706976
YH-13,3503,1.9021555788410789
OAW28,219104,3.640461878438656
SNU-8,3062316,0.6780444328053429
HMCB,11213558,3.5955546629304997
PE/CA-PJ49,11625818,4.5984764373289435
MCAS,9903786,3.9207216019302007
SNU-1214,1716436,5.314529066322949
Kasumi-2,2828334,5.794074438385768
YH-13,568763,0.2718115041974417
LCLC-103H,51037431,2.36445210450353
KMS-20,11214940,3.272421487084948
SNU-1272,24779724,4.452113053156204
MCAS,42642645,1.6659127430061134
AU565,72376,-1.9935205494525805
H-STS,44607531,1.532888966032803
BT 320,navitoclax-MST-312 (1-1 mol-mol),1.1316480984239057
BFTC-909,56963564,-0.1720168824982637
SK-N-AS,11612883,3.096326086081179
KMS-20,25062766,1.6197159272669466
BFTC-909,54454,2.6967031082973527
HEC-151,9826308,0.5114129980738326
SK-MEL-1,675434,4.153671350591838
TE 617.T,24748573,2.899256600994788
BT 139,44507138,3.6612045892844303
HMCB,4259181,-1.3658440890199388
AN3-CA,135411,1.991464550187558
AN3-CA,23635314,-4.488002581642753
ESS-1,24753719,4.181647881164435
TE 617.T,11228183,3.5711926571560593
SET-2,45279963,3.9995800028102
LNCaP clone FGC,11152667,0.3595402317003787
CA46,107970,1.651382626144423
KYSE-410,6610216,4.091315961018864
HuT 78,25227462,-5.166030621754822
Kasumi-2,24748573,1.468920481488018
SK-MEL-1,168313047,3.085681065347817
TE 617.T,3136844,3.7181899767171607
NU-DHL-1,123631,1.9528798329340396
PE/CA-PJ49,25062766,2.444834588438787
NU-DHL-1,46907787,-1.3567156835247356
RPMI-7951,9927531,5.17840544344631
KYSE-410,11485656,2.2435649092934775
YH-13,44819697,0.6102500342217575
HEC-151,16725315,3.2456111016993585
SK-MEL-1,5351362,1.125887299320229
CML-T1,24772860,-2.9357343941167713
D283 Med,246676,4.416806480399498
A4/Fukuda,5284329,2.3119801528783244
KMS-27,9927531,4.171626738694902
PaTu 8988s,66577038,3.044910362978071
NCI-H1092,4477,0.1803011714935916
PE/CA-PJ49,44486219,4.085358173139104
Ku812,20959075,-3.7806985906685298
NCI-H1395,11977753,-2.444387577547746
KMS-27,67156097,-2.33255133448615
PE/CA-PJ34 (clone C12),49793307,-5.119931749998305
SNU-1214,10127622,1.5590297578060857
BT 320,25102847,3.622666729654605
NCI-H2110,17755052,1.961446678639968
HSC-4,2733526,3.5101027459294425
D283 Med,selumetinib-navitoclax (8-1 mol-mol),1.217940754144839
CA46,2742550,3.5037926309603944
KMS-20,6505803,-0.2025622916563878
A4/Fukuda,2746,1.0000278581130588
KYSE-410,54618771,1.043731623373752
SNU-1214,5281321,-2.431599106885235
HSC-4,36462,0.7755986988683452
RPMI-7951,445091,5.789041246929377
Kasumi-2,16736978,0.2987482410922295
YH-13,3062316,-1.0789668620002044
SNU-1272,4261,0.7733171013559388
BT 320,4788,6.027753085231011
Aska-SS,4788,6.124702098349416
SK-LMS-1,24901704,3.714674503706264
PaTu 8988s,123631,3.038734585993763
LNCaP clone FGC,2945648,2.8217203916826645
KYSE-70,9935249,3.427959003246725
OAW28,208908,1.9779710002494069
SW1990,24951314,2.394074405536706
HSC-4,53232,3.536415160688875
YKG-1,5291,4.1211092927325526
SW1573,89928392,2.032641459256584
H-STS,374536,1.4789763498998243
MCAS,675434,4.4613170524920465
OE21,5335621,5.192479733807399
MM1.S,148198,-3.54523038003387
PE/CA-PJ34 (clone C12),10385095,0.6586777190246488
KYSE-70,123631,1.697265417228948
OE21,44607531,0.2159575767547405
SKM-1,568763,-0.8159483316937144
RERF-LC-Ad2,135984461,4.955680046889378
TE-15,54626689,5.678962222931802
A4/Fukuda,selumetinib-vorinostat (8-1 mol-mol),0.52731023294293
BT 320,9887053,4.397401387197895
HEC-151,9549297,4.0584666711622
NU-DHL-1,selumetinib-vorinostat (8-1 mol-mol),0.3575264561509241
KP-4,16038120,1.6550753404975762
PE/CA-PJ49,54618771,0.7503164660158113
AN3-CA,5743,3.5735914556808197
LNCaP clone FGC,9933475,1.6920769507225688
RERF-LC-A1,24785538,3.0821804308157517
KP-4,72376,-2.015139867251827
IST-Mes1,52912189,1.1075207421426316
SK-N-AS,selumetinib-tretinoin (2-1 mol-mol),-0.7614076970649476
NCI-H2172,3825829,4.682162679328668
HuT 78,25154868,3.748850122707697
RERF-LC-Ad2,vorinostat-carboplatin (1-1 mol-mol),4.276623561794826
SNU-308,54618305,4.365090105355177
BT 328,54678924,4.095049817388681
BFTC-909,selumetinib-piperlongumine (8-1 mol-mol),4.839600666891057
WM983B,72376,-0.6213123673653755
HCC2218,11494412,1.7192366491368396
SNU-308,10074640,3.162888533136693
BT 504,9549297,1.5930045076243993
HEC-151,3384730,1.630714045247598
KMBC-2,53495165,1.1717790124128142
KMRC-2,selumetinib-BRD-A02303741 (4-1 mol-mol),4.480458444032737
SET-2,crizotinib-PLX-4032 (2-1 mol-mol),0.7395547134989802
LoVo,676352,2.5317553470156646
OAW28,16720766,3.888951908869231
NCI-H2081,9935249,2.3780454134873263
LNCaP clone FGC,216468,3.3734920384995437
HuT 78,44462760,3.856546411209862
KMBC-2,2742550,4.819576117265504
HSC-4,49850262,4.158516161733518
BT 320,5328940,3.389766935980773
MM1.S,702558,5.540826177817469
PaTu 8988s,24753719,4.178289167008363
IST-Mes1,10302451,1.9071808976959603
SK-N-AS,2828334,5.874027159675306
PE/CA-PJ49,10385095,0.7863644844399451
CA46,6450551,1.1375422858810305
ESS-1,53495165,-2.215744312493367
NCI-H1395,selumetinib-BRD-A02303741 (4-1 mol-mol),5.369939363502549
LNCaP clone FGC,44241473,4.6222925565590085
SET-2,navitoclax-piperlongumine (1-1 mol-mol),-1.186634349144105
Ku812,16725315,3.503963255457298
EJM,9911830,2.3498846254734267
OAW42,54626689,4.5289682618368765
GOS-3,44241473,4.447421169667303
BT 248,25150857,2.3784591591930635
HMCB,9936388,-4.997946026418023
SKM-1,JQ-1-vorinostat (2-1 mol-mol),-0.4999254314738021
Hs 683,piperlongumine-MST-312 (1-1 mol-mol),1.8550922989500056
SET-2,2842253,3.6780344164215406
SW1990,3136844,6.37521146697811
IST-Mes1,selumetinib-decitabine (4-1 mol-mol),6.500937496154089
Aska-SS,46943432,0.9231523980754076
SKM-1,2113511,5.805612167808562
Raji,24753719,3.12822311930087
WM983B,25150857,2.077847783588117
KP-4,24753719,4.448787857438118
OAW42,2708,4.774017339067302
BFTC-909,46901937,4.445112058189045
PE/CA-PJ34 (clone C12),6918638,1.3328388585954094
WM983B,10385095,1.4622249945753911
SK-MEL-1,46191454,3.4248491247580923
Hep-G2,148198,-2.3541136469085493
GOS-3,374536,2.2437065899634843
KP-4,carboplatin-UNC0638 (2-1 mol-mol),4.225238646639508
Ku812,17759555,3.312444984916292
KYSE-410,15547703,3.736490147642331
KYSE-410,10385095,1.3109396001615272
YH-13,44589607,3.382953504149869
BT 139,6438330,1.030727178191843
YH-13,5328940,2.7108571472659073
NCI-H2172,11175137,1.9843888690025844
SNU-1272,44185566,3.1177568139661314
RPMI-7951,11214940,0.5707725902403461
H-STS,9911463,3.056276034663577
A4/Fukuda,25154868,2.544294393199085
SNU-8,387447,-4.803741501160462
SET-2,24775005,3.2774971851311516
NCI-H2081,10322450,4.110472568642291
BT 248,984333,1.3539050434846691
NU-DHL-1,219104,1.8536267097184471
KP-4,73707371,2.537312209041087
KMS-20,227681,1.9958834039585385
PaTu 8988s,54596558,4.4628427535713895
WM983B,10074640,3.483977848984454
H-STS,selumetinib-JQ-1 (4-1 mol-mol),1.7397587853483405
HARA [Human squamous cell lung carcinoma],46398810,2.9743064800682912
RPMI-7951,5291,3.179935187386984
YKG-1,9956119,4.349400441756489
BFTC-909,6918837,-1.9878509916437357
KYSE-410,1750826,-0.9328245850421172
NU-DHL-1,53392493,1.5644562418702903
SK-N-AS,73707438,4.293647797051398
HEC-151,53495165,-0.7067966609618063
HARA [Human squamous cell lung carcinoma],53232,3.05929528970331
PE/CA-PJ49,selumetinib-GDC-0941 (4-1 mol-mol),0.8657642866761842
KMBC-2,4521392,4.682823382382271
Hep-G2,24772860,-3.6408811512611137
HCC2218,3025986,-1.6636604941868665
TE 617.T,11719255,3.3427190655840526
OAW42,1750826,0.0179088263030092
BT 504,navitoclax-sorafenib (1-1 mol-mol),1.4958556336928888
LoVo,10410894,2.092646303934145
OAW28,5328940,1.8035592963336344
SET-2,36314,-4.420810932896412
A4/Fukuda,selumetinib-decitabine (4-1 mol-mol),-0.8212818207724355
ESS-1,6918328,-0.1703669492376587
RERF-LC-A1,375860,-0.507812876154058
TE 617.T,9956119,3.967002636875171
A4/Fukuda,9908783,4.281950187885367
IST-Mes1,carboplatin-UNC0638 (2-1 mol-mol),3.3529895985097675
BT 248,51039095,3.103752706938284
AU565,navitoclax-sorafenib (1-1 mol-mol),2.1956268758246225
HuT 78,54618795,2.390754899552402
SET-2,3025986,0.9668569869400652
MCAS,104842,-2.5817593322889625
H-STS,3136844,3.9456833945347833
HuT 78,UNC0638-navitoclax (1-1 mol-mol),0.0082226538693411
EJM,11455910,0.7170091081693915
SW1573,5281321,-2.072955292880288
AU565,navitoclax-MST-312 (1-1 mol-mol),1.5837862455188414
HMCB,5278396,3.758401391477414
LoVo,doxorubicin-navitoclax (2-1 mol-mol),-1.249111657931932
IST-Mes1,4259181,1.4706848514509867
KMS-20,9911830,3.122947091608452
NU-DHL-1,135875424,2.8057790902603665
HCC2218,5311281,4.447969960603379
OAW28,5287620,-1.6233190690502424
RERF-LC-Ad1,navitoclax-gemcitabine (1-1 mol-mol),2.5531217714066177
SEM,9823820,2.1841309858683866
BT 139,selumetinib-decitabine (4-1 mol-mol),7.21511875028252
SW1990,123631,2.909312008041373
BT 504,3038522,2.090180258276052
Ku812,5746,-0.7811708469290007
Ku812,tretinoin-navitoclax (4-1 mol-mol),0.7122097782880589
MCAS,135875424,3.596680652923431
JIMT-1,374536,3.743694733757177
RERF-LC-A1,24180125,3.739716378366165
GOS-3,vorinostat-carboplatin (1-1 mol-mol),4.212232190110438
SK-LMS-1,serdemetan-SCH-529074 (1-1 mol-mol),2.855322998560242
SK-N-AS,docetaxel-tanespimycin (2-1 mol-mol),-3.985757039775423
SNU-1033,31703,0.0483483778174432
PE/CA-PJ34 (clone C12),5282054,3.496383978879579
SKM-1,123631,1.8909946005603888
NCI-H1092,5287969,-2.1818617821183457
LoVo,262093,2.370412929490009
NU-DHL-1,49867930,4.548635442109189
GOS-3,3825829,4.328758127334123
CML-T1,BRD-K27188169-navitoclax (2-1 mol-mol),1.24494098413804
RERF-LC-Ad1,11175137,4.230605816025899
KYSE-410,104842,-1.9558924274335232
SK-MEL-1,5284373,-1.53821899962881
GOS-3,10302451,4.10350760632464
SKM-1,426756,6.104096040981277
WM983B,156422,4.404898935291446
NU-DHL-1,16219061,1.476487728041343
KMBC-2,BRD-A02303741-navitoclax (2-1 mol-mol),-0.0859203707063457
SW1990,24748573,2.78159398278425
SK-N-AS,9907093,4.497914888766071
TE-15,2113511,5.968719681321621
BT 330,5566,2.621258469673252
KMS-20,10127622,1.0951348794097868
HARA [Human squamous cell lung carcinoma],5978,-4.046402058806829
TE 617.T,5311281,1.5821805256738954
RERF-LC-Ad2,462382,1.275402371905796
NCI-H1395,10385095,0.8966814857932361
PaTu 8988s,navitoclax-MST-312 (1-1 mol-mol),0.8903079843693547
GOS-3,doxorubicin-navitoclax (2-1 mol-mol),-1.4068563769280584
SNU-1214,123631,-0.2014867970711348
BT 504,46215462,1.9742206662607475
HSC-4,644241,2.6183127396598262
A4/Fukuda,375860,-1.1918610484687095
KYSE-70,11178236,-1.2639965798928303
ML-1 [Human thyroid carcinoma],44589607,3.064794245292079
KMRC-2,168313200,3.0339404412127324
OAW42,9926054,1.8927643653266228
HMCB,selumetinib-MK-2206 (8-1 mol-mol),3.305781399088849
BT 139,135411,3.1054244698858566
SW1990,11717001,5.72522940053554
TE 617.T,9911463,3.539966110266211
YKG-1,5746,3.4716356966928927
WM983B,2746,3.5652531947368495
KMS-20,10296883,2.054648014794474
AN3-CA,tanespimycin-bortezomib (250-1 mol-mol),-2.8889708448552196
HMCB,9903786,3.962700823971229
SK-N-AS,107970,1.6101479775889769
KMS-20,4096211,1.0816474439893842
KMS-20,123631,1.7522842668396212
KMS-20,SNX-2112-bortezomib (250-1 mol-mol),-2.8206001469797974
MM1.S,375860,-0.3099552941005813
TE-15,decitabine-navitoclax (2-1 mol-mol),4.29792572523416
NCI-H2110,1750826,0.5855780260076004
NU-DHL-1,54618771,-0.7819429035186433
HCC2218,45279963,2.5786476360321324
KP-4,6917907,-4.3980947176178775
SNU-1272,5351362,3.155646522066241
YH-13,11222830,1.7805573322131083
NCI-H2110,3634881,3.6380485446132194
HSC-4,1566236,1.9723291328750472
YH-13,19582717,5.382815759701368
KMS-20,16725315,3.260760916795047
NCI-H1092,168313200,1.6747772833697747
CA46,navitoclax-pluripotin (1-1 mol-mol),-1.6931023620468224
HMCB,135875424,3.5183087899290686
BT 330,25227462,1.0613604603878093
YH-13,10184653,1.670229317933307
HEC-151,216345,3.2233459330078316
KMS-20,44607531,1.4954007749288158
BT 330,445091,4.429056044070297
NCI-H2110,9907093,3.9192439301831734
TE 617.T,327653,3.0456722347172738
NCI-H1092,6918638,-0.0011423595466388
SW1990,3385,3.92927023441494
LNCaP clone FGC,44566777,0.2697402956754434
KMRC-2,168313016,5.0095238893407315
KP-4,45100309,5.819085816398243
WM983B,89928392,1.4620218090463082
KYSE-70,25262965,-2.1035778811550836
KP-4,7326481,3.199087253558539
KMRC-2,10296883,4.145802538683136
SNU-1214,5328940,0.1572716308190744
OAW28,6918638,0.0048657249331401
HEC-151,5328940,1.5925494123023634
HMCB,100016,6.123582467992384
SK-N-AS,637858,1.2070263661617462
WM983B,2871966,1.0992305730624017
KYSE-410,613000,3.5449915972816575
BT 504,11626560,1.8584381847372773
SET-2,25227462,-0.701000909642151
PE/CA-PJ34 (clone C12),89928392,1.3443265924415142
AU565,16065773,1.4318565791423328
KMS-20,9926054,1.4765400556600523
SNU-8,56946209,-3.769670510670666
SKM-1,52912189,-0.3265905862540428
SK-N-AS,5746,1.3121971685390643
NCI-H1395,400769,0.1156241429574924
SW1990,246676,4.838396695986544
NCI-H2081,168313200,2.364564714683474
Hs 683,carboplatin-etoposide (40-17 mol-mol),2.425488807867045
YH-13,25227462,0.7870312069105344
BT 504,23582824,1.743741585987792
SEM,49793307,-5.17285060705878
TE 617.T,3081361,1.06773756844504
CML-T1,7326481,2.1414014754107735
NCI-H2172,452548,3.3150482537276433
YKG-1,11427553,2.5425746736996735
IST-Mes1,262093,3.164571948045499
BT 330,11707110,0.5600292055298391
KMS-27,10427712,2.83371014836836
BT 139,selumetinib-piperlongumine (8-1 mol-mol),4.6640913830640445
GOS-3,448949,2.9478585654130263
PaTu 8988s,5351362,1.2846781714572348
HCC2218,9803433,5.3162447416903005
NCO2,44490293,4.3324661865229865
D283 Med,4259181,-0.2806940214967063
CA46,alisertib-navitoclax (2-1 mol-mol),-0.3203128616100632
PE/CA-PJ49,16659841,3.576645063445311
H-STS,23939,4.59491472423784
Hs 683,5738263,2.557969884365718
SNU-1214,176870,0.0461730328895412
HEC-151,19582717,3.794727124654104
YKG-1,44819697,0.3440551836908802
SK-LMS-1,selumetinib-UNC0638 (4-1 mol-mol),4.073478284718911
LCLC-103H,6610216,4.684441214447026
NCI-H2081,5281321,-4.529040765604765
SNU-8,5351362,2.39465746218969
TE-15,216468,4.462110868583238
NCI-H2110,navitoclax-pluripotin (1-1 mol-mol),0.1078154634516552
TE 617.T,135398738,3.966056675742529
TE-15,24772860,-1.8392832942259
PE/CA-PJ34 (clone C12),4521392,4.437675700379316
EJM,66577038,3.002566519429357
Hep-G2,2729026,2.3048811631927344
JIMT-1,5287620,1.086770144331312
NCI-H2081,25150857,0.8996353500859205
NCO2,piperlongumine-MST-312 (1-1 mol-mol),0.9255786627026344
AN3-CA,9908783,6.235828315125512
KMS-20,44185566,1.377137905176795
RERF-LC-A1,409805,5.788230095208666
EJM,JQ-1-carboplatin (1-1 mol-mol),0.7172378388996342
RPMI-7951,44632017,0.9234981216419595
NCI-H1395,navitoclax-gemcitabine (1-1 mol-mol),2.205005883298022
BT 248,24180125,1.9773901044414168
KYSE-70,11238147,3.36128873589197
NCO2,568763,-0.781853170844767
CML-T1,doxorubicin-navitoclax (2-1 mol-mol),-4.289526889070848
Hep-G2,71466445,2.837099504530813
NCI-H2110,10322450,4.394668434370401
RERF-LC-Ad2,5746,3.2227004681968174
KYSE-70,9444,4.1582482593031145
SK-N-AS,122327,5.670352218488859
ESS-1,selumetinib-tretinoin (2-1 mol-mol),5.525028519961577
KP-4,24772860,-2.8953644342348683
AU565,7326481,2.6950900258123256
Kasumi-2,23725625,0.6917734152233637
WM983B,44607531,1.7924657255074248
KMS-27,24772860,-3.008057341051857
RPMI-7951,2708,3.6014757516050113
OE21,tretinoin-navitoclax (4-1 mol-mol),-2.1805876439959433
HEC-151,5280436,3.043419102339868
BT 330,5328940,2.377605998635507
OAW42,crizotinib-PLX-4032 (2-1 mol-mol),2.2114351002767965
TE 617.T,9933475,1.4725788991352122
PE/CA-PJ34 (clone C12),5978,-4.144154525901269
KMS-27,selumetinib-BRD-A02303741 (4-1 mol-mol),1.1339783497693052
KYSE-410,1242560,3.117603457732663
Kasumi-2,54618305,4.391643278203803
HMCB,25183872,-1.6540878742670562
ESS-1,375860,-0.234699059648963
KMS-27,654092,-0.6433485810907916
SKM-1,10427712,3.615808474028536
SEM,54626689,4.433727990073252
HMCB,5281321,-2.1554910502862046
CML-T1,carboplatin-UNC0638 (2-1 mol-mol),2.1290435317203023
OAW28,6917907,-5.603755883192341
HEC-151,44241473,4.57695213454535
CA46,6438330,0.8057128440407828
BT 328,24772860,-1.739359818332389
D283 Med,439501,-4.70695325279779
OE21,2949965,2.11775663365824
NCI-H2110,42611257,3.389054989545232
HSC-4,23939,4.494005895197972
YH-13,23725625,5.130607279174726
NU-DHL-1,5280436,2.443749482827121
SW1990,31703,-0.7858843712781126
CML-T1,44486219,3.9826752825954306
HuT 78,151289,1.040242806613575
BFTC-909,15547703,3.647732910564925
AN3-CA,216345,4.244798528220181
SNU-8,100016,6.375529183181613
SNU-1214,10113978,3.0914953155633964
A4/Fukuda,4521392,3.820585335578038
BT 139,15983966,1.4948166481511225
YH-13,135440466,3.138970949638139
RERF-LC-Ad2,71466578,4.353163131989011
ESS-1,25183872,-2.0695789812237058
Hs 683,11656518,2.657909620235412
AU565,53393127,4.519828407362072
Hep-G2,10427712,4.820719836314107
KYSE-70,16720766,1.38091635176305
HMCB,serdemetan-SCH-529074 (1-1 mol-mol),2.4925748009554938
TE-15,135984461,4.740662203651603
ESS-1,11707110,4.9124560181161385
RERF-LC-Ad2,65628,4.3888994667995815
Hs 683,10410894,3.5223252226939312
KP-4,11222830,1.070476457199954
SK-N-AS,36462,1.8684432223869436
RERF-LC-Ad2,44137675,3.5131029762271564
KMRC-2,10410894,3.9119211302015025
KYSE-70,54618771,1.1170424016733127
HMCB,46199207,3.64794084151039
LNCaP clone FGC,156414,1.7669501564667316
HuT 78,selumetinib-vorinostat (8-1 mol-mol),-4.277294994055841
ESS-1,16013152,5.626524469878935
SW1990,3025986,-1.519374574742827
RERF-LC-A1,11228183,4.0947635708912715
JIMT-1,11396600,4.3251237501633675
KYSE-410,11214940,4.79539855335964
PE/CA-PJ49,49793307,-5.06992611418174
NU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.2455773179911887
TE 617.T,11213558,1.2171494320369085
HSC-4,56649450,2.6853332826773144
LCLC-103H,52947716,-4.37394642139717
MCAS,441298,4.221459009048935
HuT 78,5284329,2.4236179223209513
SET-2,selumetinib-decitabine (4-1 mol-mol),-1.4911047995108635
HSC-4,5284616,2.67117659303102
ESS-1,702558,5.643160750991067
SEM,60750,-6.755912967661906
KMS-27,5291,3.6501433744509177
OAW28,BRD-A02303741-navitoclax (2-1 mol-mol),1.4319695403367312
ESS-1,9926054,1.828443058535804
Hs 683,54454,3.167936412491247
NCI-H2110,10302451,3.568351755533758
SW1990,60750,-3.7468579464707448
BT 328,107970,2.1571810870296333
BT 248,3025986,2.9298231166336297
GOS-3,24753719,4.687766883023854
BT 328,24785538,0.2054381662017833
Aska-SS,2828334,6.296749924229201
ESS-1,JQ-1-carboplatin (1-1 mol-mol),1.200091134415551
NCI-H1092,5978,-1.8741882782335129
BT 320,107970,2.3152930812829497
A4/Fukuda,25183872,-2.565081518812491
Raji,9887053,4.170344123457071
TE 617.T,135398516,2.2575540165455052
OE21,44566777,0.5053272625116136
ESS-1,4705,3.449305158476875
NCI-H2110,46215462,1.6348765239911385
Raji,3825829,3.3082858479955557
SW1573,9935249,2.8664920450292852
TE-15,11497983,5.180725305113291
OE21,vorinostat-carboplatin (1-1 mol-mol),2.300312192247963
NCI-H1395,3025944,4.281266699042143
SEM,5328940,-0.9125059164303356
RERF-LC-A1,5280436,3.710325109071107
KYSE-70,10296883,3.691258417269261
SNU-8,4259181,-0.24228140638784
NU-DHL-1,44607530,2.2321185489089026
SK-LMS-1,984333,1.1268410495571055
BFTC-909,navitoclax-piperlongumine (1-1 mol-mol),2.723586959528991
LoVo,9915743,-0.8819018227786422
KYSE-410,9911463,3.4542799068802696
NU-DHL-1,9967941,3.65346263984122
MM1.S,BRD-K27188169-navitoclax (2-1 mol-mol),4.93691832790379
HuT 78,56963564,-0.3875963553009233
KMS-27,374536,1.0390671300660683
BT 330,9444,5.3130523291210014
D283 Med,11178236,-4.81725298730488
BT 320,10184653,3.7290342309119686
H-STS,54639701,4.360992090113951
SW1990,3062316,-3.500086973246357
RERF-LC-A1,10302451,4.299129878683913
KP-4,1641662,2.8680613425765435
HCC2218,6450551,2.46170463884505
NCO2,55283,0.7467053105126041
Kasumi-2,71751553,4.151047970892257
RERF-LC-Ad2,selumetinib-MK-2206 (8-1 mol-mol),1.6130132483311332
KMRC-2,31703,0.7673744318667989
KMS-20,568763,-0.7936979653536971
D283 Med,53245473,4.5476493386622625
Hs 683,135999136,4.01183659290713
SK-N-AS,119182,-0.9588050731658172
WM983B,3634881,3.678653083806544
PE/CA-PJ34 (clone C12),JQ-1-navitoclax (2-1 mol-mol),1.827928126908855
Aska-SS,16725315,3.2387481752374203
Hep-G2,49850262,3.2140640734627843
OAW42,sirolimus-bortezomib (250-1 mol-mol),1.527275498618008
NU-DHL-1,135411,-1.8300926299415428
BT 139,9907093,5.793430367876926
SNU-1214,327653,3.7315085171271742
TE-15,45279963,3.13807888384382
LNCaP clone FGC,44137675,-0.0914155631340202
SET-2,451668,-1.0979417928240258
KMBC-2,25105715,3.761881827065379
KYSE-70,44632017,1.4611535882953923
Kasumi-2,24901704,2.1856500624020994
NCI-H1092,navitoclax-birinapant (1-1 mol-mol),1.7535361576658914
ML-1 [Human thyroid carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),2.9053104812744186
IST-Mes1,73707398,1.324483483158502
KMBC-2,54626689,4.121176613845106
Ku812,46398810,0.5455073347084224
BT 139,24772860,-2.647640860337615
YH-13,2708,5.143963890139275
SW1573,54626689,3.958399976383255
LoVo,387447,-3.727342469020989
SEM,441298,2.8242609372288485
SW1573,10322450,3.835483834832597
TE-15,46843906,2.4934004690142344
KYSE-410,3634881,3.5659315968121645
AU565,navitoclax-pluripotin (1-1 mol-mol),-0.1402455429535511
Hep-G2,25262965,-2.000044227384341
Aska-SS,24180125,2.481672199133219
BT 504,selumetinib-JQ-1 (4-1 mol-mol),2.8147645186457964
GOS-3,46215462,1.654053851935072
RPMI-7951,327653,2.8766150759858404
SKM-1,10231331,-2.5704839701228117
KMS-20,46843906,1.2536393237633636
YH-13,4261,1.8145650392112695
OAW42,3062316,1.8078797490123604
Hs 683,5702613,1.9234532000360829
HuT 78,568763,0.026722170308136
D283 Med,3136844,3.2984572039507274
TE-15,568763,1.5416541843675535
SW1990,10296883,4.2503704087411025
RERF-LC-A1,9825149,2.537885627285247
SEM,9866186,-1.7113396105566032
YH-13,66577038,3.5409561648626293
BT 504,24785538,0.3196989546500092
CA46,serdemetan-SCH-529074 (1-1 mol-mol),1.5485076626446956
SNU-1272,11238147,4.015797434617391
AU565,24785538,3.4507965915778387
PE/CA-PJ49,2945648,3.0846456774153315
KMS-20,136227924,2.296093636743899
BT 328,100016,6.778172011931934
KYSE-410,107970,2.1635571527834676
SEM,11222830,0.5269269081978375
NCI-H1092,135928012,3.192957596716536
AU565,3676137,4.605193047317769
Hs 683,19582717,3.1827290375005997
PE/CA-PJ49,25195348,2.0573199261864556
BFTC-909,5328940,1.2290524134113243
NU-DHL-1,2126,4.057777482675548
Hs 683,36462,2.0938427707720786
PE/CA-PJ34 (clone C12),445643,3.973961211408011
RERF-LC-Ad2,71751553,4.725836068423468
TE-15,73707398,1.075655915251324
SEM,445643,-5.7878039164156725
HEC-151,erlotinib-PLX-4032 (2-1 mol-mol),3.187674900849174
SET-2,JQ-1-navitoclax (2-1 mol-mol),-2.289388904955715
TE 617.T,969516,2.4231589401294027
HMCB,374536,3.816146263296923
KMRC-2,11707110,1.2359243165534883
NCI-H2081,3062316,3.530909356574639
HuT 78,11707110,-7.111344223172838
NCO2,sirolimus-bortezomib (250-1 mol-mol),-0.0508749295611852
RERF-LC-A1,46907787,1.7386055738310746
AU565,36462,0.154728470238132
SEM,46174525,1.2921885913164932
Ku812,4917,2.1486710085794907
BT 248,3854666,2.6170510866367955
LNCaP clone FGC,4521392,4.255573031439954
CA46,2130404,5.640885888744477
BT 139,5287620,-4.157590212960767
CML-T1,44543605,3.785822858271075
SW1990,25262965,-2.702241544349275
Hs 683,56973724,3.747322559671367
OAW28,71680916,5.167013104004298
YKG-1,10410894,4.5306444179161165
OAW28,71466578,4.4029072721322455
LCLC-103H,9926054,2.81223402195442
NCI-N87,3025986,-2.1031012904407818
HARA [Human squamous cell lung carcinoma],107970,2.425047737070786
NCI-H2081,107970,1.5324597930931985
ML-1 [Human thyroid carcinoma],55283,2.9349831464401936
NCO2,656346,-0.5161152848464404
OAW42,navitoclax-piperlongumine (1-1 mol-mol),2.7932758407504505
MCAS,54454,1.6754872426458818
HEC-151,168312962,-0.0086249053490707
A4/Fukuda,46843906,1.071626560517578
LNCaP clone FGC,vorinostat-carboplatin (1-1 mol-mol),2.985187583085351
PE/CA-PJ34 (clone C12),53232,2.457629300419982
BT 504,24951314,2.224755223041013
A4/Fukuda,445455,4.756694709293823
Ku812,135398738,1.774470065203487
BT 504,10231331,4.750172866148794
OAW42,24797083,1.0306219676537425
CA46,vorinostat-navitoclax (4-1 mol-mol),0.373580583037546
Hep-G2,46907787,3.3643071732848
YKG-1,409805,3.8056431996277578
HCC2218,11485656,1.6045404853234653
RERF-LC-Ad2,selumetinib-piperlongumine (8-1 mol-mol),1.7514629313981869
BFTC-909,51039095,2.7594177275421403
LoVo,5281321,-2.272723057934536
Kasumi-2,11178236,-5.568204380320254
SEM,5470400,1.0027675108194032
Kasumi-2,carboplatin-UNC0638 (2-1 mol-mol),1.808252059410855
KYSE-70,16038120,2.0286855638164054
HCC2218,9952709,2.8174958163995427
KMBC-2,selumetinib-UNC0638 (4-1 mol-mol),5.043544295314639
PaTu 8988s,9929138,5.293231117903689
NCI-H1092,5291,3.938438464985971
Hs 683,100016,6.526692615081327
OAW42,421610,1.721555611713278
RPMI-7951,15983966,-4.254718362973844
Hs 683,15547703,3.207902462535534
BT 320,selumetinib-MK-2206 (8-1 mol-mol),3.122937537933898
SNU-1033,11485656,2.0602946184269917
RERF-LC-A1,31703,-1.7117420774513727
NCI-N87,11364421,-4.7214998150919065
Hs 683,24785538,1.2142111239768636
SEM,9907093,3.7735778111244698
ESS-1,72734382,4.922090373409711
RERF-LC-A1,1242560,3.4581653789047206
CML-T1,3385,2.6066574492649184
SNU-1214,71304818,2.138044493448437
KP-4,44137675,3.4268273488123393
JIMT-1,124202324,3.4672374850401284
ESS-1,10184653,2.852659542055244
HuT 78,2828334,5.4247855811567645
ML-1 [Human thyroid carcinoma],44819697,3.711954604060423
KMS-20,3634881,2.563355579370569
TE-15,1750826,0.9215180524945688
KMS-20,11719255,0.9257373719636144
PE/CA-PJ49,9911463,4.148173895384107
TE-15,135875424,3.16520710682736
ML-1 [Human thyroid carcinoma],10184653,1.3933805894109417
Raji,327653,2.879098254460797
NCI-H2110,9911830,2.0378965069300112
GOS-3,44607531,1.5266968302788424
SK-LMS-1,67156097,0.6683125434523579
BT 504,16065773,1.4856700042901776
YH-13,5284373,3.689481808678744
ESS-1,9840324,5.937640700336064
PE/CA-PJ34 (clone C12),navitoclax-piperlongumine (1-1 mol-mol),2.16883584787438
NCI-N87,76446078,4.157863043796239
BT 328,navitoclax-pluripotin (1-1 mol-mol),-1.2977497604117467
TE 617.T,24775005,3.008345052327752
NCI-H2172,10385095,4.224975285900289
AU565,6918736,-3.127988177088939
A4/Fukuda,24856436,-2.105951383298443
MM1.S,2828334,5.0723954602187735
NCI-H1092,docetaxel-tanespimycin (2-1 mol-mol),-2.441864918067417
LoVo,36462,0.97058855741136
PE/CA-PJ49,67156097,-2.34887472187092
GOS-3,serdemetan-SCH-529074 (1-1 mol-mol),2.2992374685315533
CML-T1,36462,-1.7431711247812498
A4/Fukuda,11404337,-2.650657466190433
LoVo,208908,1.8298234127328137
LNCaP clone FGC,3025944,3.856830453076277
EJM,3384730,2.079765680312452
BT 139,51037431,6.1063918018057555
PaTu 8988s,2949965,2.4899233213350085
Kasumi-2,71466380,3.646549475683979
EJM,409805,3.072892420926549
HuT 78,17755052,0.1532683017086964
NCI-H1092,107970,1.8386309101568237
HARA [Human squamous cell lung carcinoma],6184667,2.5882672266365128
YH-13,navitoclax-gemcitabine (1-1 mol-mol),-1.557893185204028
H-STS,4259181,0.3091139042767585
BT 504,71304818,2.642906677299595
NU-DHL-1,46943432,0.1764476025909112
RERF-LC-Ad2,11404337,1.0614824386793822
NCI-H2110,44202524,1.5427817116056417
D283 Med,65628,4.590969471061447
PE/CA-PJ34 (clone C12),24797083,1.4819806490602767
H-STS,selumetinib-tretinoin (2-1 mol-mol),4.002593719006082
RERF-LC-Ad1,446155,3.5948238619356676
AN3-CA,11152667,-0.493921351954846
IST-Mes1,285033,-1.625614851116669
SNU-8,71466380,3.799489012925572
Aska-SS,25126798,4.010670771922856
SEM,2828334,4.508628490160364
WM983B,11609586,3.419821883720845
BT 248,11404337,-1.3909400551472375
WM983B,9936388,-0.2926482048121987
BFTC-909,122327,4.590877432942681
OAW28,navitoclax-MST-312 (1-1 mol-mol),0.8340042464828235
JIMT-1,26596,-0.816309459972074
SKM-1,10410894,3.4215303234711065
RERF-LC-Ad2,49766530,0.0972135502095861
NCI-N87,387447,-5.408237770865747
MCAS,2729026,3.0980354631151883
TE-15,104842,-4.310031309104666
WM983B,7251185,3.273364740755122
SK-MEL-1,6918837,-2.271383572815751
TE 617.T,2746,2.7076097617545276
KYSE-70,23582824,2.6933165956875964
NCI-N87,568763,-0.5346616138078667
PE/CA-PJ49,17755052,1.5231529598705214
Hs 683,tanespimycin-bortezomib (250-1 mol-mol),-2.2425112205370388
BT 139,11364421,1.3257085435205094
TE 617.T,11222830,1.5585172004818777
BT 248,11656518,0.6524098808252552
IST-Mes1,carboplatin-etoposide (40-17 mol-mol),4.371414865626411
RERF-LC-Ad2,selumetinib-vorinostat (8-1 mol-mol),3.1653662861701157
SK-N-AS,navitoclax-piperlongumine (1-1 mol-mol),1.1202562231890456
CA46,11214940,-0.2735426892992921
OAW28,9840324,5.735695909737487
SK-MEL-1,selumetinib-vorinostat (8-1 mol-mol),-1.3399286249767557
PE/CA-PJ34 (clone C12),7251185,3.0082102919143705
SW1990,11647372,1.9027324676319584
BFTC-909,9915743,2.0959000942543025
CA46,JQ-1-UNC0638 (2-1 mol-mol),-0.7861923396287928
BT 504,9887053,2.369836256466927
NCI-N87,5329102,2.120238068250485
KP-4,219104,3.770509519899463
NCI-H2081,57330099,4.306968967458579
YKG-1,135875424,4.553579428376037
Hs 683,81146,4.863086263601974
SNU-1214,3854666,1.2717797575016767
SK-LMS-1,selumetinib-PLX-4032 (8-1 mol-mol),3.876084734472564
Aska-SS,984333,0.5743102703142339
LoVo,sirolimus-bortezomib (250-1 mol-mol),0.1095810263563626
LCLC-103H,54143018,-0.3602717032946635
AN3-CA,24180719,3.691546686395667
SEM,53481919,3.689698909946728
AU565,25062766,2.0331930756167234
Kasumi-2,11640390,2.994278179386077
RPMI-7951,4788,6.245294366048132
SET-2,10410894,1.7754039173574685
LNCaP clone FGC,11647372,0.1561825282558437
AU565,24753719,4.632017214490639
MCAS,11625818,5.762210953784525
Aska-SS,6436223,-4.489938965385282
KMBC-2,135999136,4.121225006171559
SK-LMS-1,23582824,0.2043847791768318
OAW28,44489675,3.928609606447794
LCLC-103H,3854666,3.318934857088878
WM983B,4705,3.3375940959152244
HCC2218,2749,0.2260672738818868
TE-15,carboplatin-UNC0638 (2-1 mol-mol),4.72041849195812
AN3-CA,9911463,3.862780684019093
HSC-4,3689413,2.5472025828962055
LNCaP clone FGC,65064,5.307201363412214
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747
BT 139,107970,1.8298356347130915
HEC-151,159324,2.248651561242496
RERF-LC-A1,11612883,2.4860028966270757
TE 617.T,24772860,-3.1791034277666164
H-STS,135875424,3.212810522479317
PaTu 8988s,613753,3.359242221886772
Aska-SS,alisertib-navitoclax (2-1 mol-mol),-1.4792698488136429
AN3-CA,5329102,1.5296424840231522
HMCB,126941,-4.47992491137788
SNU-1033,16659841,4.758000486381672
NU-DHL-1,7326481,2.7791277258100804
HEC-151,10385095,0.96058203758897
WM983B,9927531,5.417064832255327
LCLC-103H,387447,-4.181459599606492
HSC-4,50905018,4.462883747891921
NCI-H1092,6438330,0.9695610451657
Hs 683,24180719,3.5923230228392953
TE 617.T,sirolimus-bortezomib (250-1 mol-mol),0.0331781036900695
OAW42,53481919,3.9958101127714287
WM983B,docetaxel-tanespimycin (2-1 mol-mol),-4.192275618550904
KYSE-410,9936388,-3.552366403662026
KP-4,54619267,3.864319528912707
A4/Fukuda,54618164,3.3817410387547575
PE/CA-PJ49,6918878,0.932833861290764
KMS-20,6610216,3.669058069013872
SW1990,selumetinib-navitoclax (8-1 mol-mol),1.0683829293373002
RPMI-7951,2729026,0.4139461540992614
NCI-H2110,3025986,-1.015275725568356
HSC-4,3815108,3.178044313970192
EJM,6918638,-1.326291213724497
PE/CA-PJ49,11657048,4.471135079465252
OAW42,16659841,4.840168699804791
HARA [Human squamous cell lung carcinoma],24951314,2.561199492034659
Raji,10184653,4.239843890669247
BT 139,23582824,0.4442856742848364
Hs 683,49867926,4.153866914474468
TE-15,25105715,3.688638378403114
SNU-1214,241158,4.530958895072107
BFTC-909,24964624,2.4776408698208003
D283 Med,5738263,2.4300934909040115
WM983B,46398810,2.315106238825782
CA46,56946209,-5.9555571874685755
BT 504,54618771,0.7999313784166654
MCAS,216239,2.896051690918329
KYSE-410,9967941,5.8848991583197385
EJM,374536,1.880245992175634
SW1990,6505803,-2.4928933936476048
Hs 683,24748573,2.9434046596633068
TE-15,selumetinib-JQ-1 (4-1 mol-mol),0.3530631195710951
ML-1 [Human thyroid carcinoma],24901704,3.6288922396747743
LoVo,44819697,3.398153390084315
BT 504,2871966,0.7830202032015324
RERF-LC-Ad1,4788,6.277207203808431
A4/Fukuda,JQ-1-vorinostat (2-1 mol-mol),-1.448511600529376
SK-N-AS,doxorubicin-navitoclax (2-1 mol-mol),-1.6839487494894478
AU565,285033,-2.964869253470222
NCI-H1395,285033,-0.7222597352874329
KMS-20,6438330,0.8417749626453567
AN3-CA,navitoclax-sorafenib (1-1 mol-mol),1.2865520246226765
KYSE-70,46199207,3.0458734214111436
MM1.S,44241473,4.365495360199436
BT 248,439501,-2.3411963573363104
D283 Med,219104,2.423967848276844
AN3-CA,SNX-2112-bortezomib (250-1 mol-mol),-3.588743722591154
KYSE-410,54143018,0.3314221651877773
ML-1 [Human thyroid carcinoma],10074640,3.5607250325369812
NCI-H1092,25262965,2.2331419117786617
Ku812,119607,3.7153481440603984
NCO2,126941,-4.452208861226123
ML-1 [Human thyroid carcinoma],9911830,3.383108057822615
PaTu 8988s,16736978,1.6757685634038475
AU565,9444,3.6632568473184888
Ku812,2113511,4.022010912633414
ESS-1,54454,2.499886449492877
TE 617.T,3503,2.650146151665676
PE/CA-PJ34 (clone C12),5335621,5.154193572953575
NCO2,46199207,2.0977055519931365
KMBC-2,568763,1.5657625412671894
D283 Med,66577038,3.783588364889245
KYSE-70,4477,1.3887255745641551
NCI-H2110,374536,1.903561652140828
PaTu 8988s,16013152,4.180001717808194
SK-MEL-1,441298,0.2576193623917456
KYSE-410,54626689,4.470007741978822
RERF-LC-A1,17759555,3.718253295678972
KMS-20,doxorubicin-navitoclax (2-1 mol-mol),-1.6675584741193203
KYSE-410,selumetinib-GDC-0941 (4-1 mol-mol),1.4678317054050969
EJM,4788,5.350018534970788
NCI-H2172,24753719,5.109863925049923
SK-LMS-1,54765302,3.9619741673005584
WM983B,24821094,3.6832479835651424
NCO2,4378219,2.896409854144592
AU565,9840324,5.90463961449661
ESS-1,selumetinib-UNC0638 (4-1 mol-mol),4.619112844343245
SK-N-AS,piperlongumine-MST-312 (1-1 mol-mol),1.1672495629160031
ML-1 [Human thyroid carcinoma],4917,3.4875612389510184
CML-T1,5311281,3.0916675116608863
SET-2,16659841,0.156050821805508
BFTC-909,375860,-1.1901103647211757
HuT 78,56949517,4.088339707137809
SW1990,445643,3.875026525774262
WM983B,241158,3.7381276806355537
TE 617.T,2126,5.664159368526071
SET-2,carboplatin-UNC0638 (2-1 mol-mol),3.459451992795011
SEM,selumetinib-GDC-0941 (4-1 mol-mol),0.0721321703925677
NCI-H2110,135411,0.5672279219720924
MCAS,3552672,2.2795897691619538
RERF-LC-Ad1,3503,3.3659937623050222
PE/CA-PJ49,BRD-A02303741-navitoclax (2-1 mol-mol),3.846975912609384
NCI-H1395,24797083,1.421721283570518
PE/CA-PJ49,135440466,1.1829092944194737
NCI-H2110,2858523,3.1162710583015416
NCO2,104842,-3.6864370202021624
Kasumi-2,89183176,5.250973362639219
SK-LMS-1,42642645,1.473121102676234
GOS-3,462382,0.0265721167554945
YKG-1,9933475,2.2328524578213007
D283 Med,2729026,2.489679691216484
RERF-LC-A1,decitabine-navitoclax (2-1 mol-mol),2.433665085884662
OE21,23635314,-4.652616263422308
CML-T1,16722836,0.8135653137043857
AN3-CA,67156097,-2.7467711936339394
NCI-N87,12001922,1.750767235665954
OAW28,3825829,4.635564939734502
RERF-LC-Ad2,107985,-4.355232294484495
SNU-8,409805,5.0276813202923325
ESS-1,445643,4.277333724215148
BT 504,135999136,1.8570291523116993
BT 248,71729975,1.811306833980593
MCAS,4917,3.1194785232106503
AU565,24821094,-3.121521346886189
NCI-H1092,9887053,3.38988914418067
OAW42,65064,5.193406212724835
PE/CA-PJ49,637858,1.923825301062206
KMS-20,25150857,1.1621716531202362
RPMI-7951,44620216,4.631665310012847
NU-DHL-1,11507802,0.1368599707509103
OAW28,216239,4.152270593115834
Raji,44493528,4.013963979075194
NCI-H1395,5287969,-1.6108462512694277
H-STS,45279963,3.2018194703407095
LNCaP clone FGC,4578,3.885552721973244
OAW28,SNX-2112-bortezomib (250-1 mol-mol),0.074441727324656
EJM,53245473,3.7165309146021417
Hs 683,72193861,0.3699767996119639
OAW42,400769,-1.7043087420108864
MCAS,984333,1.2733066723150994
SEM,2746,-0.0565030951113346
NCI-H2110,3552672,2.1088574672384435
NCO2,9936388,-6.28064659559562
RERF-LC-Ad1,24951314,3.0210341675900736
H-STS,44493528,4.270078015163244
SK-MEL-1,10385095,0.7361766454760428
RERF-LC-Ad2,5566,3.316275965247943
BT 248,selumetinib-vorinostat (8-1 mol-mol),3.707211778635912
SKM-1,44589607,2.983642754360158
LoVo,159324,-0.9516179858777442
HEC-151,BRD-A02303741-navitoclax (2-1 mol-mol),3.754080908993735
NCI-H2110,11964036,1.9928973384702835
BT 504,73707438,1.8582726815864692
TE 617.T,2874250,4.280917515238063
NCO2,638278,1.98827277198933
NCO2,9911830,-2.256494513015068
KYSE-70,54626689,6.762622459467938
Aska-SS,9935249,3.1640243411747666
HSC-4,24951314,1.4348411807415282
H-STS,11238147,1.8768672024064708
YH-13,11485656,3.672447929172867
H-STS,5287620,-2.722598412844143
SNU-8,135411,1.0950293066595111
RERF-LC-Ad2,327653,2.6151456371110404
BT 320,45279963,4.337631582225757
OE21,71466445,1.981156974013709
Kasumi-2,9911830,1.88551459110434
KYSE-70,11152667,0.5949086715112851
SNU-1214,9866186,1.23539407217274
Raji,16741245,3.933598107386241
RERF-LC-Ad1,135440466,4.040059542632656
NCI-H2081,6914657,-5.6218862052201155
OAW28,17755052,1.3145864766951243
AN3-CA,44137675,1.4304677853789944
OAW28,135440466,2.5697421477630273
KMBC-2,UNC0638-navitoclax (1-1 mol-mol),-0.2443441372437479
SK-LMS-1,135999136,4.540087324054403
BFTC-909,135440466,2.535274686795805
EJM,241158,2.554123806651753
BT 320,644241,3.936570500455286
ML-1 [Human thyroid carcinoma],navitoclax-sorafenib (1-1 mol-mol),2.2930044306717954
BFTC-909,11485656,2.882750602975944
CML-T1,42642645,-1.8637300463446456
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308
KMS-27,54619267,3.510252942114814
ESS-1,216468,-0.8835255749902827
Aska-SS,1714884,3.5797361691775427
EJM,25262965,-4.908290828803979
KMRC-2,4378219,1.94428185531496
Hs 683,2126,5.441583851055004
NCO2,67291369,0.3315161341403354
Hep-G2,10302451,3.0105378640601037
SEM,50905018,3.665116846876204
BT 330,104842,-0.5017629462874245
WM983B,25195348,3.2605946909937074
SNU-1033,serdemetan-SCH-529074 (1-1 mol-mol),1.6630124827493464
PaTu 8988s,erlotinib-PLX-4032 (2-1 mol-mol),4.531398986466389
ESS-1,44819697,-1.0610912171108204
NCI-N87,9903786,2.403456427338335
LoVo,5280436,3.7935840263164984
BT 320,123631,3.381923883037432
PE/CA-PJ49,6252,-0.003406228879289
PE/CA-PJ49,24821094,2.237306000813724
KMBC-2,11647372,4.281314262736034
Hep-G2,11626560,1.6326140498169086
BT 504,3062316,3.195375332185624
SK-LMS-1,54596558,4.453206380701554
TE-15,6918638,-0.5881050446638335
PE/CA-PJ49,151289,0.769726200239813
ESS-1,6450551,2.4356422182289106
TE-15,11964036,1.0660097449805117
SET-2,9549297,1.5914218230891424
SNU-1214,135984461,4.331180195663339
AN3-CA,11178236,-6.250252200331648
Hs 683,322968,4.8398669271169705
RERF-LC-A1,124202324,2.535691492402962
MCAS,2858523,3.142383195808636
SET-2,6450551,2.11700475180411
KMS-20,52947716,2.1848836609690485
Aska-SS,9825149,2.2830097386925177
ML-1 [Human thyroid carcinoma],9825149,3.1128843906344117
SKM-1,9911463,3.5328203832136276
YH-13,46907787,2.497821160225489
RPMI-7951,JQ-1-UNC0638 (2-1 mol-mol),1.9085754129843169
TE-15,10127622,7.615181314545947
PaTu 8988s,2749,1.4449513443083186
NCI-H1092,4788,4.950756900369662
AU565,11222830,1.6780695218323665
LCLC-103H,3825829,3.811795614479008
SNU-8,36314,-4.300047746226618
YH-13,24753719,4.493928762122736
TE 617.T,46907787,1.8996212852232837
TE 617.T,71466380,4.669546530956131
MCAS,71466445,2.5533694020857163
NCI-H2081,49766530,1.2305991234309177
MM1.S,25183872,-3.313227348504023
MCAS,carboplatin-etoposide (40-17 mol-mol),2.123955752813359
MCAS,44491742,4.8173197109659
HuT 78,9936388,-7.168553730777331
KMS-27,6184667,2.930875862033721
OAW28,11719255,3.92549874892824
NCI-H1092,44607531,1.5993128596295003
SNU-1272,JQ-1-navitoclax (2-1 mol-mol),0.2802121909183701
NCO2,11238147,1.5936993740294598
NCI-H2172,54618305,4.356498397814067
PE/CA-PJ34 (clone C12),25062766,1.9208580751990545
BT 330,4578,6.009740129400711
CA46,tretinoin-navitoclax (4-1 mol-mol),4.197829514755647
PE/CA-PJ34 (clone C12),2828334,6.063143036105902
OAW28,44607530,1.1070032957823266
BFTC-909,5351362,0.3148685714677321
A4/Fukuda,4259181,-0.5702867723998835
OAW28,637858,2.2776250733597085
HEC-151,11152667,0.2545196919023241
SK-MEL-1,10074640,3.195396086504629
HuT 78,tretinoin-navitoclax (4-1 mol-mol),-2.2971670367223243
PaTu 8988s,11612883,1.4003047610740176
HARA [Human squamous cell lung carcinoma],2130404,2.6459509712703246
Kasumi-2,49836020,6.151495097204233
SNU-1033,navitoclax-piperlongumine (1-1 mol-mol),1.3513123030743783
BT 248,selumetinib-GDC-0941 (4-1 mol-mol),1.214957443871495
KMRC-2,252682,6.436582510875352
LNCaP clone FGC,168313200,2.110708126530363
NCI-H2081,8515,3.558797146048482
BT 139,alisertib-navitoclax (2-1 mol-mol),0.2427130322449746
YH-13,9967941,5.158466300514708
D283 Med,56946209,-6.610135638072429
SNU-308,44259,1.4387037316410851
KP-4,135423438,2.950077613704309
SNU-8,89928392,1.721753144093074
AN3-CA,25161177,5.097942473778066
BT 330,5351362,1.3923603742420232
HCC2218,9908783,4.405293589440005
Hs 683,selumetinib-MK-2206 (8-1 mol-mol),3.2513983070328805
SNU-1033,54613361,2.637775236449954
ESS-1,10410894,3.4736910874659648
OAW42,3552672,1.988497635700472
SK-LMS-1,219104,4.161341014769149
BT 139,3634881,2.542487141086037
NCI-N87,selumetinib-PLX-4032 (8-1 mol-mol),3.8712321401270406
RPMI-7951,4477,0.5653184124970599
KMBC-2,11656518,1.6500132439112432
NCI-H2110,6184667,3.212045367006698
YH-13,72734382,5.819140658588148
SKM-1,15547703,2.340856724788066
PE/CA-PJ49,49766530,3.753784618730391
TE-15,426756,4.053189655465964
NCI-H2110,JQ-1-MK-0752 (1-1 mol-mol),2.610299424682689
HSC-4,ISOX-bortezomib (250-1 mol-mol),1.0749923378755126
KYSE-410,3676137,3.886818634834923
HARA [Human squamous cell lung carcinoma],135440466,2.4398826683273165
BFTC-909,navitoclax-birinapant (1-1 mol-mol),3.573845080821179
RERF-LC-Ad2,11396600,4.594180065221676
BT 328,9803433,4.554547423924098
KP-4,2874250,4.410468325412545
RPMI-7951,46224516,1.6628846173712368
HARA [Human squamous cell lung carcinoma],135999136,4.433628677785179
OAW42,44566777,1.4489343823500902
HARA [Human squamous cell lung carcinoma],4477,-0.0807211341972061
SNU-1033,53393127,-1.534783790658787
OE21,135440466,1.3796180177518549
BT 330,24753719,4.584303652526146
BT 504,6918638,2.3418262484979593
PE/CA-PJ34 (clone C12),375860,-0.361568415532625
SNU-1272,25183872,3.9601685379854583
PE/CA-PJ34 (clone C12),11626560,2.4969016411570117
SEM,5329102,-2.9466084154190124
BT 139,6918837,0.5361437768641526
Ku812,11175137,1.3138431643712536
PE/CA-PJ49,46199207,3.3536883371230526
PE/CA-PJ49,SNX-2112-bortezomib (250-1 mol-mol),-2.7085859350472945
NCI-H2110,vorinostat-navitoclax (4-1 mol-mol),2.084238396399879
PE/CA-PJ34 (clone C12),387447,-4.003769145095816
LNCaP clone FGC,71304818,1.9992076453215637
SK-N-AS,31703,-1.196134385587151
SNU-1033,984333,0.2399038951060862
CA46,1566236,0.9666867201201066
WM983B,16013152,4.264752605068201
AU565,10296883,3.47614106437246
RPMI-7951,702558,5.239771710086362
SK-MEL-1,selumetinib-UNC0638 (4-1 mol-mol),-0.6390568749212067
RERF-LC-Ad1,4259181,1.1969151495318886
HMCB,168312962,-2.518156127893363
H-STS,71680916,3.817960068109933
KYSE-70,1641662,3.490090790744947
BT 248,135659046,3.5168747963796636
BT 328,crizotinib-PLX-4032 (2-1 mol-mol),2.7816896231682886
SNU-1272,445091,5.878277369278403
TE-15,3503,1.2930980496455542
AN3-CA,11625818,3.589331976350389
NCI-H2110,676352,2.552766155691823
NCI-H1092,5311,1.4107579527755432
TE 617.T,4477,0.7099747137468548
BT 328,219104,4.206978092049304
GOS-3,1641662,3.7460543636412535
EJM,57519531,2.975105121216571
SNU-8,11626560,2.2205272197134835
KYSE-410,322968,4.816794476605758
BT 504,135411,2.214114198151371
YKG-1,10231331,5.270675851444794
Raji,11152667,-1.6469558196734089
KMS-27,107970,2.0805071505254107
KYSE-70,11396600,3.829938839575827
LNCaP clone FGC,6918328,-1.08990996538289
KYSE-70,5566,3.0340425256076813
SKM-1,2945648,2.351982295686625
RPMI-7951,216345,3.31559127630656
A4/Fukuda,5460769,3.0365194168079572
KMS-20,46943432,0.2963080368709872
NCI-H2081,SNX-2112-bortezomib (250-1 mol-mol),-1.4836997407724497
SW1573,navitoclax-birinapant (1-1 mol-mol),1.5026164736180645
SET-2,10302451,3.517530060309579
BT 330,24964624,1.4419629083261656
Ku812,124202324,0.8874162884237986
NCI-H2081,4705,3.121794828383862
Ku812,11317348,-1.076361726967916
WM983B,3825829,4.481974226562025
KYSE-410,5278396,3.492812084650607
BT 330,erlotinib-PLX-4032 (2-1 mol-mol),3.1729998083866784
BT 248,216239,2.185733710507839
ESS-1,66577038,3.102682313302671
CA46,135440466,2.9995621349054007
CA46,216345,3.098455032375494
MCAS,6438330,2.7548820430881653
OAW28,409805,4.888216855585461
NCI-H2110,445455,4.560590235855628
NCI-H1092,44462760,4.232811059835202
HEC-151,5311,1.3919062885565148
KMS-20,56946209,-4.641611942860024
OE21,52912189,0.4247065075406309
SNU-1272,9967941,2.3662546374553486
RERF-LC-Ad2,6914657,-3.5206588239370946
NU-DHL-1,12001922,1.2463642245780415
KMS-20,3038522,2.067228476552794
MM1.S,9825149,-1.0079549399990844
SNU-1033,71729975,1.596048380525692
KMS-20,25126798,3.810031241179322
WM983B,17755052,2.650943652659532
CA46,54765302,3.694944477545822
BT 328,9911463,3.726223215474182
LNCaP clone FGC,71576739,5.072405718386329
LNCaP clone FGC,53481919,3.2974380827462633
PaTu 8988s,4378219,1.968690646273728
JIMT-1,11364421,-0.2154057025735361
HSC-4,285033,-0.8602386046724618
ML-1 [Human thyroid carcinoma],26596,-0.6105391992480588
HMCB,4261,2.182520846929022
D283 Med,227681,2.8388924362301378
LoVo,49850262,2.4887252685350227
SEM,71466445,-0.7002004774951326
KMBC-2,16038120,0.25892741268573
Kasumi-2,327653,2.4977161394914953
SW1573,3384730,1.5192292760027193
OE21,6914657,-3.0452398561654057
SK-LMS-1,navitoclax-sorafenib (1-1 mol-mol),1.3547584780395672
YH-13,46199207,3.8574280996782337
OAW28,42642645,0.9360886571737812
BT 248,2729026,1.163283415080523
RERF-LC-A1,135440466,2.763827646755713
KMBC-2,49793307,-1.842905492635861
NCI-N87,11178236,-2.6087498623354977
BFTC-909,6852167,2.133526407129769
BT 504,4096211,1.4437691533711583
NCI-H1092,11609586,2.567320203791852
NCI-H2081,6918638,-1.1409095287475362
HSC-4,171352865,4.360447231593142
SK-LMS-1,25183872,-1.7193752658392725
SEM,4378219,1.9889519046071171
SET-2,151289,0.8976963811504413
PaTu 8988s,25262965,-5.220063752579666
OAW28,445455,5.326899909172617
TE 617.T,crizotinib-PLX-4032 (2-1 mol-mol),0.7930399968582251
NCI-H2081,44185566,0.8061811733567802
Hs 683,2733526,4.306174797129774
NCI-H2110,25183872,0.2482276686998807
SKM-1,tretinoin-navitoclax (4-1 mol-mol),0.5849402207655147
A4/Fukuda,6252,-3.645065834912594
SK-LMS-1,1566236,1.8712285641000048
JIMT-1,navitoclax-piperlongumine (1-1 mol-mol),2.740334607218443
KMS-20,219104,2.1050805629757483
Aska-SS,crizotinib-PLX-4032 (2-1 mol-mol),-1.4096716043895037
NCI-N87,448949,2.160730221150561
SK-MEL-1,25062766,2.897683130583979
PE/CA-PJ34 (clone C12),11625818,4.760944363107288
KMS-27,selumetinib-PLX-4032 (8-1 mol-mol),-0.3903208707161197
HSC-4,2742550,4.46855499399167
SNU-8,alisertib-navitoclax (2-1 mol-mol),0.4717323019340358
A4/Fukuda,11222830,1.361211164053787
SW1990,BRD-A02303741-carboplatin (1-1 mol-mol),4.5101495763826245
Ku812,60750,-5.176437907735511
KMRC-2,9915743,0.8631489276658242
OAW42,selumetinib-tretinoin (2-1 mol-mol),5.850501113426382
RERF-LC-Ad2,9936388,1.1598877099292195
RERF-LC-A1,44507138,1.6141546270082323
SK-N-AS,tretinoin-carboplatin (2-1 mol-mol),5.316407559513161
BT 330,2708,4.477643165741568
OAW28,5566,3.0868855994062137
SNU-8,55508,4.439953693077861
A4/Fukuda,vorinostat-carboplatin (1-1 mol-mol),1.5546210220419645
BT 504,56963564,-0.1349774914172789
LoVo,54143018,-0.354466194309244
SKM-1,25150857,2.131946056717962
YKG-1,3634881,3.332049721322664
D283 Med,6918328,-4.962430098316081
SK-N-AS,3062316,2.688368057417405
KMRC-2,25227462,1.115220732551639
CML-T1,124202324,0.7419542279604492
HSC-4,navitoclax-MST-312 (1-1 mol-mol),0.8559820038991849
HEC-151,5479543,3.510315813920412
ML-1 [Human thyroid carcinoma],9903786,1.6234934744716731
RERF-LC-Ad1,676352,3.2240701362689204
SNU-8,12003241,-0.8120802877527198
BT 504,4917,3.27245995001714
MCAS,6610355,4.210219409661457
SKM-1,46191454,-1.3563386144764775
NCI-H2081,10385095,0.3312851708861742
SNU-8,984333,1.7075817084324745
KYSE-70,vorinostat-carboplatin (1-1 mol-mol),2.3289614094858813
ML-1 [Human thyroid carcinoma],10410894,4.287937298613586
SK-LMS-1,262093,2.881429058515633
OAW28,25126798,4.214847534438453
SNU-308,5746,0.7137982637485957
NCI-H2081,carboplatin-UNC0638 (2-1 mol-mol),2.641355380173533
RPMI-7951,navitoclax-MST-312 (1-1 mol-mol),1.3595666482877595
HEC-151,25062766,1.949383068165884
HMCB,9887053,4.4985851609275995
KMS-20,BRD-A02303741-carboplatin (1-1 mol-mol),5.179174708590503
KMBC-2,4705,2.3520992205272395
BT 330,crizotinib-PLX-4032 (2-1 mol-mol),1.6276794707330204
OE21,25195348,1.239334280919703
Ku812,11404337,-0.6784609129861706
H-STS,462382,0.7084919916713189
BT 504,4378219,1.4407405746143198
OE21,984333,1.2352091637058848
ESS-1,675434,5.557520418917079
Kasumi-2,51039095,2.172369026283552
NU-DHL-1,5494449,-1.7833520753251897
D283 Med,135398738,4.108910630376311
SEM,10410894,0.6852786057514013
CA46,9823820,1.6053302041689723
HARA [Human squamous cell lung carcinoma],637858,2.3831379320922728
BT 139,salermide-PLX-4032 (12-1 mol-mol),3.718587641626584
MM1.S,16720766,-1.4015692069091197
BT 504,984333,0.1604201182537508
Hep-G2,51039095,2.027774881018878
Kasumi-2,168313200,3.5619242662151342
SNU-8,JQ-1-MK-0752 (1-1 mol-mol),2.196982018923842
LNCaP clone FGC,5284329,1.944960046338054
WM983B,24901704,3.958324797247697
AU565,alisertib-navitoclax (2-1 mol-mol),2.3316727608646266
TE-15,219104,4.3944003343810705
EJM,15547703,3.175300844457044
Kasumi-2,52912189,-0.393622705419007
CML-T1,159324,0.3275039904336689
LCLC-103H,1750826,-0.2221520552725313
KYSE-70,5281321,-0.9979352327108848
KP-4,selumetinib-PLX-4032 (8-1 mol-mol),2.96077015046319
Ku812,439501,-2.3195298765386587
SNU-1214,11507802,1.140140670038604
OAW28,25154868,4.5321266568460805
KMBC-2,107970,2.196231544396115
KP-4,BRD-K27188169-navitoclax (2-1 mol-mol),3.6878999698692776
KYSE-410,644241,2.1966590431724
PE/CA-PJ49,4705,3.0123221957178017
SK-MEL-1,navitoclax-PLX-4032 (1-1 mol-mol),-1.663832104948812
BT 248,19582717,6.9976074882401464
KP-4,5746,-1.1735495681617156
OAW28,24951314,0.5571772807313425
NCI-H2081,9956119,4.1032174456876485
SEM,53301938,6.1537936140173715
HMCB,11494412,1.1725416400884527
SEM,3854666,0.6904434014299387
HuT 78,1242560,3.6169776257670345
A4/Fukuda,71466380,2.851115718652883
SEM,11497983,-3.9195966802486417
ESS-1,15547703,2.140429677940592
OAW42,49766530,2.0594375067340085
RPMI-7951,6917907,-4.326801206648588
ESS-1,409805,3.6702401515474135
RERF-LC-Ad1,136227924,3.427007002266959
TE-15,46215462,1.4784607708053157
AU565,10184653,-2.737102807310711
LoVo,carboplatin-etoposide (40-17 mol-mol),1.7816353489464614
SNU-308,24901704,5.163894321909123
Hs 683,4261,1.6182911270348386
KMRC-2,9956119,4.342871750577885
YH-13,65064,5.536237996349119
HCC2218,11396600,2.588416382808436
SW1990,4705,4.395682074596428
HSC-4,16722836,1.7684769334825834
A4/Fukuda,262093,3.0357368226896178
CML-T1,11612883,2.4336919382311253
BT 320,135999136,1.9088296274535188
Aska-SS,23582824,0.9314351370865972
WM983B,ISOX-bortezomib (250-1 mol-mol),0.2298907098296435
HCC2218,262093,2.308676672701105
TE-15,11214940,4.604212971840754
HSC-4,439501,-1.7709622187792924
KMS-27,71304818,1.7393876180441603
KMS-27,52912189,0.3495473321033867
RERF-LC-Ad1,10385095,3.535917584536634
Raji,49793307,-4.3030150703266505
OE21,136227924,2.0991161235844404
Hep-G2,44498493,5.1826431923254335
YH-13,2746,3.803826628530811
WM983B,11214940,4.338117544052379
KMS-27,selumetinib-decitabine (4-1 mol-mol),-1.1457589946421645
NCI-H2110,375860,0.2017557628381111
PaTu 8988s,10231331,2.3383323035983787
CML-T1,26596,-2.14043660837674
KMS-27,54618305,4.755877459713762
BT 330,4705,1.8638133419743137
BT 328,637858,2.786285777963434
Raji,119182,-4.8783079767530495
NCI-H2081,piperlongumine-MST-312 (1-1 mol-mol),0.9288913570617896
NCI-H2110,6852167,2.8025502977558165
OAW28,JQ-1-navitoclax (2-1 mol-mol),0.2228593574400964
Kasumi-2,selumetinib-JQ-1 (4-1 mol-mol),-0.370012591860846
NU-DHL-1,52947716,2.976276735024036
BFTC-909,54618771,2.8225313881877545
NCI-H1092,135999136,1.996402787689235
HEC-151,176870,3.1650788397927014
Ku812,6252,-2.9657002300116924
KP-4,tanespimycin-gemcitabine (1-1 mol-mol),-3.176335740160863
D283 Med,675434,4.226898122057941
LoVo,5329102,1.3429054297502294
OAW28,9935249,3.684332158484572
AN3-CA,carboplatin-UNC0638 (2-1 mol-mol),3.453409834733988
RERF-LC-Ad2,322968,2.71312261755285
SET-2,5978,-3.155154977585104
YH-13,49793307,-1.1961754726416267
H-STS,10184653,1.7921408702106925
AU565,46943432,5.0196372017891555
PE/CA-PJ49,10127622,4.589894926216337
HSC-4,2828334,6.111197262680893
RERF-LC-A1,2828334,6.05195053730491
RERF-LC-Ad2,72376,-1.9609852844396736
YH-13,3689413,-1.970237829798131
PE/CA-PJ49,24856436,0.2032813709378295
LNCaP clone FGC,9935249,1.606284127709269
LCLC-103H,25126798,4.192348147291517
SK-MEL-1,241158,3.5443731206675646
HuT 78,6918878,-1.0659334174257225
Aska-SS,3038522,2.2994557551251864
SK-MEL-1,navitoclax-gemcitabine (1-1 mol-mol),-0.2133282979949197
SET-2,4521392,4.244272466851802
NCI-N87,11609586,1.5678533381622328
BT 248,54618795,3.2071840181570477
Raji,11234052,1.9952907949513128
KMS-20,65064,3.1315037554409466
PaTu 8988s,462382,0.5447337070478522
OAW28,753704,4.708152366597851
SKM-1,322968,1.2808637064656738
HARA [Human squamous cell lung carcinoma],156414,2.353598180094054
OAW42,44137675,4.364942945062635
HuT 78,46926350,-4.333378092380672
OAW28,24180719,4.377592888188756
BT 320,53392493,4.061896393500848
PE/CA-PJ34 (clone C12),10427712,4.368954658182041
H-STS,46926350,-4.349495266854958
NCI-N87,9825149,1.7110175659097178
TE 617.T,49867926,4.093517719231764
SNU-8,57330099,4.310413018030645
CA46,42611257,2.680269393096826
Kasumi-2,71729975,0.1244547207122276
LCLC-103H,452548,0.9517258393546928
SK-N-AS,11717001,4.264777399625889
SET-2,135875424,3.0388135878797833
HEC-151,9823820,4.10807898967116
HEC-151,444795,4.8159070538718245
HSC-4,2945648,2.59041604505869
BT 328,3634881,2.884291919608293
BT 330,11494412,3.1533604427813833
BT 330,73707398,1.1643905844402598
RERF-LC-A1,3552672,2.236907567824829
BFTC-909,216239,2.6603594422751136
NCI-H2081,11612883,1.5585709489952069
LoVo,6918736,-4.296362304597629
AN3-CA,6918328,0.7707692490833323
Hep-G2,11404337,0.9907256098180968
KP-4,selumetinib-piperlongumine (8-1 mol-mol),4.1237332827341815
SNU-1214,5284373,-0.8252665054261109
NU-DHL-1,9956119,0.6553979418631676
BT 330,navitoclax-gemcitabine (1-1 mol-mol),-1.7742765886587748
ML-1 [Human thyroid carcinoma],44607531,1.8496707927685447
LoVo,400769,-0.9988261077541156
TE 617.T,17755052,1.8954392302041911
HSC-4,9825149,2.985341504866837
BFTC-909,72376,-1.4314875177558029
NCI-H2081,36314,-5.947411488726424
HMCB,57519531,4.328338374820244
RERF-LC-Ad2,5287969,-1.5613987175817166
PaTu 8988s,56949517,4.226883317513966
SK-MEL-1,3689413,2.3373069635982495
OE21,25227462,-4.320449849945017
NU-DHL-1,9825149,2.2287917110137445
LNCaP clone FGC,navitoclax-sorafenib (1-1 mol-mol),0.830072177871062
SK-N-AS,9911463,3.98556434214228
NCO2,9967941,2.5462450000775663
BT 330,46843906,3.7826602279254895
RPMI-7951,10113978,3.377189439622248
PaTu 8988s,crizotinib-PLX-4032 (2-1 mol-mol),1.415044616335074
HuT 78,11977753,-0.8983403403257315
SET-2,tretinoin-navitoclax (4-1 mol-mol),0.1055125541678496
SNU-1272,3825829,5.135605064206703
RERF-LC-Ad2,10302451,4.090867148457294
BT 248,54678924,1.5069949057557903
SNU-8,11214940,-1.3549016918821504
NCI-H2172,52912189,3.576299193055669
Raji,36314,1.622497847644069
TE-15,44819697,4.771661570365527
OE21,6918638,0.1632098658801684
NCI-H2110,387447,-4.13995118678638
NCI-H2081,1716436,2.350567267109174
BT 330,241158,3.9809433714442166
TE-15,44202524,1.0560243162430882
LNCaP clone FGC,selumetinib-vorinostat (8-1 mol-mol),3.5283733311441208
NCI-H2110,54618164,3.868151773731383
AU565,613753,3.214352381260741
HSC-4,11647372,1.1815136799972823
NU-DHL-1,4705,3.159533609841756
KMS-20,135423438,1.13023072719564
HSC-4,65628,3.12205826618997
CML-T1,16725315,3.685793664289718
JIMT-1,216345,4.490791936156572
KP-4,11964036,3.04555991921075
BT 504,53392493,1.8531327246340508
SET-2,54596490,4.331118205930631
RERF-LC-Ad1,637858,2.9001668968564953
Kasumi-2,BRD-K55473186,1.9287541942318225
OAW28,4917,3.0899334279272046
Hs 683,crizotinib-PLX-4032 (2-1 mol-mol),1.208716890495358
NU-DHL-1,168312962,2.5247820941481183
CA46,5329102,1.3169898780971163
BT 248,52947716,0.6891318567706715
SNU-1272,9911830,3.883073952142102
NCI-H2110,JQ-1-vorinostat (2-1 mol-mol),1.1663353184581713
ML-1 [Human thyroid carcinoma],9911463,4.5829335325836436
NU-DHL-1,vorinostat-navitoclax (4-1 mol-mol),-1.7668259453714923
KP-4,7251185,3.55509362765947
HSC-4,176870,2.813832788377266
Hs 683,9825149,1.7777217272553436
WM983B,6852167,3.582375315492635
EJM,carboplatin-UNC0638 (2-1 mol-mol),3.206648557272409
KMS-20,11656518,0.4062739381385031
HSC-4,54626689,4.284935050666877
KMS-27,11647372,0.3312333587119215
CA46,11228183,3.2150932794291975
SKM-1,5335621,3.872375911033952
KMRC-2,7251185,3.015442118932741
KMRC-2,alisertib-navitoclax (2-1 mol-mol),1.1298078497441686
BT 504,crizotinib-PLX-4032 (2-1 mol-mol),1.9229974205388136
MM1.S,969516,2.341213349507295
PE/CA-PJ49,9911830,2.222449473418187
RERF-LC-A1,11178236,-5.413940539914995
KMBC-2,9884685,1.520589448798377
A4/Fukuda,168313016,2.0147776130358253
SEM,16720766,-0.2754839165177884
NCI-H2110,11657048,4.29195806881169
NU-DHL-1,5746,-1.4660940923303851
RERF-LC-Ad2,5335621,4.374608507204801
BT 248,25227462,1.1845227545958306
IST-Mes1,241158,4.374014389295604
BT 139,10322450,4.915425697373417
Ku812,6917907,-6.404390397127188
CA46,2733526,4.193969711090682
KMS-20,126941,3.518118662895743
EJM,31703,-1.6176826113818792
PaTu 8988s,216239,1.879765133929404
Raji,4788,5.107202303225676
TE 617.T,9826308,1.164230071049112
RERF-LC-Ad2,42642645,1.4647501272846788
MM1.S,107985,-4.097612409872881
SNU-1214,107970,2.341829699130604
A4/Fukuda,126941,-4.18863393868508
EJM,7326481,2.7208134108803503
BT 330,42642645,0.9623973470262224
BT 139,2126,3.939792833653474
KMRC-2,2828334,5.998826671995852
SEM,387447,-5.877720306537758
LNCaP clone FGC,11955716,-2.71802058727311
SEM,1716436,1.599764996763199
KP-4,168312962,0.839288879554725
WM983B,76446078,5.309795973967175
HCC2218,12003241,-0.1021817446699859
NCO2,navitoclax-piperlongumine (1-1 mol-mol),-0.0931412148380439
NU-DHL-1,11234052,4.39505697792573
BT 328,16725315,5.116957818378766
NCI-H2172,5278396,3.8661280169478274
MCAS,selumetinib-piperlongumine (8-1 mol-mol),0.763712530106266
NCO2,10127622,-0.3364297949820206
NU-DHL-1,10427712,3.994515346710207
OAW28,49850262,3.3861243312442264
NCI-H2110,7326481,4.411470836489669
SKM-1,44137675,2.6593794287267127
KMBC-2,6184667,2.7972954567946737
HCC2218,67291369,2.875814700305801
Hs 683,2871966,1.6246107590680972
HSC-4,73707398,0.9895931551524366
OAW42,4788,5.865839465931192
NCI-H2110,637858,3.1754566169961005
OAW28,452548,1.2278646078369797
KP-4,969516,3.31483171154376
TE-15,1566236,3.006173949892504
NU-DHL-1,11625818,2.715961384338104
SKM-1,327653,2.256314826375049
LoVo,3038522,4.270533501697307
HuT 78,3825829,4.013992283960839
SK-N-AS,54765302,4.116378818756358
MCAS,4378219,2.0291292173835993
NCI-H2110,23582824,0.7863788867419214
CML-T1,5284616,-2.6047133462283276
SW1990,24856436,-0.1901815995075366
Hep-G2,322968,4.552458908145698
Hs 683,25227462,0.9336514298487568
TE-15,119182,-1.6418031467147085
BT 248,51037431,4.063284976838012
BT 328,25150857,3.2556687678990612
KMS-20,46191454,0.3124251362481014
KP-4,9840324,5.370614226136491
KYSE-70,17755052,0.9465092626724514
CA46,JQ-1-navitoclax (2-1 mol-mol),-0.4595467452216603
NCI-N87,72734382,4.464771871646434
SKM-1,11625818,3.916071840286403
HuT 78,16720766,0.837560054131659
KMRC-2,16659841,2.6813951842594057
ESS-1,10113978,3.392450898705775
LoVo,16038120,0.8839921956645777
HCC2218,2729026,2.847632009198406
OAW28,252682,6.460081465786461
BT 328,6917907,3.783088770502935
Hs 683,25195348,3.8192568466949024
BT 328,66577038,3.3966345058951974
NCI-H2081,24797083,0.7037810965891612
HSC-4,SNX-2112-bortezomib (250-1 mol-mol),-1.2345732834782526
SK-LMS-1,11717001,5.185088162172401
NCI-H2110,5281321,-2.7282695734042473
SET-2,10427712,3.7228965704476233
SKM-1,148198,-3.315233928127138
HCC2218,568763,-0.2339231027865239
HuT 78,441298,1.9970992526454237
Hs 683,23635314,-4.006388146865234
AN3-CA,445455,4.730408681611543
Kasumi-2,23635314,-3.2137156100627973
Kasumi-2,24753719,3.2877720740856815
SEM,4096211,0.9150772033108496
Ku812,carboplatin-UNC0638 (2-1 mol-mol),2.607088734610279
SKM-1,285033,-2.3553922545886796
KYSE-70,16736978,1.1213704825993671
BT 328,3025986,-0.1303666559009026
Hep-G2,17755052,0.5179186148477235
OAW28,5280436,5.165372214799318
PE/CA-PJ34 (clone C12),ISOX-bortezomib (250-1 mol-mol),1.4521008685739432
OAW42,51039095,3.3295467575023507
OAW28,44819697,-1.5562690526140308
MM1.S,409805,4.03743481309792
NU-DHL-1,42642645,1.3661891975131202
PE/CA-PJ34 (clone C12),122327,5.619503436222374
Hs 683,5746,0.3917971153624203
CML-T1,54618164,3.634689828068523
NCI-H2081,JQ-1-MK-0752 (1-1 mol-mol),1.5845874170404597
MCAS,24951314,1.5072363043467354
HuT 78,2871966,-0.2683725528046166
TE 617.T,65064,3.122907491233594
OAW42,984333,1.2745512667924448
SNU-1214,44620216,4.405337924710413
SNU-1214,navitoclax-PLX-4032 (1-1 mol-mol),1.923242739192103
PaTu 8988s,6450551,3.88448828563756
NCI-H2081,168312962,2.2709613246712395
LoVo,8515,2.0502092932288543
KMS-20,9952709,2.6593366876189717
Aska-SS,675434,4.382693996612232
TE 617.T,54143018,0.9097668622902736
SET-2,54765302,3.648671672605155
AU565,219104,2.449004695507307
SNU-8,9884685,1.4758258715385455
BFTC-909,10113978,3.8739618499623094
Aska-SS,9967941,3.6787786216313303
SEM,6918837,-6.186756041819131
KYSE-410,6918289,2.688908806706306
ESS-1,sirolimus-bortezomib (250-1 mol-mol),0.3261097694928553
AU565,5291,4.2478378741719105
PE/CA-PJ34 (clone C12),136227924,2.74058031223244
BT 504,tanespimycin-bortezomib (250-1 mol-mol),-4.273282009198175
HCC2218,10074640,2.6631017803382604
RERF-LC-A1,11364421,-4.026647456107578
Hep-G2,4261,1.86720235378862
OAW28,6852167,2.294169410796982
LNCaP clone FGC,71751553,4.050545611826545
LNCaP clone FGC,9823820,2.7609881030084087
KMS-27,16038120,-0.8539301751141739
SK-LMS-1,46174525,4.419894327285046
JIMT-1,72734382,4.514187851134036
NCI-H1395,JQ-1-UNC0638 (2-1 mol-mol),2.0863626902926065
BT 330,24797083,1.5615746632227108
EJM,2742550,4.0665181922374805
HCC2218,60700,0.1059889943667532
RERF-LC-Ad1,17759555,3.957571120556156
HSC-4,9887053,4.087399127765092
Raji,53232,3.544478932485298
KMRC-2,72193861,3.995820057929541
MM1.S,54613361,-0.4658763422564649
OAW28,SNX-2112-bortezomib (250-1 mol-mol),0.074441727324656
PE/CA-PJ49,285033,-1.8662670095848188
KMS-27,71466445,4.755423613019404
KYSE-410,11719255,3.0201830274101464
ML-1 [Human thyroid carcinoma],285033,-2.470992399828971
KYSE-70,11455910,0.6771697782379181
SK-LMS-1,6438330,1.5875052319389198
HMCB,107970,2.4632765451158356
SEM,6852167,1.184676073870636
HuT 78,3465537,2.3062408835575923
SNU-1214,24951314,1.0660952993202617
AN3-CA,25262965,-4.540862032837182
RPMI-7951,56973724,2.888823682314247
EJM,51037431,2.8000590273437274
SW1990,crizotinib-PLX-4032 (2-1 mol-mol),1.6329799636642304
PE/CA-PJ34 (clone C12),44202524,1.483466179088964
KMS-27,73707438,4.94205625351234
KMS-20,9915743,0.2569666585707142
HuT 78,11178236,-3.136781933116147
A4/Fukuda,25161177,3.5710974046751804
ML-1 [Human thyroid carcinoma],409805,4.766723032315811
Kasumi-2,5329102,1.6326140590430216
SK-N-AS,44632017,0.789948006172064
HARA [Human squamous cell lung carcinoma],135411,-0.5831763791629045
Aska-SS,60750,0.2520411068674127
YH-13,3634881,3.1869210851626075
HEC-151,445455,5.064867513059979
NCI-H2172,44507138,4.736094102762083
LNCaP clone FGC,57330099,4.343062431668908
LoVo,24753719,4.853832341629896
NU-DHL-1,2749,0.1316403537643747
TE-15,selumetinib-PLX-4032 (8-1 mol-mol),3.712944430775503
SNU-1033,89928392,1.43326577549897
TE-15,25195348,3.308076464846487
NCI-H2081,25126798,4.162268106632209
WM983B,5470400,0.5616334351302968
KYSE-410,5702613,2.208254881931662
KMS-27,5284373,-1.5478981430340564
PE/CA-PJ34 (clone C12),5746,0.2373694033857969
SW1990,10410894,3.3215224279336937
NCO2,11317348,-1.3254326006399828
CML-T1,445455,4.626862894514658
Ku812,11228183,0.9929327430500092
KYSE-410,24772860,-3.1334090173521156
SW1990,9956119,4.049991809961811
SK-N-AS,10302451,3.6948168438870583
LoVo,3385,1.4948122184820352
Kasumi-2,374536,-0.2175337956908027
WM983B,135440466,4.420465870747341
RPMI-7951,11178236,-3.653266948914448
HMCB,73707398,1.3368186639169768
KMRC-2,12003241,-1.7913952791170802
HARA [Human squamous cell lung carcinoma],17759555,3.7036804092868847
AU565,10322450,3.206832643999438
HEC-151,446155,4.059621209738735
MCAS,navitoclax-piperlongumine (1-1 mol-mol),2.2326615000605066
AN3-CA,66577038,3.203903428846991
KMS-27,25126798,4.301851729139167
AN3-CA,11364421,-5.734422820985375
EJM,262093,1.353461350978494
HEC-151,36314,-6.940972183869406
TE-15,25154868,5.0854480005148694
Aska-SS,119182,-2.681734240555131
Hep-G2,3025986,-0.5782752651876217
SKM-1,5460769,2.732858525958475
KMS-20,135421197,1.5361253797366796
GOS-3,11404337,1.2142789078350222
NCI-N87,6610216,4.734758596227503
KMS-27,216468,0.9091039339457488
NCO2,52947716,-5.210042576749007
SNU-1214,selumetinib-piperlongumine (8-1 mol-mol),2.3658233579142713
MCAS,375860,-0.3499242525784914
SK-LMS-1,9935249,3.6088412338145366
BT 248,262093,2.0571072545208926
GOS-3,753704,4.989890215550621
Hep-G2,25183872,0.2185171281580754
AN3-CA,5282054,3.7164894333535745
LNCaP clone FGC,11175137,1.5358821473222088
H-STS,9908783,4.356832739470904
HCC2218,46174525,3.5633372392386224
NU-DHL-1,11719255,1.476075031302051
NCI-H2110,46398810,3.447174717347915
Hs 683,119607,5.92215321701615
SK-N-AS,6450551,2.700309329484188
CML-T1,445091,4.10308804654236
SK-LMS-1,168313200,3.682470833996821
A4/Fukuda,322968,1.909418940393303
Kasumi-2,11404337,-1.9658161518336
GOS-3,5311,2.439895727975568
NCI-N87,9866186,-0.0362526715344146
HARA [Human squamous cell lung carcinoma],82146,4.619283658647928
RPMI-7951,54454,1.921047833616469
KMS-20,156422,3.444760878114978
KYSE-410,11228183,1.825399411469892
NCI-H2081,57519531,0.9438571598062376
HARA [Human squamous cell lung carcinoma],2126,5.112984415511083
NCI-H2081,5282054,2.482146692013313
HARA [Human squamous cell lung carcinoma],9911463,4.1556235611039405
TE-15,23582824,0.2191758972845394
HEC-151,52912189,0.2381447663588256
HSC-4,6852167,2.6632521076475446
IST-Mes1,1641662,3.7606227939030528
D283 Med,327653,2.8736593168933786
PE/CA-PJ34 (clone C12),1750826,1.4658207982474565
KMBC-2,9935249,2.7698221479828726
RPMI-7951,5287620,-3.1537111028341527
SK-LMS-1,44566777,-0.0913690248467498
BT 328,1714884,3.4592731205549225
PE/CA-PJ34 (clone C12),2749,1.5513879621362283
KMRC-2,148198,-2.5062257311600753
KYSE-70,11485656,2.2230455690794404
CML-T1,44632017,0.7838820876699769
Aska-SS,5291,3.606073155811232
OAW28,16725315,3.4000122970226196
OAW28,9915743,2.8675584787684456
HEC-151,53232,3.7500563191364193
HSC-4,6505803,0.688410933428746
CA46,285033,-4.358161131916293
D283 Med,46926350,-5.859080576387131
BT 504,135440466,3.640234972188136
HSC-4,10296883,4.12801319058873
SNU-1033,46224516,2.2546354693256165
ML-1 [Human thyroid carcinoma],11683005,4.957719989216769
NU-DHL-1,5311281,1.858827223103547
AU565,148198,-3.941648532890003
SNU-8,66577038,3.195926950502157
NCI-H1092,24772860,3.2138830329080563
SNU-8,54618164,4.22532753412944
NU-DHL-1,10296883,3.6667794076879594
EJM,JQ-1-UNC0638 (2-1 mol-mol),-0.7989999630217455
OAW42,9911463,4.338639640842429
SW1573,5287620,-0.7347028317725576
SNU-8,24772860,-2.786404079111214
PaTu 8988s,3825829,4.7222594331906915
HuT 78,selumetinib-JQ-1 (4-1 mol-mol),-4.078257117596482
PE/CA-PJ34 (clone C12),3062316,-0.5825484419455179
BT 248,135875424,2.546043839111523
SEM,44607531,0.7149871957090602
ML-1 [Human thyroid carcinoma],123631,2.4078761561490025
RERF-LC-Ad2,6917907,-5.643167163740422
SK-LMS-1,56649450,4.729430575758327
RERF-LC-A1,1317464,5.316118725273337
RPMI-7951,46191454,0.3810355763539577
RERF-LC-Ad2,119607,5.953581699586958
NCI-H2081,5311,0.3244714847141396
SNU-308,5460769,2.0996672061045976
OAW42,9956119,3.9530618327605263
KMS-27,54618771,0.0520641396166809
HEC-151,selumetinib-MK-2206 (8-1 mol-mol),2.7056336497933295
A4/Fukuda,72967,3.695839205584607
NCI-H2081,3854666,0.2078847774714705
HCC2218,erlotinib-PLX-4032 (2-1 mol-mol),2.4789964468615735
HMCB,5287969,-1.832915880429025
D283 Med,24856436,-0.0403728829049674
MCAS,10385095,0.5712472701663329
LNCaP clone FGC,44486219,4.025087195486354
BT 330,9926054,2.1336209959126253
SK-LMS-1,24180125,3.932034764154328
SK-N-AS,11404337,-1.03684068328029
SEM,2871966,-1.3459801337867392
GOS-3,10385095,1.261141423395055
LoVo,52947716,-5.666189039665748
Raji,400769,-1.8811521380691785
BT 330,71304818,2.8134783689342235
EJM,tanespimycin-bortezomib (250-1 mol-mol),-0.1920922307802734
PE/CA-PJ49,10410894,3.0820189090316443
OAW28,9956119,4.544482925716663
SNU-1214,675434,4.01196725824336
KMS-20,46926350,-4.252708447125384
KYSE-410,568763,1.7432246593970837
WM983B,11977753,1.453257793964076
KMS-20,10410894,2.165253537613353
HuT 78,25102847,2.213703306492941
OAW28,54618771,1.1011370240470315
KYSE-70,148198,-2.193158047226166
Aska-SS,53495165,-0.2600081026021872
MCAS,2828334,5.7041828884392345
PE/CA-PJ34 (clone C12),vorinostat-carboplatin (1-1 mol-mol),4.08253378532113
HuT 78,46174525,1.5214422285401947
KMRC-2,3552672,1.8363190955361777
LoVo,9907093,0.4604974674369004
Ku812,54143018,-0.9918104054999368
OE21,16722836,1.695900510061296
RPMI-7951,24772860,-2.8129043414212633
HARA [Human squamous cell lung carcinoma],56946209,-3.7436646215458182
HCC2218,135421197,0.9685735875874713
OE21,5287620,-2.6065865417872205
SW1573,12003241,-0.6702221198842615
TE 617.T,navitoclax-MST-312 (1-1 mol-mol),0.8185651463211672
WM983B,9933475,1.7835816699135554
SNU-308,navitoclax-gemcitabine (1-1 mol-mol),-0.158413006757676
NCI-N87,3038522,3.5877635056945443
Kasumi-2,53495165,-3.989635350263354
OE21,71304818,1.669793656395023
WM983B,16065773,3.45706690293817
MM1.S,5328940,1.2024233811688534
EJM,73707398,0.7642029358076543
MM1.S,241158,2.058054746242757
KMS-27,11234052,4.628774972835408
SNU-8,46224516,2.6221554593886935
SW1573,448949,2.6434946381292703
Raji,5282054,3.374507062958241
PE/CA-PJ34 (clone C12),72193861,0.4823673810594518
OAW28,31703,0.1585101679236112
NU-DHL-1,613000,1.3520499940785358
SKM-1,44185566,1.2087289104491263
SNU-1214,107985,-3.75427796779674
OE21,3825829,4.065896901751797
D283 Med,11213558,0.9641513863181852
AN3-CA,11964036,1.072172858204418
SEM,122327,5.062595568788216
BT 139,11234052,4.216816338162274
BT 328,135440466,1.9729468656409803
GOS-3,44185566,2.676138755124573
PE/CA-PJ49,3062316,-2.7015704700942313
YH-13,53392493,1.9898975762013085
GOS-3,10296883,4.354871301885758
WM983B,135875424,3.018238153031043
GOS-3,5282054,3.980081801292934
ESS-1,44486219,4.319485753082415
KMBC-2,2871966,1.2658071123626833
H-STS,54618771,0.7523066402016166
BT 330,JQ-1-UNC0638 (2-1 mol-mol),3.496932096076456
LoVo,25154868,3.829103546750207
HARA [Human squamous cell lung carcinoma],24785538,-0.0579889747329333
AU565,73707398,1.1644887368044523
SK-N-AS,UNC0638-navitoclax (1-1 mol-mol),2.763969623467532
NCI-N87,1716436,1.6921610156965474
HMCB,46174525,5.186938834845106
JIMT-1,54618771,0.8201229283888136
YKG-1,9935249,4.562558251006297
PE/CA-PJ49,1566236,1.7621483938715563
HSC-4,650361,3.951915492066197
BT 320,135411,3.5003751238841887
A4/Fukuda,9866186,-0.2462641713744652
BT 504,16038120,1.085579305316001
LCLC-103H,4261,1.464038437484002
H-STS,46174525,4.112955577900159
NCI-N87,10385095,0.9731458206829144
BT 139,10296883,4.347610797549644
JIMT-1,11214940,4.486204116386873
NCI-H2081,71466380,3.723063290723911
KMS-27,JQ-1-carboplatin (1-1 mol-mol),2.20932469874721
YKG-1,49793307,-1.8928162197489815
NCI-H1092,24901704,2.360617916449716
PaTu 8988s,10410894,3.177464488854481
OAW28,168313200,4.298133692275281
SNU-308,25102847,4.421541484548656
SKM-1,vorinostat-carboplatin (1-1 mol-mol),1.9252377672335388
OE21,6438330,2.9063571168826834
NCI-H2081,24180719,4.062007967057392
SNU-1272,676352,3.00667023527596
NCI-N87,31703,-2.5850470675010175
JIMT-1,2729026,3.062977615792191
RERF-LC-Ad1,selumetinib-MK-2206 (8-1 mol-mol),3.552195149911139
OAW42,148124,0.6602730639600906
BT 330,675434,4.00898726797857
Kasumi-2,9868037,2.67651294484719
NCI-H1092,54613361,1.771000250382894
SNU-1033,JQ-1-MK-0752 (1-1 mol-mol),1.3281748274410412
KMRC-2,285033,0.3199202745946036
NCI-H1092,2746,3.1114505923007583
RERF-LC-A1,tanespimycin-bortezomib (250-1 mol-mol),-1.931734288189376
RPMI-7951,selumetinib-GDC-0941 (4-1 mol-mol),1.7374138302319462
PaTu 8988s,2746,3.571987596167747
YH-13,JQ-1-navitoclax (2-1 mol-mol),1.7926263588909668
MCAS,selumetinib-vorinostat (8-1 mol-mol),1.2956109897166193
SW1573,9840324,5.095993559480237
Hep-G2,navitoclax-piperlongumine (1-1 mol-mol),2.9586079970104984
AN3-CA,54596558,4.225678688908697
TE 617.T,65628,4.20520230930191
TE 617.T,navitoclax-pluripotin (1-1 mol-mol),-1.2596810773022633
ML-1 [Human thyroid carcinoma],11238147,1.6119243998814434
SKM-1,72193861,-0.5325335794598204
PaTu 8988s,168313200,2.2085646036836786
SEM,56949517,5.249537038012084
KP-4,135440466,3.0532427161305655
LoVo,selumetinib-tretinoin (2-1 mol-mol),0.1717915474841797
KMS-27,navitoclax-birinapant (1-1 mol-mol),-2.0662648148507596
SK-MEL-1,2841722,5.215818556351941
HMCB,322968,4.304190812139685
SNU-1272,navitoclax-MST-312 (1-1 mol-mol),2.3385631446874897
NU-DHL-1,44607531,1.8072861510407077
NCI-H2172,73707398,2.7683774259754914
KMS-20,5460769,-0.4034471516809727
KYSE-70,327653,3.7336437717951103
H-STS,1716436,2.174736460628774
HARA [Human squamous cell lung carcinoma],15953870,3.428154571209005
MCAS,navitoclax-gemcitabine (1-1 mol-mol),-1.9981437035032432
NU-DHL-1,104842,-6.390742979780276
SNU-308,24785538,3.8901431089761505
SW1990,119182,0.7225456675209282
RERF-LC-A1,9935249,3.663083529492861
ESS-1,10427712,4.097612541596862
H-STS,31703,-3.181617009980154
HARA [Human squamous cell lung carcinoma],4788,5.847017929418924
LNCaP clone FGC,439501,-2.4937134944398176
NCI-H1395,11427553,4.002864688694153
SNU-1272,16115403,-4.411665524606828
Kasumi-2,3503,1.0805615825532868
SEM,445091,4.25698967514786
SNU-1033,15547703,0.9378221532753946
BT 328,9884685,2.9316032553217166
SK-LMS-1,4578,4.462106050202468
LoVo,452548,-1.7762082467733018
D283 Med,2945648,2.7267209315034946
Hep-G2,135421197,1.3335693407455125
SNU-1214,10302451,0.3178594253094901
AN3-CA,107985,-2.3733374503146414
WM983B,selumetinib-JQ-1 (4-1 mol-mol),-1.7690191358032856
SNU-1214,12003241,-2.886982661469118
OAW42,4917,3.6334083751278854
Raji,148198,-3.0979012911214077
NCO2,SNX-2112-bortezomib (250-1 mol-mol),-3.289278378344736
SNU-1214,16115403,-4.416699825861742
HSC-4,24748573,1.230311327364621
TE 617.T,5978,-5.158536368271862
SW1990,327653,3.573318417462307
Kasumi-2,12003241,-2.245419673861097
Hs 683,ISOX-bortezomib (250-1 mol-mol),0.1836379152412065
SEM,52947716,1.1671680401864422
HEC-151,44607530,2.2664323505361987
RERF-LC-Ad2,selumetinib-UNC0638 (4-1 mol-mol),4.427730153317547
HuT 78,9935249,1.327110293574704
OAW28,148124,5.441417229348929
SKM-1,54613361,-1.1301405501278758
ML-1 [Human thyroid carcinoma],60700,-3.146668380067059
SNU-308,16720766,0.3051642754670216
LNCaP clone FGC,9903786,4.486079979714403
CML-T1,46174525,3.020182372643586
BFTC-909,46224516,1.8849058086882595
BT 330,25150857,1.3872666328964631
KMBC-2,2842253,6.705227553529979
HEC-151,11167602,1.902436852174608
WM983B,9884685,2.1138858450656937
AN3-CA,44486219,4.4449329254105105
NCI-H1395,16722836,3.221617987091192
CML-T1,2945648,2.7633194270668877
SET-2,72193861,1.1745173651273035
LoVo,3062316,-2.119304437973892
Aska-SS,11955716,-1.6455074883452614
WM983B,46199207,3.674728346319157
D283 Med,9927531,3.2144716566788745
BT 139,9887053,5.710056569748746
KYSE-70,44185566,2.2395157674699875
D283 Med,9840324,6.111683507272441
PE/CA-PJ49,9915743,0.4153900299925456
GOS-3,3011155,4.288572340636914
IST-Mes1,6918638,1.4350648787515894
HCC2218,54619267,3.644262219384105
Hep-G2,44819697,0.0700800273928934
SK-N-AS,151289,0.954369852434549
KYSE-410,navitoclax-birinapant (1-1 mol-mol),3.0273545148034664
Aska-SS,36462,2.182690934298482
KYSE-410,56973724,2.7264787615738695
BT 320,44607531,2.095455849416377
CML-T1,6610355,4.414519429527798
PE/CA-PJ34 (clone C12),969516,2.522946376643246
KYSE-70,9887053,4.5630363901990565
SK-LMS-1,10302451,4.013028906163852
OE21,675434,4.4580240736273105
CML-T1,3081361,0.8904525598046117
SK-N-AS,44566777,0.6776466702196053
ML-1 [Human thyroid carcinoma],44607530,1.6401891623478355
SK-MEL-1,42611257,-0.1824509258585222
KMBC-2,JQ-1-navitoclax (2-1 mol-mol),0.1634433459310504
PaTu 8988s,67291369,4.90609121399087
Raji,54649381,3.576842683556631
PE/CA-PJ49,12003241,-1.496755728928347
PE/CA-PJ49,11167602,3.7054194129551736
LoVo,vorinostat-navitoclax (4-1 mol-mol),1.8172554757062631
CA46,25062766,1.483751377697603
NCI-H1092,5281321,0.8486024687815589
Raji,12003241,2.533123505917396
KMS-20,6918638,-0.8366604804869239
SW1573,navitoclax-pluripotin (1-1 mol-mol),-0.8972243214684317
OAW42,46843906,3.688424327548771
SNU-308,doxorubicin-navitoclax (2-1 mol-mol),0.3495422569736602
NCO2,tretinoin-navitoclax (4-1 mol-mol),0.2848109036421691
SNU-1272,ISOX-bortezomib (250-1 mol-mol),1.8833687902494112
BT 504,24771867,5.715295997283281
ML-1 [Human thyroid carcinoma],151289,2.136095657957592
KMS-20,107970,1.4633641977001968
H-STS,3825829,3.5499806421209854
HCC2218,46191454,1.332680934532818
SW1990,107985,-4.22199587403486
NU-DHL-1,65628,2.3268847474457317
NCI-H1092,3825829,4.014845832677727
BT 330,9887053,2.636361390531868
RERF-LC-A1,7326481,1.599140241809489
TE 617.T,9884685,-0.3777668305269445
AN3-CA,9823820,1.790343558291452
SNU-1272,6918328,1.7738060965296416
SKM-1,11717001,-3.556230910849805
OE21,11455910,0.3483153837156987
HMCB,42642645,1.005103914323319
MM1.S,451668,2.3967499935955083
SK-MEL-1,SNX-2112-bortezomib (250-1 mol-mol),-1.8894304101380328
KYSE-70,6914657,-2.943523310206574
BT 328,selumetinib-tretinoin (2-1 mol-mol),5.411953573942954
KMBC-2,216468,4.2660484739392714
Hep-G2,124202324,1.2953785205676314
LCLC-103H,44819697,-0.523684751114598
KMRC-2,9823820,3.4713660880657016
RERF-LC-Ad2,6505803,1.9541445598040723
LoVo,119182,-3.2827225124554804
RERF-LC-Ad2,25195348,1.2152722372109874
NCI-H2081,216468,0.1625451412214818
BT 139,135440466,2.831424659347837
NU-DHL-1,SNX-2112-bortezomib (250-1 mol-mol),-2.810384781380506
RERF-LC-A1,11175137,3.456671536251262
JIMT-1,5280436,3.8197120271975193
NCI-H2081,11485656,1.3595446454141742
Kasumi-2,5746,-4.326746041624573
KMBC-2,24978538,-1.3803333865803342
BT 248,UNC0638-navitoclax (1-1 mol-mol),1.1596436088492943
SK-LMS-1,7326481,2.353103661903814
KYSE-70,3825829,3.6022414485207452
SNU-1272,107970,2.7088030141342383
PaTu 8988s,10113978,5.272463308546891
Kasumi-2,6914657,-5.1533998646952925
AN3-CA,702558,5.277719355843632
SNU-1272,11222830,2.080284552032401
OAW42,selumetinib-piperlongumine (8-1 mol-mol),4.7684278019785085
Raji,10074640,2.867480106909446
AN3-CA,71680916,4.563365541904402
GOS-3,selumetinib-UNC0638 (4-1 mol-mol),3.7794346913779577
IST-Mes1,126941,-2.6873860553959754
A4/Fukuda,10322450,2.3588003127389277
CA46,navitoclax-piperlongumine (1-1 mol-mol),1.4441341288477034
OE21,16736978,0.6479424690306809
Hep-G2,9444,4.035145780865591
NCI-H2110,66577038,3.0197995654494076
OAW28,24821094,3.6183900250040497
PE/CA-PJ34 (clone C12),11455910,0.5657744918990928
LCLC-103H,5460769,4.406822689547097
Ku812,56973724,1.3677236281972405
BT 139,11656518,1.698271601966726
BFTC-909,3689413,0.9841636034152118
Hs 683,54626689,4.697975786794028
SNU-1033,11257553,0.3367229998318771
AU565,5113032,4.518377698044194
NU-DHL-1,doxorubicin-navitoclax (2-1 mol-mol),-3.622223528982808
OAW42,3384730,3.1539995022139453
LCLC-103H,doxorubicin-navitoclax (2-1 mol-mol),-0.2805944157067913
KYSE-410,25183872,-1.4094426192679763
TE 617.T,25262965,-3.4538880737625814
KMBC-2,11964036,1.6060621816091996
PE/CA-PJ34 (clone C12),tanespimycin-gemcitabine (1-1 mol-mol),-1.6336664164478074
NU-DHL-1,119607,5.442587797739693
KMS-20,168313016,2.502907983030332
KMS-27,241158,2.104620669820106
ML-1 [Human thyroid carcinoma],445643,4.241689590807037
CML-T1,11625818,4.307055863962681
BFTC-909,135398516,3.047749913114312
KMS-20,46215462,1.529319856062388
AN3-CA,9903786,1.5268103297033566
LNCaP clone FGC,409805,5.792724487332009
KP-4,selumetinib-MK-2206 (8-1 mol-mol),2.8927851283420916
SET-2,375860,-0.3203156821570778
SEM,44819697,-3.860509167414776
YH-13,46843906,3.1529849009094604
IST-Mes1,2828334,6.0384225929755555
KMS-20,46199207,2.2005860320322532
KYSE-410,24797083,1.7449948464454093
Kasumi-2,3384730,0.4985599128931971
AU565,322968,2.504214157528526
Kasumi-2,11612883,1.7782552978814286
NCI-H1395,3854666,3.0219534193280637
AN3-CA,2874250,4.8162154482444715
GOS-3,11625818,5.199223686092666
SNU-8,piperlongumine-MST-312 (1-1 mol-mol),1.6623284799155622
SK-LMS-1,11609586,3.6592183392420226
HMCB,11152667,-0.8228544828189237
SW1990,400769,0.0834550218555617
YH-13,2828334,6.017888903931418
KMS-27,54626689,4.411427785332684
EJM,2729026,3.2130088601508247
SNU-1214,44489675,3.6563084296485417
NCI-N87,5978,-2.9043455823279185
SK-N-AS,11364421,-5.79372026699041
SEM,selumetinib-tretinoin (2-1 mol-mol),0.5709175371364448
Hs 683,11228183,2.8143338222496666
OE21,168313200,2.14822822620211
RERF-LC-A1,10184653,1.779419867903327
YKG-1,4788,6.355492243434627
RERF-LC-Ad1,selumetinib-vorinostat (8-1 mol-mol),4.734189741537759
HSC-4,44507138,3.308450875381542
SK-MEL-1,5284329,6.729877858713592
KMS-20,53393127,3.681479767939244
KMRC-2,168312962,4.413019822762519
Hs 683,44566777,1.5079586204281026
KMS-20,400769,-2.039979438204604
KMS-27,400769,-1.4116934681425155
HCC2218,44185566,2.40017687659303
SW1573,selumetinib-piperlongumine (8-1 mol-mol),4.823355107887568
Raji,71304818,2.348707554665557
Hs 683,decitabine-navitoclax (2-1 mol-mol),3.1967251504262943
LNCaP clone FGC,136227924,2.6855023326383387
HEC-151,26596,-1.920762353069635
HEC-151,9825149,3.0210150218859018
HARA [Human squamous cell lung carcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.215632811452015
CML-T1,135398738,1.6792363237461696
MM1.S,3825829,4.169189674904385
RERF-LC-A1,5479543,3.7016468145750023
BT 504,24748573,1.7265979765653547
SK-N-AS,5470400,-1.3430919405181303
BT 328,10074640,3.6733046849863986
YH-13,25102847,2.4303848050744747
NCI-N87,5351362,0.9196567139345124
BT 248,15983966,1.8194061419836256
HEC-151,tanespimycin-gemcitabine (1-1 mol-mol),-0.6306634684519514
RPMI-7951,17755052,0.7587041071085807
OAW42,10410894,3.563098372213175
MCAS,25183872,-2.415818615558872
RERF-LC-A1,54613361,-1.6211965220189513
KMBC-2,71466380,6.1487994263680354
SEM,11364421,-5.764014401440725
KMS-20,11234052,3.409972208267674
BFTC-909,selumetinib-UNC0638 (4-1 mol-mol),3.893293421232559
H-STS,53392493,1.7634078986228434
MM1.S,44607530,1.747529731398438
OAW28,23725625,6.509051762822527
Hep-G2,12003241,-0.7040118985216451
SET-2,71680916,4.354053511133045
SEM,107985,-4.245084684067336
Ku812,119182,-3.854816046340745
ESS-1,148124,-6.743563487136813
KMS-20,36462,0.8301461091099265
Raji,5978,-2.292357202104216
TE 617.T,446155,0.1543714294288768
YKG-1,24951314,2.313291828558588
KYSE-410,JQ-1-navitoclax (2-1 mol-mol),0.9940985435997014
SK-N-AS,navitoclax-pluripotin (1-1 mol-mol),-0.4342846883120743
NU-DHL-1,5278396,3.036483105356944
AU565,23725625,4.73732544358888
CML-T1,selumetinib-MK-2206 (8-1 mol-mol),2.7460107356112644
TE-15,123631,0.6559553869726535
SNU-1214,crizotinib-PLX-4032 (2-1 mol-mol),1.1503309085319278
OE21,6450551,3.896590607543263
OAW42,44632017,1.657226320025177
EJM,216239,1.8380778507015632
D283 Med,387447,-5.573112310264525
HARA [Human squamous cell lung carcinoma],24964624,2.781169175627229
HuT 78,46199207,3.332923671335415
RPMI-7951,5746,-1.3005105178038452
BT 328,4259181,1.754792833603723
TE 617.T,11167602,1.5922008252868003
OE21,54613361,-0.5839103852924844
BT 248,6505803,-0.8385222866943476
LCLC-103H,67156097,0.2607877574893626
KMRC-2,241158,4.767496150813131
OAW28,702558,5.716785737298097
BT 504,54649381,3.6811603299344418
SW1990,56649450,3.67691256278054
HuT 78,56946209,-6.9577277527161625
MM1.S,4261,-0.3517097479501856
HSC-4,3854666,2.969420021692798
NCI-N87,10302451,0.4744399528749561
HMCB,15953870,5.102048815758539
SK-N-AS,409805,3.819858792673344
BT 248,9967941,3.931710866923424
SW1573,2858523,3.1892649395611556
KMS-20,11609586,1.7506096338547088
KYSE-70,71466380,5.08916461895765
HMCB,11427553,2.900768435371354
A4/Fukuda,selumetinib-MK-2206 (8-1 mol-mol),0.2592073552888009
HSC-4,2746,3.845189406581069
SNU-8,selumetinib-tretinoin (2-1 mol-mol),1.3577737463468764
LCLC-103H,54649381,3.974778393100258
OAW28,9933475,1.6622343224708085
YH-13,24951314,1.6254044283291555
SK-LMS-1,11640390,3.725375695528182
HEC-151,16038120,1.8032484675245264
ML-1 [Human thyroid carcinoma],72199292,2.652505906746634
NCI-H2172,11626560,2.2444184668426996
HMCB,702558,5.238794075302357
SET-2,100016,6.077577626399248
YKG-1,156414,1.711503789054189
SEM,9825149,0.5680322280051573
Raji,6438330,0.931764894842744
LCLC-103H,262093,3.3068425344063326
HARA [Human squamous cell lung carcinoma],11152667,-1.8717886502550631
KMRC-2,5281672,4.440039611161242
KMS-20,BRD9876-MK-1775 (4-1 mol-mol),0.4683519431894999
SK-MEL-1,6852167,3.260361139868282
HuT 78,208908,2.8130928881015422
RERF-LC-A1,11455910,0.7727825040667291
TE 617.T,decitabine-navitoclax (2-1 mol-mol),3.662981442194223
Ku812,navitoclax-MST-312 (1-1 mol-mol),0.7208208773965746
SNU-1214,124202324,2.007945459844625
WM983B,6610355,5.6413027431092555
BT 504,11214940,3.763944940249579
NU-DHL-1,11427553,2.3101556642862575
HSC-4,60700,-2.3901041148359
IST-Mes1,11964036,1.5284066254046933
PaTu 8988s,2130404,3.505256394277455
ML-1 [Human thyroid carcinoma],676352,2.608959843452948
CML-T1,6505803,-0.3633146304142068
HEC-151,24951314,1.163377873037901
OAW42,55508,4.741991676070221
LNCaP clone FGC,decitabine-navitoclax (2-1 mol-mol),3.8356105754036025
ML-1 [Human thyroid carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),2.7869393467132344
LNCaP clone FGC,25105715,3.6102542432221703
A4/Fukuda,10302451,3.353566161735505
Hs 683,53495165,0.4818655856082811
JIMT-1,148198,-2.4064236907207786
NCO2,16736978,-0.0682626650805877
MM1.S,46224516,1.4824898133481414
PE/CA-PJ49,2126,5.496885212346356
SNU-8,selumetinib-PLX-4032 (8-1 mol-mol),2.081334250605702
SNU-8,crizotinib-PLX-4032 (2-1 mol-mol),2.308629614617598
KP-4,73707398,1.2219624501401705
NCI-H1092,4259181,1.0265302606919988
YH-13,219104,3.421374487028668
OAW28,675434,4.444033298399729
SNU-1214,452548,1.32611741110659
KP-4,49766530,-2.33091907235806
EJM,navitoclax-birinapant (1-1 mol-mol),0.3808081808829636
SK-MEL-1,3825829,5.509515179723942
KMS-27,4477,0.0382761833830738
KMS-27,135999136,1.9595465875821207
NCI-H2081,9884685,-0.1678318744759171
RERF-LC-A1,11507802,1.0346364320569787
KMRC-2,56649450,3.7925860379336576
OAW28,10074640,2.8656652346665545
SNU-1033,285033,-5.400641169333858
TE-15,285033,-1.9345935977571684
BT 139,9926054,3.0317650629280717
SK-LMS-1,135398516,2.231011064072704
OAW42,24821094,3.7932810620987953
SNU-1272,16741245,3.8765356368768566
AN3-CA,9884685,-1.0076208994656373
BT 248,241158,3.909930885156875
YH-13,11427553,1.71791693691315
NCI-H2110,selumetinib-tretinoin (2-1 mol-mol),4.2127406612871345
IST-Mes1,135398738,4.689828903809361
SKM-1,71466578,1.8721097081856155
TE 617.T,702558,4.450840732173967
HEC-151,65064,4.514175261653523
BFTC-909,44259,1.3269924163099676
Hep-G2,15547703,3.001617990319869
BT 248,tanespimycin-gemcitabine (1-1 mol-mol),-1.6636234476811602
HEC-151,BRD-K27188169-navitoclax (2-1 mol-mol),2.581586549309544
MM1.S,11152667,-1.9350060885580451
RERF-LC-Ad2,11364421,2.718069260317397
HCC2218,25161177,4.153006406170549
SNU-1214,11612883,2.1855017074755874
KMS-27,46191454,-0.9265013604002822
PE/CA-PJ34 (clone C12),55283,4.2692019597898865
HSC-4,6450551,4.030000721690881
KYSE-410,navitoclax-MST-312 (1-1 mol-mol),1.5349956003218148
HEC-151,doxorubicin-navitoclax (2-1 mol-mol),-1.3612556233539408
SNU-308,2729026,3.0372932862375692
CA46,24772860,-2.6679944090404035
SKM-1,26596,-4.237929506963809
HMCB,52912189,1.846008318835607
OE21,46843906,2.363538949964924
OAW28,107970,2.4537130721494105
NU-DHL-1,46199207,3.5516049097640243
SNU-308,176870,1.056241712459876
Hs 683,44202524,1.2205424042821535
CML-T1,6918328,-2.287128701752201
Kasumi-2,1750826,-5.270023181988586
HSC-4,9903786,4.262681016067309
HMCB,676352,1.7835731305737277
PE/CA-PJ49,2742550,3.734489746257058
SW1573,5280436,3.0542460563059253
H-STS,11964036,1.8558762688812251
CA46,11175137,1.918070959510412
WM983B,12003241,-2.729936813041864
SEM,12001922,1.121071645665963
TE-15,11609586,3.241700650449008
IST-Mes1,6450551,1.123519877762822
WM983B,3136844,5.448921350485804
KMRC-2,11222830,3.930801271298324
HCC2218,44607530,-1.0450440399880232
ML-1 [Human thyroid carcinoma],71466380,5.169213277707957
Kasumi-2,10074640,2.978792769082284
SKM-1,9967941,3.3288322621426283
NCI-H2081,3689413,-0.989992552174664
SK-N-AS,9903786,2.5201816871089653
RERF-LC-A1,6610216,4.83230051596447
Ku812,9868037,1.2688072678140785
RERF-LC-Ad2,3025944,4.191488625541467
NCI-N87,5281672,5.2421020595736145
BT 328,285033,-0.2548275745662432
Hs 683,salermide-PLX-4032 (12-1 mol-mol),5.2498039837805734
KMBC-2,285033,-0.4300275194695732
OAW28,17755052,1.3145864766951243
KMS-20,44486219,3.957177365137273
SW1990,2874250,4.4866341652918145
ML-1 [Human thyroid carcinoma],16722836,0.1571893320134409
BT 248,11647372,0.9807519416972552
HSC-4,446155,4.1145986724492865
BT 330,2871966,0.8536485035302345
MM1.S,613753,2.867673919869975
SET-2,9911830,2.246088546927402
D283 Med,3081361,2.432626618810537
RERF-LC-A1,439501,-2.669244370935075
KMBC-2,1750826,-0.4794415324441379
SEM,5311,-0.7681925912074375
NU-DHL-1,135398744,6.409233084142903
RPMI-7951,135875424,3.929226739625062
CA46,44486219,3.6158388001945463
OAW28,9956119,4.544482925716663
OE21,11507802,1.2439926105697752
JIMT-1,16720766,3.524642007290543
NU-DHL-1,1716436,2.341384326057666
SK-N-AS,9915743,0.9630784924267336
KMS-20,44489675,3.4055865865697283
Hep-G2,135398516,2.8835237684961483
RERF-LC-Ad2,24797083,1.7460478309528484
SK-N-AS,24821094,3.860013381092733
KP-4,400769,-0.5865212071302118
NU-DHL-1,16722836,0.983509194691096
KMRC-2,25102847,3.16009937811696
WM983B,5329102,1.695789687370829
AU565,45279963,3.869118795762884
PE/CA-PJ34 (clone C12),doxorubicin-navitoclax (2-1 mol-mol),-1.5110947353726836
KMBC-2,5280436,3.963085231477196
RPMI-7951,decitabine-navitoclax (2-1 mol-mol),1.2781145153350604
LoVo,11455910,2.8170443999319574
AU565,23635314,-4.115690790244737
NCI-H2110,11455910,0.8455410267883708
Aska-SS,24901704,0.9689987170877432
ML-1 [Human thyroid carcinoma],46224516,1.5473988782080883
OAW28,6918878,3.220005605820797
SET-2,2708,2.464948015256483
YH-13,25262965,-2.705880227783202
SKM-1,23725625,3.72033085826658
CA46,11625818,3.63093624941088
PE/CA-PJ49,9967941,4.975191877613584
BT 320,46224516,3.0907007884048636
YKG-1,6918638,1.332910318202703
SW1573,53245473,3.5468633352222287
LoVo,119607,4.4096130331744865
SET-2,44566777,-1.033546336439595
PaTu 8988s,16741245,5.057049957971029
NCI-N87,25262965,-2.609521679715104
GOS-3,ISOX-bortezomib (250-1 mol-mol),0.1639381713704753
IST-Mes1,46199207,3.629760005921771
HEC-151,81146,5.455769476076874
A4/Fukuda,doxorubicin-navitoclax (2-1 mol-mol),-2.572338922039687
KMBC-2,2729026,3.016115186069628
HCC2218,208908,-2.6201557122185544
PE/CA-PJ49,73707398,0.9781921467778038
SK-MEL-1,9825149,2.587305718222792
RERF-LC-A1,24901704,3.4784572983002406
SET-2,56949517,3.925434074551105
NCI-H2172,11640390,3.3047851454789536
KMS-20,selumetinib-navitoclax (8-1 mol-mol),-1.8022181228536576
NCI-H1395,327653,3.4863341416729847
KMBC-2,208908,2.0987626264881696
HEC-151,1716436,2.3472897882552934
Kasumi-2,25154868,4.0151171723744765
Raji,3543504,2.7811348432985032
OE21,375860,-0.7347528974131474
D283 Med,16038120,-1.2659800311805858
RERF-LC-Ad1,11152667,0.5366755842825199
OE21,3062316,-1.8002534504736254
MM1.S,71304818,1.9525205980727691
PE/CA-PJ49,45279963,3.800739735970884
SK-N-AS,12003241,-1.4595382352216486
BT 139,6436223,-4.846164479138538
BT 139,71729975,2.9783826602427017
PE/CA-PJ49,10296883,4.094155197512124
SW1990,11964036,1.893921505809902
NCI-N87,5278396,3.196450874168962
Kasumi-2,4917,2.8909802401946565
HuT 78,6505803,-1.3012174270497974
SEM,56963564,-0.810126734608135
ESS-1,11612883,3.2589568216623337
OAW42,64971,3.3170815725117104
RERF-LC-A1,JQ-1-UNC0638 (2-1 mol-mol),1.161874917603771
NU-DHL-1,54596490,5.416894183216897
PE/CA-PJ49,216468,2.357663395957277
HuT 78,613753,2.0595917856735104
NCI-H2110,119182,-1.092135789483473
LNCaP clone FGC,57519531,1.9149339462743336
OAW42,71466445,5.313769340389005
KMRC-2,4477,1.0568928101730144
ESS-1,25154868,5.124827046157549
OE21,2746,3.2562317048816363
KMBC-2,51039095,3.65813416171897
NCI-H1092,60700,-0.3122141816941802
HEC-151,445643,3.872369343454908
PaTu 8988s,42611257,3.954270823860523
NCI-H2110,23725625,4.931230472859012
RPMI-7951,10074640,2.626377299406927
NCI-H1395,10322450,2.951434286433811
NCI-H1092,selumetinib-piperlongumine (8-1 mol-mol),4.34690656876425
BT 248,24775005,3.1653639365719553
KYSE-410,82146,4.878809212200983
OAW42,54613361,1.329247417336848
SK-N-AS,126941,-4.538505793601846
SNU-8,3825829,4.279062116005913
KYSE-70,9911830,3.1951659700149886
SNU-8,5738263,3.0569282263832935
CA46,24180719,4.114109141176105
Ku812,selumetinib-UNC0638 (4-1 mol-mol),-0.6885180767604759
MCAS,3815108,2.6795391503759607
EJM,5328940,0.8607847045793436
GOS-3,135440466,3.2261535122506295
NU-DHL-1,2842253,5.839459621103588
SKM-1,10184653,1.0746342455202622
MM1.S,135440466,-0.9043223941603596
PaTu 8988s,322968,4.793369541663368
JIMT-1,9936388,-4.798396731889527
SNU-1033,5351362,1.310104845288504
KMS-27,104842,-6.162149674211061
CA46,9967941,3.699441503938977
YH-13,selumetinib-BRD-A02303741 (4-1 mol-mol),4.816369737179264
NU-DHL-1,4917,3.040548897529803
OAW42,5284616,3.26367963425715
BT 330,54143018,0.7587246341312203
NCI-H1395,387447,-2.916256020115362
SK-N-AS,navitoclax-MST-312 (1-1 mol-mol),0.8551111448474544
AU565,2126,4.335330080531479
SW1990,52947716,2.9769085141275338
CA46,11234052,2.4794836109026077
SNU-1272,168312962,-0.3156994107221632
BT 139,9825149,2.03233190699606
SK-N-AS,11494412,-0.8691510414375381
KMS-20,56963564,-0.3718578032159711
NCO2,10074640,-0.7446347989756452
NCI-H2081,25105715,3.7171475325174703
A4/Fukuda,10385095,0.4549399411675465
RERF-LC-Ad2,11234052,5.162064101365275
SEM,11178236,-5.071502076951621
RPMI-7951,6184667,3.432679630495054
ML-1 [Human thyroid carcinoma],11404337,0.3501599152959295
MCAS,168313047,1.9184235102562857
YKG-1,25195348,4.74888442973518
AN3-CA,4788,5.292370025398028
AU565,3038522,2.241670788617941
LCLC-103H,89928392,1.9590606242929205
NU-DHL-1,tanespimycin-gemcitabine (1-1 mol-mol),-5.858735676299637
TE-15,10385095,0.8889950613802687
HSC-4,carboplatin-etoposide (40-17 mol-mol),1.986163410800157
RERF-LC-A1,26596,-2.038549310603685
NCI-H1092,71304818,2.0604821765755497
KMS-27,49766530,0.6819698946698491
KMS-27,9911463,4.115013696687494
SW1573,JQ-1-carboplatin (1-1 mol-mol),2.7673375122522
KMBC-2,crizotinib-PLX-4032 (2-1 mol-mol),2.655410383048939
SNU-8,5566,3.274394982179717
YH-13,11364421,-5.428256768560988
HEC-151,24753719,4.229390718265724
RERF-LC-Ad1,71304818,3.4677724486162753
Hs 683,984333,1.5070108576246644
KMBC-2,11257553,1.2264195419995223
BT 320,9911463,3.706038906545982
SKM-1,168313016,3.949913306453134
H-STS,11719255,3.4202837995113025
SNU-1033,sirolimus-bortezomib (250-1 mol-mol),0.349990621506149
EJM,54619267,3.875367584336116
RPMI-7951,9825149,2.2495460787888866
KMS-27,156414,1.1434862066422389
OAW28,23582824,0.6142488529896691
HARA [Human squamous cell lung carcinoma],5746,1.191361240850758
EJM,16065773,1.9015047473462103
SNU-1214,53232,1.694141933876363
SNU-1272,erlotinib-PLX-4032 (2-1 mol-mol),3.2570907164419025
NU-DHL-1,4378219,5.179201062544345
ESS-1,11238147,2.0354593401256382
NCI-H1395,445643,4.969337372862375
BFTC-909,3552672,4.498195948808332
KYSE-70,53392493,3.454381994737171
SNU-8,51039095,3.4477657093502465
OAW28,navitoclax-PLX-4032 (1-1 mol-mol),0.8085168342151391
A4/Fukuda,4261,-0.9007526332595048
SET-2,64971,2.616449956920726
NCO2,44489367,3.401256271865541
KMS-27,322968,2.986092739223029
SW1990,46843906,3.690159048824788
A4/Fukuda,5394,2.6676913787283305
BT 328,24771867,5.867133384354764
SK-LMS-1,19582717,4.843506763590673
PE/CA-PJ34 (clone C12),6450551,2.8483436332661873
Ku812,10090485,4.033633081547376
Aska-SS,vorinostat-navitoclax (4-1 mol-mol),1.1942225208294903
HEC-151,vorinostat-carboplatin (1-1 mol-mol),3.4535763483208313
NCI-H2081,65064,5.195192489742978
SNU-1214,11178236,-3.3009861540973024
HEC-151,tretinoin-navitoclax (4-1 mol-mol),3.939553362858351
LoVo,51039095,1.8047028032602028
BT 248,7251185,2.921625124470224
YKG-1,erlotinib-PLX-4032 (2-1 mol-mol),4.830623769808739
PE/CA-PJ49,676352,1.6277548184976196
BT 504,24901704,2.3964418000494043
Raji,168313200,3.851087858415495
SK-LMS-1,9840324,5.765370049448171
HARA [Human squamous cell lung carcinoma],49867926,4.231294833351195
NCI-N87,151289,0.0450530603050232
NCI-H1395,11152667,2.8212920431399597
HEC-151,2742550,3.8773994743488966
BT 248,82146,3.895792146901818
KMBC-2,9803433,4.330600463833804
PE/CA-PJ34 (clone C12),6610355,3.907121985476104
Aska-SS,15983966,-2.33945991717623
MM1.S,44137675,2.286622980046456
SW1990,6852167,2.6280721153803843
AU565,54649381,3.996593912741648
HEC-151,3136844,3.785721585050869
SNU-1033,176870,5.499937944877444
EJM,selumetinib-PLX-4032 (8-1 mol-mol),4.757753624463101
MM1.S,107970,1.483055719195773
D283 Med,984333,-2.902754645088125
NU-DHL-1,1242560,3.5143861800076652
OAW42,54765302,4.056507379582033
NCI-H1395,3062316,3.8693774304021433
OAW42,2746,4.654777781524689
SW1573,11626560,2.096503053081923
NCI-H1092,9927531,3.406213307022425
LNCaP clone FGC,46191454,1.9215643093708543
BT 248,11238147,1.7431248737974965
LNCaP clone FGC,10231331,4.305884734347832
Aska-SS,doxorubicin-navitoclax (2-1 mol-mol),-1.3212983963393323
NCI-H1092,445091,4.147919416996549
SW1573,6610355,4.129027118562099
LNCaP clone FGC,126941,-2.139687278750632
BT 330,3025944,4.419674295508754
SKM-1,9908783,4.725135976054751
OAW42,selumetinib-BRD-A02303741 (4-1 mol-mol),5.088300967854449
WM983B,3689413,0.8501817874784955
TE-15,11228183,3.3640474187882576
BT 248,1641662,4.808188715890419
NCI-H2110,10127622,4.572029064946556
SET-2,66577038,2.976908237906438
RPMI-7951,24748573,2.4053931326402114
EJM,alisertib-navitoclax (2-1 mol-mol),1.7794919006305252
MM1.S,439501,-1.8322200924082088
PE/CA-PJ34 (clone C12),148198,-4.8428586798807265
A4/Fukuda,erlotinib-PLX-4032 (2-1 mol-mol),1.6869811830916113
ESS-1,16720766,-0.0466822400972705
SW1573,135875424,1.8143158468632437
KYSE-410,44185566,2.6133836189946344
KMS-20,2729026,2.385777395539285
CA46,3854666,0.2733202158609283
BT 330,444795,4.463557334125424
YH-13,44632017,0.8741642499289622
AN3-CA,11977753,-5.169213467666737
KMS-20,24856436,0.4598512604017683
SNU-308,11612883,3.4519110604801875
HuT 78,107985,-4.626222476681204
KP-4,23939,4.432143014879169
TE 617.T,10410894,2.186198503761745
KMRC-2,JQ-1-UNC0638 (2-1 mol-mol),2.613983630437413
YKG-1,salermide-PLX-4032 (12-1 mol-mol),5.716825477266549
Ku812,23725625,3.808154058237452
RERF-LC-A1,2949965,7.477625899094037
HuT 78,44589607,1.1336903613451157
PE/CA-PJ49,15547703,3.0197989993314134
NCI-N87,1750826,1.3506728687975464
CML-T1,11626560,-0.8907703496754931
KMBC-2,387447,-4.640187394922598
YKG-1,46901937,4.239285052925771
BT 139,135421197,2.718205377140928
A4/Fukuda,439501,-3.252400391503616
RERF-LC-Ad2,3634881,3.586750457602715
KYSE-410,selumetinib-UNC0638 (4-1 mol-mol),4.750862854057562
YKG-1,1641662,3.864636587440989
HARA [Human squamous cell lung carcinoma],5280436,4.238746998760762
KMS-27,11364421,-5.15529881457266
NCI-H1395,44491742,3.9607165302769514
ML-1 [Human thyroid carcinoma],57519531,1.467564757525082
PE/CA-PJ49,3465537,2.6771043941056254
AU565,5738263,3.0246848768630334
HuT 78,119182,-0.4026937660621582
PE/CA-PJ49,60700,-1.538607521999755
RERF-LC-A1,168312962,-2.604578699041298
MM1.S,1566236,0.950221343647725
SW1990,navitoclax-PLX-4032 (1-1 mol-mol),2.9594946441932573
GOS-3,3634881,3.062788872748443
NCO2,24964624,1.3788616759554884
PE/CA-PJ34 (clone C12),10113978,3.852320224098887
H-STS,448949,1.6135505463804922
HuT 78,decitabine-carboplatin (1-1 mol-mol),2.461978095459001
TE-15,9915743,-3.4156269103241605
YKG-1,71680916,5.750185341340424
A4/Fukuda,5287969,-2.571307610380136
AN3-CA,11626560,1.578975476242315
OAW28,11427553,3.602344276440211
SEM,24785538,0.2976290069751733
KP-4,57330099,3.669199751412474
TE 617.T,2945648,2.283999025187704
LoVo,42642645,0.0146125142547242
BT 328,24821094,3.7290564258342904
PaTu 8988s,navitoclax-piperlongumine (1-1 mol-mol),1.0029380137486594
MM1.S,25022340,4.192040904321215
YKG-1,6917907,-5.4818958682637975
NCI-N87,1641662,2.907963520285112
GOS-3,11175137,2.721300894926601
AN3-CA,71751553,3.9967289000483097
Hep-G2,753704,5.097151878686146
SEM,73707438,3.837123399224833
PaTu 8988s,navitoclax-pluripotin (1-1 mol-mol),-0.4799885460891017
BT 139,3062316,2.4169193568594474
SNU-1033,57519531,1.8795255827777344
NCI-H2110,4096211,1.8204932319862264
PE/CA-PJ34 (clone C12),400769,-0.7071092107255599
AU565,53495165,0.1395352595616783
Kasumi-2,selumetinib-decitabine (4-1 mol-mol),-0.5593050771503721
HSC-4,JQ-1-vorinostat (2-1 mol-mol),2.1995872566354864
GOS-3,613753,3.227220710192061
OAW42,2729026,3.0822890019462417
HCC2218,89928392,0.2292477103613163
NCI-N87,navitoclax-piperlongumine (1-1 mol-mol),-1.185093256857405
BFTC-909,9826308,0.9467806471528852
PaTu 8988s,11707110,-3.690877241312631
KMBC-2,3854666,3.5091352093149455
NCO2,176870,1.6259157805054876
SW1573,JQ-1-navitoclax (2-1 mol-mol),0.4708104580132937
SW1990,selumetinib-tretinoin (2-1 mol-mol),2.9707045736448707
RERF-LC-Ad2,5278396,3.853839058521952
SW1573,ISOX-bortezomib (250-1 mol-mol),0.8486273919193054
HARA [Human squamous cell lung carcinoma],carboplatin-UNC0638 (2-1 mol-mol),4.127490867447662
SW1990,carboplatin-etoposide (40-17 mol-mol),2.808160331584739
CA46,6918878,-0.7300256707111569
OAW28,4261,1.5275003221448853
RERF-LC-A1,24889392,4.23342618690457
SNU-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1167274542532347
AN3-CA,285033,-3.4589248343725503
Kasumi-2,11626560,0.3916500490858549
JIMT-1,11404337,1.30553025443882
D283 Med,71466380,4.234415328805577
LCLC-103H,navitoclax-gemcitabine (1-1 mol-mol),0.606968382197065
SKM-1,JQ-1-carboplatin (1-1 mol-mol),-0.9064446956996236
AN3-CA,2733487,6.345501913037738
RPMI-7951,6852167,2.0077345898162675
TE 617.T,9908783,5.790109793451864
Aska-SS,46224516,1.5509268521183468
NCI-H2172,216345,4.0137667402470525
NCI-N87,4788,6.175336883845895
KYSE-410,25195348,2.1737007538182973
OAW28,54618164,4.207465894202405
SW1990,4917,3.708163725655013
MCAS,JQ-1-navitoclax (2-1 mol-mol),0.8322559592301813
NCI-H1395,9911830,2.6279117929683142
PaTu 8988s,9911463,3.6809927178566855
KP-4,2113511,4.734439041389162
HSC-4,docetaxel-tanespimycin (2-1 mol-mol),1.367923691324148
IST-Mes1,44487872,4.402175961022997
HEC-151,46398810,2.8206847831158166
SET-2,JQ-1-MK-0752 (1-1 mol-mol),-1.2343828589073973
KP-4,5280436,3.7994826485786786
HuT 78,11364421,-5.802708456365859
Kasumi-2,55508,1.5459922299360274
A4/Fukuda,73707398,-0.4328093310020208
OAW42,135659046,3.5713429692189447
Hep-G2,4259181,-1.079856384384839
D283 Med,11719255,2.806098134518819
SET-2,4378219,5.019702964288066
RPMI-7951,135398516,2.029284125204852
MCAS,9907093,4.1861639948310785
PE/CA-PJ49,56946209,-4.669932218396141
RERF-LC-A1,6852167,3.5109914497052928
SNU-1272,salermide-PLX-4032 (12-1 mol-mol),6.075030129905205
HCC2218,11612883,3.5699235112121466
Kasumi-2,6610355,3.4850778191475342
RERF-LC-Ad1,65064,3.2062738089199176
NCI-H2081,10427712,3.8865371884271265
SNU-308,11485656,2.7823829895443657
SK-LMS-1,navitoclax-piperlongumine (1-1 mol-mol),0.9730805006136548
HuT 78,3385,4.463035201043826
TE 617.T,3689413,-0.0312016851133043
HMCB,selumetinib-PLX-4032 (8-1 mol-mol),4.020315220819304
LoVo,tretinoin-carboplatin (2-1 mol-mol),5.63935886980119
YH-13,53495165,2.0012799986886822
CML-T1,15983966,-4.817800919639036
SNU-1033,135411,1.2023812389363322
KP-4,72193870,3.911224578217445
Raji,227681,3.8191821490012807
BT 328,25154868,6.16063190444204
HMCB,44202524,1.5502685423041775
ML-1 [Human thyroid carcinoma],11964036,2.920411614995081
TE-15,4521392,6.17609826401505
GOS-3,4917,3.642810744950485
CML-T1,12003241,-4.650247315633356
NCI-H2081,46843906,1.767144018608114
Ku812,SNX-2112-bortezomib (250-1 mol-mol),-3.5302001962831846
Raji,9911463,2.729188500459454
Kasumi-2,24772860,-3.0702303943568197
SK-LMS-1,3854666,1.8023710888832385
CML-T1,73707398,-0.0310412376393591
PaTu 8988s,3634881,3.6338790992057417
AU565,135421197,1.4743648854968991
BT 330,208908,1.7217981038647123
BT 328,9868037,5.326885818831123
BT 248,16725315,3.27587483179283
H-STS,285033,-3.6704179985350183
JIMT-1,sirolimus-bortezomib (250-1 mol-mol),1.70536390931118
SW1573,25150857,3.3863948467965717
SNU-1214,44589607,1.2011539365154311
PE/CA-PJ49,3025944,4.226348773499964
ESS-1,46224516,3.2167819229259447
SET-2,JQ-1-UNC0638 (2-1 mol-mol),-1.9472372996283749
ESS-1,24180125,3.331979674522133
LoVo,53495165,-1.2075385636979648
CA46,9903786,1.650432742323398
PE/CA-PJ49,3689413,1.6027869787622069
ESS-1,tretinoin-navitoclax (4-1 mol-mol),5.435469154170702
PE/CA-PJ49,44493528,4.271726954290608
TE-15,25183872,-0.3952031615517913
NU-DHL-1,12003241,-2.4677988287748915
SNU-1214,89928392,0.5360423871118476
MM1.S,11507802,1.0778344524637908
Hep-G2,2858523,3.0476821102731977
TE-15,4096211,1.1922951600653937
NCI-H1395,3825829,4.5765318321652355
HEC-151,9915743,1.4580340601681427
NCI-H1092,135875424,3.039549904779009
KP-4,11238147,2.558252022651666
BFTC-909,25105715,3.3944682152224455
MCAS,5746,2.7138823307916335
KMS-27,637858,1.2889744461011985
RPMI-7951,salermide-PLX-4032 (12-1 mol-mol),5.001935410427482
ESS-1,9825149,3.69415886776762
NCI-H1395,241158,4.2689573120798165
EJM,23635314,-4.518162794650304
MCAS,5282054,3.321833855503111
WM983B,1641662,3.674232548473646
MCAS,2841722,3.7905480145249064
YH-13,24180719,3.7478543768890136
SNU-1033,11427553,3.174584917196522
LNCaP clone FGC,11455910,0.1396389722474823
NCI-H2081,44202524,1.210790184755557
Kasumi-2,44607530,0.8991199704837235
HMCB,navitoclax-pluripotin (1-1 mol-mol),-1.6437751572745434
Aska-SS,navitoclax-sorafenib (1-1 mol-mol),3.529033353230181
HEC-151,168313047,2.403687455264255
WM983B,16722836,2.1015537437120693
TE 617.T,9952709,5.0574728387335695
NU-DHL-1,selumetinib-MK-2206 (8-1 mol-mol),-0.0840641688117376
PE/CA-PJ49,4259181,0.0577258955195342
SEM,navitoclax-piperlongumine (1-1 mol-mol),-2.550226748715502
OAW42,448949,1.9056903149681816
SNU-1272,60700,2.5786985411143797
HuT 78,5746,-1.2054540829216351
HSC-4,25105715,3.6888708464756337
OAW42,54454,3.32393353634426
SNU-308,docetaxel-tanespimycin (2-1 mol-mol),-2.0146386685461692
KYSE-410,11964036,1.1280393858063724
HuT 78,11404337,-1.1966282759274738
PE/CA-PJ34 (clone C12),3385,1.9835594525471536
IST-Mes1,5329102,1.6787488330100182
NCI-H2110,54619267,3.929199476042736
SK-N-AS,11228183,3.2960711507409757
BT 328,227681,3.8990040378810544
SEM,53232,2.5377599613466746
BT 139,6917907,3.169492285726481
BT 139,11640390,3.588853002664297
RPMI-7951,2749,2.4234285226525145
SNU-308,5328940,1.5292174648752217
SW1990,16659841,3.7468858961477833
RERF-LC-Ad1,969516,3.975761175318136
LoVo,3689413,-0.0015328635235731
RERF-LC-Ad2,24180719,5.168983190689386
BT 248,17755052,0.6696435234843453
PaTu 8988s,3689413,2.020164099747706
HSC-4,25126798,3.2488654911973196
SK-LMS-1,10184653,2.639504364404616
ML-1 [Human thyroid carcinoma],tretinoin-navitoclax (4-1 mol-mol),3.335416129341979
KMS-20,71680916,4.434197723022785
D283 Med,54613361,-0.9633976035183264
HMCB,6918638,0.939566819440244
LNCaP clone FGC,5113032,4.377625008137422
AN3-CA,9915743,2.510213815091878
MM1.S,selumetinib-piperlongumine (8-1 mol-mol),2.4141492547305243
MCAS,3503,2.6496028272402756
RERF-LC-Ad1,11427553,3.528122025886616
NCI-H2110,piperlongumine-MST-312 (1-1 mol-mol),1.820600105428923
KMS-20,ISOX-bortezomib (250-1 mol-mol),0.1513994172758227
NU-DHL-1,9444,2.485842478800355
AN3-CA,4917,3.684782782332227
Raji,4477,0.6174679534102655
KMRC-2,2708,5.508421118967876
OAW42,44589607,3.2641108101481264
Hs 683,613000,2.527426456384047
SNU-1033,24771867,4.258069767516097
SK-N-AS,6252,1.7527488786639895
NU-DHL-1,67291369,-1.3620718957318685
Ku812,2749,1.0031884353437008
HEC-151,3025944,3.722964755387822
EJM,387447,-5.475320927013608
YH-13,462382,1.032048022649818
ESS-1,44185566,3.0308522030936667
AU565,9868037,3.1053436778875843
Hep-G2,5566,2.9766368191633545
SK-LMS-1,9887053,6.082946871961119
SK-MEL-1,5311,2.037950973546363
YH-13,11175137,1.3907833057777284
SK-LMS-1,decitabine-navitoclax (2-1 mol-mol),1.4771354794174532
MM1.S,3384730,0.9083087021644016
A4/Fukuda,151289,0.1986917338936865
SW1573,54686904,4.039437320121271
D283 Med,6438330,1.0407570094657193
HSC-4,56946209,-4.10163917558625
MM1.S,5566,3.0863542301618905
PE/CA-PJ34 (clone C12),selumetinib-JQ-1 (4-1 mol-mol),1.4884609912866928
SNU-1214,68056272,3.695101742442541
Kasumi-2,3543504,3.4583921680412413
GOS-3,219104,4.122096403169316
LNCaP clone FGC,6252,0.2782127642477334
PaTu 8988s,3384730,2.8335076266627386
NCI-N87,25183872,-2.1426120555107824
WM983B,JQ-1-MK-0752 (1-1 mol-mol),1.169425559234138
SK-MEL-1,5281321,-1.7017806730283251
MCAS,26596,-1.466898780296629
ML-1 [Human thyroid carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.479159740244691
LCLC-103H,124202324,2.6387819161311548
SET-2,24772860,-2.44164092451758
TE-15,148124,-8.056509685609365
WM983B,56649450,4.447962564362836
SW1990,11396600,4.084870548965884
Hs 683,25154868,5.327126206185975
A4/Fukuda,24748573,1.3032837048402657
KP-4,56963564,-0.5811650878612864
BT 248,46215462,2.381699206499341
SNU-8,5746,1.6714509344644508
Kasumi-2,54678924,1.0609274738962189
HEC-151,16736978,1.2843209009698278
KYSE-410,navitoclax-piperlongumine (1-1 mol-mol),2.0169443697094636
KMRC-2,sirolimus-bortezomib (250-1 mol-mol),0.567306978247713
WM983B,11612883,1.9867340358751635
Hs 683,55508,3.511539870113758
AU565,72193861,-0.1764123403705666
SEM,3689413,-0.1393923728957227
SK-N-AS,5460769,4.709590087634428
WM983B,2742550,4.170565550824284
KMRC-2,156422,4.661743193371779
Hs 683,5479543,5.525167734586747
HuT 78,46943432,0.3707901357093127
BT 328,400769,0.7243238216549931
BT 328,2949965,3.033023429372895
Hep-G2,42642645,0.7845833845237471
HARA [Human squamous cell lung carcinoma],5284616,3.060508834181737
ML-1 [Human thyroid carcinoma],25105715,3.821272786179671
NCI-H2110,46191454,1.7891309559503268
PE/CA-PJ34 (clone C12),176870,0.680065557462293
ML-1 [Human thyroid carcinoma],12003241,-1.866080903179476
KYSE-410,3854666,3.296773212929304
H-STS,168313200,3.688822033835753
KMS-20,BRD-K55473186,1.619659945853516
KYSE-70,44507138,1.8487883665285316
CML-T1,navitoclax-PLX-4032 (1-1 mol-mol),0.956704604832818
BFTC-909,31703,-0.9928331583982526
NCI-H2081,tanespimycin-bortezomib (250-1 mol-mol),0.018908734219335
SET-2,1716436,3.333075721211582
JIMT-1,3815108,3.508389548977638
BT 328,6610216,4.43822058219873
OE21,72193861,0.4570614689766386
OE21,5460769,0.0529032243874579
Kasumi-2,2945648,2.1908336830751436
YH-13,60700,1.6423447574414731
EJM,448949,1.6009250790915848
NCI-H2172,53392493,3.6625539807261656
Kasumi-2,219104,1.7742372806275355
LNCaP clone FGC,219104,4.612823227672206
HMCB,17755052,3.106416097908083
RERF-LC-A1,54143018,-0.6083580858468217
MM1.S,54639665,4.38877596087519
HCC2218,selumetinib-JQ-1 (4-1 mol-mol),1.4456076234612698
HMCB,24180125,3.3063760805557054
HEC-151,25150857,3.554215072236958
SET-2,selumetinib-tretinoin (2-1 mol-mol),3.45699617229081
KYSE-70,46224516,2.993089177283032
NCI-H2081,49793307,-4.448015018456752
MM1.S,tanespimycin-bortezomib (250-1 mol-mol),-0.3747840615026737
RERF-LC-A1,JQ-1-vorinostat (2-1 mol-mol),0.6134375826321787
ESS-1,11609586,3.461790355650639
TE 617.T,5328940,-0.5240714161974301
BT 504,11175137,2.4952996861177508
KP-4,5460769,4.107177099702386
KP-4,selumetinib-UNC0638 (4-1 mol-mol),5.20699540536324
SK-N-AS,16736978,1.7920660559776262
SNU-1272,17755052,3.726908872062008
HEC-151,2949965,3.303774381727868
SNU-8,15547703,3.2095801021704142
SNU-308,6914657,-1.649213598148654
MM1.S,51039095,1.544841271457304
IST-Mes1,44632017,4.619480314320218
SET-2,2130404,3.5383555094173667
CA46,54618771,1.203400154931592
TE 617.T,selumetinib-BRD-A02303741 (4-1 mol-mol),2.6480104459269596
Kasumi-2,375860,-0.7090394918812726
ML-1 [Human thyroid carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.142388159439524
MM1.S,11719255,2.0947187008170887
KYSE-410,5470400,-1.5495007517242574
ESS-1,10127622,5.583352628786162
HCC2218,24753719,4.203747077764167
NCI-N87,17759555,3.435080423112301
EJM,11222830,0.9008763267177864
TE-15,151289,-0.165043524143007
NCI-H1395,49793307,-1.2890393548834251
SEM,439501,-3.163159816591066
BT 139,3025986,0.2416849794736328
SEM,46215462,-0.5146100993456324
SK-N-AS,10184653,1.285298473339946
TE 617.T,doxorubicin-navitoclax (2-1 mol-mol),-3.986680952457477
WM983B,5287969,-2.0370853224743413
GOS-3,4578,4.471088168951713
KYSE-70,702558,6.39879445367054
CML-T1,11485656,1.9899616795432975
RPMI-7951,72376,-2.0795055355089533
LoVo,107970,2.0597080136849795
KMRC-2,16065773,3.0434544081000636
NCI-H2172,10074640,3.3243553400842516
KMS-27,6918736,-2.259439743632793
HuT 78,156414,0.7736660521630903
BT 330,44566777,0.3914033592885553
BT 330,16725315,3.2640281321348783
Ku812,71466578,3.661514598735973
KP-4,89928392,1.096858092986786
HSC-4,54143018,5.46718478704898
SNU-8,navitoclax-gemcitabine (1-1 mol-mol),1.4326989909967949
SK-N-AS,3854666,0.6008769130221079
BT 139,12001922,1.0025758835184926
BFTC-909,168312962,2.436518653578315
NU-DHL-1,60750,-6.327200330067859
KP-4,2841722,2.399493182490819
A4/Fukuda,16725315,3.095723533871789
SK-LMS-1,9823820,5.654385345746234
SK-MEL-1,6438330,2.85630766530856
OAW28,6917907,-5.603755883192341
BT 139,44566777,1.379304994580189
NCI-H2081,24821094,3.1641844707183417
HEC-151,9926054,1.821769205783168
NCI-H2172,2749,1.995653963491108
OE21,42642645,1.345400530545778
D283 Med,445091,3.8628212220629825
BT 504,44632017,1.730984939732506
AN3-CA,445091,5.023008436415508
TE-15,52912189,0.9769039830004704
SNU-308,654092,2.765487663234044
NCI-H2110,tanespimycin-bortezomib (250-1 mol-mol),-2.8330652513678274
SK-N-AS,148198,-4.149694989731526
YKG-1,241158,4.094206621053088
SK-N-AS,10410894,3.5286486855235504
GOS-3,241158,4.584939515140501
A4/Fukuda,selumetinib-navitoclax (8-1 mol-mol),1.1983954877584069
NU-DHL-1,89183176,4.0895744389875155
PE/CA-PJ34 (clone C12),52912189,3.061596603136192
NU-DHL-1,9926054,1.5745053582273782
NCI-H2110,selumetinib-MK-2206 (8-1 mol-mol),2.3924644817565683
EJM,10427712,3.7734158708408585
RERF-LC-Ad2,31703,1.0316481375838702
SNU-1214,44185566,1.1140589812850028
BT 328,5113032,4.3388133731022585
SEM,5460769,-1.0690415880949575
Raji,9903786,2.8365362494251394
YKG-1,5978,-2.4789766194906857
KYSE-410,42642645,0.880387648201634
KMBC-2,selumetinib-navitoclax (8-1 mol-mol),0.2839639839398448
LCLC-103H,9840324,5.368657773739392
A4/Fukuda,46926350,-6.021657358635238
Hep-G2,11214940,1.620296702627768
NCI-N87,44202524,1.5092428544055756
KMS-27,702558,4.517511178766302
SEM,decitabine-carboplatin (1-1 mol-mol),-2.5558539092772947
OAW42,navitoclax-MST-312 (1-1 mol-mol),1.0920538846491972
ESS-1,3038522,2.815775388267638
NCI-H1395,1242560,3.324194967981579
RPMI-7951,selumetinib-BRD-A02303741 (4-1 mol-mol),5.015404158676352
MM1.S,2746,1.322857724988492
SET-2,7251185,1.3721361326487145
Aska-SS,42642645,-6.050659008742591
Hs 683,3825829,4.070799794805118
NCI-H2110,16725315,5.265709205943982
SET-2,374536,-5.775259114630841
RERF-LC-Ad2,11427553,3.2032799731483355
YKG-1,11625818,4.5202694072392715
BT 328,327653,3.5942697932581344
KYSE-410,375860,0.3539761529169563
SET-2,4788,5.639545717723676
AU565,135659046,3.967998335471068
SET-2,ISOX-bortezomib (250-1 mol-mol),-0.1710867295006007
BT 328,3552672,2.1088972193148146
PaTu 8988s,24180125,3.4136901052211246
KMRC-2,135928012,3.7345117496586937
BT 320,6184667,3.5325258636094934
OAW28,16659841,4.936500838241895
KMBC-2,3062316,2.6254409075794793
LNCaP clone FGC,322968,4.5137290252550955
RPMI-7951,19582717,3.949815378259687
KYSE-70,73707398,2.029692143461395
HEC-151,241158,3.682505125351082
KMS-20,2874250,3.851287435238237
LoVo,selumetinib-MK-2206 (8-1 mol-mol),-1.1472378913456864
SNU-8,10427712,5.587961063746706
Ku812,5566,2.0197817582135604
SW1573,71466380,3.629171273590213
KMRC-2,navitoclax-piperlongumine (1-1 mol-mol),1.2623504539336696
SK-LMS-1,selumetinib-piperlongumine (8-1 mol-mol),4.535111432562131
PE/CA-PJ34 (clone C12),JQ-1-vorinostat (2-1 mol-mol),0.3742706792458093
SK-MEL-1,2708,4.852230966340039
KMRC-2,46199207,3.1948404300914555
SNU-308,12003241,0.0879961923245038
BT 248,54649381,3.7327878949357394
RPMI-7951,49766530,-2.0352614049405178
Hs 683,375860,-0.6026673211862823
Hs 683,6610216,4.167851340670154
KP-4,navitoclax-gemcitabine (1-1 mol-mol),-2.777259584730698
HARA [Human squamous cell lung carcinoma],11612883,2.0711773248440783
CML-T1,51037431,4.458839280310569
BT 504,9935249,2.8901634129680764
PE/CA-PJ34 (clone C12),11964036,1.19521304461458
BT 504,vorinostat-navitoclax (4-1 mol-mol),1.358887592192882
HSC-4,72199292,2.0552941548988506
OE21,11485656,1.707456262972337
ML-1 [Human thyroid carcinoma],2828334,6.601742138030732
MM1.S,4521392,4.203260754264018
KMS-27,6852167,1.4833276189220757
IST-Mes1,44589607,3.0309009389458605
Kasumi-2,11214940,0.2886545067447796
EJM,selumetinib-BRD-A02303741 (4-1 mol-mol),6.6447092258899625
Raji,135398738,3.1562560071283907
RERF-LC-A1,676352,2.0906265244368956
SNU-8,12001922,1.7857478253759511
CML-T1,5335621,4.035243944386916
CA46,5287969,-2.5448622649608925
NCI-H2081,25102847,1.5133964528442754
AN3-CA,984333,-0.6376607681335268
HCC2218,119182,3.4186020256947076
SK-MEL-1,17759555,4.406764563323516
RERF-LC-A1,5287620,-1.5841390454828197
Hs 683,5280436,2.3398809988130287
NCI-H1395,4259181,1.90835331362123
NCI-H1395,6918328,1.6549046673815768
OAW28,613753,3.2856198284724742
OAW28,selumetinib-BRD-A02303741 (4-1 mol-mol),5.828946434943108
BT 330,11364421,1.7373568839489189
SK-MEL-1,3062316,2.9119536784711637
YKG-1,9915743,1.478165176900873
SET-2,2749,1.5247234859739272
RERF-LC-A1,9803433,4.557254310183544
KMBC-2,11167602,2.9141077523233587
HARA [Human squamous cell lung carcinoma],613753,4.606319217012033
JIMT-1,54143018,0.1029225337722703
NU-DHL-1,445091,4.453700475457089
BT 139,44185566,2.413248885611864
BT 139,1566236,2.5894214641501345
HSC-4,navitoclax-sorafenib (1-1 mol-mol),2.0260640638250154
KP-4,123631,2.9884823994831495
RERF-LC-Ad2,637858,1.7897797033938452
PE/CA-PJ49,tanespimycin-gemcitabine (1-1 mol-mol),-1.6818636747930154
NCI-H2110,100016,6.079052375839209
MCAS,3025986,-1.0760873319224546
YH-13,6438330,2.6622356468059736
PE/CA-PJ49,2733526,4.226770868795057
A4/Fukuda,1242560,1.4412010240031818
SET-2,15953870,2.8793590754908926
WM983B,25154868,5.383221298988513
KMS-27,9952709,2.9518413251695477
SK-LMS-1,9926054,2.9005897081408833
HARA [Human squamous cell lung carcinoma],54619238,4.4726064543510144
SNU-1033,11455910,1.238389627301748
EJM,675434,4.21924619538193
Hs 683,9903786,4.056971165383086
SNU-308,9907093,4.131451183681241
CML-T1,72734382,3.1811123479261276
MCAS,24821094,3.5818395784670076
BFTC-909,11656518,3.71751997684089
EJM,5282054,2.6284954887881784
TE-15,9907093,4.113523246440704
Kasumi-2,5494449,-3.67008601278043
KP-4,9952709,2.7166093245907916
JIMT-1,159324,3.5615073929278016
RERF-LC-Ad2,24785538,2.4672547589811797
AN3-CA,5291,4.063376464775615
JIMT-1,73707398,1.677314809441859
LNCaP clone FGC,46943432,1.061880867154241
LoVo,24180719,2.381979820549913
BT 248,6918638,2.3802175448525844
HCC2218,44462760,4.0308527913259615
SK-LMS-1,445455,4.838165389930102
CML-T1,25105715,2.3891517916986684
Kasumi-2,148124,-6.270957848916609
HuT 78,24901704,-0.7514069981488459
OE21,445455,6.0645568713235845
PE/CA-PJ34 (clone C12),11640390,3.424218782856885
KP-4,11178236,-5.8451036129411325
SW1990,49793307,-5.12969398647881
MM1.S,23635314,-2.389508847734426
TE 617.T,24978538,3.3206422008385403
MM1.S,6852167,1.3787685421812157
SW1990,285033,-1.268748448673105
KYSE-70,4259181,-4.187670573846372
NCI-H1092,57519531,1.6858418046030903
HMCB,11625818,4.609137962647994
NCI-H2110,11625818,4.775751943194114
SK-MEL-1,16115403,-5.265649596913813
KYSE-410,135440466,2.1527835463527834
AU565,67156097,-2.287523284177128
YH-13,11955716,-0.8910132220684513
OAW42,24748573,3.2261098181059893
BT 248,9866186,3.3997152825838515
OE21,409805,3.7550255149690943
MM1.S,16725315,3.2712240196505165
HCC2218,65064,5.398971779575134
NCI-H2081,216239,1.3066578972225331
HCC2218,BRD9876-MK-1775 (4-1 mol-mol),1.4062073847367094
SNU-8,46907787,1.495459042873151
TE 617.T,11707110,-2.0138618331633564
OAW28,20959075,-3.9569108449030295
NU-DHL-1,4521392,3.4601800103971474
PE/CA-PJ34 (clone C12),44491742,3.733326745267952
RERF-LC-Ad2,53495165,-0.0238297802129515
EJM,2871966,-0.3879200189788208
SW1990,9907093,4.562381279872213
BT 328,24964624,2.9431698803975324
TE 617.T,6918837,-4.053611738094944
HCC2218,serdemetan-SCH-529074 (1-1 mol-mol),1.544370866238826
Hep-G2,JQ-1-UNC0638 (2-1 mol-mol),2.605795560708836
RERF-LC-A1,25154868,3.23583749432942
Kasumi-2,5287620,-1.535744105024607
YKG-1,72734382,5.141211314394623
RERF-LC-Ad2,17755052,2.119183120820772
AU565,66577038,2.656766135213886
TE-15,66577038,3.2233581304715053
AN3-CA,7251185,2.1715897853653168
RPMI-7951,25150857,1.9350032965663828
KMS-27,11497983,-3.919978981960082
PE/CA-PJ49,6610216,4.338624993526508
SW1573,9884685,-1.2788581073527363
NCI-H2110,11507802,3.0556812906398862
SK-LMS-1,445091,4.624083252406995
TE-15,71466578,4.537975566322263
BFTC-909,4261,3.835594401773327
SKM-1,5311,0.1549027361916286
ESS-1,6918837,-2.928241796985352
Hep-G2,vorinostat-carboplatin (1-1 mol-mol),2.5677353378270453
SEM,448949,-1.6287077587171075
SNU-1214,3689413,-0.7711373431609502
AN3-CA,11612883,1.455886821903922
H-STS,71466578,4.205777917887045
WM983B,135411,0.5869655766066777
IST-Mes1,9840324,6.735519666210419
KMS-27,9903786,2.0838522642379216
KMRC-2,salermide-PLX-4032 (12-1 mol-mol),6.473934379742123
ML-1 [Human thyroid carcinoma],136227331,5.904689393841422
RERF-LC-A1,selumetinib-vorinostat (8-1 mol-mol),2.1105956202148346
TE 617.T,2871966,-1.7687983505929656
Hep-G2,12001922,1.7010359951064702
H-STS,25102847,2.763833752411945
KMBC-2,24797083,1.4085550881351874
RPMI-7951,navitoclax-birinapant (1-1 mol-mol),1.0939904269343144
KMS-27,3825829,3.2801020801317917
IST-Mes1,10296883,4.238957650390159
PaTu 8988s,JQ-1-vorinostat (2-1 mol-mol),1.1000553998885545
HEC-151,51037431,2.702211818437642
SNU-1214,11222830,1.6691423584498886
BT 330,44589607,2.8465871158327265
Raji,24821094,3.3349426355455445
HMCB,3025944,4.29007552344394
RERF-LC-Ad1,44589607,3.7662280805427097
NCI-H1092,5287620,-3.3437578986524517
Kasumi-2,702558,4.897760229735286
BT 320,285033,5.611549861739741
SNU-1033,24951314,1.0911642280306344
HSC-4,11719255,4.924721636143113
BT 320,4261,3.457041279765096
EJM,72734382,3.5540919183880733
NCI-H1395,16065773,1.699191956744155
LNCaP clone FGC,15983966,-4.386183959225337
OAW42,52912189,4.4995245221274605
SK-N-AS,44491742,3.868464169325176
Hs 683,17755052,1.7713282136584354
NCI-H1395,135398516,2.0913666591316216
HSC-4,73707371,4.771220465805862
KYSE-410,24951314,1.1788192496872791
NCI-N87,44607531,-2.3963447234482196
HARA [Human squamous cell lung carcinoma],387447,-4.146769649621688
BT 330,11427553,2.521211397546692
SNU-8,11152667,-0.943436801192986
YH-13,613753,3.198655088804402
SNU-1214,4917,2.6474992622286555
SK-N-AS,11167602,1.8912366678699168
OAW28,1566236,3.486252592676433
SK-MEL-1,44137675,5.602923992598762
HSC-4,selumetinib-piperlongumine (8-1 mol-mol),4.641326276625381
LNCaP clone FGC,4378219,3.8557648266649704
AU565,4578,4.456552707084199
Kasumi-2,89928392,-0.7212883806223124
AN3-CA,24797083,0.189199244931192
RERF-LC-Ad2,439501,-3.088259445062755
BT 330,45279963,4.220218850689366
KP-4,navitoclax-piperlongumine (1-1 mol-mol),2.3593661555540755
RERF-LC-A1,10385095,0.5926472650541055
SNU-1272,5328940,2.3850434958560407
OAW42,11228183,2.9355720787645057
BT 504,BRD9876-MK-1775 (4-1 mol-mol),0.9055909514770598
SET-2,31703,-1.4005504220650808
CML-T1,navitoclax-gemcitabine (1-1 mol-mol),-3.0033720863451467
BT 330,135659046,3.618868703955065
WM983B,462382,0.9530027177290916
AU565,56963564,-0.3705062094323867
Hep-G2,11964036,2.846173129754555
TE 617.T,2828334,5.85541447916693
AN3-CA,17755052,-0.2934004434039564
Kasumi-2,216345,1.8251746878221435
SNU-8,46199207,3.4322546698168463
HARA [Human squamous cell lung carcinoma],11485656,2.214748392282881
OE21,10322450,4.259055597018236
SNU-1272,16720766,3.764344424348401
HEC-151,452548,0.8844863829622529
BFTC-909,9956119,4.255413767268681
NCI-N87,erlotinib-PLX-4032 (2-1 mol-mol),3.0192784761472
HSC-4,448949,2.25928901468022
KMRC-2,16722836,1.0816974151224032
KP-4,doxorubicin-navitoclax (2-1 mol-mol),-2.0953056375586945
NCI-H2110,selumetinib-JQ-1 (4-1 mol-mol),2.5540188828609907
YH-13,9915743,2.529803461221303
PE/CA-PJ49,9903786,3.1609136015972847
MM1.S,10184653,0.1720840981643339
SET-2,11404337,0.2728842638306079
OAW28,9884685,1.3567472374362477
NU-DHL-1,54618164,4.2613527063162895
HARA [Human squamous cell lung carcinoma],2708,4.268843127757034
Hep-G2,4477,1.6560348387058257
SNU-8,5282054,3.706785624209938
NCI-H2110,44819697,0.5938285996585121
AU565,16722836,1.9939850778221897
NU-DHL-1,10074640,2.3359840831804313
HEC-151,5278396,3.3762180058910936
H-STS,54613361,-0.8413528716163291
MCAS,selumetinib-tretinoin (2-1 mol-mol),3.7245773647682503
TE 617.T,5281321,-3.562368647699087
SKM-1,44607530,1.4032430904738862
SK-MEL-1,11717001,1.315563822700652
NCI-H1092,9884685,5.208907292159036
OE21,613753,3.266280413729653
GOS-3,9866186,0.992376150226647
SEM,4477,0.916929513987914
AU565,7251185,1.9736319172199277
SNU-1272,5566,3.0890958358012064
NCO2,46174525,2.052815233985192
LoVo,23635314,-2.3980395881052723
SKM-1,5282054,2.595149696397153
AN3-CA,4578,4.32429882400022
Aska-SS,227681,3.9388192472577175
KMS-27,salermide-PLX-4032 (12-1 mol-mol),5.559658617499442
A4/Fukuda,4917,1.915641979161103
Ku812,2858523,2.0099200401333563
CA46,tanespimycin-bortezomib (250-1 mol-mol),0.4718837425399894
SNU-8,selumetinib-BRD-A02303741 (4-1 mol-mol),1.2329010527569984
KP-4,54618164,4.199260962007676
NCI-N87,11455910,1.6652699053284308
NU-DHL-1,285033,-4.05787074586027
AU565,15953870,2.093538779145719
SEM,2729026,1.911580026509944
Kasumi-2,carboplatin-etoposide (40-17 mol-mol),0.2542153417603036
CA46,46907787,-0.8110179268567884
YH-13,10427712,4.6201171639095815
OAW28,10385095,1.310156197215646
Kasumi-2,2126,3.96137914347523
SNU-8,107985,-2.480678817312735
NCI-N87,46398810,2.1002609832839187
BT 320,9933475,3.009143992406663
TE-15,441298,4.343362120875242
HEC-151,10296883,3.675956149700743
HCC2218,selumetinib-GDC-0941 (4-1 mol-mol),1.5702207772151422
MM1.S,11234052,4.653102386091589
NCI-H2172,23725625,6.323541290892874
EJM,10127622,6.4367680304352675
SK-LMS-1,5978,-0.7912582712366475
Hep-G2,15983966,-0.5733589489944111
Ku812,3062316,-6.759416676198835
SK-MEL-1,9935249,4.4226392340907825
TE 617.T,5287620,-2.8248047974089188
KYSE-410,5284616,2.743882210150552
BT 139,107985,-2.6737543341342316
Kasumi-2,6918736,-2.315158162333665
MCAS,7326481,2.333692391827008
BT 248,selumetinib-PLX-4032 (8-1 mol-mol),4.4451180166492765
WM983B,9915743,1.863557730328146
SNU-1033,24772860,-2.288475118116987
MCAS,navitoclax-sorafenib (1-1 mol-mol),2.154813083369075
Kasumi-2,2733526,2.6717950038671003
SK-N-AS,46224516,1.0722496615263746
PE/CA-PJ49,navitoclax-MST-312 (1-1 mol-mol),0.8896074539476759
GOS-3,25102847,2.4743602573672585
NU-DHL-1,25183872,-1.6691954521805272
Hs 683,54143018,0.4338864337306197
NCI-H1395,10113978,4.152681883448846
Hs 683,107970,1.9317129294379751
SK-N-AS,71466380,5.120292017236573
ESS-1,56946209,-5.121784419890302
SK-LMS-1,24772860,-1.5940075969157808
Hs 683,60700,-0.414224895156259
PE/CA-PJ34 (clone C12),11152667,0.0112826586729411
KMRC-2,navitoclax-gemcitabine (1-1 mol-mol),0.8388920791058432
SK-MEL-1,216468,3.609544259210637
MM1.S,208908,2.7600413341345225
D283 Med,17755052,0.4087785710021853
NCO2,5282054,2.639964193193559
ESS-1,12001922,2.286773298620945
CML-T1,44202524,1.467740802576286
SK-LMS-1,5329102,2.479505238119822
KP-4,374536,4.362306924413596
A4/Fukuda,9907093,3.513986602103764
BT 330,25262965,1.1831066054977264
KMS-20,3543504,3.2520128843169096
BT 248,44819697,-0.5101915766327456
NCI-N87,navitoclax-sorafenib (1-1 mol-mol),-0.0367825564296656
JIMT-1,25183872,-0.5577930153722346
NCI-N87,15547703,1.070685995489879
CML-T1,11640390,3.08306987111381
NU-DHL-1,56649450,3.732895044014296
SW1990,24821094,3.800095262517989
BT 328,4096211,3.6600455300853154
KMS-27,44241473,4.927559459703403
LoVo,3136844,3.7568853791466608
HARA [Human squamous cell lung carcinoma],56963564,-0.1933628562955875
PaTu 8988s,SNX-2112-bortezomib (250-1 mol-mol),-3.3618432014620323
Ku812,tanespimycin-bortezomib (250-1 mol-mol),-1.4793309547353497
NCI-N87,24856436,-1.0645338149753525
NCI-H2110,9926054,1.839297705521365
Raji,44185566,3.214102845082995
SNU-1272,23725625,5.0585620890398735
OAW28,doxorubicin-navitoclax (2-1 mol-mol),-0.325587572552389
KMRC-2,387447,-4.643727787787694
NCI-N87,11222830,1.733835072175261
BT 248,4477,0.1181412005602309
YH-13,119607,5.844423836114236
H-STS,24964624,0.7611885125245664
TE 617.T,46926350,-4.642766988271582
SKM-1,11612883,1.510436976347248
Kasumi-2,9911463,3.4999156831259524
SET-2,3385,1.651824905688349
ML-1 [Human thyroid carcinoma],56946209,-4.214217670545523
TE 617.T,24951314,1.788416561198006
Hs 683,9915743,1.4986187440690526
Kasumi-2,156414,1.0465549823430256
NCO2,448949,0.0098140231377916
ESS-1,9903786,1.7886366060040666
PE/CA-PJ34 (clone C12),135875424,2.9771289784544934
NCO2,24771867,-1.6535896052577994
PE/CA-PJ49,15953870,3.8672773648321015
KYSE-410,decitabine-navitoclax (2-1 mol-mol),3.6389678139101065
Ku812,445091,4.27375620690436
Kasumi-2,36314,4.106836250050073
BFTC-909,11175137,1.859642091823866
NCI-N87,decitabine-navitoclax (2-1 mol-mol),0.6446345774598216
SET-2,23725625,2.73090348890391
OAW42,135875424,4.816412015133948
TE-15,400769,-0.4103749264039792
AU565,decitabine-navitoclax (2-1 mol-mol),2.1782806047891095
SNU-308,56946209,-3.292515746238392
IST-Mes1,67156097,2.0129233452386095
KMS-27,2858523,2.831836362446579
NCI-N87,piperlongumine-MST-312 (1-1 mol-mol),3.209921452990857
MM1.S,135421197,1.5136201913497214
TE-15,72734382,4.282308713316559
SEM,doxorubicin-navitoclax (2-1 mol-mol),-4.027940922325109
PE/CA-PJ49,246676,4.881777870317724
CA46,51039095,1.651262767418978
NCI-N87,984333,0.3233765721021273
Ku812,9903786,1.763683139425592
SW1990,3634881,3.9244954734122217
SK-LMS-1,1242560,3.3447561280118023
NCO2,24978538,-1.2844980566005673
IST-Mes1,selumetinib-MK-2206 (8-1 mol-mol),3.5229121932796423
KMRC-2,11427553,2.2676638482656313
EJM,219104,2.2100971150413264
AU565,selumetinib-piperlongumine (8-1 mol-mol),3.265854364361565
LoVo,72734382,4.052668353480041
D283 Med,53232,2.450854354928572
BT 504,3503,1.267204792236733
SEM,5284373,0.4038831266174929
HSC-4,122327,4.034102983304833
TE-15,156422,4.158605403638828
HSC-4,2858523,3.1192513569149245
Aska-SS,6914657,-4.988458799040991
MM1.S,9907093,3.622673002337576
HARA [Human squamous cell lung carcinoma],6252,0.9917938801151434
HuT 78,11167602,1.7844027861507523
SET-2,46398810,-1.245906502267527
IST-Mes1,11640390,3.2581579646920966
SEM,24753719,1.9867479465315392
RPMI-7951,637858,1.6619998861158691
WM983B,11497983,5.035391481204261
ESS-1,11222830,1.000273173568511
NU-DHL-1,11238147,1.5129277124969711
LNCaP clone FGC,10410894,3.366093772051826
MCAS,doxorubicin-navitoclax (2-1 mol-mol),-0.4598019759635088
Aska-SS,11640390,3.6750430081547063
LCLC-103H,53232,2.2448412228334456
SNU-1272,46398810,3.303753409066687
KP-4,568763,-0.3138086722411862
HARA [Human squamous cell lung carcinoma],216468,1.0737616041415703
KMS-27,9929138,5.026853283311406
SNU-1214,carboplatin-UNC0638 (2-1 mol-mol),3.0570508968305488
OAW28,1716436,3.318226269910468
KYSE-70,navitoclax-pluripotin (1-1 mol-mol),-0.6013562023885967
NCO2,9903786,1.4505958737560818
MCAS,11485656,2.57416789640687
HuT 78,46907787,-2.3061129610788833
BT 330,6184667,3.969064593085041
BT 330,2742550,3.720607437110895
OE21,9826308,0.6399815117118636
SNU-1033,7251185,1.3816282372442918
BT 328,374536,4.943552861027733
HEC-151,3503,2.00593361013826
SNU-308,3062316,0.6997417325646793
SNU-8,17755052,1.701415000241573
H-STS,6914657,-2.765637177138319
OE21,10296883,3.8232218432120058
OE21,4477,0.4795387541776513
NCI-H1395,67156097,2.84144563210516
OE21,446155,2.477997855575094
KMRC-2,vorinostat-navitoclax (4-1 mol-mol),1.1989801526794588
EJM,24901704,4.248858299645136
NCI-H2110,5978,-7.271449933003033
SNU-1272,216345,4.229036280799805
PE/CA-PJ34 (clone C12),2945648,3.1110047210534533
HMCB,216239,1.7149264696015345
YKG-1,25062766,3.484547068129602
KYSE-410,2126,4.711224213364265
Hs 683,1474550,4.474380523645793
BT 504,25022340,4.710807956608209
KYSE-410,JQ-1-vorinostat (2-1 mol-mol),1.3768131521604037
A4/Fukuda,25227462,-5.883792654516593
TE 617.T,selumetinib-GDC-0941 (4-1 mol-mol),0.2172055936678418
HARA [Human squamous cell lung carcinoma],6438330,2.871193568039211
AN3-CA,navitoclax-piperlongumine (1-1 mol-mol),1.1185900597539058
OAW28,11427553,3.602344276440211
OE21,3025944,4.106709914382062
SK-LMS-1,BRD-A02303741-navitoclax (2-1 mol-mol),2.6053449830229645
SNU-8,9911463,4.350153434001515
NCO2,3689413,-3.837216983883232
BT 320,doxorubicin-navitoclax (2-1 mol-mol),-0.1344051428167206
Ku812,322968,2.754974105795659
ESS-1,11964036,1.685679354186414
EJM,9840324,5.73899517118649
TE 617.T,3038522,1.9677439515706376
AU565,44607530,-0.2063452249558506
RPMI-7951,3854666,0.7955375468414883
ESS-1,9823820,4.0277339286187
SK-LMS-1,676352,1.898915322770777
JIMT-1,241158,4.281994950904064
RPMI-7951,9911830,3.3922230843192778
KYSE-70,176870,5.518340217914711
KP-4,135999136,4.290505195277357
EJM,6918837,-5.817810388992218
SNU-1214,216345,3.6404445587750383
SEM,44489675,3.2608943672828827
JIMT-1,387447,-4.243631847469051
RPMI-7951,54618771,0.8844591471525661
NCI-H2172,5566,3.083299737650171
NCI-H2081,1566236,1.4725524820150873
KMS-20,2949965,1.3339775316337088
HARA [Human squamous cell lung carcinoma],11427553,0.5044011516017802
HSC-4,46907787,5.727789952108257
SNU-1272,2749,1.9740368038979512
YH-13,25183872,-1.6197416035202905
EJM,46191454,0.9178079006601862
SNU-308,15953870,3.462040803535903
BT 328,navitoclax-piperlongumine (1-1 mol-mol),2.639428516957035
ML-1 [Human thyroid carcinoma],66577038,3.490614785347513
KP-4,44185566,2.8136768451579117
LCLC-103H,10385095,1.2650204488740564
MCAS,11626560,1.9624316490643523
Kasumi-2,46224516,1.9043930771708657
SNU-8,24964624,1.488667826326175
SEM,71680916,3.544265140998964
LNCaP clone FGC,salermide-PLX-4032 (12-1 mol-mol),5.148679103489374
KMS-20,10231331,-0.0376220922185321
KMS-20,decitabine-navitoclax (2-1 mol-mol),-0.178300212626614
A4/Fukuda,11494412,-1.359408079628026
NCI-N87,135875424,4.206412745126992
NCI-H2110,12001922,2.34278570300224
BT 248,3634881,2.1213928087500413
NCI-H1092,25105715,3.7576457289964416
BT 248,1714884,3.688077995610216
SK-LMS-1,5460769,5.744937264039862
KMRC-2,123631,3.03467045210905
IST-Mes1,3689413,0.9013533734229402
AU565,54765302,2.5229399839825604
SW1573,navitoclax-gemcitabine (1-1 mol-mol),-2.643981149214972
HARA [Human squamous cell lung carcinoma],54626689,4.600126869473187
OAW28,984333,0.3792215902143511
SK-MEL-1,selumetinib-decitabine (4-1 mol-mol),-0.7956912685815491
KMS-20,15547703,2.6043322601948455
LCLC-103H,6852167,4.45978228332794
SKM-1,23939,4.408683246884893
AU565,4261,1.5351844706992892
PE/CA-PJ49,1641662,3.1027101477617247
SK-MEL-1,219104,3.7840482124187376
NCI-H1092,9933475,2.1569011395664934
BT 248,tretinoin-navitoclax (4-1 mol-mol),2.6015159736685187
HSC-4,vorinostat-carboplatin (1-1 mol-mol),3.405772607796717
KMRC-2,216345,4.240105942298959
HuT 78,ISOX-bortezomib (250-1 mol-mol),-1.0650160762676202
SNU-1033,9933475,1.7587283970069327
Ku812,72734382,3.515851965175783
PaTu 8988s,168313016,4.471656567537183
AU565,9884685,0.3686008824574254
IST-Mes1,44185566,3.025290337876495
SK-LMS-1,6610216,4.4083288999249
NCI-H1395,selumetinib-vorinostat (8-1 mol-mol),2.147255996625455
BT 504,selumetinib-navitoclax (8-1 mol-mol),1.7234809158313482
PE/CA-PJ49,25150857,2.9621771571272246
NU-DHL-1,613753,2.5066251808010716
D283 Med,119607,5.46522088170326
KMS-20,16038120,-1.0263302002463832
SKM-1,tretinoin-carboplatin (2-1 mol-mol),1.0065568323561174
BT 504,5351362,1.101104903920824
HSC-4,11178236,-3.2670379451965164
RPMI-7951,65064,3.1043550872304495
WM983B,11625818,4.91469295226168
TE-15,156414,-3.941980071268382
SEM,5335621,4.131642173212617
PE/CA-PJ49,4578,4.709804967781291
BT 328,71304818,3.21596633578744
KYSE-70,168313047,2.1859183661660624
LoVo,54678924,0.9602640778132784
MM1.S,25262965,-3.9211538227137432
HARA [Human squamous cell lung carcinoma],168312962,2.6720428895447412
SEM,2749,0.1715728235618304
HCC2218,piperlongumine-MST-312 (1-1 mol-mol),1.2280946622585671
HSC-4,44607530,1.7156299328297433
TE-15,24964624,2.6946677854492367
MM1.S,168313047,1.9214959854165885
SK-N-AS,56946209,-4.364195647656684
CML-T1,3503,1.2439697949752524
BT 328,9926054,3.720062864226824
SW1990,71304818,2.4151211840042563
NCI-H1395,53232,3.2747143495441433
SNU-1214,135421197,1.3172671598461234
MM1.S,9936388,-7.097218801181761
PE/CA-PJ49,60750,-3.629491275028382
PE/CA-PJ34 (clone C12),36462,2.153519991196826
SK-LMS-1,73707398,1.7151608604294482
SNU-1214,159324,0.6558856370223802
OAW42,2858523,3.142180630235615
SNU-1214,6852167,3.35319741255355
Aska-SS,9915743,4.6132993472825765
CA46,11222830,0.90552754986452
MCAS,1242560,3.9777332019119385
KMS-27,135398516,-0.3174379343847421
LoVo,60750,-4.161283305326802
KMS-27,selumetinib-UNC0638 (4-1 mol-mol),0.3361487415212352
KMS-20,49867930,4.214222642380502
ESS-1,984333,0.2604103930211148
SET-2,46907787,-2.0840425279846553
CML-T1,46224516,0.9570028124056976
PE/CA-PJ49,3825829,3.9547991089939383
BT 330,72967,3.756952070615194
TE 617.T,1566236,1.7943954235614814
NCI-H2110,56946209,-5.165673550457206
KP-4,4477,-0.7302470770365643
A4/Fukuda,16722836,0.6102638619225811
NU-DHL-1,24821094,1.4406945146133665
HSC-4,24779724,5.454925638847944
NCI-H1395,11222830,1.7032197933937347
ESS-1,104842,-6.678898835642602
OAW28,ISOX-bortezomib (250-1 mol-mol),-0.0669520264254744
HARA [Human squamous cell lung carcinoma],4917,3.022180747101803
PE/CA-PJ34 (clone C12),568763,0.9098247878075588
EJM,vorinostat-navitoclax (4-1 mol-mol),0.2535752664026445
KP-4,9549297,1.1699591499626003
KMS-20,3854666,0.6836854926820529
LNCaP clone FGC,52912189,-0.9055719998181776
OAW28,3854666,2.969576020962734
HARA [Human squamous cell lung carcinoma],135423438,3.0787654328489986
SK-MEL-1,11404337,-0.7875528095472949
BT 320,46843906,4.201274452576595
D283 Med,445643,3.9929703650481914
PE/CA-PJ49,3011155,4.495062274227112
EJM,36462,0.7713020046102423
KYSE-410,637858,1.774325597801251
Ku812,135411,-0.2793980307615341
SKM-1,9956119,3.002044970915889
SK-MEL-1,9911463,4.223226979936513
SK-LMS-1,11178236,-3.975478551896793
LoVo,168313047,1.791039731088859
AN3-CA,5566,3.1575267125293793
NCI-N87,selumetinib-UNC0638 (4-1 mol-mol),3.172064031081815
BT 320,3634881,4.591305105456608
SEM,16038120,-1.4644891288976194
KMBC-2,135659046,3.5104960306219155
GOS-3,24180125,3.35218152246705
CA46,151289,0.6780663351050565
OE21,2749,1.218654717399713
ESS-1,11234052,5.5778807496063765
KMS-27,10302451,3.849053848839269
Hs 683,42642645,-0.321926076165572
SK-LMS-1,vorinostat-carboplatin (1-1 mol-mol),4.079113586943524
HARA [Human squamous cell lung carcinoma],68056272,4.667757023830857
SNU-1214,56946209,-3.438645101382296
CA46,24797083,-0.1839530161688024
RERF-LC-A1,5702613,3.261293707290771
Kasumi-2,11960529,3.120745126362072
KP-4,46224516,3.0131005396183417
SKM-1,16720766,-1.9505812671776488
SET-2,1641662,3.568397606985167
RERF-LC-A1,3503,2.3679389559296373
LNCaP clone FGC,44632017,1.0493161058029077
D283 Med,72376,-2.8932553569848385
NCI-H2110,5291,3.663817127631551
KP-4,168313047,1.8447542895379816
SK-LMS-1,24797083,1.4203781469683936
KMS-27,carboplatin-UNC0638 (2-1 mol-mol),2.884683789181856
BT 330,serdemetan-SCH-529074 (1-1 mol-mol),1.5699770652684284
MM1.S,31703,-4.019307858079406
H-STS,3081361,2.065492281733806
Raji,5311281,3.438768621179428
HCC2218,72967,3.841314233742601
EJM,9884685,0.026997005394607
LNCaP clone FGC,3503,1.5902233641471553
MM1.S,9884685,-0.9027319630033926
BT 504,52947716,0.7230139141028197
KMRC-2,444795,5.142588115774172
BFTC-909,1716436,3.115342072857748
CML-T1,24978538,-0.5146505107576096
OAW42,9911830,2.253682076539179
LoVo,selumetinib-vorinostat (8-1 mol-mol),-0.5614711347851936
PaTu 8988s,2828334,6.366685519056066
LCLC-103H,3025986,-0.1807322479633301
TE-15,5281321,-1.7873256923649707
SNU-1272,UNC0638-navitoclax (1-1 mol-mol),1.3009701153803632
KMS-27,navitoclax-piperlongumine (1-1 mol-mol),-2.594469089968951
ESS-1,46398810,3.012711144030241
NU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),-0.7283867124282789
SNU-8,11964036,0.9664399553551418
BFTC-909,2945648,3.347829093032643
LCLC-103H,6918837,-2.285347276779509
SNU-8,9907093,4.701426357025219
BT 328,24856436,4.552904501266461
BT 328,docetaxel-tanespimycin (2-1 mol-mol),-0.9357205348249352
EJM,6438330,1.051199955575325
TE-15,selumetinib-decitabine (4-1 mol-mol),3.970444444773313
SNU-8,72376,-2.198548294992271
ESS-1,9911463,4.377027533841143
NCO2,2729026,1.2481670026079306
OE21,2828334,6.183173525602709
D283 Med,26596,-3.592310964496019
LNCaP clone FGC,9915743,0.7205657109253502
RERF-LC-A1,52912189,2.7448588094782616
D283 Med,11222830,1.8597449067047809
SNU-1214,selumetinib-GDC-0941 (4-1 mol-mol),-0.7739258064747034
WM983B,4917,2.008956324466028
LoVo,327653,2.9108064375514604
NCI-H1092,60750,0.6504249492062534
NCI-H2081,53495165,-2.055173508699106
SKM-1,60750,-2.55232212647046
TE-15,7326481,3.653309357321709
SNU-1033,42642645,0.3333795520512672
SK-N-AS,676352,1.7828865151196214
PE/CA-PJ34 (clone C12),19582717,5.2106352925132375
ESS-1,5470400,4.483121200297247
NCI-H1092,tretinoin-navitoclax (4-1 mol-mol),3.4593364841450085
SK-N-AS,10231331,-1.1839301737612744
YKG-1,54454,1.2493986655314475
PE/CA-PJ49,135421197,1.7245990786454344
KP-4,25195348,2.4820805966357034
SNU-308,3025986,-0.312085619689839
MM1.S,4917,3.2531292975138033
SK-LMS-1,135440466,3.2849983532836653
MCAS,67291369,1.7014951656107709
RERF-LC-Ad2,25183872,-0.4436700906623944
SK-N-AS,17755052,2.3241816500118437
KMRC-2,selumetinib-navitoclax (8-1 mol-mol),2.5033979772822934
HuT 78,375860,-0.3004561584408421
HuT 78,44185566,0.8459615226549172
BT 139,selumetinib-vorinostat (8-1 mol-mol),4.048057418215767
Hep-G2,9956119,4.422188514955625
KYSE-70,36314,1.2189527676950276
SW1573,5351362,2.395315345585997
ML-1 [Human thyroid carcinoma],24964624,3.117302997790913
BFTC-909,navitoclax-sorafenib (1-1 mol-mol),2.944260401271062
PE/CA-PJ34 (clone C12),9935249,1.3468495063678572
SK-N-AS,135421197,2.9463042299637645
CML-T1,9868037,1.2045012402986977
RERF-LC-Ad1,1750826,-2.353785617747723
KMS-20,navitoclax-piperlongumine (1-1 mol-mol),0.7499609373098739
BT 248,5351362,1.0725587198101878
KMS-27,676352,1.6977067639732282
A4/Fukuda,11214940,3.3298423014633585
LoVo,ISOX-bortezomib (250-1 mol-mol),0.9349202186753368
NCO2,3136844,3.804678476116922
HuT 78,10296883,2.429678266579514
RERF-LC-A1,89928392,1.1830310401310955
NCI-H2110,54626689,4.627241982556493
SNU-1272,3038522,4.319393949707529
KYSE-70,10113978,1.960067513789881
JIMT-1,44185566,2.552662029785872
SNU-1214,selumetinib-JQ-1 (4-1 mol-mol),-0.4737134364925926
YKG-1,16725315,5.438032591098022
KMBC-2,2949965,2.9085438857268313
SW1573,2828334,5.538488922798482
YH-13,151289,0.8746416780528874
NU-DHL-1,426756,2.782423692029965
BT 320,16725315,5.30580008906936
KMS-27,73707398,0.1300509584750546
NCI-N87,16736978,0.698711777805788
Hep-G2,11960529,4.314757049098683
LoVo,54613361,-1.4267659732177436
SNU-308,49793307,-1.790706563652843
RERF-LC-A1,3815108,2.7626146820147106
RPMI-7951,navitoclax-pluripotin (1-1 mol-mol),-0.4900724483768682
A4/Fukuda,135398738,0.2588260022635366
Ku812,BRD-A02303741-navitoclax (2-1 mol-mol),1.860548372203261
RERF-LC-A1,4261,1.8999887687431951
OAW28,navitoclax-MST-312 (1-1 mol-mol),0.8340042464828235
MM1.S,selumetinib-MK-2206 (8-1 mol-mol),-0.3870286118827264
BFTC-909,44507138,2.8704731321552734
SNU-1033,148198,-5.122632724392466
CML-T1,25126798,3.796147395391691
SK-MEL-1,11485656,2.5093092817296307
NCI-H1395,54649381,3.0165140825256884
TE 617.T,10113978,3.7033253194318054
NCI-H1395,24821094,3.771001667275143
RERF-LC-Ad2,46926350,-4.2991338588257815
NCI-H2110,9825149,2.4425512538743672
KMRC-2,3025944,4.8383382704693405
HEC-151,54143018,-0.0525941697067482
RERF-LC-Ad1,119607,5.958194091123051
SNU-308,24951314,1.7440964726968256
GOS-3,16038120,1.102104110747453
KMBC-2,3552672,4.528759537704634
ML-1 [Human thyroid carcinoma],24856436,-1.6469735215058778
HEC-151,2858523,3.091480344450217
EJM,44493528,4.28788220416213
Aska-SS,5282054,2.790443973979982
Hep-G2,10113978,2.1536070556409252
CA46,2126,3.4622152695614767
PaTu 8988s,54765302,3.5413529163500383
SW1573,49766530,-2.79322841384178
HEC-151,10231331,4.832109833959945
MM1.S,36462,-0.6145210813224762
NU-DHL-1,11257553,-0.7159264357065991
LCLC-103H,17755052,4.357250161025299
NCI-H2081,54619267,3.7296456534329097
Aska-SS,navitoclax-pluripotin (1-1 mol-mol),4.6766362814007385
KMS-20,49766530,-1.2962307066769267
NU-DHL-1,445643,3.522779359362199
BT 248,71304818,1.6499217451033
YH-13,7251185,2.541379459758288
HARA [Human squamous cell lung carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.0458249521104828
EJM,227681,2.671980927947041
IST-Mes1,4261,1.7623274186426838
EJM,151289,0.6472385344760342
NCO2,11717001,3.223251779307543
Kasumi-2,54626689,4.779746030866953
PaTu 8988s,441298,3.298421994041664
HARA [Human squamous cell lung carcinoma],66577038,3.5726698245106445
KMS-27,25105715,3.101679923324695
D283 Med,25227462,-4.9287589290971905
HCC2218,11507802,2.2692790947966617
MM1.S,89183176,2.023432778974028
BFTC-909,448949,2.818327130228084
HMCB,5287620,-2.490214484592024
PE/CA-PJ34 (clone C12),3384730,4.479323787915653
GOS-3,2858523,3.344991232469259
SEM,9933475,1.6595519600408728
OE21,241158,4.080451555980482
RERF-LC-Ad2,5282054,2.499117900782071
OAW28,3081361,1.8855664708831448
KP-4,selumetinib-vorinostat (8-1 mol-mol),2.6285521395824527
PE/CA-PJ49,navitoclax-PLX-4032 (1-1 mol-mol),3.158588149700127
RPMI-7951,23725625,5.2145212739154205
HSC-4,4477,1.1301199037714704
BT 139,56649450,2.9826205065713745
D283 Med,6610355,3.4554564076272496
Ku812,selumetinib-piperlongumine (8-1 mol-mol),-1.2433230226916236
LNCaP clone FGC,54619267,3.520399318672114
SK-LMS-1,doxorubicin-navitoclax (2-1 mol-mol),-0.4074219237190608
BT 328,5282054,4.480246853772489
PE/CA-PJ49,11228183,3.178093510570805
NCI-H1092,46191454,1.930270640932621
BT 330,6436223,-4.427095413267329
WM983B,5278396,4.179952585615671
BT 330,4378219,1.6055397762494217
OAW28,135875424,4.470041991889524
SET-2,136227331,4.340141921453115
KMRC-2,9933475,0.5684361183115326
SEM,4259181,-0.7975863762048068
KMS-27,2113511,3.9580514489410055
LNCaP clone FGC,66577038,3.107164223519453
SKM-1,11238147,2.2552755658276875
OE21,6610355,3.409175590102683
NCO2,44589607,1.0974951357429563
KMS-20,52912189,-0.8192319241332332
CML-T1,10427712,1.89618534848285
PE/CA-PJ34 (clone C12),11609586,2.637959736879632
Ku812,5738263,2.3129138144842236
GOS-3,selumetinib-GDC-0941 (4-1 mol-mol),2.3911305512377217
EJM,11485656,1.52616093441074
Kasumi-2,56946209,-4.865772879743349
NCI-H2081,135398516,2.933732637162879
IST-Mes1,60700,-0.0817355864677207
ESS-1,72193861,1.305557473991512
BT 504,5566,2.943666707575814
ESS-1,doxorubicin-navitoclax (2-1 mol-mol),-3.174683950808786
EJM,2828334,5.892634980488002
RERF-LC-A1,9866186,1.1083803976937787
NU-DHL-1,BRD-A02303741-carboplatin (1-1 mol-mol),3.0745710267326545
AN3-CA,tanespimycin-gemcitabine (1-1 mol-mol),-1.213429357847596
OAW28,462382,0.1410996491293406
ESS-1,5278396,4.110324353246352
AN3-CA,25062766,1.4749027306647764
BFTC-909,5978,-2.385180460490498
OAW42,56949517,4.7212589533484035
SEM,11228183,-2.6667255532270957
TE 617.T,262093,2.7005370454000004
AN3-CA,12001922,1.6874605479132982
HuT 78,82146,0.1378074486168638
GOS-3,12001922,1.73057519179838
KYSE-70,tanespimycin-gemcitabine (1-1 mol-mol),0.2674613674270346
HCC2218,10322450,3.115665598848324
OAW28,4477,1.0036814180565996
HARA [Human squamous cell lung carcinoma],44632017,0.7187380309890276
Aska-SS,23725625,6.049665130232764
TE-15,24753719,4.009686025079942
OAW42,25262965,4.108534788692168
SEM,9549297,0.9674551206649342
OAW42,serdemetan-SCH-529074 (1-1 mol-mol),2.354207791479809
Ku812,46907787,-1.7178287271779615
MCAS,54618771,1.3372810495752594
PE/CA-PJ34 (clone C12),46199207,3.406755484984745
KMS-20,1714884,3.609076510233281
HMCB,753704,4.465795196553446
MCAS,52947716,-6.74647882054788
KMS-27,11625818,1.7619850217742694
KP-4,54686904,4.386725932550557
BT 504,400769,-1.0286587340824724
BT 330,3689413,-2.329423623315505
RERF-LC-Ad2,53392493,1.8485928216397516
NCI-H1092,9866186,1.8744947815698976
HSC-4,tanespimycin-bortezomib (250-1 mol-mol),0.4907221930959023
SET-2,2733487,3.345611630478478
D283 Med,400769,-1.1931139995593163
NCI-H1395,2945648,2.6727068131011285
SNU-1272,11612883,3.2902813327971936
ML-1 [Human thyroid carcinoma],16720766,0.621696324806819
BT 330,1641662,4.904949234649615
OAW28,89928392,1.6809049325642302
HCC2218,11626560,2.6153990580460396
SNU-1033,SNX-2112-bortezomib (250-1 mol-mol),-2.69596565865477
NU-DHL-1,11707110,-4.149720194824857
KMS-20,216239,1.7632685828356174
MCAS,5287620,-1.9007294396044043
SKM-1,selumetinib-piperlongumine (8-1 mol-mol),-0.1043250108144624
KMS-27,3025986,-2.2531201014218376
ML-1 [Human thyroid carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),3.3397252964004593
SW1990,11234052,4.7904085138573445
RERF-LC-A1,10410894,3.9575159109164937
KMRC-2,5329102,1.5816589334413396
LNCaP clone FGC,5287620,-2.246789776562607
RERF-LC-A1,25062766,1.5880762762251943
KYSE-70,24856436,0.5719980221753466
OE21,selumetinib-navitoclax (8-1 mol-mol),1.7269532854909095
CA46,1750826,-4.755590130007624
HCC2218,16736978,3.2618573796089834
LoVo,24772860,-3.380615847351667
SET-2,327653,2.598960189681515
SNU-8,9926054,2.0095672828148636
NCI-H1395,123631,3.1178254055309553
SK-MEL-1,5470400,0.6272012390404689
KMBC-2,71751553,4.649110275042704
IST-Mes1,5351362,3.046296530947078
HSC-4,426756,6.131320111521982
ML-1 [Human thyroid carcinoma],5281321,-2.300928121678764
A4/Fukuda,selumetinib-JQ-1 (4-1 mol-mol),-0.1942413967070371
YKG-1,UNC0638-navitoclax (1-1 mol-mol),2.987622235126213
HuT 78,5978,-3.8963684246064014
PE/CA-PJ49,1242560,3.3811009298853083
NCO2,10302451,-2.218182882660743
HCC2218,54649381,3.8304752709798464
CA46,5738263,2.2696720462337456
HEC-151,alisertib-navitoclax (2-1 mol-mol),2.5924883600099236
D283 Med,3384730,1.3777916079396086
SK-LMS-1,53325874,4.809163620762811
KYSE-410,2858523,3.007100667680198
LNCaP clone FGC,44607531,1.5778977096761553
IST-Mes1,9915743,1.0557522455188102
IST-Mes1,9825149,1.824146809937508
NCI-H2172,65064,5.016684921609816
HARA [Human squamous cell lung carcinoma],44589607,3.368220225067554
SKM-1,3038522,3.769689867373741
PaTu 8988s,44491742,3.6400918872033343
HEC-151,salermide-PLX-4032 (12-1 mol-mol),4.950081293482252
NCI-N87,216345,3.97830172236079
CML-T1,675434,3.803383794807122
AN3-CA,2858523,2.9756329830987536
BT 248,24753719,4.394714770526552
EJM,11507802,0.5924902988751046
NCI-H1092,969516,2.7305751680424573
PaTu 8988s,100016,6.475282567189534
NCO2,52912189,-0.3422473221609344
MCAS,JQ-1-carboplatin (1-1 mol-mol),0.8866425431722468
ML-1 [Human thyroid carcinoma],selumetinib-tretinoin (2-1 mol-mol),1.8296865613090936
NCI-H1092,67156097,2.7476633426389863
SNU-308,JQ-1-navitoclax (2-1 mol-mol),0.7322557838250645
SNU-8,148198,-1.3128761791294046
KYSE-410,11404337,-0.5095483106694066
SK-N-AS,400769,-1.0058832356498544
SK-N-AS,19582717,3.692925508375645
Hs 683,3038522,2.242318808618233
OE21,24964624,1.4326186271800114
BT 139,72967,3.761856387021038
ESS-1,44491742,4.277473074701454
NCO2,3038522,1.9812631722262275
LCLC-103H,54613361,0.8225640634608559
Raji,219104,3.2113175627591817
KMRC-2,serdemetan-SCH-529074 (1-1 mol-mol),2.3285498447862287
TE-15,60750,-0.4335181627273449
KMS-20,2858523,2.998494544090686
BT 139,156414,0.911612783306993
H-STS,11178236,-6.19923215257486
YH-13,24821094,3.938816405741356
SNU-8,262093,2.9266150824116877
SNU-1214,5470400,0.3959808250570928
OE21,5351362,1.3269520402296493
NU-DHL-1,216239,2.6087015234421056
SW1990,16720766,0.6444202452308027
NCI-H1395,11625818,4.225783797548463
RERF-LC-A1,136227924,2.978723056085531
KYSE-70,262093,3.701785722517592
AU565,ISOX-bortezomib (250-1 mol-mol),0.4986344136338663
LNCaP clone FGC,3825829,3.9808343636151657
BT 328,selumetinib-vorinostat (8-1 mol-mol),3.560914687145029
KYSE-410,439501,-2.4284024166032365
SK-LMS-1,2746,4.054624823156548
Hep-G2,60750,-4.7110516524032775
HEC-151,60700,-0.0125711606129759
H-STS,11494412,-0.8730313423515421
TE-15,10113978,3.8378245924643184
Kasumi-2,49867930,4.763867340262508
ESS-1,16065773,2.1890853873316596
NCI-H2110,1716436,3.4022042263381675
KMS-27,3062316,1.3205834399665888
BT 320,44507138,4.949888097685237
AU565,49836020,5.742264990221176
SNU-1033,3854666,3.138218307419996
RPMI-7951,9868037,2.673802488787611
NCI-H2081,alisertib-navitoclax (2-1 mol-mol),-2.14822930035513
CML-T1,11364421,-5.082505847469849
Aska-SS,vorinostat-carboplatin (1-1 mol-mol),2.719460579822469
HMCB,135398516,2.391390650545516
BT 330,56946209,-4.733206514470745
BFTC-909,89928392,2.1120581393996116
HEC-151,5291,4.223024984973082
NU-DHL-1,56963564,-0.6352344971867577
HMCB,984333,0.7502928259888776
D283 Med,135999136,3.641764348590375
BT 328,25195348,5.638362277561031
SK-N-AS,54618164,3.832348053095005
RPMI-7951,44505237,4.378502916493453
JIMT-1,119607,5.892319161371762
Kasumi-2,71466578,1.9217240593305729
LNCaP clone FGC,9956119,4.171775479590179
JIMT-1,24856436,0.8491199029620918
PE/CA-PJ49,6610355,4.104537207248427
KYSE-70,89928392,5.113782206339635
PE/CA-PJ49,71751553,4.17175921879406
SNU-1033,71304818,2.203127671736772
Kasumi-2,216239,2.0875832120118605
SNU-1214,navitoclax-MST-312 (1-1 mol-mol),0.6097742809788183
NU-DHL-1,3011155,4.64596997294592
PE/CA-PJ49,5311,0.6112751453740505
AU565,9866186,0.5690553044247834
SET-2,6184667,2.5703106251838914
LNCaP clone FGC,10184653,1.6496146664208813
SET-2,12001922,1.3771697775776517
SKM-1,151289,-0.219296204228563
OAW42,vorinostat-carboplatin (1-1 mol-mol),3.9172930165283697
SK-N-AS,24951314,0.901970357351847
Ku812,135440466,1.6128490007977765
LNCaP clone FGC,3081361,3.1605102026982363
SNU-8,3038522,3.557349026871971
OAW28,3815108,1.950790900509605
BT 504,selumetinib-piperlongumine (8-1 mol-mol),3.7542059669572025
EJM,SNX-2112-bortezomib (250-1 mol-mol),-3.498117100633706
NCI-H2110,51037431,3.847304773627672
PE/CA-PJ34 (clone C12),56649450,1.6238624024089472
HMCB,71680916,4.934494068760343
A4/Fukuda,2749,1.141581020051295
OAW28,53232,2.960609854482466
BT 504,44589607,3.154327880672298
EJM,71466578,1.4924180595408962
SW1990,2729026,3.047903080615765
HEC-151,24772860,-1.663502215408852
BT 504,16722836,1.5827632969628846
ML-1 [Human thyroid carcinoma],4259181,0.3770562232502641
WM983B,613753,3.174925059497959
AN3-CA,alisertib-navitoclax (2-1 mol-mol),-1.3737982896338972
Ku812,66577038,1.5928904454568968
D283 Med,11485656,1.7629558217294734
RERF-LC-A1,46224516,4.398847395000289
RERF-LC-Ad1,25102847,4.445433024758021
SEM,10184653,-0.2676312474090645
SNU-1214,24772860,-2.6292403304682197
AU565,11455910,2.266336610800082
RERF-LC-A1,25150857,3.3188132536329484
IST-Mes1,46215462,2.5624084058363676
SKM-1,56946209,-5.085207204294124
KYSE-410,49846579,3.262799564425684
YH-13,6917907,-5.576575659474619
SNU-1214,3634881,2.931050572657854
PaTu 8988s,65064,4.487458159070869
Raji,4259181,-0.4985032966889935
Kasumi-2,25150857,1.3589874253765015
KYSE-410,5281321,-0.5490032374282351
PaTu 8988s,3465537,1.2834975763885186
A4/Fukuda,5287620,-3.30087759062066
KYSE-410,46398810,2.568742472735742
ESS-1,54619267,4.300915522093122
HEC-151,tanespimycin-bortezomib (250-1 mol-mol),0.2767790074283919
AU565,262093,2.3992948308197093
KMS-20,25262965,-3.079526617825105
OE21,52947716,1.6020082935985775
Hs 683,selumetinib-piperlongumine (8-1 mol-mol),4.6915897012307735
MM1.S,11455910,0.7825849388460823
Hep-G2,3854666,3.2360339128212554
MCAS,44493528,4.628123206531076
BT 139,53232,4.606115897907571
HuT 78,3503,2.594592779968663
OE21,11977753,-4.142897881576489
KP-4,67156097,-1.9652796279366704
PE/CA-PJ49,4477,0.7414062724597128
AN3-CA,123631,2.4895292563964584
TE-15,2871966,-1.8816230451578544
SK-LMS-1,148198,-3.2983357402975484
HARA [Human squamous cell lung carcinoma],JQ-1-navitoclax (2-1 mol-mol),2.200588179814963
H-STS,24901704,3.405459257701186
KYSE-70,12001922,1.7900886800743383
AU565,1641662,2.8108586385203234
KMBC-2,46398810,2.775956594355702
NCO2,4477,0.0557809558709323
Aska-SS,5328940,1.7170196461113685
ESS-1,navitoclax-MST-312 (1-1 mol-mol),0.1700305380207872
KP-4,216468,0.9574586264454517
PE/CA-PJ34 (clone C12),135398516,2.5107066469062738
KMS-27,9911830,2.432969269856635
H-STS,11152667,-1.2361022970372575
SK-MEL-1,19582717,4.928603710750835
HCC2218,3384730,3.481352808748772
BT 139,selumetinib-MK-2206 (8-1 mol-mol),2.0878690107327555
OAW42,252682,6.4079527450237865
Aska-SS,11175137,1.8524433581649336
Kasumi-2,selumetinib-BRD-A02303741 (4-1 mol-mol),4.464770515691229
NCI-H2172,5311281,3.6090019324817626
PE/CA-PJ49,613753,3.2015206560580407
SK-LMS-1,57519531,3.451677062676746
TE-15,46926350,-4.66402826584901
HMCB,11364421,-5.583776675584482
SK-N-AS,135440466,2.227825080043858
OAW28,46843906,3.2241568449076556
HEC-151,42611257,2.939259263914983
AU565,2729026,2.5804084357046033
HuT 78,135928012,5.03508248735035
KYSE-410,72193861,2.3574856526220076
YH-13,alisertib-navitoclax (2-1 mol-mol),-1.4191269033717964
KMRC-2,25150857,2.328256139477392
OAW28,piperlongumine-MST-312 (1-1 mol-mol),2.526870142360867
PE/CA-PJ49,168313200,2.725673225296459
NCI-H2081,11507802,1.0351752373197651
KYSE-410,54613361,0.8741468052843427
SEM,2945648,0.1615373734566605
SK-N-AS,5329102,1.5335598372301635
AN3-CA,54618164,3.8831604834020688
Kasumi-2,piperlongumine-MST-312 (1-1 mol-mol),0.99360798269259
NCI-N87,11404337,-0.8803091706648726
SEM,44491742,3.581981402307046
HuT 78,71304818,2.291662678403222
CML-T1,17755052,2.353347963272661
SNU-1033,46843906,2.8992746692094795
KMRC-2,11494412,6.4606307205450015
SEM,selumetinib-piperlongumine (8-1 mol-mol),1.0176958248446395
KMS-20,11175137,2.2632484557969152
SK-LMS-1,1716436,3.783902076496232
Hs 683,46907787,3.0982371748631325
BT 139,1750826,1.464250627384646
NU-DHL-1,969516,2.257710289132893
HCC2218,2746,2.1275689170875847
NCI-H2172,44489675,4.773557971551537
H-STS,44137675,1.4047344665850907
HuT 78,7251185,-0.7654974545197635
LoVo,24785538,0.3940436885335026
KMRC-2,5281321,-2.2228246492045476
SKM-1,46907787,-1.5658410471483666
NCI-N87,16115403,-3.919428944380448
GOS-3,119182,1.862888663663923
BT 139,387447,-3.566401702341635
BFTC-909,5566,2.8568699448622263
IST-Mes1,2746,3.2096433183027604
Kasumi-2,salermide-PLX-4032 (12-1 mol-mol),2.944713771170232
CML-T1,JQ-1-UNC0638 (2-1 mol-mol),0.1970824478028413
SNU-1214,5702613,4.390712346710364
KYSE-410,46191454,2.564213585612182
SW1990,JQ-1-vorinostat (2-1 mol-mol),1.8788348022946737
BT 139,4477,0.6839306905009712
OAW28,1750826,-3.338956149870334
KYSE-410,BRD-K99584050,4.270959972469134
KMBC-2,54649381,3.86367738798119
SK-MEL-1,vorinostat-navitoclax (4-1 mol-mol),1.1480119181827646
SKM-1,4521392,4.8540748740064705
SKM-1,2946601,6.482572504848425
HEC-151,107985,-5.149498087919081
OE21,9444,3.8449200329038846
RERF-LC-Ad2,1716436,3.755030175494451
KMS-20,72193861,0.4494795381256313
KP-4,11455910,-0.3156101411278702
GOS-3,5113032,4.836446064307081
Ku812,10410894,1.977948047331864
Ku812,11455910,-0.1088527514294285
AU565,1716436,0.9342430141979629
WM983B,tanespimycin-bortezomib (250-1 mol-mol),0.7695231376052774
NCI-H1395,6610216,4.652818435628847
RERF-LC-A1,10231331,6.3240202906005045
MCAS,5329102,2.3259749403713372
CA46,56649450,3.397645307363617
CA46,375860,-0.5712781411665353
TE 617.T,serdemetan-SCH-529074 (1-1 mol-mol),0.9612641436619076
OAW28,9907093,4.094861416701174
A4/Fukuda,208908,1.6750686900112284
NCI-N87,44507138,1.5580904379761216
BT 139,10427712,3.8986944059479383
NCI-H1395,51039095,3.804794716936721
NCI-H2110,11214940,4.162880305003488
TE 617.T,carboplatin-UNC0638 (2-1 mol-mol),2.951137803819235
NCO2,11214940,-1.733735203249916
Hs 683,11626560,1.4068701984399117
Aska-SS,5566,2.9883753994933335
OAW42,25126798,4.098474655024586
PE/CA-PJ49,decitabine-navitoclax (2-1 mol-mol),3.184287268918302
OE21,11404337,-3.0833954848691234
KMS-20,decitabine-carboplatin (1-1 mol-mol),3.602021094753337
NCO2,374536,2.0610293369811172
LoVo,6918878,0.5506920931363443
NCI-N87,6917907,-5.514556019160177
HCC2218,5494449,4.847439157122507
SK-N-AS,56649450,4.865564154358712
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837
KMRC-2,25105715,3.6980162207420126
HSC-4,216468,2.5769925673594227
SNU-1033,387447,-4.464166548944418
KMS-20,11222830,0.8671541561907014
NCI-H2081,navitoclax-gemcitabine (1-1 mol-mol),-4.71616424296242
NCI-H2172,72193861,3.68298370013582
SNU-308,1242560,3.771174309636351
SK-MEL-1,54618771,1.3594910944295866
CML-T1,168313047,1.9633067789473095
HCC2218,5284616,2.8874763223731805
KYSE-70,44607531,3.0404164934883733
SNU-1033,4705,2.6216736811916044
RERF-LC-Ad2,3825829,4.845421431972124
TE-15,24797083,2.028256767173618
Ku812,docetaxel-tanespimycin (2-1 mol-mol),-7.546538272108434
HEC-151,9911830,2.8637422134890342
CML-T1,56946209,-4.816302217893272
NCI-H2081,sirolimus-bortezomib (250-1 mol-mol),-0.0413699313219798
H-STS,5311,0.9489728897085792
YKG-1,11977753,-3.046563007641072
Hs 683,25126798,3.738392490105732
TE 617.T,208908,-0.8702085838150805
NCI-H1395,5287620,-5.195854195125387
MM1.S,3854666,1.277087835200556
A4/Fukuda,25262965,-4.823082336145625
HuT 78,60700,-3.11385512766576
RERF-LC-Ad1,374536,2.042610785182273
PE/CA-PJ49,5113032,4.906572682560801
LCLC-103H,ISOX-bortezomib (250-1 mol-mol),1.0049031347782047
BT 248,BRD-A02303741-navitoclax (2-1 mol-mol),1.4606318161646668
BT 248,53495165,3.0905684330313803
Ku812,55283,1.038914433795577
Raji,54619267,4.236071325253823
HuT 78,11228183,1.5356428914171083
Raji,409805,3.871069859266368
OAW42,6852167,3.327110546741901
NCI-N87,9926054,1.7069639615174013
HMCB,SNX-2112-bortezomib (250-1 mol-mol),-0.8165650702209287
HARA [Human squamous cell lung carcinoma],67156097,-1.978765302962937
BT 504,11404337,-1.134155028298889
Hs 683,11717001,5.284697015762219
HMCB,219104,4.272733205803313
LNCaP clone FGC,BRD-A02303741-navitoclax (2-1 mol-mol),3.7065262118724114
Hep-G2,6852167,3.060489701170588
CA46,1716436,3.005257864158129
KMBC-2,9927531,4.40438479738659
Hs 683,6918638,0.9726484186750864
CML-T1,11222830,0.9922056813064216
A4/Fukuda,JQ-1-carboplatin (1-1 mol-mol),-0.863856573463552
NCO2,135984461,1.9525292456009808
GOS-3,11214940,1.8063167684007233
SW1573,selumetinib-GDC-0941 (4-1 mol-mol),3.5855850407433225
HCC2218,753704,5.019549906399212
SK-LMS-1,9952709,2.023956399550252
OE21,753704,4.973993702825942
PE/CA-PJ49,selumetinib-PLX-4032 (8-1 mol-mol),3.728065636713805
SNU-1214,23725625,3.932415720321906
NCI-H2081,17755052,2.5069462773108016
KYSE-70,54613361,0.0645626216296427
H-STS,16741245,6.378704245448754
AU565,2949965,1.8156290557963255
Ku812,decitabine-carboplatin (1-1 mol-mol),0.163228689649063
BFTC-909,6252,5.031852570794812
NCI-H2172,168312962,1.0879961512148657
HEC-151,54626689,4.464334654686751
OAW28,46224516,2.3854099680927523
HARA [Human squamous cell lung carcinoma],3136844,4.042885024123848
Kasumi-2,5291,3.833785516332381
YKG-1,16038120,1.8317392999750344
BFTC-909,56973724,3.22598802973391
WM983B,crizotinib-PLX-4032 (2-1 mol-mol),-0.112416990920183
BT 320,56963564,5.490825870792066
EJM,89183176,3.310519408856309
SK-MEL-1,42642645,1.4415647495242137
LNCaP clone FGC,5566,3.3009073934848496
NCI-H1395,44185566,2.9760824770163756
KP-4,crizotinib-PLX-4032 (2-1 mol-mol),0.5203537061486859
H-STS,11640390,4.3138571775142855
HSC-4,3384730,1.6775009570022803
RPMI-7951,57330099,4.153180907590616
HMCB,selumetinib-piperlongumine (8-1 mol-mol),4.51678007909172
KYSE-70,15547703,3.259406085484829
PE/CA-PJ34 (clone C12),25195348,3.3119594159536874
PE/CA-PJ49,11234052,4.7998888543845615
RERF-LC-A1,156414,1.959545548959112
BFTC-909,doxorubicin-navitoclax (2-1 mol-mol),-1.537563048544383
CML-T1,4261,-0.2906672064872484
RERF-LC-Ad2,46843906,4.812156389581379
NCI-H2110,148198,-2.105563861688736
KMRC-2,9926054,2.0216271093968263
PaTu 8988s,9967941,1.4650396579971054
AN3-CA,54613361,0.6928239140558707
Raji,11214940,1.3092105754624663
SNU-1214,219104,3.8192671033642105
YKG-1,11707110,2.3974603193605275
A4/Fukuda,16736978,-0.5754825114210159
BT 139,25227462,1.6832598975023767
BT 504,60750,1.0020140630015817
NCI-H1092,702558,4.580378170457022
BT 139,9936388,1.6173516252245872
LoVo,72193861,-0.0557430791680942
KMS-20,54613361,-1.869220280650564
ESS-1,123631,3.705774293108517
HSC-4,44589607,3.345116081225748
YKG-1,3689413,0.6324676509110861
H-STS,11175137,3.379012041415036
D283 Med,44486219,3.429631651942111
Kasumi-2,72734382,3.1758679904650715
IST-Mes1,5281672,4.409062773089972
HEC-151,135984461,3.687449100902744
NCI-H1395,15547703,3.241893522159582
KMBC-2,2858523,3.042051698255358
CA46,54619267,3.4754479185856604
SET-2,1239801,3.802011225535514
HSC-4,44202524,5.184990397771561
BT 139,10231331,4.592628649226856
HMCB,25102847,1.6678693363559989
SK-MEL-1,5278396,4.201894582864424
ML-1 [Human thyroid carcinoma],alisertib-navitoclax (2-1 mol-mol),-1.2100779480376045
KMS-27,12001922,1.6667680080633047
RERF-LC-A1,135875424,3.889170235593284
H-STS,11234052,1.696059842903999
PE/CA-PJ34 (clone C12),322968,4.7320744640732775
SNU-308,10385095,3.412893840135653
SK-N-AS,25227462,-1.933981675539526
H-STS,tanespimycin-gemcitabine (1-1 mol-mol),-4.299307238751318
SK-MEL-1,11626560,1.9177621423736664
SK-LMS-1,387447,-4.300147473198931
AU565,54143018,-0.7127893506095456
KYSE-70,5329102,1.9375891375175784
BT 320,676352,2.325208402765908
BFTC-909,107985,-3.700699007813787
Hep-G2,400769,-0.0290927499508633
HEC-151,JQ-1-UNC0638 (2-1 mol-mol),1.268930454659871
IST-Mes1,5278396,4.120493778859633
Kasumi-2,5281672,3.402650415017694
NU-DHL-1,9915743,0.5782531397120328
BT 139,navitoclax-piperlongumine (1-1 mol-mol),0.9371144639031332
CML-T1,6918878,-0.7643857619236708
SK-MEL-1,135423438,4.488053456325811
NCI-H1395,9866186,2.8046320736833894
RERF-LC-A1,104842,-4.286414749311876
BT 504,136227331,4.427068433279088
RERF-LC-A1,126941,-3.0666663315313945
SKM-1,89928392,0.546592586318215
TE-15,erlotinib-PLX-4032 (2-1 mol-mol),0.1642393511347769
D283 Med,decitabine-navitoclax (2-1 mol-mol),-1.6592952462928667
HSC-4,16065773,3.311693132411482
D283 Med,426756,3.908529404251969
KMS-20,selumetinib-piperlongumine (8-1 mol-mol),1.0367675116667423
TE-15,11977753,-0.2031072822871913
TE-15,56649450,2.5668764192074898
SNU-1272,119607,5.048435737669013
CA46,6184667,1.8666466805539537
SEM,44185566,0.8758222102990114
EJM,10385095,0.7131434808495797
SNU-8,6918878,1.8134579719269337
NCI-H2110,44491742,4.139827167651669
BT 330,2126,5.626411128120884
AU565,5282054,3.2331302005717153
SW1990,carboplatin-UNC0638 (2-1 mol-mol),3.853887350525919
SK-MEL-1,25183872,2.0436889125783284
KMS-27,44137675,3.9560542315733738
NCI-H2110,3136844,5.069664376003593
SET-2,11175137,2.2694521768309976
HCC2218,46398810,2.1690925426260375
HuT 78,46843906,0.7162246400250988
ESS-1,2708,3.2385388289614583
NCI-H1395,2729026,3.1697601093173136
KMS-27,5978,-4.633882828191892
OAW28,5351362,2.5555782345102407
PE/CA-PJ49,445091,4.310249844064028
BT 504,208908,2.062859770474231
NCI-H2110,53392493,3.635349980623696
NCI-N87,selumetinib-vorinostat (8-1 mol-mol),2.348461304209469
Ku812,54649381,2.9639483445767087
KYSE-70,11626560,2.028097573065789
SNU-1272,441298,1.7337519477990695
A4/Fukuda,451668,-0.3897468918932548
LNCaP clone FGC,5311281,2.449942426153834
RERF-LC-Ad1,409805,6.089650612893954
KMS-20,44589607,0.4601335864045367
OAW42,15547703,2.7089788162729764
KMRC-2,15953870,4.6713206769498585
H-STS,71304818,2.454900724059108
NCI-H1395,12001922,2.192187193874862
NCI-H2081,46191454,1.7931363741805633
KMS-20,1750826,-2.803513511799702
HMCB,JQ-1-navitoclax (2-1 mol-mol),1.0061070373244176
SK-LMS-1,119607,5.904480567296046
BFTC-909,5282054,4.21714099973987
KMRC-2,6184667,3.661056720524383
KMRC-2,156414,1.7005569347395115
KP-4,445455,4.614742729494546
HuT 78,46901937,3.36235026237692
SET-2,119607,4.996784507856945
NCO2,451668,-3.2203716031815945
HARA [Human squamous cell lung carcinoma],73707398,1.6371281450925783
SK-N-AS,26596,-3.589406361417691
BT 330,16722836,1.958946864061731
NCI-H1395,10127622,5.295029189605721
AU565,6918837,-4.408945103298963
HuT 78,44632017,1.0845444881128212
IST-Mes1,10127622,4.960728342788448
HSC-4,2841722,4.578140166849417
JIMT-1,6610216,4.8659942522490365
KP-4,36314,-5.817285417433746
SW1573,crizotinib-PLX-4032 (2-1 mol-mol),2.8041804107820796
KMS-27,10127622,-1.359556909337271
KYSE-410,3384730,2.7655912994190706
KMS-20,2842253,5.9707742385710825
SET-2,16065773,1.9278886667582409
TE 617.T,2742550,3.402468402026986
LoVo,20959075,-3.964629838563966
OAW42,ISOX-bortezomib (250-1 mol-mol),2.1239321907532327
H-STS,6438330,0.2327591369771806
KMBC-2,5282054,4.007403455924559
OAW28,16065773,3.4526029247448973
NU-DHL-1,navitoclax-pluripotin (1-1 mol-mol),-2.727717397237378
CA46,23582824,0.075225101675958
IST-Mes1,6505803,0.837907313306775
ML-1 [Human thyroid carcinoma],25262965,-1.8922435286727564
D283 Med,24772860,-2.7962047950668345
Kasumi-2,4378219,6.192429128955844
MCAS,BRD-K27188169-navitoclax (2-1 mol-mol),3.9772772002243353
LCLC-103H,46224516,4.746135980052501
NCI-H1395,73707398,1.4482642438908118
OAW42,44819697,-0.3351538376339087
SNU-8,445455,4.353348054039297
BT 320,crizotinib-PLX-4032 (2-1 mol-mol),2.9020632961686537
MCAS,1750826,-3.484933557510254
OAW42,11364421,-1.1184774965923467
BT 504,60700,1.5263815827617386
HuT 78,4096211,1.1112538350998973
PE/CA-PJ49,2746,2.1917494925150653
MM1.S,5287620,-1.6558303438795536
NCI-H1092,sirolimus-bortezomib (250-1 mol-mol),0.4958114346992872
PE/CA-PJ34 (clone C12),selumetinib-UNC0638 (4-1 mol-mol),2.452138408704013
LCLC-103H,sirolimus-bortezomib (250-1 mol-mol),2.0296751829948683
KMBC-2,409805,6.016015175624214
NCI-H2110,568763,1.7848846070854016
TE 617.T,alisertib-navitoclax (2-1 mol-mol),0.7236825350281212
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
WM983B,BRD-A02303741-navitoclax (2-1 mol-mol),4.276267519726226
OE21,5281321,-2.5477026104814726
AU565,57330099,4.7929461834362606
HARA [Human squamous cell lung carcinoma],126941,-2.554285063423382
KMBC-2,2126,4.261822440706329
NCI-N87,6852167,1.8373876080574163
NCI-H1092,25126798,3.974673346500284
AU565,444795,4.595530435398324
LNCaP clone FGC,135659046,3.5330322853898957
PaTu 8988s,9935249,3.279701271474824
SW1990,25227462,0.0707797434593802
MM1.S,5329102,1.1303790251840526
BFTC-909,439501,-2.4866456286351095
RPMI-7951,navitoclax-PLX-4032 (1-1 mol-mol),2.4036000141339424
NU-DHL-1,135984461,1.11873859248707
TE-15,60700,-0.2470975087472006
HuT 78,53232,2.0901683388522385
Kasumi-2,100016,5.973936097539331
NCI-H1395,107985,-3.679096931387758
HARA [Human squamous cell lung carcinoma],11507802,1.3937860028408913
KMBC-2,44543605,3.691802605477142
RERF-LC-A1,135423438,2.4770286699108857
KYSE-70,124202324,2.186627813347476
NCI-H2110,tretinoin-navitoclax (4-1 mol-mol),5.524341634711108
HEC-151,60750,-4.918286912586691
Hs 683,445643,3.970374608486991
SNU-1033,5311037,5.480663471936506
NU-DHL-1,5566,3.1581307498814923
SNU-1033,53232,2.540520147394444
KMS-20,71466445,3.065213582457146
RPMI-7951,11609586,1.9287484592067603
Hep-G2,5281672,4.366631199734501
OAW28,54596558,4.423614985335385
BT 328,11364421,2.7356800342957777
OAW42,5702613,4.004362567570804
BFTC-909,44607531,1.7004331217528663
SEM,15953870,2.946140214563167
KYSE-70,SNX-2112-bortezomib (250-1 mol-mol),-1.0131042472486071
HCC2218,19582717,2.3590342236199464
RERF-LC-A1,969516,2.6633032310701457
KMS-20,alisertib-navitoclax (2-1 mol-mol),-2.6675858557663825
NU-DHL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),1.320938208731918
SET-2,12003241,-1.37504024910663
Raji,11404337,2.5048803156599586
D283 Med,24180719,4.216892125950757
SNU-1033,crizotinib-PLX-4032 (2-1 mol-mol),1.9066763754153624
CA46,36462,0.0715644321871689
LoVo,44607530,0.9946707755477716
MCAS,23725625,4.4674153272431365
OAW28,68056272,3.642995313586114
SNU-1214,6914657,-4.451170657925107
SK-LMS-1,12003241,-1.0710207153229787
EJM,4521392,4.5143467912480055
Kasumi-2,25062766,0.6905738640208902
HuT 78,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.768713578692631
SNU-8,25262965,-1.972301864506803
NU-DHL-1,44489675,3.995073579717184
NCI-H1092,25161177,3.963642294094328
MM1.S,3689413,-0.3922685663675629
AN3-CA,16038120,1.3578591252446268
RERF-LC-A1,11234052,4.321779135244423
KP-4,9967941,3.485944840063267
SNU-1214,25126798,4.0560100491189575
SNU-1272,11152667,1.552242826912863
SW1990,462382,0.8888111274221407
CML-T1,6918736,-1.6116924986143133
AN3-CA,49766530,0.9400447576922468
HuT 78,11238147,3.7315717543629057
ESS-1,107985,-4.436359650155883
BT 248,11317348,2.524808263877468
AN3-CA,ISOX-bortezomib (250-1 mol-mol),0.3438036244329149
SEM,3552672,5.542055720565402
IST-Mes1,46843906,1.738626305357275
ML-1 [Human thyroid carcinoma],JQ-1-UNC0638 (2-1 mol-mol),2.6444298637243167
YKG-1,5278396,4.162705739282169
HEC-151,656346,0.6910223701420927
NCI-H2110,3081361,2.457740426443218
TE-15,9887053,4.0849522615234735
MCAS,107970,2.3689234635005274
CA46,400769,-1.5476292313826252
OAW42,168313200,2.5927841071629407
YKG-1,11404337,0.7038073229533129
H-STS,2746,2.861217997075228
LNCaP clone FGC,15953870,2.830210193885845
KP-4,5291,4.117346796976003
SNU-1272,25062766,3.227496058351171
Hs 683,24978538,3.02239694191792
NCI-N87,9967941,2.944195178928737
KMS-20,135398744,7.132407790781497
LoVo,2746,2.3133613771451524
HARA [Human squamous cell lung carcinoma],3081361,3.3764732224556533
SKM-1,16038120,-0.2538482343739291
OAW28,selumetinib-vorinostat (8-1 mol-mol),2.294734084050853
SNU-1033,6918878,2.3543358775294845
SW1990,4259181,-0.3516567866303933
Raji,439501,-2.4044549184869872
PE/CA-PJ34 (clone C12),sirolimus-bortezomib (250-1 mol-mol),0.9308222519351572
SET-2,BRD-A02303741-navitoclax (2-1 mol-mol),0.0634881941295692
NU-DHL-1,9840324,6.681797282677095
KMBC-2,5287620,-2.4056234930348963
NU-DHL-1,JQ-1-UNC0638 (2-1 mol-mol),-1.1533967446161832
WM983B,5746,1.6280841388195535
Ku812,tretinoin-carboplatin (2-1 mol-mol),4.0660943176260504
AU565,9967941,3.769081839228565
SK-LMS-1,969516,3.148006643013655
KYSE-410,44491742,3.6208474241241473
SET-2,67156097,-1.8675490835672344
SNU-1033,216239,2.417211779255053
OAW28,vorinostat-navitoclax (4-1 mol-mol),-0.0627411194762238
HARA [Human squamous cell lung carcinoma],BRD-K27188169-navitoclax (2-1 mol-mol),2.401020533417727
NCI-H2172,44137675,4.33723657992909
NCI-H2110,11647372,1.4254628745095883
LCLC-103H,11485656,2.3573418350596644
SW1573,54618164,4.339091959582753
H-STS,46199207,2.757122877037558
NCI-H2172,24856436,1.5621419745636402
BT 320,6852167,5.054396580410171
NCI-N87,3815108,3.1427265495234513
SNU-1272,9840324,5.6851374422445335
SNU-8,9915743,2.7412552085538326
BT 328,navitoclax-MST-312 (1-1 mol-mol),1.0481188204981575
SNU-8,4261,0.9369229460712624
KMBC-2,24775005,3.300529462732179
H-STS,3854666,0.1561624900748555
HMCB,5351362,3.123131663123805
LNCaP clone FGC,54618164,3.473617920574014
NCI-H1395,25183872,0.7237859951347151
Aska-SS,4578,5.1007948880015
YKG-1,216345,4.618368772629755
NCO2,6918837,-4.592061316482193
LoVo,selumetinib-navitoclax (8-1 mol-mol),1.0965034655670265
TE-15,613753,3.1421917783514273
KMS-27,3634881,2.704318622669992
BT 248,11178236,-4.1971988945266965
BFTC-909,11626560,2.2197507332783735
JIMT-1,25126798,4.34609373800797
WM983B,23582824,0.4136434058268429
BT 328,1242560,3.7217728648483552
HCC2218,374536,1.547515633749918
CA46,5328940,1.1838617633473132
PaTu 8988s,984333,1.020213634750089
Hep-G2,81146,5.451523711608541
EJM,crizotinib-PLX-4032 (2-1 mol-mol),1.5260381375566714
EJM,53495165,-2.1869464879132963
JIMT-1,5978,-1.972145533088477
TE 617.T,135421197,0.8388775868881587
NCI-H2081,serdemetan-SCH-529074 (1-1 mol-mol),0.921465468134936
AU565,vorinostat-navitoclax (4-1 mol-mol),1.0795272840825962
YH-13,53232,2.004863331527642
TE-15,5311281,1.0813449483245536
SET-2,1242560,2.568331435299952
CML-T1,11214940,-0.4703282723698588
SEM,1317464,3.839801567359689
PaTu 8988s,107985,-3.719022802572999
TE-15,2858523,3.0581585072874313
TE-15,11507802,0.98779179602805
SNU-1033,9935249,2.812235160690358
KMS-20,60750,-4.802924293659105
JIMT-1,selumetinib-JQ-1 (4-1 mol-mol),2.8828877731679667
HEC-151,11612883,2.187289533777292
ML-1 [Human thyroid carcinoma],navitoclax-pluripotin (1-1 mol-mol),-1.2739160400163367
RPMI-7951,10127622,4.472394456540677
BFTC-909,124202324,2.9321657702899295
Kasumi-2,46191454,0.4638336944386738
OE21,serdemetan-SCH-529074 (1-1 mol-mol),0.8779139743327479
BFTC-909,3825829,4.25128930140834
KYSE-410,doxorubicin-navitoclax (2-1 mol-mol),-0.1636166485621063
KMRC-2,11964036,1.8487552887442
KMS-20,375860,-0.5673020428522673
NCI-H2172,168313047,2.0397504068757693
PE/CA-PJ34 (clone C12),11396600,3.27217842552133
SW1573,serdemetan-SCH-529074 (1-1 mol-mol),2.68378670703322
BT 248,168312962,0.3799536225395565
OAW28,navitoclax-PLX-4032 (1-1 mol-mol),0.8085168342151391
OAW42,676352,1.834120917917185
Aska-SS,285033,-3.0886143623039146
NCO2,439501,-2.4046294895536446
OAW28,docetaxel-tanespimycin (2-1 mol-mol),3.524507000700441
KMS-20,5282054,2.484171809252808
LoVo,24951314,0.8531724175888866
NCI-N87,36314,2.766113993056904
Ku812,44819697,-2.8694764464804727
Hs 683,24964624,2.490055513295311
ESS-1,6505803,-2.0071033756271106
CML-T1,2130404,3.1458672398900425
CML-T1,3815108,1.7472513397157303
ESS-1,448949,2.571296753427842
Aska-SS,5351362,1.185018098934001
YH-13,123631,3.7042761573264023
AN3-CA,3854666,0.7881289812333258
NCO2,navitoclax-pluripotin (1-1 mol-mol),-4.78878940254669
KMRC-2,10302451,2.956766072446153
SKM-1,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.9272317692561286
A4/Fukuda,decitabine-carboplatin (1-1 mol-mol),0.1179398036962416
SEM,24889392,-0.6485372818048298
ESS-1,44607531,1.6327452604769903
HSC-4,135999136,1.7584955345229645
HuT 78,3081361,3.7119512098568945
BT 248,navitoclax-gemcitabine (1-1 mol-mol),0.2474795408705132
HCC2218,9935249,-1.250761387060799
BT 504,11507802,1.683396503304019
A4/Fukuda,6450551,1.0528971846899622
NCI-H2081,46199207,1.540391568515102
SK-LMS-1,216468,3.93467689992105
HuT 78,11152667,-1.8885306635916228
EJM,1750826,-2.1256322025072323
NCI-H2172,216468,5.592406085337583
OE21,2708,5.840495936667117
Aska-SS,73707398,1.256290456128312
NCI-H2110,5284616,3.413803921011568
KYSE-410,10127622,6.217588658348878
NU-DHL-1,56973724,1.6300802460905772
MCAS,3038522,3.685183083956727
NU-DHL-1,54596558,4.252396729652346
LNCaP clone FGC,135440466,3.277240111201423
BT 248,5284616,2.1714532824885473
PE/CA-PJ34 (clone C12),216345,4.0155895974355555
EJM,selumetinib-JQ-1 (4-1 mol-mol),1.9175380074632984
IST-Mes1,5566,2.9881744281003373
GOS-3,11234052,4.638302294933858
NCI-H2110,11364421,-5.382703147813924
CA46,53481919,3.755788894439918
KYSE-70,26596,-1.4453873864890578
SK-MEL-1,52947716,-7.074518315407896
Raji,71466380,3.4025085363686376
PE/CA-PJ49,71680916,4.792524361784542
YKG-1,4917,3.898835828558946
LoVo,375860,-0.1162329718395109
OAW28,135398516,2.0767833136681437
AU565,selumetinib-decitabine (4-1 mol-mol),5.684619389149027
HSC-4,9444,4.231424733159592
NU-DHL-1,selumetinib-piperlongumine (8-1 mol-mol),1.0467236701826856
SW1990,5329102,1.774987171180741
Ku812,123631,1.6677708488644187
KYSE-410,3081361,2.1077424153727535
EJM,168313016,4.883313185195125
Ku812,25262965,-2.692215385678303
CA46,135398738,2.145043320547598
PaTu 8988s,135421197,1.1460063606701134
HEC-151,56946209,-4.508348377915924
KMS-20,16741245,4.955396324130607
KMS-20,6914657,-2.6641551420146277
SNU-1033,4096211,2.270906667975924
MM1.S,4259181,0.3083006728289762
Kasumi-2,7251185,0.9050560163252253
SNU-1272,44607531,2.5999559202839384
Hs 683,135875424,4.08610069423659
JIMT-1,135398516,2.510359051442101
Aska-SS,6252,2.0109053160371495
TE-15,16736978,2.388321065089742
AU565,156422,4.303267692822867
BT 320,sirolimus-bortezomib (250-1 mol-mol),1.2360663463766004
AU565,71466445,4.046585104708946
KP-4,25183872,-0.6810408036254354
Kasumi-2,9956119,1.4541571674658873
HARA [Human squamous cell lung carcinoma],5291,4.037970789679042
H-STS,11427553,1.5169535049673049
MCAS,151289,1.3537471569868331
WM983B,11238147,2.6064740410873313
SNU-1272,6918837,-2.3331308300912332
GOS-3,46224516,1.1736861645065142
SNU-1033,4917,2.624881391157713
MM1.S,8515,6.088299107521539
NCI-H2110,salermide-PLX-4032 (12-1 mol-mol),5.468211494078165
OAW28,11152667,0.0990704789630026
KP-4,448949,2.4235294348887733
EJM,9929138,6.263891211273599
AN3-CA,selumetinib-navitoclax (8-1 mol-mol),2.227792232631343
KP-4,navitoclax-sorafenib (1-1 mol-mol),2.387001258454205
SK-N-AS,carboplatin-UNC0638 (2-1 mol-mol),2.9779855493631433
RPMI-7951,11364421,-4.7201296636782795
RERF-LC-A1,49836020,4.4326562717782005
NCI-H2110,4917,3.7009084145755216
Hs 683,216239,2.6289304351017595
PE/CA-PJ49,24772860,-2.410818078519462
SKM-1,136227924,2.5339244468963407
H-STS,2828334,6.0228832587508006
WM983B,piperlongumine-MST-312 (1-1 mol-mol),2.3377069137678066
BT 330,7326481,4.958680714168664
D283 Med,11955716,-2.6841002299683336
SK-N-AS,24180719,3.641877528230763
KYSE-410,10410894,3.2952841577918774
NCI-H2081,104842,-6.196868817242243
AN3-CA,3025944,4.226836027530371
Aska-SS,6610216,4.460274887229386
NCI-H2081,11455910,0.9023670010212674
NCO2,selumetinib-MK-2206 (8-1 mol-mol),0.5445005400828021
Hs 683,73707398,1.2895938784946597
NCI-H2110,24951314,1.7833745955098474
SW1990,5281321,-2.022256600799693
Kasumi-2,10113978,2.7713645825563153
PE/CA-PJ34 (clone C12),54596490,5.097353286236204
LNCaP clone FGC,6852167,3.159871073492599
NCI-H1092,10074640,3.1933502668870464
NCI-H1395,5329102,2.4714501130754294
BFTC-909,12001922,1.803559970478093
KYSE-410,1716436,2.7110967894013847
KMS-20,45279963,3.236905004417033
MCAS,16720766,0.9829581263949466
SK-N-AS,9935249,1.6086220249478496
JIMT-1,46907787,4.113382124971396
PE/CA-PJ34 (clone C12),426756,4.422998932397389
WM983B,49793307,1.698638022841096
KYSE-410,docetaxel-tanespimycin (2-1 mol-mol),-4.488089598990408
OE21,9933475,1.3312258090067837
SET-2,57519531,1.5815611603941668
KMBC-2,44491742,4.484748547607026
PaTu 8988s,9926054,1.8956430403525124
LoVo,654092,0.3814222362545946
NCO2,11656518,-0.7631050697296534
SK-MEL-1,124202324,3.0885647549901707
TE 617.T,9926054,1.7506239081922086
OAW28,11396600,3.5740319462685535
LoVo,11238147,1.4038592423826672
KYSE-410,54649381,4.165413744231657
HARA [Human squamous cell lung carcinoma],docetaxel-tanespimycin (2-1 mol-mol),-6.628155731353656
OAW28,vorinostat-carboplatin (1-1 mol-mol),2.457555978857692
KYSE-70,selumetinib-GDC-0941 (4-1 mol-mol),1.855556078867097
SET-2,148198,-7.743060156944655
EJM,17755052,2.369354031148252
KMRC-2,446155,4.179289387738745
KMRC-2,24901704,3.4652957344934787
BT 248,753704,4.567621051188063
HSC-4,24821094,3.2038955653523713
Hep-G2,119607,5.22772984823061
OAW28,46174525,4.143540766033049
YKG-1,25102847,1.9293075860384323
KMBC-2,123631,1.9610940520550155
KYSE-410,UNC0638-navitoclax (1-1 mol-mol),2.9728532369388425
H-STS,676352,1.5630553052267655
HuT 78,36462,0.7819646320410331
SK-MEL-1,52912189,1.2295049671911489
KMS-27,11626560,0.5459873226362797
LNCaP clone FGC,71466578,2.9422708697309377
RPMI-7951,16038120,0.7557486439637527
NCI-H2081,6918328,-1.921531809564582
NCO2,15983966,-5.066327542257379
SK-MEL-1,4788,5.719996521880845
ESS-1,54596490,4.349195883265103
BFTC-909,654092,0.6323398211983356
NCI-H1092,151289,2.971736983161978
SK-N-AS,24753719,3.666987280744212
YH-13,36462,2.0221735206643743
NCI-H1092,SNX-2112-bortezomib (250-1 mol-mol),0.0447588085081416
NCI-H1395,6917907,2.884455684924325
NU-DHL-1,72734382,3.1751450889524593
Hep-G2,46843906,2.934188713214244
BT 248,10410894,2.478264779428893
BT 320,3552672,1.9342456765414169
NCI-N87,2841722,4.410495760007658
SW1990,selumetinib-BRD-A02303741 (4-1 mol-mol),3.2981500130451753
NCI-H1395,23582824,0.9688847884522048
SK-N-AS,JQ-1-UNC0638 (2-1 mol-mol),0.8581123748547943
SK-N-AS,25126798,4.02497951005336
BT 139,15953870,4.456672182655599
SNU-1033,44589607,3.2892143664644142
RERF-LC-Ad2,11152667,0.7033188335171204
NCI-H2110,2746,2.5947990205927405
SET-2,11427553,1.302198083186921
Kasumi-2,selumetinib-navitoclax (8-1 mol-mol),-1.4155555334459644
GOS-3,54618164,5.027817061073729
RERF-LC-Ad2,2749,2.8556039448512314
NCI-H2172,6610216,4.169971132764112
Raji,10113978,1.8720249970674376
YH-13,387447,-4.910282103327875
KP-4,44607531,2.2938853216764987
KMRC-2,322968,3.4299636827157003
HEC-151,327653,2.9802978395573123
SNU-8,54613361,-0.0435743875336692
SNU-1214,BRD-A02303741-navitoclax (2-1 mol-mol),-0.2601448097331313
BT 139,BRD-A02303741-navitoclax (2-1 mol-mol),1.9732620235846352
RERF-LC-A1,navitoclax-MST-312 (1-1 mol-mol),0.841884147703823
SW1990,135398738,4.6011979379855665
BT 248,2708,3.971792549478314
JIMT-1,3062316,-0.2153664006727099
HEC-151,4259181,-0.935569196791714
HCC2218,9884685,-1.464365341774582
Aska-SS,49766530,-1.4586728518943333
KYSE-70,67156097,-2.3379446798215127
KP-4,16219061,2.8645986536697965
OAW28,6610216,3.9661844518771185
OAW28,3503,2.6573145013500743
OAW28,262093,2.853078829548121
NCI-H2081,54626689,4.922665584817983
HSC-4,51039095,3.5449735354798
AU565,60700,-0.684074891390158
LoVo,16722836,0.1488668556579147
SET-2,89183176,2.321946976910911
SKM-1,107970,2.3266449159028735
PE/CA-PJ34 (clone C12),54618305,4.348682714943588
SNU-308,3025944,4.421498495522431
SNU-1214,erlotinib-PLX-4032 (2-1 mol-mol),0.9511109417824108
MM1.S,71466578,0.9736156366581122
SW1573,135411,2.599466343128946
HARA [Human squamous cell lung carcinoma],374536,3.8012573814376567
Hs 683,4705,2.6530339386806476
GOS-3,17755052,3.2453279413753147
Aska-SS,9933475,1.583955769626178
KYSE-70,24180719,3.52071426185984
NCO2,46907787,-1.209980225717052
OAW28,5746,2.6048591865024657
PaTu 8988s,969516,3.9630929777783663
HARA [Human squamous cell lung carcinoma],452548,-0.3270885928487969
MM1.S,72734382,3.2405632872404233
RERF-LC-Ad2,444795,4.5594337932678455
Kasumi-2,1242560,3.251932247793875
BT 320,15983966,3.4202708205912087
HuT 78,selumetinib-decitabine (4-1 mol-mol),-2.9552795966960823
WM983B,42642645,1.301241234400086
IST-Mes1,219104,4.071310239310072
HMCB,23635314,-3.4339046991489743
BT 139,25161177,3.287797573016262
Kasumi-2,10410894,1.8135964606255892
HEC-151,46215462,3.299053185970681
BT 330,9911463,3.351892794022171
HCC2218,2742550,3.114607696672168
MCAS,24748573,-1.0691794347023724
TE-15,11656518,2.447571109654658
NCI-N87,5479543,3.770784511292927
WM983B,135421197,2.3980917008752725
SNU-308,9936388,-0.5886369856263455
HMCB,11507802,1.157749348598854
LNCaP clone FGC,56949517,2.4559029214773824
MCAS,10231331,-0.2141548705956653
HEC-151,124202324,2.4256348200617452
HARA [Human squamous cell lung carcinoma],44507138,3.9193587835112
KMS-20,9933475,1.7150335171182485
BT 320,53393127,4.811652436573408
BFTC-909,23939,4.493588141952023
OE21,135398516,0.478939949697748
ESS-1,44462760,5.293674505936234
SNU-1214,54639024,4.425030534008987
PE/CA-PJ34 (clone C12),24772860,-2.582582767798194
ESS-1,6438330,2.0697444258880173
SK-MEL-1,16725315,3.7157639868390113
SK-LMS-1,4477,0.1265946384524251
OE21,6918328,-0.8017876191186217
OAW28,107985,-3.5497769626209217
HARA [Human squamous cell lung carcinoma],54454,2.560964814308564
KMBC-2,135875424,3.177506278142116
SK-LMS-1,24951314,2.160829965238104
D283 Med,11152667,-1.23900039901842
OAW42,5329102,1.734444168913986
SKM-1,6450551,0.4724418001355981
ML-1 [Human thyroid carcinoma],8515,2.907082200923046
OE21,4096211,1.2391392667305623
OAW28,5282054,3.6220988157242946
EJM,decitabine-navitoclax (2-1 mol-mol),0.2249299573101983
HSC-4,BRD-K27188169-navitoclax (2-1 mol-mol),3.591026933435327
Ku812,9549297,1.3276484644733737
D283 Med,123631,1.7488376783176118
EJM,46843906,2.2065096868149294
ESS-1,446155,0.8462553588843746
HuT 78,676352,2.2606140524406984
NCI-H2110,9823820,4.01768744149593
EJM,5291,3.786529645155132
H-STS,54143018,0.5439646012734883
HARA [Human squamous cell lung carcinoma],54618305,5.079823174852019
NCI-H1092,navitoclax-piperlongumine (1-1 mol-mol),0.63980848570381
NCI-H2081,637858,0.9384843122739523
NCO2,57519531,1.4575682087802182
AU565,selumetinib-JQ-1 (4-1 mol-mol),3.812986745391109
A4/Fukuda,selumetinib-GDC-0941 (4-1 mol-mol),-1.0916711617769086
NCI-H2081,10127622,5.641065202822249
JIMT-1,4096211,2.268308216863952
Aska-SS,2749,2.558429780989752
HEC-151,6918289,2.9359862334604085
ESS-1,vorinostat-carboplatin (1-1 mol-mol),3.745022747956192
RPMI-7951,alisertib-navitoclax (2-1 mol-mol),0.5274498370004379
SK-N-AS,644241,2.0495505337377393
HEC-151,11964036,2.8276517069986027
SNU-1033,12001922,1.3471825847750112
TE-15,2733526,4.691356739445882
OE21,11625818,4.024138239241509
BFTC-909,11507802,1.7199271215311116
SKM-1,16722836,0.5905694358336332
NCI-H2081,3385,5.204021808998722
KMRC-2,54765302,3.811296252656916
MCAS,322968,4.019295540139923
CML-T1,20959075,-3.2800173274392983
IST-Mes1,crizotinib-PLX-4032 (2-1 mol-mol),1.4798286107475835
RERF-LC-A1,56963564,-0.131127043846449
JIMT-1,445091,5.374656804563228
LoVo,285033,-2.045623665035502
Aska-SS,168312962,3.7841820579012864
BT 139,25102847,3.0960881456640954
NCI-N87,656346,-0.0410900008101642
KYSE-410,11612883,2.6710093722065875
OAW28,vorinostat-carboplatin (1-1 mol-mol),2.457555978857692
PE/CA-PJ49,10322450,5.083749464761158
AN3-CA,11955716,-2.3983129306617808
ESS-1,11178236,-5.021714388014341
BT 328,448949,2.700509720099411
SEM,5978,-6.46174172667932
SNU-1214,119607,5.217980812355715
KP-4,675434,4.172438441595691
D283 Med,216345,1.9831386358290584
LoVo,tanespimycin-gemcitabine (1-1 mol-mol),0.1756680673297083
ML-1 [Human thyroid carcinoma],24951314,0.9772476096511332
SEM,JQ-1-carboplatin (1-1 mol-mol),-2.3661872454189634
SNU-308,637858,3.38776683487698
NCI-H1092,11455910,0.2647471022018075
RERF-LC-A1,5311,1.1178326001171262
NCI-N87,637858,1.7879892218708664
HARA [Human squamous cell lung carcinoma],123631,2.9564926917309635
HMCB,25126798,4.221661983457504
SNU-8,6918736,-2.3375998846881543
SEM,42642645,-5.09846827798555
AN3-CA,25102847,0.707734828928581
BT 504,11719255,3.4197657367599765
SEM,BRD-A02303741-carboplatin (1-1 mol-mol),3.6880829932604247
RERF-LC-Ad2,16065773,2.896033119143574
BT 330,23635314,-1.0389926397651292
BT 330,52947716,-8.855474291024809
HEC-151,441298,2.008915484481665
KMBC-2,navitoclax-piperlongumine (1-1 mol-mol),-0.7575567643300402
HARA [Human squamous cell lung carcinoma],11178236,-2.833191042701781
SEM,SNX-2112-bortezomib (250-1 mol-mol),-3.272404633264421
BFTC-909,3384730,4.46542670181497
NCO2,16741245,2.188809083459236
JIMT-1,44607531,1.6281393475781123
LCLC-103H,carboplatin-UNC0638 (2-1 mol-mol),4.047221694463868
PE/CA-PJ49,6184667,3.0743635737706287
JIMT-1,676352,2.76517027589877
KYSE-410,2729026,2.3808934175081378
TE-15,11427553,2.4729252663942685
AU565,11507802,1.2242731086346843
IST-Mes1,65064,5.185430309398801
PE/CA-PJ34 (clone C12),4477,0.7585627353016603
TE-15,salermide-PLX-4032 (12-1 mol-mol),5.474506118716033
SK-LMS-1,selumetinib-GDC-0941 (4-1 mol-mol),2.0421958472836335
A4/Fukuda,15983966,4.102938700353478
SNU-1033,25227462,-2.9576169404781947
OAW42,6918638,1.325262653338047
KMS-20,JQ-1-carboplatin (1-1 mol-mol),-1.0722659574284303
OAW42,5311,2.221158806378111
JIMT-1,4788,5.948014419187362
BT 248,selumetinib-UNC0638 (4-1 mol-mol),4.192258549840557
OE21,4259181,-0.2444735464140802
MM1.S,73707386,0.9217883452214084
H-STS,erlotinib-PLX-4032 (2-1 mol-mol),4.123094127064452
KMBC-2,262093,2.431705852322835
SK-MEL-1,erlotinib-PLX-4032 (2-1 mol-mol),2.98736872317439
OE21,selumetinib-tretinoin (2-1 mol-mol),0.421110586770226
KYSE-410,selumetinib-MK-2206 (8-1 mol-mol),2.2155459155232182
NU-DHL-1,9826308,0.2321848028640403
BT 320,375860,4.032556785404055
AU565,44632017,0.8977842888684593
LCLC-103H,6918878,2.1817193013668157
NCI-H2110,5328940,1.6135446259472608
SET-2,10113978,3.44756755844501
KYSE-410,44632017,4.131355537094701
KMBC-2,ISOX-bortezomib (250-1 mol-mol),0.6592727050482347
HEC-151,46843906,4.015581502156025
BT 328,6914657,-4.350943519439018
BT 248,1716436,2.58950342299198
OAW42,11626560,2.8357734174407243
BFTC-909,9911463,4.114346930944119
SW1990,11238147,2.1916804245922217
Kasumi-2,72376,-3.459838502439841
BT 248,54618771,0.8718785044821341
AU565,9911463,3.1332064122278687
BT 320,11455910,4.86644863423661
HEC-151,54618164,3.8374774746461706
OAW28,89183176,4.823946494889004
SNU-8,selumetinib-vorinostat (8-1 mol-mol),1.098702489226645
OAW42,3503,2.8996474822841285
Aska-SS,54649381,3.801699572591553
SEM,23725625,1.850131021404486
Raji,serdemetan-SCH-529074 (1-1 mol-mol),2.061630355858183
SK-N-AS,11625818,4.772166431765391
D283 Med,11497983,0.3282977330400873
OAW28,5746,2.6048591865024657
SK-MEL-1,doxorubicin-navitoclax (2-1 mol-mol),-1.5657162610852515
YKG-1,23582824,0.6705184906158483
SKM-1,135411,-0.1897153244847568
RPMI-7951,10385095,1.3251666848544306
MM1.S,24901704,2.7745891166557786
SK-LMS-1,72376,-1.9296704821697563
TE 617.T,42642645,0.6329124315380535
Hs 683,2949965,2.6175575845695933
YKG-1,5280436,2.781391544714978
KMS-27,selumetinib-vorinostat (8-1 mol-mol),-1.5585431850605205
HEC-151,navitoclax-piperlongumine (1-1 mol-mol),2.1681324903190147
YKG-1,89928392,2.561295118158604
SW1573,16725315,3.253832365815957
YH-13,11964036,1.205712988485349
Raji,10127622,5.596219893755101
WM983B,56946209,-4.125540259013796
RERF-LC-A1,2945648,2.841081708390336
SEM,5281672,3.3448340158126055
Hs 683,426756,5.100809290243355
BFTC-909,16722836,1.424017650466323
NCI-H1395,44589607,3.310256586301432
RPMI-7951,44819697,-0.9414715677570764
PE/CA-PJ49,984333,1.495833138659802
KYSE-70,219104,3.9271840577372705
SK-N-AS,3634881,3.3849445885867517
HARA [Human squamous cell lung carcinoma],241158,4.240217877475157
SNU-308,6505803,-0.8731800664163156
LCLC-103H,5311,1.5725563498835111
SNU-1214,322968,3.163367067092735
SW1573,23725625,4.357604161446221
HCC2218,4261,0.480758694129974
IST-Mes1,24180719,3.838804357743771
BT 330,salermide-PLX-4032 (12-1 mol-mol),3.272323891336513
HARA [Human squamous cell lung carcinoma],3854666,0.7328632401261175
SKM-1,9911830,2.174138233230932
SK-N-AS,10127622,0.7323259658130998
HSC-4,6918328,0.4827098957230251
HSC-4,11455910,0.337268703123225
PE/CA-PJ34 (clone C12),selumetinib-decitabine (4-1 mol-mol),1.8573238716263332
BFTC-909,5329102,1.9658448878596055
PaTu 8988s,6610216,4.229616892314871
KP-4,3062316,2.9758786475429195
AN3-CA,15983966,-4.416614083786217
LNCaP clone FGC,11507802,2.5099467265832915
BT 328,31703,-0.2898094024615853
NCI-H1395,11626560,2.322318216024447
IST-Mes1,11222830,1.7720886037954378
KMS-27,44632017,0.8900196687878457
KP-4,2733526,3.3373615423632192
BT 328,1566236,2.4214904059930156
HMCB,119607,5.35343199280946
KMS-27,11964036,0.90121658773837
SNU-1033,5291,3.6453584755644366
LoVo,6252,1.008875569338637
HSC-4,9826308,3.3704185574061456
NCI-H2110,11178236,-2.385448769325721
ML-1 [Human thyroid carcinoma],JQ-1-vorinostat (2-1 mol-mol),1.0159563388217403
HSC-4,208908,1.4999275809756432
NCI-H2172,4788,5.873949794280354
SK-MEL-1,JQ-1-carboplatin (1-1 mol-mol),3.273117082595556
KMBC-2,44489675,4.815586661350087
MCAS,crizotinib-PLX-4032 (2-1 mol-mol),2.21255914817553
OAW28,65064,5.229460149894731
EJM,10410894,1.930744280371102
EJM,72199292,1.3006755250597923
SK-LMS-1,25062766,3.3547965546318324
PE/CA-PJ49,11626560,1.499452370410067
HSC-4,445643,4.123722857917103
RPMI-7951,136227924,2.219680452566263
KYSE-410,5311281,2.9358960951405817
NCI-N87,216239,2.2423368269273753
MCAS,36314,4.089980392616843
CML-T1,navitoclax-MST-312 (1-1 mol-mol),0.6606923209980897
Kasumi-2,25161177,3.916701757551495
AN3-CA,46191454,1.6354260060942205
SEM,637858,0.6523373975707702
BT 330,9825149,1.038089152704002
Hs 683,1641662,3.565270683929052
AU565,60750,-2.174078373186638
KMBC-2,tanespimycin-gemcitabine (1-1 mol-mol),1.4795294977237738
GOS-3,piperlongumine-MST-312 (1-1 mol-mol),1.994862701912013
HSC-4,135411,-0.261300177061483
H-STS,6505803,0.5486553702983976
Aska-SS,9907093,3.884182057089656
Hs 683,6505803,-1.9207933299910505
BT 330,67156097,3.647776091251183
PaTu 8988s,25150857,0.8411246368631857
SNU-1033,6610355,4.276058849180123
TE-15,107970,2.289738953976788
BT 504,5738263,3.636444708254344
NCI-H2110,2945648,3.4982521508878763
IST-Mes1,51037431,5.172794571797409
BT 504,navitoclax-gemcitabine (1-1 mol-mol),-2.4811281686912356
HARA [Human squamous cell lung carcinoma],42642645,0.3266919515257925
BT 139,73707398,1.451350595417811
ML-1 [Human thyroid carcinoma],44185566,2.5450411112530475
Kasumi-2,53392493,1.5560274267449214
NU-DHL-1,24978538,-3.3743364704490224
NCO2,decitabine-navitoclax (2-1 mol-mol),-3.540424950180813
NCI-H1092,89928392,0.7576351526304943
NU-DHL-1,54678924,1.1302571335689575
TE 617.T,vorinostat-navitoclax (4-1 mol-mol),1.1998993642927214
LoVo,219104,3.1119995266948237
MCAS,2746,3.159271623653468
KMS-20,5978,-3.862125436085328
NU-DHL-1,JQ-1-carboplatin (1-1 mol-mol),-1.21461572309572
IST-Mes1,salermide-PLX-4032 (12-1 mol-mol),6.709164103992604
AN3-CA,72193861,0.4572966127744896
AN3-CA,44607530,0.9977206657387836
ML-1 [Human thyroid carcinoma],decitabine-carboplatin (1-1 mol-mol),4.481069697343496
NCI-H2081,2871966,0.7006851296353342
Kasumi-2,46843906,1.3893397569967554
CA46,4578,4.451375135730711
NCI-H1092,2749,2.105029797010796
BT 139,11178236,-1.4908860807124438
MM1.S,3081361,2.3105527639319097
SET-2,55283,3.9035205221786664
NU-DHL-1,tretinoin-carboplatin (2-1 mol-mol),1.578778354574034
SET-2,637858,1.0371530211435662
BT 328,5351362,3.058518390164376
NCI-H1395,10074640,3.7402432932443137
Raji,57519531,1.2334704389871811
WM983B,5311,2.0481944502348295
KMRC-2,4259181,1.2333196545111071
BFTC-909,9927531,5.31835549136936
OE21,selumetinib-GDC-0941 (4-1 mol-mol),0.0714781013058572
Raji,446155,3.9594959965174543
SET-2,vorinostat-carboplatin (1-1 mol-mol),1.5706437227758208
OAW28,crizotinib-PLX-4032 (2-1 mol-mol),2.110933622393645
Hs 683,16736978,1.840534683645933
WM983B,44566777,0.3326986329257097
HEC-151,44202524,1.4448897283808455
SK-MEL-1,vorinostat-carboplatin (1-1 mol-mol),3.606190776062645
KP-4,3081361,3.8659709447157815
Ku812,9826308,-0.187387651853026
IST-Mes1,2871966,0.3614602719279896
WM983B,969516,2.923117236784819
EJM,123631,3.178477510788884
OE21,docetaxel-tanespimycin (2-1 mol-mol),-6.983016683122649
BT 139,navitoclax-MST-312 (1-1 mol-mol),0.7116034048397698
SW1990,156414,1.6914107782596666
NCO2,426756,5.118302207503611
SW1990,10231331,2.104617413508516
Hs 683,44607530,2.2726737213749564
Hep-G2,4788,5.9429406045428586
AN3-CA,11640390,3.6086639972683554
YKG-1,107970,2.756113266406284
HMCB,25262965,-1.6581729760544606
H-STS,JQ-1-navitoclax (2-1 mol-mol),0.1797969837721217
SNU-1214,9907093,4.1629772242299365
AU565,439501,-2.8703859168743384
NU-DHL-1,44137675,1.8440314002595644
TE 617.T,135875424,2.9015039808938483
HuT 78,44819697,-0.2139990316964177
SW1573,salermide-PLX-4032 (12-1 mol-mol),4.9189296859442315
HSC-4,5280436,3.1415705358429884
LoVo,6438330,1.2087527750724023
CA46,docetaxel-tanespimycin (2-1 mol-mol),-7.203765496579748
BT 248,selumetinib-JQ-1 (4-1 mol-mol),2.943393356661563
BT 139,tanespimycin-gemcitabine (1-1 mol-mol),-3.724124078532147
SEM,9956119,1.5287909021793558
SET-2,11485656,1.7886595096067897
LCLC-103H,2749,2.3536386264122897
OAW42,24978538,2.903847751640872
OE21,JQ-1-UNC0638 (2-1 mol-mol),0.7092763534327602
SNU-1214,52912189,1.010183035410781
SK-LMS-1,16013152,4.349323816725978
NCI-H1395,navitoclax-pluripotin (1-1 mol-mol),0.5678965327909137
LoVo,71304818,2.0724805960279027
Kasumi-2,4521392,4.1748849427500625
BT 139,docetaxel-tanespimycin (2-1 mol-mol),-4.169767352390419
NCI-H1092,5328940,2.2239525200024812
SK-LMS-1,25105715,3.7582919754579938
HEC-151,136227924,2.850288220591168
MCAS,11396600,3.718076439368648
AN3-CA,216468,2.584012324066889
RERF-LC-Ad2,7251185,1.8072338580113816
HARA [Human squamous cell lung carcinoma],25183872,-0.077265330214196
YKG-1,11178236,-5.715271869049359
OAW42,6450551,3.6149025185851418
YKG-1,10302451,4.0412794748223835
Aska-SS,selumetinib-piperlongumine (8-1 mol-mol),4.134540064953037
A4/Fukuda,613753,2.966875582154842
NCI-H2110,15983966,-4.372575735276371
Hep-G2,6918837,-3.422320688651726
ML-1 [Human thyroid carcinoma],12001922,2.2640831281012916
JIMT-1,71304818,3.0755973540657906
AN3-CA,11497983,4.368419442647311
ML-1 [Human thyroid carcinoma],44491742,4.3341380025681175
MCAS,2874250,5.406237635191556
Hep-G2,5282054,4.608034876508238
HMCB,60700,1.0606608504131512
SK-LMS-1,24785538,2.5373488880819157
WM983B,24771867,3.973677625635561
SW1573,44185566,2.872643000979188
A4/Fukuda,100016,4.8831896191852096
EJM,5746,0.8997924429706388
HSC-4,1716436,3.018983829466311
MM1.S,36314,1.7843068012903331
KP-4,piperlongumine-MST-312 (1-1 mol-mol),1.2024606545381415
TE-15,44185566,2.9529174101649796
BT 330,568763,0.0623204630185717
NCI-H2081,119182,0.5857992910725418
OAW28,54649381,3.786658613217657
Raji,2729026,2.2038396204117503
SW1990,54618305,4.718025842071016
YH-13,11404337,1.1602704800571209
KMS-20,16720766,-0.6400494103311998
KMS-20,387447,-4.754784447636382
Ku812,421610,4.009209669697973
SK-N-AS,decitabine-carboplatin (1-1 mol-mol),4.4291297187741065
Hep-G2,10231331,-0.8368419788063003
ESS-1,5287620,-2.0869622348593624
JIMT-1,219104,4.063810189257062
HuT 78,25161177,3.1402397670522877
LCLC-103H,613753,3.297001367545156
KYSE-70,1716436,3.404085131889099
LCLC-103H,25062766,1.6835820129417671
WM983B,9826308,-0.292993493547983
ESS-1,5978,-3.0981583425056787
KMS-27,9915743,0.5712823893171636
RPMI-7951,6438330,2.3921336529099357
KMS-20,24180125,1.3264637419284662
TE-15,15983966,-0.6041186145494649
BFTC-909,8515,4.73152093133166
LoVo,71680916,4.224958300762603
SNU-8,65064,2.9443742563963555
ML-1 [Human thyroid carcinoma],9952709,4.669340472029816
BT 139,25154868,4.942516527102922
PE/CA-PJ34 (clone C12),6918837,-2.593805851370388
OAW28,11977753,-1.87780111267196
OE21,9956119,3.601171000116071
SEM,11964036,-0.8070570708115667
AN3-CA,4261,2.1641897406909285
LoVo,54618164,3.038824107117225
LoVo,374536,3.1459286411718055
IST-Mes1,docetaxel-tanespimycin (2-1 mol-mol),2.3952937403433685
D283 Med,23939,4.340055640528423
NCI-H2110,54143018,1.0459653529397772
Kasumi-2,11167602,2.198810465874189
CA46,54678924,0.940253932332064
MCAS,24964624,2.6917475181600388
KYSE-410,2842253,4.506572282444764
D283 Med,9952709,1.9575920153591797
NCI-H1395,2708,5.386847702037966
SW1573,vorinostat-navitoclax (4-1 mol-mol),1.892054443323453
Hs 683,65064,5.005451582048715
OAW28,676352,1.7843387493833531
Kasumi-2,1566236,1.00471674851072
NCI-H1395,36314,2.584917869739777
RERF-LC-Ad2,24753719,4.674751178496499
NU-DHL-1,2746,0.9771874808438498
NU-DHL-1,5978,-4.279769734598632
MCAS,46843906,3.427852323124774
KMS-27,11455910,0.2864489394234576
BT 320,2828334,6.462824713587457
YKG-1,49867926,5.593368072360718
AU565,16736978,1.4090353018278403
KMRC-2,44566777,2.916165299357533
SK-N-AS,11977753,-2.0255062128731196
MCAS,25150857,3.0365638700183424
HuT 78,26596,-1.9929249611117947
SW1990,54454,0.8815842407729143
Aska-SS,44607531,1.822137800218542
CML-T1,54619267,3.062776009775362
KMRC-2,53232,5.206621782747443
SKM-1,5328940,0.3112400146687634
H-STS,65064,3.392920845714817
OE21,702558,5.698291072797489
BT 330,2746,4.080308483434876
SNU-1214,10231331,0.2722984048431807
HSC-4,568763,1.3764913265299208
MCAS,5566,3.352816905659856
SET-2,25105715,3.703330817780227
HEC-151,17755052,1.492406720227873
HARA [Human squamous cell lung carcinoma],9823820,4.297752192216693
PE/CA-PJ34 (clone C12),15983966,4.022628798760432
SNU-8,44491742,5.735879763811486
SNU-308,JQ-1-carboplatin (1-1 mol-mol),5.335805605025179
JIMT-1,6610355,5.989276746101715
HEC-151,3062316,-0.2172135639655068
SK-LMS-1,11955716,-1.5913671626842558
CML-T1,25154868,3.739287072403725
LCLC-103H,168313047,2.9871523947187306
OAW42,5287969,-2.2045001719880273
BT 504,1750826,0.3670940783180309
OE21,26596,-3.6158126221637823
MCAS,10427712,4.5640470140597165
LNCaP clone FGC,46907787,-0.4203114771143783
OAW42,216239,2.4908530518587533
ML-1 [Human thyroid carcinoma],11214940,1.6315509593699482
HSC-4,126941,-2.3076253927529127
SKM-1,71466380,3.1609741047778965
KMBC-2,3385,5.16637302671959
YKG-1,2746,3.802533592415727
WM983B,24978538,1.199415805684907
SK-MEL-1,3025986,1.1302454580451071
SEM,9927531,4.847523560791686
HMCB,16659841,4.044533184021594
SW1990,6914657,-2.9873541347075774
BT 330,135421197,3.0606427160011433
YKG-1,156422,4.407092102753243
H-STS,53495165,-1.641069756041938
EJM,tretinoin-navitoclax (4-1 mol-mol),2.7267851224914854
Ku812,57330099,2.587307401238269
EJM,208908,2.014256342304326
SEM,selumetinib-navitoclax (8-1 mol-mol),-0.6843578882476046
JIMT-1,56963564,0.7284787251362428
CML-T1,72376,-3.431780344099396
TE 617.T,16219061,2.878352247115407
NCI-H1092,23725625,4.586662466959233
HSC-4,64971,1.7199562834608897
HMCB,44819697,-1.3294210375282771
SW1990,9911463,4.278474352365717
KMS-20,16219061,1.4676215792149392
SK-N-AS,156422,4.603989835385585
SNU-1214,11625818,2.8882147103355043
EJM,11364421,-6.655313631459131
RERF-LC-A1,12001922,1.989956989154949
SK-LMS-1,24964624,3.0877384242952903
SK-LMS-1,439501,-2.6023396475730967
KMS-20,9866186,-0.9814068490558976
NU-DHL-1,selumetinib-decitabine (4-1 mol-mol),-0.5267480512116699
RERF-LC-Ad2,11485656,2.920676874689175
BFTC-909,15983966,-4.834157449814871
LNCaP clone FGC,tanespimycin-bortezomib (250-1 mol-mol),-2.6061183463030138
A4/Fukuda,1641662,2.3667755294261297
OAW42,16038120,1.5643750388834057
YH-13,10127622,5.098767589051213
SNU-1033,6438330,2.412682257725534
BFTC-909,4378219,4.497242068417329
SNU-8,24775005,3.6289506087302015
HEC-151,753704,4.907356002546064
OE21,erlotinib-PLX-4032 (2-1 mol-mol),-1.4046764949857564
TE 617.T,5287969,-2.246039947920682
NCI-H2172,135440466,3.920075838881322
YH-13,44202524,1.4196385072137423
BT 504,10184653,1.7591667973560186
BT 139,613753,3.3719914419642376
CA46,2729026,2.6315261399645755
OAW28,2828334,6.258958244852924
YKG-1,9884685,-0.1545508204895388
BFTC-909,46398810,2.674147192871529
SK-N-AS,53232,3.4826205512179436
D283 Med,57519531,1.3990443657534628
H-STS,5746,0.9486967341675628
NCO2,16720766,-1.7446420439566903
SNU-1214,104842,-1.1109200217804778
SET-2,10184653,0.8254197833466991
NCI-H1092,17755052,3.7440295863343342
KMS-27,46174525,3.4749969625152604
MCAS,72376,-3.5735765785817373
TE 617.T,6505803,-2.094273905964543
WM983B,11427553,3.2258665701767875
SKM-1,168313047,1.823669024693072
Kasumi-2,11485656,1.64011250363507
Ku812,136227924,2.6493599225721742
LNCaP clone FGC,11612883,2.993446616877049
NCI-H2081,9911463,2.5760332235225016
AU565,11612883,2.0019521527087982
BT 328,3384730,1.2152683647278577
SNU-8,54143018,-0.3270913068576444
Kasumi-2,46943432,0.9724659287269805
NCI-H1395,11228183,4.844045820829891
TE 617.T,11612883,2.497162119511236
TE-15,72376,-1.582377580745315
OAW28,11497983,4.916879328733168
BT 328,BRD-K55473186,3.4747994390176027
YKG-1,285033,-2.298749012962292
BT 139,5460769,4.859801196456228
HEC-151,4477,1.2372126866923474
SW1573,24964624,5.100144587499453
A4/Fukuda,216468,0.7779788317268376
NU-DHL-1,5281672,2.8333763139746813
OAW28,51039095,2.7471743585791075
TE 617.T,11977753,-2.378492704797965
Raji,2749,0.6023054030818428
KYSE-410,11364421,-2.2224816076543132
OAW42,2126,4.812631411432029
PE/CA-PJ34 (clone C12),10296883,4.08655394492647
KMS-20,7326481,3.962170132504471
AN3-CA,vorinostat-navitoclax (4-1 mol-mol),1.3111669472742835
H-STS,25150857,2.2324697691811277
BT 330,24951314,0.5033054509561667
SK-LMS-1,25262965,-2.583780574879674
EJM,49793307,-4.860528919004407
SNU-1214,5460769,-0.9519860634538546
PE/CA-PJ49,56963564,-0.0152605899958885
HCC2218,9967941,1.8608671040934277
KMBC-2,4917,3.3261464777108736
KP-4,54613361,-1.758234906082912
SNU-1033,tanespimycin-bortezomib (250-1 mol-mol),-1.1601474483832803
SW1990,119607,5.501984818830774
TE-15,176870,0.8443195231211779
LNCaP clone FGC,25262965,-4.44239132451972
YH-13,46398810,3.0158285746499645
NCI-H1395,4261,3.7287687859459377
CML-T1,9884685,1.1136090650670494
GOS-3,54619267,4.509336729831847
HEC-151,5470400,-2.6727104085641376
ESS-1,5281321,-2.6789892941924034
Raji,3815108,1.348726927410812
HuT 78,4917,3.0693457272323825
LoVo,151289,0.7390860710542093
SNU-308,100016,6.582722131637771
HSC-4,11485656,2.41592786996926
SET-2,tanespimycin-bortezomib (250-1 mol-mol),0.2740236023779227
BT 504,25154868,4.869005114214688
ESS-1,2733487,7.1971924455192955
TE 617.T,16065773,1.4641864926037722
NU-DHL-1,1566236,-0.7944323454419335
NCO2,11178236,-5.51663583040708
HMCB,16725315,3.1918238782276274
BT 328,54618771,1.300712581347958
HEC-151,11175137,1.9694841907666147
NCI-H2081,445455,4.231009644823477
OE21,252682,6.2458833625766665
D283 Med,salermide-PLX-4032 (12-1 mol-mol),4.644943358179887
AN3-CA,3136844,5.019620857220237
OAW28,2708,5.3328257603707545
LNCaP clone FGC,176870,4.130944067195273
TE-15,11657048,5.376807899993406
BT 320,136227331,4.5584663350036605
D283 Med,2749,1.8420962714891145
D283 Med,4788,3.843501603973715
NCI-H1395,4378219,4.7590684323615635
NCI-H1092,7326481,2.520886584471623
MCAS,387447,-5.167136486263057
NCI-H1092,55508,4.291309194674307
D283 Med,selumetinib-JQ-1 (4-1 mol-mol),1.653180962560337
OAW42,carboplatin-etoposide (40-17 mol-mol),3.546891036077686
HARA [Human squamous cell lung carcinoma],salermide-PLX-4032 (12-1 mol-mol),5.233652502193764
ML-1 [Human thyroid carcinoma],60750,0.2716917716617745
HEC-151,11238147,1.8644347040117784
KMS-27,46907787,-0.4980850656291734
OAW28,5113032,5.506773811436986
LNCaP clone FGC,24180125,4.5156786529947714
NCI-H2172,650361,3.904571472219665
KYSE-410,10184653,-0.7069417943968711
BT 248,tretinoin-carboplatin (2-1 mol-mol),4.674619984359253
OE21,navitoclax-gemcitabine (1-1 mol-mol),-2.221611192043541
KYSE-410,2733526,3.0552963215428286
SET-2,23635314,-3.981492201444291
KMRC-2,3038522,2.4328384098536793
Aska-SS,72376,-2.7542136978541136
CML-T1,5738263,2.8352523784169525
HARA [Human squamous cell lung carcinoma],selumetinib-UNC0638 (4-1 mol-mol),6.072288250407716
LCLC-103H,409805,5.797514940413998
SET-2,15547703,2.979815125731124
BT 328,53495165,1.3387140928137258
NCI-H2110,400769,-0.3675284283858097
SNU-1214,60750,2.067077163111611
SW1990,66577038,3.4185516807761847
NCI-H2110,19582717,3.427888450014282
OE21,445643,3.8717408037013703
KMRC-2,44819697,0.3716244404602152
BFTC-909,3465537,1.8561429441463555
BT 504,73707398,1.4743566299164823
LoVo,73707398,0.5951327141059009
EJM,54618164,3.6862835131456455
NCI-N87,374536,0.3041613365805376
RERF-LC-A1,3062316,2.4874055353470417
SK-MEL-1,salermide-PLX-4032 (12-1 mol-mol),2.4876146823986005
HEC-151,4521392,4.2001313231876205
OE21,135984461,4.867121216346128
KMS-20,6918736,-1.6214038389500036
TE 617.T,5394,4.359465611245191
BT 330,409805,3.8422840862788386
OE21,400769,-1.1322682679141538
OAW28,25102847,1.9718431113444057
JIMT-1,5335621,5.040295264454438
WM983B,navitoclax-piperlongumine (1-1 mol-mol),2.9541107113529335
Raji,100016,6.465762715187829
OAW28,3025944,4.579278298637093
NU-DHL-1,11485656,2.738678590842112
KP-4,25126798,3.6651026061979
MM1.S,100016,6.180279624553647
CML-T1,56973724,1.0958106846759064
LoVo,JQ-1-UNC0638 (2-1 mol-mol),3.1589551233195428
RPMI-7951,122327,4.401671664381031
JIMT-1,72376,-0.077724504585934
IST-Mes1,JQ-1-vorinostat (2-1 mol-mol),0.3770936853030046
SKM-1,12003241,-1.1629643414911237
YH-13,6852167,1.959387815211575
H-STS,148198,-3.664450029895992
SNU-1033,67291369,4.3431955493007175
LNCaP clone FGC,42642645,0.6379836145749267
NCI-H2110,176870,4.703150335420955
LCLC-103H,6610355,5.240935503280419
PE/CA-PJ34 (clone C12),navitoclax-sorafenib (1-1 mol-mol),3.0314337084555656
YH-13,44607531,1.7046203795980872
MCAS,6505803,-1.4160035963714128
LoVo,5328940,0.1711764774474706
PE/CA-PJ34 (clone C12),11656518,2.490076098843588
Raji,3385,2.7756153582112133
SK-MEL-1,6610355,4.62343191856456
PaTu 8988s,selumetinib-JQ-1 (4-1 mol-mol),0.3498739449396179
HSC-4,46843906,4.814917111969106
BT 248,44185566,1.9117845458549376
OAW42,10127622,5.194234121898302
SK-MEL-1,11178236,-1.0254457455861472
BT 328,44484893,4.396363776297363
SNU-1272,selumetinib-UNC0638 (4-1 mol-mol),4.820393329674523
HSC-4,168312962,-1.5337410071263893
YKG-1,selumetinib-MK-2206 (8-1 mol-mol),2.8155089157668627
CML-T1,387447,-5.712019248069361
KMS-20,9840324,7.129228187943907
KMS-20,25154868,4.103093703114607
HSC-4,219104,4.150323587810277
BFTC-909,3081361,3.110656330811392
KMBC-2,9936388,2.279378439007598
KMBC-2,6610355,5.7367694497488895
SK-LMS-1,6184667,1.7547566715976322
SNU-8,322968,3.931908512694919
TE 617.T,erlotinib-PLX-4032 (2-1 mol-mol),0.933535349864826
ESS-1,5746,0.0804906650229093
HMCB,24785538,2.1780409626739177
NCI-H1092,5460769,5.922318384562557
RERF-LC-Ad2,3062316,0.3390724872590722
BT 320,11494412,4.421767883618589
A4/Fukuda,11238147,1.0973923844128086
SEM,19582717,2.6237313520594996
NCI-H2110,53232,4.104445138935315
CML-T1,107985,-4.139753917879256
D283 Med,navitoclax-birinapant (1-1 mol-mol),0.5906558429150628
H-STS,11214940,-0.2831016216432358
JIMT-1,11178236,-2.7544521556172556
YH-13,JQ-1-vorinostat (2-1 mol-mol),1.6666990115178115
KMS-20,54619267,3.8128952871152046
NCI-H2081,ISOX-bortezomib (250-1 mol-mol),0.1773494358411905
HEC-151,89928392,1.5427367273356516
SNU-308,46191454,3.85812081805359
HARA [Human squamous cell lung carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),2.096379077317258
TE 617.T,44819697,-1.9200443333950732
SW1990,426756,4.883420539625358
WM983B,24797083,0.9002100971171597
Hs 683,148198,-3.2312790086257057
RPMI-7951,375860,-1.2606970188300772
NCI-H1092,45279963,3.5521369654749035
YH-13,71304818,3.292650030763082
BT 139,10074640,2.997567621853052
PE/CA-PJ49,vorinostat-navitoclax (4-1 mol-mol),0.9022905377904028
LoVo,25262965,-3.8912736240644694
NCI-H2081,44819697,-2.617512109063003
KYSE-70,2858523,3.054228167220651
BT 328,9933475,2.2718026120514216
NU-DHL-1,56949517,4.418216826583101
RPMI-7951,53232,2.1899974119602352
CML-T1,375860,-0.8039918924580166
Ku812,ISOX-bortezomib (250-1 mol-mol),-0.3300342480244748
ML-1 [Human thyroid carcinoma],2858523,3.273643216387516
LoVo,10296883,3.831816674357036
OE21,73707398,1.45276102032063
OAW28,53392493,2.314719178940984
NCO2,11964036,0.7324746192138377
Kasumi-2,3081361,2.7656675201923555
SNU-1214,54618305,4.749041864711717
IST-Mes1,24856436,3.396810776549086
YH-13,46926350,-4.088990629945516
HEC-151,387447,-4.537682357362599
PE/CA-PJ49,2874250,5.065168424533156
HMCB,46215462,2.3614914052536062
IST-Mes1,387447,-3.626604128124616
D283 Med,navitoclax-piperlongumine (1-1 mol-mol),0.4568546586164775
SK-LMS-1,44241473,5.38031759835473
AU565,tanespimycin-gemcitabine (1-1 mol-mol),-2.222908317148695
SET-2,1566236,1.327292849582041
SW1990,44819697,-0.3435815177199327
KP-4,24748573,1.4715994589045538
Raji,68056272,3.875053228439545
IST-Mes1,vorinostat-carboplatin (1-1 mol-mol),3.785712345618982
HARA [Human squamous cell lung carcinoma],2828334,6.6956020196427115
YH-13,2749,2.5667946574986473
HEC-151,9929138,7.082890356746388
PaTu 8988s,156414,1.7268071269453409
YKG-1,16065773,3.101018624838753
NCI-H2081,11427553,0.4745229676826807
BT 330,doxorubicin-navitoclax (2-1 mol-mol),-2.187349846488524
OAW28,4259181,0.9119817479539226
Hep-G2,10184653,1.7532809843488162
HARA [Human squamous cell lung carcinoma],3385,4.962584280578164
HARA [Human squamous cell lung carcinoma],5281321,-1.682952924947167
BT 330,11178236,-5.971414065790444
SNU-8,sirolimus-bortezomib (250-1 mol-mol),0.5784576721065883
BT 330,2828334,6.027702866230108
RPMI-7951,25105715,2.9409610580806396
OE21,25262965,-4.357084277861301
NCO2,JQ-1-UNC0638 (2-1 mol-mol),-0.7692843608444572
HEC-151,24901704,3.5854197233536382
KMBC-2,erlotinib-PLX-4032 (2-1 mol-mol),5.711685673840677
HARA [Human squamous cell lung carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),3.6972893846800545
AU565,44486219,4.217962962304986
CML-T1,24180719,2.7823494948279373
OAW28,9911463,4.007690751229585
H-STS,135984461,1.3384437031548353
Ku812,selumetinib-GDC-0941 (4-1 mol-mol),-2.0259411915786294
RERF-LC-Ad1,3062316,2.885097567128067
CA46,156422,3.7635879578153126
AU565,11955716,1.5670888997114951
PaTu 8988s,sirolimus-bortezomib (250-1 mol-mol),0.5300595749454592
SKM-1,6918328,-1.5551778635865745
AU565,tretinoin-carboplatin (2-1 mol-mol),5.430851550447548
RERF-LC-Ad2,11964036,2.3866453788190034
Hs 683,11152667,-1.390521313969312
HEC-151,11234052,3.9846011660902367
NCI-H1395,2742550,4.633125791317317
OE21,11497983,4.210886829963034
KMS-20,1566236,0.9059478778030634
SEM,72199292,-0.295310917507193
PaTu 8988s,JQ-1-MK-0752 (1-1 mol-mol),2.5222168454811587
Raji,5291,3.273680351166006
LNCaP clone FGC,11364421,-5.720348695353833
Aska-SS,9911463,4.275261976243402
HEC-151,24775005,2.9454361304694805
RPMI-7951,9936388,-2.1957578683042205
SNU-1272,11625818,6.086171109339369
LNCaP clone FGC,12003241,-1.977151768552247
Raji,969516,2.3459011615837677
PE/CA-PJ34 (clone C12),12001922,2.3473594689504687
SW1990,16065773,1.719871366206884
SNU-1214,9444,4.604017653648716
KYSE-410,5287620,-2.2725432544483426
PE/CA-PJ49,tanespimycin-bortezomib (250-1 mol-mol),-1.0553859212416536
PaTu 8988s,selumetinib-GDC-0941 (4-1 mol-mol),-0.6255434999404949
ML-1 [Human thyroid carcinoma],136227924,2.8741817701449506
BT 248,42642645,1.464081071598135
PE/CA-PJ49,72376,-1.5815489184590188
SET-2,54618771,0.9858111819135928
SK-LMS-1,11455910,0.8292842204783425
SNU-308,10184653,0.2436604548829367
WM983B,carboplatin-UNC0638 (2-1 mol-mol),3.49361351031539
NCI-H1092,11494412,2.17753949415027
BT 320,JQ-1-vorinostat (2-1 mol-mol),2.723123137570139
BT 330,12001922,1.1352898980242132
BT 139,2945648,2.7036265554332095
SNU-1272,322968,5.073692716750646
SNU-1033,135440466,1.6329331691132638
BT 504,135421197,2.466290644112219
HARA [Human squamous cell lung carcinoma],54143018,-1.1176720961651934
GOS-3,10184653,2.042716455984749
HEC-151,46907787,1.109021567995486
CA46,6917907,-5.812984110767001
NCI-H2172,46398810,3.0587069990018865
BT 330,alisertib-navitoclax (2-1 mol-mol),-2.4408521522698767
SEM,53495165,-1.8232376140676845
CML-T1,17759555,3.491613035913433
BT 328,6436223,-4.925516012264063
SK-N-AS,24775005,3.645057665569913
RPMI-7951,2945648,3.164942400305847
OAW28,selumetinib-UNC0638 (4-1 mol-mol),3.3800048421879314
OAW28,5281321,-1.4060991234994806
PE/CA-PJ34 (clone C12),54619267,4.022513572459868
LNCaP clone FGC,54765302,3.729529595013661
CML-T1,JQ-1-carboplatin (1-1 mol-mol),0.6334590834009667
PE/CA-PJ49,5280436,2.0810163091034672
SK-LMS-1,3689413,-2.0473825870324935
Hs 683,alisertib-navitoclax (2-1 mol-mol),-1.5712729640696714
CML-T1,25183872,-2.27655686726873
LoVo,10302451,1.0215583424111876
BT 320,72376,3.3397736941212433
LoVo,216345,1.1599721320761718
SNU-8,54649381,3.860275528998684
HEC-151,24821094,3.275946905421496
OAW28,navitoclax-gemcitabine (1-1 mol-mol),-0.0926576582551772
KP-4,644241,3.5135167482418703
MM1.S,25102847,1.6569670603022522
OE21,119182,0.647900745165355
KMS-20,445091,4.2633800487131275
Ku812,638278,2.0428029041013387
NCI-H1092,327653,2.585630282314354
OAW28,selumetinib-MK-2206 (8-1 mol-mol),3.6165441684706736
KP-4,11234052,4.267357628081607
IST-Mes1,3825829,6.080187468224706
RERF-LC-Ad2,4261,3.541910546022979
OAW28,11719255,3.92549874892824
SK-LMS-1,23725625,5.609537444639145
CA46,208908,1.4900061271350116
AU565,11485656,2.0156354686346174
SNU-308,159324,3.7188145940777617
OAW28,2729026,2.5871569751548047
SK-LMS-1,11494412,2.2164540785451106
SNU-1272,24964624,2.8014320140467124
HSC-4,72376,-2.108784759313747
Hs 683,24856436,-0.2136505281073007
HuT 78,49867930,4.292430272792475
BT 504,decitabine-carboplatin (1-1 mol-mol),5.818236074562138
D283 Med,6852167,1.541783481002512
AN3-CA,613753,3.2881872693616
D283 Med,25126798,4.439280321419275
BT 330,10074640,3.124160063926403
H-STS,3025944,4.171325659510201
NU-DHL-1,3543504,4.940281677285891
AN3-CA,1641662,2.8953238480153836
ESS-1,6852167,2.0941643944902055
PE/CA-PJ49,53495165,-2.0273546331636223
LNCaP clone FGC,3038522,2.1505332840631413
YH-13,42642645,0.7428971462414599
CML-T1,BRD-K03911514,3.1384749532861234
KYSE-410,56649450,1.649053942309861
TE 617.T,11455910,0.3917461009813664
SNU-1214,11626560,1.3344620508576424
IST-Mes1,9933475,1.3564169932051346
NCO2,2749,0.8662677634716749
OAW28,439501,-0.9322268226633188
KMBC-2,107985,-4.329865422149039
LCLC-103H,24856436,0.7675880464447634
RERF-LC-A1,119607,4.454642721343021
SK-LMS-1,4705,3.2417588485362554
SK-MEL-1,serdemetan-SCH-529074 (1-1 mol-mol),1.4644488936181317
KYSE-410,675434,4.273259332206393
NU-DHL-1,135928012,0.9972695617711916
BT 248,67156097,4.587573075901519
Kasumi-2,3011155,3.05813684599445
Hs 683,49766530,0.8674069188410214
PaTu 8988s,67156097,-2.6078446731543754
SK-MEL-1,65064,5.30456407772584
YKG-1,SNX-2112-bortezomib (250-1 mol-mol),-1.7572291199138872
NU-DHL-1,54613361,-0.5915809815117075
PE/CA-PJ34 (clone C12),tanespimycin-bortezomib (250-1 mol-mol),-1.982258316980141
KYSE-410,49850262,3.861570035849352
ESS-1,11404337,-0.7954778123034105
RERF-LC-A1,638278,3.3372184014322475
KP-4,3384730,1.9659289598707523
BT 504,10385095,1.155084659325028
HEC-151,3815108,2.591309919436277
KMS-20,25161177,3.641930132688034
ESS-1,navitoclax-birinapant (1-1 mol-mol),-5.210357307930014
BT 330,2749,0.2806852407253283
TE-15,374536,3.2802674358624926
KMBC-2,6505803,0.8249091565927539
MM1.S,24772860,-3.323759307224156
BT 330,3854666,1.6927657875958029
KP-4,2945648,2.872287877926181
PE/CA-PJ34 (clone C12),216468,0.8117185056100308
LoVo,4788,4.577300245187766
HuT 78,285033,-3.0605390542745092
D283 Med,crizotinib-PLX-4032 (2-1 mol-mol),3.638694658116099
NCI-H2110,2871966,1.1507738299242007
SNU-1214,6610216,3.72445074492986
RERF-LC-Ad1,11404337,1.7320849295693297
CA46,68056272,3.136594245199668
KYSE-410,11625818,4.768458424942497
NCI-H1092,decitabine-navitoclax (2-1 mol-mol),4.733361910852782
HARA [Human squamous cell lung carcinoma],53481919,4.643044937502802
KMRC-2,selumetinib-UNC0638 (4-1 mol-mol),2.8244446537596013
EJM,2733487,6.457690507426682
KMS-20,11364421,0.7913102999239922
LNCaP clone FGC,5284616,-5.194516474442037
OE21,44493528,4.16320367055504
BT 330,44241473,4.196358562733664
BFTC-909,637858,2.264716830291231
KYSE-410,12003241,-2.1155115062785805
SEM,135875424,2.4848737039506426
ESS-1,3552672,1.6370770083868251
SK-LMS-1,123631,3.0949156571459846
Kasumi-2,2949965,2.010544177145751
WM983B,25105715,3.1376334636609244
NCI-H2081,51039095,1.7581275368381517
HARA [Human squamous cell lung carcinoma],25102847,2.0322740825170555
SK-LMS-1,navitoclax-birinapant (1-1 mol-mol),2.0684906730597703
OE21,216468,0.7894672125707919
SK-N-AS,44137675,4.147290712781994
RERF-LC-Ad1,navitoclax-piperlongumine (1-1 mol-mol),2.3229899285484352
EJM,71680916,4.438801841668279
KP-4,15547703,3.1306886492492665
HARA [Human squamous cell lung carcinoma],135398516,1.8495805389969304
OE21,44543605,3.861252295360997
OE21,445091,4.160069232896354
H-STS,16659841,4.209446171340807
KMS-27,675434,4.061572812426806
BT 504,2746,4.403785985788142
BFTC-909,6438330,3.0201113942824436
Hep-G2,3062316,2.0384050526370454
NCI-H1395,54619267,3.786802198247579
LCLC-103H,439501,-2.3624899744714956
Hs 683,11234052,4.410991782811801
KMS-27,12003241,-0.3161890721272481
NCI-H1395,613753,3.1434817827730126
Aska-SS,11494412,1.6723137258667875
YH-13,carboplatin-etoposide (40-17 mol-mol),2.297149147603289
Ku812,16722836,-0.2272484724796736
PE/CA-PJ49,5746,1.1840250110629396
PaTu 8988s,374536,0.6964721820737422
SNU-1214,1641662,3.48771227860231
YH-13,72193861,0.945446843514748
SW1573,selumetinib-MK-2206 (8-1 mol-mol),4.390623431255029
SW1990,6918837,-2.228569736722479
JIMT-1,4521392,5.105306306885342
KMS-27,65064,3.02992990636513
TE 617.T,23725625,4.689900861752102
PE/CA-PJ34 (clone C12),24753719,4.157355819781257
BFTC-909,159324,4.114702101808939
WM983B,24753719,6.015635762527396
OAW28,54619267,3.96587417417148
HCC2218,44507138,1.661210096504924
Ku812,1716436,3.2496939057778738
LNCaP clone FGC,11238147,1.713751089163336
SNU-1214,11396600,3.7056462791365847
RPMI-7951,10090485,4.437995283311912
SW1990,11609586,3.716895090235181
KMS-20,16736978,-0.5263513628668083
TE 617.T,12001922,1.7952011808857071
BFTC-909,5291,3.495280995080932
SNU-1033,44185566,1.7669218302114065
SET-2,60750,-4.586930142507914
KMRC-2,6918837,-1.7199510522110808
SET-2,2126,3.918228348888737
BT 139,selumetinib-PLX-4032 (8-1 mol-mol),3.878194147055926
Aska-SS,46926350,-3.8852893541417455
PE/CA-PJ34 (clone C12),24856436,0.073315127978312
Raji,72376,-4.086139502727304
NCI-N87,444795,4.906796024963376
IST-Mes1,17755052,1.8699185860343792
Aska-SS,6918736,-2.1239055092676615
PE/CA-PJ34 (clone C12),9444,4.358841089309469
RPMI-7951,675434,4.528835067595089
D283 Med,selumetinib-GDC-0941 (4-1 mol-mol),1.1541990578163812
EJM,2113511,5.268537886906316
LoVo,135398516,0.8347424818537327
KMS-27,6917907,-6.097066724901309
HCC2218,selumetinib-MK-2206 (8-1 mol-mol),1.7074362554421436
MCAS,24856436,0.2567380893611684
HCC2218,doxorubicin-navitoclax (2-1 mol-mol),0.3064126907990808
NCI-H1395,11455910,1.7673103520073516
Ku812,5287620,-1.7974758930014358
Hs 683,2130404,3.573514599351806
Kasumi-2,135398516,1.3882982648798712
NCI-H2081,44607531,1.066204155267354
SNU-8,3815108,0.8679959369818034
HEC-151,285033,-2.1318823022506184
NCO2,9825149,0.951103368265373
OAW42,10302451,3.168446299952244
SNU-1272,3062316,3.6318670446165817
Kasumi-2,SNX-2112-bortezomib (250-1 mol-mol),-2.9653989283259805
BFTC-909,10127622,5.216996592058982
MM1.S,67156097,-2.2685663617789045
SNU-1214,9935249,2.745312094811984
PE/CA-PJ34 (clone C12),16065773,2.5490560227958436
SW1990,1750826,-1.720199004206297
RPMI-7951,25154868,4.817276169138943
H-STS,168312962,2.3265280063565177
NCI-H2081,73707398,0.6809572071185331
BT 504,387447,-4.821883327941117
Kasumi-2,448949,-0.5395388127141975
BFTC-909,11238147,5.503103761619835
ESS-1,JQ-1-MK-0752 (1-1 mol-mol),0.8350024005295179
IST-Mes1,24785538,1.075792459113639
KMS-20,26596,-2.568893435013116
GOS-3,9936388,2.12022290506738
KMS-20,vorinostat-navitoclax (4-1 mol-mol),0.2184557123667096
HMCB,262093,2.6900614407313355
EJM,25227462,-4.274317957574103
HuT 78,15983966,-6.777458587771195
HuT 78,9803433,5.134294603794936
D283 Med,11238147,1.1761560661302457
JIMT-1,tretinoin-navitoclax (4-1 mol-mol),5.863432308147719
NU-DHL-1,11494412,-1.1621345375437304
RERF-LC-Ad2,135398744,6.529632870190649
SNU-8,10231331,0.8787847787611084
SNU-1033,24964624,2.601972187646178
BT 330,15547703,3.0125474836751756
KP-4,24978538,2.208867172081004
H-STS,5113032,5.339439762793735
ESS-1,9907093,4.140542010053599
HCC2218,9915743,-6.199285187365854
A4/Fukuda,26596,-3.7061252239164553
KMBC-2,54618164,4.620014952617177
LCLC-103H,SNX-2112-bortezomib (250-1 mol-mol),1.1416751854356344
KYSE-410,135411,3.024507508048007
CML-T1,9903786,2.526700219209825
YH-13,56649450,3.222212852506819
LNCaP clone FGC,148124,-8.012505540487231
WM983B,selumetinib-MK-2206 (8-1 mol-mol),-0.9710752250712618
YKG-1,2742550,5.856053185506653
KMRC-2,5291,3.728115184544096
SET-2,72199292,1.0742082962080146
SW1573,159324,2.9705070550476274
TE-15,9911830,2.3751205563534064
NCI-H2081,navitoclax-pluripotin (1-1 mol-mol),1.3803711022863172
SKM-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.830110061350853
KP-4,2749,2.361168615001136
SET-2,5746,-1.570988148221185
RERF-LC-Ad2,24856436,4.538529090428389
HCC2218,crizotinib-PLX-4032 (2-1 mol-mol),2.9875837963122427
Ku812,navitoclax-gemcitabine (1-1 mol-mol),-4.518116419352301
CA46,4096211,0.9281979530192106
NCI-H1092,11427553,2.7182169046328837
NCI-H1395,serdemetan-SCH-529074 (1-1 mol-mol),2.764228376704601
Ku812,426756,5.933292752952192
SET-2,25262965,-2.0268431974032013
SET-2,702558,3.0142996947729848
SK-N-AS,24180125,1.1974349379888387
Aska-SS,49836020,4.404663805549638
Hep-G2,1716436,2.124902478350978
NCI-H1395,24964624,3.1015144047697367
SEM,24748573,1.745245431773973
HEC-151,53481919,3.609306129178792
D283 Med,10427712,4.834864727067545
Ku812,24856436,-0.802197411924791
SNU-1214,9936388,-5.365264992891118
KMS-27,16736978,-0.5913535811359448
SK-LMS-1,104842,-1.9221862175064584
MCAS,BRD-A02303741-navitoclax (2-1 mol-mol),3.1168789876023117
PE/CA-PJ49,3384730,2.3774538016412765
JIMT-1,136227924,4.112902711551938
NCO2,12003241,-5.3551857747003
OAW28,52912189,1.8010258653688298
KYSE-410,46224516,3.135861836382126
KYSE-410,44489675,4.9964303572855995
KMRC-2,6918638,2.530608433892335
SNU-8,2828334,6.367919006563491
H-STS,10302451,3.908664464224374
YH-13,31703,-0.371701474811386
CML-T1,123631,1.8980514916470088
D283 Med,168313016,4.168522701530026
CML-T1,10074640,0.1978471501959747
SNU-308,5278396,3.621291065796055
RERF-LC-A1,36462,1.7424004173726408
BT 504,637858,1.8465103710961657
RERF-LC-A1,322968,4.131661042265317
JIMT-1,54454,2.3336505642787717
OE21,10302451,0.4947890408637831
BT 320,4259181,1.858689674297262
BT 139,24951314,1.6700082362111186
RPMI-7951,135421197,2.3107830834906324
AN3-CA,6917907,-5.7065684857519186
SK-LMS-1,135421197,1.8226321341170344
JIMT-1,262093,3.7926345151691208
HEC-151,5287620,-2.44893597251525
OE21,44185566,1.237363329886175
BT 139,3854666,3.266069647715192
YH-13,crizotinib-PLX-4032 (2-1 mol-mol),1.6930776874276643
KMRC-2,24748573,3.264041019770869
HuT 78,11494412,0.3707002136667609
CML-T1,16741245,3.55536863016822
OAW28,tretinoin-navitoclax (4-1 mol-mol),1.3460784377141035
AU565,702558,5.325524002647016
SET-2,9915743,0.156310507538352
Kasumi-2,45279963,3.7710739544623233
Hs 683,72199292,1.8937209912313913
SET-2,piperlongumine-MST-312 (1-1 mol-mol),1.1695579595502636
RERF-LC-Ad2,11609586,3.457016103236202
BT 248,selumetinib-MK-2206 (8-1 mol-mol),1.8493949286996905
HuT 78,71466578,1.9923030103429336
H-STS,11507802,0.4528511080463978
BT 328,119607,6.140002337362805
H-STS,16065773,1.8153092417887848
KMS-27,1750826,-0.889143246867569
IST-Mes1,151289,3.762568892374828
Hs 683,46215462,1.5874451556641451
LNCaP clone FGC,148198,-3.4579469990265124
OAW28,3689413,-1.4375749125930504
TE 617.T,11656518,1.2463696913193645
HuT 78,42642645,0.2069800565131915
SET-2,44819697,-4.543529613323342
A4/Fukuda,135928012,2.23734461349398
NCO2,49850262,2.861605974249572
BT 320,67291369,4.380585752028441
PaTu 8988s,6918638,1.3708196410669105
SNU-308,25183872,-0.4312596852258337
SET-2,9884685,0.7877386877892533
A4/Fukuda,11977753,-3.131569873612884
ESS-1,5328940,1.6515492105558514
EJM,BRD-A02303741-navitoclax (2-1 mol-mol),2.6594376626213614
TE-15,5291,4.113420590945033
NCI-H1092,15983966,1.932051104008448
MM1.S,1716436,2.248600681663511
BT 139,5328940,1.1830416254021676
PaTu 8988s,15983966,3.43832073761555
CA46,navitoclax-gemcitabine (1-1 mol-mol),-1.1536671772218576
TE-15,375860,-0.9577501669745316
Ku812,9444,3.739860815114633
Ku812,26596,-2.18380806647072
BT 330,24748573,2.0465375235525176
SW1990,9840324,6.0153251354755914
SNU-308,46199207,3.55488110741621
NCI-H1092,11626560,1.887558219337559
WM983B,56973724,4.131819257136554
EJM,5281321,-4.177995468364573
H-STS,135928012,3.8653043239054976
SEM,25262965,1.0326177265018786
LCLC-103H,60700,2.200977496577784
PE/CA-PJ34 (clone C12),135928012,3.818108144360031
HCC2218,9907093,4.588586152552087
SKM-1,5746,0.5128586399928746
HEC-151,11228183,2.0673314322119984
SNU-1214,3503,2.330033043654758
OAW42,5287620,0.2628898084964829
SK-N-AS,54454,3.61366747666526
A4/Fukuda,10410894,1.64506751408979
Kasumi-2,11964036,-0.3814812468505845
WM983B,5311281,1.4233978571520485
H-STS,135398516,1.890546081861667
NCI-H2081,24772860,-1.2700497080166275
Ku812,24964624,1.8261107869601476
RERF-LC-Ad1,selumetinib-tretinoin (2-1 mol-mol),4.153167483660677
ESS-1,65064,5.283025860998633
SW1990,445091,4.416962817156631
SET-2,54618305,3.97030944643435
KYSE-70,24797083,1.8843278101436565
NU-DHL-1,3384730,0.9179743420778778
SNU-1033,5281321,0.0827670253007856
RERF-LC-A1,16219061,3.1638860624505356
D283 Med,49793307,-5.548587928279458
A4/Fukuda,9933475,1.717973727652582
KMS-27,568763,1.003046085220826
LNCaP clone FGC,135875424,3.855348592559951
SK-MEL-1,selumetinib-MK-2206 (8-1 mol-mol),-0.892255761471651
KYSE-410,9952709,3.3732272384526265
KMS-20,4915,4.238712853992716
KP-4,387447,-4.423356409037355
BT 139,9915743,2.3473723766604833
ML-1 [Human thyroid carcinoma],613753,2.773006926215127
HSC-4,9936388,2.361545024779824
BT 328,107985,-2.461939045328001
YKG-1,327653,3.641218936705474
BT 328,salermide-PLX-4032 (12-1 mol-mol),4.7270242729207625
ESS-1,135999136,4.050088319286221
KMS-27,2708,3.181722849238598
JIMT-1,72193861,0.7240141902254947
D283 Med,11647372,0.822685670820016
KMBC-2,6438330,1.6296124635179827
SKM-1,107985,-4.676728901872281
AU565,12003241,-0.6235660341918571
BT 320,24951314,2.328206990278251
OAW28,119607,5.347849335106357
RERF-LC-Ad1,25150857,3.1338616756027173
KP-4,11167602,1.7428553982677493
PE/CA-PJ49,5281321,-0.2336539299049501
OE21,1239801,3.897845306753703
ESS-1,89928392,1.2376133771759263
HuT 78,BRD9876-MK-1775 (4-1 mol-mol),0.7890849571488777
SET-2,10296883,3.6220267482667943
OE21,126941,-2.789719125532102
OE21,3384730,3.1797767333044136
HARA [Human squamous cell lung carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),5.192132134204876
MM1.S,9967941,3.082231496587742
BT 328,25102847,3.596555529465503
NCI-H2110,16720766,0.4927290073632293
SNU-8,216345,4.58176579196645
MM1.S,16065773,2.0312570616659125
SK-N-AS,11396600,3.143624411786837
A4/Fukuda,613000,-0.1954730319333323
EJM,44185566,2.4578466315948013
KMS-20,9935249,1.026705986562312
HuT 78,11485656,1.3035734242835073
CML-T1,sirolimus-bortezomib (250-1 mol-mol),-2.349010287951753
OAW28,6918328,-0.6493981710218658
LNCaP clone FGC,216345,2.061788892653963
SEM,2742550,2.6060865780770293
HCC2218,5329102,2.177989682830739
NCO2,11485656,2.116269191877006
A4/Fukuda,16038120,-3.113498344638628
HSC-4,53301938,4.738168418112686
BT 328,10427712,5.978304580808892
JIMT-1,9884685,2.6126732364530487
EJM,navitoclax-pluripotin (1-1 mol-mol),0.1382872848010396
KMRC-2,11364421,2.112587869696082
SK-N-AS,11507802,0.3405234960570104
SKM-1,24180719,1.95578575443114
NCI-H1092,6918837,-4.303898755117286
Kasumi-2,24856436,-1.5154163657154227
BT 139,doxorubicin-navitoclax (2-1 mol-mol),-1.2563388109973497
BT 320,1566236,4.371560124605876
SEM,3062316,2.096847795011344
ESS-1,54618164,4.192374601121606
LNCaP clone FGC,46224516,2.2037418982015784
YKG-1,969516,4.834181385446052
KYSE-70,65064,5.1318583658275205
SK-LMS-1,2945648,3.017032092447854
HSC-4,51037431,1.5211622982639597
HuT 78,24951314,-0.9560314989082764
MCAS,11455910,0.7655577193657753
RERF-LC-A1,82146,3.6888007957813818
YKG-1,42642645,0.5403714198289554
KMRC-2,1239801,5.8496258004918245
BT 248,3689413,-0.3734654016267222
KMRC-2,11213558,0.8524914998044264
SK-N-AS,6610355,4.764933909614688
SK-MEL-1,5746,1.0334358443095557
RERF-LC-A1,6438330,1.04343799659797
RPMI-7951,57519531,2.017467458096007
NCI-H1092,5278396,3.4693209388519137
RERF-LC-Ad1,54618164,4.2675139031657325
OE21,24771867,2.4466208199603185
NCO2,6918878,-0.348225123723106
SEM,44137675,3.2773016295912445
GOS-3,11152667,0.5000513857969126
LoVo,25150857,3.1045912764862056
OAW28,9926054,1.976123345191561
OE21,89928392,1.5103918625166863
OE21,2874250,4.449052629030129
D283 Med,24978538,0.887710634714784
BT 328,carboplatin-etoposide (40-17 mol-mol),5.134403751038302
HARA [Human squamous cell lung carcinoma],3025944,5.227932597847333
WM983B,2708,5.43325523760452
JIMT-1,24951314,1.9988350206312655
RERF-LC-A1,5978,-3.712672630483916
HMCB,44486219,4.542033268900389
BFTC-909,selumetinib-PLX-4032 (8-1 mol-mol),5.555922755682714
LNCaP clone FGC,6918638,-0.3198952238594262
MM1.S,42642645,-0.2096887803746246
A4/Fukuda,24901704,2.035809268681581
D283 Med,15953870,2.787040507745561
LoVo,1716436,2.86184708699294
NCI-H2081,23582824,1.3516004716610026
LNCaP clone FGC,JQ-1-vorinostat (2-1 mol-mol),-1.3563908691082545
HCC2218,23725625,3.711729810486442
OAW28,12003241,-0.542287488877267
NU-DHL-1,753704,3.856303412590113
SET-2,5291,3.646355415614293
NCI-H1395,1750826,-3.702055011401398
HSC-4,135421197,2.1482643592466495
KMBC-2,227681,3.9637269491798386
KMS-20,104842,-4.95901486656118
HEC-151,5351362,1.6437904555870773
KMS-20,51039095,1.9722708258577504
BT 504,5281321,1.393652367072018
AN3-CA,sirolimus-bortezomib (250-1 mol-mol),0.0528830702221854
NU-DHL-1,56646779,5.05824342116676
Ku812,2945648,2.863676297745722
HuT 78,135984461,1.9427901339992903
Aska-SS,5287969,-1.6668619193384573
HEC-151,2733526,3.519855754703022
BFTC-909,vorinostat-carboplatin (1-1 mol-mol),0.6014624935477999
OAW28,11175137,3.6697867992343607
NCI-H1395,1566236,2.7287407900944056
Hs 683,navitoclax-pluripotin (1-1 mol-mol),0.0441092724696649
SKM-1,9915743,-0.8868720134451151
HSC-4,1750826,0.4564084690350189
Aska-SS,52912189,1.2158641058153243
SW1990,6610216,4.556945274841773
Kasumi-2,26596,-3.0246532529835273
BT 139,ISOX-bortezomib (250-1 mol-mol),0.8371078463924151
GOS-3,19582717,5.639915925254865
Aska-SS,135398516,1.3915584627152666
PaTu 8988s,5282054,3.7753481211747824
NCI-H2081,9826308,-1.325713373036652
Ku812,23635314,-2.972505773411878
Ku812,6918736,-3.1871453727372514
AU565,16720766,2.906162391657848
PE/CA-PJ49,135659046,3.5549002552522175
SK-N-AS,11955716,-2.998019151969342
H-STS,carboplatin-etoposide (40-17 mol-mol),0.1150499890044187
SKM-1,4261,-0.5534245942964136
OE21,71751553,4.442993146906493
NCI-H2172,46843906,2.9426070503982684
BT 139,5329102,2.274248668376467
H-STS,9915743,1.4562053378516668
ML-1 [Human thyroid carcinoma],400769,0.4240275581269139
NCI-H1395,5738263,4.098342920501159
MM1.S,135928012,3.410124861289675
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263
JIMT-1,3385,4.841304830901386
KYSE-70,9907093,3.6347338213446454
Hs 683,24772860,-1.8987479201847817
HCC2218,navitoclax-birinapant (1-1 mol-mol),2.2134337805756985
AU565,9549297,3.94244046983191
SK-MEL-1,6918878,2.5312683960728264
WM983B,9825149,1.9497866084143765
KMBC-2,439501,-3.686477603107828
SNU-1272,31703,1.4762999099427376
OAW28,252682,6.460081465786461
SW1573,4788,4.2029613497215195
MCAS,2945648,2.573954473525045
D283 Med,81146,5.645785388190545
HSC-4,54618164,4.183236352259565
NCI-H2081,11404337,-2.077246389622244
SNU-8,16722836,2.156858559437684
SNU-1214,409805,4.003952928265266
CA46,107985,-3.181693098398671
SKM-1,3062316,1.7707772464859106
HARA [Human squamous cell lung carcinoma],168313047,3.4416690801744574
ML-1 [Human thyroid carcinoma],11485656,3.567697107596816
NCI-H1092,54596558,4.902565947797631
YKG-1,9907093,5.058925928948357
SNU-1272,51039095,3.39193895302749
Raji,451668,-0.235814270926015
SK-N-AS,9823820,4.207805510730484
SK-N-AS,5280436,2.1716641859051826
BT 320,216345,4.58398991647949
LCLC-103H,11214940,0.1061912978653702
OAW28,135999136,1.5944266420299655
KP-4,42611257,3.463003113916947
RPMI-7951,5335621,4.393846950764213
KMRC-2,11612883,3.017077992042704
SK-MEL-1,10427712,4.321948029724774
KP-4,navitoclax-MST-312 (1-1 mol-mol),1.073103176546053
NCI-N87,439501,-2.2970478950560715
SW1990,4261,2.5081676502355985
PaTu 8988s,11955716,-2.6399696193516164
LoVo,15953870,2.9352023189332703
A4/Fukuda,984333,-0.4165614363108865
SNU-1033,5470400,-4.183042746355976
NCI-H1092,25102847,3.2602491068155572
PE/CA-PJ49,5978,-4.082783454175707
BT 504,71729975,0.9780893315836542
BT 139,11494412,3.8637696290948815
MM1.S,2708,4.3305699285872095
RERF-LC-A1,navitoclax-pluripotin (1-1 mol-mol),-0.5249640621265976
BT 330,72193861,1.6966256104912456
LCLC-103H,5566,3.313293371548573
SEM,4917,2.902637653661685
MM1.S,10302451,3.7035556434363808
RPMI-7951,4378219,1.8029418546764064
RERF-LC-A1,122327,4.351638560118517
BT 328,selumetinib-piperlongumine (8-1 mol-mol),4.372590392700236
SK-N-AS,6438330,2.8096003946223775
PE/CA-PJ49,16720766,0.7184318893810459
KMS-27,6610355,3.513461387639252
RPMI-7951,67156097,-1.9803086890967103
EJM,45279963,3.0633820554062345
Aska-SS,3062316,2.173986451757374
LoVo,17755052,-0.1303127354802701
SNU-1214,51039095,2.453803390320648
HMCB,selumetinib-GDC-0941 (4-1 mol-mol),1.81562386250498
NCI-H2110,135999136,4.378229186440323
TE 617.T,52912189,2.3175017557302797
CML-T1,5311,-0.0657355385312412
KMS-27,3689413,0.1610585283674763
NU-DHL-1,568763,-0.5697749505348572
HMCB,5329102,2.553440838947416
Hs 683,3062316,0.7713399730021859
PE/CA-PJ34 (clone C12),9887053,4.7354636419859935
YH-13,136227924,2.93381240838723
NCI-H2110,11238147,1.9999305345415608
OE21,322968,4.800040293873742
CML-T1,2749,0.3257235213594381
EJM,36314,-6.683540661368917
AN3-CA,3384730,2.8247802599275618
RERF-LC-A1,15983966,-3.8365295469075993
HMCB,carboplatin-UNC0638 (2-1 mol-mol),4.229494663747289
PE/CA-PJ49,2113511,6.499373647207172
EJM,969516,2.0507913702378886
CA46,49867926,4.142181337076857
IST-Mes1,25183872,0.0748637978909832
PE/CA-PJ34 (clone C12),135659046,3.607473265136562
ML-1 [Human thyroid carcinoma],327653,3.144384021244803
Hs 683,24775005,3.4836460982496633
OAW42,53392493,3.778300609599929
KMS-27,638278,2.799419886682137
TE 617.T,3062316,-0.9321506482338564
HCC2218,400769,-0.8822322308261966
Hs 683,selumetinib-PLX-4032 (8-1 mol-mol),4.4747755051391
KMBC-2,16065773,2.994561730317731
SW1573,4705,3.887877577681455
SNU-1214,5311,1.4424355919167942
NCI-N87,56963564,-0.4773091963101655
SNU-8,2113511,5.362037141803559
BFTC-909,36462,4.374665451212183
NCI-N87,452548,-1.772451424496647
SET-2,3384730,2.0546342840453216
YKG-1,9911463,4.439291278473792
WM983B,44819697,3.598656489370058
BT 330,11152667,1.4109610692427392
SNU-8,71680916,3.8189095341297703
HCC2218,11964036,1.3824566955772797
KMS-20,71729975,0.4297208720314417
PE/CA-PJ34 (clone C12),SNX-2112-bortezomib (250-1 mol-mol),-3.0590637711179745
SNU-308,1641662,4.06307518178202
SK-MEL-1,100016,6.470813601542051
NCI-H2110,81146,4.4232530547981
NCI-H2081,25161177,4.359001869176978
HMCB,46398810,3.6730747784920226
CA46,10184653,1.13668363671425
BFTC-909,3136844,3.2427360302120403
HMCB,11717001,6.037652275918416
NCI-H2110,6918638,0.2299759669474582
WM983B,6438330,2.962606334844457
NCI-H1092,erlotinib-PLX-4032 (2-1 mol-mol),3.728956989705323
CML-T1,11507802,-0.1369004319183971
BT 320,5978,5.361358451203573
D283 Med,5746,-2.9158663455035434
LoVo,3543504,4.109477120593384
YH-13,448949,1.5692102118953517
PE/CA-PJ34 (clone C12),9927531,5.274687585125943
NU-DHL-1,6610355,3.4648292160050373
SKM-1,452548,-4.875448432121974
BT 504,5329102,2.00439646221093
IST-Mes1,1750826,2.0701004204652778
BT 248,135999136,1.3787773380664552
SNU-1033,5978,2.257122010870001
JIMT-1,654092,-1.4010722347381654
RPMI-7951,49867926,4.495804760733926
HEC-151,24748573,2.21609783337234
KYSE-410,24978538,2.729267614475142
SK-LMS-1,11485656,3.417878040932413
EJM,60700,-2.1593175727596856
Hs 683,11214940,1.610301401893697
A4/Fukuda,168312962,0.589698091471745
KMRC-2,11178236,-3.7450875682341143
Kasumi-2,72199292,0.0568572050486096
CA46,9911463,2.565133854881976
HSC-4,156422,5.249929789072156
H-STS,54678924,1.1797889556191294
YH-13,12001922,2.42245560318508
NCI-H2110,25227462,0.962572407565559
HMCB,docetaxel-tanespimycin (2-1 mol-mol),-7.206922464155887
PE/CA-PJ34 (clone C12),54618164,4.074052686035258
OAW28,46191454,1.726492969979986
LCLC-103H,11626560,2.415835881093142
OAW42,navitoclax-birinapant (1-1 mol-mol),2.674244240099842
HEC-151,10322450,3.547902209799766
Hs 683,54649381,3.1065100499344034
TE 617.T,46191454,0.1498319013060245
ML-1 [Human thyroid carcinoma],1285940,4.2577484489413004
RERF-LC-Ad1,126941,-1.292812823712893
SW1990,11222830,2.726200871669508
LoVo,53232,3.084407514553567
HuT 78,5278396,2.15665743131779
Hep-G2,5978,6.393090792335967
BT 248,5566,1.2795658146577915
ML-1 [Human thyroid carcinoma],4096211,3.147888642031647
AN3-CA,151289,0.5319797330722529
HCC2218,8515,1.7075905965554727
ESS-1,119182,0.4984219071249969
CA46,24785538,1.2011715151517115
OAW28,168312962,3.352489814007426
PaTu 8988s,16038120,-0.9491700742017304
LoVo,44493528,4.114958638118981
A4/Fukuda,25062766,1.3929374396347198
D283 Med,erlotinib-PLX-4032 (2-1 mol-mol),2.6364358466676627
OAW28,44486219,3.976522680156617
GOS-3,24964624,2.7234427755560233
BT 330,6918736,-1.8375752033286947
A4/Fukuda,3062316,0.4248767517614322
SNU-308,25195348,4.257440412888309
LoVo,10184653,-0.0525672628767589
NU-DHL-1,100016,6.7557445252971355
AN3-CA,5287969,-2.418502797890807
JIMT-1,25150857,2.6281102602598083
BT 248,119182,0.6885021238666414
SNU-8,25150857,2.244462666981657
D283 Med,7251185,1.5816987638690432
Hep-G2,53392493,3.106454846806137
NU-DHL-1,carboplatin-UNC0638 (2-1 mol-mol),3.3161247745153277
SNU-308,969516,3.243815847086935
AU565,3854666,0.9438607721687704
AU565,sirolimus-bortezomib (250-1 mol-mol),0.9370118878253954
TE-15,67156097,-2.99459281057827
Hs 683,2749,1.5429350911360808
SW1990,tanespimycin-bortezomib (250-1 mol-mol),-3.036947159692904
SNU-8,54454,1.9724642800889125
YKG-1,56973724,4.73671500707
KMRC-2,24771867,3.343574460922249
D283 Med,56649450,1.3695223630329627
PaTu 8988s,6852167,3.1010868108448832
KMBC-2,71729975,0.876835648832875
OAW28,262093,2.853078829548121
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633
HSC-4,72193861,2.788231918333871
SNU-1214,24856436,-0.5176223298445978
HEC-151,decitabine-navitoclax (2-1 mol-mol),3.101947586139779
KMRC-2,969516,2.9883028529807083
SEM,25022340,5.24487165377703
MCAS,11427553,3.4727199316582227
OE21,11175137,1.6816702571856903
OAW42,24771867,3.645967625884045
KMBC-2,3081361,3.23383852332178
HuT 78,5743,-2.915718812288148
ML-1 [Human thyroid carcinoma],4261,2.09291450929782
A4/Fukuda,57519531,1.5811593813701257
SNU-1214,136227924,2.9720785133706213
SW1990,36462,1.719748778334474
NCI-H2110,46843906,2.832724697614329
SKM-1,decitabine-carboplatin (1-1 mol-mol),-0.2461784142024601
SNU-1272,72376,1.3199699316246591
MM1.S,89928392,0.1055731132110887
AN3-CA,6918736,-2.607088446666294
TE 617.T,51037431,3.159720457999306
NCI-H2081,2828334,5.70400376605512
CML-T1,135421197,0.9317392273651705
PaTu 8988s,5470400,-0.4207196157643424
H-STS,426756,4.2891566150656875
KMRC-2,5113032,5.093384649259218
RPMI-7951,11404337,-1.491748801484046
SNU-1033,3634881,3.607045840169791
PaTu 8988s,3552672,2.0694229073359156
Raji,6917907,-0.3162927321321608
SW1573,BRD-K27188169-navitoclax (2-1 mol-mol),1.518643472033959
GOS-3,46199207,3.558565735467231
HARA [Human squamous cell lung carcinoma],selumetinib-MK-2206 (8-1 mol-mol),2.6906074312139676
CA46,445455,4.357290874085763
KYSE-410,10026128,4.447643449479421
MM1.S,12003241,-0.8577985614667851
BT 320,44819697,2.9489346663339187
BFTC-909,10184653,1.6906150005550105
KMBC-2,1641662,3.704374614283828
Hep-G2,11175137,2.5182853193143813
ML-1 [Human thyroid carcinoma],9823820,3.655965927562111
BT 139,10184653,1.800707038819732
KMS-27,73707386,3.821733041812712
SNU-8,JQ-1-navitoclax (2-1 mol-mol),1.3845326513040788
BFTC-909,656346,-0.1018552101429806
HSC-4,42642645,1.8060847122685193
CML-T1,24964624,2.008023563128915
Hep-G2,11152667,-0.2869645192447481
HuT 78,126941,-2.6954395482949844
LoVo,9967941,3.621110602900207
ESS-1,3025944,4.241330613062884
SK-N-AS,5284616,3.1365283994196713
SW1990,sirolimus-bortezomib (250-1 mol-mol),0.2169201029218291
BT 248,ISOX-bortezomib (250-1 mol-mol),0.8192035269806958
TE 617.T,tanespimycin-bortezomib (250-1 mol-mol),-1.7403863885968738
KMBC-2,5566,4.423461642371862
SK-MEL-1,6918328,-0.0660615752465356
KMRC-2,448949,3.3117772729308728
KMS-27,3854666,0.5713663154579435
BT 504,24964624,1.8977369719928563
WM983B,navitoclax-birinapant (1-1 mol-mol),3.174180250147361
SNU-1033,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.3301681028325698
CML-T1,BRD-A02303741-navitoclax (2-1 mol-mol),1.3394174355089614
NCI-N87,135411,0.0487965919912929
D283 Med,11228183,0.836865512138477
NU-DHL-1,BRD-A02303741-navitoclax (2-1 mol-mol),-1.4482260747427786
BT 330,9911830,2.954651946077228
ESS-1,44197249,5.299862122462015
SET-2,5738263,3.0276812186300153
Raji,60750,-3.9202655295609494
SK-LMS-1,44607531,1.6255294147035286
OAW28,2749,3.2113189756487683
RERF-LC-A1,5329102,2.3583301015747726
YH-13,9866186,1.6052834410324497
TE 617.T,44202524,1.3944067361692245
Ku812,60700,0.4505355107695148
BT 504,56946209,-4.727527174984681
NCI-N87,8515,4.286102801865053
PE/CA-PJ34 (clone C12),3136844,4.07403193003179
SEM,2126,4.2087863854026
SNU-308,42642645,2.1176694587678617
D283 Med,6450551,2.1323753590226686
WM983B,selumetinib-UNC0638 (4-1 mol-mol),-1.4103390047505937
AU565,selumetinib-UNC0638 (4-1 mol-mol),4.121266553774429
CML-T1,445643,3.3065494006722327
LoVo,24964624,-0.96112559187181
HSC-4,44137675,2.9134227764609735
LoVo,24901704,1.9806347162028537
KP-4,tretinoin-navitoclax (4-1 mol-mol),3.646303274153599
NCI-H1092,44491742,3.604656167614849
D283 Med,11317348,2.3932264978402613
WM983B,262093,4.372812176554698
HuT 78,11656518,1.0208848045852064
HEC-151,2874250,4.717571099068939
JIMT-1,327653,3.612061547111272
RERF-LC-Ad2,5287620,-2.1666968362828274
Raji,4096211,1.4072280963801722
BT 504,71576739,5.237084746687369
HCC2218,119607,3.922202464613258
NU-DHL-1,11717001,3.5993200450588634
SK-LMS-1,ISOX-bortezomib (250-1 mol-mol),0.2560089101624855
SEM,46191454,0.071038860902165
LCLC-103H,15983966,-3.7104987444823343
SK-LMS-1,9907093,6.302813167842978
HSC-4,piperlongumine-MST-312 (1-1 mol-mol),1.1147970090966637
KMBC-2,65064,5.566156368628648
HuT 78,6436223,-5.212835622139217
SKM-1,241158,1.623725861036911
H-STS,753704,4.594437808877669
CA46,selumetinib-MK-2206 (8-1 mol-mol),2.416379770776117
SK-LMS-1,54454,1.964594890023988
BFTC-909,JQ-1-UNC0638 (2-1 mol-mol),2.2684379316791112
SNU-308,409805,5.466137259646633
HMCB,5328940,1.9903033853027137
HMCB,45279963,3.8576212029181343
LNCaP clone FGC,25183872,-1.0962417460080476
YKG-1,24772860,-1.277942485629484
IST-Mes1,25262965,-0.2533063216587133
HCC2218,11364421,1.1672869749146255
SEM,9903786,1.5227669871926164
SK-MEL-1,44486093,4.944156496715651
TE 617.T,375860,-0.5164864785345091
Aska-SS,24785538,0.938194107656888
HCC2218,23635314,1.9160689040832388
SNU-1214,3385,4.1529729205972306
JIMT-1,56946209,-2.9765919788425155
SEM,5351362,0.4245704934919823
SW1990,12001922,2.3012891946870866
KMS-27,navitoclax-PLX-4032 (1-1 mol-mol),-1.756220732176217
Ku812,67156097,-2.3155423886631117
SNU-308,5280436,4.624627017937284
AN3-CA,11214940,3.76725106540636
OE21,44486219,3.8380849815177616
RPMI-7951,vorinostat-carboplatin (1-1 mol-mol),0.9974437990960702
NCI-H1092,10385095,0.6716651912361483
PE/CA-PJ49,9933475,1.7173266599177646
NCI-H2081,107985,-4.4331361775732905
HSC-4,selumetinib-navitoclax (8-1 mol-mol),1.957846901945355
CA46,11152667,-1.1506421067609531
KMS-20,65628,3.828249966077918
SET-2,136227924,2.6175155289445646
SK-MEL-1,107985,-3.868431540150408
KMRC-2,9936388,3.0990467374612813
KMBC-2,25195348,3.3424120098205643
NU-DHL-1,UNC0638-navitoclax (1-1 mol-mol),-2.039060237587124
YH-13,9884685,0.7618617096747208
BT 328,123631,3.6473377820687847
BT 328,selumetinib-GDC-0941 (4-1 mol-mol),2.0917542081125067
JIMT-1,5746,2.690521458648517
TE-15,11234052,4.285608247306556
D283 Med,1566236,1.5114731538286772
SNU-8,60750,1.7310690504443438
SKM-1,439501,-2.678240610691138
AU565,49793307,-1.974878634968376
CML-T1,52947716,-5.195799479557534
KMRC-2,11640390,3.840288818498483
LNCaP clone FGC,36462,0.9338803006106506
TE-15,selumetinib-MK-2206 (8-1 mol-mol),2.8531290134214093
LCLC-103H,25150857,2.578776067195156
PE/CA-PJ34 (clone C12),5281672,4.445747577315385
SNU-1272,72734382,5.027303621851128
Ku812,10184653,0.6444023558931821
PE/CA-PJ49,6918328,-1.1088201791469847
SEM,136227924,1.2424830449991908
AU565,11626560,1.628517095800036
SKM-1,676352,2.3445946302797984
BT 248,11455910,-0.0312737668402554
HuT 78,9823820,3.0138958683813537
NCI-H1395,9911463,3.814426972193391
D283 Med,52912189,0.6805327994585112
OE21,3634881,3.2741606130174357
GOS-3,navitoclax-MST-312 (1-1 mol-mol),2.0809346375553877
A4/Fukuda,969516,2.117405484631732
PaTu 8988s,carboplatin-UNC0638 (2-1 mol-mol),2.6893749166795047
SKM-1,crizotinib-PLX-4032 (2-1 mol-mol),0.9277132426054632
NCI-H1395,44137675,3.7508448726513737
PE/CA-PJ49,16038120,0.3848230880228235
SNU-1272,9911463,4.2598402664697685
WM983B,5281321,0.2278427866175756
LoVo,10231331,-0.6826574775964468
OAW28,135875424,4.470041991889524
NCI-H2110,54596490,5.001361284562202
SW1573,119607,3.675967979424282
JIMT-1,44819697,-2.2514358315006726
BT 330,9803433,6.095354123290605
OE21,11964036,0.9502618768704822
BT 504,11317348,1.5211243748925338
HMCB,151289,0.8924062734288687
ESS-1,24785538,2.1020731787092943
BT 328,sirolimus-bortezomib (250-1 mol-mol),2.117607620911863
SK-MEL-1,6623618,2.3243400339928546
SNU-308,54454,2.6349591428314114
KMS-27,135440466,1.8359860014950335
LCLC-103H,25154868,4.797034578602238
KMS-27,216345,4.13074054952734
YH-13,241158,3.687700430080618
KP-4,3038522,3.9168803347503105
ML-1 [Human thyroid carcinoma],119182,-2.1546594526399647
RPMI-7951,11485656,2.1770384312644246
OAW28,9907093,4.094861416701174
SNU-8,4477,0.155555271951445
KYSE-70,4261,1.9447398866595849
BT 504,148124,0.8340830795428085
OE21,54596558,5.583192649858686
RERF-LC-A1,6184667,2.2627349674148745
Ku812,65064,2.9938168255221234
BT 248,421610,3.3246840566564484
RPMI-7951,crizotinib-PLX-4032 (2-1 mol-mol),1.5126241501158122
NCI-H2110,9803433,6.043701280949829
Kasumi-2,52947716,-3.704060756771708
SNU-308,9877608,6.965514964870985
A4/Fukuda,31703,-2.1013190360416147
PE/CA-PJ34 (clone C12),3634881,3.34497371174834
IST-Mes1,6852167,3.791716512628995
HARA [Human squamous cell lung carcinoma],5566,3.127581032716584
OAW28,3689413,-1.4375749125930504
PE/CA-PJ34 (clone C12),11364421,-5.934192321219949
RERF-LC-A1,53232,3.057187345441784
HMCB,selumetinib-JQ-1 (4-1 mol-mol),1.6185777798994516
NCI-H2110,4378219,2.2471941094410752
IST-Mes1,375860,0.4088289358172842
CA46,16038120,1.1324791438314847
D283 Med,216468,1.9230482030211824
PE/CA-PJ34 (clone C12),9826308,-1.235624594971424
NCI-H2172,24951314,2.272328238210006
LNCaP clone FGC,carboplatin-etoposide (40-17 mol-mol),1.692445189331318
NCI-N87,11175137,1.8903805503335804
SW1573,24797083,0.9725439959134782
LNCaP clone FGC,11494412,0.5135445267768279
HuT 78,doxorubicin-navitoclax (2-1 mol-mol),-0.8174100340859971
SNU-1033,637858,1.4383513056323138
PE/CA-PJ49,46398810,2.870074478872764
WM983B,135659046,3.887851853089627
SKM-1,3384730,1.003819632931897
SNU-1033,15953870,4.135823998081224
MCAS,656346,0.9240137968686226
LNCaP clone FGC,JQ-1-carboplatin (1-1 mol-mol),-0.8145893926012049
BFTC-909,5311281,3.2468587214362175
SK-N-AS,3136844,3.6976917377368976
OAW42,docetaxel-tanespimycin (2-1 mol-mol),-0.519146323182349
EJM,UNC0638-navitoclax (1-1 mol-mol),1.2280431327330104
PE/CA-PJ34 (clone C12),54596558,4.3489795544634315
NCI-N87,24772860,-4.531203546207334
AN3-CA,65064,5.356494247928247
NCI-H2081,72193861,0.0859869526456893
BT 139,sirolimus-bortezomib (250-1 mol-mol),1.2497154154601016
CML-T1,2126,4.385584292912835
NCI-H2110,6918328,-0.2547690999366837
RERF-LC-A1,49793307,-2.536895059272766
BT 330,5280436,5.191650160397472
CML-T1,6918289,0.3823031541189219
NCI-H2110,10184653,1.1943735267322029
BT 139,46199207,1.7979142661010763
WM983B,11396600,3.738380516099371
AU565,2945648,3.081352201841014
BFTC-909,17755052,1.7621152527207813
HEC-151,1750826,-0.7392796870326657
OAW28,JQ-1-navitoclax (2-1 mol-mol),0.2228593574400964
ML-1 [Human thyroid carcinoma],135423438,1.332992654992983
ML-1 [Human thyroid carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),1.7858982688933729
HEC-151,2841722,4.53693591236262
CA46,9825149,2.310107059064329
SEM,9911830,1.1725597754210613
YH-13,10231331,5.93947704147761
Hs 683,2113511,6.229191209412549
SK-N-AS,selumetinib-JQ-1 (4-1 mol-mol),-0.8317042212420149
HMCB,5282054,2.5555962503374254
HEC-151,613753,3.2816732653219636
PaTu 8988s,3543504,5.213357808010328
OAW28,60700,1.95920843974679
H-STS,24951314,0.6840074671900861
OAW28,10427712,4.195688642509306
SW1990,navitoclax-birinapant (1-1 mol-mol),3.1067469492017232
KMBC-2,56649450,2.455679969245251
HMCB,9926054,1.939305093595803
ML-1 [Human thyroid carcinoma],168313047,1.965548883908303
HSC-4,24772860,-3.179601965562413
HuT 78,1641662,3.992228724834443
HMCB,1750826,1.2340633069907747
WM983B,serdemetan-SCH-529074 (1-1 mol-mol),1.7978861681758218
OAW28,11609586,2.8574541529278883
PaTu 8988s,53495165,1.8041587149483471
SNU-1214,25262965,0.0915990021409113
Ku812,11497983,0.3868240418152458
TE 617.T,9903786,3.301651498076641
PE/CA-PJ49,2708,4.888337248916052
SK-LMS-1,168312962,-2.079743636604986
PE/CA-PJ34 (clone C12),23635314,-4.428756055244555
KP-4,124202324,2.9493285207276436
LNCaP clone FGC,49793307,-4.8595948386046155
Hs 683,123631,1.7758111782879298
YH-13,446155,1.265827677839166
HARA [Human squamous cell lung carcinoma],11609586,3.326388879496588
Raji,107985,-3.425855595457866
AU565,176870,1.580958212812136
AU565,54618771,1.1954147839624212
D283 Med,31703,-2.9030613182863205
Ku812,25195348,0.9000183512628003
NCI-H2081,6918837,-5.022444332992493
BT 504,1641662,4.608328686129772
PaTu 8988s,selumetinib-PLX-4032 (8-1 mol-mol),2.527572283068169
SW1990,BRD-A02303741-navitoclax (2-1 mol-mol),5.14877156626653
Aska-SS,9926054,1.7306138768842658
CA46,12003241,-2.799565618947511
BT 248,3543504,4.235039119755324
A4/Fukuda,SNX-2112-bortezomib (250-1 mol-mol),-3.583227894628943
AN3-CA,3081361,1.150999325724236
OAW28,16720766,3.888951908869231
HuT 78,11507802,0.6434442936513365
Raji,568763,2.0961925057450292
ML-1 [Human thyroid carcinoma],16065773,2.2629168527060117
Aska-SS,24779724,-1.025302849370559
HEC-151,11640390,3.665486165588669
OAW28,71466380,4.3449274646859495
BFTC-909,44486219,4.380685277356905
HCC2218,2708,4.7571446912258395
BT 328,676352,2.591297575109724
SEM,49846579,-5.376308546778199
KMS-20,374536,-2.9179307309900553
HCC2218,9956119,-0.5434816491483623
Ku812,9927531,3.686533687467188
WM983B,11717001,-0.4402421696022563
SNU-1214,19582717,3.35756148215671
SNU-1033,2749,1.0851493879986265
JIMT-1,selumetinib-navitoclax (8-1 mol-mol),4.498937602869861
IST-Mes1,2858523,3.245314531932087
BFTC-909,tanespimycin-gemcitabine (1-1 mol-mol),0.2587370636739561
LNCaP clone FGC,67156097,-2.4913542577132146
Ku812,89183176,4.102616384722936
RPMI-7951,3384730,2.702292851333149
PE/CA-PJ49,53481919,5.670803300643561
MM1.S,44543605,5.063671171274212
ML-1 [Human thyroid carcinoma],5566,3.147714437598846
HSC-4,3062316,-0.6194675763886993
PE/CA-PJ49,969516,2.635444891032022
HARA [Human squamous cell lung carcinoma],216345,4.215325728716343
OAW28,navitoclax-sorafenib (1-1 mol-mol),1.7172583203628091
Hep-G2,3815108,3.2270973506014182
OAW28,1641662,3.6011202742070014
Hs 683,11404337,-0.8094527425397864
BFTC-909,216345,4.226804426652683
SEM,568763,-0.2568424606167109
GOS-3,123631,3.414822398468875
YH-13,24180125,3.319627413046534
MM1.S,SNX-2112-bortezomib (250-1 mol-mol),-2.3785977719805595
Hs 683,11955716,-2.7747078575525905
SNU-1214,3025986,-0.5805769676199715
SNU-8,BRD-A02303741-navitoclax (2-1 mol-mol),4.867149955163663
OAW42,7251185,3.469686761828365
PaTu 8988s,1566236,3.825164305906747
PE/CA-PJ49,6914657,-2.970553124332036
NU-DHL-1,9907093,3.5839802480186713
A4/Fukuda,71304818,1.5363144884487692
KMS-20,969516,2.5083831299130233
KYSE-410,31703,-0.1350071468847997
YKG-1,375860,0.0929787084961373
NCO2,1750826,-5.115242536897958
Raji,3689413,-1.7827501217470076
A4/Fukuda,3689413,-1.7998697854540155
NU-DHL-1,11626560,1.4033689860474627
SNU-1214,vorinostat-carboplatin (1-1 mol-mol),2.9413523332998315
SNU-1214,11364421,-4.764362919019471
BT 504,219104,3.3137019221767976
SNU-8,71466578,4.470861654123333
KP-4,4259181,0.4203041141920705
PE/CA-PJ49,5328940,1.2749025619233272
YKG-1,selumetinib-UNC0638 (4-1 mol-mol),5.486260238223351
LoVo,16720766,-0.1141862087465287
NCI-H2172,11178236,-2.5566689408995593
YKG-1,JQ-1-vorinostat (2-1 mol-mol),1.103772140957631
SEM,4261,-1.241514720735086
PE/CA-PJ49,54454,3.1575698747952576
MCAS,3689413,-1.1400919247426515
TE 617.T,6450551,3.191526585759877
Kasumi-2,24785538,0.7031648291020229
KMS-20,6918328,-1.3033852220053452
LNCaP clone FGC,11626560,2.371237682390705
GOS-3,2113511,5.9542710024554
NCI-H1395,54618771,3.4411900765558125
Ku812,445643,2.6180665518205046
BT 139,2733526,2.8212973326719304
Ku812,9929138,4.0796690015060095
LCLC-103H,2858523,3.130368506768724
SK-LMS-1,3038522,2.3745353119009245
OAW28,25195348,5.036760517156048
SK-MEL-1,216345,4.219747658132905
BFTC-909,3025944,6.464154930724253
ML-1 [Human thyroid carcinoma],54454,2.7684179569761422
D283 Med,10113978,2.100289947071623
SNU-1033,11175137,3.157480409419269
Aska-SS,89928392,1.1550841986309472
SNU-1033,168312962,3.0466986481809406
PE/CA-PJ49,1750826,1.990183315257249
Hs 683,25262965,-2.449137301356105
TE-15,71680916,5.234367240209889
ESS-1,285033,-3.536353243580582
SW1990,409805,4.048741151107136
SNU-1272,446155,4.168307414617033
ESS-1,11214940,1.1922635318190942
RERF-LC-Ad2,3552672,2.262924134176728
PE/CA-PJ49,10427712,4.818708753366325
SK-MEL-1,navitoclax-sorafenib (1-1 mol-mol),-1.788106036814861
KMS-20,54454,4.411646924173224
KYSE-410,654092,0.1859492790790137
SNU-1214,5746,1.6489281214471312
SNU-308,3503,2.890100962673665
PE/CA-PJ49,262093,3.242343498921695
SNU-308,119607,5.862083488797092
BT 328,24797083,3.187781247629872
SNU-1214,46943432,1.6748160233466023
MCAS,11507802,1.640527744084139
Hs 683,5291,3.518739684260069
H-STS,36462,-1.1706487337003968
HSC-4,5329102,2.7247882686097458
H-STS,2871966,-0.6937217649488046
MCAS,452548,-0.1240356114015149
Aska-SS,navitoclax-piperlongumine (1-1 mol-mol),2.115176063293757
BT 504,selumetinib-vorinostat (8-1 mol-mol),3.416857931230803
OAW42,25150857,2.243439327050555
KMBC-2,49836020,0.1766293750985906
NCI-H1395,5566,3.555593017937037
TE-15,3025986,-1.5294083137639527
BFTC-909,44491742,4.0640318167931255
PaTu 8988s,89928392,2.576588793876801
PE/CA-PJ34 (clone C12),71466380,4.94810327160088
HSC-4,24901704,4.088081803824046
SK-MEL-1,54619267,4.267661371411892
MM1.S,16038120,-1.5361112717361085
AU565,BRD9876-MK-1775 (4-1 mol-mol),-0.166226177958293
SNU-1272,73707398,1.7046938678660917
ML-1 [Human thyroid carcinoma],3038522,3.665928761402901
Raji,73707398,0.7917635742848352
LNCaP clone FGC,11717001,4.310122679605935
LNCaP clone FGC,135999136,2.023158565172241
D283 Med,11640390,0.8547144759523356
NCI-H1395,439501,0.2163751108150007
IST-Mes1,11234052,4.921331368768723
SEM,54618305,4.259603919662889
NCI-N87,6918328,-0.6140119948836108
SNU-1033,49836020,1.7840304926095434
RPMI-7951,49793307,-2.8906561335679473
HARA [Human squamous cell lung carcinoma],11626560,1.1307601374566012
MCAS,2708,5.102956403259028
SNU-8,9967941,2.953060128377935
SK-MEL-1,54618164,4.203160521869226
PaTu 8988s,24785538,-0.1319104813604629
NCI-H2110,16736978,1.6836733571257971
OE21,462382,0.6347226239367584
SEM,8515,3.1734533469366064
HCC2218,168313016,4.988518158983073
HCC2218,11955716,-1.901873274308428
NCI-H2172,25126798,3.994275511302363
OE21,46907787,0.1329558963792394
RPMI-7951,selumetinib-decitabine (4-1 mol-mol),5.604258441807631
BFTC-909,44137675,3.23817368119839
BT 330,15983966,1.8406845073782188
Raji,6252,-4.099967470274552
RERF-LC-A1,1239801,3.310778457493512
OE21,11427553,2.458070036132566
HuT 78,11214940,1.6478986529716984
SNU-1214,3062316,-2.6139765207076064
NCI-H2110,57330099,5.373662696434695
LoVo,11404337,-0.8407014552816361
SNU-1214,72734382,5.46139158929195
ESS-1,carboplatin-UNC0638 (2-1 mol-mol),3.6411517750033986
Aska-SS,6917907,-6.004886110594022
MM1.S,24964624,-1.3172140659784457
TE 617.T,7251185,1.6615053823648038
KMRC-2,54618771,2.1629104463678335
BFTC-909,445091,4.3207806819680625
OE21,56963564,0.5882361592475003
Hep-G2,9911830,2.4259359362723147
CA46,2113511,3.5674790523720317
KYSE-410,11167602,2.662008040827567
D283 Med,25105715,3.463494794398442
SNU-8,selumetinib-UNC0638 (4-1 mol-mol),1.307835764252158
GOS-3,vorinostat-navitoclax (4-1 mol-mol),3.0226897716285905
HSC-4,55283,3.529343210540244
HMCB,71304818,2.4359376321219046
OE21,5566,2.95647125808646
RPMI-7951,25183872,-1.0536451007514205
BT 248,56649450,1.4607260014057133
SK-LMS-1,9549297,1.617547275845102
YKG-1,5329102,2.298479401722923
EJM,24180125,2.4307327863044215
LNCaP clone FGC,2749,1.1736843806937565
ESS-1,53392493,1.9514593982408732
CA46,11213558,2.4131379110887496
BT 139,5351362,1.0294081440467506
HSC-4,11152667,-1.532358108136572
HMCB,2871966,0.8621861028027487
KMS-27,25195348,3.2487462992442437
NCI-H1395,11494412,4.0372714005300026
SK-MEL-1,57330099,4.254471281788059
HuT 78,JQ-1-MK-0752 (1-1 mol-mol),-1.2241508901650953
OAW28,10385095,1.310156197215646
LNCaP clone FGC,54143018,0.4809008552653854
Aska-SS,6852167,0.8511531756898867
RPMI-7951,123631,2.176055459854137
NCI-H2081,439501,-4.570953887500971
ML-1 [Human thyroid carcinoma],9887053,4.856845998315694
SK-N-AS,9926054,1.80921327911472
RERF-LC-Ad1,2729026,3.1916819737077544
BT 139,11964036,2.0973433466968587
H-STS,72376,-2.162494963695944
NCI-H1395,5284373,3.990100299544354
WM983B,SNX-2112-bortezomib (250-1 mol-mol),-0.9271132278334678
HARA [Human squamous cell lung carcinoma],3825829,3.0637384073868787
NCI-H1092,16722836,3.014278758354336
Aska-SS,969516,3.631447738748967
KMRC-2,24964624,3.0030349135178884
PaTu 8988s,56946209,-6.332681007571092
BT 330,2729026,1.1636644149412527
MCAS,ISOX-bortezomib (250-1 mol-mol),1.124686826511184
WM983B,52912189,2.395668058367169
NCO2,168312962,-1.942186561556568
Raji,46943432,0.8190341583035305
SW1990,15953870,4.463395728130823
SEM,66577038,2.939382481525851
SK-LMS-1,11656518,1.0446346440224212
ESS-1,selumetinib-piperlongumine (8-1 mol-mol),3.862491311780521
LNCaP clone FGC,3552672,4.707114477173716
RPMI-7951,104842,-2.886076741729941
LCLC-103H,selumetinib-UNC0638 (4-1 mol-mol),4.765653535390657
BT 330,3543504,4.802620749525746
CML-T1,25102847,0.4234360383549997
TE-15,53232,1.7812903569341405
NU-DHL-1,46843906,1.439459382050455
D283 Med,54454,3.694221793159312
CA46,navitoclax-MST-312 (1-1 mol-mol),1.8648125815203176
NCI-H2081,navitoclax-MST-312 (1-1 mol-mol),0.8717360318084046
Hep-G2,219104,4.303712261907195
GOS-3,9935249,3.5788705539521315
RPMI-7951,44137675,2.7666009410901284
Raji,5281321,-0.7829578369432236
Hep-G2,637858,2.4710681435790747
LNCaP clone FGC,3689413,0.5325071990753445
HCC2218,51037431,1.0791921367059885
KMBC-2,navitoclax-MST-312 (1-1 mol-mol),0.0263119667661449
WM983B,72734382,4.6650436117725995
SNU-1272,3025944,5.229392036537965
PaTu 8988s,5746,2.3512258375405235
A4/Fukuda,3503,1.0521499831923595
BT 328,409805,5.840944403536212
KMRC-2,1641662,4.678757518299194
SNU-308,24964624,2.3333426495769567
A4/Fukuda,45279963,1.9027034071047564
A4/Fukuda,135398516,0.099848878431286
KMRC-2,carboplatin-UNC0638 (2-1 mol-mol),3.5447345065764937
ESS-1,54613361,0.2104463314777853
NCI-N87,54618771,0.8863121899707505
A4/Fukuda,salermide-PLX-4032 (12-1 mol-mol),4.8455357298985655
Aska-SS,17755052,-1.6126335800222398
OE21,5746,0.6324178329845088
YH-13,6918736,-3.6084117176459913
KYSE-410,JQ-1-UNC0638 (2-1 mol-mol),2.635802003886042
HEC-151,2945648,2.9108937547424376
SK-LMS-1,46926350,-3.8599934013437434
Hep-G2,24180125,3.881955939132959
HSC-4,navitoclax-piperlongumine (1-1 mol-mol),2.6552743905338905
PaTu 8988s,53481919,3.618361431835983
NCI-H1395,3503,1.633865651752571
PaTu 8988s,16659841,5.259060239450496
SNU-1214,11485656,2.376217579776436
PE/CA-PJ34 (clone C12),42611257,3.7997794760186654
SKM-1,49793307,-4.429104877934936
WM983B,375860,0.0821681125114241
NCO2,135398738,4.9032466202523945
NCO2,159324,-0.155118322085548
PaTu 8988s,selumetinib-vorinostat (8-1 mol-mol),2.3854275000826592
SET-2,24771867,3.532138745646488
CML-T1,452548,-3.528686830959828
HuT 78,2874250,-2.74453547874646
SW1990,9926054,1.8053433824091036
BT 504,5280436,4.716753593717743
KYSE-70,serdemetan-SCH-529074 (1-1 mol-mol),2.076858890087622
A4/Fukuda,46191454,-2.2780561859524457
SK-N-AS,54618771,1.0154959522530718
OAW42,11494412,1.718292738866412
KMBC-2,6918328,-0.1114347675868699
PE/CA-PJ34 (clone C12),6918328,0.8445281698362359
RERF-LC-A1,54619267,4.7763582628553936
BT 330,24785538,-0.5573762170833948
PE/CA-PJ49,168312962,3.718091644443816
Kasumi-2,969516,1.973265868556714
LNCaP clone FGC,54618305,4.126133237949938
EJM,445643,4.021541307883637
SEM,9826308,-1.408975626974659
MCAS,44507138,1.683657005496222
NCI-H2172,17759555,5.1206120286253425
AU565,4477,0.8975719043136093
MM1.S,6918878,-0.530970823966065
PE/CA-PJ49,50905018,4.362942896292534
SNU-1033,navitoclax-MST-312 (1-1 mol-mol),1.0077386216365567
MCAS,1566236,2.0523817086491296
Kasumi-2,9549297,1.4131024835139536
YKG-1,107985,-2.4631339535317993
KMS-27,44185566,2.2798928208944287
LoVo,613753,3.444351424595812
SNU-1033,409805,7.650675265058521
SKM-1,4788,4.719822695202535
CML-T1,23635314,-1.5423479854884166
LNCaP clone FGC,vorinostat-navitoclax (4-1 mol-mol),1.1003389364553935
ML-1 [Human thyroid carcinoma],15953870,3.8046885468141016
EJM,4261,0.9185867852984516
SW1990,46215462,1.636650619537341
Hs 683,10302451,3.704535359284315
RPMI-7951,82146,4.419432545694383
PE/CA-PJ49,136227924,2.4190721025981987
Ku812,753704,4.676427896259273
BT 328,72193861,3.7422212299852946
ESS-1,44632017,1.0852608734168645
PaTu 8988s,5311,1.267782379432991
RPMI-7951,selumetinib-MK-2206 (8-1 mol-mol),3.2832065602787712
SNU-1272,navitoclax-pluripotin (1-1 mol-mol),0.4939467184694363
ML-1 [Human thyroid carcinoma],ISOX-bortezomib (250-1 mol-mol),0.9716953544539896
PE/CA-PJ49,46224516,4.646092336237554
BFTC-909,11317348,4.568727931072339
HEC-151,44589607,2.8063930431223465
SNU-1272,selumetinib-navitoclax (8-1 mol-mol),2.1860356940542087
AU565,11214940,0.9865925706012508
ML-1 [Human thyroid carcinoma],5282054,2.990899024296238
LoVo,11719255,3.552916809155198
SK-MEL-1,44607531,1.6286422022372613
NCI-H1092,44489675,3.6172638586076937
SNU-8,10302451,3.487044127075749
Aska-SS,25161177,4.387383753124496
SK-N-AS,BRD-A02303741-carboplatin (1-1 mol-mol),4.459385478102044
NCO2,navitoclax-birinapant (1-1 mol-mol),-0.9403268243211336
RERF-LC-A1,16725315,4.377978611699284
GOS-3,984333,1.7865923354783255
TE 617.T,10074640,3.37516320161221
YKG-1,46843906,3.149273077560738
NU-DHL-1,5470400,3.3692959530783155
LoVo,3634881,2.800959668083557
HCC2218,24180125,2.93475065656583
OE21,navitoclax-piperlongumine (1-1 mol-mol),3.383148476178937
YH-13,10302451,3.810654470358069
LCLC-103H,753704,5.396939392004122
LNCaP clone FGC,3384730,2.6704407926087783
NCI-H2110,56949517,4.332039777651592
Hs 683,54618771,0.8006472003548896
RERF-LC-Ad2,2828334,6.229076280366517
RERF-LC-A1,5311281,3.134930168677258
CML-T1,5278396,2.8291940129393054
SKM-1,5329102,1.247777123403785
PaTu 8988s,135659046,3.7225208809385073
KYSE-70,10427712,2.9549225300897977
H-STS,16725315,4.449964499354371
Kasumi-2,446155,3.789762475260846
Aska-SS,51039095,3.6384675258199857
OE21,45279963,3.506365906002621
GOS-3,322968,4.726179979484062
TE-15,5280436,1.6052639817547756
SNU-8,57519531,3.1479992665124623
BT 248,4378219,1.4454405763629643
OAW28,24856436,0.1607500363529794
D283 Med,702558,2.919468662006613
LNCaP clone FGC,51037431,3.363500928465347
Kasumi-2,24978538,-3.812533145701136
H-STS,17755052,1.4518907441282063
OE21,9935249,1.7053577449970625
SET-2,26596,-1.642607786787168
AU565,71466380,5.723316888337632
PE/CA-PJ49,44462760,5.03856691343424
SK-LMS-1,tretinoin-navitoclax (4-1 mol-mol),2.6933978808882513
OE21,54143018,0.6332765597065765
BT 139,6610216,4.145166206340405
KMS-27,119182,-1.6421871247609852
CML-T1,5284329,2.20205002414717
TE-15,5566,3.0500751380182396
KMBC-2,11612883,3.512280172644111
SEM,71304818,2.4443931751083254
KYSE-70,72734382,4.428008981499565
JIMT-1,15953870,3.7526391312242744
BT 504,57330099,4.022742556485053
NCO2,72193861,-1.008893487292728
BT 139,16722836,1.5591777456407394
KMBC-2,11228183,0.6800152041543918
MCAS,24785538,2.440371429478031
ML-1 [Human thyroid carcinoma],selumetinib-vorinostat (8-1 mol-mol),1.7610539005616883
HuT 78,23725625,5.900572836007656
Raji,19582717,3.2823671659131244
SNU-8,637858,2.315225412035183
SEM,135398744,6.34358667151958
PaTu 8988s,25227462,-3.957838993193877
KMRC-2,409805,5.9581282148190855
WM983B,2729026,2.1809700397444236
SNU-1214,31703,0.2327477554999883
AU565,4096211,1.4857810053347718
BT 330,6610216,4.420410954018115
SET-2,navitoclax-MST-312 (1-1 mol-mol),-0.8441968581506685
BT 330,216239,1.743255722435545
SNU-1033,6436223,-5.381153416381445
LNCaP clone FGC,selumetinib-JQ-1 (4-1 mol-mol),0.1140146745231702
NCI-H1092,44202524,3.663544570122555
SNU-1272,3384730,4.452220632140668
OAW28,24797083,1.7501511491860735
HuT 78,9952709,1.8932187114351076
OAW28,selumetinib-navitoclax (8-1 mol-mol),1.984152872487984
OAW28,6610355,6.153508691776863
D283 Med,JQ-1-UNC0638 (2-1 mol-mol),3.413583109357789
Hs 683,16219061,3.2988722475842303
KMS-20,4917,2.7295029836090565
PE/CA-PJ34 (clone C12),9866186,0.7220729418823932
NCO2,3025944,3.8629471495724066
JIMT-1,16725315,4.749806824303487
NU-DHL-1,3854666,0.0415857497138207
SNU-1214,3543504,3.87558640728975
SNU-1214,sirolimus-bortezomib (250-1 mol-mol),0.3499333667052599
HARA [Human squamous cell lung carcinoma],60750,0.0702005032300629
KYSE-410,3385,5.3788897343124376
EJM,24753719,3.944145631978448
A4/Fukuda,219104,2.2512696330904447
ESS-1,6914657,-3.5334126406740594
RERF-LC-A1,24978538,2.115179228694349
JIMT-1,107985,-0.7659824645781472
KP-4,216345,4.1905872453643065
SKM-1,11960529,3.62763439473286
SKM-1,135398516,2.107945219475692
TE-15,4259181,-0.9180245906878618
MM1.S,227681,1.7327122613945027
LNCaP clone FGC,46843906,2.034507662403873
NCI-H2172,9903786,4.970438346504575
PE/CA-PJ34 (clone C12),9907093,4.32490374707387
SNU-308,65064,5.346277065283632
Kasumi-2,135875424,2.5938758238859494
RERF-LC-A1,tanespimycin-gemcitabine (1-1 mol-mol),-1.4594951582143432
HCC2218,9911463,3.007199101123831
RPMI-7951,67291369,2.8154779502053016
NCI-H2172,676352,2.4225571956967804
NCI-H1092,23635314,1.8043090109267528
BT 328,216345,4.606684867794206
BT 320,4917,2.82304614910839
NCI-H1092,119607,5.038336546670844
NCI-N87,54618164,3.997308077582706
YKG-1,46398810,2.968837802015958
Hep-G2,65064,4.407687978914002
HEC-151,9952709,2.93542691790346
SET-2,168313016,3.716090786123575
SK-MEL-1,969516,3.0413778322072944
SK-MEL-1,60700,0.4818903953735158
SNU-1214,54454,1.0965137828709777
YKG-1,11640390,4.261360521088683
WM983B,9911463,4.352284884356164
HCC2218,53392493,1.6336256448398232
SW1573,16065773,3.287625611468905
LoVo,docetaxel-tanespimycin (2-1 mol-mol),-4.329942307031701
GOS-3,3081361,3.4367790874806015
CML-T1,10113978,1.6264516706818362
LoVo,1566236,1.5203890875485482
RPMI-7951,2113511,4.6851966794067925
A4/Fukuda,176870,1.9874765150136215
RERF-LC-Ad2,25262965,-2.693840311584002
Kasumi-2,44607531,1.0542160339181526
HSC-4,11626560,2.5873766751252436
SNU-1033,25150857,2.130511087959952
OAW28,11612883,3.952715585132085
KP-4,11507802,0.4427590304942607
SET-2,7326481,3.5585893321455724
HuT 78,5113032,3.627590183655839
SW1990,9908783,5.688653533069491
CA46,44607531,1.0933116261411373
OE21,16065773,2.7500210477660354
SNU-1214,54649381,3.4023462512727516
OE21,51037431,3.791500924421856
Hep-G2,444795,7.091940765135057
A4/Fukuda,426756,4.168045276817785
A4/Fukuda,4096211,1.2598455852625392
BFTC-909,44202524,2.4582417316930916
BT 330,selumetinib-navitoclax (8-1 mol-mol),1.8958449254541392
KP-4,3854666,1.6469581431730445
BT 139,4705,1.2736947517063846
NCO2,327653,2.297487174577918
KMBC-2,navitoclax-gemcitabine (1-1 mol-mol),-0.4940632335872953
AU565,9803433,4.3672163986823085
KMS-27,23725625,4.667804380563468
D283 Med,selumetinib-tretinoin (2-1 mol-mol),-0.135437445848875
BT 504,676352,1.8688641381756124
CA46,426756,4.77193452473935
YKG-1,168313200,2.942374611054984
KYSE-70,doxorubicin-navitoclax (2-1 mol-mol),1.6680875974880454
IST-Mes1,25126798,3.982374188902535
KMS-20,24951314,0.1651472976854425
KMS-20,1641662,2.6653075673908564
KYSE-410,49766530,0.2031131423748078
Hs 683,navitoclax-MST-312 (1-1 mol-mol),0.9161458061573864
TE 617.T,400769,-0.3997612253478387
HEC-151,122327,4.377570322773753
PE/CA-PJ34 (clone C12),702558,5.513865527518569
HuT 78,navitoclax-gemcitabine (1-1 mol-mol),-2.9372402673732205
PaTu 8988s,126941,-4.289594837447488
KYSE-410,51039095,3.0078200287209165
HCC2218,46926350,-3.897277890341576
CA46,3634881,2.7183374991781903
PE/CA-PJ49,selumetinib-MK-2206 (8-1 mol-mol),2.3211771397352137
IST-Mes1,11507802,2.196367921071978
PE/CA-PJ34 (clone C12),24180719,3.969047374225328
KYSE-70,387447,-2.8804562370412765
OAW28,11455910,2.4986666790908583
EJM,navitoclax-gemcitabine (1-1 mol-mol),-5.027748230090614
YH-13,702558,5.825874792265712
LNCaP clone FGC,2949965,2.2467264551243993
RERF-LC-Ad2,89928392,1.2500542472683187
NU-DHL-1,5329102,1.5398804917088604
PE/CA-PJ34 (clone C12),11404337,0.4327507632811037
NCI-H1395,135875424,3.644181585171065
IST-Mes1,374536,3.187270781803884
CML-T1,5282054,3.0197566265123754
BT 139,675434,4.372766341294952
YKG-1,3062316,3.550628439107019
HSC-4,54686904,4.85379149564711
WM983B,135398516,2.087104369429688
AU565,54618795,2.974070020268914
BT 248,444795,4.817055384579841
RPMI-7951,44489675,3.6085251470230224
PE/CA-PJ34 (clone C12),2708,4.740071919144502
NU-DHL-1,24797083,0.8543647878457378
NCI-H1395,53495165,1.995718788623105
NCI-H2110,3038522,3.139256124703558
NCI-H1395,375860,1.7808246881173873
GOS-3,57519531,1.810044257027968
SKM-1,50905018,4.354316940379774
Hep-G2,71680916,5.349288664380335
WM983B,60700,0.1621839049279425
ESS-1,216239,3.396393497889356
KMBC-2,25183872,-1.1751157821952534
SNU-1214,654092,-0.8857733624045308
PE/CA-PJ49,702558,5.79167098378283
D283 Med,9933475,1.5513206335845269
NCI-H2172,44241473,5.356586155091817
NCI-H2081,salermide-PLX-4032 (12-1 mol-mol),5.178894750925086
PE/CA-PJ49,44632017,0.7421325130952813
MCAS,25062766,2.1662078190580085
OAW28,5335621,5.136061685098042
H-STS,44566777,0.8546674055066537
KMS-20,119607,4.302564368851616
BT 504,6852167,5.8705785953298255
SNU-1033,54618771,0.4334411730243536
HARA [Human squamous cell lung carcinoma],4096211,1.410240196225579
BT 139,216345,2.003802202628343
A4/Fukuda,5978,-3.163562671527086
NCI-H1395,navitoclax-piperlongumine (1-1 mol-mol),2.9868041104516245
SK-LMS-1,5738263,4.396067245075149
SNU-1214,65064,4.148568727564404
AU565,104842,-3.8153307910583014
SET-2,4096211,2.089514790841445
A4/Fukuda,2113511,3.845432548996496
NCO2,3854666,-0.3022721957151304
LoVo,67156097,-2.753278115102512
RERF-LC-Ad2,5113032,4.576998956244217
SW1990,53325874,4.767228471561693
PaTu 8988s,10184653,1.0549683128731666
BFTC-909,119607,6.015893315993201
NCI-N87,26596,-0.8687464208841552
OE21,216239,2.081942890669219
HEC-151,11626927,4.237303713859301
BT 248,navitoclax-birinapant (1-1 mol-mol),0.9680614151724524
PaTu 8988s,serdemetan-SCH-529074 (1-1 mol-mol),1.9776411306305544
NU-DHL-1,107985,-5.852649208769622
HEC-151,54649381,3.9974164574496824
AU565,107985,-3.572249289009051
BT 330,selumetinib-PLX-4032 (8-1 mol-mol),4.410131517671973
NCI-H2110,16659841,3.1191566994365147
PE/CA-PJ49,4096211,1.6961227521771136
SNU-308,5978,-1.1640731069355073
SK-N-AS,227681,3.559149115047235
NCI-N87,11213558,1.0018400483751706
OE21,54618164,3.767482528775002
KYSE-410,168313047,2.9642256553070796
HSC-4,44185566,3.0805483382503844
NCI-N87,2828334,6.0279909292271165
BT 328,135875424,3.085389187382682
A4/Fukuda,9887053,3.945623871756388
HARA [Human squamous cell lung carcinoma],5351362,1.123570314509272
HuT 78,6917907,-7.494534936281525
RERF-LC-Ad1,5282054,4.000708411224595
RERF-LC-A1,2874250,5.124044947283605
CML-T1,10302451,-1.0288409878116755
TE 617.T,11494412,-0.0865540584067903
TE 617.T,44607531,-0.797135035283961
NCI-N87,11625818,1.9405356473547937
HARA [Human squamous cell lung carcinoma],72193861,-0.0489023079435419
RPMI-7951,4917,2.3080292416300874
A4/Fukuda,crizotinib-PLX-4032 (2-1 mol-mol),-0.0418615820710858
NCI-H2172,5291,3.961077690922126
BT 504,15953870,4.189590150947692
HARA [Human squamous cell lung carcinoma],439501,-2.358364257130844
PE/CA-PJ49,439501,-2.9475727314168174
CA46,5281321,-3.5082232289526663
LCLC-103H,1242560,4.075882567780665
Ku812,4259181,-1.0914400455544095
HMCB,44589607,2.914653389177592
Ku812,5311,0.5445817614844265
BT 248,JQ-1-navitoclax (2-1 mol-mol),0.658869929233474
KMBC-2,46199207,3.631177458951401
SKM-1,navitoclax-MST-312 (1-1 mol-mol),0.2103824065609011
TE-15,5470400,-2.757197006714044
YKG-1,5566,3.213592507672074
SKM-1,9866186,0.3816129775524117
KMS-20,421610,2.181473098974352
KMS-20,11404337,-1.24048912938788
KYSE-410,6918736,-0.0092820973609371
CML-T1,10322450,3.1347292789416934
BT 320,11257553,3.955696091315844
MCAS,46199207,3.5595414630698152
HMCB,11640390,3.771072765277519
NU-DHL-1,10127622,1.0560175006999375
LCLC-103H,54618164,4.386311073286264
AU565,11497983,3.5183187315924185
NCI-H1092,148198,-7.112179510843006
PE/CA-PJ34 (clone C12),984333,0.8782712724781023
KMRC-2,54626689,4.800851370562855
SKM-1,3815108,3.188772071922917
SK-LMS-1,10074640,3.661191985858004
NCO2,navitoclax-sorafenib (1-1 mol-mol),0.3035982943908881
KMS-20,73707438,0.304623121226347
MCAS,9911830,3.0082836124394214
OE21,5280436,1.8081382274823423
BT 248,10427712,4.022427006719253
SNU-1033,16065773,2.5318700618978007
LCLC-103H,24785538,3.0357718488755423
HEC-151,JQ-1-carboplatin (1-1 mol-mol),1.2344499659819954
SNU-1033,JQ-1-carboplatin (1-1 mol-mol),1.515968870431384
BT 330,5287969,-1.4719993323531353
KMRC-2,navitoclax-MST-312 (1-1 mol-mol),0.8384543480139683
KMRC-2,44607531,1.5632454082494247
BFTC-909,136227924,2.3418993883842134
SET-2,24797083,1.3463282154315572
OAW42,216345,3.898731588448133
OAW28,4261,1.5275003221448853
D283 Med,25062766,1.4055870376887964
PE/CA-PJ34 (clone C12),56963564,0.4073431502200141
BT 139,136227924,3.476406727957654
KMS-20,6852167,1.0361135786452058
ESS-1,5460769,-0.3251379363550979
CA46,9884685,-1.0270691788705264
SK-LMS-1,72193861,2.7252079033502676
RERF-LC-Ad2,3503,2.250409262953343
KP-4,selumetinib-JQ-1 (4-1 mol-mol),2.1555803314083635
PE/CA-PJ34 (clone C12),3825829,4.057915478742878
TE 617.T,54618771,-2.3163435045847436
NCI-H1092,6505803,2.777743929422052
BT 320,ISOX-bortezomib (250-1 mol-mol),1.4901983753773511
RPMI-7951,carboplatin-UNC0638 (2-1 mol-mol),2.186057143713863
BT 328,selumetinib-UNC0638 (4-1 mol-mol),5.206465568197119
RPMI-7951,25062766,1.4776301133262697
Raji,54143018,-0.8038928001043883
HARA [Human squamous cell lung carcinoma],71304818,2.9544117211144147
CA46,49766530,-5.499020578204802
NCI-H2110,216239,3.010643148225552
NCI-H1092,54619267,3.872554434622377
Ku812,10127622,-2.476292288821415
NCI-H1395,doxorubicin-navitoclax (2-1 mol-mol),0.3327602651018742
SEM,3825829,3.0657110006972026
NCI-H2172,66577038,3.596216662258609
HARA [Human squamous cell lung carcinoma],16038120,0.7093520184689783
OAW28,16038120,1.1273660282184277
NCI-H1092,tanespimycin-gemcitabine (1-1 mol-mol),0.9307316859155624
PE/CA-PJ34 (clone C12),16722836,1.614238744479456
NCI-H1395,11717001,5.001255257039283
OAW28,navitoclax-pluripotin (1-1 mol-mol),-0.843922258994718
YKG-1,vorinostat-navitoclax (4-1 mol-mol),2.284483308866315
Hs 683,2945648,3.084046242394678
CML-T1,25195348,1.1650045100950834
BT 248,119607,5.038088774684491
AN3-CA,445643,5.011387684987895
JIMT-1,4261,2.422903471771653
Hs 683,44632017,0.8900941738880314
KMRC-2,16741245,6.502208850196386
MM1.S,1242560,2.8271935424204786
SNU-1272,216239,2.083500892876492
SK-MEL-1,654092,0.0671829755376614
KYSE-410,44607530,1.8240121580330635
PE/CA-PJ34 (clone C12),16659841,3.7885969371213704
CA46,637858,0.8997823848237061
HuT 78,68056272,3.666874851860886
KMS-27,16741245,2.5294483123867115
HARA [Human squamous cell lung carcinoma],6505803,-0.6058988133854029
SNU-1272,135875424,4.314381098584833
NU-DHL-1,54649381,3.9562595650424375
WM983B,5287620,-3.0703867982754387
LoVo,44241473,4.10673515965005
HuT 78,322968,0.3476030188480727
MCAS,51037431,1.5804023066668025
HMCB,44632017,0.9230813407361356
A4/Fukuda,11707110,-3.666992219196893
KMRC-2,46224516,1.0513672467692918
SNU-8,6450551,4.187914273502316
Aska-SS,selumetinib-navitoclax (8-1 mol-mol),5.320747711873069
BT 320,2858523,3.05792743854883
RERF-LC-A1,11964036,3.0580716078518555
WM983B,409805,3.828493612521517
Kasumi-2,66577038,2.680052495523132
OAW42,2733526,4.2379977258148065
NCO2,24785538,0.3479067940421194
SEM,54619267,2.973964414484695
RERF-LC-Ad2,ISOX-bortezomib (250-1 mol-mol),1.6620551731965916
HARA [Human squamous cell lung carcinoma],ISOX-bortezomib (250-1 mol-mol),0.5382016887520487
CML-T1,676352,1.5222388602604249
KMS-20,4578,4.142060591748304
NCI-H1395,46926350,-3.2144597586965515
NCO2,66577038,1.6389037161780544
SET-2,49846579,1.764293772248107
Raji,135875424,2.0989109294233264
PE/CA-PJ34 (clone C12),327653,3.4791017722352815
HMCB,135440466,2.2236465110977988
BFTC-909,46199207,3.2760821272908753
KMS-20,16065773,1.6920071988630498
ML-1 [Human thyroid carcinoma],54639126,4.430736107428324
CML-T1,9840324,5.6593047828259495
PE/CA-PJ49,navitoclax-sorafenib (1-1 mol-mol),3.038592174870093
OE21,54678924,1.4309083952693855
BT 504,2749,0.5104870955177306
SNU-1033,71680916,4.277496611581877
PE/CA-PJ49,46174525,4.261402269559326
LNCaP clone FGC,67291369,1.777562821585299
KMS-27,3025944,4.260679999843123
NU-DHL-1,5284329,2.6170218668943632
SET-2,73707398,0.747643412090769
BT 330,24821094,2.125553783080606
BT 504,374536,2.887745172362633
LoVo,136227924,4.6796674015936075
NCI-H2172,3025944,4.329147396053403
KMS-20,24901704,1.7542686332224908
WM983B,135999136,4.467967668661813
BT 320,erlotinib-PLX-4032 (2-1 mol-mol),4.456521882362605
BT 330,selumetinib-piperlongumine (8-1 mol-mol),3.896837261696385
HMCB,9911463,4.262652850494811
LCLC-103H,11175137,3.539726420007949
SK-LMS-1,46199207,3.667357630180187
NCO2,51037431,3.257175705839609
OAW28,613753,3.2856198284724742
Kasumi-2,5738263,2.363328574896373
BT 139,BRD-K55473186,3.20697937041343
SNU-308,656346,3.271973298432795
PE/CA-PJ49,selumetinib-navitoclax (8-1 mol-mol),2.4477082122700655
NCI-H2172,6917907,1.1991748078755609
Hep-G2,44185566,1.2927959850835242
NCI-N87,57519531,1.4365599080949227
ML-1 [Human thyroid carcinoma],11152667,-4.726499990059393
NCI-H1395,4788,5.899577984060707
RERF-LC-A1,11485656,2.3794985324061217
LoVo,11977753,-2.85765012298846
KYSE-410,2841722,4.557147350090864
Hs 683,11427553,2.1811271780472983
WM983B,54618771,1.7213296960323683
BT 248,9911463,2.7908107916357436
NCI-H2081,374536,1.9264579533537656
KMS-20,10184653,1.4307527517519167
NU-DHL-1,46398810,1.6641868117973977
SW1573,10385095,0.5068001344623563
OE21,11609586,1.989609074462123
TE 617.T,UNC0638-navitoclax (1-1 mol-mol),1.3072146472034474
RERF-LC-Ad2,6918837,-1.2883848481250342
NCI-H2110,46199207,3.4338454475007807
SEM,613000,-0.3108787408101454
AN3-CA,navitoclax-pluripotin (1-1 mol-mol),-1.6190260246598227
PE/CA-PJ49,navitoclax-piperlongumine (1-1 mol-mol),2.610996953930581
SNU-1033,56649450,2.0286705758027144
SNU-308,49850262,4.866731965414422
A4/Fukuda,54619267,3.184419267966046
HCC2218,17755052,-0.3435339731300795
KMS-20,44507138,1.4113768398696636
BT 139,5746,0.3581690049929101
AU565,erlotinib-PLX-4032 (2-1 mol-mol),2.347179893247943
AU565,53392493,1.7262495119460306
BT 248,702558,5.9883095131036495
BT 328,11222830,1.4031048122319796
TE 617.T,SNX-2112-bortezomib (250-1 mol-mol),-3.542024974050954
AU565,1566236,1.7493429265082687
OAW28,9840324,5.735695909737487
KMBC-2,JQ-1-MK-0752 (1-1 mol-mol),5.054925786618905
AN3-CA,446155,1.829066428866823
KMBC-2,9907093,5.425782821141152
SNU-1214,46901937,3.826869108468287
SK-MEL-1,2729026,0.783016701629589
ESS-1,tanespimycin-gemcitabine (1-1 mol-mol),-1.9725488510506712
TE 617.T,6918328,0.5232426228966834
RPMI-7951,navitoclax-gemcitabine (1-1 mol-mol),-1.9936108856149684
SK-LMS-1,53232,1.4394485400514911
KYSE-70,3025944,3.9400169946897226
ESS-1,navitoclax-piperlongumine (1-1 mol-mol),0.9788398984790389
BT 330,2842253,6.3702274717066105
OAW42,70680404,3.738050456724604
Aska-SS,15953870,4.084404755513187
BT 330,135440466,2.4249688767909383
SET-2,122327,4.075304929861821
IST-Mes1,72193861,3.6955595837075137
Hep-G2,1750826,0.4131687532811144
IST-Mes1,89928392,1.562289834411229
JIMT-1,navitoclax-MST-312 (1-1 mol-mol),2.9533945060553757
Ku812,alisertib-navitoclax (2-1 mol-mol),-1.9869824570436432
RERF-LC-Ad2,11625818,4.943642256275433
CML-T1,44137675,3.6793288779986377
EJM,5951923,6.145734491390667
TE-15,54618164,4.596489817745785
SNU-1214,JQ-1-navitoclax (2-1 mol-mol),-0.2635916949837394
Ku812,12001922,1.5776657122495092
KMS-27,25183872,-2.068864908594192
RERF-LC-Ad1,11178236,-2.382860044467462
TE-15,168313200,2.769784502897391
BFTC-909,6505803,-2.7076869289136147
BFTC-909,selumetinib-GDC-0941 (4-1 mol-mol),1.742559417066922
Aska-SS,702558,5.279806161399073
KMS-20,135398516,0.4779911076393339
NCI-H2081,9952709,2.2305361453905284
RERF-LC-Ad2,11175137,3.7973989123571665
ML-1 [Human thyroid carcinoma],637858,1.1825057393141218
SET-2,23582824,0.7450424862816116
SEM,6918878,-2.4366739995343196
OAW42,17755052,2.4089852264449125
SNU-1033,25062766,2.0712439100177393
BT 504,3384730,0.2743670550406502
HSC-4,159324,3.192829599869501
NCO2,9884685,1.5735117508455894
Ku812,10113978,1.4581505574303557
LCLC-103H,5280436,3.915693008197807
ESS-1,5311037,3.6560576458162295
CA46,carboplatin-etoposide (40-17 mol-mol),0.8336753262316364
SEM,25183872,-3.2065373842883687
EJM,25161177,4.274116422039874
YH-13,24964624,2.65969154668954
ML-1 [Human thyroid carcinoma],216345,4.790115930225849
Ku812,9825149,0.757991873961122
SNU-1033,9866186,1.161302246288351
KMS-27,10074640,2.787372900594659
OAW42,445643,4.011560146323174
OAW42,446155,1.8636348427191165
AU565,387447,-4.131425766006191
KMRC-2,104842,0.4163688071678419
KYSE-410,3025986,-0.9572320671493456
RERF-LC-Ad1,42642645,1.4403465890046834
YKG-1,1239801,4.465183015374798
LNCaP clone FGC,1716436,2.823622083342099
SW1990,73707398,1.200617797087527
CA46,4477,-0.2706834990523855
KMRC-2,24785538,1.9810416518294935
KP-4,10074640,3.3562516491812473
YH-13,vorinostat-carboplatin (1-1 mol-mol),4.1657170851740855
HCC2218,3854666,2.216625580917516
BFTC-909,52947716,3.1995758728854224
BFTC-909,BRD-K27188169-navitoclax (2-1 mol-mol),3.3946327784578245
SW1573,25183872,-2.56928333929943
BT 504,selumetinib-MK-2206 (8-1 mol-mol),2.719378134582424
RERF-LC-Ad2,10074640,3.692209839516339
HEC-151,vorinostat-navitoclax (4-1 mol-mol),2.0027819292472193
HSC-4,10385095,0.4573663196580717
SET-2,3854666,1.160822920042355
BT 320,11640390,5.348028911341183
KMS-20,BRD-A02303741-navitoclax (2-1 mol-mol),1.210365618273724
OAW28,51039095,2.7471743585791075
Ku812,46174525,2.0497895392537133
A4/Fukuda,11609586,0.4485915276425587
LCLC-103H,5351362,2.584280827744259
KP-4,327653,3.0161374219123727
HARA [Human squamous cell lung carcinoma],26596,-2.1080424946580245
LNCaP clone FGC,135411,1.269325429429485
IST-Mes1,serdemetan-SCH-529074 (1-1 mol-mol),2.635765253356215
BT 330,54618305,6.276995186966791
NCI-H1395,6610355,4.529724434844308
PE/CA-PJ49,11707110,2.840144820082537
Aska-SS,6918878,2.6155918137055973
OAW28,71466578,4.4029072721322455
HMCB,7251185,3.03450552612139
PaTu 8988s,107970,1.550826733385026
EJM,252682,5.970760325898544
SK-LMS-1,2858523,3.096035867427568
HARA [Human squamous cell lung carcinoma],568763,1.3363257274557196
HEC-151,6252,-0.631577765285913
PaTu 8988s,24964624,3.005673973446249
TE 617.T,25161177,3.228800177382168
PE/CA-PJ49,44819697,0.1954599537080359
ML-1 [Human thyroid carcinoma],UNC0638-navitoclax (1-1 mol-mol),2.518264645027629
OAW42,9952709,4.444964197036944
KMRC-2,71304818,3.686445866652109
AU565,216239,2.683840039589205
SK-N-AS,JQ-1-carboplatin (1-1 mol-mol),2.0637783416612767
YH-13,selumetinib-JQ-1 (4-1 mol-mol),2.881387318518872
SEM,46926350,-4.492601003803031
SNU-1033,119607,5.415425235504449
Hs 683,7251185,3.0057343513623036
KMRC-2,11656518,3.740037309052016
HSC-4,156414,0.4374127066870092
SNU-8,44137675,3.738684584786805
MCAS,4788,5.287180776673087
Raji,15547703,3.0439493228256183
TE-15,9823820,4.008583302696159
Kasumi-2,12001922,1.274437651383908
HCC2218,73707438,1.7281107307453174
SEM,54618164,3.8944596685913138
OAW42,3689413,0.5201903722679624
LNCaP clone FGC,11214940,3.923278804570468
OAW28,5278396,3.588828047742794
BT 248,54596558,3.9995548839878503
HCC2218,6438330,2.0468099735071865
RERF-LC-Ad1,5311,3.464534219485875
SNU-1214,24753719,4.20428044650039
CML-T1,2742550,2.9758871773228366
WM983B,53392493,3.770374039918625
RERF-LC-Ad2,5351362,2.9757711645344105
HCC2218,322968,2.14614660643138
SNU-308,60700,1.6377484625650067
ESS-1,JQ-1-UNC0638 (2-1 mol-mol),1.0012685328426527
PE/CA-PJ49,selumetinib-BRD-A02303741 (4-1 mol-mol),4.735000987700845
HCC2218,5978,0.2771464646510415
SET-2,15983966,-4.296182260528854
YH-13,11507802,0.9123185813590028
CML-T1,11175137,2.223157836501134
ESS-1,11955716,-2.238673877316504
NCI-H2081,52947716,1.970928272197099
RERF-LC-A1,613753,3.226502948696401
RERF-LC-A1,57519531,1.7133184511132986
Hs 683,11167602,3.3707679458067195
NCI-H1092,carboplatin-etoposide (40-17 mol-mol),2.1846305146298852
Hs 683,44185566,2.9251167986243347
NCI-H1092,3552672,1.5396506423580394
JIMT-1,15547703,3.758014956877308
TE-15,5328940,0.2955762085250979
A4/Fukuda,51037431,0.9928208538339424
SK-N-AS,25102847,2.9067835696639053
EJM,49867930,4.535292738275801
KMBC-2,6918638,1.17976161020614
KP-4,6252,0.7313578355314097
RPMI-7951,BRD-A02303741-carboplatin (1-1 mol-mol),4.1288937818997695
HuT 78,16013152,3.8354573431378185
LoVo,5282054,3.3404837473565077
BT 139,5311,2.7929451938045355
KMBC-2,16725315,3.826236477379129
Hs 683,25062766,2.2319076725821714
NCI-H2172,doxorubicin-navitoclax (2-1 mol-mol),1.5806613828001743
HCC2218,135984461,4.242222575016064
D283 Med,doxorubicin-navitoclax (2-1 mol-mol),-2.991531954647572
OE21,JQ-1-MK-0752 (1-1 mol-mol),0.8288579789909071
OAW28,ISOX-bortezomib (250-1 mol-mol),-0.0669520264254744
LoVo,656346,0.766025679375412
PaTu 8988s,11494412,1.3671050203889736
NCI-H1092,9823820,4.957338648627321
CML-T1,46398810,1.457844995716712
KMS-20,serdemetan-SCH-529074 (1-1 mol-mol),1.5449813132699757
PE/CA-PJ49,44607531,0.2655934961567524
NCI-H1395,119607,5.849828221842235
CA46,71466380,3.212448709653588
KMS-20,24964624,0.3956961700125998
OE21,46215462,1.559582352466536
SNU-308,54619267,4.081885658033266
LNCaP clone FGC,11404337,0.2192821981043099
PaTu 8988s,5329102,1.5064447610423493
Raji,6918837,-4.178794520867055
HEC-151,16722836,1.6765297492906277
BT 328,alisertib-navitoclax (2-1 mol-mol),0.3590132286260764
WM983B,11647372,2.5025576525701796
PE/CA-PJ49,3081361,0.9228632415234772
D283 Med,36462,-0.7003958685437419
Hs 683,64971,3.6391231978651466
PE/CA-PJ34 (clone C12),4259181,0.3767954059641493
BT 139,216239,2.0237892251606513
AN3-CA,24821094,2.333650308154893
SNU-1272,9903786,4.921324329124853
KYSE-410,54619267,4.169541955466141
BFTC-909,168313047,1.967772312792883
BT 328,4705,3.594890989297502
NCI-H1092,3384730,3.333041277553113
BT 328,SNX-2112-bortezomib (250-1 mol-mol),-2.692646777339037
ML-1 [Human thyroid carcinoma],135659046,3.731165476589243
HEC-151,156414,1.2927614693415013
PE/CA-PJ34 (clone C12),16725315,5.214730305618214
BT 320,5566,3.007077893151021
OE21,23725625,5.730307601781646
KMS-20,15983966,1.6874259889880727
WM983B,4378219,2.293586704374939
A4/Fukuda,1716436,2.785785051354721
ESS-1,25062766,1.641098624401774
RPMI-7951,3062316,0.109951341405492
AN3-CA,selumetinib-GDC-0941 (4-1 mol-mol),1.0170906897464025
Aska-SS,2949965,2.3817646321620938
NCI-H1092,10427712,4.783956203495579
SET-2,53495165,-2.0941219446387347
PaTu 8988s,148124,-0.8669711950509935
WM983B,6918638,0.63474278918499
HEC-151,navitoclax-MST-312 (1-1 mol-mol),1.3333991440572028
TE-15,25102847,1.8663159044636977
Hs 683,44819697,0.4352103232561417
MCAS,3543504,4.5617609044392955
LoVo,2828334,5.515630519838643
KMS-27,3385,3.2431788484740993
BT 328,selumetinib-MK-2206 (8-1 mol-mol),3.5375003025596596
SNU-1033,53495165,0.0808215902221362
Hs 683,selumetinib-BRD-A02303741 (4-1 mol-mol),4.926542916228776
NCO2,54649381,3.617596248249218
Hs 683,9823820,5.340119686592485
Raji,doxorubicin-navitoclax (2-1 mol-mol),-1.4888855783591863
BT 328,241158,5.267624320159163
MCAS,73707398,1.1782781305000984
CML-T1,57519531,1.0516100309241616
KYSE-410,16725315,3.3139770396099943
TE 617.T,56963564,0.1382790284756134
SNU-1214,54686904,4.412043989333209
KMS-27,decitabine-carboplatin (1-1 mol-mol),3.5592603787119472
OAW28,selumetinib-MK-2206 (8-1 mol-mol),3.6165441684706736
TE 617.T,285033,-5.256321811666982
OAW28,71680916,5.167013104004298
TE-15,25150857,2.8317844054679977
SNU-8,73707398,1.2983083910911808
SNU-1214,9929138,6.834852342367116
WM983B,123631,2.6992335678646877
KYSE-70,5287620,-1.7159794680358271
SK-N-AS,60700,-0.322355316178559
SNU-1272,11364421,0.105074823044801
NU-DHL-1,9933475,1.7184020266323787
AU565,445643,3.872431437053606
SW1573,73707398,2.4757839790774123
SW1990,219104,4.210148447482214
KMRC-2,1750826,-1.9203371760077488
HuT 78,9887053,1.4751024014992844
NCI-H1395,1716436,2.423237318066945
PE/CA-PJ34 (clone C12),26596,-1.1037163261022582
BT 328,2828334,7.045901610155557
PaTu 8988s,11626560,1.379807477109151
BT 504,25102847,1.923766603884073
NCI-H1092,400769,-0.5957387539071202
NCO2,452548,-2.4142920487376607
KMS-27,426756,4.187084446884802
KMS-27,5566,2.9589346041205995
Raji,10302451,3.856690135156121
HARA [Human squamous cell lung carcinoma],9936388,-6.286258703982233
BFTC-909,42642645,1.561027146692027
KP-4,6852167,2.7219764725227753
TE 617.T,216345,2.5267034047564807
Ku812,10231331,-1.9439726513116764
BT 330,11404337,-0.3310722205999429
CA46,451668,2.285623139838705
PE/CA-PJ49,54613361,-0.71410826322886
SKM-1,124202324,1.09229022845767
EJM,doxorubicin-navitoclax (2-1 mol-mol),-1.6863315158060843
KP-4,2949965,3.3875389698140412
Hep-G2,71466578,4.87571024377078
HARA [Human squamous cell lung carcinoma],24772860,-1.3203429479269333
SW1990,46199207,3.658278833189125
SKM-1,6918736,-4.119160923301796
LCLC-103H,navitoclax-pluripotin (1-1 mol-mol),-1.2011629729293944
OE21,387447,-4.65456656277309
PE/CA-PJ34 (clone C12),613753,3.1668131618299444
LNCaP clone FGC,4259181,1.1537445787746927
A4/Fukuda,4915,4.811112690158961
OAW42,1242560,3.732961581201449
CA46,6610216,4.017162804005507
OAW42,73707398,1.7425852441434224
OAW42,49867930,4.504410570488263
ESS-1,71751553,4.681072103352448
Aska-SS,6505803,-1.3133371843623132
NCO2,55508,4.66792071317611
NCO2,10113978,1.186992416215085
MM1.S,54618771,0.954891721558104
PaTu 8988s,6914657,-2.9857558603888124
GOS-3,10410894,4.409774071454934
NU-DHL-1,4261,-0.9383444517557142
IST-Mes1,2749,1.654199391381554
HSC-4,erlotinib-PLX-4032 (2-1 mol-mol),2.314385393540324
KP-4,navitoclax-PLX-4032 (1-1 mol-mol),3.1090656860064456
SK-N-AS,5351362,0.8857056530928049
KMBC-2,36462,2.9079010396533302
NCI-H2172,16725315,5.920732263272158
LoVo,4261,-0.8211989197292223
OAW42,selumetinib-JQ-1 (4-1 mol-mol),3.6330242229616694
OAW42,3025944,4.208059240331757
A4/Fukuda,24772860,-3.4983689572797307
PaTu 8988s,36462,3.2992976849858593
KYSE-70,9911463,3.4914249269651307
D283 Med,10127622,5.31032518886127
HuT 78,4705,4.420154035532244
NU-DHL-1,135999136,3.842512591140382
IST-Mes1,4788,5.898872389352922
Ku812,126941,-4.2292627127122575
YKG-1,49766530,1.555111020821771
NU-DHL-1,docetaxel-tanespimycin (2-1 mol-mol),-4.786935307033958
Kasumi-2,44137675,1.606596454570492
SK-LMS-1,49793307,-2.1486855233456796
TE 617.T,5479543,3.228503749183166
ML-1 [Human thyroid carcinoma],6623618,2.7004595127938686
EJM,5113032,5.279570802403047
SEM,613753,2.3547167164197247
PaTu 8988s,tanespimycin-bortezomib (250-1 mol-mol),-2.9825646134003825
YKG-1,148198,-3.345136621371903
Kasumi-2,10296883,1.6134498936175832
NCI-H2172,31703,1.6705454899623176
BT 320,119607,6.086126545734404
CML-T1,5281321,-0.1268784610637486
BFTC-909,3634881,3.6308731463535704
NCI-N87,613753,3.043533794547513
Hs 683,151289,0.7881286519354692
Hs 683,136227331,4.5546400151434066
BT 248,25154868,4.640538278810453
BT 248,969516,3.2750512548532136
BT 328,5287620,-1.6650936654034112
BFTC-909,9866186,1.150003196853964
SKM-1,71304818,2.6002187783001154
OAW28,24901704,3.441244042276163
NCI-N87,15953870,2.623738434863841
BT 248,11364421,0.4256883677591794
H-STS,selumetinib-navitoclax (8-1 mol-mol),5.1723559591536015
SNU-8,6917907,-4.432679706023793
SET-2,227681,2.8578313168643787
KMBC-2,54618795,4.253399568860813
SNU-1033,6918837,-2.690001447352867
MCAS,53495165,-0.3458300431996322
NCI-H1092,10302451,4.171918094429464
PE/CA-PJ34 (clone C12),241158,3.3825380068249276
NCI-N87,6918736,-4.217256713101777
YKG-1,66577038,3.063547577829753
HARA [Human squamous cell lung carcinoma],3062316,1.9438846554207736
BT 320,11222830,2.3629400148118354
AN3-CA,doxorubicin-navitoclax (2-1 mol-mol),-0.1644094320922892
SNU-8,24951314,1.2731371289268598
SNU-1033,65064,4.2871969578202735
OE21,11222830,1.596711740965295
OAW28,11222830,1.7030270245193828
OE21,11640390,3.5513799311082175
Kasumi-2,44507138,0.9761318750595236
OAW28,45279963,4.210324099066774
SNU-8,135875424,4.308406363333984
ML-1 [Human thyroid carcinoma],216239,2.965937740464059
GOS-3,2749,1.7643517607481882
CA46,navitoclax-PLX-4032 (1-1 mol-mol),3.7945066500570057
A4/Fukuda,7251185,1.076285820033946
KMRC-2,11626560,1.6099167107882515
KP-4,23725625,5.2230373683189235
SK-N-AS,285033,-3.3069800080651137
SNU-1033,54143018,3.812965937787427
NU-DHL-1,3062316,-0.3341948851357335
Hs 683,44489675,3.7743974579303465
HuT 78,2842253,5.94786669464028
NCI-H2172,24797083,1.3731500491005717
HMCB,56649450,4.482181356100994
PE/CA-PJ34 (clone C12),6184667,2.6739231408415893
NCI-H2110,24753719,4.19042786016423
SEM,9926054,1.3281424685311425
EJM,ISOX-bortezomib (250-1 mol-mol),0.254764569122289
RPMI-7951,168312962,2.348138858924481
OAW28,11404337,-1.5682838378564492
HEC-151,46943432,3.433057061661308
HCC2218,56963564,-0.6513209132887624
SNU-1214,208908,0.2392860714899357
OAW28,5566,3.0868855994062137
LNCaP clone FGC,5311,1.482149606168657
BT 328,selumetinib-JQ-1 (4-1 mol-mol),3.8675980198640465
SNU-1272,JQ-1-UNC0638 (2-1 mol-mol),2.22691909239422
BT 330,15953870,3.8560811614803696
KYSE-410,159324,2.9190840710884385
JIMT-1,24964624,3.030428603133226
PE/CA-PJ49,JQ-1-MK-0752 (1-1 mol-mol),3.1427050678514608
NCI-H2110,7251185,3.3996634094182725
Kasumi-2,10322450,3.5434418993684114
BT 248,57330099,3.914766288587865
BT 320,5282054,5.407913205549652
SK-N-AS,11238147,2.933375400117524
BT 330,676352,2.486537166636609
YH-13,3081361,3.4000588476390963
HARA [Human squamous cell lung carcinoma],9444,4.21141613858085
KMS-20,selumetinib-MK-2206 (8-1 mol-mol),-0.1303266651447604
SNU-8,11427553,3.552514953315588
SK-LMS-1,409805,6.056363964674445
SNU-1033,24797083,2.041031359710837
YKG-1,5311,2.0355380974233928
KMRC-2,tanespimycin-bortezomib (250-1 mol-mol),2.039285304893744
HSC-4,3503,2.6271988960037502
HEC-151,11507802,1.3948793909557524
YH-13,9926054,1.834128888426512
LoVo,54619267,3.1603381625719
BT 504,25126798,4.232402417423457
SNU-8,42642645,1.5422938580488428
HSC-4,5291,4.568554891244716
LoVo,10127622,2.21220618035224
NCI-H2081,2746,1.7876165118995768
NCI-H2081,2858523,3.0254216671755114
BT 328,navitoclax-gemcitabine (1-1 mol-mol),1.6667788304977649
LNCaP clone FGC,3543504,3.746355174755062
IST-Mes1,969516,2.6899901133592103
SNU-308,5282054,5.076445837500988
RPMI-7951,241158,3.4568590473726273
Aska-SS,selumetinib-JQ-1 (4-1 mol-mol),-0.4940381618393021
OAW28,serdemetan-SCH-529074 (1-1 mol-mol),2.2159278934374416
AU565,135411,0.1136824900578053
KYSE-410,44819697,0.9782497759883692
MM1.S,4378219,2.139277509194807
D283 Med,6252,-2.3531201064109526
HEC-151,9866186,1.196173458220247
ESS-1,637858,1.315760041448024
LCLC-103H,15953870,3.949183325485151
MCAS,5351362,1.7771601249531883
ESS-1,5311,0.311650985953959
MCAS,71466578,4.945747928602411
SK-N-AS,421610,1.7660213915627938
IST-Mes1,7251185,3.206804970970884
HSC-4,107970,2.304506496588027
NCI-H2110,71466445,4.525976755285506
Ku812,71466380,3.9178457046107704
HuT 78,1750826,-2.627767008630374
PE/CA-PJ34 (clone C12),54143018,0.7240710800326328
HEC-151,selumetinib-BRD-A02303741 (4-1 mol-mol),4.0698233593046735
SNU-1272,5311281,4.230708828078394
NU-DHL-1,ISOX-bortezomib (250-1 mol-mol),-0.6058420278393776
SW1990,selumetinib-UNC0638 (4-1 mol-mol),2.944809271766447
SK-N-AS,6184667,3.5471122490282307
TE 617.T,11214940,1.9376192277077016
SEM,71466578,1.2445916775629704
OAW42,135423438,3.883711298971531
KMS-27,44259,0.2014836924539016
HCC2218,5282054,2.4788530599446656
OE21,6917907,-6.174409961475981
PE/CA-PJ49,208908,1.8982859122138596
NCO2,6505803,-0.6279815858005762
OAW42,135984461,3.763630222707139
LNCaP clone FGC,24901704,3.287653019708383
CML-T1,9967941,3.2676581028704503
OE21,2742550,3.7946471320286568
BT 504,15983966,-4.295867174918995
PE/CA-PJ34 (clone C12),5281321,-0.3897758283892497
RERF-LC-Ad2,135398516,3.70367523902645
YH-13,23635314,-3.92693267445326
LNCaP clone FGC,24180719,3.4893851088457266
NCI-H2110,44543605,3.9595151388935226
KMBC-2,168312962,0.6415345617808151
SEM,6505803,-1.7011482867291614
KMBC-2,9952709,2.878804400852848
NCI-H2110,5470400,-1.567028418385665
OAW28,3634881,3.2370607224140473
BT 504,54454,4.743443336619994
SKM-1,56963564,-1.6088992179098347
BFTC-909,JQ-1-vorinostat (2-1 mol-mol),1.4357033395957943
BT 330,11222830,1.4594926246246218
TE-15,16013152,5.11463322397938
PE/CA-PJ34 (clone C12),selumetinib-BRD-A02303741 (4-1 mol-mol),2.3443290551447173
A4/Fukuda,446155,1.0805751863544764
KYSE-70,5351362,2.601126509135012
NU-DHL-1,15953870,2.3700996174311095
SET-2,3136844,4.073170521818995
KMS-27,3465537,3.890176803896576
NCI-N87,44589607,2.3758044537421026
AU565,44185566,1.721131526136141
OAW28,24785538,1.1869022382798196
HuT 78,3634881,0.7628736071702301
NU-DHL-1,11214940,0.1576497417416405
KYSE-410,15983966,-1.007567423181931
Ku812,10077130,3.943478130533959
TE 617.T,23939,4.422369494200264
KP-4,441298,0.2346253273061312
KMBC-2,44607530,2.1464142113547804
EJM,5566,2.9848804377366545
KMS-20,2708,3.4127805917695095
NU-DHL-1,decitabine-carboplatin (1-1 mol-mol),-0.9080396977162584
D283 Med,9887053,1.695110985326941
NCI-H2172,72376,1.185130981132838
A4/Fukuda,16659841,2.2699989015311437
LNCaP clone FGC,navitoclax-birinapant (1-1 mol-mol),2.777103449634557
IST-Mes1,119607,5.839609606963759
LNCaP clone FGC,60700,-1.3738906500494386
SET-2,doxorubicin-navitoclax (2-1 mol-mol),-1.5394953542498078
WM983B,24785538,3.644224729658294
SK-MEL-1,5282054,3.318735413524673
SKM-1,216468,0.4318372825903644
SNU-308,216468,4.097191393615079
OAW28,10427712,4.195688642509306
RERF-LC-A1,1716436,3.128403126409071
NCI-N87,2733487,6.3981873446173285
EJM,119607,4.869876061461073
MCAS,44607530,2.813061724586131
SKM-1,16741245,1.8575385373814357
SNU-1033,2729026,2.996817399923943
SK-MEL-1,676352,1.9426183565413324
KMRC-2,9927531,6.175340087469203
BT 330,SNX-2112-bortezomib (250-1 mol-mol),-2.8993198862024205
CML-T1,2733526,2.616681149896765
JIMT-1,400769,-0.5129453841959077
SK-LMS-1,6852167,3.2249832474571893
Aska-SS,322968,2.5996922122858286
RERF-LC-Ad2,49793307,-3.0853357906020125
LoVo,54454,2.7172548619434025
BT 330,984333,-0.0959079494022657
BT 248,navitoclax-piperlongumine (1-1 mol-mol),1.2015082500214636
ML-1 [Human thyroid carcinoma],2841722,5.015074505803474
LoVo,44632017,0.6073588127957028
BT 330,5470400,0.2607731475044393
TE 617.T,54596558,3.8847882662433086
HuT 78,selumetinib-UNC0638 (4-1 mol-mol),-2.012028836437227
YH-13,11977753,-2.376684100731715
BT 504,644241,2.5369130082852234
NCI-H2172,2828334,5.9971239300966666
Ku812,11214940,0.086295431184551
ESS-1,2742550,4.194579887734085
CML-T1,136227924,1.8923919385229255
CML-T1,446155,3.2304119453056632
AN3-CA,44241473,5.120578762393663
H-STS,selumetinib-GDC-0941 (4-1 mol-mol),1.9537724783491248
SNU-1214,448949,2.107335730874522
SNU-1214,6918736,-2.2535813174061845
NCI-H2110,11609586,2.483630448963632
WM983B,44462760,1.89861905340126
NCI-H1395,8515,4.661084548760473
SET-2,tretinoin-carboplatin (2-1 mol-mol),4.541519979051109
H-STS,doxorubicin-navitoclax (2-1 mol-mol),-4.029519086979923
H-STS,6918837,-3.5766968439685662
TE-15,9952709,3.278986592526564
SET-2,11626560,-0.1084885136053665
A4/Fukuda,44589607,1.1710928843495056
HuT 78,444795,-1.7173791831946914
ML-1 [Human thyroid carcinoma],16038120,1.3266996549374028
KP-4,9907093,4.376940232486132
SEM,375860,-0.9031870337732496
SNU-1033,11609586,2.722899451063462
SKM-1,49850262,2.605889729576421
BT 328,24180719,4.750415959710981
BT 330,9956119,4.409669867240458
NCO2,119607,4.067975692349996
HMCB,6610216,4.4861904027359145
SEM,135999136,1.8493753189775255
KMBC-2,9926054,2.0094384239747294
TE 617.T,6918878,1.9615768244510037
CML-T1,10385095,0.9719029483379856
YKG-1,2729026,3.207992670398629
EJM,135411,0.4460244130907568
HuT 78,2746,0.9832751477780014
MM1.S,46191454,-0.4947942037268417
IST-Mes1,46907787,2.643041583848796
AU565,72199292,-0.5217195589045935
PE/CA-PJ34 (clone C12),44607530,0.8156299641770444
EJM,46199207,3.0615007754696095
SNU-1272,11404337,1.107901220459772
SNU-1214,4259181,-2.0986949595329527
ML-1 [Human thyroid carcinoma],374536,-3.4857090018028956
ESS-1,52912189,1.4491066421108545
YH-13,135398516,1.589784182396859
BFTC-909,3062316,2.03384364484094
H-STS,72193861,0.730927574550533
MM1.S,selumetinib-decitabine (4-1 mol-mol),4.192899101848816
MCAS,serdemetan-SCH-529074 (1-1 mol-mol),2.3575545697640043
KMS-20,16659841,2.744899000651292
BT 504,9967941,3.2040296156629022
HARA [Human squamous cell lung carcinoma],151289,0.6137813450564443
MCAS,46398810,2.9404325213939364
Kasumi-2,navitoclax-MST-312 (1-1 mol-mol),-2.959240355083437
OE21,176870,-1.551021133678407
NCI-H2081,3634881,3.1906450882675785
TE-15,11178236,-2.699061593629313
HSC-4,53392493,2.986961827224748
TE-15,JQ-1-UNC0638 (2-1 mol-mol),-0.5241568674316489
PE/CA-PJ34 (clone C12),9967941,4.772694615178541
BT 504,11238147,1.665690684626607
NCI-N87,159324,0.0331676951949142
KMS-27,148198,-3.735247787675698
KMBC-2,9911463,3.851747430991294
HARA [Human squamous cell lung carcinoma],16725315,4.551171651287005
Raji,26596,-2.574302974428465
GOS-3,1242560,4.3763601819059526
AN3-CA,selumetinib-tretinoin (2-1 mol-mol),4.656553495981066
SK-N-AS,25262965,-1.97376797519549
HEC-151,3385,3.772390411553772
TE-15,168312962,5.254824497149209
SNU-1033,446155,4.017329310578931
KMBC-2,216239,2.9233965853231587
D283 Med,46843906,0.2520687270302775
CML-T1,400769,-1.2523952078832103
IST-Mes1,71304818,2.7451890534908427
NCI-H2110,10296883,4.192584749950301
BFTC-909,11404337,0.4468911705694049
MM1.S,5743,-3.388771568562768
HARA [Human squamous cell lung carcinoma],tanespimycin-gemcitabine (1-1 mol-mol),0.469334809183726
LCLC-103H,44589607,5.73143810200521
A4/Fukuda,2858523,2.415383768636832
SNU-308,10302451,1.9995275040024083
EJM,10074640,3.565491607836162
LoVo,23725625,5.102020281972671
WM983B,decitabine-navitoclax (2-1 mol-mol),3.536561236356397
NCI-H2110,JQ-1-UNC0638 (2-1 mol-mol),2.777765951368402
BT 248,3062316,2.7315660903773606
KMS-27,159324,1.3693882554650931
KMBC-2,11404337,0.8852156711792197
PE/CA-PJ34 (clone C12),9911463,3.905990041696765
NCI-H2081,71466445,4.38598643785932
MCAS,4521392,4.429986941577358
KP-4,654092,-1.6065035678404882
SEM,123631,1.8586141248102523
WM983B,445091,4.3881574566217685
KMRC-2,24797083,1.3154639139008475
RPMI-7951,3136844,3.4252156043373945
LoVo,15983966,-3.091518031584947
BT 248,11609586,2.7692010936053064
HuT 78,148124,-4.9142161440271135
OAW28,25154868,4.5321266568460805
LoVo,15547703,1.4569683263207862
OAW42,71304818,3.5395170473338133
BT 320,7251185,3.9998923472411008
SNU-1033,4259181,1.0677542833514009
Hs 683,3465537,3.213284685402938
HEC-151,24771867,2.9837344862982
RPMI-7951,selumetinib-piperlongumine (8-1 mol-mol),3.783430933117755
KYSE-410,24785538,1.121475010860572
SNU-1214,26596,-1.0463524319184982
LNCaP clone FGC,1239801,4.741594223771951
NU-DHL-1,11977753,-1.9405951450279333
NCI-H2081,navitoclax-sorafenib (1-1 mol-mol),1.2084558654866828
KYSE-410,25062766,2.1712810564055505
TE 617.T,4578,4.427740747516631
SKM-1,11719255,2.1127493004030655
TE 617.T,135659046,3.676706194159886
ESS-1,4096211,2.024431300625148
LNCaP clone FGC,11485656,1.8681426570872277
WM983B,65064,5.382049220614742
OAW42,24753719,4.028981617914578
PE/CA-PJ34 (clone C12),decitabine-navitoclax (2-1 mol-mol),5.825207158072148
TE 617.T,53392493,1.8253386460043184
OE21,9549297,2.549848830295622
RERF-LC-Ad2,serdemetan-SCH-529074 (1-1 mol-mol),2.1261176554719525
NCI-H2110,10385095,0.9459448618339928
SEM,10427712,3.915195829350839
NU-DHL-1,25062766,1.3260870058815484
PaTu 8988s,tanespimycin-gemcitabine (1-1 mol-mol),-1.822995270028692
PE/CA-PJ49,navitoclax-gemcitabine (1-1 mol-mol),-3.329741193737403
EJM,676352,1.4630125029054086
OE21,25161177,4.249814406822135
BT 328,9549297,2.748428048509406
MCAS,decitabine-navitoclax (2-1 mol-mol),1.3286044996274589
LCLC-103H,5282054,4.318037012068525
HMCB,71576739,-3.3278802588106955
TE 617.T,3634881,2.7724417169905937
NCI-N87,322968,2.9452063604799417
OE21,JQ-1-carboplatin (1-1 mol-mol),0.5069290847889931
BT 320,SNX-2112-bortezomib (250-1 mol-mol),1.4191259031936097
OE21,1242560,3.6647995918292424
SNU-1214,3465537,5.236709132299774
KMBC-2,44566777,-1.4027522495205034
PaTu 8988s,25105715,3.655682529941988
RPMI-7951,12001922,1.647334289946116
Hep-G2,5311281,3.757916922752933
A4/Fukuda,10184653,1.3612642262853822
HCC2218,89183176,2.3867110966376464
KMS-27,56946209,-4.916734128569137
SK-LMS-1,6918638,1.135857739605079
SW1990,57519531,1.8615678215575773
D283 Med,11494412,-0.6782080211757803
NCI-H2081,9933475,1.7869131663343656
BT 139,5284616,2.5107293050927457
SK-N-AS,1239801,4.598489629899238
Kasumi-2,44491742,3.800345149395397
KP-4,23635314,-1.4803709011127404
A4/Fukuda,4477,0.5783674149898913
SET-2,445091,4.080599416481313
KYSE-410,9840324,6.043585972673271
SEM,16065773,1.5866010830455777
RERF-LC-A1,4096211,1.669959896625484
AU565,44566777,1.2994228207825576
MCAS,409805,5.6817502143710685
NCO2,2828334,5.6518272818106094
MM1.S,JQ-1-UNC0638 (2-1 mol-mol),0.1865642255881416
SKM-1,navitoclax-pluripotin (1-1 mol-mol),-0.780320881442614
HEC-151,5566,3.259333295747091
KMS-27,ISOX-bortezomib (250-1 mol-mol),-0.0872942946358621
KP-4,12003241,-0.2003950722684058
LNCaP clone FGC,54626689,4.472345767671783
OAW28,637858,2.2776250733597085
SET-2,5278396,3.705713194683595
ESS-1,4477,0.5531720696297147
PaTu 8988s,176870,3.825949689559086
RPMI-7951,4259181,-0.293226545536714
YKG-1,4477,1.5489937349359375
BT 320,16722836,3.1587292617762435
A4/Fukuda,135999136,4.178898868342667
MCAS,123631,2.0688356997390884
OAW28,15953870,5.078636607909671
SW1990,44493528,4.327134813333531
Kasumi-2,11228183,-3.3606954683588057
Hep-G2,piperlongumine-MST-312 (1-1 mol-mol),2.8906524908682143
NU-DHL-1,135440466,3.3716397656308827
BT 330,1750826,-2.942167561904214
NCI-H2081,148198,-5.584711698479823
MCAS,51039095,3.4523930786190937
KMS-20,12001922,1.070822318900554
HEC-151,44607531,1.801754904846464
BT 248,44241473,4.372252470027867
ML-1 [Human thyroid carcinoma],11175137,2.0792526924223735
LCLC-103H,11178236,-3.9998022652524816
HEC-151,9911463,4.0043305736729105
KMS-27,5738263,2.490078653325268
JIMT-1,46398810,3.1310531193454705
HARA [Human squamous cell lung carcinoma],16722836,2.4020375260133595
KMBC-2,5328940,2.0515381672179305
SET-2,49793307,-5.300633765510322
SKM-1,71680916,4.070179784204398
H-STS,3634881,3.254926671083326
HARA [Human squamous cell lung carcinoma],400769,-0.3643318812201842
TE-15,9444,4.167765632206863
SET-2,sirolimus-bortezomib (250-1 mol-mol),0.175715922868153
KP-4,11485656,2.2916969527324778
TE-15,65628,4.191504747725539
OAW28,25102847,1.9718431113444057
HARA [Human squamous cell lung carcinoma],5479543,3.520150804916199
AU565,16038120,1.417918520815656
OE21,ISOX-bortezomib (250-1 mol-mol),0.2016252783580098
NCI-H1092,11977753,0.4568762986768944
CML-T1,6184667,4.239961832830672
LNCaP clone FGC,9884685,-0.2879888364865913
WM983B,73707398,1.4395905386733596
NCI-H2081,148124,-3.831662126446776
LCLC-103H,9903786,3.9967722976793696
YKG-1,11719255,4.471587264464231
BT 504,54618164,4.1210357013114365
HEC-151,20959075,-3.1296550695223075
NCI-H2081,3543504,2.734133783068638
D283 Med,9956119,3.549058379846889
MCAS,2749,1.4531198452067708
SET-2,11955716,-2.510198617741863
KP-4,10385095,0.8824730127283659
TE 617.T,25102847,2.403945205063307
SK-N-AS,24785538,1.8079798143875896
BT 139,52947716,1.016721134995223
KMS-20,9956119,3.554120536013074
RPMI-7951,46199207,3.018080532945558
OAW28,10302451,2.68651474445359
MM1.S,24180125,2.972534828152793
SNU-308,31703,0.6656471212282582
CML-T1,54613361,-1.4794949633252166
OE21,46224516,1.3684984332825172
BT 504,46199207,1.672337010359158
ML-1 [Human thyroid carcinoma],72376,-3.175400377997246
HARA [Human squamous cell lung carcinoma],24901704,2.881552784728447
OAW28,5113032,5.506773811436986
CML-T1,5566,2.203374574789853
SEM,4578,3.613772546494987
HSC-4,46174525,4.818915916273074
PE/CA-PJ34 (clone C12),selumetinib-vorinostat (8-1 mol-mol),2.6799974676882883
CML-T1,448949,0.9677195275785144
OAW42,decitabine-navitoclax (2-1 mol-mol),1.371312575913585
SK-MEL-1,24180719,0.1393206335004591
SET-2,25102847,3.1923802096251648
SW1990,24964624,2.8456248953182137
OAW28,25227462,0.9824255132553372
LNCaP clone FGC,25154868,2.839691532506865
PaTu 8988s,135398738,4.654350293354078
HMCB,11485656,2.0030375268355116
Raji,676352,2.12389585593329
TE-15,docetaxel-tanespimycin (2-1 mol-mol),-6.9142501406211725
HuT 78,5284616,0.3056845634963596
JIMT-1,selumetinib-PLX-4032 (8-1 mol-mol),4.596703454445104
LCLC-103H,9911830,2.9324210354523195
KP-4,5702613,3.803419922999385
SK-MEL-1,JQ-1-vorinostat (2-1 mol-mol),1.036649294787113
SKM-1,25262965,-1.3150053661970005
Ku812,5460769,3.1615206717567608
SEM,107970,1.646444978651256
KMRC-2,2858523,3.2070058966935115
AN3-CA,5287620,-3.0172646542127266
JIMT-1,24771867,4.00022735533514
RPMI-7951,5282054,3.73037875419875
NCI-H2110,675434,4.551322569606733
TE 617.T,46199207,2.701675473879776
RERF-LC-A1,753704,5.469921396897314
Aska-SS,11404337,-0.8839501993376483
CA46,100016,3.773189878640827
Ku812,11396600,2.326776145026828
H-STS,5978,-3.0576178887146592
GOS-3,135875424,4.516628943420056
KMBC-2,11455910,1.9151529363040984
MCAS,5335621,4.384496350289802
Hep-G2,5329102,1.3159700162106798
KP-4,656346,-0.2586646350408599
ESS-1,vorinostat-navitoclax (4-1 mol-mol),0.8107114414663552
KYSE-410,16219061,3.535016267547529
BT 248,65628,4.438815715072134
ML-1 [Human thyroid carcinoma],24821094,3.2142530929148982
IST-Mes1,navitoclax-piperlongumine (1-1 mol-mol),2.2991023643561115
JIMT-1,54613361,0.6487008798118125
RERF-LC-Ad2,6610216,4.489268569667584
D283 Med,49766530,-3.2280701678526853
SET-2,135999136,1.840217367729006
NCI-N87,136227924,3.040461203265333
BFTC-909,23635314,-1.3241610546701814
OAW28,46926350,-3.936437112233884
KMBC-2,44819697,2.777025588666699
NCI-H2110,56963564,0.3870789119863705
PE/CA-PJ34 (clone C12),11719255,3.7761142192038353
TE 617.T,4259181,-1.3173271639424509
EJM,9933475,2.243114584101206
HuT 78,alisertib-navitoclax (2-1 mol-mol),-1.6997195751754324
Kasumi-2,navitoclax-piperlongumine (1-1 mol-mol),-3.156994425462095
TE 617.T,5335621,4.3358986748904655
CA46,89183176,2.547561715641907
BT 330,navitoclax-sorafenib (1-1 mol-mol),1.5761874727240903
HMCB,25062766,3.4032091718136543
SW1990,16722836,2.0467561159840058
YH-13,56963564,0.220500691161984
LCLC-103H,16720766,-0.0672646551504544
NCI-H2081,11964036,1.4263107800421957
Kasumi-2,54618164,3.8625919459899833
SKM-1,16725315,3.1863557694530495
KP-4,3136844,3.746119336549442
WM983B,51039095,2.9483833185478363
A4/Fukuda,23725625,4.971593284778653
Aska-SS,24964624,0.7459195537143974
NCI-H1395,5351362,2.8626857880223757
H-STS,135411,0.6360583946211977
PE/CA-PJ34 (clone C12),25154868,5.263511922776674
BT 330,24772860,-2.5000585413753815
HEC-151,67156097,-1.3315707739035665
KYSE-410,navitoclax-pluripotin (1-1 mol-mol),-0.8981907830687923
LNCaP clone FGC,2733526,4.4157191232054736
RERF-LC-A1,25105715,3.58294251367128
NCI-H2081,5287969,-2.131479495140116
MCAS,285033,-1.470619911744651
NCO2,5291,-2.318194289123567
YKG-1,11167602,4.915993662125618
OAW28,2749,3.2113189756487683
TE-15,409805,5.7286558076606955
HEC-151,16741245,2.6065582573051893
GOS-3,11497983,4.172510051232983
KMRC-2,15983966,1.552076724290525
OE21,3854666,0.7782353690934734
MCAS,6450551,3.1349872094378815
AU565,24856436,-0.2368560911374172
KMBC-2,11427553,3.346878465040894
CA46,439501,-3.521132637790176
NCI-N87,44620216,3.650574309449747
NCO2,6610216,3.0387992514470663
EJM,44202524,0.907560202578118
Ku812,675434,3.5526828376641952
NU-DHL-1,374536,0.7676256966435839
NCO2,4917,2.3835198240149733
OAW28,168313016,5.164256635335989
KYSE-70,72193861,1.5917149982909504
CML-T1,44507138,0.8933545312764144
BT 328,3062316,3.412447048158849
TE 617.T,252682,6.17928013673487
NCI-H2081,327653,2.703400517065932
OAW42,9825149,2.5605980307138365
NCI-H2110,navitoclax-gemcitabine (1-1 mol-mol),-4.243546622798395
Kasumi-2,ISOX-bortezomib (250-1 mol-mol),-0.8608455854799354
NCI-H2110,11485656,1.6105476919050796
MM1.S,11364421,-5.91278520312213
SKM-1,4378219,1.146896788222022
KMS-20,676352,1.1111615273565725
SNU-1214,9967941,3.4599845144853916
PaTu 8988s,119607,5.3348234532520875
BT 139,19582717,5.798754830706931
CML-T1,10077130,2.746402588915116
SK-N-AS,11455910,1.0183707360563456
SET-2,57330099,4.519463071900052
Hs 683,tretinoin-navitoclax (4-1 mol-mol),4.212339797785814
ESS-1,71466445,5.77037971840281
BT 248,12003241,-0.5635987052840526
HMCB,44462760,4.190588820303925
BT 330,60700,-0.8929467454140042
OE21,49793307,-5.20007789952048
LNCaP clone FGC,54639665,5.111125595868773
HEC-151,25195348,3.5295436007133323
HSC-4,24856436,1.7831446753384608
NCI-H1395,9927531,4.9557176619227015
RERF-LC-A1,2126,3.914603915476064
SEM,17755052,1.610064105024121
SKM-1,2729026,2.7681439157014753
OAW42,6252,0.8295671910914174
NCI-H2172,54618771,2.767787208774524
SEM,148124,-5.566475057371884
NCI-N87,11396600,3.282772907192936
SK-MEL-1,89928392,0.9499393545350372
KP-4,119182,-1.1774371415684783
Kasumi-2,9967941,2.996370075692804
SW1990,216468,3.5659839916407305
Aska-SS,4521392,4.288945960666941
OE21,16038120,0.6992947070479802
NCI-H2110,216468,1.4609586053844608
KMRC-2,46843906,3.6969408784619966
KMBC-2,selumetinib-vorinostat (8-1 mol-mol),1.67831087866627
PaTu 8988s,24748573,3.6833420319814487
WM983B,9935249,3.2390804243426876
Hep-G2,11364421,-0.8819636691754982
Hs 683,444795,5.839973604661916
SNU-1272,24785538,2.381533689270871
BT 330,168312962,3.1827136044568087
HSC-4,136227924,4.2199200707906845
PE/CA-PJ34 (clone C12),44137675,3.7024298491160095
Hs 683,selumetinib-decitabine (4-1 mol-mol),5.275083439030192
Ku812,3025986,-0.7700675438788807
NCI-H2172,25150857,2.903675927541502
HuT 78,44507138,1.1414703687130772
NCO2,71680916,3.949812821101266
TE 617.T,24901704,3.3231457770531736
OAW28,2708,5.3328257603707545
SET-2,168312962,1.288351871230535
PE/CA-PJ49,6917907,-5.829346001088612
NU-DHL-1,5479543,3.232300897170713
CML-T1,54454,4.932328921432074
SKM-1,11175137,1.89374364392194
HMCB,11214940,4.410091116591445
NCI-H1092,JQ-1-navitoclax (2-1 mol-mol),1.6253507016019415
BT 330,148198,-5.294661964865024
AN3-CA,10296883,3.730893077527662
SET-2,2113511,5.707178743986511
LNCaP clone FGC,446155,3.719256081694015
OE21,navitoclax-pluripotin (1-1 mol-mol),-1.4136373161087934
HARA [Human squamous cell lung carcinoma],selumetinib-piperlongumine (8-1 mol-mol),4.925037100159097
NU-DHL-1,8515,3.2734160853720105
CML-T1,208908,1.88775844056814
AN3-CA,crizotinib-PLX-4032 (2-1 mol-mol),1.4874439223623748
Hep-G2,72193861,3.225479457080403
CML-T1,613753,3.0468922998366357
BFTC-909,6623618,2.802037410677928
GOS-3,docetaxel-tanespimycin (2-1 mol-mol),-1.4336653490933862
AN3-CA,252682,7.06469427676738
SK-N-AS,25154868,5.229660200765619
BFTC-909,11228183,3.298719229946038
BT 330,6852167,3.461733809833727
SNU-1272,vorinostat-carboplatin (1-1 mol-mol),4.458352308548227
OAW42,374536,-0.8010162168150948
Hep-G2,136227924,2.2133800896817304
KYSE-410,11507802,0.9736774052187488
CML-T1,73707386,2.9358077283853974
YH-13,375860,-0.5335760796053879
JIMT-1,5566,3.00902450097185
PE/CA-PJ34 (clone C12),135999136,4.2559270335643955
Ku812,44486219,3.768405676871863
KYSE-70,60700,2.818490002790748
NU-DHL-1,50905018,3.2450154850069093
HARA [Human squamous cell lung carcinoma],11238147,2.905443405294126
HARA [Human squamous cell lung carcinoma],11640390,3.0925981241806983
Aska-SS,4378219,4.576786984257773
GOS-3,148198,-2.930015056129616
LoVo,44486219,3.9526381308541025
Kasumi-2,54618795,2.2160859361178624
SK-LMS-1,54618771,1.3800871170557885
ML-1 [Human thyroid carcinoma],5470400,0.2567315670041485
NCI-H1092,10184653,1.2833708133715205
CML-T1,tretinoin-carboplatin (2-1 mol-mol),3.366911214203907
Aska-SS,100016,5.454856815374324
HCC2218,navitoclax-MST-312 (1-1 mol-mol),0.956940950080559
TE 617.T,9444,4.54046469334786
ESS-1,9884685,0.689834242395422
RERF-LC-A1,24748573,1.9017666313180503
BT 328,16065773,3.5166527038097906
Aska-SS,navitoclax-birinapant (1-1 mol-mol),3.748625753251114
EJM,selumetinib-vorinostat (8-1 mol-mol),1.9565276246961512
YKG-1,53495165,0.7600331159064647
TE 617.T,4261,1.6006330563406768
NU-DHL-1,24771867,-3.1166811668070844
NCI-H1395,16741245,6.143335067349052
TE-15,selumetinib-UNC0638 (4-1 mol-mol),4.91335463818381
BT 330,327653,3.419413627791973
IST-Mes1,2113511,6.40207592921409
BT 330,carboplatin-UNC0638 (2-1 mol-mol),2.6250580335818228
MM1.S,168312962,-0.6288845561945676
RPMI-7951,2130404,3.231380778195222
NCI-H2172,17755052,2.9928260796165196
HuT 78,135421197,0.0616295171222303
SNU-1214,5335621,6.2577168024968675
NCI-H1395,49766530,-2.8850236043305792
RERF-LC-A1,11152667,1.3803453308335734
SET-2,6438330,0.4596866663258824
KMS-27,5311,0.4888181345330854
BT 504,241158,4.311533589367548
HMCB,15983966,-4.400200199699085
SNU-308,124202324,2.379759434386111
YH-13,9907093,4.406851873711971
Kasumi-2,11497983,-3.4342418883602406
A4/Fukuda,25195348,0.8993846970771071
NCI-H1395,6450551,6.187307607667542
SEM,135659046,3.5193041881341087
SET-2,24951314,0.2183359263596641
HARA [Human squamous cell lung carcinoma],10184653,0.92256613856931
HuT 78,6252,0.7757631208196515
SW1990,5566,3.2018418511552937
ML-1 [Human thyroid carcinoma],135398516,0.6909808613935852
MM1.S,9840324,5.541225191096644
SNU-1214,doxorubicin-navitoclax (2-1 mol-mol),0.3140477617848352
SW1990,44137675,3.438362060135723
SEM,6436223,-5.97261058273431
EJM,10184653,1.0173463538393004
NCI-H2081,702558,5.114835001496795
AN3-CA,5278396,3.224746709449046
GOS-3,49766530,-1.0492623989714644
Hs 683,46199207,2.9953123395602703
SNU-8,6610355,3.667955701623089
OE21,19582717,3.6173239158070674
NCI-N87,11427553,2.9770783714757005
SEM,49766530,0.1216347460182048
SK-N-AS,7326481,2.8003305841414905
Ku812,vorinostat-carboplatin (1-1 mol-mol),2.0345642738218386
ESS-1,67291369,3.683100317554582
Ku812,73707438,3.988741413659523
SKM-1,3552672,1.0574054456056317
KMS-27,16720766,-1.503343187948689
LoVo,navitoclax-piperlongumine (1-1 mol-mol),1.788433807521411
BT 330,6917907,-6.368853634848569
OAW42,42642645,1.4127058185888346
BFTC-909,24785538,3.0409365635840433
BT 139,44491742,4.209444035840443
BT 248,122327,5.08009478305936
KP-4,4096211,1.045693693470395
EJM,11612883,2.7547358243223368
PE/CA-PJ49,11455910,0.6367427486190916
OAW42,46926350,-3.851405236672868
HMCB,1641662,3.3637139334178343
JIMT-1,135411,1.1222176810647364
NCI-H2110,135398516,2.6738042917327385
AN3-CA,3062316,1.3770411989146902
NCI-H2172,2858523,3.5880883683386915
OAW42,11647372,2.181693860822225
OE21,11717001,4.412432147312286
TE-15,7251185,3.1886736649035656
Hs 683,46191454,1.864722809202389
Hs 683,6610355,4.617456613389187
SW1990,SNX-2112-bortezomib (250-1 mol-mol),-2.6554849763111807
SET-2,24856436,-1.7721570824148565
MCAS,sirolimus-bortezomib (250-1 mol-mol),0.8032325328072784
KMBC-2,8515,4.644578296093967
AU565,168313200,1.787588028354966
HARA [Human squamous cell lung carcinoma],9935249,3.837366541191349
ESS-1,3634881,3.263518505021081
SNU-1272,168313016,6.45685474572034
NCO2,9915743,0.6795436219303662
KMS-27,5281672,6.396603390578461
YH-13,72376,-1.189178232069283
LNCaP clone FGC,12001922,2.092576995336353
Aska-SS,6918837,-3.0940676227061155
SNU-1272,72193861,3.3833778859953294
SK-LMS-1,11427553,3.5159920643615745
EJM,462382,0.2605249998779805
SKM-1,11964036,0.1293394770460754
SEM,119607,5.617200032788747
PE/CA-PJ34 (clone C12),carboplatin-UNC0638 (2-1 mol-mol),3.7033637644797217
NCI-N87,1239801,5.115918121174403
Ku812,9887053,2.4680731307119785
SK-N-AS,49836020,4.951261339623108
HuT 78,tretinoin-carboplatin (2-1 mol-mol),-1.6984319930029828
NCO2,24772860,-3.0039448567254095
KMS-27,107985,-3.725151900067263
HSC-4,10427712,3.709601221495256
KYSE-410,44202524,1.688546222164906
CA46,2874250,4.668483912698598
BT 504,24772860,-2.6137650480581818
KMRC-2,2113511,8.452933982441557
PE/CA-PJ49,selumetinib-JQ-1 (4-1 mol-mol),1.4139822071582016
PE/CA-PJ49,vorinostat-carboplatin (1-1 mol-mol),1.7635048618773828
TE 617.T,navitoclax-gemcitabine (1-1 mol-mol),-4.956703675225032
RERF-LC-Ad1,9444,4.3231726239662045
MCAS,6610216,4.229351733917807
SK-N-AS,1242560,3.6355645717207024
SNU-1033,135984461,1.7836640453843908
Ku812,219104,2.2435781346241743
GOS-3,16065773,2.51000734865302
EJM,26596,-3.57565028157041
HuT 78,11175137,-0.1403149097241058
BT 328,702558,5.711275260817638
NCO2,3384730,0.8911303578919837
YH-13,969516,2.628286868310954
A4/Fukuda,3081361,1.810117399969756
IST-Mes1,16065773,3.0641757349077925
RPMI-7951,16736978,1.3640230791983192
HARA [Human squamous cell lung carcinoma],6918837,-1.4537868658939308
SNU-1272,5280436,4.574353860374468
SET-2,salermide-PLX-4032 (12-1 mol-mol),5.224494931200647
SKM-1,11396600,2.556560537938587
Raji,5566,2.9720798314318477
WM983B,10427712,3.911438930557604
PE/CA-PJ34 (clone C12),6914657,-4.423290668811461
Aska-SS,54619267,4.321796866323048
CA46,erlotinib-PLX-4032 (2-1 mol-mol),3.1947109713205033
KYSE-410,122327,4.394987930415306
Kasumi-2,tretinoin-navitoclax (4-1 mol-mol),-1.7233092596957704
MM1.S,5311,0.1972006182392905
HCC2218,327653,1.357600314803345
KMS-27,navitoclax-MST-312 (1-1 mol-mol),-1.901648609736443
SNU-1214,selumetinib-decitabine (4-1 mol-mol),1.9441376366653231
HEC-151,23635314,-2.5037099558105727
NCI-H2172,24821094,4.093523635745637
LoVo,89183176,4.107889784939482
BT 504,44566777,-0.5181592653822163
SNU-308,5311,2.317161878139482
YKG-1,44137675,3.325068196687256
Kasumi-2,navitoclax-sorafenib (1-1 mol-mol),-1.696804912117395
NCO2,11364421,-4.919235380712394
SW1573,1566236,3.3872191513469025
LNCaP clone FGC,serdemetan-SCH-529074 (1-1 mol-mol),1.845658775945097
SET-2,selumetinib-MK-2206 (8-1 mol-mol),1.7607206315112338
Kasumi-2,135398738,1.5778578151552838
OAW42,426756,3.935892288529094
NCI-H1395,4705,3.4784735381586183
KMRC-2,4578,5.1902183794487975
NCI-H2081,44462760,3.7666296085166375
A4/Fukuda,11964036,-0.0142982917472374
AN3-CA,56963564,0.0711443344118292
CA46,44185566,1.786162700750641
NU-DHL-1,10302451,2.2542174061675055
SEM,3011155,5.750051022389146
Kasumi-2,24821094,1.7820431474601306
SET-2,613753,2.542152072032537
Ku812,656346,0.2651161677447766
LoVo,46224516,4.94892102130723
BT 504,navitoclax-MST-312 (1-1 mol-mol),1.020497589759095
HSC-4,44819697,-1.3561318696958864
RERF-LC-Ad1,15983966,3.1811444894910896
ESS-1,2733526,5.879363294342396
KMBC-2,89928392,1.7581263697604317
HEC-151,66577038,3.228211368838608
SK-MEL-1,54626689,4.627988024732575
NCI-H2081,9444,4.107001529584513
SK-MEL-1,71466445,4.292797719025509
AN3-CA,44543605,5.28797283911383
KMRC-2,SNX-2112-bortezomib (250-1 mol-mol),0.782253631071063
D283 Med,11404337,-0.900512184015852
SET-2,45100481,4.393455446981079
SK-MEL-1,5335621,4.49962965231419
NCI-H2081,25262965,-3.276528067385419
OAW42,65628,4.461928912240859
JIMT-1,selumetinib-tretinoin (2-1 mol-mol),6.18789284741759
SEM,54678924,1.6439221988057715
KYSE-410,126941,-0.1479111087820589
NCI-H1092,11175137,2.874404641509256
KMS-20,44620216,3.7048661868251536
HMCB,navitoclax-MST-312 (1-1 mol-mol),0.7821438430480089
SNU-8,navitoclax-pluripotin (1-1 mol-mol),-0.2823616495473457
SNU-1272,2729026,3.2131573278118015
OAW28,44489675,3.928609606447794
LoVo,10427712,4.119455144779727
OE21,56949517,4.209689564616798
NU-DHL-1,16725315,3.081538232770875
TE 617.T,1716436,2.776815289007698
PE/CA-PJ49,5470400,0.1521447371968943
ESS-1,2828334,6.174159424614295
Raji,52912189,0.0180017052979321
SET-2,54626689,4.509616884336031
OAW28,1716436,3.318226269910468
PE/CA-PJ49,446155,1.2823819658822335
NU-DHL-1,10385095,-0.0540424655836512
HuT 78,409805,4.736359437343851
SKM-1,11485656,1.846158462004935
HEC-151,54619267,3.743184211293532
NCI-H2110,55508,3.902465685482405
TE-15,16038120,0.1842728168046561
PE/CA-PJ49,selumetinib-piperlongumine (8-1 mol-mol),4.461234490795515
ML-1 [Human thyroid carcinoma],135411,-0.343606028350642
RERF-LC-Ad1,9911463,4.614184078770455
ML-1 [Human thyroid carcinoma],441298,2.939924630100921
MCAS,5280436,3.1569010943943003
SNU-1272,44137675,4.576444163035884
NCI-H1092,4705,2.99261822421246
YKG-1,10184653,2.523602968950428
EJM,44607530,2.5070049311277423
MCAS,3062316,-0.1716556504853732
Aska-SS,25102847,-1.0664097342177898
RPMI-7951,4096211,1.9647494652292783
NCI-H2110,241158,3.1912359933366465
RERF-LC-A1,9926054,2.5963235420247965
AU565,11228183,3.2105327090314133
Kasumi-2,16065773,1.6844864290683614
AN3-CA,4477,-0.0945656012999716
YKG-1,6914657,-2.9791287497746186
HCC2218,25062766,2.21521740758537
SK-MEL-1,17755052,4.410861901759893
MM1.S,53495165,-2.546366748086311
SNU-8,71304818,2.561757279775672
BT 248,8515,3.628450909279232
MM1.S,25150857,1.609855553563615
SNU-1272,44507138,4.148225527043363
Aska-SS,46907787,-0.8953027920417477
WM983B,25126798,4.29047193328144
D283 Med,44202524,1.228437692555833
KP-4,44589607,2.085326438076347
NCI-H1395,54618305,4.493399620925908
Hs 683,439501,-3.4221859538690467
HuT 78,5351362,0.379509393598873
BFTC-909,SNX-2112-bortezomib (250-1 mol-mol),0.3698834200349636
PE/CA-PJ34 (clone C12),5479543,3.749651315015809
Kasumi-2,44819697,-2.5261102007933154
SW1990,81146,4.42209056734023
YKG-1,11507802,1.2532518288313863
HEC-151,3543504,4.035104451563593
KMS-20,3503,1.0882007303901744
CML-T1,10127622,3.755726914771393
Kasumi-2,60750,-5.618830215487252
BFTC-909,6914657,-4.61933610547547
TE-15,208908,-0.7821846792440665
MM1.S,135875424,3.0538620465615587
OAW28,3825829,4.635564939734502
NCI-H2172,5746,2.735879314274068
OAW42,9915743,3.0067264030666907
KMRC-2,6610216,4.281887950309424
ESS-1,4259181,0.7076598943715965
HEC-151,49793307,-2.295287882760735
SNU-8,53232,3.6338789299334513
KP-4,6918328,1.3801914149197738
PE/CA-PJ49,ISOX-bortezomib (250-1 mol-mol),0.160457655470904
Kasumi-2,5479543,2.6831620827512004
PaTu 8988s,104842,-0.666004861540946
NCI-H1395,969516,2.7506221381545823
Kasumi-2,BRD9876-MK-1775 (4-1 mol-mol),0.2372012332768771
RERF-LC-A1,9956119,4.832741578954074
SEM,11626927,4.390660689868242
AN3-CA,60700,1.9216907704274913
HARA [Human squamous cell lung carcinoma],1750826,2.2891380116234616
NCI-N87,11647372,-1.5140697510658656
SW1990,44566777,-0.1581198274864337
LoVo,25126798,3.7423562181337338
RERF-LC-Ad2,selumetinib-JQ-1 (4-1 mol-mol),5.304471125852225
CML-T1,135411,-2.1332231058037796
MM1.S,24797083,1.1984729512209644
AU565,3025944,3.700689922668097
CML-T1,969516,2.44416602520126
Kasumi-2,5566,3.0024962406609874
Hs 683,71466578,5.36710853249766
BT 248,2949965,2.620236046838219
LoVo,25062766,1.8850615394111836
OAW28,6918837,-3.92509053266304
H-STS,44462760,2.174167118730489
NCI-H2110,1474550,4.464144178106605
BT 248,135421197,1.5349499708791383
SNU-8,73707386,4.786793714978147
YKG-1,17755052,1.8826754774817915
BFTC-909,5281672,4.401358042981416
